Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-05-09
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| A1BG | -0.0165798 |
| A1BG-AS1 | 0.0839094 |
| A1CF | -0.0195474 |
| A2M | -0.0367321 |
| A2M-AS1 | -0.0528997 |
| A2ML1 | 0.0317153 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 21942 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 17453 |
| num_profile_genes_not_in_sets | 4489 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 3186 |
| num_genesets_included | 7275 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 6 | 2.04e-04 | -0.876 | 0.02290 |
| GOMF FATTY ACYL COA SYNTHASE ACTIVITY | 6 | 3.18e-04 | 0.849 | 0.02930 |
| GOMF IGE BINDING | 5 | 1.10e-03 | 0.843 | 0.06380 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 6 | 6.17e-04 | 0.807 | 0.04510 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 1.78e-03 | -0.807 | 0.08370 |
| GOBP MEDIUM CHAIN FATTY ACID CATABOLIC PROCESS | 5 | 4.08e-03 | 0.742 | 0.13500 |
| GOBP CYTOLYSIS BY HOST OF SYMBIONT CELLS | 6 | 1.79e-03 | -0.736 | 0.08370 |
| GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT | 5 | 4.81e-03 | 0.728 | 0.14700 |
| GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY | 8 | 4.79e-04 | 0.713 | 0.03890 |
| GOBP LOBAR BRONCHUS DEVELOPMENT | 6 | 2.69e-03 | 0.707 | 0.10600 |
| GOCC CLATHRIN COMPLEX | 6 | 2.75e-03 | 0.706 | 0.10700 |
| GOBP TRACHEA CARTILAGE DEVELOPMENT | 7 | 1.77e-03 | 0.682 | 0.08370 |
| GOMF ACETYLESTERASE ACTIVITY | 5 | 8.90e-03 | 0.675 | 0.20300 |
| GOBP SMOOTH MUSCLE ADAPTATION | 5 | 9.00e-03 | 0.674 | 0.20500 |
| GOMF CXCR3 CHEMOKINE RECEPTOR BINDING | 5 | 1.09e-02 | -0.658 | 0.22600 |
| GOBP EXOCYST LOCALIZATION | 5 | 1.11e-02 | 0.655 | 0.22700 |
| GOBP LEUKOTRIENE CATABOLIC PROCESS | 6 | 5.73e-03 | 0.651 | 0.16400 |
| GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY | 5 | 1.19e-02 | 0.649 | 0.23600 |
| GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT | 7 | 3.00e-03 | 0.648 | 0.11400 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 9 | 8.62e-04 | 0.641 | 0.05660 |
| GOMF DIACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 5 | 1.36e-02 | 0.637 | 0.25200 |
| GOBP DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM | 6 | 7.20e-03 | -0.633 | 0.18200 |
| GOCC MUSCLE MYOSIN COMPLEX | 15 | 5.13e-05 | -0.604 | 0.00905 |
| GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY | 5 | 1.96e-02 | 0.603 | 0.30000 |
| GOBP DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 10 | 9.64e-04 | -0.603 | 0.05990 |
| GOBP RESPONSE TO OZONE | 5 | 2.10e-02 | 0.596 | 0.31200 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 7 | 6.72e-03 | 0.592 | 0.17900 |
| GOMF TRAIL BINDING | 5 | 2.29e-02 | 0.587 | 0.32300 |
| GOBP INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX | 7 | 7.11e-03 | -0.587 | 0.18100 |
| GOMF PHOSPHOLIPASE A2 INHIBITOR ACTIVITY | 6 | 1.31e-02 | 0.585 | 0.25000 |
| GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 6 | 1.32e-02 | 0.584 | 0.25000 |
| GOBP REGULATION OF GUANYLATE CYCLASE ACTIVITY | 6 | 1.34e-02 | 0.583 | 0.25100 |
| GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS | 5 | 2.46e-02 | 0.580 | 0.33300 |
| GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS | 8 | 4.66e-03 | 0.578 | 0.14500 |
| GOMF BUTYRATE COA LIGASE ACTIVITY | 8 | 4.78e-03 | 0.576 | 0.14600 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 14 | 1.95e-04 | 0.575 | 0.02220 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 2.86e-02 | 0.565 | 0.35900 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 1.67e-02 | 0.564 | 0.27500 |
| GOMF 2 ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 6 | 1.69e-02 | 0.563 | 0.27700 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 5 | 2.94e-02 | 0.562 | 0.36500 |
| GOBP REGULATION OF MUCUS SECRETION | 8 | 5.89e-03 | 0.562 | 0.16700 |
| GOBP COMPARTMENT PATTERN SPECIFICATION | 5 | 2.98e-02 | 0.561 | 0.36800 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 11 | 1.29e-03 | 0.560 | 0.07020 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 1.88e-02 | -0.554 | 0.29500 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 8 | 6.72e-03 | 0.553 | 0.17900 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.94e-02 | 0.551 | 0.29900 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 12 | 9.60e-04 | 0.550 | 0.05990 |
| GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT | 6 | 1.98e-02 | -0.549 | 0.30100 |
| GOBP SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 5 | 3.34e-02 | 0.549 | 0.38800 |
| GOCC OTHER ORGANISM PART | 5 | 3.43e-02 | -0.547 | 0.39200 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 6 | 2.04e-04 | -8.76e-01 | 2.29e-02 |
| GOMF FATTY ACYL COA SYNTHASE ACTIVITY | 6 | 3.18e-04 | 8.49e-01 | 2.93e-02 |
| GOMF IGE BINDING | 5 | 1.10e-03 | 8.43e-01 | 6.38e-02 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 6 | 6.17e-04 | 8.07e-01 | 4.51e-02 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 1.78e-03 | -8.07e-01 | 8.37e-02 |
| GOBP MEDIUM CHAIN FATTY ACID CATABOLIC PROCESS | 5 | 4.08e-03 | 7.42e-01 | 1.35e-01 |
| GOBP CYTOLYSIS BY HOST OF SYMBIONT CELLS | 6 | 1.79e-03 | -7.36e-01 | 8.37e-02 |
| GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT | 5 | 4.81e-03 | 7.28e-01 | 1.47e-01 |
| GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY | 8 | 4.79e-04 | 7.13e-01 | 3.89e-02 |
| GOBP LOBAR BRONCHUS DEVELOPMENT | 6 | 2.69e-03 | 7.07e-01 | 1.06e-01 |
| GOCC CLATHRIN COMPLEX | 6 | 2.75e-03 | 7.06e-01 | 1.07e-01 |
| GOBP TRACHEA CARTILAGE DEVELOPMENT | 7 | 1.77e-03 | 6.82e-01 | 8.37e-02 |
| GOMF ACETYLESTERASE ACTIVITY | 5 | 8.90e-03 | 6.75e-01 | 2.03e-01 |
| GOBP SMOOTH MUSCLE ADAPTATION | 5 | 9.00e-03 | 6.74e-01 | 2.05e-01 |
| GOMF CXCR3 CHEMOKINE RECEPTOR BINDING | 5 | 1.09e-02 | -6.58e-01 | 2.26e-01 |
| GOBP EXOCYST LOCALIZATION | 5 | 1.11e-02 | 6.55e-01 | 2.27e-01 |
| GOBP LEUKOTRIENE CATABOLIC PROCESS | 6 | 5.73e-03 | 6.51e-01 | 1.64e-01 |
| GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY | 5 | 1.19e-02 | 6.49e-01 | 2.36e-01 |
| GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT | 7 | 3.00e-03 | 6.48e-01 | 1.14e-01 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 9 | 8.62e-04 | 6.41e-01 | 5.66e-02 |
| GOMF DIACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 5 | 1.36e-02 | 6.37e-01 | 2.52e-01 |
| GOBP DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM | 6 | 7.20e-03 | -6.33e-01 | 1.82e-01 |
| GOCC MUSCLE MYOSIN COMPLEX | 15 | 5.13e-05 | -6.04e-01 | 9.05e-03 |
| GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY | 5 | 1.96e-02 | 6.03e-01 | 3.00e-01 |
| GOBP DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 10 | 9.64e-04 | -6.03e-01 | 5.99e-02 |
| GOBP RESPONSE TO OZONE | 5 | 2.10e-02 | 5.96e-01 | 3.12e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 7 | 6.72e-03 | 5.92e-01 | 1.79e-01 |
| GOMF TRAIL BINDING | 5 | 2.29e-02 | 5.87e-01 | 3.23e-01 |
| GOBP INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX | 7 | 7.11e-03 | -5.87e-01 | 1.81e-01 |
| GOMF PHOSPHOLIPASE A2 INHIBITOR ACTIVITY | 6 | 1.31e-02 | 5.85e-01 | 2.50e-01 |
| GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 6 | 1.32e-02 | 5.84e-01 | 2.50e-01 |
| GOBP REGULATION OF GUANYLATE CYCLASE ACTIVITY | 6 | 1.34e-02 | 5.83e-01 | 2.51e-01 |
| GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS | 5 | 2.46e-02 | 5.80e-01 | 3.33e-01 |
| GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS | 8 | 4.66e-03 | 5.78e-01 | 1.45e-01 |
| GOMF BUTYRATE COA LIGASE ACTIVITY | 8 | 4.78e-03 | 5.76e-01 | 1.46e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 14 | 1.95e-04 | 5.75e-01 | 2.22e-02 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 2.86e-02 | 5.65e-01 | 3.59e-01 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 1.67e-02 | 5.64e-01 | 2.75e-01 |
| GOMF 2 ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 6 | 1.69e-02 | 5.63e-01 | 2.77e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 5 | 2.94e-02 | 5.62e-01 | 3.65e-01 |
| GOBP REGULATION OF MUCUS SECRETION | 8 | 5.89e-03 | 5.62e-01 | 1.67e-01 |
| GOBP COMPARTMENT PATTERN SPECIFICATION | 5 | 2.98e-02 | 5.61e-01 | 3.68e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 11 | 1.29e-03 | 5.60e-01 | 7.02e-02 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 1.88e-02 | -5.54e-01 | 2.95e-01 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 8 | 6.72e-03 | 5.53e-01 | 1.79e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.94e-02 | 5.51e-01 | 2.99e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 12 | 9.60e-04 | 5.50e-01 | 5.99e-02 |
| GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT | 6 | 1.98e-02 | -5.49e-01 | 3.01e-01 |
| GOBP SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 5 | 3.34e-02 | 5.49e-01 | 3.88e-01 |
| GOCC OTHER ORGANISM PART | 5 | 3.43e-02 | -5.47e-01 | 3.92e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 5 | 3.54e-02 | 5.43e-01 | 3.95e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 12 | 1.14e-03 | 5.42e-01 | 6.42e-02 |
| GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY | 6 | 2.15e-02 | 5.42e-01 | 3.16e-01 |
| GOBP PLATELET DEGRANULATION | 7 | 1.33e-02 | 5.40e-01 | 2.51e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 12 | 1.22e-03 | 5.39e-01 | 6.74e-02 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 3.73e-02 | 5.38e-01 | 4.03e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION | 8 | 8.82e-03 | 5.35e-01 | 2.03e-01 |
| GOBP OSMOSENSORY SIGNALING PATHWAY | 5 | 3.86e-02 | 5.34e-01 | 4.08e-01 |
| GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT | 11 | 2.19e-03 | 5.33e-01 | 9.32e-02 |
| GOMF RETINOIC ACID RESPONSIVE ELEMENT BINDING | 6 | 2.37e-02 | 5.33e-01 | 3.28e-01 |
| GOBP ISOPRENOID TRANSPORT | 5 | 4.00e-02 | 5.30e-01 | 4.12e-01 |
| GOBP SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION | 10 | 3.94e-03 | -5.26e-01 | 1.33e-01 |
| GOCC SPERMATOPROTEASOME COMPLEX | 5 | 4.17e-02 | -5.26e-01 | 4.19e-01 |
| GOCC U7 SNRNP | 7 | 1.62e-02 | -5.25e-01 | 2.73e-01 |
| GOMF ALCOHOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.68e-02 | 5.22e-01 | 3.48e-01 |
| GOBP BRONCHUS DEVELOPMENT | 11 | 2.76e-03 | 5.21e-01 | 1.07e-01 |
| GOBP EOSINOPHIL DIFFERENTIATION | 6 | 2.72e-02 | 5.21e-01 | 3.50e-01 |
| GOBP SYNAPTIC TRANSMISSION GLYCINERGIC | 5 | 4.39e-02 | 5.20e-01 | 4.29e-01 |
| GOBP CARDIOLIPIN ACYL CHAIN REMODELING | 5 | 4.43e-02 | 5.19e-01 | 4.32e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 5 | 4.50e-02 | -5.18e-01 | 4.37e-01 |
| GOBP POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 5 | 4.55e-02 | 5.16e-01 | 4.39e-01 |
| GOBP REGULATION OF T CELL COSTIMULATION | 5 | 4.59e-02 | 5.15e-01 | 4.41e-01 |
| GOBP POSITIVE REGULATION OF GONADOTROPIN SECRETION | 7 | 1.85e-02 | 5.14e-01 | 2.93e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 8 | 1.20e-02 | -5.13e-01 | 2.37e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 17 | 2.67e-04 | 5.11e-01 | 2.65e-02 |
| GOBP RESPONSE TO L ASCORBIC ACID | 6 | 3.04e-02 | 5.10e-01 | 3.71e-01 |
| GOBP POSITIVE REGULATION OF MUCUS SECRETION | 5 | 4.82e-02 | 5.10e-01 | 4.52e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 8 | 1.25e-02 | 5.10e-01 | 2.43e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 6 | 3.10e-02 | 5.09e-01 | 3.76e-01 |
| GOBP LIPID HYDROXYLATION | 7 | 1.99e-02 | -5.08e-01 | 3.01e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 9 | 8.50e-03 | 5.07e-01 | 1.99e-01 |
| GOBP RENAL WATER ABSORPTION | 6 | 3.17e-02 | 5.06e-01 | 3.80e-01 |
| GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION | 8 | 1.32e-02 | 5.06e-01 | 2.50e-01 |
| GOBP POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 5.03e-02 | 5.05e-01 | 4.60e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 6 | 3.24e-02 | 5.04e-01 | 3.84e-01 |
| GOBP NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 5 | 5.12e-02 | 5.04e-01 | 4.64e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 11 | 3.86e-03 | 5.03e-01 | 1.31e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 3.30e-02 | -5.03e-01 | 3.87e-01 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 5.17e-02 | 5.02e-01 | 4.67e-01 |
| GOBP TYROSINE CATABOLIC PROCESS | 6 | 3.36e-02 | 5.01e-01 | 3.88e-01 |
| GOBP NEURAL FOLD FORMATION | 7 | 2.18e-02 | -5.01e-01 | 3.18e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 5 | 5.27e-02 | -5.00e-01 | 4.73e-01 |
| GOBP STEM CELL FATE SPECIFICATION | 6 | 3.45e-02 | 4.98e-01 | 3.93e-01 |
| GOBP CEREBRAL CORTEX TANGENTIAL MIGRATION | 5 | 5.36e-02 | -4.98e-01 | 4.76e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 6 | 3.47e-02 | -4.98e-01 | 3.93e-01 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 5.46e-02 | 4.96e-01 | 4.78e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 5.51e-02 | -4.95e-01 | 4.80e-01 |
| GOBP NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE | 7 | 2.33e-02 | 4.95e-01 | 3.26e-01 |
| GOMF CCR6 CHEMOKINE RECEPTOR BINDING | 5 | 5.53e-02 | 4.95e-01 | 4.80e-01 |
| GOBP POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY | 5 | 5.57e-02 | 4.94e-01 | 4.80e-01 |
| GOCC GATOR2 COMPLEX | 5 | 5.57e-02 | -4.94e-01 | 4.80e-01 |
| GOCC SERINE PROTEASE INHIBITOR COMPLEX | 6 | 3.63e-02 | 4.94e-01 | 3.97e-01 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 12 | 3.13e-03 | 4.92e-01 | 1.17e-01 |
| GOMF ARGININE BINDING | 8 | 1.59e-02 | 4.92e-01 | 2.72e-01 |
| GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS | 7 | 2.42e-02 | 4.92e-01 | 3.32e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 10 | 7.21e-03 | 4.91e-01 | 1.82e-01 |
| GOBP SPERM MITOCHONDRIAL SHEATH ASSEMBLY | 6 | 3.75e-02 | -4.90e-01 | 4.04e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 10 | 7.27e-03 | 4.90e-01 | 1.82e-01 |
| GOBP RIBOFLAVIN METABOLIC PROCESS | 5 | 5.84e-02 | 4.89e-01 | 4.88e-01 |
| GOCC MULTIVESICULAR BODY LUMEN | 6 | 3.85e-02 | 4.88e-01 | 4.08e-01 |
| GOBP T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 5 | 5.93e-02 | 4.87e-01 | 4.93e-01 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 6 | 3.89e-02 | 4.87e-01 | 4.08e-01 |
| GOCC MPP7 DLG1 LIN7 COMPLEX | 5 | 5.95e-02 | 4.87e-01 | 4.93e-01 |
| GOBP PROTEIN C LINKED GLYCOSYLATION | 5 | 5.98e-02 | 4.86e-01 | 4.93e-01 |
| GOMF ALKALINE PHOSPHATASE ACTIVITY | 6 | 3.94e-02 | 4.86e-01 | 4.11e-01 |
| GOMF ACETYLCHOLINE RECEPTOR INHIBITOR ACTIVITY | 6 | 3.95e-02 | 4.85e-01 | 4.12e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 7 | 2.65e-02 | -4.84e-01 | 3.47e-01 |
| GOCC CBM COMPLEX | 5 | 6.09e-02 | 4.84e-01 | 4.95e-01 |
| GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY | 7 | 2.67e-02 | 4.84e-01 | 3.47e-01 |
| GOBP FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY | 5 | 6.17e-02 | 4.82e-01 | 4.98e-01 |
| GOBP ELASTIN CATABOLIC PROCESS | 5 | 6.20e-02 | -4.82e-01 | 4.99e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 7 | 2.79e-02 | 4.80e-01 | 3.54e-01 |
| GOBP REGULATION OF CD40 SIGNALING PATHWAY | 6 | 4.22e-02 | -4.79e-01 | 4.22e-01 |
| GOBP RESPONSE TO CGMP | 8 | 1.90e-02 | 4.79e-01 | 2.97e-01 |
| GOBP COBALAMIN TRANSPORT | 8 | 1.92e-02 | 4.78e-01 | 2.99e-01 |
| GOBP CELLULAR RESPONSE TO TEMPERATURE STIMULUS | 5 | 6.52e-02 | 4.76e-01 | 5.12e-01 |
| GOBP PANCREATIC JUICE SECRETION | 11 | 6.39e-03 | 4.75e-01 | 1.74e-01 |
| GOBP ER TO GOLGI CERAMIDE TRANSPORT | 5 | 6.67e-02 | 4.74e-01 | 5.18e-01 |
| GOMF CORTICOTROPIN RELEASING HORMONE RECEPTOR BINDING | 5 | 6.72e-02 | 4.73e-01 | 5.20e-01 |
| GOMF FATTY ACID LIGASE ACTIVITY | 20 | 2.54e-04 | 4.72e-01 | 2.60e-02 |
| GOCC FC RECEPTOR COMPLEX | 5 | 6.74e-02 | 4.72e-01 | 5.21e-01 |
| GOBP ARTICULAR CARTILAGE DEVELOPMENT | 5 | 6.80e-02 | -4.71e-01 | 5.21e-01 |
| GOBP NUCLEAR MIGRATION ALONG MICROTUBULE | 5 | 6.82e-02 | -4.71e-01 | 5.21e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 13 | 3.30e-03 | 4.71e-01 | 1.20e-01 |
| GOCC PROTEASE INHIBITOR COMPLEX | 8 | 2.13e-02 | 4.70e-01 | 3.14e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 4.66e-02 | -4.69e-01 | 4.44e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 12 | 4.91e-03 | 4.69e-01 | 1.48e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB | 5 | 7.06e-02 | -4.67e-01 | 5.28e-01 |
| GOMF LIPID ANTIGEN BINDING | 5 | 7.06e-02 | -4.67e-01 | 5.28e-01 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 10 | 1.07e-02 | -4.66e-01 | 2.24e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 9 | 1.56e-02 | 4.65e-01 | 2.68e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 8 | 2.28e-02 | -4.65e-01 | 3.23e-01 |
| GOBP CHOLINE METABOLIC PROCESS | 6 | 4.89e-02 | -4.64e-01 | 4.54e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 14 | 2.65e-03 | 4.64e-01 | 1.05e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 2.31e-02 | 4.64e-01 | 3.24e-01 |
| GOBP EPOXIDE METABOLIC PROCESS | 5 | 7.30e-02 | 4.63e-01 | 5.36e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 7 | 3.40e-02 | 4.63e-01 | 3.90e-01 |
| GOBP METANEPHRIC LOOP OF HENLE DEVELOPMENT | 6 | 5.02e-02 | 4.62e-01 | 4.60e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 7 | 3.49e-02 | 4.60e-01 | 3.94e-01 |
| GOCC CYTOSKELETON OF PRESYNAPTIC ACTIVE ZONE | 8 | 2.44e-02 | -4.60e-01 | 3.32e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE | 5 | 7.54e-02 | 4.59e-01 | 5.44e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 5 | 7.55e-02 | 4.59e-01 | 5.44e-01 |
| GOMF BETA 2 ADRENERGIC RECEPTOR BINDING | 6 | 5.17e-02 | 4.59e-01 | 4.67e-01 |
| GOBP OLFACTORY NERVE DEVELOPMENT | 6 | 5.20e-02 | 4.58e-01 | 4.68e-01 |
| GOBP CELLULAR RESPONSE TO CGMP | 7 | 3.60e-02 | 4.58e-01 | 3.97e-01 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 5.32e-02 | -4.56e-01 | 4.75e-01 |
| GOBP UTP METABOLIC PROCESS | 12 | 6.32e-03 | 4.55e-01 | 1.73e-01 |
| GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 7 | 3.75e-02 | 4.54e-01 | 4.04e-01 |
| GOBP CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY | 8 | 2.63e-02 | -4.54e-01 | 3.46e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 18 | 8.74e-04 | 4.53e-01 | 5.66e-02 |
| GOBP RESPONSE TO GRAM POSITIVE BACTERIUM | 5 | 8.01e-02 | 4.52e-01 | 5.55e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 6 | 5.53e-02 | 4.52e-01 | 4.80e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 8 | 2.75e-02 | 4.50e-01 | 3.52e-01 |
| GOBP CHORIONIC TROPHOBLAST CELL PROLIFERATION | 5 | 8.15e-02 | -4.50e-01 | 5.59e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 6 | 5.64e-02 | 4.50e-01 | 4.82e-01 |
| GOBP REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 5 | 8.17e-02 | -4.50e-01 | 5.59e-01 |
| GOBP NEUTROPHIL MEDIATED KILLING OF GRAM NEGATIVE BACTERIUM | 6 | 5.65e-02 | 4.50e-01 | 4.82e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 9 | 1.98e-02 | 4.48e-01 | 3.01e-01 |
| GOMF EXTRACELLULAR MATRIX PROTEIN BINDING | 6 | 5.76e-02 | -4.48e-01 | 4.85e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 6 | 5.76e-02 | 4.48e-01 | 4.85e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 7 | 4.04e-02 | 4.47e-01 | 4.14e-01 |
| GOCC B CELL RECEPTOR COMPLEX | 5 | 8.38e-02 | 4.46e-01 | 5.66e-01 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 6 | 5.88e-02 | 4.46e-01 | 4.89e-01 |
| GOBP DELAMINATION | 7 | 4.16e-02 | 4.45e-01 | 4.19e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.96e-02 | 4.44e-01 | 3.66e-01 |
| GOBP NEGATIVE REGULATION OF CGMP MEDIATED SIGNALING | 6 | 5.96e-02 | -4.44e-01 | 4.93e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 6 | 5.97e-02 | 4.44e-01 | 4.93e-01 |
| GOBP C 5 METHYLATION OF CYTOSINE | 5 | 8.68e-02 | 4.42e-01 | 5.72e-01 |
| GOBP POSITIVE REGULATION OF ODONTOGENESIS | 7 | 4.28e-02 | 4.42e-01 | 4.24e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 6.08e-02 | -4.42e-01 | 4.95e-01 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 9 | 2.17e-02 | 4.42e-01 | 3.17e-01 |
| GOBP POSITIVE REGULATION OF DNA CATABOLIC PROCESS | 5 | 8.76e-02 | -4.41e-01 | 5.74e-01 |
| GOMF DOUBLE STRANDED RNA ADENOSINE DEAMINASE ACTIVITY | 6 | 6.23e-02 | 4.40e-01 | 5.01e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 8.91e-02 | 4.39e-01 | 5.77e-01 |
| GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 6 | 6.39e-02 | -4.37e-01 | 5.07e-01 |
| GOMF LACTATE DEHYDROGENASE ACTIVITY | 6 | 6.39e-02 | 4.37e-01 | 5.07e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 9 | 2.34e-02 | 4.36e-01 | 3.26e-01 |
| GOMF ESTROGEN 16 ALPHA HYDROXYLASE ACTIVITY | 8 | 3.27e-02 | -4.36e-01 | 3.86e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 6.49e-02 | 4.35e-01 | 5.11e-01 |
| GOBP REGULATION OF GASTRIC ACID SECRETION | 6 | 6.52e-02 | 4.35e-01 | 5.12e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 6.52e-02 | 4.35e-01 | 5.12e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 9.26e-02 | 4.34e-01 | 5.84e-01 |
| GOBP THREONINE METABOLIC PROCESS | 5 | 9.31e-02 | -4.34e-01 | 5.86e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 19 | 1.07e-03 | 4.33e-01 | 6.38e-02 |
| GOCC NETWORK FORMING COLLAGEN TRIMER | 6 | 6.61e-02 | -4.33e-01 | 5.15e-01 |
| GOBP PROTEIN LIPOYLATION | 5 | 9.44e-02 | -4.32e-01 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 13 | 7.00e-03 | 4.32e-01 | 1.80e-01 |
| GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 12 | 9.60e-03 | 4.32e-01 | 2.11e-01 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 11 | 1.33e-02 | 4.31e-01 | 2.51e-01 |
| GOBP RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 6 | 6.82e-02 | -4.30e-01 | 5.21e-01 |
| GOBP PERICYTE CELL DIFFERENTIATION | 11 | 1.36e-02 | 4.30e-01 | 2.52e-01 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 7 | 4.91e-02 | 4.29e-01 | 4.55e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 6 | 6.87e-02 | 4.29e-01 | 5.23e-01 |
| GOBP PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN | 16 | 3.05e-03 | -4.28e-01 | 1.15e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 1.92e-02 | 4.28e-01 | 2.99e-01 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 5 | 9.83e-02 | -4.27e-01 | 5.95e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 15 | 4.21e-03 | 4.27e-01 | 1.36e-01 |
| GOBP D AMINO ACID TRANSPORT | 6 | 7.04e-02 | 4.26e-01 | 5.28e-01 |
| GOCC BRISC COMPLEX | 5 | 9.86e-02 | 4.26e-01 | 5.95e-01 |
| GOMF TRACE AMINE RECEPTOR ACTIVITY | 7 | 5.11e-02 | -4.26e-01 | 4.64e-01 |
| GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING | 6 | 7.13e-02 | 4.25e-01 | 5.32e-01 |
| GOBP RESPONSE TO CORTICOTROPIN RELEASING HORMONE | 5 | 9.97e-02 | 4.25e-01 | 5.95e-01 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 7 | 5.16e-02 | 4.25e-01 | 4.67e-01 |
| GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY | 7 | 5.16e-02 | -4.25e-01 | 4.67e-01 |
| GOBP REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR | 9 | 2.78e-02 | -4.24e-01 | 3.53e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 12 | 1.12e-02 | 4.23e-01 | 2.27e-01 |
| GOBP POSITIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 7.29e-02 | 4.23e-01 | 5.36e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 32 | 3.52e-05 | 4.22e-01 | 7.24e-03 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 18 | 1.93e-03 | -4.22e-01 | 8.77e-02 |
| GOCC INNER ACROSOMAL MEMBRANE | 5 | 1.02e-01 | 4.22e-01 | 5.97e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 7 | 5.46e-02 | 4.20e-01 | 4.78e-01 |
| GOBP CARDIAC MUSCLE TISSUE REGENERATION | 8 | 4.00e-02 | -4.19e-01 | 4.12e-01 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 1.05e-01 | -4.19e-01 | 5.99e-01 |
| GOBP VITAMIN A METABOLIC PROCESS | 8 | 4.08e-02 | -4.18e-01 | 4.16e-01 |
| GOCC LATE ENDOSOME LUMEN | 8 | 4.08e-02 | 4.18e-01 | 4.16e-01 |
| GOBP D ASPARTATE IMPORT ACROSS PLASMA MEMBRANE | 5 | 1.06e-01 | 4.17e-01 | 6.02e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 5 | 1.06e-01 | 4.17e-01 | 6.02e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION | 6 | 7.69e-02 | 4.17e-01 | 5.48e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 15 | 5.22e-03 | 4.16e-01 | 1.56e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 6 | 7.75e-02 | 4.16e-01 | 5.49e-01 |
| GOMF NERVE GROWTH FACTOR BINDING | 6 | 7.77e-02 | 4.16e-01 | 5.49e-01 |
| GOBP CYTOPLASM ORGANIZATION | 15 | 5.37e-03 | 4.15e-01 | 1.60e-01 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 8 | 4.29e-02 | -4.13e-01 | 4.24e-01 |
| GOBP MOTOR LEARNING | 7 | 5.88e-02 | 4.13e-01 | 4.89e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 10 | 2.40e-02 | 4.12e-01 | 3.31e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 1.11e-01 | 4.12e-01 | 6.14e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 8.07e-02 | 4.12e-01 | 5.57e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CARDIAC CONDUCTION ELECTRICAL COUPLING | 5 | 1.11e-01 | 4.11e-01 | 6.15e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 10 | 2.43e-02 | 4.11e-01 | 3.32e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 7 | 6.00e-02 | 4.10e-01 | 4.94e-01 |
| GOBP POSITIVE REGULATION OF IMMATURE T CELL PROLIFERATION | 5 | 1.12e-01 | 4.10e-01 | 6.17e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 8 | 4.45e-02 | -4.10e-01 | 4.33e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 7 | 6.02e-02 | 4.10e-01 | 4.94e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 14 | 7.91e-03 | 4.10e-01 | 1.91e-01 |
| GOMF EPINEPHRINE BINDING | 6 | 8.21e-02 | 4.10e-01 | 5.60e-01 |
| GOBP REGULATION OF ODONTOGENESIS | 18 | 2.61e-03 | 4.10e-01 | 1.04e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR PH REDUCTION | 5 | 1.13e-01 | -4.09e-01 | 6.21e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 8.14e-03 | 4.08e-01 | 1.94e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 8 | 4.55e-02 | -4.08e-01 | 4.39e-01 |
| GOBP LEUKOTRIENE B4 METABOLIC PROCESS | 5 | 1.14e-01 | 4.08e-01 | 6.22e-01 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 12 | 1.44e-02 | 4.08e-01 | 2.58e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 9 | 3.43e-02 | 4.07e-01 | 3.92e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 11 | 1.94e-02 | 4.07e-01 | 2.99e-01 |
| GOCC FACIT COLLAGEN TRIMER | 6 | 8.46e-02 | -4.07e-01 | 5.68e-01 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 12 | 1.48e-02 | 4.06e-01 | 2.61e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 13 | 1.13e-02 | 4.06e-01 | 2.28e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIA COMPLEX | 5 | 1.17e-01 | 4.05e-01 | 6.28e-01 |
| GOBP MESENDODERM DEVELOPMENT | 9 | 3.57e-02 | -4.04e-01 | 3.96e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 10 | 2.73e-02 | 4.03e-01 | 3.50e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 17 | 4.04e-03 | 4.03e-01 | 1.34e-01 |
| GOBP TYPE II PNEUMOCYTE DIFFERENTIATION | 6 | 8.80e-02 | -4.02e-01 | 5.75e-01 |
| GOCC ALVEOLAR LAMELLAR BODY | 7 | 6.53e-02 | 4.02e-01 | 5.12e-01 |
| GOBP NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 5 | 1.19e-01 | 4.02e-01 | 6.30e-01 |
| GOCC SEROTONIN ACTIVATED CATION SELECTIVE CHANNEL COMPLEX | 5 | 1.19e-01 | -4.02e-01 | 6.30e-01 |
| GOMF SEROTONIN GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY | 5 | 1.19e-01 | -4.02e-01 | 6.30e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 5 | 1.20e-01 | 4.02e-01 | 6.30e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION | 5 | 1.20e-01 | 4.02e-01 | 6.30e-01 |
| GOBP CELLULAR RESPONSE TO UV A | 10 | 2.78e-02 | -4.02e-01 | 3.53e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 12 | 1.63e-02 | 4.00e-01 | 2.73e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 5.00e-02 | 4.00e-01 | 4.58e-01 |
| GOBP ICOSANOID CATABOLIC PROCESS | 9 | 3.76e-02 | 4.00e-01 | 4.04e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB | 7 | 6.68e-02 | -4.00e-01 | 5.18e-01 |
| GOMF BITTER TASTE RECEPTOR ACTIVITY | 23 | 9.06e-04 | -4.00e-01 | 5.77e-02 |
| GOBP CYTOLYSIS | 7 | 6.72e-02 | -3.99e-01 | 5.20e-01 |
| GOCC GLYCINERGIC SYNAPSE | 7 | 6.75e-02 | 3.99e-01 | 5.21e-01 |
| GOBP TRNA 3 END PROCESSING | 6 | 9.06e-02 | -3.99e-01 | 5.79e-01 |
| GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY | 5 | 1.23e-01 | -3.98e-01 | 6.38e-01 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 6 | 9.14e-02 | -3.98e-01 | 5.82e-01 |
| GOBP THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION | 6 | 9.16e-02 | 3.98e-01 | 5.82e-01 |
| GOCC SPERM HEAD PLASMA MEMBRANE | 6 | 9.18e-02 | -3.97e-01 | 5.82e-01 |
| GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY | 5 | 1.24e-01 | -3.97e-01 | 6.38e-01 |
| GOBP TOLL SIGNALING PATHWAY | 10 | 2.99e-02 | 3.96e-01 | 3.69e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY | 5 | 1.26e-01 | -3.95e-01 | 6.43e-01 |
| GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY | 7 | 7.03e-02 | 3.95e-01 | 5.28e-01 |
| GOBP NITRIC OXIDE TRANSPORT | 5 | 1.26e-01 | 3.95e-01 | 6.43e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 8 | 5.34e-02 | 3.94e-01 | 4.75e-01 |
| GOCC INTERPHOTORECEPTOR MATRIX | 6 | 9.46e-02 | -3.94e-01 | 5.89e-01 |
| GOMF KETOSTEROID MONOOXYGENASE ACTIVITY | 5 | 1.27e-01 | -3.94e-01 | 6.43e-01 |
| GOBP RENAL WATER TRANSPORT | 9 | 4.09e-02 | 3.94e-01 | 4.16e-01 |
| GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 6 | 9.56e-02 | 3.93e-01 | 5.89e-01 |
| GOBP SPERMIDINE TRANSPORT | 5 | 1.28e-01 | -3.93e-01 | 6.44e-01 |
| GOMF GAP JUNCTION HEMI CHANNEL ACTIVITY | 6 | 9.65e-02 | 3.92e-01 | 5.92e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 18 | 4.00e-03 | 3.92e-01 | 1.33e-01 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 8 | 5.51e-02 | 3.92e-01 | 4.80e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 1.30e-01 | 3.91e-01 | 6.48e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 8 | 5.56e-02 | -3.91e-01 | 4.80e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 9 | 4.26e-02 | 3.90e-01 | 4.24e-01 |
| GOCC SMN COMPLEX | 9 | 4.26e-02 | 3.90e-01 | 4.24e-01 |
| GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY | 7 | 7.41e-02 | 3.90e-01 | 5.41e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 7 | 7.42e-02 | 3.90e-01 | 5.41e-01 |
| GOMF SUMO POLYMER BINDING | 5 | 1.32e-01 | -3.89e-01 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 13 | 1.52e-02 | 3.89e-01 | 2.64e-01 |
| GOCC CEREBELLAR CLIMBING FIBER TO PURKINJE CELL SYNAPSE | 7 | 7.50e-02 | 3.89e-01 | 5.43e-01 |
| GOCC MICROTUBULE BUNDLE | 6 | 9.93e-02 | 3.89e-01 | 5.95e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES | 6 | 9.94e-02 | 3.88e-01 | 5.95e-01 |
| GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY | 7 | 7.53e-02 | 3.88e-01 | 5.44e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 1.33e-01 | -3.88e-01 | 6.51e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 9.97e-02 | 3.88e-01 | 5.95e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 15 | 9.27e-03 | 3.88e-01 | 2.07e-01 |
| GOMF NADPLUS PROTEIN ARGININE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 9.99e-02 | -3.88e-01 | 5.95e-01 |
| GOMF OLFACTORY RECEPTOR ACTIVITY | 337 | 1.52e-34 | -3.88e-01 | 1.55e-30 |
| GOBP MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE | 6 | 1.01e-01 | -3.87e-01 | 5.95e-01 |
| GOBP CARDIAC SEPTUM CELL DIFFERENTIATION | 5 | 1.34e-01 | 3.87e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 5 | 1.35e-01 | -3.86e-01 | 6.53e-01 |
| GOMF BIOTIN BINDING | 5 | 1.35e-01 | 3.86e-01 | 6.53e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 13 | 1.62e-02 | -3.85e-01 | 2.73e-01 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 12 | 2.09e-02 | 3.85e-01 | 3.12e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 5 | 1.36e-01 | 3.85e-01 | 6.55e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 7 | 7.80e-02 | 3.85e-01 | 5.49e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 10 | 3.52e-02 | 3.85e-01 | 3.95e-01 |
| GOBP INTESTINAL HEXOSE ABSORPTION | 5 | 1.37e-01 | -3.84e-01 | 6.57e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 12 | 2.12e-02 | 3.84e-01 | 3.14e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 7 | 7.86e-02 | 3.84e-01 | 5.51e-01 |
| GOCC ROD PHOTORECEPTOR OUTER SEGMENT | 5 | 1.38e-01 | -3.83e-01 | 6.58e-01 |
| GOBP RESPONSE TO MERCURY ION | 10 | 3.59e-02 | 3.83e-01 | 3.97e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 14 | 1.31e-02 | 3.83e-01 | 2.50e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 11 | 2.80e-02 | 3.83e-01 | 3.54e-01 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 6 | 1.05e-01 | 3.83e-01 | 5.99e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 5 | 1.38e-01 | -3.83e-01 | 6.59e-01 |
| GOMF ODORANT BINDING | 100 | 3.80e-11 | -3.82e-01 | 4.86e-08 |
| GOMF 4 GALACTOSYL N ACETYLGLUCOSAMINIDE 3 ALPHA L FUCOSYLTRANSFERASE ACTIVITY | 6 | 1.05e-01 | 3.82e-01 | 5.99e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 4.74e-02 | 3.82e-01 | 4.48e-01 |
| GOBP GOLGI VESICLE FUSION TO TARGET MEMBRANE | 5 | 1.40e-01 | 3.81e-01 | 6.60e-01 |
| GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY | 6 | 1.06e-01 | 3.81e-01 | 6.02e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 24 | 1.22e-03 | 3.81e-01 | 6.74e-02 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 7 | 8.06e-02 | -3.81e-01 | 5.57e-01 |
| GOBP DETECTION OF VIRUS | 6 | 1.06e-01 | 3.81e-01 | 6.02e-01 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 6.26e-02 | -3.80e-01 | 5.02e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 23 | 1.60e-03 | 3.80e-01 | 7.98e-02 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 5 | 1.42e-01 | -3.80e-01 | 6.64e-01 |
| GOBP MACROPINOCYTOSIS | 10 | 3.77e-02 | 3.80e-01 | 4.04e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 6 | 1.08e-01 | -3.79e-01 | 6.05e-01 |
| GOBP ZYMOGEN INHIBITION | 7 | 8.24e-02 | 3.79e-01 | 5.61e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 9 | 4.89e-02 | 3.79e-01 | 4.54e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 5 | 1.42e-01 | 3.79e-01 | 6.65e-01 |
| GOBP INTRACELLULAR WATER HOMEOSTASIS | 6 | 1.08e-01 | 3.79e-01 | 6.06e-01 |
| GOBP MEIOTIC DNA DOUBLE STRAND BREAK FORMATION | 6 | 1.09e-01 | -3.78e-01 | 6.07e-01 |
| GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY | 8 | 6.41e-02 | -3.78e-01 | 5.08e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN | 16 | 8.84e-03 | -3.78e-01 | 2.03e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 7 | 8.35e-02 | 3.78e-01 | 5.65e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 10 | 3.87e-02 | 3.78e-01 | 4.08e-01 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 12 | 2.37e-02 | 3.77e-01 | 3.28e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 10 | 3.89e-02 | 3.77e-01 | 4.08e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 8 | 6.49e-02 | 3.77e-01 | 5.11e-01 |
| GOMF P TYPE POTASSIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.52e-02 | -3.76e-01 | 5.70e-01 |
| GOCC ELASTIC FIBER | 5 | 1.46e-01 | 3.75e-01 | 6.73e-01 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 12 | 2.44e-02 | 3.75e-01 | 3.32e-01 |
| GOCC GINS COMPLEX | 5 | 1.46e-01 | 3.75e-01 | 6.73e-01 |
| GOCC AMINOACYL TRNA SYNTHETASE MULTIENZYME COMPLEX | 10 | 3.99e-02 | -3.75e-01 | 4.12e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 17 | 7.42e-03 | 3.75e-01 | 1.83e-01 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 14 | 1.53e-02 | 3.74e-01 | 2.64e-01 |
| GOBP GASTRIC ACID SECRETION | 13 | 1.97e-02 | 3.73e-01 | 3.01e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 10 | 4.13e-02 | -3.73e-01 | 4.17e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 19 | 4.92e-03 | 3.73e-01 | 1.48e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 1.50e-01 | 3.72e-01 | 6.80e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 9 | 5.34e-02 | 3.72e-01 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 7 | 8.85e-02 | 3.72e-01 | 5.75e-01 |
| GOBP BLOOD COAGULATION INTRINSIC PATHWAY | 6 | 1.16e-01 | 3.71e-01 | 6.25e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 6 | 1.16e-01 | 3.71e-01 | 6.25e-01 |
| GOBP FOLLICLE STIMULATING HORMONE SECRETION | 8 | 6.94e-02 | 3.71e-01 | 5.25e-01 |
| GOBP METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT | 5 | 1.51e-01 | 3.71e-01 | 6.82e-01 |
| GOMF U4 SNRNA BINDING | 6 | 1.16e-01 | 3.70e-01 | 6.26e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 10 | 4.27e-02 | 3.70e-01 | 4.24e-01 |
| GOMF BILE ACID BINDING | 10 | 4.27e-02 | -3.70e-01 | 4.24e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 11 | 3.36e-02 | -3.70e-01 | 3.88e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 12 | 2.66e-02 | 3.70e-01 | 3.47e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 12 | 2.66e-02 | 3.70e-01 | 3.47e-01 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 1.17e-01 | 3.69e-01 | 6.28e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 7 | 9.10e-02 | 3.69e-01 | 5.81e-01 |
| GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 18 | 6.85e-03 | -3.68e-01 | 1.80e-01 |
| GOMF ALCOHOL DEHYDROGENASE ACTIVITY ZINC DEPENDENT | 7 | 9.17e-02 | -3.68e-01 | 5.82e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 12 | 2.74e-02 | 3.68e-01 | 3.51e-01 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 10 | 4.43e-02 | 3.67e-01 | 4.32e-01 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 16 | 1.10e-02 | 3.67e-01 | 2.27e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 6 | 1.19e-01 | 3.67e-01 | 6.30e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 9 | 5.65e-02 | 3.67e-01 | 4.82e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 5.65e-02 | -3.67e-01 | 4.82e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 29 | 6.23e-04 | 3.67e-01 | 4.52e-02 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 9 | 5.69e-02 | 3.67e-01 | 4.83e-01 |
| GOBP CEREBELLAR GRANULAR LAYER FORMATION | 6 | 1.20e-01 | -3.66e-01 | 6.31e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 9 | 5.70e-02 | 3.66e-01 | 4.83e-01 |
| GOBP POLE PLASM ASSEMBLY | 6 | 1.20e-01 | 3.66e-01 | 6.32e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 14 | 1.77e-02 | -3.66e-01 | 2.85e-01 |
| GOBP LATERAL SPROUTING FROM AN EPITHELIUM | 10 | 4.52e-02 | -3.66e-01 | 4.37e-01 |
| GOCC PWP2P CONTAINING SUBCOMPLEX OF 90S PRERIBOSOME | 5 | 1.57e-01 | -3.66e-01 | 6.91e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING | 5 | 1.57e-01 | 3.66e-01 | 6.91e-01 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 1.21e-01 | -3.66e-01 | 6.33e-01 |
| GOBP POSITIVE REGULATION OF COMPLEMENT ACTIVATION | 6 | 1.21e-01 | -3.65e-01 | 6.35e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST PROLIFERATION | 9 | 5.79e-02 | -3.65e-01 | 4.86e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 20 | 4.73e-03 | 3.65e-01 | 1.45e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 1.84e-02 | 3.64e-01 | 2.92e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 9.55e-02 | 3.64e-01 | 5.89e-01 |
| GOCC CALCITONIN FAMILY RECEPTOR COMPLEX | 5 | 1.59e-01 | -3.64e-01 | 6.93e-01 |
| GOBP MITOTIC SPINDLE ELONGATION | 11 | 3.69e-02 | -3.63e-01 | 4.01e-01 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 27 | 1.10e-03 | 3.63e-01 | 6.38e-02 |
| GOBP SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION | 10 | 4.74e-02 | 3.62e-01 | 4.48e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL ACTIVATION | 8 | 7.62e-02 | 3.62e-01 | 5.45e-01 |
| GOBP NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 9 | 6.02e-02 | -3.62e-01 | 4.94e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 11 | 3.78e-02 | -3.62e-01 | 4.05e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 12 | 3.01e-02 | 3.61e-01 | 3.70e-01 |
| GOMF GLUTAMATE SODIUM SYMPORTER ACTIVITY | 5 | 1.62e-01 | 3.61e-01 | 6.95e-01 |
| GOMF HETEROTRIMERIC G PROTEIN BINDING | 5 | 1.62e-01 | -3.61e-01 | 6.95e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 9.83e-02 | 3.61e-01 | 5.95e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 363 | 3.11e-32 | -3.61e-01 | 1.59e-28 |
| GOBP NEGATIVE REGULATION OF SYNAPSE ASSEMBLY | 8 | 7.74e-02 | -3.61e-01 | 5.49e-01 |
| GOBP GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION | 5 | 1.63e-01 | 3.60e-01 | 6.95e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 14 | 1.96e-02 | -3.60e-01 | 3.00e-01 |
| GOMF IGG BINDING | 6 | 1.26e-01 | 3.60e-01 | 6.43e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 9.89e-02 | -3.60e-01 | 5.95e-01 |
| GOBP ACINAR CELL DIFFERENTIATION | 5 | 1.64e-01 | -3.59e-01 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE | 6 | 1.27e-01 | 3.59e-01 | 6.43e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 6 | 1.28e-01 | -3.59e-01 | 6.43e-01 |
| GOMF TELOMERASE ACTIVITY | 6 | 1.28e-01 | -3.59e-01 | 6.43e-01 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 7 | 1.00e-01 | 3.59e-01 | 5.95e-01 |
| GOCC COMMITMENT COMPLEX | 5 | 1.65e-01 | 3.59e-01 | 6.97e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 22 | 3.57e-03 | 3.59e-01 | 1.26e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 9 | 6.24e-02 | 3.59e-01 | 5.01e-01 |
| GOBP DISTAL CONVOLUTED TUBULE DEVELOPMENT | 5 | 1.65e-01 | 3.59e-01 | 6.97e-01 |
| GOMF RAGE RECEPTOR BINDING | 10 | 4.95e-02 | 3.59e-01 | 4.57e-01 |
| GOBP OOCYTE CONSTRUCTION | 8 | 7.90e-02 | 3.59e-01 | 5.52e-01 |
| GOBP FLAVIN CONTAINING COMPOUND METABOLIC PROCESS | 6 | 1.28e-01 | 3.58e-01 | 6.45e-01 |
| GOCC INNER DYNEIN ARM | 5 | 1.66e-01 | 3.57e-01 | 7.00e-01 |
| GOBP ACTIN MYOSIN FILAMENT SLIDING | 16 | 1.34e-02 | -3.57e-01 | 2.52e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 7 | 1.02e-01 | -3.57e-01 | 5.97e-01 |
| GOBP REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 5 | 1.67e-01 | 3.57e-01 | 7.00e-01 |
| GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT | 7 | 1.03e-01 | -3.56e-01 | 5.97e-01 |
| GOMF ALKANE 1 MONOOXYGENASE ACTIVITY | 5 | 1.68e-01 | 3.56e-01 | 7.00e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 1.69e-01 | -3.56e-01 | 7.01e-01 |
| GOBP NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 6 | 1.32e-01 | 3.56e-01 | 6.51e-01 |
| GOBP IMMATURE T CELL PROLIFERATION | 12 | 3.30e-02 | 3.56e-01 | 3.87e-01 |
| GOCC CHROMOSOME CENTROMERIC CORE DOMAIN | 17 | 1.12e-02 | -3.55e-01 | 2.27e-01 |
| GOBP CARDIAC CHAMBER FORMATION | 12 | 3.31e-02 | 3.55e-01 | 3.87e-01 |
| GOBP GLYCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 1.69e-01 | 3.55e-01 | 7.01e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 13 | 2.67e-02 | 3.55e-01 | 3.47e-01 |
| GOCC RNA CAP BINDING COMPLEX | 19 | 7.39e-03 | 3.55e-01 | 1.83e-01 |
| GOBP VITAMIN B6 METABOLIC PROCESS | 5 | 1.70e-01 | 3.55e-01 | 7.03e-01 |
| GOMF AMINOACYLASE ACTIVITY | 6 | 1.33e-01 | -3.54e-01 | 6.51e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 7 | 1.05e-01 | 3.54e-01 | 5.99e-01 |
| GOBP REGULATION OF OOCYTE MATURATION | 7 | 1.05e-01 | 3.54e-01 | 5.99e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 24 | 2.70e-03 | 3.54e-01 | 1.06e-01 |
| GOBP RESPONSE TO UV A | 13 | 2.72e-02 | -3.54e-01 | 3.50e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 6 | 1.34e-01 | 3.53e-01 | 6.53e-01 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 1.71e-01 | 3.53e-01 | 7.04e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 10 | 5.30e-02 | 3.53e-01 | 4.74e-01 |
| GOMF FIBRINOGEN BINDING | 5 | 1.71e-01 | -3.53e-01 | 7.04e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM AXON REGENERATION | 8 | 8.37e-02 | -3.53e-01 | 5.66e-01 |
| GOBP GENERAL ADAPTATION SYNDROME BEHAVIORAL PROCESS | 5 | 1.72e-01 | -3.53e-01 | 7.04e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 12 | 3.43e-02 | 3.53e-01 | 3.92e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 12 | 3.45e-02 | -3.53e-01 | 3.93e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 26 | 1.87e-03 | 3.52e-01 | 8.60e-02 |
| GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY | 5 | 1.73e-01 | 3.52e-01 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 11 | 4.32e-02 | -3.52e-01 | 4.25e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 6 | 1.36e-01 | -3.52e-01 | 6.54e-01 |
| GOBP TRUNK SEGMENTATION | 5 | 1.73e-01 | 3.52e-01 | 7.05e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 8 | 8.51e-02 | 3.52e-01 | 5.69e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 17 | 1.21e-02 | -3.51e-01 | 2.38e-01 |
| GOCC SMAD PROTEIN COMPLEX | 9 | 6.81e-02 | 3.51e-01 | 5.21e-01 |
| GOMF LAMININ 1 BINDING | 7 | 1.08e-01 | -3.51e-01 | 6.05e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 16 | 1.51e-02 | 3.51e-01 | 2.63e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 6 | 1.37e-01 | 3.51e-01 | 6.57e-01 |
| GOMF L LACTATE DEHYDROGENASE ACTIVITY | 5 | 1.75e-01 | 3.51e-01 | 7.05e-01 |
| GOBP REGULATION OF SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 6 | 1.37e-01 | 3.51e-01 | 6.58e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION | 8 | 8.62e-02 | 3.50e-01 | 5.71e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 10 | 5.52e-02 | 3.50e-01 | 4.80e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 13 | 2.88e-02 | -3.50e-01 | 3.61e-01 |
| GOCC MEMBRANE ATTACK COMPLEX | 7 | 1.09e-01 | -3.49e-01 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN | 5 | 1.77e-01 | -3.49e-01 | 7.09e-01 |
| GOBP L ALANINE TRANSPORT | 10 | 5.61e-02 | -3.49e-01 | 4.82e-01 |
| GOCC CIA COMPLEX | 5 | 1.77e-01 | 3.49e-01 | 7.09e-01 |
| GOBP SPINDLE ELONGATION | 13 | 2.96e-02 | -3.48e-01 | 3.66e-01 |
| GOBP RETINAL PIGMENT EPITHELIUM DEVELOPMENT | 6 | 1.40e-01 | -3.48e-01 | 6.61e-01 |
| GOBP ERK5 CASCADE | 5 | 1.78e-01 | -3.48e-01 | 7.11e-01 |
| GOBP ASPARTATE METABOLIC PROCESS | 8 | 8.88e-02 | -3.47e-01 | 5.76e-01 |
| GOMF COMPLEMENT COMPONENT C3B BINDING | 9 | 7.14e-02 | -3.47e-01 | 5.32e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 1.12e-01 | 3.47e-01 | 6.17e-01 |
| GOBP POSITIVE REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE | 8 | 8.93e-02 | -3.47e-01 | 5.77e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 5 | 1.79e-01 | 3.47e-01 | 7.12e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 9 | 7.18e-02 | -3.47e-01 | 5.34e-01 |
| GOMF STRUCTURAL CONSTITUENT OF PRESYNAPTIC ACTIVE ZONE | 5 | 1.80e-01 | -3.46e-01 | 7.12e-01 |
| GOMF EPOXIDE HYDROLASE ACTIVITY | 6 | 1.42e-01 | 3.46e-01 | 6.65e-01 |
| GOBP LOOP OF HENLE DEVELOPMENT | 12 | 3.79e-02 | 3.46e-01 | 4.05e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 16 | 1.65e-02 | 3.46e-01 | 2.75e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 19 | 9.06e-03 | 3.46e-01 | 2.06e-01 |
| GOMF SODIUM PHOSPHATE SYMPORTER ACTIVITY | 13 | 3.10e-02 | 3.45e-01 | 3.77e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 15 | 2.05e-02 | 3.45e-01 | 3.08e-01 |
| GOBP REGULATION OF LIPID TRANSPORTER ACTIVITY | 6 | 1.43e-01 | 3.45e-01 | 6.68e-01 |
| GOBP REGULATION OF PLASMA CELL DIFFERENTIATION | 5 | 1.81e-01 | 3.45e-01 | 7.14e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 42 | 1.09e-04 | 3.45e-01 | 1.60e-02 |
| GOMF INOSITOL TETRAKISPHOSPHATE KINASE ACTIVITY | 5 | 1.82e-01 | 3.44e-01 | 7.15e-01 |
| GOBP REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE | 6 | 1.44e-01 | -3.44e-01 | 6.69e-01 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 6 | 1.44e-01 | 3.44e-01 | 6.69e-01 |
| GOBP REGULATION OF CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP | 5 | 1.83e-01 | 3.44e-01 | 7.16e-01 |
| GOBP REGULATION OF PROTEIN KINASE C ACTIVITY | 5 | 1.83e-01 | -3.44e-01 | 7.16e-01 |
| GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT | 12 | 3.94e-02 | 3.43e-01 | 4.11e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 16 | 1.74e-02 | -3.43e-01 | 2.82e-01 |
| GOBP CARDIAC VENTRICLE FORMATION | 8 | 9.28e-02 | 3.43e-01 | 5.85e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE | 6 | 1.46e-01 | 3.43e-01 | 6.73e-01 |
| GOCC PHAGOLYSOSOME | 5 | 1.84e-01 | 3.43e-01 | 7.18e-01 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 10 | 6.09e-02 | -3.42e-01 | 4.95e-01 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 11 | 4.95e-02 | 3.42e-01 | 4.57e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 19 | 9.85e-03 | 3.42e-01 | 2.13e-01 |
| GOBP AUTOCRINE SIGNALING | 6 | 1.47e-01 | -3.42e-01 | 6.74e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 19 | 1.00e-02 | 3.41e-01 | 2.14e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 12 | 4.14e-02 | 3.40e-01 | 4.17e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 7 | 1.20e-01 | 3.40e-01 | 6.30e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 5 | 1.88e-01 | 3.40e-01 | 7.24e-01 |
| GOBP AMYLIN RECEPTOR SIGNALING PATHWAY | 6 | 1.50e-01 | -3.39e-01 | 6.80e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 10 | 6.31e-02 | -3.39e-01 | 5.04e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 11 | 5.16e-02 | 3.39e-01 | 4.67e-01 |
| GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 1.90e-01 | 3.38e-01 | 7.24e-01 |
| GOMF MELANOCORTIN RECEPTOR ACTIVITY | 6 | 1.51e-01 | -3.38e-01 | 6.82e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 25 | 3.46e-03 | 3.38e-01 | 1.24e-01 |
| GOCC PRESYNAPTIC CYTOSKELETON | 11 | 5.25e-02 | -3.38e-01 | 4.71e-01 |
| GOBP EXOCRINE PANCREAS DEVELOPMENT | 7 | 1.22e-01 | 3.37e-01 | 6.36e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 21 | 7.43e-03 | 3.37e-01 | 1.83e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 10 | 6.49e-02 | -3.37e-01 | 5.11e-01 |
| GOBP POLY N ACETYLLACTOSAMINE METABOLIC PROCESS | 7 | 1.22e-01 | 3.37e-01 | 6.36e-01 |
| GOMF CLATHRIN LIGHT CHAIN BINDING | 7 | 1.24e-01 | 3.36e-01 | 6.38e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER | 5 | 1.93e-01 | 3.36e-01 | 7.26e-01 |
| GOMF I SMAD BINDING | 16 | 2.00e-02 | 3.36e-01 | 3.01e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 14 | 2.95e-02 | 3.36e-01 | 3.66e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION | 8 | 1.00e-01 | -3.36e-01 | 5.95e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 1.00e-01 | 3.35e-01 | 5.95e-01 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 8 | 1.00e-01 | -3.35e-01 | 5.95e-01 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 8 | 1.01e-01 | -3.35e-01 | 5.95e-01 |
| GOMF OXYSTEROL BINDING | 8 | 1.01e-01 | -3.35e-01 | 5.95e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 15 | 2.46e-02 | 3.35e-01 | 3.33e-01 |
| GOBP EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION | 5 | 1.94e-01 | 3.35e-01 | 7.27e-01 |
| GOCC SARCOPLASMIC RETICULUM LUMEN | 9 | 8.19e-02 | 3.35e-01 | 5.60e-01 |
| GOBP REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT | 5 | 1.95e-01 | 3.34e-01 | 7.27e-01 |
| GOMF TYPE I INTERFERON RECEPTOR BINDING | 13 | 3.69e-02 | -3.34e-01 | 4.01e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 12 | 4.52e-02 | 3.34e-01 | 4.37e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 21 | 8.08e-03 | 3.34e-01 | 1.94e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 11 | 5.55e-02 | 3.33e-01 | 4.80e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 6 | 1.57e-01 | 3.33e-01 | 6.91e-01 |
| GOCC CHROMOSOME PASSENGER COMPLEX | 6 | 1.57e-01 | -3.33e-01 | 6.91e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 11 | 5.57e-02 | 3.33e-01 | 4.80e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 8 | 1.03e-01 | 3.33e-01 | 5.97e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 9 | 8.41e-02 | 3.32e-01 | 5.66e-01 |
| GOBP POSITIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 1.98e-01 | -3.32e-01 | 7.29e-01 |
| GOBP PROSTHETIC GROUP METABOLIC PROCESS | 6 | 1.59e-01 | -3.32e-01 | 6.93e-01 |
| GOBP REGULATION OF PANCREATIC JUICE SECRETION | 7 | 1.29e-01 | 3.32e-01 | 6.46e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 7 | 1.29e-01 | 3.31e-01 | 6.46e-01 |
| GOMF U2 SNRNA BINDING | 6 | 1.60e-01 | -3.31e-01 | 6.93e-01 |
| GOBP LUNG ASSOCIATED MESENCHYME DEVELOPMENT | 8 | 1.05e-01 | -3.31e-01 | 5.99e-01 |
| GOBP NOREPINEPHRINE UPTAKE | 8 | 1.05e-01 | -3.31e-01 | 5.99e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 16 | 2.19e-02 | -3.31e-01 | 3.18e-01 |
| GOBP GLOMERULAR MESANGIAL CELL DEVELOPMENT | 5 | 2.01e-01 | 3.30e-01 | 7.32e-01 |
| GOBP REGULATION OF ANTIMICROBIAL PEPTIDE PRODUCTION | 9 | 8.61e-02 | -3.30e-01 | 5.70e-01 |
| GOBP REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE | 12 | 4.81e-02 | -3.30e-01 | 4.52e-01 |
| GOBP REGULATION OF HISTONE DEACETYLATION | 5 | 2.02e-01 | -3.29e-01 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 15 | 2.74e-02 | 3.29e-01 | 3.51e-01 |
| GOBP URATE TRANSPORT | 11 | 5.89e-02 | 3.29e-01 | 4.89e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 5 | 2.03e-01 | -3.29e-01 | 7.34e-01 |
| GOBP DNA METHYLATION ON CYTOSINE | 6 | 1.63e-01 | 3.29e-01 | 6.96e-01 |
| GOBP N ACYLETHANOLAMINE METABOLIC PROCESS | 5 | 2.03e-01 | 3.28e-01 | 7.34e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI MEMBRANE | 5 | 2.04e-01 | -3.28e-01 | 7.34e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 14 | 3.35e-02 | 3.28e-01 | 3.88e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 8 | 1.08e-01 | -3.28e-01 | 6.06e-01 |
| GOMF SODIUM INDEPENDENT ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 2.32e-02 | -3.28e-01 | 3.25e-01 |
| GOBP METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT | 9 | 8.91e-02 | 3.27e-01 | 5.77e-01 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 6 | 1.66e-01 | 3.26e-01 | 6.99e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 11 | 6.13e-02 | 3.26e-01 | 4.97e-01 |
| GOMF INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED MONOATOMIC CATION CHANNEL ACTIVITY | 10 | 7.44e-02 | 3.26e-01 | 5.41e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 1.67e-01 | 3.26e-01 | 7.00e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 23 | 6.89e-03 | 3.25e-01 | 1.80e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 6 | 1.68e-01 | 3.25e-01 | 7.00e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 17 | 2.04e-02 | -3.25e-01 | 3.06e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 5 | 2.09e-01 | 3.25e-01 | 7.39e-01 |
| GOCC MICOS COMPLEX | 6 | 1.68e-01 | 3.25e-01 | 7.01e-01 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 1.69e-01 | 3.24e-01 | 7.01e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 6 | 1.69e-01 | 3.24e-01 | 7.01e-01 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 9 | 9.21e-02 | 3.24e-01 | 5.83e-01 |
| GOBP GLYCOLIPID TRANSPORT | 8 | 1.13e-01 | 3.24e-01 | 6.18e-01 |
| GOBP REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY | 7 | 1.38e-01 | -3.23e-01 | 6.59e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 10 | 7.71e-02 | -3.23e-01 | 5.48e-01 |
| GOBP REGULATION OF POTASSIUM ION IMPORT | 5 | 2.12e-01 | -3.23e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 10 | 7.76e-02 | 3.22e-01 | 5.49e-01 |
| GOBP REGULATION OF XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE | 12 | 5.33e-02 | -3.22e-01 | 4.75e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 10 | 7.78e-02 | -3.22e-01 | 5.49e-01 |
| GOBP CMP METABOLIC PROCESS | 8 | 1.15e-01 | 3.22e-01 | 6.23e-01 |
| GOBP METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 6 | 1.72e-01 | -3.22e-01 | 7.04e-01 |
| GOBP RESPONSE TO LITHIUM ION | 15 | 3.09e-02 | 3.22e-01 | 3.76e-01 |
| GOCC ANKYRIN 1 COMPLEX | 7 | 1.41e-01 | 3.21e-01 | 6.63e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN | 6 | 1.73e-01 | 3.21e-01 | 7.05e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 39 | 5.25e-04 | 3.21e-01 | 4.13e-02 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 5 | 2.14e-01 | -3.21e-01 | 7.45e-01 |
| GOBP MESANGIAL CELL DEVELOPMENT | 6 | 1.74e-01 | 3.21e-01 | 7.05e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 9 | 9.57e-02 | -3.21e-01 | 5.89e-01 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 7.93e-02 | -3.20e-01 | 5.52e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 16 | 2.65e-02 | 3.20e-01 | 3.47e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 26 | 4.70e-03 | 3.20e-01 | 1.45e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 8 | 1.17e-01 | 3.20e-01 | 6.28e-01 |
| GOBP LYMPHOCYTE ANERGY | 7 | 1.43e-01 | -3.20e-01 | 6.68e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 5 | 2.16e-01 | -3.19e-01 | 7.48e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 15 | 3.23e-02 | -3.19e-01 | 3.84e-01 |
| GOBP FLAVONE METABOLIC PROCESS | 6 | 1.77e-01 | 3.19e-01 | 7.09e-01 |
| GOBP ETHANOL OXIDATION | 9 | 9.80e-02 | -3.19e-01 | 5.95e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 2.18e-01 | -3.18e-01 | 7.49e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 25 | 5.95e-03 | -3.18e-01 | 1.68e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 2.19e-01 | -3.18e-01 | 7.50e-01 |
| GOBP REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 10 | 8.21e-02 | -3.17e-01 | 5.60e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 12 | 5.72e-02 | 3.17e-01 | 4.83e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 1.79e-01 | -3.17e-01 | 7.11e-01 |
| GOMF KERATIN FILAMENT BINDING | 6 | 1.80e-01 | -3.16e-01 | 7.12e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 1.47e-01 | 3.16e-01 | 6.74e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 11 | 6.94e-02 | 3.16e-01 | 5.25e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 10 | 8.34e-02 | 3.16e-01 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 6 | 1.81e-01 | -3.16e-01 | 7.13e-01 |
| GOBP ECTODERMAL CELL DIFFERENTIATION | 6 | 1.81e-01 | 3.16e-01 | 7.13e-01 |
| GOBP MAINTENANCE OF ANIMAL ORGAN IDENTITY | 5 | 2.22e-01 | -3.16e-01 | 7.54e-01 |
| GOBP MESANGIAL CELL DIFFERENTIATION | 7 | 1.48e-01 | 3.15e-01 | 6.76e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 20 | 1.46e-02 | 3.15e-01 | 2.59e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 16 | 2.90e-02 | -3.15e-01 | 3.61e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 6 | 1.81e-01 | -3.15e-01 | 7.14e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 18 | 2.07e-02 | -3.15e-01 | 3.09e-01 |
| GOBP NEGATIVE REGULATION OF FEEDING BEHAVIOR | 6 | 1.82e-01 | 3.15e-01 | 7.14e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE ACTIVATION | 5 | 2.24e-01 | -3.14e-01 | 7.57e-01 |
| GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.24e-01 | 3.14e-01 | 6.38e-01 |
| GOMF NITRITE REDUCTASE ACTIVITY | 5 | 2.24e-01 | 3.14e-01 | 7.57e-01 |
| GOMF DOPAMINE NEUROTRANSMITTER RECEPTOR ACTIVITY | 5 | 2.24e-01 | -3.14e-01 | 7.57e-01 |
| GOBP MESENCHYMAL STEM CELL MAINTENANCE INVOLVED IN NEPHRON MORPHOGENESIS | 6 | 1.83e-01 | -3.14e-01 | 7.16e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 41 | 5.15e-04 | 3.13e-01 | 4.08e-02 |
| GOCC PRESYNAPTIC CYTOSOL | 12 | 6.04e-02 | 3.13e-01 | 4.94e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 11 | 7.25e-02 | 3.13e-01 | 5.36e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 17 | 2.57e-02 | 3.13e-01 | 3.40e-01 |
| GOBP BRONCHIOLE DEVELOPMENT | 5 | 2.27e-01 | -3.12e-01 | 7.59e-01 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 7 | 1.53e-01 | 3.12e-01 | 6.84e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 438 | 3.46e-29 | -3.12e-01 | 1.18e-25 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 39 | 7.44e-04 | 3.12e-01 | 5.21e-02 |
| GOMF VINCULIN BINDING | 11 | 7.32e-02 | 3.12e-01 | 5.37e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 6 | 1.86e-01 | -3.12e-01 | 7.22e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 10 | 8.79e-02 | 3.12e-01 | 5.75e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 18 | 2.21e-02 | 3.12e-01 | 3.18e-01 |
| GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 10 | 8.80e-02 | 3.12e-01 | 5.75e-01 |
| GOBP MESENCHYME MIGRATION | 5 | 2.28e-01 | 3.12e-01 | 7.60e-01 |
| GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS | 8 | 1.27e-01 | 3.12e-01 | 6.43e-01 |
| GOBP DISTAL TUBULE DEVELOPMENT | 12 | 6.21e-02 | 3.11e-01 | 4.99e-01 |
| GOCC FHF COMPLEX | 5 | 2.29e-01 | 3.11e-01 | 7.60e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 2.29e-01 | 3.11e-01 | 7.60e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX | 5 | 2.29e-01 | 3.11e-01 | 7.60e-01 |
| GOMF MEMBRANE POTENTIAL DRIVEN UNIPORTER ACTIVITY | 5 | 2.30e-01 | 3.10e-01 | 7.60e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 1.89e-01 | 3.10e-01 | 7.24e-01 |
| GOBP NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 9 | 1.07e-01 | 3.10e-01 | 6.05e-01 |
| GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY | 10 | 8.99e-02 | 3.10e-01 | 5.78e-01 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 2.31e-01 | 3.10e-01 | 7.60e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 23 | 1.02e-02 | 3.10e-01 | 2.16e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 57 | 5.40e-05 | 3.09e-01 | 9.37e-03 |
| GOBP UREA TRANSPORT | 11 | 7.60e-02 | 3.09e-01 | 5.45e-01 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 2.32e-01 | 3.09e-01 | 7.61e-01 |
| GOMF LYSOPHOSPHATIDIC ACID BINDING | 7 | 1.58e-01 | -3.09e-01 | 6.91e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 33 | 2.16e-03 | 3.08e-01 | 9.32e-02 |
| GOMF PEPTIDOGLYCAN IMMUNE RECEPTOR ACTIVITY | 5 | 2.33e-01 | 3.08e-01 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 1.92e-01 | 3.08e-01 | 7.26e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 10 | 9.21e-02 | 3.08e-01 | 5.83e-01 |
| GOMF BMP BINDING | 19 | 2.03e-02 | 3.07e-01 | 3.05e-01 |
| GOCC MISMATCH REPAIR COMPLEX | 8 | 1.32e-01 | -3.07e-01 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC | 6 | 1.93e-01 | -3.07e-01 | 7.26e-01 |
| GOCC COMPACT MYELIN | 14 | 4.67e-02 | 3.07e-01 | 4.45e-01 |
| GOCC MIB COMPLEX | 11 | 7.79e-02 | 3.07e-01 | 5.49e-01 |
| GOMF FERRIC IRON BINDING | 9 | 1.11e-01 | 3.07e-01 | 6.15e-01 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 44 | 4.34e-04 | -3.07e-01 | 3.61e-02 |
| GOMF LIPOTEICHOIC ACID BINDING | 5 | 2.35e-01 | 3.06e-01 | 7.62e-01 |
| GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 5 | 2.35e-01 | 3.06e-01 | 7.62e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 2.44e-02 | 3.06e-01 | 3.32e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 12 | 6.64e-02 | 3.06e-01 | 5.17e-01 |
| GOCC BASAL DENDRITE | 6 | 1.94e-01 | -3.06e-01 | 7.27e-01 |
| GOBP NEUTROPHIL CLEARANCE | 6 | 1.95e-01 | 3.06e-01 | 7.27e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 451 | 7.48e-29 | -3.06e-01 | 1.91e-25 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 7 | 1.61e-01 | 3.06e-01 | 6.95e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 9 | 1.12e-01 | 3.06e-01 | 6.18e-01 |
| GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 1.35e-01 | 3.05e-01 | 6.53e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 8 | 1.35e-01 | 3.05e-01 | 6.53e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 10 | 9.49e-02 | 3.05e-01 | 5.89e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 31 | 3.29e-03 | 3.05e-01 | 1.20e-01 |
| GOBP KETONE BODY BIOSYNTHETIC PROCESS | 6 | 1.96e-01 | -3.05e-01 | 7.27e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT | 6 | 1.96e-01 | -3.05e-01 | 7.27e-01 |
| GOMF GLUTATHIONE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.38e-01 | 3.04e-01 | 7.63e-01 |
| GOBP INSULIN PROCESSING | 8 | 1.36e-01 | -3.04e-01 | 6.55e-01 |
| GOBP CGMP CATABOLIC PROCESS | 5 | 2.39e-01 | -3.04e-01 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 6 | 1.98e-01 | 3.04e-01 | 7.29e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 9 | 1.15e-01 | 3.04e-01 | 6.23e-01 |
| GOBP CELLULAR RESPONSE TO GLUCAGON STIMULUS | 11 | 8.12e-02 | 3.04e-01 | 5.59e-01 |
| GOBP MELANOCYTE PROLIFERATION | 5 | 2.40e-01 | -3.03e-01 | 7.65e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 17 | 3.03e-02 | 3.03e-01 | 3.71e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 9.67e-02 | 3.03e-01 | 5.93e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 25 | 8.68e-03 | 3.03e-01 | 2.01e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 21 | 1.62e-02 | 3.03e-01 | 2.73e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 8 | 1.38e-01 | 3.03e-01 | 6.59e-01 |
| GOBP TAURINE TRANSPORT | 8 | 1.39e-01 | 3.02e-01 | 6.59e-01 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 10 | 9.84e-02 | -3.02e-01 | 5.95e-01 |
| GOMF COLLAGEN BINDING INVOLVED IN CELL MATRIX ADHESION | 5 | 2.43e-01 | 3.02e-01 | 7.66e-01 |
| GOMF ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2 6 SIALYLTRANSFERASE ACTIVITY | 6 | 2.01e-01 | 3.02e-01 | 7.32e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 15 | 4.31e-02 | -3.02e-01 | 4.25e-01 |
| GOBP TYROSINE METABOLIC PROCESS | 17 | 3.14e-02 | 3.02e-01 | 3.78e-01 |
| GOMF R SMAD BINDING | 25 | 9.13e-03 | 3.01e-01 | 2.06e-01 |
| GOBP CARDIAC MUSCLE MYOBLAST PROLIFERATION | 7 | 1.68e-01 | -3.01e-01 | 7.00e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 10 | 9.93e-02 | 3.01e-01 | 5.95e-01 |
| GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 6 | 2.02e-01 | 3.01e-01 | 7.32e-01 |
| GOBP AGGRESSIVE BEHAVIOR | 7 | 1.68e-01 | -3.01e-01 | 7.00e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 11 | 8.40e-02 | 3.01e-01 | 5.66e-01 |
| GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY | 5 | 2.45e-01 | 3.00e-01 | 7.68e-01 |
| GOBP DIACYLGLYCEROL CATABOLIC PROCESS | 5 | 2.45e-01 | 3.00e-01 | 7.68e-01 |
| GOBP ALDITOL BIOSYNTHETIC PROCESS | 5 | 2.45e-01 | 3.00e-01 | 7.68e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 6 | 2.03e-01 | -3.00e-01 | 7.34e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 10 | 1.00e-01 | 3.00e-01 | 5.95e-01 |
| GOCC COMPLEX OF COLLAGEN TRIMERS | 19 | 2.35e-02 | -3.00e-01 | 3.27e-01 |
| GOBP VOLUNTARY SKELETAL MUSCLE CONTRACTION | 5 | 2.45e-01 | 3.00e-01 | 7.68e-01 |
| GOMF CO SMAD BINDING | 9 | 1.19e-01 | 3.00e-01 | 6.30e-01 |
| GOCC SPERM PLASMA MEMBRANE | 14 | 5.21e-02 | -3.00e-01 | 4.68e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 10 | 1.01e-01 | -3.00e-01 | 5.95e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 21 | 1.74e-02 | -3.00e-01 | 2.82e-01 |
| GOBP REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY | 5 | 2.47e-01 | 2.99e-01 | 7.68e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN REGULATION OF CELL PROLIFERATION | 6 | 2.04e-01 | -2.99e-01 | 7.35e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 33 | 2.93e-03 | 2.99e-01 | 1.12e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 8 | 1.43e-01 | 2.99e-01 | 6.67e-01 |
| GOBP STEM CELL FATE COMMITMENT | 10 | 1.01e-01 | 2.99e-01 | 5.97e-01 |
| GOBP OTOLITH DEVELOPMENT | 10 | 1.02e-01 | 2.99e-01 | 5.97e-01 |
| GOMF G PROTEIN COUPLED ADENOSINE RECEPTOR ACTIVITY | 5 | 2.47e-01 | 2.99e-01 | 7.69e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 17 | 3.30e-02 | 2.99e-01 | 3.87e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 8 | 1.44e-01 | 2.98e-01 | 6.69e-01 |
| GOBP REGULATION OF ARTERY MORPHOGENESIS | 11 | 8.66e-02 | -2.98e-01 | 5.72e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 2.48e-01 | -2.98e-01 | 7.70e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSFER ACTIVITY | 5 | 2.48e-01 | -2.98e-01 | 7.70e-01 |
| GOBP SENSORY PERCEPTION OF SOUR TASTE | 9 | 1.22e-01 | 2.97e-01 | 6.36e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 9 | 1.23e-01 | 2.97e-01 | 6.36e-01 |
| GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 6 | 2.08e-01 | 2.97e-01 | 7.39e-01 |
| GOCC BRCA1 A COMPLEX | 7 | 1.74e-01 | 2.97e-01 | 7.05e-01 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 13 | 6.40e-02 | 2.97e-01 | 5.08e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 23 | 1.40e-02 | 2.96e-01 | 2.54e-01 |
| GOBP AMMONIUM HOMEOSTASIS | 5 | 2.52e-01 | 2.96e-01 | 7.74e-01 |
| GOMF ESTROGEN 2 HYDROXYLASE ACTIVITY | 5 | 2.52e-01 | -2.96e-01 | 7.74e-01 |
| GOMF ANKYRIN REPEAT BINDING | 6 | 2.10e-01 | -2.96e-01 | 7.41e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 16 | 4.08e-02 | 2.95e-01 | 4.16e-01 |
| GOBP PHOSPHATE ION HOMEOSTASIS | 20 | 2.22e-02 | 2.95e-01 | 3.19e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE MATURATION | 5 | 2.53e-01 | -2.95e-01 | 7.75e-01 |
| GOBP MAMMARY GLAND FORMATION | 7 | 1.76e-01 | -2.95e-01 | 7.09e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 5 | 2.53e-01 | 2.95e-01 | 7.75e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 16 | 4.11e-02 | 2.95e-01 | 4.17e-01 |
| GOMF OPSONIN BINDING | 19 | 2.61e-02 | -2.95e-01 | 3.44e-01 |
| GOCC DEUTEROSOME | 6 | 2.11e-01 | -2.95e-01 | 7.43e-01 |
| GOBP MONOTERPENOID METABOLIC PROCESS | 6 | 2.12e-01 | -2.95e-01 | 7.43e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 10 | 1.07e-01 | 2.94e-01 | 6.04e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 11 | 9.09e-02 | 2.94e-01 | 5.81e-01 |
| GOCC GID COMPLEX | 5 | 2.54e-01 | 2.94e-01 | 7.76e-01 |
| GOBP AMP CATABOLIC PROCESS | 5 | 2.54e-01 | 2.94e-01 | 7.76e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 1.78e-01 | 2.94e-01 | 7.11e-01 |
| GOCC NUCLEAR LAMINA | 10 | 1.08e-01 | 2.94e-01 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 2.55e-01 | 2.94e-01 | 7.76e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 9 | 1.27e-01 | 2.94e-01 | 6.43e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION | 5 | 2.55e-01 | 2.94e-01 | 7.77e-01 |
| GOMF RECEPTOR SIGNALING PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 5 | 2.56e-01 | -2.94e-01 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 2.13e-01 | 2.93e-01 | 7.45e-01 |
| GOCC MITOCHONDRIAL CRISTA | 8 | 1.51e-01 | 2.93e-01 | 6.83e-01 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 8 | 1.52e-01 | 2.93e-01 | 6.83e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 17 | 3.66e-02 | 2.93e-01 | 4.00e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DEVELOPMENT | 5 | 2.57e-01 | 2.93e-01 | 7.78e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 6 | 2.15e-01 | 2.92e-01 | 7.47e-01 |
| GOMF BETA GLUCOSIDASE ACTIVITY | 6 | 2.16e-01 | -2.92e-01 | 7.48e-01 |
| GOBP CARDIAC PACEMAKER CELL DIFFERENTIATION | 11 | 9.39e-02 | 2.92e-01 | 5.89e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 8 | 1.53e-01 | 2.92e-01 | 6.85e-01 |
| GOBP RESPONSE TO ZINC ION STARVATION | 9 | 1.30e-01 | 2.92e-01 | 6.48e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 11 | 9.41e-02 | 2.92e-01 | 5.89e-01 |
| GOBP XENOBIOTIC GLUCURONIDATION | 6 | 2.16e-01 | 2.91e-01 | 7.48e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 11 | 9.44e-02 | 2.91e-01 | 5.89e-01 |
| GOBP HISTONE H4 K16 ACETYLATION | 6 | 2.17e-01 | 2.91e-01 | 7.49e-01 |
| GOBP PROSTAGLANDIN SECRETION | 17 | 3.80e-02 | 2.91e-01 | 4.05e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH | 9 | 1.31e-01 | 2.91e-01 | 6.51e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 12 | 8.17e-02 | 2.90e-01 | 5.59e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 10 | 1.13e-01 | 2.90e-01 | 6.18e-01 |
| GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION | 7 | 1.84e-01 | 2.90e-01 | 7.18e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 21 | 2.16e-02 | 2.90e-01 | 3.17e-01 |
| GOBP TORC2 SIGNALING | 12 | 8.26e-02 | 2.89e-01 | 5.62e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 23 | 1.63e-02 | 2.89e-01 | 2.73e-01 |
| GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.33e-01 | -2.89e-01 | 6.51e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 30 | 6.12e-03 | 2.89e-01 | 1.70e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 20 | 2.52e-02 | 2.89e-01 | 3.37e-01 |
| GOBP GASTRIC MOTILITY | 5 | 2.63e-01 | 2.89e-01 | 7.83e-01 |
| GOBP MALE SEX DETERMINATION | 11 | 9.71e-02 | 2.89e-01 | 5.93e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 8 | 1.57e-01 | -2.89e-01 | 6.91e-01 |
| GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE | 8 | 1.57e-01 | -2.89e-01 | 6.91e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 14 | 6.15e-02 | 2.89e-01 | 4.97e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 2.21e-01 | 2.89e-01 | 7.53e-01 |
| GOMF TYPE 2 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 5 | 2.64e-01 | 2.88e-01 | 7.83e-01 |
| GOCC BOX H ACA RNP COMPLEX | 7 | 1.86e-01 | -2.88e-01 | 7.22e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 5 | 2.64e-01 | -2.88e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF ACTION POTENTIAL | 8 | 1.58e-01 | -2.88e-01 | 6.91e-01 |
| GOBP NOREPINEPHRINE METABOLIC PROCESS | 12 | 8.41e-02 | 2.88e-01 | 5.66e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 17 | 3.98e-02 | 2.88e-01 | 4.12e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 9 | 1.35e-01 | 2.88e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 6 | 2.22e-01 | 2.88e-01 | 7.55e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.35e-01 | -2.88e-01 | 6.53e-01 |
| GOCC CATENIN COMPLEX | 31 | 5.57e-03 | -2.88e-01 | 1.64e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 5 | 2.65e-01 | -2.88e-01 | 7.83e-01 |
| GOBP PROSTATIC BUD FORMATION | 8 | 1.59e-01 | -2.88e-01 | 6.93e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 20 | 2.60e-02 | 2.88e-01 | 3.43e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 15 | 5.39e-02 | 2.87e-01 | 4.77e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 3.47e-02 | 2.87e-01 | 3.93e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 6 | 2.23e-01 | -2.87e-01 | 7.56e-01 |
| GOBP NEURON GLIAL CELL SIGNALING | 5 | 2.67e-01 | 2.87e-01 | 7.83e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 32 | 4.98e-03 | 2.87e-01 | 1.49e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL | 6 | 2.24e-01 | 2.87e-01 | 7.57e-01 |
| GOBP CITRATE TRANSPORT | 5 | 2.67e-01 | 2.87e-01 | 7.83e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 12 | 8.57e-02 | -2.86e-01 | 5.70e-01 |
| GOBP MYCOTOXIN METABOLIC PROCESS | 6 | 2.24e-01 | -2.86e-01 | 7.57e-01 |
| GOBP XMP METABOLIC PROCESS | 7 | 1.90e-01 | -2.86e-01 | 7.24e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 11 | 1.00e-01 | 2.86e-01 | 5.95e-01 |
| GOBP CORTICOTROPIN SECRETION | 7 | 1.90e-01 | 2.86e-01 | 7.24e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 7 | 1.90e-01 | 2.86e-01 | 7.24e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 16 | 4.76e-02 | 2.86e-01 | 4.49e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 20 | 2.69e-02 | 2.86e-01 | 3.48e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 15 | 5.55e-02 | -2.86e-01 | 4.80e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 18 | 3.60e-02 | -2.86e-01 | 3.97e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 31 | 5.96e-03 | 2.85e-01 | 1.68e-01 |
| GOBP ADULT FEEDING BEHAVIOR | 9 | 1.38e-01 | 2.85e-01 | 6.59e-01 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 16 | 4.82e-02 | 2.85e-01 | 4.52e-01 |
| GOBP PROGESTERONE BIOSYNTHETIC PROCESS | 6 | 2.26e-01 | -2.85e-01 | 7.59e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 8 | 1.63e-01 | 2.85e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 10 | 1.19e-01 | 2.85e-01 | 6.30e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 16 | 4.84e-02 | 2.85e-01 | 4.52e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 9 | 1.39e-01 | 2.85e-01 | 6.59e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 6 | 2.27e-01 | 2.85e-01 | 7.59e-01 |
| GOBP COPPER ION HOMEOSTASIS | 17 | 4.20e-02 | 2.85e-01 | 4.21e-01 |
| GOBP CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS | 8 | 1.63e-01 | -2.85e-01 | 6.95e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 11 | 1.02e-01 | 2.85e-01 | 5.97e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 2.70e-01 | -2.85e-01 | 7.85e-01 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 8 | 1.64e-01 | -2.84e-01 | 6.96e-01 |
| GOMF OPIOID RECEPTOR BINDING | 7 | 1.93e-01 | 2.84e-01 | 7.26e-01 |
| GOCC GRANULAR COMPONENT | 7 | 1.93e-01 | 2.84e-01 | 7.26e-01 |
| GOBP CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION | 7 | 1.94e-01 | 2.84e-01 | 7.26e-01 |
| GOBP TELOMERE TETHERING AT NUCLEAR PERIPHERY | 6 | 2.29e-01 | -2.84e-01 | 7.60e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 13 | 7.67e-02 | 2.84e-01 | 5.48e-01 |
| GOBP INTESTINE SMOOTH MUSCLE CONTRACTION | 8 | 1.65e-01 | 2.83e-01 | 6.98e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT | 9 | 1.41e-01 | 2.83e-01 | 6.63e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 14 | 6.65e-02 | 2.83e-01 | 5.17e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 2.73e-01 | 2.83e-01 | 7.87e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 11 | 1.04e-01 | 2.83e-01 | 5.99e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 8 | 1.66e-01 | 2.83e-01 | 7.00e-01 |
| GOBP AXONEMAL CENTRAL APPARATUS ASSEMBLY | 6 | 2.31e-01 | 2.82e-01 | 7.60e-01 |
| GOBP ADP BIOSYNTHETIC PROCESS | 5 | 2.74e-01 | 2.82e-01 | 7.87e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 15 | 5.82e-02 | 2.82e-01 | 4.87e-01 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 12 | 9.04e-02 | 2.82e-01 | 5.78e-01 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 32 | 5.71e-03 | 2.82e-01 | 1.64e-01 |
| GOMF RNA CAP BINDING | 20 | 2.89e-02 | 2.82e-01 | 3.61e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 7 | 1.96e-01 | 2.82e-01 | 7.27e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 8 | 1.67e-01 | 2.82e-01 | 7.00e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 17 | 4.41e-02 | 2.82e-01 | 4.31e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 13 | 7.84e-02 | 2.82e-01 | 5.50e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 15 | 5.88e-02 | -2.82e-01 | 4.89e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 1.69e-02 | -2.82e-01 | 2.77e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 21 | 2.54e-02 | 2.82e-01 | 3.38e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 11 | 1.06e-01 | 2.81e-01 | 6.02e-01 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 19 | 3.37e-02 | 2.81e-01 | 3.88e-01 |
| GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 12 | 9.17e-02 | 2.81e-01 | 5.82e-01 |
| GOMF INSULIN BINDING | 5 | 2.76e-01 | 2.81e-01 | 7.88e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 6 | 2.33e-01 | 2.81e-01 | 7.61e-01 |
| GOBP GLUTATHIONE TRANSPORT | 9 | 1.45e-01 | 2.81e-01 | 6.70e-01 |
| GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.98e-01 | -2.81e-01 | 7.29e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 7 | 1.98e-01 | 2.81e-01 | 7.29e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 13 | 7.98e-02 | 2.81e-01 | 5.54e-01 |
| GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION | 6 | 2.34e-01 | -2.81e-01 | 7.61e-01 |
| GOMF CALCITONIN FAMILY RECEPTOR ACTIVITY | 6 | 2.35e-01 | -2.80e-01 | 7.62e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 9 | 1.46e-01 | -2.80e-01 | 6.73e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR ACTIVITY | 9 | 1.46e-01 | -2.80e-01 | 6.73e-01 |
| GOBP DEHYDROASCORBIC ACID TRANSPORT | 9 | 1.46e-01 | 2.80e-01 | 6.73e-01 |
| GOBP CALCIUM ACTIVATED PHOSPHOLIPID SCRAMBLING | 5 | 2.79e-01 | 2.80e-01 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 8 | 1.71e-01 | -2.79e-01 | 7.04e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 2.79e-01 | 2.79e-01 | 7.93e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 17 | 4.62e-02 | 2.79e-01 | 4.44e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 12 | 9.44e-02 | 2.79e-01 | 5.89e-01 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 1.72e-01 | -2.79e-01 | 7.04e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 2.80e-01 | 2.79e-01 | 7.93e-01 |
| GOBP GALACTOLIPID BIOSYNTHETIC PROCESS | 6 | 2.37e-01 | -2.79e-01 | 7.63e-01 |
| GOBP NEUROTRANSMITTER CATABOLIC PROCESS | 8 | 1.72e-01 | 2.79e-01 | 7.04e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY | 7 | 2.02e-01 | 2.79e-01 | 7.32e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL ELONGATION | 5 | 2.81e-01 | 2.78e-01 | 7.93e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 12 | 9.51e-02 | 2.78e-01 | 5.89e-01 |
| GOBP TESTOSTERONE BIOSYNTHETIC PROCESS | 11 | 1.10e-01 | -2.78e-01 | 6.12e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 2.02e-01 | -2.78e-01 | 7.33e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 6 | 2.38e-01 | 2.78e-01 | 7.63e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 25 | 1.62e-02 | 2.78e-01 | 2.73e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 1.74e-01 | 2.78e-01 | 7.05e-01 |
| GOCC BORC COMPLEX | 8 | 1.74e-01 | 2.78e-01 | 7.05e-01 |
| GOBP LUNG LOBE DEVELOPMENT | 7 | 2.03e-01 | -2.78e-01 | 7.34e-01 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 6 | 2.39e-01 | 2.78e-01 | 7.63e-01 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 8 | 1.74e-01 | 2.78e-01 | 7.05e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT | 6 | 2.39e-01 | 2.77e-01 | 7.64e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 26 | 1.44e-02 | 2.77e-01 | 2.58e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 7 | 2.05e-01 | 2.77e-01 | 7.35e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 18 | 4.21e-02 | 2.77e-01 | 4.21e-01 |
| GOMF O PALMITOYLTRANSFERASE ACTIVITY | 5 | 2.84e-01 | -2.77e-01 | 7.95e-01 |
| GOBP REGULATION OF AMACRINE CELL DIFFERENTIATION | 6 | 2.41e-01 | 2.77e-01 | 7.65e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 36 | 4.12e-03 | 2.76e-01 | 1.35e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 22 | 2.50e-02 | 2.76e-01 | 3.36e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 7 | 2.06e-01 | 2.76e-01 | 7.37e-01 |
| GOBP RESPONSE TO ACIDIC PH | 28 | 1.15e-02 | 2.76e-01 | 2.29e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 8 | 1.77e-01 | 2.76e-01 | 7.10e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY | 7 | 2.07e-01 | -2.76e-01 | 7.37e-01 |
| GOBP TRACHEA MORPHOGENESIS | 11 | 1.14e-01 | 2.75e-01 | 6.21e-01 |
| GOCC SPECTRIN ASSOCIATED CYTOSKELETON | 9 | 1.53e-01 | 2.75e-01 | 6.84e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 12 | 9.86e-02 | 2.75e-01 | 5.95e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR WOUND HEALING | 7 | 2.07e-01 | -2.75e-01 | 7.38e-01 |
| GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS | 12 | 9.89e-02 | -2.75e-01 | 5.95e-01 |
| GOBP CORTISOL SECRETION | 5 | 2.87e-01 | 2.75e-01 | 7.95e-01 |
| GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION | 10 | 1.32e-01 | 2.75e-01 | 6.51e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS | 7 | 2.08e-01 | 2.75e-01 | 7.39e-01 |
| GOBP NEGATIVE REGULATION OF PHOTORECEPTOR CELL DIFFERENTIATION | 6 | 2.44e-01 | 2.75e-01 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 8 | 1.79e-01 | -2.75e-01 | 7.11e-01 |
| GOMF POTASSIUM CHANNEL INHIBITOR ACTIVITY | 5 | 2.88e-01 | -2.74e-01 | 7.96e-01 |
| GOBP METANEPHRIC DISTAL TUBULE DEVELOPMENT | 7 | 2.09e-01 | 2.74e-01 | 7.40e-01 |
| GOBP LIPOPHAGY | 7 | 2.09e-01 | 2.74e-01 | 7.40e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 8.73e-02 | -2.74e-01 | 5.74e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 13 | 8.75e-02 | 2.74e-01 | 5.74e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 8 | 1.80e-01 | 2.74e-01 | 7.13e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 8 | 1.80e-01 | 2.74e-01 | 7.13e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CHROMATIN | 78 | 2.94e-05 | -2.74e-01 | 6.54e-03 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 7 | 2.10e-01 | -2.74e-01 | 7.42e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY | 5 | 2.90e-01 | 2.73e-01 | 7.96e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 18 | 4.47e-02 | -2.73e-01 | 4.34e-01 |
| GOBP REGULATION OF ODONTOBLAST DIFFERENTIATION | 5 | 2.90e-01 | -2.73e-01 | 7.96e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 21 | 3.04e-02 | -2.73e-01 | 3.71e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 11 | 1.17e-01 | 2.73e-01 | 6.28e-01 |
| GOMF PROTEIN KINASE B BINDING | 10 | 1.35e-01 | 2.73e-01 | 6.53e-01 |
| GOCC FIBRILLAR COLLAGEN TRIMER | 12 | 1.02e-01 | -2.73e-01 | 5.97e-01 |
| GOBP PRENYLATION | 11 | 1.17e-01 | -2.73e-01 | 6.28e-01 |
| GOBP PENILE ERECTION | 7 | 2.12e-01 | -2.73e-01 | 7.43e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 36 | 4.66e-03 | 2.72e-01 | 1.45e-01 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 7 | 2.12e-01 | -2.72e-01 | 7.44e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 26 | 1.63e-02 | 2.72e-01 | 2.73e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 31 | 8.76e-03 | 2.72e-01 | 2.02e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 30 | 9.93e-03 | 2.72e-01 | 2.14e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 9.94e-03 | -2.72e-01 | 2.14e-01 |
| GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX | 5 | 2.93e-01 | 2.72e-01 | 7.97e-01 |
| GOBP POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION | 5 | 2.93e-01 | 2.72e-01 | 7.97e-01 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 10 | 1.37e-01 | 2.72e-01 | 6.58e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVITY | 5 | 2.93e-01 | -2.71e-01 | 7.97e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 6 | 2.50e-01 | -2.71e-01 | 7.71e-01 |
| GOBP CHIASMA ASSEMBLY | 6 | 2.50e-01 | 2.71e-01 | 7.71e-01 |
| GOBP HEART VALVE FORMATION | 15 | 6.90e-02 | 2.71e-01 | 5.23e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 20 | 3.58e-02 | -2.71e-01 | 3.96e-01 |
| GOBP RENAL ABSORPTION | 32 | 7.93e-03 | 2.71e-01 | 1.91e-01 |
| GOBP NEGATIVE REGULATION OF KIDNEY DEVELOPMENT | 5 | 2.94e-01 | -2.71e-01 | 7.98e-01 |
| GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.84e-01 | -2.71e-01 | 7.18e-01 |
| GOCC PSEUDOPODIUM | 16 | 6.05e-02 | 2.71e-01 | 4.94e-01 |
| GOBP DENDRITE ARBORIZATION | 10 | 1.38e-01 | -2.71e-01 | 6.59e-01 |
| GOBP PERICENTRIC HETEROCHROMATIN FORMATION | 5 | 2.94e-01 | -2.71e-01 | 7.98e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 7 | 2.15e-01 | -2.71e-01 | 7.46e-01 |
| GOBP MDA 5 SIGNALING PATHWAY | 11 | 1.20e-01 | 2.71e-01 | 6.31e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 13 | 9.14e-02 | 2.70e-01 | 5.82e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 6 | 2.51e-01 | 2.70e-01 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 8 | 1.86e-01 | 2.70e-01 | 7.21e-01 |
| GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 8 | 1.86e-01 | 2.70e-01 | 7.22e-01 |
| GOCC PREFOLDIN COMPLEX | 6 | 2.53e-01 | 2.70e-01 | 7.75e-01 |
| GOBP CLEAVAGE FURROW FORMATION | 7 | 2.17e-01 | 2.70e-01 | 7.48e-01 |
| GOCC PERINUCLEOLAR COMPARTMENT | 5 | 2.97e-01 | 2.69e-01 | 7.99e-01 |
| GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION | 9 | 1.62e-01 | 2.69e-01 | 6.95e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 13 | 9.29e-02 | 2.69e-01 | 5.85e-01 |
| GOBP NOREPINEPHRINE BIOSYNTHETIC PROCESS | 8 | 1.87e-01 | 2.69e-01 | 7.23e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 5 | 2.97e-01 | 2.69e-01 | 7.99e-01 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 2.54e-01 | 2.69e-01 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 1.88e-01 | -2.69e-01 | 7.23e-01 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 5 | 2.98e-01 | 2.69e-01 | 7.99e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 1.23e-01 | 2.69e-01 | 6.36e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 14 | 8.17e-02 | 2.69e-01 | 5.59e-01 |
| GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT | 5 | 2.98e-01 | 2.69e-01 | 7.99e-01 |
| GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY | 5 | 2.98e-01 | 2.69e-01 | 7.99e-01 |
| GOBP TRACHEA DEVELOPMENT | 18 | 4.84e-02 | 2.69e-01 | 4.52e-01 |
| GOBP POSITIVE REGULATION OF FERTILIZATION | 5 | 2.98e-01 | -2.69e-01 | 7.99e-01 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 2.98e-01 | -2.69e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 8 | 1.89e-01 | -2.68e-01 | 7.24e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 8 | 1.89e-01 | 2.68e-01 | 7.24e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 15 | 7.20e-02 | 2.68e-01 | 5.34e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 34 | 6.85e-03 | 2.68e-01 | 1.80e-01 |
| GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS | 6 | 2.56e-01 | 2.68e-01 | 7.77e-01 |
| GOMF FOLIC ACID BINDING | 13 | 9.48e-02 | 2.68e-01 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 15 | 7.28e-02 | 2.68e-01 | 5.36e-01 |
| GOBP REGULATION OF RESPONSE TO DRUG | 15 | 7.28e-02 | -2.68e-01 | 5.36e-01 |
| GOCC GOLGI TRANS CISTERNA | 9 | 1.65e-01 | 2.67e-01 | 6.97e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 8 | 1.90e-01 | 2.67e-01 | 7.24e-01 |
| GOMF BETA GALACTOSIDASE ACTIVITY | 5 | 3.01e-01 | -2.67e-01 | 8.02e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 2.57e-01 | -2.67e-01 | 7.78e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 10 | 1.44e-01 | -2.67e-01 | 6.69e-01 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 10 | 1.44e-01 | 2.67e-01 | 6.69e-01 |
| GOMF ERBB 3 CLASS RECEPTOR BINDING | 5 | 3.02e-01 | 2.67e-01 | 8.02e-01 |
| GOBP MYELOID DENDRITIC CELL CHEMOTAXIS | 5 | 3.03e-01 | 2.66e-01 | 8.02e-01 |
| GOMF MITOCHONDRION TARGETING SEQUENCE BINDING | 5 | 3.03e-01 | 2.66e-01 | 8.02e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 20 | 3.94e-02 | -2.66e-01 | 4.11e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 3.03e-01 | -2.66e-01 | 8.02e-01 |
| GOBP DORSAL AORTA DEVELOPMENT | 10 | 1.45e-01 | 2.66e-01 | 6.72e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 19 | 4.50e-02 | -2.66e-01 | 4.37e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 6 | 2.60e-01 | 2.66e-01 | 7.81e-01 |
| GOMF PROTEINASE ACTIVATED RECEPTOR ACTIVITY | 5 | 3.04e-01 | -2.65e-01 | 8.02e-01 |
| GOBP TERPENOID CATABOLIC PROCESS | 8 | 1.94e-01 | 2.65e-01 | 7.27e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 11 | 1.28e-01 | -2.65e-01 | 6.43e-01 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 6 | 2.61e-01 | 2.65e-01 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 17 | 5.86e-02 | 2.65e-01 | 4.89e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 15 | 7.57e-02 | 2.65e-01 | 5.44e-01 |
| GOCC MYOSIN II COMPLEX | 26 | 1.94e-02 | -2.65e-01 | 2.99e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 5 | 3.06e-01 | 2.64e-01 | 8.02e-01 |
| GOBP MICROGLIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 5 | 3.07e-01 | -2.64e-01 | 8.03e-01 |
| GOBP INNERVATION | 26 | 1.98e-02 | 2.64e-01 | 3.01e-01 |
| GOBP B CELL CHEMOTAXIS | 6 | 2.63e-01 | 2.64e-01 | 7.83e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 11 | 1.30e-01 | -2.64e-01 | 6.48e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP | 6 | 2.63e-01 | 2.64e-01 | 7.83e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 14 | 8.76e-02 | 2.64e-01 | 5.74e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 27 | 1.77e-02 | 2.64e-01 | 2.85e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 17 | 5.99e-02 | 2.64e-01 | 4.93e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 14 | 8.77e-02 | 2.64e-01 | 5.74e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 13 | 1.00e-01 | 2.63e-01 | 5.95e-01 |
| GOCC DENTATE GYRUS MOSSY FIBER | 6 | 2.64e-01 | 2.63e-01 | 7.83e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 16 | 6.81e-02 | -2.63e-01 | 5.21e-01 |
| GOBP REGULATION OF CENTROMERE COMPLEX ASSEMBLY | 6 | 2.64e-01 | -2.63e-01 | 7.83e-01 |
| GOBP CELLULAR RESPONSE TO UV C | 5 | 3.08e-01 | -2.63e-01 | 8.05e-01 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 7 | 2.28e-01 | 2.63e-01 | 7.60e-01 |
| GOBP AXIAL MESODERM DEVELOPMENT | 8 | 1.98e-01 | 2.63e-01 | 7.29e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 1.72e-01 | 2.63e-01 | 7.04e-01 |
| GOCC CORTICAL GRANULE | 6 | 2.65e-01 | 2.63e-01 | 7.83e-01 |
| GOBP SERTOLI CELL PROLIFERATION | 5 | 3.09e-01 | -2.63e-01 | 8.05e-01 |
| GOMF SULFATIDE BINDING | 6 | 2.65e-01 | -2.63e-01 | 7.83e-01 |
| GOBP PHAGOSOME MATURATION | 28 | 1.61e-02 | 2.63e-01 | 2.73e-01 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 1.73e-01 | 2.62e-01 | 7.05e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 2.66e-01 | -2.62e-01 | 7.83e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 12 | 1.16e-01 | -2.62e-01 | 6.25e-01 |
| GOBP BUD ELONGATION INVOLVED IN LUNG BRANCHING | 7 | 2.30e-01 | -2.62e-01 | 7.60e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 22 | 3.34e-02 | 2.62e-01 | 3.88e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 27 | 1.85e-02 | 2.62e-01 | 2.93e-01 |
| GOBP SNRNA MODIFICATION | 6 | 2.67e-01 | -2.62e-01 | 7.83e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 9 | 1.74e-01 | -2.62e-01 | 7.05e-01 |
| GOBP FIBROBLAST ACTIVATION | 15 | 7.92e-02 | 2.62e-01 | 5.52e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 2.67e-01 | -2.62e-01 | 7.83e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 10 | 1.52e-01 | 2.62e-01 | 6.83e-01 |
| GOBP DCMP CATABOLIC PROCESS | 6 | 2.67e-01 | 2.62e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 16 | 7.02e-02 | 2.61e-01 | 5.28e-01 |
| GOCC IKAPPAB KINASE COMPLEX | 6 | 2.68e-01 | 2.61e-01 | 7.83e-01 |
| GOMF GLYCINE BINDING | 10 | 1.52e-01 | 2.61e-01 | 6.83e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 25 | 2.38e-02 | 2.61e-01 | 3.28e-01 |
| GOBP AMINO ACID BETAINE BIOSYNTHETIC PROCESS | 5 | 3.12e-01 | -2.61e-01 | 8.08e-01 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 16 | 7.06e-02 | -2.61e-01 | 5.28e-01 |
| GOBP DENDRITIC TRANSPORT | 12 | 1.18e-01 | 2.61e-01 | 6.29e-01 |
| GOBP SOMATOTROPIN SECRETING CELL DIFFERENTIATION | 5 | 3.12e-01 | 2.61e-01 | 8.08e-01 |
| GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 1.04e-01 | -2.61e-01 | 5.99e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 22 | 3.44e-02 | 2.61e-01 | 3.92e-01 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 9 | 1.76e-01 | -2.61e-01 | 7.08e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 12 | 1.18e-01 | 2.60e-01 | 6.30e-01 |
| GOBP REGULATION OF CORTICOTROPIN SECRETION | 5 | 3.13e-01 | 2.60e-01 | 8.08e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 19 | 4.94e-02 | 2.60e-01 | 4.56e-01 |
| GOBP ENDOTHELIAL CELL MATRIX ADHESION | 8 | 2.03e-01 | -2.60e-01 | 7.33e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 7 | 2.33e-01 | 2.60e-01 | 7.61e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 15 | 8.14e-02 | 2.60e-01 | 5.59e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 10 | 1.55e-01 | 2.60e-01 | 6.88e-01 |
| GOBP L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 2.70e-01 | 2.60e-01 | 7.85e-01 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 1.36e-01 | 2.60e-01 | 6.55e-01 |
| GOMF CARD DOMAIN BINDING | 16 | 7.20e-02 | 2.60e-01 | 5.34e-01 |
| GOBP POSITIVE REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION | 5 | 3.15e-01 | -2.60e-01 | 8.08e-01 |
| GOMF ALPHA 1 3 FUCOSYLTRANSFERASE ACTIVITY | 8 | 2.04e-01 | 2.60e-01 | 7.34e-01 |
| GOBP CELLULAR RESPONSE TO PH | 26 | 2.20e-02 | 2.60e-01 | 3.18e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 3.15e-01 | 2.60e-01 | 8.08e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT | 5 | 3.15e-01 | 2.59e-01 | 8.08e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 6 | 2.71e-01 | 2.59e-01 | 7.85e-01 |
| GOBP INNATE IMMUNE RESPONSE IN MUCOSA | 26 | 2.22e-02 | -2.59e-01 | 3.19e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 16 | 7.27e-02 | 2.59e-01 | 5.36e-01 |
| GOBP REGULATION OF ARACHIDONIC ACID SECRETION | 7 | 2.36e-01 | -2.59e-01 | 7.62e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 53 | 1.11e-03 | 2.59e-01 | 6.40e-02 |
| GOMF TAP BINDING | 7 | 2.36e-01 | -2.59e-01 | 7.62e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 7 | 2.36e-01 | 2.59e-01 | 7.62e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 3.17e-01 | 2.59e-01 | 8.09e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 8 | 2.05e-01 | -2.59e-01 | 7.36e-01 |
| GOMF CERAMIDE BINDING | 19 | 5.11e-02 | 2.58e-01 | 4.64e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 15 | 8.31e-02 | -2.58e-01 | 5.64e-01 |
| GOCC CDC73 PAF1 COMPLEX | 7 | 2.36e-01 | -2.58e-01 | 7.63e-01 |
| GOBP ESTABLISHMENT OF LEFT RIGHT ASYMMETRY | 6 | 2.73e-01 | -2.58e-01 | 7.87e-01 |
| GOBP UREA TRANSMEMBRANE TRANSPORT | 9 | 1.80e-01 | 2.58e-01 | 7.12e-01 |
| GOBP REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION | 8 | 2.06e-01 | 2.58e-01 | 7.37e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 9 | 1.80e-01 | 2.58e-01 | 7.13e-01 |
| GOBP EPITHELIAL FLUID TRANSPORT | 11 | 1.38e-01 | 2.58e-01 | 6.59e-01 |
| GOMF ALPHA N ACETYLNEURAMINATE ALPHA 2 8 SIALYLTRANSFERASE ACTIVITY | 6 | 2.74e-01 | -2.58e-01 | 7.87e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 12 | 1.22e-01 | -2.58e-01 | 6.36e-01 |
| GOBP GROWTH INVOLVED IN HEART MORPHOGENESIS | 5 | 3.18e-01 | -2.58e-01 | 8.10e-01 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 11 | 1.39e-01 | 2.58e-01 | 6.59e-01 |
| GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 7 | 2.38e-01 | 2.58e-01 | 7.63e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 38 | 6.01e-03 | 2.58e-01 | 1.68e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 12 | 1.23e-01 | -2.57e-01 | 6.36e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 10 | 1.59e-01 | -2.57e-01 | 6.93e-01 |
| GOCC MULTIVESICULAR BODY INTERNAL VESICLE | 6 | 2.76e-01 | 2.57e-01 | 7.88e-01 |
| GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE | 6 | 2.76e-01 | 2.57e-01 | 7.88e-01 |
| GOMF INTERLEUKIN 12 RECEPTOR BINDING | 5 | 3.20e-01 | 2.57e-01 | 8.10e-01 |
| GOBP METANEPHRIC PROXIMAL TUBULE DEVELOPMENT | 5 | 3.20e-01 | -2.57e-01 | 8.10e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.09e-01 | -2.57e-01 | 7.40e-01 |
| GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 5 | 3.21e-01 | 2.56e-01 | 8.10e-01 |
| GOMF CAMP BINDING | 22 | 3.74e-02 | 2.56e-01 | 4.04e-01 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 23 | 3.34e-02 | 2.56e-01 | 3.88e-01 |
| GOBP REGULATION OF ENAMEL MINERALIZATION | 7 | 2.41e-01 | -2.56e-01 | 7.65e-01 |
| GOMF MUTSALPHA COMPLEX BINDING | 7 | 2.41e-01 | -2.56e-01 | 7.65e-01 |
| GOCC UNIPLEX COMPLEX | 6 | 2.77e-01 | 2.56e-01 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 3.22e-01 | 2.56e-01 | 8.10e-01 |
| GOBP REGULATION OF NODAL SIGNALING PATHWAY | 9 | 1.84e-01 | -2.56e-01 | 7.18e-01 |
| GOBP LUTEOLYSIS | 6 | 2.78e-01 | -2.56e-01 | 7.92e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 13 | 1.11e-01 | 2.56e-01 | 6.14e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 21 | 4.27e-02 | 2.55e-01 | 4.24e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 14 | 9.80e-02 | -2.55e-01 | 5.95e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 1.85e-01 | 2.55e-01 | 7.20e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 3.23e-01 | -2.55e-01 | 8.10e-01 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 2.79e-01 | 2.55e-01 | 7.93e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 2.43e-01 | -2.55e-01 | 7.66e-01 |
| GOBP CHONDROBLAST DIFFERENTIATION | 5 | 3.24e-01 | 2.55e-01 | 8.10e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 17 | 6.90e-02 | -2.55e-01 | 5.23e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 10 | 1.63e-01 | 2.55e-01 | 6.95e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 10 | 1.63e-01 | 2.55e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 5 | 3.24e-01 | 2.55e-01 | 8.10e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 23 | 3.46e-02 | 2.55e-01 | 3.93e-01 |
| GOBP INTRACELLULAR NITROGEN HOMEOSTASIS | 5 | 3.25e-01 | -2.54e-01 | 8.10e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR II BINDING | 8 | 2.13e-01 | 2.54e-01 | 7.44e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 7 | 2.44e-01 | -2.54e-01 | 7.67e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE A2 ACTIVITY | 8 | 2.13e-01 | -2.54e-01 | 7.44e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 12 | 1.28e-01 | 2.54e-01 | 6.43e-01 |
| GOMF CARBOXYLESTERASE ACTIVITY | 6 | 2.81e-01 | 2.54e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 26 | 2.50e-02 | -2.54e-01 | 3.35e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 12 | 1.28e-01 | 2.54e-01 | 6.43e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 3.25e-01 | -2.54e-01 | 8.11e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 17 | 6.98e-02 | 2.54e-01 | 5.27e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 3.25e-01 | -2.54e-01 | 8.11e-01 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.14e-01 | 2.54e-01 | 7.45e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 7 | 2.45e-01 | 2.54e-01 | 7.68e-01 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 9 | 1.87e-01 | 2.54e-01 | 7.23e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 25 | 2.81e-02 | -2.54e-01 | 3.54e-01 |
| GOBP TOXIN TRANSPORT | 11 | 1.45e-01 | -2.54e-01 | 6.71e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 24 | 3.15e-02 | 2.54e-01 | 3.79e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 17 | 7.06e-02 | 2.53e-01 | 5.28e-01 |
| GOBP POSITIVE REGULATION OF GONAD DEVELOPMENT | 8 | 2.15e-01 | 2.53e-01 | 7.46e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 7 | 2.46e-01 | 2.53e-01 | 7.68e-01 |
| GOBP REGULATION OF THYROID HORMONE GENERATION | 7 | 2.47e-01 | 2.53e-01 | 7.68e-01 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 2.83e-01 | -2.53e-01 | 7.95e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY | 7 | 2.47e-01 | 2.53e-01 | 7.69e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE | 7 | 2.47e-01 | 2.53e-01 | 7.69e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING | 7 | 2.47e-01 | 2.52e-01 | 7.69e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 2.84e-01 | 2.52e-01 | 7.95e-01 |
| GOBP POST EMBRYONIC EYE MORPHOGENESIS | 7 | 2.48e-01 | -2.52e-01 | 7.69e-01 |
| GOBP INTERNEURON MIGRATION | 14 | 1.02e-01 | -2.52e-01 | 5.97e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 5 | 3.29e-01 | 2.52e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 22 | 4.08e-02 | 2.52e-01 | 4.16e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 24 | 3.26e-02 | 2.52e-01 | 3.86e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 2.17e-01 | 2.52e-01 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 38 | 7.21e-03 | 2.52e-01 | 1.82e-01 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 2.85e-01 | 2.52e-01 | 7.95e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 13 | 1.16e-01 | 2.52e-01 | 6.25e-01 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 8 | 2.17e-01 | 2.52e-01 | 7.49e-01 |
| GOBP FACIAL NERVE MORPHOGENESIS | 9 | 1.91e-01 | 2.52e-01 | 7.25e-01 |
| GOCC GLYCOGEN GRANULE | 7 | 2.49e-01 | 2.52e-01 | 7.71e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 38 | 7.29e-03 | -2.52e-01 | 1.82e-01 |
| GOCC SYMMETRIC SYNAPSE | 8 | 2.18e-01 | 2.52e-01 | 7.49e-01 |
| GOBP INOSINE METABOLIC PROCESS | 5 | 3.30e-01 | 2.51e-01 | 8.15e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 15 | 9.17e-02 | 2.51e-01 | 5.82e-01 |
| GOBP BASOLATERAL PROTEIN SECRETION | 5 | 3.30e-01 | 2.51e-01 | 8.15e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 19 | 5.78e-02 | 2.51e-01 | 4.86e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 14 | 1.03e-01 | 2.51e-01 | 5.98e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 10 | 1.69e-01 | 2.51e-01 | 7.01e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 5 | 3.31e-01 | -2.51e-01 | 8.15e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 12 | 1.32e-01 | 2.51e-01 | 6.51e-01 |
| GOBP BEHAVIORAL RESPONSE TO NICOTINE | 9 | 1.92e-01 | -2.51e-01 | 7.26e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 14 | 1.04e-01 | 2.51e-01 | 5.99e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION | 11 | 1.50e-01 | 2.51e-01 | 6.80e-01 |
| GOBP TELOMERE LOCALIZATION | 12 | 1.33e-01 | -2.51e-01 | 6.51e-01 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 13 | 1.18e-01 | -2.51e-01 | 6.29e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 8 | 2.20e-01 | -2.51e-01 | 7.51e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 9 | 1.93e-01 | -2.50e-01 | 7.26e-01 |
| GOBP MRNA MODIFICATION | 31 | 1.60e-02 | -2.50e-01 | 2.73e-01 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 1.34e-01 | -2.50e-01 | 6.53e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 49 | 2.47e-03 | 2.50e-01 | 1.01e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 1.51e-01 | 2.50e-01 | 6.82e-01 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 13 | 1.19e-01 | 2.50e-01 | 6.30e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 15 | 9.41e-02 | 2.50e-01 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 23 | 3.84e-02 | 2.49e-01 | 4.07e-01 |
| GOBP NEGATIVE REGULATION OF B CELL DIFFERENTIATION | 6 | 2.90e-01 | 2.49e-01 | 7.96e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 22 | 4.31e-02 | 2.49e-01 | 4.25e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 23 | 3.87e-02 | 2.49e-01 | 4.08e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS | 6 | 2.91e-01 | -2.49e-01 | 7.97e-01 |
| GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY | 9 | 1.96e-01 | 2.49e-01 | 7.27e-01 |
| GOBP RESPONSE TO PH | 41 | 5.80e-03 | 2.49e-01 | 1.66e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 5 | 3.35e-01 | 2.49e-01 | 8.19e-01 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 9 | 1.96e-01 | 2.49e-01 | 7.27e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 12 | 1.36e-01 | 2.49e-01 | 6.55e-01 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 9 | 1.96e-01 | -2.49e-01 | 7.27e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDOGLYCAN | 6 | 2.91e-01 | 2.49e-01 | 7.97e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 7 | 2.55e-01 | 2.49e-01 | 7.76e-01 |
| GOBP REGULATION OF FLAGELLATED SPERM MOTILITY | 18 | 6.78e-02 | -2.49e-01 | 5.21e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 11 | 1.53e-01 | 2.49e-01 | 6.85e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 47 | 3.20e-03 | 2.49e-01 | 1.18e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 2.92e-01 | -2.48e-01 | 7.97e-01 |
| GOBP MESONEPHRIC DUCT DEVELOPMENT | 8 | 2.24e-01 | -2.48e-01 | 7.57e-01 |
| GOMF GALACTOSIDASE ACTIVITY | 6 | 2.93e-01 | -2.48e-01 | 7.97e-01 |
| GOMF PIRNA BINDING | 5 | 3.37e-01 | 2.48e-01 | 8.20e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 13 | 1.22e-01 | -2.48e-01 | 6.36e-01 |
| GOBP SUCCINATE METABOLIC PROCESS | 5 | 3.38e-01 | -2.48e-01 | 8.21e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 29 | 2.11e-02 | 2.47e-01 | 3.13e-01 |
| GOBP HYPOTONIC RESPONSE | 13 | 1.23e-01 | 2.47e-01 | 6.36e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 9 | 1.99e-01 | 2.47e-01 | 7.29e-01 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 20 | 5.55e-02 | -2.47e-01 | 4.80e-01 |
| GOMF U1 SNRNP BINDING | 6 | 2.94e-01 | -2.47e-01 | 7.98e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 10 | 1.76e-01 | 2.47e-01 | 7.08e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 10 | 1.76e-01 | 2.47e-01 | 7.08e-01 |
| GOBP CERAMIDE 1 PHOSPHATE TRANSPORT | 7 | 2.58e-01 | 2.47e-01 | 7.78e-01 |
| GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY | 7 | 2.58e-01 | 2.47e-01 | 7.78e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 12 | 1.39e-01 | -2.47e-01 | 6.59e-01 |
| GOBP RESPONSE TO UV B | 21 | 5.06e-02 | 2.46e-01 | 4.62e-01 |
| GOBP GTP METABOLIC PROCESS | 24 | 3.67e-02 | 2.46e-01 | 4.00e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 21 | 5.08e-02 | -2.46e-01 | 4.62e-01 |
| GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT | 15 | 9.89e-02 | -2.46e-01 | 5.95e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 25 | 3.33e-02 | -2.46e-01 | 3.88e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 16 | 8.86e-02 | -2.46e-01 | 5.75e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 26 | 3.01e-02 | 2.46e-01 | 3.70e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 11 | 1.58e-01 | -2.46e-01 | 6.91e-01 |
| GOCC TRANSLOCON COMPLEX | 5 | 3.42e-01 | -2.46e-01 | 8.22e-01 |
| GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION | 9 | 2.02e-01 | 2.46e-01 | 7.33e-01 |
| GOBP BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 2.98e-01 | -2.46e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 3.42e-01 | 2.45e-01 | 8.22e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 2.98e-01 | -2.45e-01 | 7.99e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 8 | 2.30e-01 | -2.45e-01 | 7.60e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 18 | 7.19e-02 | 2.45e-01 | 5.34e-01 |
| GOMF BH DOMAIN BINDING | 9 | 2.03e-01 | 2.45e-01 | 7.34e-01 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 8 | 2.30e-01 | 2.45e-01 | 7.60e-01 |
| GOMF ACID THIOL LIGASE ACTIVITY | 29 | 2.24e-02 | 2.45e-01 | 3.20e-01 |
| GOBP REGULATION OF FIBRINOLYSIS | 18 | 7.20e-02 | -2.45e-01 | 5.34e-01 |
| GOBP PROTEIN SIDE CHAIN DEGLUTAMYLATION | 5 | 3.43e-01 | -2.45e-01 | 8.22e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 16 | 8.99e-02 | 2.45e-01 | 5.78e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR COMPLEX | 11 | 1.60e-01 | -2.45e-01 | 6.93e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL LEADING EDGE | 5 | 3.43e-01 | 2.45e-01 | 8.22e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 16 | 9.02e-02 | 2.45e-01 | 5.78e-01 |
| GOMF HISTAMINE RECEPTOR ACTIVITY | 6 | 2.99e-01 | 2.45e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 3.43e-01 | -2.45e-01 | 8.23e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 9 | 2.04e-01 | -2.45e-01 | 7.34e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 23 | 4.24e-02 | -2.44e-01 | 4.23e-01 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 2.31e-01 | -2.44e-01 | 7.61e-01 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 13 | 1.28e-01 | -2.44e-01 | 6.43e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 39 | 8.37e-03 | 2.44e-01 | 1.97e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 23 | 4.28e-02 | 2.44e-01 | 4.24e-01 |
| GOCC HEMIDESMOSOME | 8 | 2.32e-01 | -2.44e-01 | 7.61e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 9 | 2.05e-01 | 2.44e-01 | 7.36e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 9 | 2.05e-01 | 2.44e-01 | 7.36e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 13 | 1.28e-01 | 2.44e-01 | 6.44e-01 |
| GOBP PROTEIN DE ADP RIBOSYLATION | 5 | 3.45e-01 | -2.44e-01 | 8.24e-01 |
| GOBP MIDGUT DEVELOPMENT | 10 | 1.82e-01 | -2.44e-01 | 7.14e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 39 | 8.48e-03 | 2.44e-01 | 1.99e-01 |
| GOCC EARLY PHAGOSOME | 12 | 1.44e-01 | 2.44e-01 | 6.69e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 38 | 9.41e-03 | 2.43e-01 | 2.08e-01 |
| GOCC FILTRATION DIAPHRAGM | 8 | 2.33e-01 | -2.43e-01 | 7.61e-01 |
| GOMF GUANYLATE CYCLASE ACTIVITY | 7 | 2.65e-01 | 2.43e-01 | 7.83e-01 |
| GOBP MACROPHAGE PROLIFERATION | 12 | 1.45e-01 | -2.43e-01 | 6.71e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 14 | 1.16e-01 | 2.43e-01 | 6.25e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 14 | 1.16e-01 | -2.43e-01 | 6.25e-01 |
| GOMF BMP RECEPTOR BINDING | 11 | 1.63e-01 | 2.43e-01 | 6.95e-01 |
| GOMF MORPHOGEN ACTIVITY | 8 | 2.34e-01 | -2.43e-01 | 7.61e-01 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 18 | 7.45e-02 | 2.43e-01 | 5.41e-01 |
| GOBP SUCCINATE TRANSMEMBRANE TRANSPORT | 6 | 3.03e-01 | 2.43e-01 | 8.02e-01 |
| GOMF SUCCINATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.03e-01 | 2.43e-01 | 8.02e-01 |
| GOBP EQUILIBRIOCEPTION | 7 | 2.66e-01 | 2.43e-01 | 7.83e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION | 6 | 3.03e-01 | 2.43e-01 | 8.02e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 14 | 1.16e-01 | 2.43e-01 | 6.26e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 10 | 1.84e-01 | 2.42e-01 | 7.18e-01 |
| GOBP CILIARY BODY MORPHOGENESIS | 5 | 3.48e-01 | 2.42e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 22 | 4.91e-02 | -2.42e-01 | 4.55e-01 |
| GOCC MRNA CAP BINDING COMPLEX | 11 | 1.64e-01 | 2.42e-01 | 6.97e-01 |
| GOBP PROTEIN DEMETHYLATION | 9 | 2.08e-01 | 2.42e-01 | 7.39e-01 |
| GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 6 | 3.04e-01 | -2.42e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF ENAMEL MINERALIZATION | 5 | 3.48e-01 | -2.42e-01 | 8.26e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 6 | 3.05e-01 | 2.42e-01 | 8.02e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 11 | 1.65e-01 | 2.42e-01 | 6.97e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 10 | 1.86e-01 | 2.42e-01 | 7.21e-01 |
| GOBP PROTEIN LOCALIZATION TO AXON | 9 | 2.09e-01 | -2.42e-01 | 7.40e-01 |
| GOMF AMINO ACID BINDING | 47 | 4.15e-03 | 2.42e-01 | 1.35e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 46 | 4.60e-03 | 2.41e-01 | 1.44e-01 |
| GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY | 11 | 1.66e-01 | 2.41e-01 | 6.98e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 17 | 8.49e-02 | -2.41e-01 | 5.68e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 13 | 1.32e-01 | -2.41e-01 | 6.51e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 39 | 9.10e-03 | 2.41e-01 | 2.06e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 26 | 3.32e-02 | 2.41e-01 | 3.88e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 28 | 2.71e-02 | 2.41e-01 | 3.50e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL DEGRANULATION | 5 | 3.51e-01 | -2.41e-01 | 8.26e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 34 | 1.50e-02 | 2.41e-01 | 2.62e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 24 | 4.10e-02 | 2.41e-01 | 4.16e-01 |
| GOMF CADMIUM ION BINDING | 5 | 3.51e-01 | 2.41e-01 | 8.26e-01 |
| GOBP NEURAL PLATE ANTERIOR POSTERIOR REGIONALIZATION | 5 | 3.51e-01 | 2.41e-01 | 8.26e-01 |
| GOBP LIPID EXPORT FROM CELL | 47 | 4.28e-03 | 2.41e-01 | 1.37e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC | 8 | 2.38e-01 | -2.41e-01 | 7.63e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 18 | 7.71e-02 | -2.41e-01 | 5.48e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 24 | 4.13e-02 | 2.41e-01 | 4.17e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 9 | 2.11e-01 | 2.41e-01 | 7.43e-01 |
| GOBP REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 7 | 2.71e-01 | -2.40e-01 | 7.85e-01 |
| GOCC LATERAL ELEMENT | 14 | 1.19e-01 | 2.40e-01 | 6.30e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 11 | 1.67e-01 | 2.40e-01 | 7.00e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 12 | 1.50e-01 | -2.40e-01 | 6.80e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 13 | 1.34e-01 | 2.40e-01 | 6.53e-01 |
| GOMF UNIPORTER ACTIVITY | 8 | 2.40e-01 | 2.40e-01 | 7.64e-01 |
| GOCC CYTOSOLIC REGION | 19 | 7.00e-02 | 2.40e-01 | 5.28e-01 |
| GOBP ENDOTHELIAL CELL MORPHOGENESIS | 9 | 2.13e-01 | -2.40e-01 | 7.44e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 11 | 1.69e-01 | 2.40e-01 | 7.01e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 12 | 1.51e-01 | 2.39e-01 | 6.82e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 5 | 3.54e-01 | 2.39e-01 | 8.28e-01 |
| GOCC JUNCTIONAL MEMBRANE COMPLEX | 6 | 3.10e-01 | -2.39e-01 | 8.06e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 21 | 5.79e-02 | 2.39e-01 | 4.86e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS OXYGEN AS ACCEPTOR | 5 | 3.55e-01 | -2.39e-01 | 8.29e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CELL COMMUNICATION BY ELECTRICAL COUPLING | 8 | 2.42e-01 | 2.39e-01 | 7.65e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL | 5 | 3.55e-01 | -2.39e-01 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 1.70e-01 | -2.39e-01 | 7.04e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 42 | 7.48e-03 | -2.39e-01 | 1.83e-01 |
| GOCC SECONDARY LYSOSOME | 16 | 9.87e-02 | 2.38e-01 | 5.95e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 3.12e-01 | -2.38e-01 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 25 | 3.94e-02 | 2.38e-01 | 4.11e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 41 | 8.39e-03 | 2.38e-01 | 1.97e-01 |
| GOMF COBALAMIN BINDING | 9 | 2.17e-01 | 2.38e-01 | 7.48e-01 |
| GOMF LACTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.13e-01 | 2.38e-01 | 8.08e-01 |
| GOBP CRANIAL SUTURE MORPHOGENESIS | 8 | 2.44e-01 | -2.38e-01 | 7.68e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 9 | 2.17e-01 | -2.38e-01 | 7.49e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 2.17e-01 | 2.38e-01 | 7.49e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 10 | 1.93e-01 | 2.38e-01 | 7.26e-01 |
| GOBP COMMON BILE DUCT DEVELOPMENT | 5 | 3.58e-01 | 2.38e-01 | 8.31e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 19 | 7.31e-02 | -2.38e-01 | 5.36e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 3.14e-01 | -2.37e-01 | 8.08e-01 |
| GOBP DETECTION OF STIMULUS | 571 | 2.77e-22 | -2.37e-01 | 5.68e-19 |
| GOBP RESPONSE TO IRON II ION | 6 | 3.14e-01 | 2.37e-01 | 8.08e-01 |
| GOBP RESPONSE TO INACTIVITY | 12 | 1.55e-01 | 2.37e-01 | 6.88e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 13 | 1.39e-01 | -2.37e-01 | 6.59e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 11 | 1.74e-01 | 2.37e-01 | 7.05e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 21 | 6.03e-02 | 2.37e-01 | 4.94e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 14 | 1.25e-01 | -2.37e-01 | 6.41e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 16 | 1.01e-01 | 2.37e-01 | 5.96e-01 |
| GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS | 8 | 2.46e-01 | -2.37e-01 | 7.68e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 9 | 2.19e-01 | 2.37e-01 | 7.50e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 27 | 3.33e-02 | 2.37e-01 | 3.88e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 30 | 2.49e-02 | 2.37e-01 | 3.35e-01 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 2.79e-01 | 2.37e-01 | 7.92e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 7 | 2.79e-01 | -2.37e-01 | 7.92e-01 |
| GOBP REGULATION OF PHENOTYPIC SWITCHING | 6 | 3.16e-01 | 2.36e-01 | 8.09e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 1.74e-01 | -2.36e-01 | 7.05e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 3.16e-01 | -2.36e-01 | 8.09e-01 |
| GOMF FK506 BINDING | 10 | 1.96e-01 | 2.36e-01 | 7.27e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 3.17e-01 | -2.36e-01 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 7 | 2.80e-01 | -2.36e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 21 | 6.12e-02 | -2.36e-01 | 4.97e-01 |
| GOCC CYTOLYTIC GRANULE | 13 | 1.41e-01 | 2.36e-01 | 6.62e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 1.57e-01 | -2.36e-01 | 6.91e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 3.61e-01 | 2.36e-01 | 8.33e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 14 | 1.27e-01 | -2.36e-01 | 6.43e-01 |
| GOCC NODE OF RANVIER | 16 | 1.03e-01 | -2.36e-01 | 5.97e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 16 | 1.03e-01 | 2.36e-01 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 7 | 2.81e-01 | 2.35e-01 | 7.93e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 50 | 3.97e-03 | 2.35e-01 | 1.33e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 6 | 3.18e-01 | -2.35e-01 | 8.10e-01 |
| GOBP MUSCLE CELL FATE COMMITMENT | 20 | 6.84e-02 | 2.35e-01 | 5.22e-01 |
| GOBP NOTOCHORD MORPHOGENESIS | 8 | 2.49e-01 | 2.35e-01 | 7.71e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 18 | 8.39e-02 | 2.35e-01 | 5.66e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 7 | 2.81e-01 | -2.35e-01 | 7.93e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 3.19e-01 | 2.35e-01 | 8.10e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 15 | 1.15e-01 | 2.35e-01 | 6.24e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 11 | 1.77e-01 | -2.35e-01 | 7.10e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN D | 5 | 3.63e-01 | -2.35e-01 | 8.33e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 17 | 9.37e-02 | 2.35e-01 | 5.88e-01 |
| GOBP REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 3.63e-01 | 2.35e-01 | 8.33e-01 |
| GOBP HEXOSE PHOSPHATE TRANSPORT | 7 | 2.82e-01 | -2.35e-01 | 7.94e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 7 | 2.83e-01 | 2.35e-01 | 7.94e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 3.20e-01 | 2.34e-01 | 8.10e-01 |
| GOBP RESPONSE TO DISACCHARIDE | 7 | 2.83e-01 | -2.34e-01 | 7.94e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 37 | 1.37e-02 | 2.34e-01 | 2.52e-01 |
| GOMF GLYCOSPHINGOLIPID BINDING | 10 | 2.00e-01 | 2.34e-01 | 7.31e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 9 | 2.24e-01 | -2.34e-01 | 7.57e-01 |
| GOMF S100 PROTEIN BINDING | 14 | 1.29e-01 | 2.34e-01 | 6.48e-01 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 9 | 2.25e-01 | -2.34e-01 | 7.57e-01 |
| GOBP HYPERSENSITIVITY | 10 | 2.01e-01 | 2.34e-01 | 7.32e-01 |
| GOBP HEMIDESMOSOME ASSEMBLY | 6 | 3.22e-01 | -2.34e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 17 | 9.54e-02 | 2.34e-01 | 5.89e-01 |
| GOBP GLUCOCORTICOID SECRETION | 12 | 1.61e-01 | 2.34e-01 | 6.95e-01 |
| GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY | 7 | 2.85e-01 | 2.33e-01 | 7.95e-01 |
| GOBP PROTEIN SULFATION | 6 | 3.22e-01 | 2.33e-01 | 8.10e-01 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 7 | 2.85e-01 | 2.33e-01 | 7.95e-01 |
| GOBP POSITIVE REGULATION OF ANOIKIS | 6 | 3.22e-01 | -2.33e-01 | 8.10e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 2.85e-01 | 2.33e-01 | 7.95e-01 |
| GOMF URATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 2.26e-01 | 2.33e-01 | 7.59e-01 |
| GOBP REGULATION OF GONADOTROPIN SECRETION | 11 | 1.81e-01 | 2.33e-01 | 7.13e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 2.86e-01 | 2.33e-01 | 7.95e-01 |
| GOBP REGULATION OF CGMP MEDIATED SIGNALING | 11 | 1.81e-01 | -2.33e-01 | 7.14e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 21 | 6.49e-02 | 2.33e-01 | 5.11e-01 |
| GOBP MITOCHONDRION MORPHOGENESIS | 20 | 7.18e-02 | -2.33e-01 | 5.34e-01 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 3.68e-01 | 2.33e-01 | 8.33e-01 |
| GOBP MAST CELL PROLIFERATION | 7 | 2.87e-01 | 2.33e-01 | 7.95e-01 |
| GOMF STEROL ESTERASE ACTIVITY | 7 | 2.87e-01 | 2.33e-01 | 7.95e-01 |
| GOBP NORADRENERGIC NEURON DIFFERENTIATION | 10 | 2.03e-01 | 2.33e-01 | 7.34e-01 |
| GOBP NEURONAL ACTION POTENTIAL PROPAGATION | 9 | 2.27e-01 | -2.32e-01 | 7.60e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 32 | 2.29e-02 | 2.32e-01 | 3.23e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 11 | 1.82e-01 | 2.32e-01 | 7.14e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 59 | 2.03e-03 | 2.32e-01 | 8.96e-02 |
| GOMF N ACETYLGLUCOSAMINE 6 O SULFOTRANSFERASE ACTIVITY | 6 | 3.25e-01 | 2.32e-01 | 8.10e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 13 | 1.47e-01 | 2.32e-01 | 6.74e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 14 | 1.33e-01 | -2.32e-01 | 6.51e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 17 | 9.78e-02 | -2.32e-01 | 5.95e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 41 | 1.02e-02 | 2.32e-01 | 2.16e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 9 | 2.29e-01 | -2.32e-01 | 7.60e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 34 | 1.94e-02 | -2.32e-01 | 2.99e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 17 | 9.83e-02 | -2.32e-01 | 5.95e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 23 | 5.46e-02 | 2.31e-01 | 4.78e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 19 | 8.07e-02 | 2.31e-01 | 5.57e-01 |
| GOBP SECONDARY HEART FIELD SPECIFICATION | 11 | 1.84e-01 | 2.31e-01 | 7.18e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 10 | 2.05e-01 | 2.31e-01 | 7.36e-01 |
| GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION | 5 | 3.70e-01 | 2.31e-01 | 8.33e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 16 | 1.09e-01 | 2.31e-01 | 6.09e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 31 | 2.59e-02 | 2.31e-01 | 3.42e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 10 | 2.06e-01 | -2.31e-01 | 7.37e-01 |
| GOBP ANDROGEN BIOSYNTHETIC PROCESS | 10 | 2.06e-01 | -2.31e-01 | 7.37e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 37 | 1.50e-02 | 2.31e-01 | 2.62e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 3.71e-01 | -2.31e-01 | 8.33e-01 |
| GOBP ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION | 6 | 3.27e-01 | 2.31e-01 | 8.13e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 5 | 3.71e-01 | 2.31e-01 | 8.33e-01 |
| GOBP MYOBLAST FATE COMMITMENT | 6 | 3.28e-01 | 2.31e-01 | 8.13e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 34 | 1.99e-02 | 2.31e-01 | 3.01e-01 |
| GOCC PI BODY | 10 | 2.07e-01 | 2.31e-01 | 7.37e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 13 | 1.50e-01 | 2.30e-01 | 6.81e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 3.73e-01 | 2.30e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 29 | 3.19e-02 | 2.30e-01 | 3.81e-01 |
| GOMF INHIBITORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 11 | 1.86e-01 | 2.30e-01 | 7.22e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 22 | 6.17e-02 | 2.30e-01 | 4.98e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE C ACTIVITY | 5 | 3.73e-01 | 2.30e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 7 | 2.92e-01 | 2.30e-01 | 7.97e-01 |
| GOMF MHC CLASS II PROTEIN BINDING | 7 | 2.92e-01 | 2.30e-01 | 7.97e-01 |
| GOBP REGULATION OF CORTISOL BIOSYNTHETIC PROCESS | 7 | 2.92e-01 | 2.30e-01 | 7.97e-01 |
| GOMF QUINONE BINDING | 15 | 1.23e-01 | 2.30e-01 | 6.38e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 7 | 2.92e-01 | 2.30e-01 | 7.97e-01 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 11 | 1.87e-01 | -2.30e-01 | 7.23e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 11 | 1.87e-01 | -2.30e-01 | 7.23e-01 |
| GOBP LACTATE TRANSMEMBRANE TRANSPORT | 7 | 2.93e-01 | 2.30e-01 | 7.97e-01 |
| GOMF FMN BINDING | 15 | 1.24e-01 | 2.29e-01 | 6.38e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 14 | 1.37e-01 | 2.29e-01 | 6.58e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 82 | 3.35e-04 | 2.29e-01 | 2.98e-02 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 11 | 1.89e-01 | 2.29e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 11 | 1.89e-01 | 2.29e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 11 | 1.89e-01 | -2.29e-01 | 7.24e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 9 | 2.35e-01 | -2.29e-01 | 7.62e-01 |
| GOBP METANEPHRIC S SHAPED BODY MORPHOGENESIS | 5 | 3.76e-01 | 2.28e-01 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 11 | 1.90e-01 | 2.28e-01 | 7.24e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 2.11e-01 | 2.28e-01 | 7.43e-01 |
| GOBP VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION | 13 | 1.54e-01 | 2.28e-01 | 6.87e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 15 | 1.26e-01 | 2.28e-01 | 6.43e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 13 | 1.55e-01 | -2.28e-01 | 6.87e-01 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 8 | 2.64e-01 | 2.28e-01 | 7.83e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 8 | 2.64e-01 | 2.28e-01 | 7.83e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 23 | 5.83e-02 | 2.28e-01 | 4.88e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 19 | 8.55e-02 | 2.28e-01 | 5.70e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 6 | 3.34e-01 | 2.28e-01 | 8.18e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 8 | 2.65e-01 | 2.28e-01 | 7.83e-01 |
| GOBP KERATINOCYTE MIGRATION | 20 | 7.80e-02 | 2.28e-01 | 5.49e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 21 | 7.11e-02 | 2.27e-01 | 5.31e-01 |
| GOBP BLEB ASSEMBLY | 11 | 1.91e-01 | 2.27e-01 | 7.25e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 2.13e-01 | 2.27e-01 | 7.44e-01 |
| GOBP INTERLEUKIN 21 PRODUCTION | 5 | 3.79e-01 | -2.27e-01 | 8.36e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 8 | 2.66e-01 | 2.27e-01 | 7.83e-01 |
| GOBP LEUKOTRIENE D4 BIOSYNTHETIC PROCESS | 5 | 3.79e-01 | -2.27e-01 | 8.36e-01 |
| GOBP MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE | 5 | 3.79e-01 | -2.27e-01 | 8.36e-01 |
| GOCC CELL TRAILING EDGE | 13 | 1.56e-01 | 2.27e-01 | 6.91e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 40 | 1.30e-02 | 2.27e-01 | 2.49e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION | 5 | 3.80e-01 | -2.27e-01 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 21 | 7.20e-02 | 2.27e-01 | 5.34e-01 |
| GOBP RESPONSE TO IRON ION | 28 | 3.78e-02 | 2.27e-01 | 4.05e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 23 | 5.98e-02 | 2.27e-01 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 12 | 1.74e-01 | -2.27e-01 | 7.05e-01 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 6 | 3.37e-01 | 2.26e-01 | 8.20e-01 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 13 | 1.57e-01 | 2.26e-01 | 6.91e-01 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 12 | 1.74e-01 | -2.26e-01 | 7.05e-01 |
| GOMF PYRUVATE DEHYDROGENASE LIPOAMIDE PHOSPHATASE ACTIVITY | 5 | 3.81e-01 | -2.26e-01 | 8.37e-01 |
| GOBP REPLICATIVE SENESCENCE | 17 | 1.06e-01 | -2.26e-01 | 6.02e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 12 | 1.75e-01 | 2.26e-01 | 7.07e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 8 | 2.68e-01 | -2.26e-01 | 7.84e-01 |
| GOBP REGULATION OF ASTROCYTE ACTIVATION | 8 | 2.68e-01 | -2.26e-01 | 7.84e-01 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 10 | 2.16e-01 | 2.26e-01 | 7.48e-01 |
| GOBP ERBB4 ERBB4 SIGNALING PATHWAY | 6 | 3.38e-01 | -2.26e-01 | 8.21e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 28 | 3.85e-02 | 2.26e-01 | 4.08e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 7 | 3.01e-01 | -2.26e-01 | 8.02e-01 |
| GOMF SELENIUM BINDING | 9 | 2.41e-01 | -2.26e-01 | 7.65e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 29 | 3.54e-02 | 2.26e-01 | 3.95e-01 |
| GOCC SPERM CONNECTING PIECE | 9 | 2.41e-01 | 2.26e-01 | 7.65e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 20 | 8.08e-02 | -2.26e-01 | 5.57e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE | 5 | 3.83e-01 | 2.25e-01 | 8.38e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE | 6 | 3.39e-01 | -2.25e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 12 | 1.76e-01 | -2.25e-01 | 7.09e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE GROWTH | 6 | 3.39e-01 | 2.25e-01 | 8.22e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 12 | 1.76e-01 | 2.25e-01 | 7.09e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURAL PLASTICITY | 7 | 3.02e-01 | -2.25e-01 | 8.02e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 60 | 2.53e-03 | 2.25e-01 | 1.03e-01 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 3.83e-01 | 2.25e-01 | 8.38e-01 |
| GOMF POLYSACCHARIDE BINDING | 21 | 7.41e-02 | 2.25e-01 | 5.41e-01 |
| GOBP REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS | 7 | 3.02e-01 | -2.25e-01 | 8.02e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 1.19e-01 | -2.25e-01 | 6.30e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 11 | 1.96e-01 | 2.25e-01 | 7.27e-01 |
| GOBP EYE PIGMENTATION | 5 | 3.84e-01 | -2.25e-01 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 33 | 2.54e-02 | -2.25e-01 | 3.38e-01 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 11 | 1.97e-01 | 2.25e-01 | 7.27e-01 |
| GOBP RESPONSE TO THYROGLOBULIN TRIIODOTHYRONINE | 5 | 3.84e-01 | 2.25e-01 | 8.39e-01 |
| GOBP RESPONSE TO ZINC ION | 48 | 7.07e-03 | 2.25e-01 | 1.81e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 17 | 1.09e-01 | 2.24e-01 | 6.09e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 21 | 7.50e-02 | -2.24e-01 | 5.43e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 3.42e-01 | -2.24e-01 | 8.22e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 13 | 1.62e-01 | -2.24e-01 | 6.95e-01 |
| GOCC PARASPECKLES | 7 | 3.05e-01 | 2.24e-01 | 8.02e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 19 | 9.10e-02 | 2.24e-01 | 5.81e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 2.45e-01 | 2.24e-01 | 7.68e-01 |
| GOCC NADPH OXIDASE COMPLEX | 13 | 1.63e-01 | 2.24e-01 | 6.95e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 21 | 7.60e-02 | 2.24e-01 | 5.45e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 31 | 3.12e-02 | 2.24e-01 | 3.77e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 14 | 1.48e-01 | -2.24e-01 | 6.75e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 1.99e-01 | -2.24e-01 | 7.30e-01 |
| GOMF ALPHA ADRENERGIC RECEPTOR ACTIVITY | 6 | 3.43e-01 | 2.24e-01 | 8.22e-01 |
| GOBP REGULATION OF GLUCAGON SECRETION | 8 | 2.74e-01 | 2.23e-01 | 7.87e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 25 | 5.34e-02 | 2.23e-01 | 4.75e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 1.11e-01 | -2.23e-01 | 6.15e-01 |
| GOBP ACID SECRETION | 43 | 1.14e-02 | 2.23e-01 | 2.29e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 14 | 1.49e-01 | 2.23e-01 | 6.77e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 31 | 3.17e-02 | 2.23e-01 | 3.80e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 8 | 2.75e-01 | 2.23e-01 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 5 | 3.88e-01 | -2.23e-01 | 8.41e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 19 | 9.27e-02 | -2.23e-01 | 5.85e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 28 | 4.13e-02 | 2.23e-01 | 4.17e-01 |
| GOMF SPHINGOLIPID BINDING | 28 | 4.13e-02 | 2.23e-01 | 4.17e-01 |
| GOBP CELLULAR RESPONSE TO COCAINE | 8 | 2.76e-01 | 2.23e-01 | 7.88e-01 |
| GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY | 21 | 7.75e-02 | 2.23e-01 | 5.49e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 8 | 2.76e-01 | -2.22e-01 | 7.88e-01 |
| GOBP TOXIN METABOLIC PROCESS | 14 | 1.50e-01 | -2.22e-01 | 6.80e-01 |
| GOBP LYMPHANGIOGENESIS | 18 | 1.03e-01 | -2.22e-01 | 5.98e-01 |
| GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION | 12 | 1.83e-01 | -2.22e-01 | 7.16e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 16 | 1.24e-01 | 2.22e-01 | 6.38e-01 |
| GOBP SYMPATHETIC NEURON PROJECTION EXTENSION | 5 | 3.90e-01 | 2.22e-01 | 8.42e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 9 | 2.49e-01 | 2.22e-01 | 7.71e-01 |
| GOBP NEGATIVE REGULATION OF NEURON MIGRATION | 9 | 2.49e-01 | -2.22e-01 | 7.71e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 3.91e-01 | 2.22e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 31 | 3.27e-02 | 2.22e-01 | 3.86e-01 |
| GOBP HINDBRAIN TANGENTIAL CELL MIGRATION | 5 | 3.91e-01 | 2.21e-01 | 8.42e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 11 | 2.04e-01 | -2.21e-01 | 7.34e-01 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 7 | 3.10e-01 | 2.21e-01 | 8.07e-01 |
| GOMF NEUROLIGIN FAMILY PROTEIN BINDING | 5 | 3.91e-01 | -2.21e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 8 | 2.79e-01 | 2.21e-01 | 7.93e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 2.26e-01 | -2.21e-01 | 7.59e-01 |
| GOBP HISTAMINE METABOLIC PROCESS | 6 | 3.49e-01 | 2.21e-01 | 8.26e-01 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 7 | 3.11e-01 | -2.21e-01 | 8.08e-01 |
| GOBP PHENYLPROPANOID METABOLIC PROCESS | 6 | 3.49e-01 | 2.21e-01 | 8.26e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 38 | 1.86e-02 | 2.21e-01 | 2.94e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 7 | 3.13e-01 | 2.20e-01 | 8.08e-01 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 7 | 3.13e-01 | 2.20e-01 | 8.08e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 1.40e-01 | -2.20e-01 | 6.60e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 2.81e-01 | -2.20e-01 | 7.93e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 32 | 3.11e-02 | 2.20e-01 | 3.77e-01 |
| GOBP MESODERMAL CELL FATE SPECIFICATION | 12 | 1.87e-01 | -2.20e-01 | 7.23e-01 |
| GOBP RECEPTOR DIFFUSION TRAPPING | 10 | 2.28e-01 | -2.20e-01 | 7.60e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 11 | 2.06e-01 | 2.20e-01 | 7.37e-01 |
| GOBP NEPHRIC DUCT FORMATION | 5 | 3.94e-01 | -2.20e-01 | 8.44e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 16 | 1.28e-01 | 2.20e-01 | 6.43e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 29 | 4.03e-02 | 2.20e-01 | 4.14e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 6 | 3.51e-01 | -2.20e-01 | 8.26e-01 |
| GOMF PROTEIN KINASE C ACTIVITY | 16 | 1.28e-01 | 2.20e-01 | 6.43e-01 |
| GOMF CLATHRIN BINDING | 68 | 1.71e-03 | 2.20e-01 | 8.29e-02 |
| GOCC CARDIAC MYOFIBRIL | 6 | 3.51e-01 | 2.20e-01 | 8.26e-01 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 8 | 2.81e-01 | 2.20e-01 | 7.93e-01 |
| GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS | 6 | 3.51e-01 | 2.20e-01 | 8.26e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 15 | 1.41e-01 | -2.20e-01 | 6.62e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 10 | 2.29e-01 | 2.20e-01 | 7.60e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 7 | 3.14e-01 | 2.20e-01 | 8.08e-01 |
| GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS | 5 | 3.95e-01 | 2.19e-01 | 8.45e-01 |
| GOBP POSITIVE REGULATION OF CILIUM MOVEMENT | 11 | 2.08e-01 | -2.19e-01 | 7.39e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 71 | 1.40e-03 | 2.19e-01 | 7.45e-02 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 3.15e-01 | 2.19e-01 | 8.08e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 47 | 9.36e-03 | 2.19e-01 | 2.08e-01 |
| GOBP REGULATION OF MELANOCYTE DIFFERENTIATION | 6 | 3.53e-01 | 2.19e-01 | 8.27e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 13 | 1.72e-01 | 2.19e-01 | 7.04e-01 |
| GOMF GAMMA CATENIN BINDING | 12 | 1.89e-01 | -2.19e-01 | 7.24e-01 |
| GOBP PENETRATION OF ZONA PELLUCIDA | 9 | 2.56e-01 | 2.19e-01 | 7.77e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 16 | 1.30e-01 | 2.19e-01 | 6.48e-01 |
| GOBP ANDROGEN CATABOLIC PROCESS | 5 | 3.97e-01 | 2.19e-01 | 8.45e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 9 | 2.56e-01 | 2.19e-01 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION | 12 | 1.90e-01 | -2.19e-01 | 7.24e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 6 | 3.54e-01 | -2.19e-01 | 8.28e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 14 | 1.57e-01 | 2.18e-01 | 6.91e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 15 | 1.43e-01 | -2.18e-01 | 6.68e-01 |
| GOBP REGULATION OF GASTRULATION | 16 | 1.31e-01 | 2.18e-01 | 6.50e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 23 | 7.01e-02 | -2.18e-01 | 5.28e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 3.18e-01 | 2.18e-01 | 8.10e-01 |
| GOMF INSULIN RECEPTOR BINDING | 21 | 8.38e-02 | 2.18e-01 | 5.66e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 12 | 1.91e-01 | 2.18e-01 | 7.25e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 3.99e-01 | 2.18e-01 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 8 | 2.86e-01 | 2.18e-01 | 7.95e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 3.56e-01 | 2.18e-01 | 8.30e-01 |
| GOMF GAMMA AMINOBUTYRIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.87e-01 | 2.17e-01 | 7.95e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 9 | 2.59e-01 | 2.17e-01 | 7.78e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 27 | 5.06e-02 | 2.17e-01 | 4.62e-01 |
| GOBP METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE | 5 | 4.00e-01 | -2.17e-01 | 8.46e-01 |
| GOMF ER RETENTION SEQUENCE BINDING | 5 | 4.00e-01 | 2.17e-01 | 8.46e-01 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 12 | 1.93e-01 | -2.17e-01 | 7.26e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 17 | 1.22e-01 | -2.17e-01 | 6.35e-01 |
| GOBP NADPH REGENERATION | 21 | 8.57e-02 | 2.17e-01 | 5.70e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 15 | 1.46e-01 | 2.17e-01 | 6.73e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID BIOSYNTHETIC PROCESS | 6 | 3.58e-01 | 2.17e-01 | 8.31e-01 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 9 | 2.61e-01 | 2.16e-01 | 7.82e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 14 | 1.61e-01 | 2.16e-01 | 6.95e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 12 | 1.95e-01 | -2.16e-01 | 7.27e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 4.03e-01 | -2.16e-01 | 8.46e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 6.71e-02 | -2.16e-01 | 5.20e-01 |
| GOBP UMP CATABOLIC PROCESS | 5 | 4.03e-01 | 2.16e-01 | 8.47e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 21 | 8.70e-02 | 2.16e-01 | 5.73e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 58 | 4.50e-03 | 2.16e-01 | 1.43e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 10 | 2.38e-01 | 2.15e-01 | 7.63e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 7 | 3.24e-01 | -2.15e-01 | 8.10e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 15 | 1.49e-01 | 2.15e-01 | 6.78e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 70 | 1.85e-03 | 2.15e-01 | 8.58e-02 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 2.39e-01 | 2.15e-01 | 7.63e-01 |
| GOBP SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX | 5 | 4.05e-01 | -2.15e-01 | 8.49e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 14 | 1.64e-01 | -2.15e-01 | 6.96e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 19 | 1.05e-01 | 2.15e-01 | 5.99e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 31 | 3.83e-02 | 2.15e-01 | 4.07e-01 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 21 | 8.82e-02 | 2.15e-01 | 5.75e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 29 | 4.52e-02 | 2.15e-01 | 4.37e-01 |
| GOCC ACTIN FILAMENT | 105 | 1.42e-04 | 2.15e-01 | 1.81e-02 |
| GOBP DETOXIFICATION OF COPPER ION | 15 | 1.50e-01 | 2.15e-01 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 4.05e-01 | 2.15e-01 | 8.49e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 4.06e-01 | -2.15e-01 | 8.49e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 10 | 2.40e-01 | -2.15e-01 | 7.64e-01 |
| GOBP UTERUS MORPHOGENESIS | 6 | 3.63e-01 | 2.15e-01 | 8.33e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 9 | 2.65e-01 | -2.15e-01 | 7.83e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 16 | 1.37e-01 | 2.15e-01 | 6.58e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 13 | 1.81e-01 | -2.14e-01 | 7.13e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 9 | 2.66e-01 | -2.14e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 28 | 4.98e-02 | 2.14e-01 | 4.58e-01 |
| GOCC GTPASE COMPLEX | 38 | 2.24e-02 | 2.14e-01 | 3.20e-01 |
| GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY | 11 | 2.19e-01 | 2.14e-01 | 7.50e-01 |
| GOBP RESPONSE TO MUSCLE INACTIVITY | 9 | 2.66e-01 | 2.14e-01 | 7.83e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 5 | 4.07e-01 | -2.14e-01 | 8.49e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 15 | 1.52e-01 | 2.14e-01 | 6.83e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 4.08e-01 | -2.14e-01 | 8.49e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 17 | 1.27e-01 | 2.14e-01 | 6.43e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 29 | 4.64e-02 | 2.14e-01 | 4.44e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 44 | 1.42e-02 | 2.14e-01 | 2.56e-01 |
| GOMF AMINO ACID PROTON SYMPORTER ACTIVITY | 6 | 3.65e-01 | -2.14e-01 | 8.33e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 9 | 2.67e-01 | -2.14e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF THYROID HORMONE GENERATION | 5 | 4.08e-01 | 2.13e-01 | 8.49e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 18 | 1.17e-01 | 2.13e-01 | 6.28e-01 |
| GOBP METANEPHRIC PART OF URETERIC BUD DEVELOPMENT | 6 | 3.66e-01 | 2.13e-01 | 8.33e-01 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 3.66e-01 | 2.13e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 9 | 2.68e-01 | -2.13e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 10 | 2.43e-01 | -2.13e-01 | 7.66e-01 |
| GOCC GEMINI OF COILED BODIES | 11 | 2.21e-01 | 2.13e-01 | 7.54e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 18 | 1.18e-01 | -2.13e-01 | 6.29e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 32 | 3.71e-02 | 2.13e-01 | 4.03e-01 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 9 | 2.69e-01 | 2.13e-01 | 7.84e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 23 | 7.74e-02 | 2.13e-01 | 5.49e-01 |
| GOMF PATCHED BINDING | 8 | 2.98e-01 | -2.13e-01 | 7.99e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 23 | 7.76e-02 | 2.13e-01 | 5.49e-01 |
| GOBP OXIDATIVE DEMETHYLATION | 14 | 1.68e-01 | -2.13e-01 | 7.01e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 2.02e-01 | 2.13e-01 | 7.33e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 9 | 2.70e-01 | -2.13e-01 | 7.84e-01 |
| GOMF ACROSIN BINDING | 5 | 4.11e-01 | 2.13e-01 | 8.49e-01 |
| GOBP ECTODERM DEVELOPMENT | 21 | 9.20e-02 | 2.12e-01 | 5.83e-01 |
| GOBP SINOATRIAL NODE CELL DIFFERENTIATION | 6 | 3.68e-01 | 2.12e-01 | 8.33e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 54 | 6.99e-03 | 2.12e-01 | 1.80e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 10 | 2.46e-01 | 2.12e-01 | 7.68e-01 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 6 | 3.69e-01 | 2.12e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 12 | 2.04e-01 | 2.12e-01 | 7.34e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 28 | 5.23e-02 | 2.12e-01 | 4.69e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 6 | 3.69e-01 | 2.12e-01 | 8.33e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 7 | 3.32e-01 | -2.12e-01 | 8.15e-01 |
| GOBP REGULATION OF MESODERM DEVELOPMENT | 6 | 3.69e-01 | -2.12e-01 | 8.33e-01 |
| GOBP GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS | 8 | 3.00e-01 | -2.12e-01 | 8.00e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 12 | 2.04e-01 | -2.12e-01 | 7.35e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 21 | 9.35e-02 | -2.11e-01 | 5.88e-01 |
| GOMF INTRACELLULAR CAMP ACTIVATED CATION CHANNEL ACTIVITY | 8 | 3.01e-01 | 2.11e-01 | 8.01e-01 |
| GOBP PIGMENT ACCUMULATION | 11 | 2.25e-01 | 2.11e-01 | 7.57e-01 |
| GOBP RIBOFLAVIN TRANSPORT | 6 | 3.70e-01 | 2.11e-01 | 8.33e-01 |
| GOMF RIBOFLAVIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.70e-01 | 2.11e-01 | 8.33e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 17 | 1.32e-01 | 2.11e-01 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 18 | 1.21e-01 | -2.11e-01 | 6.33e-01 |
| GOBP RESPONSE TO INSECTICIDE | 6 | 3.71e-01 | 2.11e-01 | 8.33e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 14 | 1.72e-01 | 2.11e-01 | 7.04e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 11 | 2.26e-01 | -2.11e-01 | 7.59e-01 |
| GOMF RETINYL PALMITATE ESTERASE ACTIVITY | 6 | 3.71e-01 | 2.11e-01 | 8.33e-01 |
| GOBP NEURON FATE SPECIFICATION | 34 | 3.33e-02 | 2.11e-01 | 3.88e-01 |
| GOBP OMEGA HYDROXYLASE P450 PATHWAY | 11 | 2.26e-01 | -2.11e-01 | 7.59e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN OSTEOBLAST DIFFERENTIATION | 7 | 3.34e-01 | -2.11e-01 | 8.18e-01 |
| GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION | 5 | 4.14e-01 | 2.11e-01 | 8.51e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 22 | 8.70e-02 | 2.11e-01 | 5.73e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 46 | 1.35e-02 | 2.11e-01 | 2.52e-01 |
| GOMF ACTIVIN BINDING | 11 | 2.27e-01 | 2.10e-01 | 7.60e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 13 | 1.89e-01 | 2.10e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 7 | 3.35e-01 | 2.10e-01 | 8.19e-01 |
| GOMF PROFILIN BINDING | 10 | 2.50e-01 | 2.10e-01 | 7.71e-01 |
| GOBP NEUTROPHIL MIGRATION | 118 | 7.97e-05 | 2.10e-01 | 1.32e-02 |
| GOCC B WICH COMPLEX | 7 | 3.36e-01 | -2.10e-01 | 8.20e-01 |
| GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 13 | 1.90e-01 | 2.10e-01 | 7.24e-01 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 2.75e-01 | -2.10e-01 | 7.88e-01 |
| GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE | 5 | 4.16e-01 | 2.10e-01 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 15 | 1.59e-01 | 2.10e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 2.08e-01 | -2.10e-01 | 7.39e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 19 | 1.13e-01 | 2.10e-01 | 6.21e-01 |
| GOBP CARDIAC PACEMAKER CELL DEVELOPMENT | 9 | 2.76e-01 | 2.10e-01 | 7.88e-01 |
| GOBP PEROXISOME FISSION | 9 | 2.76e-01 | 2.10e-01 | 7.88e-01 |
| GOCC METHYLOSOME | 13 | 1.91e-01 | -2.09e-01 | 7.25e-01 |
| GOBP REGULATION OF NOREPINEPHRINE SECRETION | 13 | 1.91e-01 | 2.09e-01 | 7.25e-01 |
| GOBP PINOCYTOSIS | 22 | 8.93e-02 | 2.09e-01 | 5.77e-01 |
| GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 7 | 3.38e-01 | -2.09e-01 | 8.21e-01 |
| GOMF NEUROPEPTIDE Y RECEPTOR ACTIVITY | 10 | 2.52e-01 | 2.09e-01 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 3.06e-01 | 2.09e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 35 | 3.23e-02 | 2.09e-01 | 3.84e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 37 | 2.79e-02 | 2.09e-01 | 3.54e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 15 | 1.61e-01 | -2.09e-01 | 6.95e-01 |
| GOBP STEROID HORMONE SECRETION | 27 | 6.05e-02 | 2.09e-01 | 4.94e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 27 | 6.05e-02 | 2.09e-01 | 4.94e-01 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 3.76e-01 | 2.09e-01 | 8.35e-01 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 6 | 3.76e-01 | -2.09e-01 | 8.35e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 10 | 2.54e-01 | -2.08e-01 | 7.76e-01 |
| GOBP COPPER ION IMPORT | 6 | 3.76e-01 | 2.08e-01 | 8.35e-01 |
| GOCC TORC2 COMPLEX | 9 | 2.79e-01 | 2.08e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR RECYCLING | 5 | 4.21e-01 | -2.08e-01 | 8.54e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 7 | 3.41e-01 | 2.08e-01 | 8.22e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 8 | 3.09e-01 | 2.08e-01 | 8.05e-01 |
| GOCC LIPOPOLYSACCHARIDE RECEPTOR COMPLEX | 5 | 4.21e-01 | 2.08e-01 | 8.54e-01 |
| GOBP APOPTOTIC PROCESS IN BONE MARROW CELL | 6 | 3.78e-01 | -2.08e-01 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 5 | 4.22e-01 | 2.07e-01 | 8.54e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 2.16e-02 | 2.07e-01 | 3.17e-01 |
| GOBP CILIARY BASAL BODY ORGANIZATION | 5 | 4.22e-01 | 2.07e-01 | 8.55e-01 |
| GOBP REGULATION OF PRE MIRNA PROCESSING | 6 | 3.80e-01 | -2.07e-01 | 8.36e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 17 | 1.39e-01 | -2.07e-01 | 6.59e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 97 | 4.27e-04 | 2.07e-01 | 3.59e-02 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 16 | 1.52e-01 | 2.07e-01 | 6.83e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 2.57e-01 | -2.07e-01 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 10 | 2.57e-01 | -2.07e-01 | 7.78e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 21 | 1.01e-01 | 2.07e-01 | 5.96e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 31 | 4.64e-02 | 2.07e-01 | 4.44e-01 |
| GOBP RESPONSE TO LEAD ION | 19 | 1.19e-01 | 2.07e-01 | 6.30e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 6 | 3.81e-01 | -2.07e-01 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION | 7 | 3.44e-01 | 2.06e-01 | 8.23e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 11 | 2.36e-01 | 2.06e-01 | 7.62e-01 |
| GOBP OTOLITH MORPHOGENESIS | 5 | 4.24e-01 | 2.06e-01 | 8.56e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 7 | 3.45e-01 | -2.06e-01 | 8.23e-01 |
| GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY | 7 | 3.45e-01 | 2.06e-01 | 8.23e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 13 | 1.99e-01 | -2.06e-01 | 7.29e-01 |
| GOCC POSTSYNAPTIC ENDOCYTIC ZONE | 5 | 4.26e-01 | 2.06e-01 | 8.57e-01 |
| GOMF INTRACELLULAR CGMP ACTIVATED CATION CHANNEL ACTIVITY | 6 | 3.83e-01 | 2.06e-01 | 8.38e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 17 | 1.42e-01 | 2.06e-01 | 6.65e-01 |
| GOBP LIPOXIN METABOLIC PROCESS | 5 | 4.26e-01 | 2.06e-01 | 8.57e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 11 | 2.38e-01 | 2.06e-01 | 7.63e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 2.86e-01 | -2.05e-01 | 7.95e-01 |
| GOBP GRANULOCYTE MIGRATION | 145 | 1.94e-05 | 2.05e-01 | 4.62e-03 |
| GOBP REGULATION OF GLOMERULAR FILTRATION | 8 | 3.14e-01 | 2.05e-01 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 8 | 3.14e-01 | 2.05e-01 | 8.08e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 3.84e-01 | -2.05e-01 | 8.38e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 23 | 8.84e-02 | -2.05e-01 | 5.75e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 9 | 2.86e-01 | 2.05e-01 | 7.95e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 16 | 1.56e-01 | 2.05e-01 | 6.89e-01 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 11 | 2.39e-01 | 2.05e-01 | 7.63e-01 |
| GOBP PERICARDIUM MORPHOGENESIS | 8 | 3.15e-01 | -2.05e-01 | 8.08e-01 |
| GOCC CUTICULAR PLATE | 8 | 3.16e-01 | 2.05e-01 | 8.09e-01 |
| GOMF INTERLEUKIN 1 BINDING | 9 | 2.87e-01 | -2.05e-01 | 7.95e-01 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 8 | 3.16e-01 | 2.05e-01 | 8.09e-01 |
| GOBP REGULATION OF EATING BEHAVIOR | 7 | 3.48e-01 | 2.05e-01 | 8.26e-01 |
| GOCC MICROFIBRIL | 13 | 2.01e-01 | -2.05e-01 | 7.32e-01 |
| GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE | 9 | 2.88e-01 | 2.05e-01 | 7.95e-01 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 15 | 1.70e-01 | -2.05e-01 | 7.03e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE | 7 | 3.49e-01 | 2.05e-01 | 8.26e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT | 5 | 4.29e-01 | 2.04e-01 | 8.59e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 7 | 3.49e-01 | -2.04e-01 | 8.26e-01 |
| GOBP CEREBROSPINAL FLUID CIRCULATION | 15 | 1.71e-01 | 2.04e-01 | 7.04e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 31 | 4.92e-02 | 2.04e-01 | 4.55e-01 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 8 | 3.17e-01 | 2.04e-01 | 8.10e-01 |
| GOCC MICROTUBULE MINUS END | 7 | 3.50e-01 | 2.04e-01 | 8.26e-01 |
| GOBP REGULATION OF SOMITOGENESIS | 6 | 3.87e-01 | 2.04e-01 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 8 | 3.18e-01 | 2.04e-01 | 8.10e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 44 | 1.93e-02 | 2.04e-01 | 2.99e-01 |
| GOBP MAST CELL ACTIVATION | 66 | 4.21e-03 | 2.04e-01 | 1.36e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING | 9 | 2.90e-01 | 2.04e-01 | 7.96e-01 |
| GOBP CARTILAGE MORPHOGENESIS | 10 | 2.65e-01 | 2.04e-01 | 7.83e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 12 | 2.22e-01 | -2.03e-01 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 10 | 2.65e-01 | 2.03e-01 | 7.83e-01 |
| GOBP KINETOCHORE ASSEMBLY | 16 | 1.59e-01 | -2.03e-01 | 6.93e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 2.65e-01 | 2.03e-01 | 7.83e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS | 7 | 3.52e-01 | 2.03e-01 | 8.26e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 11 | 2.43e-01 | 2.03e-01 | 7.66e-01 |
| GOBP ASCENDING AORTA DEVELOPMENT | 5 | 4.31e-01 | -2.03e-01 | 8.60e-01 |
| GOBP REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 5 | 4.31e-01 | -2.03e-01 | 8.60e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 9 | 2.91e-01 | 2.03e-01 | 7.97e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 69 | 3.52e-03 | 2.03e-01 | 1.25e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 12 | 2.23e-01 | 2.03e-01 | 7.56e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 4.32e-01 | -2.03e-01 | 8.60e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 9 | 2.92e-01 | -2.03e-01 | 7.97e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 7 | 3.52e-01 | 2.03e-01 | 8.27e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 13 | 2.05e-01 | 2.03e-01 | 7.36e-01 |
| GOBP REGULATION OF MALE GONAD DEVELOPMENT | 8 | 3.20e-01 | 2.03e-01 | 8.10e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 30 | 5.46e-02 | -2.03e-01 | 4.78e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 2.67e-01 | -2.03e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 2.67e-01 | 2.03e-01 | 7.83e-01 |
| GOBP DENSE CORE GRANULE EXOCYTOSIS | 10 | 2.68e-01 | -2.02e-01 | 7.83e-01 |
| GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 5 | 4.33e-01 | 2.02e-01 | 8.60e-01 |
| GOCC BBSOME | 8 | 3.22e-01 | -2.02e-01 | 8.10e-01 |
| GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL | 7 | 3.54e-01 | 2.02e-01 | 8.28e-01 |
| GOCC ZONULA ADHERENS | 8 | 3.22e-01 | 2.02e-01 | 8.10e-01 |
| GOMF PROLINE SODIUM SYMPORTER ACTIVITY | 5 | 4.34e-01 | 2.02e-01 | 8.60e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 8 | 3.22e-01 | -2.02e-01 | 8.10e-01 |
| GOBP IRIS MORPHOGENESIS | 10 | 2.69e-01 | 2.02e-01 | 7.84e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 29 | 5.99e-02 | 2.02e-01 | 4.93e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 7 | 3.55e-01 | 2.02e-01 | 8.29e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 18 | 1.38e-01 | 2.02e-01 | 6.59e-01 |
| GOBP SLEEP | 22 | 1.01e-01 | 2.02e-01 | 5.97e-01 |
| GOMF ADP PHOSPHATASE ACTIVITY | 5 | 4.35e-01 | 2.02e-01 | 8.60e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 14 | 1.92e-01 | 2.02e-01 | 7.25e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 3.56e-01 | -2.02e-01 | 8.30e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 8 | 3.24e-01 | -2.02e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 16 | 1.63e-01 | 2.01e-01 | 6.95e-01 |
| GOBP ASPARAGINE METABOLIC PROCESS | 5 | 4.35e-01 | 2.01e-01 | 8.60e-01 |
| GOMF CARDIOLIPIN BINDING | 11 | 2.47e-01 | 2.01e-01 | 7.69e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 14 | 1.92e-01 | 2.01e-01 | 7.26e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 20 | 1.19e-01 | -2.01e-01 | 6.30e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 26 | 7.55e-02 | 2.01e-01 | 5.44e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 36 | 3.66e-02 | 2.01e-01 | 4.00e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 20 | 1.19e-01 | 2.01e-01 | 6.30e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 8 | 3.25e-01 | 2.01e-01 | 8.10e-01 |
| GOBP NETRIN ACTIVATED SIGNALING PATHWAY | 9 | 2.96e-01 | -2.01e-01 | 7.99e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 2.28e-01 | 2.01e-01 | 7.60e-01 |
| GOBP PROTEIN REPAIR | 7 | 3.58e-01 | 2.01e-01 | 8.31e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 55 | 1.00e-02 | 2.01e-01 | 2.14e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 39 | 3.01e-02 | 2.01e-01 | 3.70e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 88 | 1.14e-03 | 2.01e-01 | 6.42e-02 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 18 | 1.41e-01 | 2.01e-01 | 6.62e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 12 | 2.29e-01 | 2.01e-01 | 7.60e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 8 | 3.26e-01 | 2.01e-01 | 8.11e-01 |
| GOMF MHC CLASS I PROTEIN COMPLEX BINDING | 6 | 3.95e-01 | -2.00e-01 | 8.45e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 9 | 2.98e-01 | -2.00e-01 | 7.99e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 25 | 8.28e-02 | -2.00e-01 | 5.62e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 44 | 2.15e-02 | 2.00e-01 | 3.16e-01 |
| GOCC CLATHRIN VESICLE COAT | 33 | 4.64e-02 | 2.00e-01 | 4.44e-01 |
| GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY | 7 | 3.59e-01 | -2.00e-01 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 71 | 3.54e-03 | 2.00e-01 | 1.26e-01 |
| GOBP REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS | 6 | 3.96e-01 | -2.00e-01 | 8.45e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 21 | 1.12e-01 | -2.00e-01 | 6.18e-01 |
| GOMF DEOXYRIBONUCLEOTIDE BINDING | 5 | 4.39e-01 | 2.00e-01 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 4.39e-01 | 2.00e-01 | 8.62e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 7 | 3.60e-01 | 2.00e-01 | 8.32e-01 |
| GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY | 7 | 3.60e-01 | 2.00e-01 | 8.32e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 19 | 1.32e-01 | 2.00e-01 | 6.51e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 13 | 2.13e-01 | 1.99e-01 | 7.44e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 3.29e-01 | 1.99e-01 | 8.15e-01 |
| GOCC JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE | 9 | 3.01e-01 | -1.99e-01 | 8.01e-01 |
| GOMF CUPROUS ION BINDING | 8 | 3.29e-01 | -1.99e-01 | 8.15e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 28 | 6.80e-02 | -1.99e-01 | 5.21e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 23 | 9.81e-02 | -1.99e-01 | 5.95e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 14 | 1.97e-01 | 1.99e-01 | 7.27e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 10 | 2.75e-01 | 1.99e-01 | 7.88e-01 |
| GOBP SYNAPTIC VESICLE COATING | 5 | 4.41e-01 | -1.99e-01 | 8.63e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 7 | 3.62e-01 | -1.99e-01 | 8.33e-01 |
| GOBP AMYGDALA DEVELOPMENT | 5 | 4.41e-01 | -1.99e-01 | 8.63e-01 |
| GOBP DRINKING BEHAVIOR | 8 | 3.30e-01 | 1.99e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 3.30e-01 | 1.99e-01 | 8.15e-01 |
| GOCC CONDENSIN COMPLEX | 8 | 3.30e-01 | 1.99e-01 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 7 | 3.63e-01 | -1.99e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 11 | 2.54e-01 | -1.99e-01 | 7.76e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 17 | 1.56e-01 | -1.99e-01 | 6.91e-01 |
| GOMF N N DIMETHYLANILINE MONOOXYGENASE ACTIVITY | 5 | 4.42e-01 | -1.99e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 27 | 7.41e-02 | 1.99e-01 | 5.41e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 37 | 3.66e-02 | 1.99e-01 | 4.00e-01 |
| GOBP ACETATE ESTER METABOLIC PROCESS | 6 | 4.00e-01 | -1.99e-01 | 8.46e-01 |
| GOCC CHITOSOME | 19 | 1.34e-01 | 1.98e-01 | 6.53e-01 |
| GOBP POSITIVE REGULATION OF CATECHOLAMINE SECRETION | 12 | 2.34e-01 | 1.98e-01 | 7.61e-01 |
| GOBP FOREBRAIN NEURON FATE COMMITMENT | 7 | 3.63e-01 | 1.98e-01 | 8.33e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 3.31e-01 | 1.98e-01 | 8.15e-01 |
| GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY | 12 | 2.34e-01 | -1.98e-01 | 7.61e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 8 | 3.31e-01 | 1.98e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 70 | 4.10e-03 | 1.98e-01 | 1.35e-01 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 9 | 3.03e-01 | -1.98e-01 | 8.02e-01 |
| GOBP MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION | 5 | 4.43e-01 | 1.98e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY | 9 | 3.03e-01 | -1.98e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 2.55e-01 | 1.98e-01 | 7.76e-01 |
| GOBP FAT SOLUBLE VITAMIN CATABOLIC PROCESS | 11 | 2.55e-01 | 1.98e-01 | 7.76e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 63 | 6.55e-03 | 1.98e-01 | 1.77e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 6 | 4.01e-01 | 1.98e-01 | 8.46e-01 |
| GOMF BH3 DOMAIN BINDING | 6 | 4.01e-01 | 1.98e-01 | 8.46e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 4.43e-01 | 1.98e-01 | 8.65e-01 |
| GOMF G PROTEIN COUPLED OPIOID RECEPTOR ACTIVITY | 7 | 3.65e-01 | -1.98e-01 | 8.33e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 23 | 1.00e-01 | 1.98e-01 | 5.95e-01 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 9 | 3.04e-01 | 1.98e-01 | 8.02e-01 |
| GOBP COMMA SHAPED BODY MORPHOGENESIS | 5 | 4.44e-01 | 1.98e-01 | 8.65e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 8 | 3.33e-01 | 1.98e-01 | 8.16e-01 |
| GOMF RETROMER COMPLEX BINDING | 7 | 3.65e-01 | 1.98e-01 | 8.33e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 13 | 2.18e-01 | 1.97e-01 | 7.49e-01 |
| GOBP SEMICIRCULAR CANAL MORPHOGENESIS | 7 | 3.66e-01 | -1.97e-01 | 8.33e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 7 | 3.66e-01 | -1.97e-01 | 8.33e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 37 | 3.79e-02 | 1.97e-01 | 4.05e-01 |
| GOCC U2 SNRNP | 24 | 9.46e-02 | -1.97e-01 | 5.89e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 16 | 1.72e-01 | 1.97e-01 | 7.04e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 13 | 2.19e-01 | -1.97e-01 | 7.50e-01 |
| GOBP SELF PROTEOLYSIS | 12 | 2.37e-01 | 1.97e-01 | 7.63e-01 |
| GOCC NUCLEOSOME | 114 | 2.82e-04 | -1.97e-01 | 2.71e-02 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 12 | 2.38e-01 | 1.97e-01 | 7.63e-01 |
| GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 14 | 2.02e-01 | 1.97e-01 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 4.46e-01 | -1.97e-01 | 8.67e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 12 | 2.38e-01 | 1.97e-01 | 7.63e-01 |
| GOMF MHC CLASS IB RECEPTOR ACTIVITY | 7 | 3.68e-01 | -1.97e-01 | 8.33e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 37 | 3.86e-02 | 1.97e-01 | 4.08e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 13 | 2.20e-01 | -1.96e-01 | 7.51e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 9 | 3.07e-01 | -1.96e-01 | 8.03e-01 |
| GOBP POSITIVE REGULATION OF GASTRULATION | 6 | 4.05e-01 | 1.96e-01 | 8.49e-01 |
| GOBP TOOTH ERUPTION | 5 | 4.47e-01 | -1.96e-01 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 4.47e-01 | 1.96e-01 | 8.67e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 8 | 3.37e-01 | -1.96e-01 | 8.20e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 19 | 1.39e-01 | 1.96e-01 | 6.59e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 50 | 1.64e-02 | 1.96e-01 | 2.74e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 6 | 4.05e-01 | 1.96e-01 | 8.49e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 16 | 1.75e-01 | 1.96e-01 | 7.05e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 7 | 3.69e-01 | 1.96e-01 | 8.33e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 17 | 1.62e-01 | 1.96e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 12 | 2.40e-01 | 1.96e-01 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 6 | 4.06e-01 | -1.96e-01 | 8.49e-01 |
| GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 5 | 4.49e-01 | 1.96e-01 | 8.68e-01 |
| GOBP TELENCEPHALON REGIONALIZATION | 13 | 2.22e-01 | 1.96e-01 | 7.54e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 15 | 1.90e-01 | 1.96e-01 | 7.24e-01 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 6 | 4.07e-01 | 1.96e-01 | 8.49e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY | 7 | 3.70e-01 | 1.96e-01 | 8.33e-01 |
| GOBP RESPONSE TO SYMBIONT | 6 | 4.07e-01 | 1.96e-01 | 8.49e-01 |
| GOBP MELANIN METABOLIC PROCESS | 24 | 9.73e-02 | 1.96e-01 | 5.94e-01 |
| GOMF THYROID HORMONE BINDING | 6 | 4.07e-01 | 1.96e-01 | 8.49e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 12 | 2.41e-01 | 1.95e-01 | 7.65e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 12 | 2.41e-01 | 1.95e-01 | 7.65e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 6 | 4.07e-01 | 1.95e-01 | 8.49e-01 |
| GOCC AUTOLYSOSOME | 11 | 2.62e-01 | 1.95e-01 | 7.83e-01 |
| GOBP SIALYLATION | 8 | 3.39e-01 | -1.95e-01 | 8.22e-01 |
| GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION | 8 | 3.39e-01 | 1.95e-01 | 8.22e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 88 | 1.55e-03 | 1.95e-01 | 7.90e-02 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 116 | 2.83e-04 | 1.95e-01 | 2.71e-02 |
| GOBP POSITIVE REGULATION OF MAST CELL CHEMOTAXIS | 5 | 4.50e-01 | 1.95e-01 | 8.69e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 13 | 2.23e-01 | -1.95e-01 | 7.56e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 22 | 1.13e-01 | 1.95e-01 | 6.21e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 20 | 1.31e-01 | 1.95e-01 | 6.51e-01 |
| GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY | 22 | 1.14e-01 | 1.95e-01 | 6.21e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 7 | 3.72e-01 | -1.95e-01 | 8.33e-01 |
| GOBP IMP CATABOLIC PROCESS | 5 | 4.51e-01 | 1.95e-01 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 6 | 4.08e-01 | -1.95e-01 | 8.49e-01 |
| GOBP REGULATION OF KIDNEY SIZE | 5 | 4.51e-01 | -1.95e-01 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 8 | 3.40e-01 | -1.95e-01 | 8.22e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 11 | 2.64e-01 | -1.95e-01 | 7.83e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 8 | 3.41e-01 | -1.95e-01 | 8.22e-01 |
| GOBP VENTRAL MIDLINE DEVELOPMENT | 6 | 4.09e-01 | -1.95e-01 | 8.49e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 6 | 4.09e-01 | 1.95e-01 | 8.49e-01 |
| GOBP L GLUTAMATE IMPORT | 38 | 3.80e-02 | 1.95e-01 | 4.05e-01 |
| GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING | 8 | 3.41e-01 | -1.95e-01 | 8.22e-01 |
| GOBP REGULATION OF FAS SIGNALING PATHWAY | 6 | 4.09e-01 | 1.94e-01 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 11 | 2.64e-01 | 1.94e-01 | 7.83e-01 |
| GOMF LIPASE BINDING | 7 | 3.73e-01 | -1.94e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 8 | 3.41e-01 | -1.94e-01 | 8.22e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 18 | 1.54e-01 | -1.94e-01 | 6.86e-01 |
| GOBP CARNITINE TRANSPORT | 8 | 3.42e-01 | 1.94e-01 | 8.22e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 31 | 6.14e-02 | 1.94e-01 | 4.97e-01 |
| GOCC PARANODAL JUNCTION | 8 | 3.42e-01 | 1.94e-01 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 7 | 3.74e-01 | 1.94e-01 | 8.34e-01 |
| GOBP RESPONSE TO YEAST | 7 | 3.74e-01 | 1.94e-01 | 8.34e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 6.59e-02 | 1.94e-01 | 5.14e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 8 | 3.42e-01 | -1.94e-01 | 8.22e-01 |
| GOBP PHENOL CONTAINING COMPOUND CATABOLIC PROCESS | 7 | 3.74e-01 | 1.94e-01 | 8.34e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 4.11e-01 | 1.94e-01 | 8.49e-01 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 11 | 2.65e-01 | 1.94e-01 | 7.83e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 18 | 1.55e-01 | 1.94e-01 | 6.87e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 7 | 3.75e-01 | -1.94e-01 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 15 | 1.94e-01 | 1.94e-01 | 7.27e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 4.11e-01 | -1.94e-01 | 8.49e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 2.66e-01 | 1.94e-01 | 7.83e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 19 | 1.44e-01 | 1.94e-01 | 6.69e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 12 | 2.46e-01 | 1.94e-01 | 7.68e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 18 | 1.55e-01 | -1.94e-01 | 6.89e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 9 | 3.15e-01 | 1.93e-01 | 8.08e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 14 | 2.10e-01 | 1.93e-01 | 7.42e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 14 | 2.11e-01 | 1.93e-01 | 7.42e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 3.44e-01 | 1.93e-01 | 8.23e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 17 | 1.68e-01 | 1.93e-01 | 7.00e-01 |
| GOCC LAMIN FILAMENT | 5 | 4.55e-01 | 1.93e-01 | 8.70e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 22 | 1.17e-01 | 1.93e-01 | 6.28e-01 |
| GOBP GROWTH HORMONE SECRETION | 13 | 2.28e-01 | 1.93e-01 | 7.60e-01 |
| GOMF METAL ION SENSOR ACTIVITY | 5 | 4.55e-01 | 1.93e-01 | 8.70e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 122 | 2.35e-04 | 1.93e-01 | 2.48e-02 |
| GOBP HISTONE H3 K4 METHYLATION | 18 | 1.57e-01 | 1.93e-01 | 6.91e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 25 | 9.55e-02 | -1.93e-01 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 51 | 1.73e-02 | 1.93e-01 | 2.82e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 5 | 4.56e-01 | 1.92e-01 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 1.27e-01 | -1.92e-01 | 6.43e-01 |
| GOBP REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 4.15e-01 | 1.92e-01 | 8.51e-01 |
| GOMF MRF BINDING | 5 | 4.56e-01 | 1.92e-01 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 10 | 2.93e-01 | 1.92e-01 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 8 | 3.47e-01 | -1.92e-01 | 8.26e-01 |
| GOMF NADPLUS BINDING | 18 | 1.58e-01 | 1.92e-01 | 6.92e-01 |
| GOBP POSITIVE REGULATION OF MIRNA PROCESSING | 5 | 4.57e-01 | -1.92e-01 | 8.71e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 13 | 2.31e-01 | 1.92e-01 | 7.60e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 17 | 1.71e-01 | 1.92e-01 | 7.04e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 12 | 2.50e-01 | 1.92e-01 | 7.72e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 73 | 4.60e-03 | 1.92e-01 | 1.44e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 11 | 2.71e-01 | -1.92e-01 | 7.85e-01 |
| GOBP PHOSPHATE ION TRANSPORT | 28 | 7.90e-02 | 1.92e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 29 | 7.39e-02 | 1.92e-01 | 5.41e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 13 | 2.32e-01 | 1.92e-01 | 7.61e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 2.32e-01 | 1.92e-01 | 7.61e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 12 | 2.50e-01 | -1.92e-01 | 7.72e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 10 | 2.94e-01 | 1.92e-01 | 7.98e-01 |
| GOMF MUTLALPHA COMPLEX BINDING | 7 | 3.80e-01 | 1.92e-01 | 8.37e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 46 | 2.47e-02 | 1.91e-01 | 3.34e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 19 | 1.49e-01 | 1.91e-01 | 6.78e-01 |
| GOBP DUCTUS ARTERIOSUS CLOSURE | 5 | 4.59e-01 | -1.91e-01 | 8.72e-01 |
| GOCC U4 SNRNP | 10 | 2.95e-01 | -1.91e-01 | 7.98e-01 |
| GOCC CLATHRIN COAT | 47 | 2.33e-02 | 1.91e-01 | 3.26e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 9 | 3.21e-01 | -1.91e-01 | 8.10e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 4.59e-01 | 1.91e-01 | 8.72e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 4.18e-01 | 1.91e-01 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 3.81e-01 | 1.91e-01 | 8.37e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 20 | 1.39e-01 | 1.91e-01 | 6.59e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 78 | 3.55e-03 | 1.91e-01 | 1.26e-01 |
| GOBP LUTEINIZATION | 12 | 2.52e-01 | 1.91e-01 | 7.74e-01 |
| GOBP AXONOGENESIS INVOLVED IN INNERVATION | 9 | 3.21e-01 | 1.91e-01 | 8.10e-01 |
| GOCC MHC PROTEIN COMPLEX | 24 | 1.06e-01 | -1.91e-01 | 6.02e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 SIGNALING PATHWAY | 6 | 4.18e-01 | -1.91e-01 | 8.53e-01 |
| GOCC R2TP COMPLEX | 5 | 4.60e-01 | -1.91e-01 | 8.72e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 6 | 4.18e-01 | -1.91e-01 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 5 | 4.60e-01 | -1.91e-01 | 8.72e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 10 | 2.97e-01 | -1.91e-01 | 7.99e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 14 | 2.17e-01 | -1.91e-01 | 7.49e-01 |
| GOBP ELASTIN METABOLIC PROCESS | 8 | 3.51e-01 | -1.91e-01 | 8.26e-01 |
| GOBP REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT | 8 | 3.51e-01 | 1.90e-01 | 8.26e-01 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 23 | 1.14e-01 | 1.90e-01 | 6.22e-01 |
| GOCC SPERM FIBROUS SHEATH | 6 | 4.20e-01 | -1.90e-01 | 8.54e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 27 | 8.71e-02 | 1.90e-01 | 5.73e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 59 | 1.15e-02 | 1.90e-01 | 2.29e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 6 | 4.20e-01 | 1.90e-01 | 8.54e-01 |
| GOCC CILIARY ROOTLET | 15 | 2.02e-01 | 1.90e-01 | 7.33e-01 |
| GOBP ANTIBACTERIAL INNATE IMMUNE RESPONSE | 6 | 4.20e-01 | 1.90e-01 | 8.54e-01 |
| GOMF PRIMARY MIRNA BINDING | 9 | 3.24e-01 | 1.90e-01 | 8.10e-01 |
| GOBP LEYDIG CELL DIFFERENTIATION | 9 | 3.25e-01 | 1.89e-01 | 8.11e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 14 | 2.20e-01 | 1.89e-01 | 7.51e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 741 | 1.55e-18 | -1.89e-01 | 2.64e-15 |
| GOBP POLYKETIDE METABOLIC PROCESS | 10 | 3.00e-01 | -1.89e-01 | 8.00e-01 |
| GOMF INTERLEUKIN 2 RECEPTOR BINDING | 5 | 4.63e-01 | 1.89e-01 | 8.74e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 18 | 1.65e-01 | 1.89e-01 | 6.97e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 23 | 1.16e-01 | 1.89e-01 | 6.26e-01 |
| GOMF RETINOIC ACID BINDING | 26 | 9.51e-02 | 1.89e-01 | 5.89e-01 |
| GOCC PRP19 COMPLEX | 12 | 2.57e-01 | -1.89e-01 | 7.78e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 25 | 1.02e-01 | -1.89e-01 | 5.97e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 4.23e-01 | -1.89e-01 | 8.56e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 70 | 6.30e-03 | 1.89e-01 | 1.73e-01 |
| GOBP EPIBOLY | 37 | 4.69e-02 | 1.89e-01 | 4.46e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 17 | 1.78e-01 | 1.89e-01 | 7.11e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 8 | 3.56e-01 | 1.89e-01 | 8.30e-01 |
| GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL | 12 | 2.58e-01 | 1.88e-01 | 7.78e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 39 | 4.17e-02 | 1.88e-01 | 4.19e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 8 | 3.56e-01 | -1.88e-01 | 8.30e-01 |
| GOBP MESENCHYMAL EPITHELIAL CELL SIGNALING | 7 | 3.89e-01 | 1.88e-01 | 8.41e-01 |
| GOBP INDUCTION OF BACTERIAL AGGLUTINATION | 6 | 4.25e-01 | -1.88e-01 | 8.57e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 15 | 2.07e-01 | -1.88e-01 | 7.38e-01 |
| GOBP NOSE DEVELOPMENT | 16 | 1.93e-01 | 1.88e-01 | 7.26e-01 |
| GOMF CCR1 CHEMOKINE RECEPTOR BINDING | 5 | 4.67e-01 | 1.88e-01 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 5 | 4.67e-01 | 1.88e-01 | 8.75e-01 |
| GOBP HISTONE H3 ACETYLATION | 6 | 4.25e-01 | 1.88e-01 | 8.57e-01 |
| GOBP MICROGLIAL CELL PROLIFERATION | 8 | 3.57e-01 | -1.88e-01 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 28 | 8.53e-02 | 1.88e-01 | 5.70e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 28 | 8.57e-02 | -1.88e-01 | 5.70e-01 |
| GOCC COPI COATED VESICLE | 25 | 1.04e-01 | 1.88e-01 | 5.99e-01 |
| GOBP NAD TRANSPORT | 5 | 4.68e-01 | -1.88e-01 | 8.75e-01 |
| GOBP POLYOL TRANSMEMBRANE TRANSPORT | 10 | 3.04e-01 | 1.88e-01 | 8.02e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 48 | 2.46e-02 | -1.88e-01 | 3.33e-01 |
| GOBP MALATE METABOLIC PROCESS | 9 | 3.30e-01 | -1.87e-01 | 8.15e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 8 | 3.59e-01 | 1.87e-01 | 8.31e-01 |
| GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE | 8 | 3.59e-01 | -1.87e-01 | 8.31e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 18 | 1.69e-01 | -1.87e-01 | 7.01e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 9 | 3.30e-01 | -1.87e-01 | 8.15e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 35 | 5.52e-02 | -1.87e-01 | 4.80e-01 |
| GOBP RESPONSE TO GLUCAGON | 20 | 1.47e-01 | 1.87e-01 | 6.74e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 3.31e-01 | 1.87e-01 | 8.15e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 20 | 1.48e-01 | -1.87e-01 | 6.75e-01 |
| GOCC U5 SNRNP | 22 | 1.29e-01 | -1.87e-01 | 6.46e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 18 | 1.70e-01 | 1.87e-01 | 7.02e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION | 5 | 4.69e-01 | 1.87e-01 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 9 | 3.32e-01 | -1.87e-01 | 8.15e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 9 | 3.32e-01 | -1.87e-01 | 8.15e-01 |
| GOCC OMEGASOME | 5 | 4.70e-01 | 1.87e-01 | 8.75e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 53 | 1.87e-02 | 1.87e-01 | 2.95e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 26 | 9.94e-02 | 1.87e-01 | 5.95e-01 |
| GOBP GERMINAL CENTER FORMATION | 14 | 2.27e-01 | 1.87e-01 | 7.59e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 4.70e-01 | 1.87e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 14 | 2.27e-01 | 1.86e-01 | 7.60e-01 |
| GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS | 11 | 2.84e-01 | 1.86e-01 | 7.95e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 10 | 3.07e-01 | 1.86e-01 | 8.03e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 8 | 3.61e-01 | 1.86e-01 | 8.33e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 2.85e-01 | 1.86e-01 | 7.95e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 16 | 1.97e-01 | -1.86e-01 | 7.27e-01 |
| GOBP SOMATOSTATIN RECEPTOR SIGNALING PATHWAY | 5 | 4.71e-01 | -1.86e-01 | 8.76e-01 |
| GOMF SOMATOSTATIN RECEPTOR ACTIVITY | 5 | 4.71e-01 | -1.86e-01 | 8.76e-01 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 8 | 3.62e-01 | -1.86e-01 | 8.33e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC ENDOSOME TO LYSOSOME | 7 | 3.94e-01 | -1.86e-01 | 8.44e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 8 | 3.62e-01 | 1.86e-01 | 8.33e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 13 | 2.46e-01 | 1.86e-01 | 7.68e-01 |
| GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS | 7 | 3.94e-01 | 1.86e-01 | 8.44e-01 |
| GOBP NEPHRIC DUCT DEVELOPMENT | 14 | 2.29e-01 | -1.86e-01 | 7.60e-01 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 10 | 3.09e-01 | 1.86e-01 | 8.05e-01 |
| GOBP DECIDUALIZATION | 24 | 1.15e-01 | 1.86e-01 | 6.24e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 19 | 1.61e-01 | 1.86e-01 | 6.95e-01 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 4.72e-01 | 1.86e-01 | 8.77e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 36 | 5.37e-02 | 1.86e-01 | 4.76e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 28 | 8.89e-02 | 1.86e-01 | 5.76e-01 |
| GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT | 6 | 4.31e-01 | -1.86e-01 | 8.60e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 18 | 1.73e-01 | -1.86e-01 | 7.04e-01 |
| GOCC MYOFILAMENT | 26 | 1.01e-01 | 1.86e-01 | 5.97e-01 |
| GOBP DIAPHRAGM DEVELOPMENT | 8 | 3.64e-01 | 1.86e-01 | 8.33e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 3.10e-01 | 1.86e-01 | 8.06e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 4.31e-01 | 1.85e-01 | 8.60e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 41 | 3.99e-02 | 1.85e-01 | 4.12e-01 |
| GOBP TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE | 5 | 4.73e-01 | 1.85e-01 | 8.77e-01 |
| GOMF GAMMA AMINOBUTYRIC ACID SODIUM CHLORIDE SYMPORTER ACTIVITY | 5 | 4.73e-01 | 1.85e-01 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 8 | 3.64e-01 | 1.85e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 49 | 2.49e-02 | 1.85e-01 | 3.35e-01 |
| GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 8 | 3.64e-01 | 1.85e-01 | 8.33e-01 |
| GOMF ALPHA 2A ADRENERGIC RECEPTOR BINDING | 5 | 4.73e-01 | 1.85e-01 | 8.77e-01 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 3.36e-01 | 1.85e-01 | 8.20e-01 |
| GOBP ASTROCYTE CELL MIGRATION | 9 | 3.36e-01 | -1.85e-01 | 8.20e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 21 | 1.42e-01 | 1.85e-01 | 6.65e-01 |
| GOMF HEXOKINASE ACTIVITY | 5 | 4.74e-01 | 1.85e-01 | 8.77e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 11 | 2.88e-01 | -1.85e-01 | 7.96e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 23 | 1.25e-01 | 1.85e-01 | 6.40e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 16 | 2.00e-01 | 1.85e-01 | 7.32e-01 |
| GOCC CALCINEURIN COMPLEX | 6 | 4.33e-01 | 1.85e-01 | 8.60e-01 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 3.97e-01 | -1.85e-01 | 8.45e-01 |
| GOBP SHORT TERM MEMORY | 10 | 3.12e-01 | 1.85e-01 | 8.08e-01 |
| GOBP AXIS ELONGATION | 27 | 9.67e-02 | -1.85e-01 | 5.93e-01 |
| GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL | 5 | 4.75e-01 | -1.85e-01 | 8.77e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 28 | 9.09e-02 | -1.85e-01 | 5.81e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 79 | 4.56e-03 | 1.85e-01 | 1.44e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 2.68e-01 | 1.85e-01 | 7.84e-01 |
| GOBP PROTEIN IMPORT | 7 | 3.98e-01 | 1.85e-01 | 8.45e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION | 11 | 2.89e-01 | 1.85e-01 | 7.96e-01 |
| GOBP RIG I SIGNALING PATHWAY | 28 | 9.11e-02 | 1.84e-01 | 5.81e-01 |
| GOMF KINETOCHORE BINDING | 6 | 4.34e-01 | -1.84e-01 | 8.60e-01 |
| GOBP NEPHRIC DUCT MORPHOGENESIS | 10 | 3.13e-01 | -1.84e-01 | 8.08e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 11 | 2.90e-01 | 1.84e-01 | 7.96e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 71 | 7.26e-03 | 1.84e-01 | 1.82e-01 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 6 | 4.35e-01 | -1.84e-01 | 8.60e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 15 | 2.17e-01 | 1.84e-01 | 7.49e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 7 | 3.99e-01 | 1.84e-01 | 8.46e-01 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 13 | 2.51e-01 | -1.84e-01 | 7.74e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 5.63e-02 | 1.84e-01 | 4.82e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY | 6 | 4.36e-01 | -1.84e-01 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS | 8 | 3.68e-01 | 1.84e-01 | 8.33e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 11 | 2.92e-01 | 1.84e-01 | 7.97e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 9 | 3.40e-01 | 1.84e-01 | 8.22e-01 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 6 | 4.36e-01 | -1.84e-01 | 8.60e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 6 | 4.36e-01 | -1.84e-01 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 4.36e-01 | -1.83e-01 | 8.60e-01 |
| GOBP REGULATION OF GROWTH RATE | 5 | 4.77e-01 | 1.83e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 10 | 3.15e-01 | -1.83e-01 | 8.08e-01 |
| GOMF WNT PROTEIN BINDING | 31 | 7.71e-02 | -1.83e-01 | 5.48e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 42 | 3.97e-02 | 1.83e-01 | 4.12e-01 |
| GOBP NEURAL CREST CELL FATE COMMITMENT | 6 | 4.37e-01 | 1.83e-01 | 8.61e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 9 | 3.41e-01 | -1.83e-01 | 8.22e-01 |
| GOBP FOREBRAIN NEUROBLAST DIVISION | 5 | 4.78e-01 | -1.83e-01 | 8.79e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 20 | 1.56e-01 | -1.83e-01 | 6.91e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 27 | 9.95e-02 | 1.83e-01 | 5.95e-01 |
| GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION | 10 | 3.16e-01 | -1.83e-01 | 8.09e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 12 | 2.72e-01 | 1.83e-01 | 7.87e-01 |
| GOBP RESPONSE TO FOLIC ACID | 10 | 3.17e-01 | 1.83e-01 | 8.09e-01 |
| GOBP PARENTAL BEHAVIOR | 10 | 3.17e-01 | -1.83e-01 | 8.09e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 17 | 1.92e-01 | -1.83e-01 | 7.26e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 31 | 7.81e-02 | 1.83e-01 | 5.49e-01 |
| GOCC STEREOCILIUM TIP | 19 | 1.68e-01 | 1.83e-01 | 7.00e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 27 | 1.00e-01 | -1.83e-01 | 5.95e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 13 | 2.54e-01 | 1.83e-01 | 7.76e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 16 | 2.06e-01 | 1.83e-01 | 7.37e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 45 | 3.40e-02 | 1.83e-01 | 3.90e-01 |
| GOCC PHAGOCYTIC CUP | 28 | 9.43e-02 | 1.83e-01 | 5.89e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 37 | 5.45e-02 | 1.83e-01 | 4.78e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 10 | 3.17e-01 | 1.83e-01 | 8.10e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 65 | 1.09e-02 | 1.83e-01 | 2.26e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 8 | 3.71e-01 | 1.82e-01 | 8.33e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 44 | 3.62e-02 | 1.82e-01 | 3.97e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 9 | 3.43e-01 | 1.82e-01 | 8.22e-01 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 46 | 3.23e-02 | -1.82e-01 | 3.84e-01 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 7 | 4.03e-01 | 1.82e-01 | 8.46e-01 |
| GOBP S SHAPED BODY MORPHOGENESIS | 7 | 4.03e-01 | 1.82e-01 | 8.46e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 16 | 2.06e-01 | 1.82e-01 | 7.37e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 2.57e-02 | 1.82e-01 | 3.40e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 38 | 5.17e-02 | 1.82e-01 | 4.67e-01 |
| GOCC POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 4.80e-01 | 1.82e-01 | 8.80e-01 |
| GOBP NEUTROPHIL CHEMOTAXIS | 99 | 1.72e-03 | 1.82e-01 | 8.33e-02 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 8 | 3.72e-01 | 1.82e-01 | 8.33e-01 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 9 | 3.44e-01 | 1.82e-01 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 12 | 2.75e-01 | 1.82e-01 | 7.88e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 3.19e-01 | 1.82e-01 | 8.10e-01 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 2.96e-01 | 1.82e-01 | 7.99e-01 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 8 | 3.73e-01 | -1.82e-01 | 8.33e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 22 | 1.40e-01 | -1.82e-01 | 6.61e-01 |
| GOBP CELLULAR RESPONSE TO L GLUTAMATE | 5 | 4.82e-01 | 1.82e-01 | 8.80e-01 |
| GOBP DETECTION OF MUSCLE STRETCH | 7 | 4.06e-01 | -1.81e-01 | 8.49e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 23 | 1.32e-01 | 1.81e-01 | 6.51e-01 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.82e-01 | 1.81e-01 | 8.80e-01 |
| GOMF ENONE REDUCTASE ACTIVITY | 5 | 4.83e-01 | -1.81e-01 | 8.80e-01 |
| GOBP DESMOSOME ORGANIZATION | 10 | 3.21e-01 | 1.81e-01 | 8.10e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 128 | 3.96e-04 | 1.81e-01 | 3.42e-02 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 57 | 1.79e-02 | 1.81e-01 | 2.88e-01 |
| GOBP C TERMINAL PROTEIN LIPIDATION | 5 | 4.83e-01 | 1.81e-01 | 8.80e-01 |
| GOCC MRNA EDITING COMPLEX | 15 | 2.24e-01 | -1.81e-01 | 7.57e-01 |
| GOBP POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 4.42e-01 | 1.81e-01 | 8.64e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 14 | 2.41e-01 | -1.81e-01 | 7.65e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 32 | 7.62e-02 | 1.81e-01 | 5.45e-01 |
| GOCC CONTRACTILE RING | 10 | 3.21e-01 | 1.81e-01 | 8.10e-01 |
| GOBP GROOMING BEHAVIOR | 17 | 1.96e-01 | -1.81e-01 | 7.27e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 12 | 2.78e-01 | 1.81e-01 | 7.91e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 27 | 1.04e-01 | 1.81e-01 | 5.99e-01 |
| GOCC FIBRINOGEN COMPLEX | 8 | 3.76e-01 | -1.81e-01 | 8.35e-01 |
| GOBP OVIDUCT DEVELOPMENT | 5 | 4.84e-01 | -1.81e-01 | 8.80e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 22 | 1.42e-01 | 1.81e-01 | 6.65e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 3.76e-01 | 1.81e-01 | 8.35e-01 |
| GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION | 7 | 4.08e-01 | -1.81e-01 | 8.49e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 6 | 4.43e-01 | -1.81e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 51 | 2.57e-02 | 1.81e-01 | 3.40e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 69 | 9.53e-03 | 1.80e-01 | 2.10e-01 |
| GOMF COMPLEMENT COMPONENT C1Q COMPLEX BINDING | 8 | 3.77e-01 | -1.80e-01 | 8.35e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 12 | 2.79e-01 | -1.80e-01 | 7.93e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 5 | 4.85e-01 | -1.80e-01 | 8.80e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 17 | 1.98e-01 | -1.80e-01 | 7.29e-01 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 9 | 3.50e-01 | 1.80e-01 | 8.26e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 4.10e-01 | -1.80e-01 | 8.49e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 13 | 2.61e-01 | 1.80e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 5 | 4.86e-01 | -1.80e-01 | 8.80e-01 |
| GOMF DYSTROGLYCAN BINDING | 10 | 3.25e-01 | 1.80e-01 | 8.10e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 35 | 6.56e-02 | 1.80e-01 | 5.13e-01 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 27 | 1.06e-01 | 1.80e-01 | 6.02e-01 |
| GOBP FACIAL NERVE STRUCTURAL ORGANIZATION | 7 | 4.10e-01 | 1.80e-01 | 8.49e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 2.28e-01 | 1.80e-01 | 7.60e-01 |
| GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION | 6 | 4.46e-01 | 1.80e-01 | 8.66e-01 |
| GOBP PREPULSE INHIBITION | 13 | 2.62e-01 | -1.80e-01 | 7.83e-01 |
| GOBP REGULATION OF INTESTINAL ABSORPTION | 12 | 2.81e-01 | 1.80e-01 | 7.93e-01 |
| GOBP MAST CELL CHEMOTAXIS | 10 | 3.25e-01 | 1.80e-01 | 8.11e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 44 | 3.93e-02 | 1.80e-01 | 4.11e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 46 | 3.51e-02 | 1.80e-01 | 3.95e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 4.46e-01 | 1.79e-01 | 8.67e-01 |
| GOBP SKELETAL MUSCLE TISSUE GROWTH | 9 | 3.51e-01 | 1.79e-01 | 8.26e-01 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 11 | 3.03e-01 | 1.79e-01 | 8.02e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 4.47e-01 | -1.79e-01 | 8.67e-01 |
| GOBP PODOSOME ASSEMBLY | 19 | 1.76e-01 | 1.79e-01 | 7.08e-01 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 5 | 4.88e-01 | 1.79e-01 | 8.82e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 34 | 7.05e-02 | 1.79e-01 | 5.28e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 4.47e-01 | -1.79e-01 | 8.67e-01 |
| GOCC RUFFLE | 178 | 3.75e-05 | 1.79e-01 | 7.24e-03 |
| GOMF CHANNEL ACTIVATOR ACTIVITY | 6 | 4.47e-01 | 1.79e-01 | 8.67e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 8 | 3.81e-01 | 1.79e-01 | 8.37e-01 |
| GOBP REGULATION OF BONE REMODELING | 49 | 3.02e-02 | 1.79e-01 | 3.70e-01 |
| GOMF TASTE RECEPTOR ACTIVITY | 29 | 9.53e-02 | -1.79e-01 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 18 | 1.89e-01 | 1.79e-01 | 7.24e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 3.04e-01 | 1.79e-01 | 8.02e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 44 | 4.02e-02 | 1.79e-01 | 4.13e-01 |
| GOBP INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE | 8 | 3.81e-01 | 1.79e-01 | 8.37e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 11 | 3.05e-01 | 1.79e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 22 | 1.47e-01 | 1.79e-01 | 6.74e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 11 | 3.05e-01 | 1.79e-01 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 6 | 4.49e-01 | -1.79e-01 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 53 | 2.45e-02 | 1.79e-01 | 3.33e-01 |
| GOBP NEGATIVE REGULATION OF GONADOTROPIN SECRETION | 7 | 4.13e-01 | 1.79e-01 | 8.51e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 33 | 7.59e-02 | 1.79e-01 | 5.45e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 7 | 4.13e-01 | 1.79e-01 | 8.51e-01 |
| GOMF TELOMERASE RNA BINDING | 21 | 1.57e-01 | -1.78e-01 | 6.91e-01 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 59 | 1.77e-02 | 1.78e-01 | 2.85e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 18 | 1.90e-01 | -1.78e-01 | 7.24e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 18 | 1.90e-01 | 1.78e-01 | 7.24e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 8 | 3.82e-01 | 1.78e-01 | 8.38e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 11 | 3.06e-01 | -1.78e-01 | 8.02e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 4.50e-01 | 1.78e-01 | 8.69e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 24 | 1.31e-01 | -1.78e-01 | 6.50e-01 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 11 | 3.06e-01 | -1.78e-01 | 8.02e-01 |
| GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 3.30e-01 | -1.78e-01 | 8.15e-01 |
| GOBP GAP JUNCTION MEDIATED INTERCELLULAR TRANSPORT | 6 | 4.50e-01 | -1.78e-01 | 8.70e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 81 | 5.61e-03 | 1.78e-01 | 1.64e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 4.15e-01 | 1.78e-01 | 8.51e-01 |
| GOCC DYSTROGLYCAN COMPLEX | 7 | 4.15e-01 | 1.78e-01 | 8.51e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 73 | 8.62e-03 | 1.78e-01 | 2.00e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 69 | 1.07e-02 | 1.78e-01 | 2.24e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 3.31e-01 | 1.78e-01 | 8.15e-01 |
| GOMF OXYGEN SENSOR ACTIVITY | 5 | 4.91e-01 | 1.78e-01 | 8.83e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 18 | 1.92e-01 | 1.78e-01 | 7.26e-01 |
| GOCC DENDRITE TERMINUS | 12 | 2.87e-01 | -1.78e-01 | 7.95e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 6 | 4.52e-01 | -1.77e-01 | 8.70e-01 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 7 | 4.17e-01 | -1.77e-01 | 8.53e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 14 | 2.51e-01 | 1.77e-01 | 7.74e-01 |
| GOCC MYELIN SHEATH ADAXONAL REGION | 6 | 4.52e-01 | 1.77e-01 | 8.70e-01 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 7 | 4.17e-01 | -1.77e-01 | 8.53e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 18 | 1.93e-01 | 1.77e-01 | 7.26e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 18 | 1.93e-01 | -1.77e-01 | 7.26e-01 |
| GOBP DEPYRIMIDINATION | 8 | 3.86e-01 | 1.77e-01 | 8.40e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 4.93e-01 | -1.77e-01 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 13 | 2.70e-01 | 1.77e-01 | 7.85e-01 |
| GOBP PARATHYROID GLAND DEVELOPMENT | 7 | 4.18e-01 | 1.77e-01 | 8.53e-01 |
| GOBP ERBB3 SIGNALING PATHWAY | 5 | 4.94e-01 | 1.77e-01 | 8.83e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 51 | 2.91e-02 | 1.77e-01 | 3.62e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 21 | 1.61e-01 | 1.77e-01 | 6.95e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 24 | 1.34e-01 | 1.77e-01 | 6.53e-01 |
| GOCC MANCHETTE | 16 | 2.22e-01 | -1.77e-01 | 7.54e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 11 | 3.11e-01 | -1.77e-01 | 8.07e-01 |
| GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 10 | 3.34e-01 | -1.76e-01 | 8.18e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 4.54e-01 | 1.76e-01 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 12 | 2.90e-01 | 1.76e-01 | 7.96e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 19 | 1.83e-01 | 1.76e-01 | 7.16e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 45 | 4.07e-02 | 1.76e-01 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 13 | 2.71e-01 | -1.76e-01 | 7.85e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN PARTURITION | 5 | 4.95e-01 | 1.76e-01 | 8.83e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 10 | 3.35e-01 | 1.76e-01 | 8.19e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 6 | 4.55e-01 | -1.76e-01 | 8.70e-01 |
| GOMF ALKANESULFONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.96e-01 | 1.76e-01 | 8.83e-01 |
| GOBP RESPONSE TO GONADOTROPIN RELEASING HORMONE | 7 | 4.20e-01 | 1.76e-01 | 8.54e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 28 | 1.07e-01 | 1.76e-01 | 6.05e-01 |
| GOCC CCR4 NOT COMPLEX | 14 | 2.55e-01 | -1.76e-01 | 7.76e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 12 | 2.92e-01 | 1.76e-01 | 7.97e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 65 | 1.42e-02 | 1.76e-01 | 2.56e-01 |
| GOMF MYOSIN LIGHT CHAIN BINDING | 8 | 3.89e-01 | -1.76e-01 | 8.42e-01 |
| GOCC DENDRITIC SHAFT | 40 | 5.44e-02 | 1.76e-01 | 4.78e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 18 | 1.97e-01 | -1.76e-01 | 7.27e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 11 | 3.13e-01 | -1.76e-01 | 8.08e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 123 | 7.64e-04 | 1.76e-01 | 5.30e-02 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 21 | 1.63e-01 | -1.76e-01 | 6.96e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 17 | 2.10e-01 | 1.76e-01 | 7.42e-01 |
| GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION | 8 | 3.90e-01 | -1.75e-01 | 8.42e-01 |
| GOMF GLUTAMATE GATED CALCIUM ION CHANNEL ACTIVITY | 5 | 4.97e-01 | -1.75e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 17 | 2.11e-01 | -1.75e-01 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 114 | 1.23e-03 | 1.75e-01 | 6.74e-02 |
| GOBP REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION | 7 | 4.23e-01 | -1.75e-01 | 8.55e-01 |
| GOBP HEME TRANSPORT | 9 | 3.63e-01 | -1.75e-01 | 8.33e-01 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 23 | 1.46e-01 | -1.75e-01 | 6.73e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 3.38e-01 | 1.75e-01 | 8.21e-01 |
| GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 11 | 3.15e-01 | 1.75e-01 | 8.08e-01 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 3.64e-01 | -1.75e-01 | 8.33e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 18 | 1.99e-01 | 1.75e-01 | 7.29e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 12 | 2.94e-01 | 1.75e-01 | 7.98e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 23 | 1.47e-01 | 1.75e-01 | 6.74e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 17 | 2.12e-01 | 1.75e-01 | 7.44e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 24 | 1.39e-01 | 1.75e-01 | 6.59e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 12 | 2.95e-01 | 1.75e-01 | 7.98e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 6 | 4.59e-01 | 1.75e-01 | 8.72e-01 |
| GOBP MESENCHYMAL STEM CELL PROLIFERATION | 10 | 3.39e-01 | -1.75e-01 | 8.22e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 10 | 3.39e-01 | -1.75e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 31 | 9.28e-02 | 1.74e-01 | 5.85e-01 |
| GOBP GLYCINE BIOSYNTHETIC PROCESS | 7 | 4.24e-01 | -1.74e-01 | 8.56e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION | 14 | 2.59e-01 | 1.74e-01 | 7.78e-01 |
| GOCC POLYSOMAL RIBOSOME | 28 | 1.10e-01 | -1.74e-01 | 6.13e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 18 | 2.01e-01 | -1.74e-01 | 7.32e-01 |
| GOBP FEMALE MEIOSIS I | 13 | 2.77e-01 | -1.74e-01 | 7.89e-01 |
| GOBP KINETOCHORE ORGANIZATION | 20 | 1.77e-01 | -1.74e-01 | 7.10e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 25 | 1.32e-01 | 1.74e-01 | 6.51e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 3.40e-01 | 1.74e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 79 | 7.45e-03 | 1.74e-01 | 1.83e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 8 | 3.94e-01 | 1.74e-01 | 8.44e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 3.41e-01 | 1.74e-01 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 20 | 1.78e-01 | 1.74e-01 | 7.11e-01 |
| GOBP O GLYCAN PROCESSING | 42 | 5.10e-02 | 1.74e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 17 | 2.14e-01 | 1.74e-01 | 7.45e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 19 | 1.89e-01 | -1.74e-01 | 7.24e-01 |
| GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 5.01e-01 | 1.74e-01 | 8.86e-01 |
| GOMF BUBBLE DNA BINDING | 8 | 3.95e-01 | 1.74e-01 | 8.44e-01 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 11 | 3.18e-01 | -1.74e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF ACROSOME REACTION | 11 | 3.18e-01 | -1.74e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 26 | 1.25e-01 | 1.74e-01 | 6.41e-01 |
| GOBP VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 5 | 5.01e-01 | -1.74e-01 | 8.86e-01 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 2.97e-01 | -1.74e-01 | 7.99e-01 |
| GOBP B CELL LINEAGE COMMITMENT | 6 | 4.61e-01 | -1.74e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 15 | 2.44e-01 | 1.74e-01 | 7.68e-01 |
| GOBP WALKING BEHAVIOR | 35 | 7.54e-02 | -1.74e-01 | 5.44e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 18 | 2.02e-01 | 1.74e-01 | 7.33e-01 |
| GOBP PLATELET AGGREGATION | 71 | 1.14e-02 | 1.74e-01 | 2.29e-01 |
| GOMF SH2 DOMAIN BINDING | 40 | 5.74e-02 | 1.74e-01 | 4.85e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 10 | 3.42e-01 | 1.74e-01 | 8.22e-01 |
| GOBP CELLULAR RESPONSE TO AMMONIUM ION | 5 | 5.02e-01 | 1.73e-01 | 8.87e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 93 | 3.85e-03 | 1.73e-01 | 1.31e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 11 | 3.20e-01 | 1.73e-01 | 8.10e-01 |
| GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 8 | 3.96e-01 | 1.73e-01 | 8.45e-01 |
| GOMF PHOTORECEPTOR ACTIVITY | 13 | 2.80e-01 | -1.73e-01 | 7.93e-01 |
| GOBP REGULATION OF MICROVILLUS ASSEMBLY | 6 | 4.62e-01 | 1.73e-01 | 8.73e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 37 | 6.83e-02 | 1.73e-01 | 5.21e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 21 | 1.70e-01 | 1.73e-01 | 7.02e-01 |
| GOBP HYALOID VASCULAR PLEXUS REGRESSION | 7 | 4.28e-01 | 1.73e-01 | 8.58e-01 |
| GOBP MICTURITION | 8 | 3.97e-01 | -1.73e-01 | 8.45e-01 |
| GOBP POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 5.03e-01 | -1.73e-01 | 8.87e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 50 | 3.43e-02 | -1.73e-01 | 3.92e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 13 | 2.80e-01 | 1.73e-01 | 7.93e-01 |
| GOBP GERM CELL PROLIFERATION | 10 | 3.44e-01 | 1.73e-01 | 8.23e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 19 | 1.93e-01 | -1.73e-01 | 7.26e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 50 | 3.47e-02 | 1.73e-01 | 3.93e-01 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 4.29e-01 | 1.73e-01 | 8.59e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 5.04e-01 | 1.73e-01 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 19 | 1.93e-01 | -1.73e-01 | 7.26e-01 |
| GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 13 | 2.81e-01 | 1.73e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 24 | 1.44e-01 | 1.72e-01 | 6.69e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 30 | 1.02e-01 | 1.72e-01 | 5.97e-01 |
| GOCC SPINDLE POLE CENTROSOME | 13 | 2.82e-01 | -1.72e-01 | 7.93e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 34 | 8.19e-02 | 1.72e-01 | 5.60e-01 |
| GOBP TRANSLATIONAL TERMINATION | 15 | 2.48e-01 | -1.72e-01 | 7.69e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 3.23e-01 | 1.72e-01 | 8.10e-01 |
| GOBP RESPONSE TO BILE ACID | 7 | 4.30e-01 | 1.72e-01 | 8.60e-01 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 6 | 4.65e-01 | 1.72e-01 | 8.74e-01 |
| GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS | 7 | 4.30e-01 | -1.72e-01 | 8.60e-01 |
| GOMF PEROXIREDOXIN ACTIVITY | 7 | 4.31e-01 | -1.72e-01 | 8.60e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 104 | 2.43e-03 | 1.72e-01 | 1.00e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 15 | 2.49e-01 | -1.72e-01 | 7.71e-01 |
| GOBP REGULATION OF SENSORY PERCEPTION | 17 | 2.20e-01 | -1.72e-01 | 7.51e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 8 | 4.00e-01 | 1.72e-01 | 8.46e-01 |
| GOMF CD4 RECEPTOR BINDING | 8 | 4.00e-01 | 1.72e-01 | 8.46e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 5.06e-01 | 1.72e-01 | 8.88e-01 |
| GOBP FOLIC ACID TRANSPORT | 10 | 3.47e-01 | 1.72e-01 | 8.26e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 165 | 1.41e-04 | 1.72e-01 | 1.81e-02 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 16 | 2.34e-01 | 1.72e-01 | 7.61e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 15 | 2.50e-01 | -1.72e-01 | 7.71e-01 |
| GOBP ARGININE METABOLIC PROCESS | 19 | 1.95e-01 | 1.72e-01 | 7.27e-01 |
| GOBP CELLULAR RESPONSE TO WATER STIMULUS | 6 | 4.66e-01 | -1.72e-01 | 8.75e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 13 | 2.84e-01 | 1.72e-01 | 7.95e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 26 | 1.30e-01 | 1.72e-01 | 6.48e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 3.73e-01 | -1.71e-01 | 8.33e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 19 | 1.96e-01 | 1.71e-01 | 7.27e-01 |
| GOBP CELLULAR EXTRAVASATION | 71 | 1.25e-02 | 1.71e-01 | 2.43e-01 |
| GOBP REGULATION OF EOSINOPHIL MIGRATION | 6 | 4.67e-01 | 1.71e-01 | 8.75e-01 |
| GOBP GLOSSOPHARYNGEAL NERVE DEVELOPMENT | 5 | 5.07e-01 | 1.71e-01 | 8.89e-01 |
| GOBP DENDRITIC CELL MIGRATION | 32 | 9.35e-02 | 1.71e-01 | 5.88e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 60 | 2.17e-02 | 1.71e-01 | 3.18e-01 |
| GOMF LIPOPEPTIDE BINDING | 10 | 3.48e-01 | -1.71e-01 | 8.26e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 9 | 3.74e-01 | -1.71e-01 | 8.33e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 66 | 1.61e-02 | 1.71e-01 | 2.73e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 29 | 1.11e-01 | 1.71e-01 | 6.14e-01 |
| GOMF MELANOCORTIN RECEPTOR BINDING | 5 | 5.08e-01 | 1.71e-01 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF AXON GUIDANCE | 5 | 5.08e-01 | -1.71e-01 | 8.89e-01 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 29 | 1.11e-01 | 1.71e-01 | 6.14e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 63 | 1.89e-02 | 1.71e-01 | 2.97e-01 |
| GOCC PROXIMAL DENDRITE | 6 | 4.68e-01 | 1.71e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 60 | 2.21e-02 | 1.71e-01 | 3.18e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 3.05e-01 | -1.71e-01 | 8.02e-01 |
| GOBP REGULATION OF RESTING MEMBRANE POTENTIAL | 10 | 3.50e-01 | -1.71e-01 | 8.26e-01 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 5.08e-01 | 1.71e-01 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 42 | 5.55e-02 | 1.71e-01 | 4.80e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 52 | 3.32e-02 | 1.71e-01 | 3.88e-01 |
| GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY | 16 | 2.37e-01 | 1.71e-01 | 7.63e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 117 | 1.44e-03 | 1.71e-01 | 7.53e-02 |
| GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY | 5 | 5.09e-01 | 1.71e-01 | 8.89e-01 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 12 | 3.06e-01 | -1.70e-01 | 8.03e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 78 | 9.25e-03 | 1.70e-01 | 2.07e-01 |
| GOBP LEUKOCYTE AGGREGATION | 12 | 3.07e-01 | 1.70e-01 | 8.03e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 28 | 1.19e-01 | -1.70e-01 | 6.30e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 16 | 2.38e-01 | -1.70e-01 | 7.63e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 9 | 3.76e-01 | -1.70e-01 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE | 7 | 4.35e-01 | -1.70e-01 | 8.60e-01 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 13 | 2.88e-01 | 1.70e-01 | 7.95e-01 |
| GOBP REGULATION OF SARCOMERE ORGANIZATION | 9 | 3.77e-01 | -1.70e-01 | 8.35e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 9 | 3.77e-01 | 1.70e-01 | 8.35e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 16 | 2.39e-01 | -1.70e-01 | 7.63e-01 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 19 | 1.99e-01 | 1.70e-01 | 7.30e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 28 | 1.19e-01 | 1.70e-01 | 6.30e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 53 | 3.23e-02 | -1.70e-01 | 3.84e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 31 | 1.01e-01 | 1.70e-01 | 5.97e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 10 | 3.52e-01 | -1.70e-01 | 8.27e-01 |
| GOBP FATTY ACID ELONGATION SATURATED FATTY ACID | 7 | 4.36e-01 | 1.70e-01 | 8.60e-01 |
| GOMF FATTY ACID ELONGASE ACTIVITY | 7 | 4.36e-01 | 1.70e-01 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 31 | 1.02e-01 | 1.70e-01 | 5.97e-01 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 5.11e-01 | 1.70e-01 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 26 | 1.34e-01 | -1.70e-01 | 6.53e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 32 | 9.64e-02 | 1.70e-01 | 5.92e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 12 | 3.08e-01 | 1.70e-01 | 8.05e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 20 | 1.89e-01 | -1.70e-01 | 7.24e-01 |
| GOMF SNRNP BINDING | 9 | 3.78e-01 | -1.70e-01 | 8.36e-01 |
| GOBP SEX DETERMINATION | 18 | 2.13e-01 | 1.70e-01 | 7.44e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.78e-01 | 1.70e-01 | 8.36e-01 |
| GOBP CELL PROLIFERATION IN MIDBRAIN | 8 | 4.06e-01 | -1.70e-01 | 8.49e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 5.12e-01 | -1.69e-01 | 8.89e-01 |
| GOBP MATURATION OF LSU RRNA | 27 | 1.27e-01 | -1.69e-01 | 6.43e-01 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 21 | 1.79e-01 | 1.69e-01 | 7.11e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 23 | 1.59e-01 | -1.69e-01 | 6.93e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 11 | 3.31e-01 | 1.69e-01 | 8.15e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 37 | 7.46e-02 | 1.69e-01 | 5.41e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 18 | 2.14e-01 | 1.69e-01 | 7.45e-01 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 9 | 3.79e-01 | 1.69e-01 | 8.36e-01 |
| GOCC PLATELET DENSE GRANULE MEMBRANE | 5 | 5.12e-01 | 1.69e-01 | 8.89e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 13 | 2.91e-01 | 1.69e-01 | 7.97e-01 |
| GOBP POLYAMINE TRANSPORT | 16 | 2.42e-01 | -1.69e-01 | 7.65e-01 |
| GOMF ICOSANOID BINDING | 8 | 4.08e-01 | 1.69e-01 | 8.49e-01 |
| GOCC RADIAL SPOKE | 5 | 5.13e-01 | 1.69e-01 | 8.89e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 6 | 4.73e-01 | 1.69e-01 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 25 | 1.44e-01 | 1.69e-01 | 6.69e-01 |
| GOBP RESPONSE TO STILBENOID | 8 | 4.08e-01 | -1.69e-01 | 8.49e-01 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 14 | 2.74e-01 | 1.69e-01 | 7.87e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 28 | 1.22e-01 | 1.69e-01 | 6.36e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 20 | 1.91e-01 | -1.69e-01 | 7.25e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 16 | 2.43e-01 | 1.69e-01 | 7.66e-01 |
| GOBP MINERALOCORTICOID SECRETION | 7 | 4.40e-01 | 1.69e-01 | 8.62e-01 |
| GOBP FORELIMB MORPHOGENESIS | 39 | 6.84e-02 | 1.69e-01 | 5.21e-01 |
| GOBP SENSORY PERCEPTION | 862 | 4.18e-17 | -1.69e-01 | 6.12e-14 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 11 | 3.33e-01 | 1.68e-01 | 8.18e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED PTERIDINE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 7 | 4.40e-01 | 1.68e-01 | 8.63e-01 |
| GOBP INTESTINAL EPITHELIAL CELL MATURATION | 6 | 4.75e-01 | -1.68e-01 | 8.77e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 61 | 2.30e-02 | 1.68e-01 | 3.24e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 28 | 1.23e-01 | -1.68e-01 | 6.38e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 17 | 2.30e-01 | 1.68e-01 | 7.60e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 38 | 7.28e-02 | 1.68e-01 | 5.36e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 14 | 2.76e-01 | -1.68e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 22 | 1.72e-01 | -1.68e-01 | 7.04e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 13 | 2.94e-01 | -1.68e-01 | 7.98e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 11 | 3.35e-01 | -1.68e-01 | 8.19e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 72 | 1.37e-02 | 1.68e-01 | 2.52e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 18 | 2.18e-01 | 1.68e-01 | 7.49e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 4.11e-01 | 1.68e-01 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF RELAXATION OF MUSCLE | 7 | 4.42e-01 | 1.68e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 32 | 1.01e-01 | -1.68e-01 | 5.95e-01 |
| GOCC CORVET COMPLEX | 7 | 4.42e-01 | 1.68e-01 | 8.64e-01 |
| GOBP ADENOSINE METABOLIC PROCESS | 10 | 3.59e-01 | 1.68e-01 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 18 | 2.18e-01 | 1.68e-01 | 7.49e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 11 | 3.36e-01 | 1.67e-01 | 8.20e-01 |
| GOCC LAMELLAR BODY | 17 | 2.32e-01 | 1.67e-01 | 7.61e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 20 | 1.95e-01 | 1.67e-01 | 7.27e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 21 | 1.84e-01 | 1.67e-01 | 7.18e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 18 | 2.19e-01 | 1.67e-01 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION | 6 | 4.78e-01 | 1.67e-01 | 8.79e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 17 | 2.32e-01 | -1.67e-01 | 7.61e-01 |
| GOBP EPINEPHRINE TRANSPORT | 11 | 3.37e-01 | -1.67e-01 | 8.20e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 12 | 3.16e-01 | 1.67e-01 | 8.09e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 17 | 2.33e-01 | -1.67e-01 | 7.61e-01 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 53 | 3.52e-02 | 1.67e-01 | 3.95e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 26 | 1.40e-01 | -1.67e-01 | 6.61e-01 |
| GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION | 7 | 4.44e-01 | -1.67e-01 | 8.65e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 15 | 2.63e-01 | 1.67e-01 | 7.83e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 5.18e-01 | -1.67e-01 | 8.90e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 23 | 1.66e-01 | 1.67e-01 | 6.98e-01 |
| GOBP MESODERMAL CELL FATE COMMITMENT | 17 | 2.33e-01 | -1.67e-01 | 7.61e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY | 9 | 3.86e-01 | 1.67e-01 | 8.40e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 21 | 1.85e-01 | 1.67e-01 | 7.21e-01 |
| GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS | 7 | 4.44e-01 | -1.67e-01 | 8.66e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 2.80e-01 | 1.67e-01 | 7.93e-01 |
| GOCC MICROVILLUS MEMBRANE | 32 | 1.03e-01 | 1.67e-01 | 5.97e-01 |
| GOBP THYROID HORMONE TRANSPORT | 10 | 3.61e-01 | 1.67e-01 | 8.33e-01 |
| GOBP REGULATION OF G2 MI TRANSITION OF MEIOTIC CELL CYCLE | 5 | 5.19e-01 | 1.67e-01 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 13 | 2.98e-01 | -1.67e-01 | 7.99e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 10 | 3.62e-01 | 1.66e-01 | 8.33e-01 |
| GOMF 3 CHLOROALLYL ALDEHYDE DEHYDROGENASE ACTIVITY | 5 | 5.19e-01 | -1.66e-01 | 8.90e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 5.19e-01 | -1.66e-01 | 8.90e-01 |
| GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.20e-01 | 1.66e-01 | 8.90e-01 |
| GOBP CERAMIDE TRANSPORT | 17 | 2.35e-01 | 1.66e-01 | 7.62e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 41 | 6.55e-02 | 1.66e-01 | 5.12e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 89 | 6.72e-03 | 1.66e-01 | 1.79e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY | 7 | 4.46e-01 | 1.66e-01 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 37 | 8.03e-02 | 1.66e-01 | 5.56e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 5.20e-01 | 1.66e-01 | 8.90e-01 |
| GOBP DORSAL ROOT GANGLION DEVELOPMENT | 7 | 4.47e-01 | 1.66e-01 | 8.67e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 12 | 3.19e-01 | 1.66e-01 | 8.10e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 39 | 7.28e-02 | 1.66e-01 | 5.36e-01 |
| GOMF COMPLEMENT BINDING | 24 | 1.59e-01 | -1.66e-01 | 6.93e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY ACYL GROUPS CONVERTED INTO ALKYL ON TRANSFER | 5 | 5.20e-01 | 1.66e-01 | 8.90e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 10 | 3.63e-01 | 1.66e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 4.17e-01 | 1.66e-01 | 8.53e-01 |
| GOCC MCM COMPLEX | 8 | 4.17e-01 | -1.66e-01 | 8.53e-01 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 8 | 4.17e-01 | 1.66e-01 | 8.53e-01 |
| GOBP PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT | 8 | 4.17e-01 | 1.66e-01 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 35 | 9.03e-02 | 1.65e-01 | 5.78e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 4.83e-01 | -1.65e-01 | 8.80e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 77 | 1.21e-02 | -1.65e-01 | 2.38e-01 |
| GOBP CHITIN METABOLIC PROCESS | 6 | 4.83e-01 | -1.65e-01 | 8.80e-01 |
| GOMF CHITINASE ACTIVITY | 6 | 4.83e-01 | -1.65e-01 | 8.80e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY | 8 | 4.18e-01 | -1.65e-01 | 8.53e-01 |
| GOBP PROTEIN DESUMOYLATION | 8 | 4.18e-01 | -1.65e-01 | 8.53e-01 |
| GOBP METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION | 5 | 5.22e-01 | -1.65e-01 | 8.91e-01 |
| GOBP VACUOLAR LOCALIZATION | 82 | 9.74e-03 | 1.65e-01 | 2.12e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 6 | 4.84e-01 | 1.65e-01 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 12 | 3.22e-01 | -1.65e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 5 | 5.23e-01 | -1.65e-01 | 8.91e-01 |
| GOBP HEAT ACCLIMATION | 5 | 5.23e-01 | 1.65e-01 | 8.91e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 27 | 1.38e-01 | 1.65e-01 | 6.59e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 10 | 3.67e-01 | 1.65e-01 | 8.33e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 14 | 2.86e-01 | 1.65e-01 | 7.95e-01 |
| GOBP RETINA HOMEOSTASIS | 75 | 1.37e-02 | -1.65e-01 | 2.52e-01 |
| GOBP CELLULAR RESPONSE TO LUTEINIZING HORMONE STIMULUS | 5 | 5.24e-01 | -1.65e-01 | 8.91e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 13 | 3.04e-01 | -1.65e-01 | 8.02e-01 |
| GOBP CHEMOKINE PRODUCTION | 101 | 4.25e-03 | 1.65e-01 | 1.36e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 3.93e-01 | -1.65e-01 | 8.43e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 18 | 2.27e-01 | 1.64e-01 | 7.60e-01 |
| GOBP ETHANOL CATABOLIC PROCESS | 10 | 3.68e-01 | -1.64e-01 | 8.33e-01 |
| GOCC PIP BODY | 5 | 5.24e-01 | -1.64e-01 | 8.91e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 49 | 4.65e-02 | -1.64e-01 | 4.44e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 3.24e-01 | -1.64e-01 | 8.10e-01 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 11 | 3.45e-01 | 1.64e-01 | 8.24e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 12 | 3.24e-01 | 1.64e-01 | 8.10e-01 |
| GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 12 | 3.25e-01 | 1.64e-01 | 8.10e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 24 | 1.64e-01 | -1.64e-01 | 6.96e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 12 | 3.25e-01 | -1.64e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 41 | 6.90e-02 | -1.64e-01 | 5.23e-01 |
| GOBP DUMP METABOLIC PROCESS | 7 | 4.52e-01 | 1.64e-01 | 8.70e-01 |
| GOBP NEURONAL DENSE CORE VESICLE EXOCYTOSIS | 7 | 4.52e-01 | -1.64e-01 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 27 | 1.40e-01 | 1.64e-01 | 6.61e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 7 | 4.52e-01 | -1.64e-01 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 10 | 3.69e-01 | 1.64e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 107 | 3.38e-03 | 1.64e-01 | 1.22e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 13 | 3.06e-01 | 1.64e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 27 | 1.40e-01 | -1.64e-01 | 6.61e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 60 | 2.81e-02 | -1.64e-01 | 3.54e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 33 | 1.03e-01 | -1.64e-01 | 5.98e-01 |
| GOBP RESPONSE TO GRAVITY | 9 | 3.95e-01 | 1.64e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 7 | 4.53e-01 | -1.64e-01 | 8.70e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 15 | 2.72e-01 | 1.64e-01 | 7.86e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 10 | 3.70e-01 | -1.64e-01 | 8.33e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 116 | 2.32e-03 | 1.64e-01 | 9.74e-02 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 15 | 2.72e-01 | 1.64e-01 | 7.87e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 18 | 2.29e-01 | -1.64e-01 | 7.60e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 9 | 3.96e-01 | -1.64e-01 | 8.45e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 2.73e-01 | -1.64e-01 | 7.87e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 7 | 4.54e-01 | -1.63e-01 | 8.70e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 18 | 2.30e-01 | 1.63e-01 | 7.60e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST CELL | 8 | 4.24e-01 | 1.63e-01 | 8.56e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 81 | 1.10e-02 | 1.63e-01 | 2.27e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 8 | 4.24e-01 | 1.63e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 8 | 4.24e-01 | 1.63e-01 | 8.56e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 11 | 3.49e-01 | -1.63e-01 | 8.26e-01 |
| GOBP GAP JUNCTION ASSEMBLY | 16 | 2.59e-01 | 1.63e-01 | 7.78e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 26 | 1.50e-01 | 1.63e-01 | 6.80e-01 |
| GOBP REVERSIBLE DIFFERENTIATION | 11 | 3.49e-01 | 1.63e-01 | 8.26e-01 |
| GOBP MAST CELL MIGRATION | 13 | 3.09e-01 | 1.63e-01 | 8.05e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 21 | 1.97e-01 | 1.63e-01 | 7.27e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 21 | 1.97e-01 | -1.63e-01 | 7.27e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 6 | 4.90e-01 | 1.63e-01 | 8.82e-01 |
| GOCC NURD COMPLEX | 15 | 2.75e-01 | 1.63e-01 | 7.88e-01 |
| GOCC DENDRITIC GROWTH CONE | 8 | 4.26e-01 | -1.63e-01 | 8.57e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 34 | 1.01e-01 | 1.63e-01 | 5.95e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 3.29e-01 | -1.63e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 28 | 1.36e-01 | 1.63e-01 | 6.57e-01 |
| GOBP CILIUM DISASSEMBLY | 5 | 5.29e-01 | 1.63e-01 | 8.93e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 11 | 3.51e-01 | 1.62e-01 | 8.26e-01 |
| GOMF LIPOPROTEIN LIPASE ACTIVITY | 9 | 3.99e-01 | -1.62e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 10 | 3.74e-01 | -1.62e-01 | 8.34e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 11 | 3.52e-01 | -1.62e-01 | 8.27e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 46 | 5.72e-02 | 1.62e-01 | 4.83e-01 |
| GOCC ENDOLYSOSOME | 26 | 1.53e-01 | 1.62e-01 | 6.84e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 12 | 3.31e-01 | 1.62e-01 | 8.15e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 27 | 1.45e-01 | 1.62e-01 | 6.71e-01 |
| GOBP RENAL VESICLE FORMATION | 8 | 4.28e-01 | 1.62e-01 | 8.58e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 4.00e-01 | 1.62e-01 | 8.46e-01 |
| GOMF LYSOZYME ACTIVITY | 9 | 4.00e-01 | -1.62e-01 | 8.46e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 4.00e-01 | 1.62e-01 | 8.46e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 19 | 2.22e-01 | -1.62e-01 | 7.54e-01 |
| GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS | 10 | 3.75e-01 | 1.62e-01 | 8.35e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 47 | 5.49e-02 | -1.62e-01 | 4.79e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 8 | 4.28e-01 | 1.62e-01 | 8.59e-01 |
| GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY | 5 | 5.31e-01 | -1.62e-01 | 8.93e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 18 | 2.35e-01 | 1.62e-01 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 20 | 2.11e-01 | 1.62e-01 | 7.42e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 59 | 3.18e-02 | 1.62e-01 | 3.81e-01 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 52 | 4.39e-02 | -1.62e-01 | 4.29e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 25 | 1.62e-01 | 1.62e-01 | 6.95e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 38 | 8.49e-02 | 1.62e-01 | 5.68e-01 |
| GOBP NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 5 | 5.32e-01 | -1.61e-01 | 8.94e-01 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 5 | 5.32e-01 | 1.61e-01 | 8.94e-01 |
| GOBP NCRNA CATABOLIC PROCESS | 54 | 4.05e-02 | 1.61e-01 | 4.15e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 13 | 3.14e-01 | 1.61e-01 | 8.08e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 15 | 2.80e-01 | 1.61e-01 | 7.93e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 8 | 4.30e-01 | 1.61e-01 | 8.60e-01 |
| GOBP SOFT PALATE DEVELOPMENT | 5 | 5.33e-01 | 1.61e-01 | 8.94e-01 |
| GOMF LRR DOMAIN BINDING | 16 | 2.65e-01 | -1.61e-01 | 7.83e-01 |
| GOBP SEROTONIN SECRETION | 9 | 4.03e-01 | 1.61e-01 | 8.46e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 41 | 7.44e-02 | -1.61e-01 | 5.41e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 94 | 6.99e-03 | 1.61e-01 | 1.80e-01 |
| GOCC SPECTRIN | 9 | 4.03e-01 | 1.61e-01 | 8.46e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 20 | 2.13e-01 | -1.61e-01 | 7.45e-01 |
| GOBP MUCUS SECRETION | 18 | 2.38e-01 | 1.61e-01 | 7.63e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 7 | 4.62e-01 | 1.61e-01 | 8.72e-01 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 19 | 2.25e-01 | 1.61e-01 | 7.58e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 30 | 1.28e-01 | 1.60e-01 | 6.44e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 13 | 3.17e-01 | -1.60e-01 | 8.09e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 33 | 1.11e-01 | -1.60e-01 | 6.14e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 32 | 1.16e-01 | 1.60e-01 | 6.26e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 5.35e-01 | -1.60e-01 | 8.94e-01 |
| GOBP LUNG GROWTH | 6 | 4.97e-01 | 1.60e-01 | 8.83e-01 |
| GOBP LIMB JOINT MORPHOGENESIS | 5 | 5.35e-01 | -1.60e-01 | 8.94e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 5.35e-01 | 1.60e-01 | 8.94e-01 |
| GOBP COMPLEMENT ACTIVATION LECTIN PATHWAY | 11 | 3.58e-01 | -1.60e-01 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 4.63e-01 | -1.60e-01 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 68 | 2.24e-02 | 1.60e-01 | 3.20e-01 |
| GOMF CHANNEL REGULATOR ACTIVITY | 135 | 1.32e-03 | 1.60e-01 | 7.16e-02 |
| GOBP REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION | 11 | 3.58e-01 | -1.60e-01 | 8.31e-01 |
| GOBP LIPOXYGENASE PATHWAY | 11 | 3.58e-01 | 1.60e-01 | 8.31e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 35 | 1.02e-01 | 1.60e-01 | 5.97e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 9 | 4.06e-01 | 1.60e-01 | 8.49e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 15 | 2.84e-01 | -1.60e-01 | 7.95e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE | 5 | 5.36e-01 | -1.60e-01 | 8.94e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 9 | 4.06e-01 | 1.60e-01 | 8.49e-01 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 9 | 4.07e-01 | 1.60e-01 | 8.49e-01 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 15 | 2.84e-01 | -1.60e-01 | 7.95e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 24 | 1.76e-01 | -1.60e-01 | 7.08e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 9 | 4.07e-01 | 1.60e-01 | 8.49e-01 |
| GOMF LIPASE INHIBITOR ACTIVITY | 18 | 2.41e-01 | 1.60e-01 | 7.65e-01 |
| GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE | 10 | 3.82e-01 | 1.60e-01 | 8.38e-01 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 2.69e-01 | -1.59e-01 | 7.84e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 17 | 2.55e-01 | 1.59e-01 | 7.76e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 9 | 4.08e-01 | 1.59e-01 | 8.49e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 16 | 2.70e-01 | 1.59e-01 | 7.84e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 9 | 4.08e-01 | 1.59e-01 | 8.49e-01 |
| GOMF FATZ BINDING | 5 | 5.38e-01 | 1.59e-01 | 8.95e-01 |
| GOBP SECRETION BY TISSUE | 44 | 6.77e-02 | 1.59e-01 | 5.21e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 76 | 1.64e-02 | 1.59e-01 | 2.74e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 15 | 2.86e-01 | -1.59e-01 | 7.95e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 27 | 1.52e-01 | -1.59e-01 | 6.83e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 13 | 3.21e-01 | -1.59e-01 | 8.10e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 21 | 2.07e-01 | 1.59e-01 | 7.38e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 23 | 1.87e-01 | -1.59e-01 | 7.23e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 3.21e-01 | -1.59e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF SARCOMERE ORGANIZATION | 6 | 5.00e-01 | -1.59e-01 | 8.86e-01 |
| GOBP MESODERMAL CELL MIGRATION | 5 | 5.38e-01 | -1.59e-01 | 8.96e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 36 | 9.92e-02 | -1.59e-01 | 5.95e-01 |
| GOMF APOLIPOPROTEIN A I BINDING | 5 | 5.39e-01 | -1.59e-01 | 8.96e-01 |
| GOMF ADP BINDING | 35 | 1.04e-01 | 1.59e-01 | 5.99e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 18 | 2.44e-01 | 1.59e-01 | 7.67e-01 |
| GOBP TRANSCYTOSIS | 20 | 2.19e-01 | 1.59e-01 | 7.51e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 24 | 1.78e-01 | 1.59e-01 | 7.11e-01 |
| GOBP HINDBRAIN MATURATION | 5 | 5.39e-01 | -1.59e-01 | 8.96e-01 |
| GOMF FATTY ACID BINDING | 47 | 5.99e-02 | 1.59e-01 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 23 | 1.88e-01 | 1.59e-01 | 7.24e-01 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 3.85e-01 | 1.58e-01 | 8.40e-01 |
| GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 7 | 4.68e-01 | 1.58e-01 | 8.75e-01 |
| GOMF NEUROTROPHIN BINDING | 10 | 3.86e-01 | 1.58e-01 | 8.40e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 11 | 3.63e-01 | 1.58e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL MIGRATION | 5 | 5.40e-01 | 1.58e-01 | 8.96e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 4.69e-01 | -1.58e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 100 | 6.32e-03 | 1.58e-01 | 1.73e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 111 | 4.03e-03 | 1.58e-01 | 1.34e-01 |
| GOCC EMC COMPLEX | 9 | 4.12e-01 | 1.58e-01 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 5.41e-01 | -1.58e-01 | 8.96e-01 |
| GOBP TACHYKININ RECEPTOR SIGNALING PATHWAY | 8 | 4.39e-01 | -1.58e-01 | 8.62e-01 |
| GOBP REGULATION OF CARDIOBLAST DIFFERENTIATION | 5 | 5.41e-01 | 1.58e-01 | 8.96e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 4.70e-01 | 1.58e-01 | 8.75e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 3.87e-01 | -1.58e-01 | 8.41e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 13 | 3.25e-01 | -1.58e-01 | 8.10e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 10 | 3.88e-01 | 1.58e-01 | 8.41e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 13 | 3.25e-01 | 1.58e-01 | 8.10e-01 |
| GOBP SINOATRIAL NODE DEVELOPMENT | 12 | 3.44e-01 | 1.58e-01 | 8.23e-01 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 3.25e-01 | -1.58e-01 | 8.11e-01 |
| GOBP SULFATION | 20 | 2.23e-01 | 1.58e-01 | 7.56e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 9 | 4.13e-01 | 1.57e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 43 | 7.41e-02 | 1.57e-01 | 5.41e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 5.42e-01 | -1.57e-01 | 8.97e-01 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 7 | 4.71e-01 | -1.57e-01 | 8.76e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 35 | 1.07e-01 | 1.57e-01 | 6.05e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 14 | 3.08e-01 | 1.57e-01 | 8.05e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 72 | 2.11e-02 | 1.57e-01 | 3.13e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 230 | 3.99e-05 | 1.57e-01 | 7.57e-03 |
| GOBP POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 11 | 3.67e-01 | 1.57e-01 | 8.33e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 16 | 2.77e-01 | 1.57e-01 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 35 | 1.08e-01 | 1.57e-01 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 15 | 2.93e-01 | -1.57e-01 | 7.97e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 4.72e-01 | 1.57e-01 | 8.77e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 3.91e-01 | 1.57e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION | 5 | 5.44e-01 | 1.57e-01 | 8.98e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 55 | 4.44e-02 | 1.57e-01 | 4.33e-01 |
| GOBP REGULATION OF OPSONIZATION | 10 | 3.91e-01 | 1.57e-01 | 8.42e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 83 | 1.36e-02 | 1.57e-01 | 2.52e-01 |
| GOBP TRIGEMINAL NERVE DEVELOPMENT | 10 | 3.91e-01 | 1.57e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 7 | 4.73e-01 | -1.57e-01 | 8.77e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 17 | 2.64e-01 | -1.57e-01 | 7.83e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 4.73e-01 | 1.56e-01 | 8.77e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 27 | 1.60e-01 | -1.56e-01 | 6.93e-01 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 4.74e-01 | -1.56e-01 | 8.77e-01 |
| GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 16 | 2.79e-01 | -1.56e-01 | 7.93e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 11 | 3.69e-01 | 1.56e-01 | 8.33e-01 |
| GOBP INTERCELLULAR TRANSPORT | 10 | 3.92e-01 | -1.56e-01 | 8.43e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 41 | 8.34e-02 | 1.56e-01 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 92 | 9.61e-03 | 1.56e-01 | 2.11e-01 |
| GOCC COLLAGEN TRIMER | 83 | 1.39e-02 | -1.56e-01 | 2.53e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 302 | 3.06e-06 | 1.56e-01 | 1.08e-03 |
| GOBP SKELETAL MUSCLE THIN FILAMENT ASSEMBLY | 7 | 4.75e-01 | 1.56e-01 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL | 5 | 5.46e-01 | 1.56e-01 | 8.98e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 7 | 4.75e-01 | -1.56e-01 | 8.77e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 50 | 5.65e-02 | 1.56e-01 | 4.82e-01 |
| GOMF NF KAPPAB BINDING | 28 | 1.53e-01 | 1.56e-01 | 6.85e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 57 | 4.18e-02 | 1.56e-01 | 4.20e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 8 | 4.45e-01 | 1.56e-01 | 8.66e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 15 | 2.96e-01 | 1.56e-01 | 7.99e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 34 | 1.16e-01 | 1.56e-01 | 6.25e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 12 | 3.50e-01 | 1.56e-01 | 8.26e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 5.09e-01 | 1.56e-01 | 8.89e-01 |
| GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 5 | 5.46e-01 | -1.56e-01 | 8.99e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 19 | 2.40e-01 | 1.56e-01 | 7.64e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 18 | 2.53e-01 | 1.56e-01 | 7.75e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 17 | 2.66e-01 | 1.56e-01 | 7.83e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 11 | 3.71e-01 | -1.56e-01 | 8.33e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 10 | 3.94e-01 | 1.56e-01 | 8.44e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 46 | 6.79e-02 | 1.56e-01 | 5.21e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 12 | 3.51e-01 | 1.56e-01 | 8.26e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 29 | 1.47e-01 | 1.56e-01 | 6.74e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 2.97e-01 | 1.55e-01 | 7.99e-01 |
| GOBP BLOOD VESSEL MATURATION | 8 | 4.47e-01 | -1.55e-01 | 8.67e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 21 | 2.18e-01 | -1.55e-01 | 7.49e-01 |
| GOBP RRNA CATABOLIC PROCESS | 21 | 2.18e-01 | 1.55e-01 | 7.49e-01 |
| GOBP RESPONSE TO AMINE | 45 | 7.17e-02 | 1.55e-01 | 5.34e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 94 | 9.33e-03 | -1.55e-01 | 2.08e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 27 | 1.63e-01 | -1.55e-01 | 6.95e-01 |
| GOBP MESENCHYMAL CELL DEVELOPMENT | 6 | 5.11e-01 | 1.55e-01 | 8.89e-01 |
| GOBP ACETATE ESTER TRANSPORT | 9 | 4.21e-01 | -1.55e-01 | 8.54e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 15 | 2.99e-01 | 1.55e-01 | 7.99e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 73 | 2.20e-02 | 1.55e-01 | 3.18e-01 |
| GOBP APOPTOTIC CHROMOSOME CONDENSATION | 6 | 5.11e-01 | 1.55e-01 | 8.89e-01 |
| GOBP FEAR RESPONSE | 43 | 7.87e-02 | 1.55e-01 | 5.51e-01 |
| GOBP ADENOSINE TO INOSINE EDITING | 7 | 4.78e-01 | 1.55e-01 | 8.79e-01 |
| GOBP REGULATION OF INOSITOL 1 4 5 TRISPHOSPHATE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 5.49e-01 | 1.55e-01 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 26 | 1.72e-01 | -1.55e-01 | 7.04e-01 |
| GOBP RESPONSE TO DOPAMINE | 70 | 2.51e-02 | 1.55e-01 | 3.37e-01 |
| GOBP CARDIAC CELL FATE COMMITMENT | 16 | 2.84e-01 | 1.55e-01 | 7.95e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 17 | 2.69e-01 | 1.55e-01 | 7.84e-01 |
| GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 6 | 5.12e-01 | 1.55e-01 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 7 | 4.79e-01 | -1.55e-01 | 8.79e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 33 | 1.24e-01 | 1.55e-01 | 6.38e-01 |
| GOBP CELL PROLIFERATION IN HINDBRAIN | 16 | 2.84e-01 | -1.55e-01 | 7.95e-01 |
| GOBP DENSE CORE GRANULE LOCALIZATION | 10 | 3.97e-01 | -1.55e-01 | 8.45e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 27 | 1.65e-01 | 1.55e-01 | 6.97e-01 |
| GOBP RESPONSE TO ERYTHROPOIETIN | 7 | 4.79e-01 | 1.55e-01 | 8.79e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 6 | 5.12e-01 | 1.54e-01 | 8.89e-01 |
| GOBP FLAVONOID GLUCURONIDATION | 5 | 5.50e-01 | 1.54e-01 | 9.01e-01 |
| GOCC RUFFLE MEMBRANE | 99 | 7.97e-03 | 1.54e-01 | 1.92e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 141 | 1.56e-03 | 1.54e-01 | 7.91e-02 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 10 | 3.98e-01 | -1.54e-01 | 8.46e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 16 | 2.86e-01 | -1.54e-01 | 7.95e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 20 | 2.33e-01 | 1.54e-01 | 7.61e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 6 | 5.13e-01 | 1.54e-01 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 5.14e-01 | 1.54e-01 | 8.89e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 10 | 3.99e-01 | 1.54e-01 | 8.46e-01 |
| GOCC PODOSOME | 31 | 1.38e-01 | 1.54e-01 | 6.59e-01 |
| GOBP LACTATE METABOLIC PROCESS | 18 | 2.59e-01 | 1.54e-01 | 7.78e-01 |
| GOCC MICROVILLUS | 94 | 1.00e-02 | 1.54e-01 | 2.15e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 8 | 4.52e-01 | 1.54e-01 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 34 | 1.21e-01 | -1.54e-01 | 6.33e-01 |
| GOBP REGULATION OF MITOPHAGY | 15 | 3.03e-01 | 1.54e-01 | 8.02e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 15 | 3.03e-01 | 1.54e-01 | 8.02e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 17 | 2.73e-01 | 1.54e-01 | 7.87e-01 |
| GOCC VARICOSITY | 8 | 4.52e-01 | 1.53e-01 | 8.70e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 21 | 2.23e-01 | 1.53e-01 | 7.56e-01 |
| GOBP ASYMMETRIC NEUROBLAST DIVISION | 5 | 5.52e-01 | 1.53e-01 | 9.01e-01 |
| GOBP CORNIFICATION | 9 | 4.25e-01 | -1.53e-01 | 8.57e-01 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 6 | 5.15e-01 | 1.53e-01 | 8.90e-01 |
| GOCC FILAMENTOUS ACTIN | 28 | 1.60e-01 | 1.53e-01 | 6.93e-01 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 5.53e-01 | 1.53e-01 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 10 | 4.01e-01 | -1.53e-01 | 8.46e-01 |
| GOMF DIACYLGLYCEROL BINDING | 13 | 3.39e-01 | 1.53e-01 | 8.22e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 45 | 7.54e-02 | -1.53e-01 | 5.44e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 7 | 4.83e-01 | 1.53e-01 | 8.80e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 37 | 1.07e-01 | 1.53e-01 | 6.04e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 39 | 9.80e-02 | 1.53e-01 | 5.95e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 5.53e-01 | 1.53e-01 | 9.01e-01 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 5.53e-01 | 1.53e-01 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 75 | 2.19e-02 | 1.53e-01 | 3.18e-01 |
| GOBP REGULATION OF PROSTATIC BUD FORMATION | 5 | 5.53e-01 | -1.53e-01 | 9.01e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 105 | 6.75e-03 | 1.53e-01 | 1.79e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 14 | 3.22e-01 | 1.53e-01 | 8.10e-01 |
| GOCC AXON HILLOCK | 7 | 4.83e-01 | 1.53e-01 | 8.80e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 5 | 5.54e-01 | 1.53e-01 | 9.01e-01 |
| GOMF ADRENERGIC RECEPTOR ACTIVITY | 9 | 4.27e-01 | 1.53e-01 | 8.58e-01 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 6 | 5.17e-01 | 1.53e-01 | 8.90e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 20 | 2.37e-01 | 1.53e-01 | 7.63e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 15 | 3.06e-01 | 1.53e-01 | 8.02e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 26 | 1.78e-01 | 1.53e-01 | 7.11e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 201 | 1.91e-04 | 1.53e-01 | 2.20e-02 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 37 | 1.08e-01 | 1.53e-01 | 6.06e-01 |
| GOCC BASEMENT MEMBRANE COLLAGEN TRIMER | 6 | 5.18e-01 | -1.53e-01 | 8.90e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 26 | 1.78e-01 | 1.53e-01 | 7.11e-01 |
| GOBP DORSAL AORTA MORPHOGENESIS | 8 | 4.55e-01 | 1.53e-01 | 8.70e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 56 | 4.84e-02 | 1.52e-01 | 4.52e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 20 | 2.38e-01 | -1.52e-01 | 7.63e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 10 | 4.04e-01 | -1.52e-01 | 8.47e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 14 | 3.24e-01 | -1.52e-01 | 8.10e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 3.07e-01 | 1.52e-01 | 8.03e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 2.63e-01 | -1.52e-01 | 7.83e-01 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 18 | 2.63e-01 | -1.52e-01 | 7.83e-01 |
| GOBP REGULATION OF BLOOD VOLUME BY RENIN ANGIOTENSIN | 6 | 5.18e-01 | 1.52e-01 | 8.90e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 13 | 3.42e-01 | 1.52e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 61 | 3.99e-02 | 1.52e-01 | 4.12e-01 |
| GOBP RESPONSE TO CORTICOSTERONE | 12 | 3.62e-01 | 1.52e-01 | 8.33e-01 |
| GOBP ATRIOVENTRICULAR VALVE FORMATION | 8 | 4.56e-01 | 1.52e-01 | 8.71e-01 |
| GOCC CONE PHOTORECEPTOR OUTER SEGMENT | 8 | 4.57e-01 | 1.52e-01 | 8.71e-01 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 11 | 3.83e-01 | 1.52e-01 | 8.38e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 16 | 2.93e-01 | 1.52e-01 | 7.97e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION | 6 | 5.19e-01 | -1.52e-01 | 8.90e-01 |
| GOBP CORTICOSTERONE SECRETION | 5 | 5.56e-01 | 1.52e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING | 8 | 4.57e-01 | 1.52e-01 | 8.71e-01 |
| GOBP RIGHTING REFLEX | 8 | 4.57e-01 | 1.52e-01 | 8.71e-01 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 33 | 1.31e-01 | 1.52e-01 | 6.51e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 24 | 1.98e-01 | -1.52e-01 | 7.29e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 19 | 2.53e-01 | -1.52e-01 | 7.75e-01 |
| GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT | 10 | 4.06e-01 | 1.52e-01 | 8.49e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 42 | 8.91e-02 | 1.52e-01 | 5.77e-01 |
| GOBP REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 11 | 3.84e-01 | -1.52e-01 | 8.39e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 43 | 8.58e-02 | 1.51e-01 | 5.70e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 13 | 3.45e-01 | -1.51e-01 | 8.23e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 51 | 6.14e-02 | 1.51e-01 | 4.97e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 12 | 3.64e-01 | 1.51e-01 | 8.33e-01 |
| GOCC DENDRITIC SPINE HEAD | 7 | 4.88e-01 | 1.51e-01 | 8.82e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION | 7 | 4.88e-01 | 1.51e-01 | 8.82e-01 |
| GOBP REGULATION OF PHOSPHATE TRANSPORT | 6 | 5.21e-01 | 1.51e-01 | 8.91e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 23 | 2.10e-01 | 1.51e-01 | 7.41e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 39 | 1.03e-01 | 1.51e-01 | 5.97e-01 |
| GOCC COHESIN COMPLEX | 8 | 4.60e-01 | 1.51e-01 | 8.72e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 4.09e-01 | -1.51e-01 | 8.49e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 15 | 3.12e-01 | 1.51e-01 | 8.08e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 16 | 2.97e-01 | 1.51e-01 | 7.99e-01 |
| GOBP REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 7 | 4.90e-01 | -1.51e-01 | 8.82e-01 |
| GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 8 | 4.61e-01 | 1.51e-01 | 8.72e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 74 | 2.52e-02 | 1.50e-01 | 3.37e-01 |
| GOCC SPHERICAL HIGH DENSITY LIPOPROTEIN PARTICLE | 8 | 4.61e-01 | 1.50e-01 | 8.72e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 4.91e-01 | 1.50e-01 | 8.82e-01 |
| GOBP LEUKOCYTE MIGRATION | 380 | 4.82e-07 | 1.50e-01 | 2.60e-04 |
| GOBP SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION | 5 | 5.61e-01 | 1.50e-01 | 9.05e-01 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 11 | 3.88e-01 | -1.50e-01 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 80 | 2.02e-02 | 1.50e-01 | 3.04e-01 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 13 | 3.49e-01 | -1.50e-01 | 8.26e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 3.31e-01 | -1.50e-01 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 11 | 3.89e-01 | 1.50e-01 | 8.41e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 5.25e-01 | -1.50e-01 | 8.91e-01 |
| GOBP ALKALOID METABOLIC PROCESS | 7 | 4.92e-01 | -1.50e-01 | 8.83e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 19 | 2.58e-01 | 1.50e-01 | 7.78e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 31 | 1.49e-01 | 1.50e-01 | 6.77e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 10 | 4.12e-01 | 1.50e-01 | 8.50e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 9 | 4.37e-01 | -1.50e-01 | 8.61e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 47 | 7.57e-02 | -1.50e-01 | 5.44e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL BUD | 14 | 3.32e-01 | -1.50e-01 | 8.16e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 47 | 7.60e-02 | 1.50e-01 | 5.45e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 10 | 4.13e-01 | -1.49e-01 | 8.51e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 10 | 4.13e-01 | -1.49e-01 | 8.51e-01 |
| GOBP HYDROGEN SULFIDE METABOLIC PROCESS | 6 | 5.26e-01 | 1.49e-01 | 8.92e-01 |
| GOBP MAST CELL MEDIATED IMMUNITY | 55 | 5.54e-02 | 1.49e-01 | 4.80e-01 |
| GOBP HISTONE UBIQUITINATION | 8 | 4.65e-01 | -1.49e-01 | 8.74e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION | 10 | 4.14e-01 | -1.49e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 16 | 3.01e-01 | 1.49e-01 | 8.02e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 102 | 9.22e-03 | 1.49e-01 | 2.07e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 12 | 3.71e-01 | -1.49e-01 | 8.33e-01 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 8 | 4.65e-01 | -1.49e-01 | 8.74e-01 |
| GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY | 10 | 4.14e-01 | -1.49e-01 | 8.51e-01 |
| GOBP WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY | 5 | 5.64e-01 | -1.49e-01 | 9.05e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT | 8 | 4.65e-01 | 1.49e-01 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 7 | 4.95e-01 | 1.49e-01 | 8.83e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 206 | 2.26e-04 | 1.49e-01 | 2.45e-02 |
| GOBP HINDGUT DEVELOPMENT | 8 | 4.65e-01 | -1.49e-01 | 8.75e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 18 | 2.74e-01 | 1.49e-01 | 7.87e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 30 | 1.58e-01 | 1.49e-01 | 6.91e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 6 | 5.28e-01 | 1.49e-01 | 8.93e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 16 | 3.03e-01 | -1.49e-01 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 37 | 1.18e-01 | -1.49e-01 | 6.29e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 4.67e-01 | 1.49e-01 | 8.75e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 11 | 3.94e-01 | 1.49e-01 | 8.44e-01 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 25 | 1.99e-01 | 1.49e-01 | 7.29e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 185 | 4.93e-04 | 1.49e-01 | 3.94e-02 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 33 | 1.40e-01 | 1.49e-01 | 6.60e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 5.65e-01 | -1.48e-01 | 9.05e-01 |
| GOBP MACROPHAGE ACTIVATION | 108 | 7.68e-03 | 1.48e-01 | 1.87e-01 |
| GOMF LBD DOMAIN BINDING | 6 | 5.29e-01 | 1.48e-01 | 8.93e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 44 | 8.86e-02 | -1.48e-01 | 5.75e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 11 | 3.94e-01 | -1.48e-01 | 8.44e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 55 | 5.71e-02 | 1.48e-01 | 4.83e-01 |
| GOBP MRNA POLYADENYLATION | 24 | 2.09e-01 | -1.48e-01 | 7.39e-01 |
| GOBP POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS | 5 | 5.66e-01 | -1.48e-01 | 9.05e-01 |
| GOBP ADENOSINE TRANSPORT | 5 | 5.66e-01 | 1.48e-01 | 9.05e-01 |
| GOCC PAR POLARITY COMPLEX | 6 | 5.30e-01 | 1.48e-01 | 8.93e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 17 | 2.90e-01 | -1.48e-01 | 7.96e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL REMODELING | 6 | 5.30e-01 | 1.48e-01 | 8.93e-01 |
| GOBP REGULATION OF MACROPHAGE FUSION | 5 | 5.66e-01 | -1.48e-01 | 9.05e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 23 | 2.19e-01 | 1.48e-01 | 7.50e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 42 | 9.67e-02 | 1.48e-01 | 5.93e-01 |
| GOBP MRNA METHYLATION | 17 | 2.90e-01 | -1.48e-01 | 7.96e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 32 | 1.47e-01 | 1.48e-01 | 6.74e-01 |
| GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 5.30e-01 | -1.48e-01 | 8.93e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 8 | 4.68e-01 | -1.48e-01 | 8.75e-01 |
| GOBP NEUROENDOCRINE CELL DIFFERENTIATION | 16 | 3.05e-01 | 1.48e-01 | 8.02e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 13 | 3.56e-01 | 1.48e-01 | 8.30e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 11 | 3.95e-01 | 1.48e-01 | 8.45e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 34 | 1.35e-01 | 1.48e-01 | 6.54e-01 |
| GOCC SPECIFIC GRANULE | 155 | 1.49e-03 | 1.48e-01 | 7.77e-02 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 8 | 4.69e-01 | 1.48e-01 | 8.75e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE | 5 | 5.67e-01 | 1.48e-01 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS BY VEGF ACTIVATED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 5.67e-01 | -1.48e-01 | 9.05e-01 |
| GOBP MEIOTIC CHROMOSOME SEPARATION | 8 | 4.69e-01 | -1.48e-01 | 8.75e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 7 | 4.99e-01 | 1.48e-01 | 8.85e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 11 | 3.97e-01 | 1.48e-01 | 8.45e-01 |
| GOBP THYMOCYTE MIGRATION | 6 | 5.31e-01 | -1.48e-01 | 8.93e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 65 | 3.98e-02 | 1.47e-01 | 4.12e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 37 | 1.21e-01 | -1.47e-01 | 6.32e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 36 | 1.26e-01 | 1.47e-01 | 6.43e-01 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 6 | 5.32e-01 | -1.47e-01 | 8.94e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 14 | 3.40e-01 | -1.47e-01 | 8.22e-01 |
| GOBP VITAMIN CATABOLIC PROCESS | 14 | 3.40e-01 | 1.47e-01 | 8.22e-01 |
| GOMF GPI ANCHOR BINDING | 7 | 5.00e-01 | 1.47e-01 | 8.86e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 24 | 2.12e-01 | 1.47e-01 | 7.43e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 22 | 2.32e-01 | 1.47e-01 | 7.61e-01 |
| GOBP MICROTUBULE SEVERING | 8 | 4.71e-01 | 1.47e-01 | 8.76e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 67 | 3.72e-02 | 1.47e-01 | 4.03e-01 |
| GOMF SIALIC ACID BINDING | 22 | 2.32e-01 | 1.47e-01 | 7.61e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 23 | 2.22e-01 | -1.47e-01 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 44 | 9.15e-02 | 1.47e-01 | 5.82e-01 |
| GOBP PHAGOCYTOSIS | 228 | 1.30e-04 | 1.47e-01 | 1.77e-02 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 68 | 3.60e-02 | 1.47e-01 | 3.97e-01 |
| GOBP SOMATIC MOTOR NEURON DIFFERENTIATION | 5 | 5.69e-01 | 1.47e-01 | 9.06e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 11 | 3.99e-01 | 1.47e-01 | 8.46e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 11 | 3.99e-01 | 1.47e-01 | 8.46e-01 |
| GOBP VALINE METABOLIC PROCESS | 7 | 5.01e-01 | 1.47e-01 | 8.86e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 13 | 3.59e-01 | 1.47e-01 | 8.31e-01 |
| GOBP REGULATION OF MONOCYTE EXTRAVASATION | 7 | 5.01e-01 | -1.47e-01 | 8.86e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 89 | 1.66e-02 | 1.47e-01 | 2.75e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 14 | 3.42e-01 | -1.47e-01 | 8.22e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 10 | 4.21e-01 | 1.47e-01 | 8.54e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 5.34e-01 | 1.47e-01 | 8.94e-01 |
| GOBP PROLINE TRANSMEMBRANE TRANSPORT | 9 | 4.46e-01 | -1.47e-01 | 8.66e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 5.70e-01 | 1.47e-01 | 9.06e-01 |
| GOMF 5S RRNA BINDING | 9 | 4.46e-01 | 1.47e-01 | 8.66e-01 |
| GOBP CHROMATIN LOOPING | 11 | 4.00e-01 | -1.47e-01 | 8.46e-01 |
| GOBP ER OVERLOAD RESPONSE | 11 | 4.00e-01 | 1.47e-01 | 8.46e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 21 | 2.45e-01 | 1.47e-01 | 7.68e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 14 | 3.42e-01 | 1.47e-01 | 8.22e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 23 | 2.24e-01 | -1.47e-01 | 7.57e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 56 | 5.79e-02 | 1.46e-01 | 4.86e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 8 | 4.73e-01 | 1.46e-01 | 8.77e-01 |
| GOCC TERTIARY GRANULE | 157 | 1.54e-03 | 1.46e-01 | 7.88e-02 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 14 | 3.43e-01 | 1.46e-01 | 8.22e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 3.80e-01 | -1.46e-01 | 8.36e-01 |
| GOBP OOCYTE MATURATION | 33 | 1.46e-01 | 1.46e-01 | 6.73e-01 |
| GOBP HAIR CYCLE PHASE | 9 | 4.47e-01 | -1.46e-01 | 8.67e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 83 | 2.12e-02 | 1.46e-01 | 3.14e-01 |
| GOBP ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING | 6 | 5.35e-01 | 1.46e-01 | 8.94e-01 |
| GOBP DETECTION OF CALCIUM ION | 13 | 3.61e-01 | 1.46e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 18 | 2.83e-01 | -1.46e-01 | 7.94e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 15 | 3.27e-01 | 1.46e-01 | 8.13e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION | 11 | 4.02e-01 | -1.46e-01 | 8.46e-01 |
| GOBP INTERLEUKIN 17 PRODUCTION | 46 | 8.66e-02 | 1.46e-01 | 5.72e-01 |
| GOBP REGULATION OF SYNAPSE PRUNING | 6 | 5.36e-01 | 1.46e-01 | 8.94e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 16 | 3.12e-01 | 1.46e-01 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 48 | 8.03e-02 | 1.46e-01 | 5.56e-01 |
| GOBP CARNITINE TRANSMEMBRANE TRANSPORT | 6 | 5.36e-01 | 1.46e-01 | 8.94e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 62 | 4.72e-02 | 1.46e-01 | 4.47e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 11 | 4.03e-01 | 1.46e-01 | 8.46e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 11 | 4.03e-01 | 1.46e-01 | 8.46e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 11 | 4.03e-01 | 1.46e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 13 | 3.63e-01 | -1.46e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF OPSONIZATION | 8 | 4.76e-01 | 1.46e-01 | 8.78e-01 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 12 | 3.82e-01 | 1.46e-01 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 18 | 2.85e-01 | 1.46e-01 | 7.95e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 9 | 4.50e-01 | 1.46e-01 | 8.69e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 15 | 3.29e-01 | 1.46e-01 | 8.15e-01 |
| GOCC CLATHRIN COATED PIT | 73 | 3.15e-02 | 1.46e-01 | 3.79e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 27 | 1.91e-01 | 1.45e-01 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 72 | 3.29e-02 | 1.45e-01 | 3.87e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 10 | 4.26e-01 | 1.45e-01 | 8.57e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 5.73e-01 | 1.45e-01 | 9.06e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 23 | 2.28e-01 | 1.45e-01 | 7.60e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 47 | 8.48e-02 | 1.45e-01 | 5.68e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 22 | 2.38e-01 | 1.45e-01 | 7.63e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 32 | 1.55e-01 | 1.45e-01 | 6.89e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 8 | 4.77e-01 | -1.45e-01 | 8.79e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 26 | 2.00e-01 | 1.45e-01 | 7.32e-01 |
| GOBP NUCLEOSIDE SALVAGE | 8 | 4.77e-01 | 1.45e-01 | 8.79e-01 |
| GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 14 | 3.47e-01 | -1.45e-01 | 8.26e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 21 | 2.50e-01 | 1.45e-01 | 7.72e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 35 | 1.38e-01 | -1.45e-01 | 6.58e-01 |
| GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 4.51e-01 | 1.45e-01 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION | 5 | 5.75e-01 | -1.45e-01 | 9.06e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 13 | 3.65e-01 | 1.45e-01 | 8.33e-01 |
| GOCC PIGMENT GRANULE | 109 | 8.96e-03 | 1.45e-01 | 2.04e-01 |
| GOCC SUPER ELONGATION COMPLEX | 5 | 5.75e-01 | 1.45e-01 | 9.06e-01 |
| GOMF SYNDECAN BINDING | 5 | 5.75e-01 | -1.45e-01 | 9.06e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 36 | 1.33e-01 | 1.45e-01 | 6.51e-01 |
| GOBP NEURAL PLATE MORPHOGENESIS | 5 | 5.75e-01 | -1.45e-01 | 9.06e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 17 | 3.02e-01 | -1.45e-01 | 8.02e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 10 | 4.28e-01 | 1.45e-01 | 8.59e-01 |
| GOBP HEART VALVE DEVELOPMENT | 72 | 3.37e-02 | 1.45e-01 | 3.88e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 50 | 7.68e-02 | 1.45e-01 | 5.48e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 38 | 1.23e-01 | -1.45e-01 | 6.37e-01 |
| GOBP LIPID DROPLET DISASSEMBLY | 6 | 5.40e-01 | 1.45e-01 | 8.96e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION | 7 | 5.08e-01 | -1.45e-01 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 7 | 5.08e-01 | 1.44e-01 | 8.89e-01 |
| GOBP LIPID OXIDATION | 112 | 8.25e-03 | 1.44e-01 | 1.96e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 5.76e-01 | 1.44e-01 | 9.06e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 230 | 1.62e-04 | 1.44e-01 | 2.00e-02 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 5.40e-01 | 1.44e-01 | 8.96e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 22 | 2.42e-01 | 1.44e-01 | 7.65e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 18 | 2.90e-01 | -1.44e-01 | 7.96e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 178 | 9.06e-04 | 1.44e-01 | 5.77e-02 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 18 | 2.90e-01 | -1.44e-01 | 7.96e-01 |
| GOCC TRAMP COMPLEX | 5 | 5.77e-01 | 1.44e-01 | 9.06e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 55 | 6.45e-02 | 1.44e-01 | 5.10e-01 |
| GOBP EOSINOPHIL MIGRATION | 28 | 1.87e-01 | 1.44e-01 | 7.23e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION | 5 | 5.77e-01 | 1.44e-01 | 9.06e-01 |
| GOBP CATECHOLAMINE UPTAKE | 18 | 2.90e-01 | -1.44e-01 | 7.96e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 14 | 3.51e-01 | 1.44e-01 | 8.26e-01 |
| GOMF NEUROPEPTIDE ACTIVITY | 29 | 1.80e-01 | 1.44e-01 | 7.12e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 93 | 1.64e-02 | 1.44e-01 | 2.74e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 7 | 5.09e-01 | 1.44e-01 | 8.89e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 29 | 1.80e-01 | 1.44e-01 | 7.12e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 19 | 2.77e-01 | 1.44e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 5.10e-01 | -1.44e-01 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 5.10e-01 | 1.44e-01 | 8.89e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 3.05e-01 | 1.44e-01 | 8.02e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 93 | 1.66e-02 | 1.44e-01 | 2.75e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 11 | 4.09e-01 | 1.44e-01 | 8.49e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 16 | 3.20e-01 | 1.44e-01 | 8.10e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 9 | 4.56e-01 | 1.44e-01 | 8.70e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 8 | 4.82e-01 | -1.44e-01 | 8.80e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 42 | 1.07e-01 | 1.44e-01 | 6.05e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 17 | 3.06e-01 | -1.44e-01 | 8.02e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 5 | 5.78e-01 | 1.44e-01 | 9.07e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 28 | 1.89e-01 | 1.43e-01 | 7.24e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 180 | 9.08e-04 | 1.43e-01 | 5.77e-02 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 8 | 4.83e-01 | 1.43e-01 | 8.80e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 34 | 1.48e-01 | 1.43e-01 | 6.76e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 13 | 3.71e-01 | 1.43e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 21 | 2.56e-01 | -1.43e-01 | 7.77e-01 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 183 | 8.36e-04 | 1.43e-01 | 5.56e-02 |
| GOBP TRANSFERRIN TRANSPORT | 10 | 4.33e-01 | 1.43e-01 | 8.60e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 20 | 2.68e-01 | -1.43e-01 | 7.83e-01 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 5.80e-01 | -1.43e-01 | 9.08e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 7 | 5.13e-01 | 1.43e-01 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 6 | 5.44e-01 | 1.43e-01 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 5 | 5.80e-01 | 1.43e-01 | 9.08e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 7 | 5.13e-01 | -1.43e-01 | 8.89e-01 |
| GOBP RESPONSE TO LECTIN | 21 | 2.57e-01 | -1.43e-01 | 7.78e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 5.13e-01 | 1.43e-01 | 8.89e-01 |
| GOBP L AMINO ACID TRANSPORT | 84 | 2.37e-02 | 1.43e-01 | 3.28e-01 |
| GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 10 | 4.34e-01 | 1.43e-01 | 8.60e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 5.45e-01 | 1.43e-01 | 8.98e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS | 5 | 5.81e-01 | -1.43e-01 | 9.08e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 80 | 2.75e-02 | 1.43e-01 | 3.52e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 44 | 1.02e-01 | 1.42e-01 | 5.97e-01 |
| GOBP CATECHOLAMINE SECRETION | 60 | 5.63e-02 | 1.42e-01 | 4.82e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 23 | 2.37e-01 | 1.42e-01 | 7.63e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 27 | 2.00e-01 | 1.42e-01 | 7.32e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 290 | 3.00e-05 | 1.42e-01 | 6.54e-03 |
| GOCC SET1C COMPASS COMPLEX | 14 | 3.56e-01 | 1.42e-01 | 8.30e-01 |
| GOBP RESPONSE TO FRUCTOSE | 8 | 4.86e-01 | 1.42e-01 | 8.80e-01 |
| GOBP VESTIBULOCOCHLEAR NERVE FORMATION | 5 | 5.82e-01 | -1.42e-01 | 9.08e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 16 | 3.25e-01 | -1.42e-01 | 8.10e-01 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 8 | 4.86e-01 | 1.42e-01 | 8.80e-01 |
| GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 9 | 4.60e-01 | 1.42e-01 | 8.72e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 45 | 9.91e-02 | 1.42e-01 | 5.95e-01 |
| GOMF HSP90 PROTEIN BINDING | 40 | 1.20e-01 | -1.42e-01 | 6.31e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 50 | 8.24e-02 | 1.42e-01 | 5.61e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 9 | 4.61e-01 | 1.42e-01 | 8.72e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 11 | 4.15e-01 | 1.42e-01 | 8.52e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 14 | 3.58e-01 | 1.42e-01 | 8.31e-01 |
| GOMF CO RECEPTOR BINDING | 13 | 3.76e-01 | 1.42e-01 | 8.35e-01 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 6 | 5.48e-01 | -1.42e-01 | 9.00e-01 |
| GOBP DENTINOGENESIS | 6 | 5.48e-01 | -1.42e-01 | 9.00e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 43 | 1.08e-01 | -1.42e-01 | 6.05e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 119 | 7.58e-03 | 1.42e-01 | 1.85e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 34 | 1.53e-01 | 1.42e-01 | 6.84e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 10 | 4.38e-01 | -1.42e-01 | 8.62e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 16 | 3.27e-01 | 1.42e-01 | 8.12e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 9 | 4.62e-01 | 1.42e-01 | 8.73e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 11 | 4.16e-01 | 1.42e-01 | 8.53e-01 |
| GOBP RNA 5 END PROCESSING | 21 | 2.62e-01 | -1.42e-01 | 7.83e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 9 | 4.62e-01 | -1.41e-01 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT | 5 | 5.84e-01 | -1.41e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 16 | 3.27e-01 | 1.41e-01 | 8.13e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 74 | 3.54e-02 | 1.41e-01 | 3.95e-01 |
| GOBP NADP METABOLIC PROCESS | 41 | 1.17e-01 | 1.41e-01 | 6.28e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.84e-01 | -1.41e-01 | 9.09e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 18 | 3.00e-01 | 1.41e-01 | 8.00e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 23 | 2.41e-01 | -1.41e-01 | 7.65e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 20 | 2.74e-01 | -1.41e-01 | 7.87e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 21 | 2.63e-01 | -1.41e-01 | 7.83e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 9 | 4.63e-01 | 1.41e-01 | 8.74e-01 |
| GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION | 8 | 4.90e-01 | -1.41e-01 | 8.82e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 29 | 1.89e-01 | 1.41e-01 | 7.24e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 55 | 7.04e-02 | 1.41e-01 | 5.28e-01 |
| GOCC DENSE BODY | 5 | 5.85e-01 | 1.41e-01 | 9.10e-01 |
| GOMF WW DOMAIN BINDING | 22 | 2.53e-01 | 1.41e-01 | 7.75e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 9 | 4.64e-01 | 1.41e-01 | 8.74e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 34 | 1.55e-01 | 1.41e-01 | 6.89e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 6 | 5.50e-01 | 1.41e-01 | 9.01e-01 |
| GOMF PROTEIN PHOSPHATASE 2B BINDING | 6 | 5.50e-01 | -1.41e-01 | 9.01e-01 |
| GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 8 | 4.91e-01 | 1.41e-01 | 8.82e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 9 | 4.65e-01 | 1.41e-01 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 40 | 1.23e-01 | 1.41e-01 | 6.38e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 203 | 5.47e-04 | 1.41e-01 | 4.21e-02 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 24 | 2.33e-01 | -1.41e-01 | 7.61e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 5.19e-01 | -1.41e-01 | 8.90e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 7 | 5.19e-01 | 1.41e-01 | 8.90e-01 |
| GOMF CHITIN BINDING | 8 | 4.91e-01 | -1.41e-01 | 8.82e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 54 | 7.39e-02 | 1.41e-01 | 5.41e-01 |
| GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION | 11 | 4.20e-01 | 1.41e-01 | 8.54e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 1.45e-01 | -1.41e-01 | 6.70e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 119 | 8.14e-03 | 1.40e-01 | 1.94e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 117 | 8.70e-03 | -1.40e-01 | 2.01e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 49 | 8.92e-02 | 1.40e-01 | 5.77e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 5.20e-01 | -1.40e-01 | 8.90e-01 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 33 | 1.63e-01 | 1.40e-01 | 6.95e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 29 | 1.91e-01 | -1.40e-01 | 7.25e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 6 | 5.52e-01 | 1.40e-01 | 9.01e-01 |
| GOBP GLUTAMINE TRANSPORT | 9 | 4.67e-01 | 1.40e-01 | 8.75e-01 |
| GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY | 8 | 4.92e-01 | 1.40e-01 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 86 | 2.47e-02 | 1.40e-01 | 3.34e-01 |
| GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 12 | 4.01e-01 | -1.40e-01 | 8.46e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 2.91e-01 | -1.40e-01 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 161 | 2.18e-03 | 1.40e-01 | 9.32e-02 |
| GOMF ARYLESTERASE ACTIVITY | 6 | 5.53e-01 | 1.40e-01 | 9.01e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 13 | 3.82e-01 | 1.40e-01 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 14 | 3.65e-01 | -1.40e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 14 | 3.65e-01 | 1.40e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 110 | 1.13e-02 | 1.40e-01 | 2.28e-01 |
| GOBP MODULATION BY VIRUS OF HOST PROCESS | 7 | 5.22e-01 | 1.40e-01 | 8.91e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 2.80e-01 | -1.40e-01 | 7.93e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 111 | 1.10e-02 | 1.40e-01 | 2.27e-01 |
| GOBP GLIAL CELL FATE SPECIFICATION | 7 | 5.22e-01 | 1.40e-01 | 8.91e-01 |
| GOMF NADP BINDING | 50 | 8.78e-02 | 1.40e-01 | 5.74e-01 |
| GOBP HAIR FOLLICLE MATURATION | 15 | 3.50e-01 | -1.39e-01 | 8.26e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 49 | 9.14e-02 | -1.39e-01 | 5.82e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 13 | 3.84e-01 | -1.39e-01 | 8.39e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 17 | 3.20e-01 | -1.39e-01 | 8.10e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 89 | 2.31e-02 | 1.39e-01 | 3.24e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 5.24e-01 | -1.39e-01 | 8.91e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 7 | 5.24e-01 | -1.39e-01 | 8.91e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 39 | 1.33e-01 | 1.39e-01 | 6.51e-01 |
| GOBP REGULATION OF MESODERMAL CELL DIFFERENTIATION | 9 | 4.70e-01 | 1.39e-01 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 32 | 1.73e-01 | 1.39e-01 | 7.05e-01 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 4.70e-01 | -1.39e-01 | 8.76e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 18 | 3.07e-01 | -1.39e-01 | 8.03e-01 |
| GOBP PML BODY ORGANIZATION | 7 | 5.24e-01 | 1.39e-01 | 8.91e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 5.25e-01 | -1.39e-01 | 8.91e-01 |
| GOMF GABA RECEPTOR ACTIVITY | 19 | 2.95e-01 | 1.39e-01 | 7.98e-01 |
| GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 13 | 3.86e-01 | 1.39e-01 | 8.41e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 28 | 2.04e-01 | 1.39e-01 | 7.34e-01 |
| GOCC CELL TIP | 5 | 5.91e-01 | -1.39e-01 | 9.11e-01 |
| GOBP VITAMIN TRANSPORT | 52 | 8.36e-02 | 1.39e-01 | 5.66e-01 |
| GOBP FLOOR PLATE DEVELOPMENT | 11 | 4.26e-01 | -1.39e-01 | 8.57e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 30 | 1.89e-01 | 1.39e-01 | 7.24e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 168 | 1.94e-03 | 1.39e-01 | 8.77e-02 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 132 | 5.97e-03 | 1.39e-01 | 1.68e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 14 | 3.69e-01 | -1.39e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 99 | 1.72e-02 | 1.39e-01 | 2.81e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 31 | 1.82e-01 | 1.39e-01 | 7.14e-01 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 5.92e-01 | 1.39e-01 | 9.12e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 23 | 2.50e-01 | -1.38e-01 | 7.72e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 11 | 4.26e-01 | 1.38e-01 | 8.58e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 70 | 4.52e-02 | -1.38e-01 | 4.37e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 14 | 3.70e-01 | 1.38e-01 | 8.33e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 80 | 3.24e-02 | 1.38e-01 | 3.85e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 8 | 4.98e-01 | -1.38e-01 | 8.84e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 10 | 4.49e-01 | -1.38e-01 | 8.68e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 9 | 4.73e-01 | -1.38e-01 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 148 | 3.69e-03 | 1.38e-01 | 1.29e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 24 | 2.42e-01 | -1.38e-01 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 9 | 4.73e-01 | 1.38e-01 | 8.77e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 3.71e-01 | -1.38e-01 | 8.33e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 17 | 3.24e-01 | -1.38e-01 | 8.10e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 32 | 1.77e-01 | 1.38e-01 | 7.10e-01 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 12 | 4.09e-01 | -1.38e-01 | 8.49e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 14 | 3.72e-01 | 1.38e-01 | 8.33e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 118 | 9.75e-03 | 1.38e-01 | 2.12e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.74e-01 | 1.38e-01 | 8.77e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 41 | 1.27e-01 | 1.38e-01 | 6.43e-01 |
| GOBP VITAMIN D3 METABOLIC PROCESS | 6 | 5.59e-01 | 1.38e-01 | 9.04e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 5.59e-01 | -1.38e-01 | 9.04e-01 |
| GOBP REGULATION OF AXON GUIDANCE | 13 | 3.90e-01 | -1.38e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 59 | 6.74e-02 | 1.38e-01 | 5.21e-01 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 22 | 2.64e-01 | 1.38e-01 | 7.83e-01 |
| GOBP GLIAL CELL FATE COMMITMENT | 13 | 3.91e-01 | 1.37e-01 | 8.42e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 13 | 3.91e-01 | -1.37e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 56 | 7.53e-02 | 1.37e-01 | 5.44e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 43 | 1.19e-01 | 1.37e-01 | 6.30e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 5.29e-01 | 1.37e-01 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 26 | 2.26e-01 | 1.37e-01 | 7.59e-01 |
| GOBP REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY | 6 | 5.61e-01 | -1.37e-01 | 9.05e-01 |
| GOMF GALACTOSYLCERAMIDASE ACTIVITY | 5 | 5.95e-01 | -1.37e-01 | 9.13e-01 |
| GOBP LEUCINE TRANSPORT | 10 | 4.53e-01 | 1.37e-01 | 8.70e-01 |
| GOBP COPPER ION TRANSPORT | 15 | 3.58e-01 | 1.37e-01 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 7 | 5.30e-01 | 1.37e-01 | 8.93e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 25 | 2.35e-01 | 1.37e-01 | 7.62e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 15 | 3.58e-01 | 1.37e-01 | 8.31e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 4.31e-01 | 1.37e-01 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 100 | 1.80e-02 | 1.37e-01 | 2.88e-01 |
| GOBP VOCALIZATION BEHAVIOR | 15 | 3.59e-01 | -1.37e-01 | 8.31e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 15 | 3.59e-01 | -1.37e-01 | 8.31e-01 |
| GOBP ANTERIOR HEAD DEVELOPMENT | 7 | 5.31e-01 | 1.37e-01 | 8.93e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 14 | 3.75e-01 | 1.37e-01 | 8.35e-01 |
| GOBP MIDBRAIN HINDBRAIN BOUNDARY DEVELOPMENT | 7 | 5.31e-01 | 1.37e-01 | 8.93e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 5.62e-01 | 1.37e-01 | 9.05e-01 |
| GOBP REGULATION OF VESICLE SIZE | 19 | 3.02e-01 | 1.37e-01 | 8.02e-01 |
| GOBP GENERAL ADAPTATION SYNDROME | 6 | 5.62e-01 | -1.37e-01 | 9.05e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 33 | 1.74e-01 | 1.37e-01 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 14 | 3.76e-01 | -1.37e-01 | 8.35e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 88 | 2.68e-02 | -1.37e-01 | 3.48e-01 |
| GOBP CELLULAR RESPONSE TO HEPARIN | 5 | 5.97e-01 | -1.37e-01 | 9.15e-01 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 9 | 4.78e-01 | -1.37e-01 | 8.79e-01 |
| GOMF SUMO LIGASE ACTIVITY | 13 | 3.94e-01 | -1.36e-01 | 8.44e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 22 | 2.68e-01 | 1.36e-01 | 7.83e-01 |
| GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 22 | 2.68e-01 | -1.36e-01 | 7.83e-01 |
| GOMF C PALMITOYLTRANSFERASE ACTIVITY | 5 | 5.97e-01 | 1.36e-01 | 9.15e-01 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 14 | 3.77e-01 | -1.36e-01 | 8.35e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 31 | 1.89e-01 | -1.36e-01 | 7.24e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 102 | 1.74e-02 | 1.36e-01 | 2.82e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 19 | 3.04e-01 | 1.36e-01 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 14 | 3.78e-01 | 1.36e-01 | 8.36e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 115 | 1.17e-02 | 1.36e-01 | 2.32e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 29 | 2.05e-01 | 1.36e-01 | 7.35e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 5.64e-01 | 1.36e-01 | 9.05e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 11 | 4.35e-01 | -1.36e-01 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 19 | 3.05e-01 | -1.36e-01 | 8.02e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 34 | 1.70e-01 | 1.36e-01 | 7.03e-01 |
| GOMF CHEMOATTRACTANT ACTIVITY | 34 | 1.70e-01 | 1.36e-01 | 7.03e-01 |
| GOBP ZYGOTIC DETERMINATION OF ANTERIOR POSTERIOR AXIS EMBRYO | 6 | 5.64e-01 | 1.36e-01 | 9.05e-01 |
| GOCC DENDRITE CYTOPLASM | 26 | 2.30e-01 | 1.36e-01 | 7.60e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 9 | 4.80e-01 | -1.36e-01 | 8.80e-01 |
| GOBP SNRNA TRANSPORT | 6 | 5.64e-01 | 1.36e-01 | 9.05e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 46 | 1.11e-01 | -1.36e-01 | 6.14e-01 |
| GOCC DYNEIN AXONEMAL PARTICLE | 20 | 2.93e-01 | -1.36e-01 | 7.97e-01 |
| GOBP REGULATION OF METANEPHROS DEVELOPMENT | 5 | 5.99e-01 | -1.36e-01 | 9.15e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 26 | 2.31e-01 | 1.36e-01 | 7.60e-01 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 13 | 3.97e-01 | -1.36e-01 | 8.45e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 13 | 3.97e-01 | -1.36e-01 | 8.45e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 36 | 1.59e-01 | -1.36e-01 | 6.93e-01 |
| GOBP EPIDERMAL CELL FATE SPECIFICATION | 5 | 6.00e-01 | -1.36e-01 | 9.15e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 13 | 3.97e-01 | 1.36e-01 | 8.45e-01 |
| GOBP GLUTAMATE REUPTAKE | 6 | 5.65e-01 | 1.36e-01 | 9.05e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 90 | 2.63e-02 | -1.35e-01 | 3.46e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 235 | 3.48e-04 | 1.35e-01 | 3.07e-02 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 16 | 3.49e-01 | 1.35e-01 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 26 | 2.32e-01 | 1.35e-01 | 7.61e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 9 | 4.82e-01 | 1.35e-01 | 8.80e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 12 | 4.17e-01 | 1.35e-01 | 8.53e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 8 | 5.08e-01 | 1.35e-01 | 8.89e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 9 | 4.83e-01 | 1.35e-01 | 8.80e-01 |
| GOBP FORMATE METABOLIC PROCESS | 6 | 5.67e-01 | -1.35e-01 | 9.05e-01 |
| GOMF HEMOGLOBIN BINDING | 9 | 4.83e-01 | 1.35e-01 | 8.80e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 108 | 1.54e-02 | 1.35e-01 | 2.66e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 50 | 9.88e-02 | 1.35e-01 | 5.95e-01 |
| GOBP RESPONSE TO SORBITOL | 6 | 5.67e-01 | 1.35e-01 | 9.05e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 8 | 5.09e-01 | -1.35e-01 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 66 | 5.84e-02 | 1.35e-01 | 4.88e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 9 | 4.84e-01 | 1.35e-01 | 8.80e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 25 | 2.44e-01 | -1.35e-01 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 6 | 5.68e-01 | 1.35e-01 | 9.05e-01 |
| GOBP REGULATION OF CHONDROCYTE DEVELOPMENT | 6 | 5.68e-01 | 1.35e-01 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 10 | 4.61e-01 | 1.34e-01 | 8.72e-01 |
| GOBP MICROVILLUS ORGANIZATION | 28 | 2.18e-01 | 1.34e-01 | 7.49e-01 |
| GOBP FATTY ACID BETA OXIDATION | 74 | 4.55e-02 | 1.34e-01 | 4.39e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 41 | 1.37e-01 | 1.34e-01 | 6.57e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 34 | 1.75e-01 | 1.34e-01 | 7.07e-01 |
| GOBP REGULATION OF GLOMERULUS DEVELOPMENT | 5 | 6.03e-01 | -1.34e-01 | 9.19e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 13 | 4.02e-01 | -1.34e-01 | 8.46e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 13 | 4.02e-01 | 1.34e-01 | 8.46e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 82 | 3.56e-02 | 1.34e-01 | 3.96e-01 |
| GOBP GLANDULAR EPITHELIAL CELL MATURATION | 9 | 4.86e-01 | -1.34e-01 | 8.80e-01 |
| GOBP IMP METABOLIC PROCESS | 17 | 3.38e-01 | -1.34e-01 | 8.21e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 63 | 6.54e-02 | 1.34e-01 | 5.12e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 16 | 3.53e-01 | 1.34e-01 | 8.27e-01 |
| GOBP MYOBLAST MIGRATION | 13 | 4.02e-01 | 1.34e-01 | 8.46e-01 |
| GOBP REGULATION OF MICROVILLUS LENGTH | 7 | 5.39e-01 | -1.34e-01 | 8.96e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 5 | 6.04e-01 | 1.34e-01 | 9.19e-01 |
| GOBP L SERINE METABOLIC PROCESS | 12 | 4.21e-01 | 1.34e-01 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 32 | 1.90e-01 | -1.34e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 7 | 5.39e-01 | 1.34e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 25 | 2.46e-01 | -1.34e-01 | 7.68e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 10 | 4.64e-01 | 1.34e-01 | 8.74e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 10 | 4.64e-01 | 1.34e-01 | 8.74e-01 |
| GOBP TENDON DEVELOPMENT | 5 | 6.04e-01 | 1.34e-01 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 83 | 3.52e-02 | 1.34e-01 | 3.95e-01 |
| GOMF ORGANIC ACID BINDING | 207 | 9.22e-04 | 1.34e-01 | 5.83e-02 |
| GOBP PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION | 6 | 5.71e-01 | 1.34e-01 | 9.06e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 23 | 2.68e-01 | 1.33e-01 | 7.83e-01 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 22 | 2.79e-01 | -1.33e-01 | 7.92e-01 |
| GOBP THALAMUS DEVELOPMENT | 11 | 4.44e-01 | -1.33e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 19 | 3.14e-01 | 1.33e-01 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 158 | 3.81e-03 | 1.33e-01 | 1.31e-01 |
| GOMF RNA POLYMERASE II ACTIVITY | 9 | 4.88e-01 | -1.33e-01 | 8.82e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 25 | 2.48e-01 | -1.33e-01 | 7.70e-01 |
| GOBP MICROVILLUS ASSEMBLY | 20 | 3.02e-01 | 1.33e-01 | 8.02e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 3.88e-01 | -1.33e-01 | 8.41e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 20 | 3.02e-01 | 1.33e-01 | 8.02e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 27 | 2.31e-01 | 1.33e-01 | 7.60e-01 |
| GOMF CYCLOSPORIN A BINDING | 17 | 3.42e-01 | -1.33e-01 | 8.22e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE | 5 | 6.06e-01 | 1.33e-01 | 9.20e-01 |
| GOCC EUCHROMATIN | 56 | 8.47e-02 | -1.33e-01 | 5.68e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 22 | 2.80e-01 | 1.33e-01 | 7.93e-01 |
| GOBP INTESTINAL STEM CELL HOMEOSTASIS | 6 | 5.72e-01 | -1.33e-01 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MIGRATION | 6 | 5.73e-01 | 1.33e-01 | 9.06e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 8 | 5.15e-01 | 1.33e-01 | 8.90e-01 |
| GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION | 6 | 5.73e-01 | 1.33e-01 | 9.06e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 50 | 1.04e-01 | 1.33e-01 | 5.99e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 18 | 3.29e-01 | -1.33e-01 | 8.15e-01 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 29 | 2.15e-01 | -1.33e-01 | 7.48e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 4.90e-01 | 1.33e-01 | 8.82e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 13 | 4.07e-01 | -1.33e-01 | 8.49e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 3.73e-01 | -1.33e-01 | 8.33e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 15 | 3.73e-01 | -1.33e-01 | 8.33e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 32 | 1.94e-01 | -1.33e-01 | 7.27e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 18 | 3.30e-01 | 1.33e-01 | 8.15e-01 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 15 | 3.74e-01 | -1.33e-01 | 8.33e-01 |
| GOMF AMMONIA LYASE ACTIVITY | 5 | 6.07e-01 | 1.33e-01 | 9.20e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 6.08e-01 | 1.33e-01 | 9.20e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 11 | 4.46e-01 | 1.33e-01 | 8.67e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 25 | 2.51e-01 | -1.33e-01 | 7.74e-01 |
| GOBP NEURON FATE COMMITMENT | 73 | 5.03e-02 | 1.32e-01 | 4.60e-01 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 8 | 5.17e-01 | 1.32e-01 | 8.90e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 22 | 2.82e-01 | 1.32e-01 | 7.94e-01 |
| GOBP RESPONSE TO HUMAN CHORIONIC GONADOTROPIN | 5 | 6.09e-01 | 1.32e-01 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 118 | 1.31e-02 | 1.32e-01 | 2.50e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 22 | 2.83e-01 | 1.32e-01 | 7.94e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 4.28e-01 | -1.32e-01 | 8.59e-01 |
| GOBP CHORIO ALLANTOIC FUSION | 7 | 5.45e-01 | -1.32e-01 | 8.98e-01 |
| GOCC MEIOTIC SPINDLE | 15 | 3.75e-01 | 1.32e-01 | 8.35e-01 |
| GOBP ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION | 6 | 5.75e-01 | 1.32e-01 | 9.06e-01 |
| GOCC STEREOCILIA COUPLING LINK | 7 | 5.45e-01 | 1.32e-01 | 8.98e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 10 | 4.70e-01 | 1.32e-01 | 8.75e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 9 | 4.93e-01 | -1.32e-01 | 8.83e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 12 | 4.29e-01 | 1.32e-01 | 8.59e-01 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 25 | 2.54e-01 | 1.32e-01 | 7.76e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 6.10e-01 | -1.32e-01 | 9.20e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 148 | 5.64e-03 | 1.32e-01 | 1.64e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 14 | 3.93e-01 | 1.32e-01 | 8.44e-01 |
| GOBP TRICUSPID VALVE MORPHOGENESIS | 5 | 6.10e-01 | -1.32e-01 | 9.20e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 22 | 2.85e-01 | 1.32e-01 | 7.95e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS | 8 | 5.19e-01 | 1.32e-01 | 8.90e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 8 | 5.19e-01 | 1.32e-01 | 8.90e-01 |
| GOCC BLOC COMPLEX | 14 | 3.94e-01 | 1.32e-01 | 8.44e-01 |
| GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS | 8 | 5.19e-01 | 1.32e-01 | 8.90e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 66 | 6.45e-02 | 1.32e-01 | 5.10e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 9 | 4.94e-01 | -1.32e-01 | 8.83e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 50 | 1.08e-01 | -1.32e-01 | 6.05e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 6 | 5.77e-01 | 1.32e-01 | 9.06e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 17 | 3.48e-01 | 1.31e-01 | 8.26e-01 |
| GOMF PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ACTIVITY | 9 | 4.95e-01 | 1.31e-01 | 8.83e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 42 | 1.40e-01 | 1.31e-01 | 6.61e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 70 | 5.72e-02 | 1.31e-01 | 4.83e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 441 | 2.21e-06 | 1.31e-01 | 8.45e-04 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 5.47e-01 | 1.31e-01 | 8.99e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 5.77e-01 | 1.31e-01 | 9.06e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 196 | 1.52e-03 | 1.31e-01 | 7.88e-02 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 9 | 4.95e-01 | 1.31e-01 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 35 | 1.79e-01 | 1.31e-01 | 7.11e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 15 | 3.79e-01 | 1.31e-01 | 8.36e-01 |
| GOBP CORNEA DEVELOPMENT IN CAMERA TYPE EYE | 12 | 4.31e-01 | 1.31e-01 | 8.60e-01 |
| GOBP COLLECTING DUCT DEVELOPMENT | 15 | 3.79e-01 | 1.31e-01 | 8.36e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 127 | 1.07e-02 | 1.31e-01 | 2.24e-01 |
| GOBP NK T CELL ACTIVATION | 12 | 4.31e-01 | -1.31e-01 | 8.60e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 19 | 3.22e-01 | -1.31e-01 | 8.10e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 50 | 1.09e-01 | 1.31e-01 | 6.07e-01 |
| GOMF N ACETYLGALACTOSAMINE 4 O SULFOTRANSFERASE ACTIVITY | 5 | 6.12e-01 | 1.31e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 122 | 1.24e-02 | 1.31e-01 | 2.43e-01 |
| GOBP ACYLGLYCEROL TRANSPORT | 8 | 5.21e-01 | -1.31e-01 | 8.91e-01 |
| GOBP POINTED END ACTIN FILAMENT CAPPING | 7 | 5.48e-01 | 1.31e-01 | 9.00e-01 |
| GOBP RESPONSE TO INSULIN | 262 | 2.62e-04 | 1.31e-01 | 2.63e-02 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 28 | 2.30e-01 | 1.31e-01 | 7.60e-01 |
| GOMF GLUTAMATE BINDING | 8 | 5.21e-01 | -1.31e-01 | 8.91e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 22 | 2.88e-01 | 1.31e-01 | 7.95e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 134 | 8.89e-03 | 1.31e-01 | 2.03e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 28 | 2.31e-01 | -1.31e-01 | 7.60e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 13 | 4.14e-01 | -1.31e-01 | 8.51e-01 |
| GOBP MONOCYTE AGGREGATION | 5 | 6.13e-01 | 1.31e-01 | 9.21e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 5.80e-01 | -1.31e-01 | 9.08e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 4.98e-01 | 1.31e-01 | 8.84e-01 |
| GOCC KERATIN FILAMENT | 90 | 3.23e-02 | -1.31e-01 | 3.84e-01 |
| GOBP CELL MIGRATION INVOLVED IN METANEPHROS DEVELOPMENT | 5 | 6.13e-01 | 1.31e-01 | 9.21e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 6.13e-01 | -1.30e-01 | 9.21e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 84 | 3.88e-02 | 1.30e-01 | 4.08e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 6.14e-01 | -1.30e-01 | 9.21e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 7 | 5.50e-01 | 1.30e-01 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 4.99e-01 | 1.30e-01 | 8.85e-01 |
| GOCC FILOPODIUM MEMBRANE | 17 | 3.53e-01 | -1.30e-01 | 8.27e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 45 | 1.31e-01 | 1.30e-01 | 6.50e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 158 | 4.75e-03 | 1.30e-01 | 1.45e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 123 | 1.27e-02 | 1.30e-01 | 2.45e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING | 12 | 4.35e-01 | 1.30e-01 | 8.60e-01 |
| GOMF POLY A BINDING | 23 | 2.81e-01 | -1.30e-01 | 7.93e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 27 | 2.43e-01 | 1.30e-01 | 7.66e-01 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 6 | 5.82e-01 | 1.30e-01 | 9.08e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 194 | 1.81e-03 | 1.30e-01 | 8.41e-02 |
| GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.52e-01 | 1.30e-01 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 15 | 3.84e-01 | 1.30e-01 | 8.38e-01 |
| GOBP DETECTION OF LIPOPOLYSACCHARIDE | 5 | 6.15e-01 | 1.30e-01 | 9.21e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 5.52e-01 | 1.30e-01 | 9.01e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 8 | 5.25e-01 | 1.30e-01 | 8.91e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 33 | 1.97e-01 | 1.30e-01 | 7.27e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 77 | 4.89e-02 | 1.30e-01 | 4.54e-01 |
| GOBP RESPONSE TO TYPE III INTERFERON | 11 | 4.56e-01 | 1.30e-01 | 8.71e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 7 | 5.52e-01 | 1.30e-01 | 9.01e-01 |
| GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.82e-01 | 1.30e-01 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 19 | 3.28e-01 | -1.30e-01 | 8.14e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 16 | 3.69e-01 | -1.30e-01 | 8.33e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 11 | 4.57e-01 | -1.30e-01 | 8.71e-01 |
| GOBP CHONDROCYTE PROLIFERATION | 24 | 2.72e-01 | -1.30e-01 | 7.86e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 7 | 5.53e-01 | 1.30e-01 | 9.01e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 68 | 6.47e-02 | 1.30e-01 | 5.11e-01 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 5.53e-01 | -1.30e-01 | 9.01e-01 |
| GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 8 | 5.26e-01 | 1.30e-01 | 8.92e-01 |
| GOBP REGULATION OF ALDOSTERONE METABOLIC PROCESS | 8 | 5.26e-01 | 1.29e-01 | 8.92e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 4.58e-01 | 1.29e-01 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 24 | 2.73e-01 | 1.29e-01 | 7.87e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 34 | 1.92e-01 | 1.29e-01 | 7.26e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 16 | 3.71e-01 | -1.29e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 33 | 1.99e-01 | 1.29e-01 | 7.29e-01 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 139 | 8.54e-03 | 1.29e-01 | 1.99e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 88 | 3.62e-02 | 1.29e-01 | 3.97e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 7 | 5.54e-01 | 1.29e-01 | 9.01e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 10 | 4.79e-01 | -1.29e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 9 | 5.02e-01 | 1.29e-01 | 8.87e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 6.17e-01 | 1.29e-01 | 9.22e-01 |
| GOMF MANNOSIDASE ACTIVITY | 15 | 3.87e-01 | -1.29e-01 | 8.41e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 12 | 4.39e-01 | 1.29e-01 | 8.62e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 7 | 5.54e-01 | -1.29e-01 | 9.01e-01 |
| GOBP METANEPHRIC TUBULE FORMATION | 6 | 5.84e-01 | 1.29e-01 | 9.09e-01 |
| GOBP GDP METABOLIC PROCESS | 9 | 5.03e-01 | 1.29e-01 | 8.87e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 183 | 2.63e-03 | 1.29e-01 | 1.04e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 6.18e-01 | -1.29e-01 | 9.22e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 11 | 4.59e-01 | -1.29e-01 | 8.72e-01 |
| GOBP PARANODAL JUNCTION ASSEMBLY | 6 | 5.85e-01 | -1.29e-01 | 9.09e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 17 | 3.58e-01 | -1.29e-01 | 8.31e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 9 | 5.03e-01 | 1.29e-01 | 8.87e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 37 | 1.75e-01 | 1.29e-01 | 7.07e-01 |
| GOCC CILIARY TRANSITION FIBER | 8 | 5.28e-01 | 1.29e-01 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 31 | 2.15e-01 | 1.29e-01 | 7.47e-01 |
| GOBP DAMP METABOLIC PROCESS | 7 | 5.56e-01 | 1.29e-01 | 9.02e-01 |
| GOBP PEPTIDE MODIFICATION | 5 | 6.19e-01 | -1.29e-01 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 17 | 3.59e-01 | 1.29e-01 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 5.56e-01 | 1.29e-01 | 9.02e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 27 | 2.48e-01 | 1.28e-01 | 7.69e-01 |
| GOMF T CELL RECEPTOR BINDING | 11 | 4.61e-01 | -1.28e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 34 | 1.95e-01 | -1.28e-01 | 7.27e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 17 | 3.59e-01 | 1.28e-01 | 8.31e-01 |
| GOCC CYTOCHROME COMPLEX | 34 | 1.95e-01 | -1.28e-01 | 7.27e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 39 | 1.65e-01 | 1.28e-01 | 6.98e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 217 | 1.12e-03 | 1.28e-01 | 6.42e-02 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 5.30e-01 | -1.28e-01 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 4.06e-01 | 1.28e-01 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 15 | 3.90e-01 | -1.28e-01 | 8.42e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 15 | 3.90e-01 | 1.28e-01 | 8.42e-01 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 26 | 2.58e-01 | 1.28e-01 | 7.78e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 11 | 4.62e-01 | -1.28e-01 | 8.73e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 22 | 2.99e-01 | -1.28e-01 | 7.99e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 219 | 1.10e-03 | 1.28e-01 | 6.38e-02 |
| GOCC RNA POLYMERASE I COMPLEX | 13 | 4.25e-01 | -1.28e-01 | 8.57e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 22 | 2.99e-01 | 1.28e-01 | 7.99e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 116 | 1.73e-02 | 1.28e-01 | 2.82e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 20 | 3.22e-01 | 1.28e-01 | 8.10e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 8 | 5.31e-01 | 1.28e-01 | 8.93e-01 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 11 | 4.63e-01 | 1.28e-01 | 8.74e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 40 | 1.62e-01 | 1.28e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 28 | 2.42e-01 | 1.28e-01 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 7 | 5.58e-01 | -1.28e-01 | 9.03e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 6 | 5.88e-01 | 1.28e-01 | 9.11e-01 |
| GOBP FUSED ANTRUM STAGE | 6 | 5.88e-01 | 1.28e-01 | 9.11e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 19 | 3.35e-01 | 1.28e-01 | 8.19e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 16 | 3.77e-01 | 1.28e-01 | 8.35e-01 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 6 | 5.89e-01 | 1.28e-01 | 9.11e-01 |
| GOBP DOPAMINE SECRETION | 41 | 1.58e-01 | 1.28e-01 | 6.91e-01 |
| GOBP GANGLION DEVELOPMENT | 17 | 3.63e-01 | 1.27e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 16 | 3.77e-01 | -1.27e-01 | 8.36e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 31 | 2.20e-01 | -1.27e-01 | 7.51e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 20 | 3.24e-01 | -1.27e-01 | 8.10e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 36 | 1.86e-01 | 1.27e-01 | 7.22e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 18 | 3.50e-01 | 1.27e-01 | 8.26e-01 |
| GOBP CELL CHEMOTAXIS | 304 | 1.36e-04 | 1.27e-01 | 1.78e-02 |
| GOBP REGULATION OF GAP JUNCTION ASSEMBLY | 9 | 5.09e-01 | 1.27e-01 | 8.89e-01 |
| GOBP DTMP METABOLIC PROCESS | 6 | 5.90e-01 | 1.27e-01 | 9.11e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 13 | 4.27e-01 | 1.27e-01 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 7 | 5.60e-01 | -1.27e-01 | 9.05e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 42 | 1.54e-01 | 1.27e-01 | 6.87e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 80 | 4.96e-02 | 1.27e-01 | 4.57e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 65 | 7.67e-02 | 1.27e-01 | 5.48e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 16 | 3.79e-01 | 1.27e-01 | 8.36e-01 |
| GOBP MINERALOCORTICOID METABOLIC PROCESS | 13 | 4.28e-01 | -1.27e-01 | 8.59e-01 |
| GOCC CATSPER COMPLEX | 14 | 4.11e-01 | -1.27e-01 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 88 | 3.97e-02 | 1.27e-01 | 4.12e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 27 | 2.54e-01 | 1.27e-01 | 7.76e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 59 | 9.23e-02 | -1.27e-01 | 5.83e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 33 | 2.08e-01 | 1.27e-01 | 7.39e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 7 | 5.62e-01 | -1.27e-01 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 22 | 3.04e-01 | -1.27e-01 | 8.02e-01 |
| GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS | 6 | 5.91e-01 | 1.27e-01 | 9.11e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION | 7 | 5.62e-01 | 1.27e-01 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 28 | 2.46e-01 | -1.27e-01 | 7.68e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 49 | 1.25e-01 | -1.27e-01 | 6.41e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 14 | 4.12e-01 | 1.27e-01 | 8.50e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 7 | 5.62e-01 | -1.27e-01 | 9.05e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 34 | 2.02e-01 | 1.27e-01 | 7.32e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 7 | 5.62e-01 | -1.26e-01 | 9.05e-01 |
| GOBP FUCOSYLATION | 17 | 3.67e-01 | 1.26e-01 | 8.33e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 25 | 2.74e-01 | 1.26e-01 | 7.87e-01 |
| GOBP RNA 3 END PROCESSING | 90 | 3.81e-02 | -1.26e-01 | 4.06e-01 |
| GOMF REGULATORY RNA BINDING | 49 | 1.26e-01 | 1.26e-01 | 6.43e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 28 | 2.47e-01 | 1.26e-01 | 7.69e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 35 | 1.96e-01 | -1.26e-01 | 7.27e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 7 | 5.63e-01 | -1.26e-01 | 9.05e-01 |
| GOMF ARACHIDONIC ACID MONOOXYGENASE ACTIVITY | 17 | 3.67e-01 | -1.26e-01 | 8.33e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 35 | 1.96e-01 | 1.26e-01 | 7.27e-01 |
| GOMF GLYCOGEN BINDING | 7 | 5.63e-01 | 1.26e-01 | 9.05e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 10 | 4.89e-01 | -1.26e-01 | 8.82e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 51 | 1.19e-01 | -1.26e-01 | 6.30e-01 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 12 | 4.49e-01 | 1.26e-01 | 8.68e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 10 | 4.89e-01 | 1.26e-01 | 8.82e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 20 | 3.28e-01 | 1.26e-01 | 8.14e-01 |
| GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 4.49e-01 | -1.26e-01 | 8.68e-01 |
| GOBP PRIMITIVE STREAK FORMATION | 10 | 4.90e-01 | -1.26e-01 | 8.82e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 48 | 1.31e-01 | 1.26e-01 | 6.50e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 5.13e-01 | 1.26e-01 | 8.89e-01 |
| GOBP MYELIN ASSEMBLY | 24 | 2.85e-01 | -1.26e-01 | 7.95e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 4.31e-01 | -1.26e-01 | 8.60e-01 |
| GOBP REGULATION OF TOOTH MINERALIZATION | 10 | 4.90e-01 | -1.26e-01 | 8.82e-01 |
| GOCC TOR COMPLEX | 11 | 4.69e-01 | 1.26e-01 | 8.75e-01 |
| GOCC PORE COMPLEX | 24 | 2.85e-01 | -1.26e-01 | 7.95e-01 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 7 | 5.64e-01 | 1.26e-01 | 9.05e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 51 | 1.20e-01 | -1.26e-01 | 6.30e-01 |
| GOBP SKIN MORPHOGENESIS | 13 | 4.32e-01 | 1.26e-01 | 8.60e-01 |
| GOBP AORTA MORPHOGENESIS | 38 | 1.79e-01 | 1.26e-01 | 7.12e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 43 | 1.53e-01 | 1.26e-01 | 6.85e-01 |
| GOBP ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS | 6 | 5.93e-01 | -1.26e-01 | 9.12e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 139 | 1.04e-02 | 1.26e-01 | 2.20e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 124 | 1.55e-02 | 1.26e-01 | 2.67e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 6 | 5.93e-01 | -1.26e-01 | 9.12e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX | 6 | 5.94e-01 | 1.26e-01 | 9.12e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 4.32e-01 | 1.26e-01 | 8.60e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 5.13e-01 | 1.26e-01 | 8.89e-01 |
| GOMF MIRNA BINDING | 39 | 1.74e-01 | 1.26e-01 | 7.05e-01 |
| GOBP FILOPODIUM ASSEMBLY | 65 | 7.95e-02 | 1.26e-01 | 5.52e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 314 | 1.27e-04 | 1.26e-01 | 1.77e-02 |
| GOCC INTEGRIN COMPLEX | 30 | 2.33e-01 | 1.26e-01 | 7.61e-01 |
| GOBP STEM CELL DIVISION | 30 | 2.34e-01 | 1.26e-01 | 7.61e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 6.27e-01 | 1.26e-01 | 9.25e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 35 | 1.99e-01 | -1.26e-01 | 7.29e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 18 | 3.57e-01 | 1.26e-01 | 8.30e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 24 | 2.87e-01 | 1.25e-01 | 7.95e-01 |
| GOMF LYSOPHOSPHATIDIC ACID PHOSPHATASE ACTIVITY | 6 | 5.95e-01 | 1.25e-01 | 9.13e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 30 | 2.34e-01 | 1.25e-01 | 7.61e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 58 | 9.85e-02 | 1.25e-01 | 5.95e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 21 | 3.20e-01 | 1.25e-01 | 8.10e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 121 | 1.72e-02 | 1.25e-01 | 2.81e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 19 | 3.44e-01 | 1.25e-01 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 14 | 4.17e-01 | -1.25e-01 | 8.53e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 18 | 3.58e-01 | 1.25e-01 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 10 | 4.93e-01 | 1.25e-01 | 8.83e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 43 | 1.55e-01 | 1.25e-01 | 6.89e-01 |
| GOBP SEMICIRCULAR CANAL DEVELOPMENT | 9 | 5.16e-01 | -1.25e-01 | 8.90e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 54 | 1.12e-01 | 1.25e-01 | 6.16e-01 |
| GOBP GONADOTROPIN SECRETION | 17 | 3.72e-01 | 1.25e-01 | 8.33e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 3.21e-01 | -1.25e-01 | 8.10e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 39 | 1.76e-01 | -1.25e-01 | 7.09e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 26 | 2.70e-01 | 1.25e-01 | 7.84e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 27 | 2.61e-01 | 1.25e-01 | 7.82e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 15 | 4.02e-01 | 1.25e-01 | 8.46e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 41 | 1.67e-01 | 1.25e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 60 | 9.46e-02 | 1.25e-01 | 5.89e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 11 | 4.74e-01 | 1.25e-01 | 8.77e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 8 | 5.41e-01 | -1.25e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 85 | 4.69e-02 | 1.25e-01 | 4.46e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 34 | 2.08e-01 | 1.25e-01 | 7.39e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 9 | 5.17e-01 | -1.25e-01 | 8.90e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 9 | 5.17e-01 | -1.25e-01 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 62 | 8.96e-02 | 1.25e-01 | 5.78e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 113 | 2.21e-02 | -1.25e-01 | 3.18e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL | 5 | 6.29e-01 | 1.25e-01 | 9.25e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 18 | 3.60e-01 | 1.25e-01 | 8.32e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 16 | 3.88e-01 | 1.25e-01 | 8.41e-01 |
| GOBP FOCAL ADHESION ASSEMBLY | 83 | 4.99e-02 | 1.25e-01 | 4.58e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 191 | 3.00e-03 | 1.24e-01 | 1.14e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 46 | 1.44e-01 | 1.24e-01 | 6.69e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 23 | 3.01e-01 | 1.24e-01 | 8.02e-01 |
| GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 8 | 5.42e-01 | -1.24e-01 | 8.97e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 31 | 2.30e-01 | -1.24e-01 | 7.60e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 24 | 2.91e-01 | 1.24e-01 | 7.97e-01 |
| GOMF NOTCH BINDING | 23 | 3.02e-01 | 1.24e-01 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 75 | 6.25e-02 | 1.24e-01 | 5.02e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 33 | 2.16e-01 | 1.24e-01 | 7.48e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY | 9 | 5.18e-01 | 1.24e-01 | 8.90e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 31 | 2.31e-01 | 1.24e-01 | 7.60e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 8 | 5.43e-01 | -1.24e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 27 | 2.64e-01 | 1.24e-01 | 7.83e-01 |
| GOBP EOSINOPHIL ACTIVATION | 8 | 5.43e-01 | -1.24e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 44 | 1.54e-01 | 1.24e-01 | 6.87e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 10 | 4.97e-01 | -1.24e-01 | 8.83e-01 |
| GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 8 | 5.43e-01 | 1.24e-01 | 8.97e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 27 | 2.64e-01 | 1.24e-01 | 7.83e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 66 | 8.14e-02 | 1.24e-01 | 5.59e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 6 | 5.99e-01 | -1.24e-01 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 19 | 3.49e-01 | 1.24e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 7 | 5.70e-01 | -1.24e-01 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 6 | 5.99e-01 | -1.24e-01 | 9.15e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 18 | 3.63e-01 | -1.24e-01 | 8.33e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 16 | 3.91e-01 | 1.24e-01 | 8.42e-01 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.31e-01 | 1.24e-01 | 9.25e-01 |
| GOMF DOUBLE STRANDED METHYLATED DNA BINDING | 5 | 6.31e-01 | 1.24e-01 | 9.25e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 180 | 4.15e-03 | 1.24e-01 | 1.35e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 42 | 1.65e-01 | -1.24e-01 | 6.97e-01 |
| GOBP PEROXISOMAL TRANSPORT | 22 | 3.15e-01 | -1.24e-01 | 8.08e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 44 | 1.55e-01 | 1.24e-01 | 6.89e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 11 | 4.77e-01 | -1.24e-01 | 8.79e-01 |
| GOBP SKELETAL MUSCLE ATROPHY | 5 | 6.32e-01 | -1.24e-01 | 9.25e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 84 | 4.99e-02 | 1.24e-01 | 4.58e-01 |
| GOBP GLYCEROL TRANSMEMBRANE TRANSPORT | 7 | 5.71e-01 | 1.24e-01 | 9.06e-01 |
| GOMF GLYCEROL TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.71e-01 | 1.24e-01 | 9.06e-01 |
| GOMF BENZODIAZEPINE RECEPTOR ACTIVITY | 9 | 5.20e-01 | 1.24e-01 | 8.90e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 56 | 1.09e-01 | -1.24e-01 | 6.09e-01 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 25 | 2.84e-01 | 1.24e-01 | 7.95e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 27 | 2.66e-01 | 1.24e-01 | 7.83e-01 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 8 | 5.45e-01 | 1.24e-01 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 216 | 1.76e-03 | 1.24e-01 | 8.37e-02 |
| GOBP MELANOCYTE DIFFERENTIATION | 24 | 2.95e-01 | -1.24e-01 | 7.98e-01 |
| GOMF STEROID HORMONE BINDING | 6 | 6.00e-01 | -1.23e-01 | 9.16e-01 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 5.45e-01 | 1.23e-01 | 8.98e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 70 | 7.41e-02 | -1.23e-01 | 5.41e-01 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 5.72e-01 | -1.23e-01 | 9.06e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 10 | 4.99e-01 | 1.23e-01 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE BY EPINEPHRINE NOREPINEPHRINE | 6 | 6.01e-01 | -1.23e-01 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 11 | 4.79e-01 | 1.23e-01 | 8.79e-01 |
| GOMF MISMATCHED DNA BINDING | 14 | 4.25e-01 | -1.23e-01 | 8.57e-01 |
| GOCC 9PLUS0 MOTILE CILIUM | 5 | 6.33e-01 | 1.23e-01 | 9.25e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 67 | 8.11e-02 | -1.23e-01 | 5.58e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 10 | 5.00e-01 | -1.23e-01 | 8.86e-01 |
| GOMF ACYL COA OXIDASE ACTIVITY | 7 | 5.73e-01 | 1.23e-01 | 9.06e-01 |
| GOBP GALACTOLIPID METABOLIC PROCESS | 9 | 5.22e-01 | -1.23e-01 | 8.91e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 12 | 4.60e-01 | 1.23e-01 | 8.72e-01 |
| GOBP AGGREPHAGY | 10 | 5.00e-01 | 1.23e-01 | 8.86e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 10 | 5.00e-01 | -1.23e-01 | 8.86e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 31 | 2.36e-01 | -1.23e-01 | 7.62e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 45 | 1.53e-01 | 1.23e-01 | 6.85e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 67 | 8.16e-02 | -1.23e-01 | 5.59e-01 |
| GOBP PRESYNAPTIC MEMBRANE ORGANIZATION | 6 | 6.02e-01 | 1.23e-01 | 9.17e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 62 | 9.38e-02 | 1.23e-01 | 5.89e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 23 | 3.07e-01 | -1.23e-01 | 8.03e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 78 | 6.04e-02 | 1.23e-01 | 4.94e-01 |
| GOBP ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS | 5 | 6.34e-01 | 1.23e-01 | 9.25e-01 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 22 | 3.18e-01 | -1.23e-01 | 8.10e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 214 | 1.95e-03 | 1.23e-01 | 8.77e-02 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 19 | 3.54e-01 | -1.23e-01 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 12 | 4.61e-01 | 1.23e-01 | 8.72e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 11 | 4.80e-01 | -1.23e-01 | 8.80e-01 |
| GOBP ADULT HEART DEVELOPMENT | 13 | 4.43e-01 | 1.23e-01 | 8.65e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 39 | 1.85e-01 | 1.23e-01 | 7.19e-01 |
| GOMF ACTIN FILAMENT BINDING | 203 | 2.57e-03 | 1.23e-01 | 1.03e-01 |
| GOBP CAMP BIOSYNTHETIC PROCESS | 10 | 5.02e-01 | -1.23e-01 | 8.87e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 5.74e-01 | 1.23e-01 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 5 | 6.35e-01 | 1.23e-01 | 9.25e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 9 | 5.24e-01 | -1.23e-01 | 8.91e-01 |
| GOMF GDP BINDING | 69 | 7.81e-02 | 1.23e-01 | 5.49e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 8 | 5.48e-01 | 1.23e-01 | 9.00e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING | 11 | 4.81e-01 | 1.23e-01 | 8.80e-01 |
| GOBP RRNA BASE METHYLATION | 9 | 5.24e-01 | 1.23e-01 | 8.91e-01 |
| GOBP STRESS FIBER ASSEMBLY | 108 | 2.78e-02 | 1.23e-01 | 3.53e-01 |
| GOBP AMINE TRANSPORT | 106 | 2.93e-02 | 1.23e-01 | 3.64e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 101 | 3.34e-02 | 1.22e-01 | 3.88e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 11 | 4.82e-01 | 1.22e-01 | 8.80e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 44 | 1.60e-01 | -1.22e-01 | 6.93e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 8 | 5.49e-01 | 1.22e-01 | 9.00e-01 |
| GOCC CHOLINERGIC SYNAPSE | 11 | 4.82e-01 | -1.22e-01 | 8.80e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 5.75e-01 | -1.22e-01 | 9.06e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 44 | 1.60e-01 | 1.22e-01 | 6.93e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 21 | 3.32e-01 | 1.22e-01 | 8.15e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 47 | 1.47e-01 | 1.22e-01 | 6.74e-01 |
| GOMF INOSITOL 1 3 4 5 6 PENTAKISPHOSPHATE KINASE ACTIVITY | 5 | 6.36e-01 | 1.22e-01 | 9.26e-01 |
| GOMF MHC CLASS IB PROTEIN BINDING | 7 | 5.75e-01 | -1.22e-01 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 24 | 3.00e-01 | -1.22e-01 | 8.01e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 11 | 4.83e-01 | -1.22e-01 | 8.80e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 17 | 3.83e-01 | 1.22e-01 | 8.38e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 10 | 5.04e-01 | -1.22e-01 | 8.87e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 12 | 4.64e-01 | -1.22e-01 | 8.74e-01 |
| GOCC INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED CATION CHANNEL COMPLEX | 5 | 6.37e-01 | 1.22e-01 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 30 | 2.48e-01 | -1.22e-01 | 7.69e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 8 | 5.50e-01 | -1.22e-01 | 9.01e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 43 | 1.67e-01 | 1.22e-01 | 7.00e-01 |
| GOCC GABA RECEPTOR COMPLEX | 18 | 3.71e-01 | 1.22e-01 | 8.33e-01 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 6.37e-01 | 1.22e-01 | 9.26e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 260 | 7.19e-04 | 1.22e-01 | 5.07e-02 |
| GOBP TRNA 5 END PROCESSING | 15 | 4.14e-01 | -1.22e-01 | 8.51e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MATURATION | 6 | 6.06e-01 | -1.22e-01 | 9.20e-01 |
| GOBP CELLULAR PIGMENTATION | 60 | 1.03e-01 | 1.22e-01 | 5.98e-01 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 35 | 2.13e-01 | 1.22e-01 | 7.44e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 18 | 3.72e-01 | 1.22e-01 | 8.33e-01 |
| GOBP T CELL CHEMOTAXIS | 26 | 2.83e-01 | -1.22e-01 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 20 | 3.47e-01 | 1.22e-01 | 8.26e-01 |
| GOMF SODIUM ION BINDING | 8 | 5.52e-01 | -1.22e-01 | 9.01e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 227 | 1.61e-03 | 1.22e-01 | 7.98e-02 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 12 | 4.66e-01 | -1.22e-01 | 8.75e-01 |
| GOCC INO80 COMPLEX | 15 | 4.15e-01 | -1.21e-01 | 8.52e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 9 | 5.28e-01 | -1.21e-01 | 8.93e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 26 | 2.84e-01 | 1.21e-01 | 7.95e-01 |
| GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 27 | 2.75e-01 | 1.21e-01 | 7.88e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 146 | 1.14e-02 | 1.21e-01 | 2.29e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 29 | 2.58e-01 | -1.21e-01 | 7.78e-01 |
| GOBP BRAINSTEM DEVELOPMENT | 7 | 5.78e-01 | -1.21e-01 | 9.07e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 42 | 1.74e-01 | 1.21e-01 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF AMINE METABOLIC PROCESS | 6 | 6.07e-01 | 1.21e-01 | 9.20e-01 |
| GOCC LAMININ COMPLEX | 9 | 5.29e-01 | -1.21e-01 | 8.93e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 312 | 2.33e-04 | 1.21e-01 | 2.48e-02 |
| GOMF STAT FAMILY PROTEIN BINDING | 11 | 4.87e-01 | 1.21e-01 | 8.81e-01 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 21 | 3.37e-01 | 1.21e-01 | 8.20e-01 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 6.39e-01 | 1.21e-01 | 9.28e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 54 | 1.24e-01 | 1.21e-01 | 6.38e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 84 | 5.51e-02 | 1.21e-01 | 4.80e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 300 | 3.11e-04 | 1.21e-01 | 2.90e-02 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 70 | 8.01e-02 | 1.21e-01 | 5.55e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 15 | 4.17e-01 | 1.21e-01 | 8.53e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 10 | 5.08e-01 | 1.21e-01 | 8.89e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 12 | 4.69e-01 | -1.21e-01 | 8.75e-01 |
| GOCC CALCIUM AND CALMODULIN DEPENDENT PROTEIN KINASE COMPLEX | 5 | 6.40e-01 | 1.21e-01 | 9.28e-01 |
| GOBP RECEPTOR CLUSTERING | 53 | 1.28e-01 | 1.21e-01 | 6.44e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR BINDING | 11 | 4.88e-01 | -1.21e-01 | 8.82e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 16 | 4.03e-01 | 1.21e-01 | 8.46e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 12 | 4.69e-01 | 1.21e-01 | 8.75e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 20 | 3.50e-01 | 1.21e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 10 | 5.09e-01 | 1.21e-01 | 8.89e-01 |
| GOBP BONE TRABECULA FORMATION | 10 | 5.09e-01 | -1.21e-01 | 8.89e-01 |
| GOBP DETECTION OF BACTERIUM | 16 | 4.04e-01 | 1.21e-01 | 8.47e-01 |
| GOMF METAL CLUSTER BINDING | 66 | 9.03e-02 | 1.21e-01 | 5.78e-01 |
| GOCC VESICLE COAT | 61 | 1.03e-01 | 1.21e-01 | 5.98e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 160 | 8.54e-03 | 1.20e-01 | 1.99e-01 |
| GOMF DEATH DOMAIN BINDING | 11 | 4.89e-01 | 1.20e-01 | 8.82e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 5.81e-01 | -1.20e-01 | 9.08e-01 |
| GOMF SPECTRIN BINDING | 26 | 2.88e-01 | 1.20e-01 | 7.95e-01 |
| GOMF LAMIN BINDING | 15 | 4.19e-01 | 1.20e-01 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 30 | 2.54e-01 | 1.20e-01 | 7.76e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 19 | 3.64e-01 | 1.20e-01 | 8.33e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 7 | 5.81e-01 | 1.20e-01 | 9.08e-01 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 13 | 4.53e-01 | 1.20e-01 | 8.70e-01 |
| GOBP REGULATION OF DNA METHYLATION | 20 | 3.52e-01 | -1.20e-01 | 8.26e-01 |
| GOCC WNT SIGNALOSOME | 13 | 4.53e-01 | -1.20e-01 | 8.70e-01 |
| GOBP OXYGEN METABOLIC PROCESS | 5 | 6.41e-01 | -1.20e-01 | 9.28e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 34 | 2.25e-01 | 1.20e-01 | 7.57e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 8 | 5.56e-01 | -1.20e-01 | 9.02e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 86 | 5.40e-02 | 1.20e-01 | 4.77e-01 |
| GOMF ACTIVIN RECEPTOR BINDING | 8 | 5.56e-01 | 1.20e-01 | 9.02e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 28 | 2.71e-01 | 1.20e-01 | 7.85e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 4.37e-01 | 1.20e-01 | 8.61e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 28 | 2.71e-01 | 1.20e-01 | 7.85e-01 |
| GOBP REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS | 5 | 6.42e-01 | 1.20e-01 | 9.28e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 5 | 6.42e-01 | -1.20e-01 | 9.28e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 54 | 1.27e-01 | 1.20e-01 | 6.43e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 12 | 4.71e-01 | 1.20e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 91 | 4.78e-02 | 1.20e-01 | 4.50e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 20 | 3.53e-01 | -1.20e-01 | 8.27e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 84 | 5.72e-02 | 1.20e-01 | 4.83e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 37 | 2.06e-01 | 1.20e-01 | 7.37e-01 |
| GOBP SODIUM ION TRANSPORT | 235 | 1.53e-03 | 1.20e-01 | 7.88e-02 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 102 | 3.63e-02 | 1.20e-01 | 3.97e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 6 | 6.11e-01 | 1.20e-01 | 9.21e-01 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.11e-01 | 1.20e-01 | 9.21e-01 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 17 | 3.92e-01 | 1.20e-01 | 8.43e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 43 | 1.74e-01 | 1.20e-01 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 14 | 4.38e-01 | -1.20e-01 | 8.62e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 24 | 3.10e-01 | 1.20e-01 | 8.06e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 27 | 2.82e-01 | 1.20e-01 | 7.93e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 7 | 5.84e-01 | -1.20e-01 | 9.09e-01 |
| GOCC POSTSYNAPTIC CYTOSKELETON | 10 | 5.12e-01 | 1.20e-01 | 8.89e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 5.12e-01 | -1.20e-01 | 8.89e-01 |
| GOMF TYPE 1 ANGIOTENSIN RECEPTOR BINDING | 6 | 6.12e-01 | 1.20e-01 | 9.21e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 6.12e-01 | -1.20e-01 | 9.21e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 28 | 2.73e-01 | 1.20e-01 | 7.87e-01 |
| GOBP INTRACELLULAR PHOSPHATE ION HOMEOSTASIS | 10 | 5.13e-01 | 1.20e-01 | 8.89e-01 |
| GOBP MYOBLAST FUSION | 47 | 1.56e-01 | 1.19e-01 | 6.91e-01 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 6.44e-01 | 1.19e-01 | 9.29e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 28 | 2.74e-01 | 1.19e-01 | 7.87e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 31 | 2.50e-01 | 1.19e-01 | 7.72e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 4.74e-01 | 1.19e-01 | 8.77e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 20 | 3.56e-01 | 1.19e-01 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 19 | 3.68e-01 | 1.19e-01 | 8.33e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 5.35e-01 | 1.19e-01 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 14 | 4.40e-01 | 1.19e-01 | 8.62e-01 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 7 | 5.85e-01 | -1.19e-01 | 9.09e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 11 | 4.93e-01 | 1.19e-01 | 8.83e-01 |
| GOBP MITOPHAGY | 34 | 2.29e-01 | 1.19e-01 | 7.60e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 62 | 1.05e-01 | 1.19e-01 | 5.99e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 112 | 2.94e-02 | -1.19e-01 | 3.65e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 42 | 1.82e-01 | -1.19e-01 | 7.14e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 142 | 1.43e-02 | 1.19e-01 | 2.56e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 18 | 3.82e-01 | -1.19e-01 | 8.37e-01 |
| GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.45e-01 | -1.19e-01 | 9.29e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 45 | 1.67e-01 | -1.19e-01 | 7.00e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 13 | 4.58e-01 | -1.19e-01 | 8.71e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 86 | 5.66e-02 | 1.19e-01 | 4.82e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 118 | 2.57e-02 | 1.19e-01 | 3.40e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 10 | 5.15e-01 | -1.19e-01 | 8.90e-01 |
| GOBP ENDOCARDIAL CUSHION FUSION | 5 | 6.45e-01 | -1.19e-01 | 9.29e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 54 | 1.31e-01 | 1.19e-01 | 6.51e-01 |
| GOBP POLYOL METABOLIC PROCESS | 103 | 3.72e-02 | 1.19e-01 | 4.03e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 14 | 4.42e-01 | 1.19e-01 | 8.63e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 351 | 1.32e-04 | 1.19e-01 | 1.77e-02 |
| GOBP METHIONINE METABOLIC PROCESS | 15 | 4.26e-01 | 1.19e-01 | 8.57e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 5.61e-01 | 1.19e-01 | 9.05e-01 |
| GOBP AMACRINE CELL DIFFERENTIATION | 12 | 4.76e-01 | 1.19e-01 | 8.78e-01 |
| GOMF NAD BINDING | 55 | 1.28e-01 | 1.19e-01 | 6.44e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 24 | 3.14e-01 | 1.19e-01 | 8.08e-01 |
| GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 5 | 6.46e-01 | 1.19e-01 | 9.29e-01 |
| GOBP TRANSDIFFERENTIATION | 7 | 5.87e-01 | 1.19e-01 | 9.11e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 40 | 1.94e-01 | 1.19e-01 | 7.27e-01 |
| GOBP RESPONSE TO ISCHEMIA | 62 | 1.06e-01 | 1.19e-01 | 6.02e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 85 | 5.89e-02 | -1.19e-01 | 4.89e-01 |
| GOBP NEURON NEURON SYNAPTIC TRANSMISSION | 6 | 6.15e-01 | 1.18e-01 | 9.21e-01 |
| GOBP REGULATION OF FEMALE GONAD DEVELOPMENT | 7 | 5.87e-01 | 1.18e-01 | 9.11e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 12 | 4.77e-01 | 1.18e-01 | 8.79e-01 |
| GOMF 7SK SNRNA BINDING | 9 | 5.38e-01 | -1.18e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 25 | 3.05e-01 | -1.18e-01 | 8.02e-01 |
| GOBP PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS | 5 | 6.47e-01 | -1.18e-01 | 9.29e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 37 | 2.13e-01 | 1.18e-01 | 7.44e-01 |
| GOBP RESPONSE TO FATTY ACID | 55 | 1.29e-01 | 1.18e-01 | 6.46e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR BINDING | 6 | 6.16e-01 | -1.18e-01 | 9.21e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 9 | 5.39e-01 | -1.18e-01 | 8.96e-01 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 13 | 4.60e-01 | -1.18e-01 | 8.72e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 106 | 3.54e-02 | -1.18e-01 | 3.95e-01 |
| GOBP OBSERVATIONAL LEARNING | 7 | 5.88e-01 | 1.18e-01 | 9.11e-01 |
| GOBP PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS | 6 | 6.16e-01 | -1.18e-01 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 50 | 1.48e-01 | -1.18e-01 | 6.76e-01 |
| GOBP DIGESTION | 128 | 2.09e-02 | 1.18e-01 | 3.12e-01 |
| GOMF FATTY ACID OMEGA HYDROXYLASE ACTIVITY | 7 | 5.88e-01 | 1.18e-01 | 9.11e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 12 | 4.79e-01 | 1.18e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 12 | 4.79e-01 | 1.18e-01 | 8.79e-01 |
| GOBP MEMBRANE DOCKING | 91 | 5.16e-02 | 1.18e-01 | 4.67e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 33 | 2.41e-01 | -1.18e-01 | 7.65e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 14 | 4.45e-01 | -1.18e-01 | 8.66e-01 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 28 | 2.80e-01 | 1.18e-01 | 7.93e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 17 | 4.00e-01 | 1.18e-01 | 8.46e-01 |
| GOBP TRYPTOPHAN TRANSPORT | 5 | 6.48e-01 | 1.18e-01 | 9.30e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 43 | 1.81e-01 | 1.18e-01 | 7.14e-01 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 6 | 6.17e-01 | -1.18e-01 | 9.22e-01 |
| GOBP AMIDE TRANSPORT | 344 | 1.74e-04 | 1.18e-01 | 2.07e-02 |
| GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 6.48e-01 | -1.18e-01 | 9.30e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 30 | 2.64e-01 | 1.18e-01 | 7.83e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 26 | 2.99e-01 | 1.18e-01 | 7.99e-01 |
| GOBP PHOTORECEPTOR CELL MORPHOGENESIS | 5 | 6.49e-01 | 1.18e-01 | 9.30e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 9 | 5.41e-01 | 1.18e-01 | 8.96e-01 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 8 | 5.65e-01 | -1.18e-01 | 9.05e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 195 | 4.66e-03 | 1.18e-01 | 1.45e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 12 | 4.81e-01 | 1.17e-01 | 8.80e-01 |
| GOCC NURF COMPLEX | 5 | 6.49e-01 | -1.17e-01 | 9.30e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 23 | 3.30e-01 | 1.17e-01 | 8.15e-01 |
| GOBP MITOTIC DNA REPLICATION | 15 | 4.31e-01 | 1.17e-01 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 52 | 1.43e-01 | 1.17e-01 | 6.68e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 16 | 4.16e-01 | -1.17e-01 | 8.53e-01 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 24 | 3.20e-01 | 1.17e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 179 | 6.78e-03 | 1.17e-01 | 1.79e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 36 | 2.23e-01 | 1.17e-01 | 7.56e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 22 | 3.41e-01 | -1.17e-01 | 8.22e-01 |
| GOMF PHOSPHODIESTERASE I ACTIVITY | 5 | 6.50e-01 | 1.17e-01 | 9.30e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 71 | 8.76e-02 | 1.17e-01 | 5.74e-01 |
| GOBP FOLATE TRANSMEMBRANE TRANSPORT | 5 | 6.50e-01 | 1.17e-01 | 9.30e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 44 | 1.79e-01 | -1.17e-01 | 7.11e-01 |
| GOBP REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 9 | 5.43e-01 | 1.17e-01 | 8.97e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 17 | 4.03e-01 | 1.17e-01 | 8.46e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 169 | 8.59e-03 | 1.17e-01 | 2.00e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 15 | 4.32e-01 | 1.17e-01 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 5 | 6.50e-01 | 1.17e-01 | 9.30e-01 |
| GOBP COLLATERAL SPROUTING | 26 | 3.02e-01 | 1.17e-01 | 8.02e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 11 | 5.02e-01 | -1.17e-01 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 304 | 4.54e-04 | 1.17e-01 | 3.72e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 142 | 1.62e-02 | 1.17e-01 | 2.73e-01 |
| GOBP GLYCINE TRANSPORT | 14 | 4.49e-01 | 1.17e-01 | 8.68e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 114 | 3.11e-02 | 1.17e-01 | 3.77e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 5.92e-01 | 1.17e-01 | 9.12e-01 |
| GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 6 | 6.20e-01 | -1.17e-01 | 9.23e-01 |
| GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS | 8 | 5.67e-01 | 1.17e-01 | 9.05e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 61 | 1.15e-01 | -1.17e-01 | 6.23e-01 |
| GOCC AXON INITIAL SEGMENT | 21 | 3.54e-01 | -1.17e-01 | 8.28e-01 |
| GOBP COPII COATED VESICLE BUDDING | 42 | 1.90e-01 | 1.17e-01 | 7.24e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 100 | 4.36e-02 | 1.17e-01 | 4.28e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 61 | 1.15e-01 | 1.17e-01 | 6.23e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 310 | 4.11e-04 | 1.17e-01 | 3.47e-02 |
| GOBP PLATELET ACTIVATION | 128 | 2.27e-02 | 1.17e-01 | 3.22e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 34 | 2.40e-01 | 1.17e-01 | 7.64e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 14 | 4.50e-01 | 1.17e-01 | 8.70e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 31 | 2.62e-01 | 1.16e-01 | 7.83e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 11 | 5.04e-01 | -1.16e-01 | 8.87e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 66 | 1.02e-01 | 1.16e-01 | 5.97e-01 |
| GOMF CHONDROITIN SULFOTRANSFERASE ACTIVITY | 5 | 6.52e-01 | 1.16e-01 | 9.30e-01 |
| GOBP RESPONSE TO COLD | 43 | 1.87e-01 | 1.16e-01 | 7.23e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 16 | 4.20e-01 | 1.16e-01 | 8.54e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 16 | 4.20e-01 | -1.16e-01 | 8.54e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 71 | 9.01e-02 | 1.16e-01 | 5.78e-01 |
| GOBP MATURATION OF 5 8S RRNA | 35 | 2.34e-01 | -1.16e-01 | 7.61e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 10 | 5.24e-01 | -1.16e-01 | 8.91e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 27 | 2.96e-01 | 1.16e-01 | 7.99e-01 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 11 | 5.04e-01 | -1.16e-01 | 8.87e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 20 | 3.68e-01 | -1.16e-01 | 8.33e-01 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 20 | 3.68e-01 | 1.16e-01 | 8.33e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 58 | 1.26e-01 | 1.16e-01 | 6.43e-01 |
| GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 11 | 5.05e-01 | -1.16e-01 | 8.88e-01 |
| GOBP SPERM EJACULATION | 5 | 6.53e-01 | 1.16e-01 | 9.30e-01 |
| GOBP CELL CELL RECOGNITION | 72 | 8.86e-02 | 1.16e-01 | 5.75e-01 |
| GOBP NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 7 | 5.95e-01 | -1.16e-01 | 9.13e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 86 | 6.29e-02 | 1.16e-01 | 5.04e-01 |
| GOBP ENDOSOME ORGANIZATION | 92 | 5.45e-02 | 1.16e-01 | 4.78e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 14 | 4.52e-01 | -1.16e-01 | 8.70e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 65 | 1.06e-01 | 1.16e-01 | 6.02e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 45 | 1.78e-01 | 1.16e-01 | 7.11e-01 |
| GOBP REGULATION OF XENOPHAGY | 9 | 5.47e-01 | 1.16e-01 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 31 | 2.64e-01 | 1.16e-01 | 7.83e-01 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 13 | 4.70e-01 | -1.16e-01 | 8.75e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 4.53e-01 | 1.16e-01 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 69 | 9.62e-02 | 1.16e-01 | 5.91e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 12 | 4.87e-01 | 1.16e-01 | 8.81e-01 |
| GOMF POLY PURINE TRACT BINDING | 28 | 2.89e-01 | -1.16e-01 | 7.96e-01 |
| GOCC SEX CHROMATIN | 6 | 6.23e-01 | 1.16e-01 | 9.24e-01 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 50 | 1.57e-01 | 1.16e-01 | 6.91e-01 |
| GOMF RRNA BINDING | 62 | 1.15e-01 | 1.16e-01 | 6.25e-01 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 13 | 4.70e-01 | -1.16e-01 | 8.76e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 37 | 2.24e-01 | 1.16e-01 | 7.57e-01 |
| GOMF FLOPPASE ACTIVITY | 15 | 4.38e-01 | 1.16e-01 | 8.62e-01 |
| GOBP RESPONSE TO MANGANESE ION | 17 | 4.09e-01 | 1.16e-01 | 8.49e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 11 | 5.07e-01 | -1.16e-01 | 8.89e-01 |
| GOBP RESPONSE TO HYPEROXIA | 18 | 3.96e-01 | -1.16e-01 | 8.45e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 17 | 4.10e-01 | 1.15e-01 | 8.49e-01 |
| GOBP P38MAPK CASCADE | 57 | 1.32e-01 | 1.15e-01 | 6.51e-01 |
| GOCC CLATHRIN SCULPTED MONOAMINE TRANSPORT VESICLE | 5 | 6.55e-01 | -1.15e-01 | 9.30e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 17 | 4.10e-01 | 1.15e-01 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 8 | 5.72e-01 | 1.15e-01 | 9.06e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 21 | 3.60e-01 | 1.15e-01 | 8.32e-01 |
| GOBP ORGANELLE FUSION | 156 | 1.29e-02 | 1.15e-01 | 2.49e-01 |
| GOMF ALPHA CATENIN BINDING | 10 | 5.28e-01 | -1.15e-01 | 8.93e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 17 | 4.11e-01 | 1.15e-01 | 8.49e-01 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 25 | 3.18e-01 | 1.15e-01 | 8.10e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 32 | 2.59e-01 | -1.15e-01 | 7.79e-01 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 66 | 1.06e-01 | 1.15e-01 | 6.02e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 17 | 4.12e-01 | -1.15e-01 | 8.50e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 56 | 1.37e-01 | 1.15e-01 | 6.57e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 20 | 3.74e-01 | -1.15e-01 | 8.33e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 24 | 3.30e-01 | 1.15e-01 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 5.74e-01 | 1.15e-01 | 9.06e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 31 | 2.69e-01 | 1.15e-01 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 14 | 4.58e-01 | 1.15e-01 | 8.71e-01 |
| GOBP REGULATION OF EXCRETION | 11 | 5.11e-01 | -1.15e-01 | 8.89e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 5.30e-01 | -1.15e-01 | 8.93e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 21 | 3.63e-01 | -1.15e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 146 | 1.69e-02 | 1.15e-01 | 2.77e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 364 | 1.75e-04 | 1.14e-01 | 2.07e-02 |
| GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 5.11e-01 | 1.14e-01 | 8.89e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 14 | 4.58e-01 | 1.14e-01 | 8.72e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 17 | 4.14e-01 | -1.14e-01 | 8.51e-01 |
| GOBP THIAMINE TRANSPORT | 8 | 5.75e-01 | -1.14e-01 | 9.06e-01 |
| GOBP BRAIN MORPHOGENESIS | 37 | 2.28e-01 | -1.14e-01 | 7.60e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 3.32e-01 | -1.14e-01 | 8.15e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 12 | 4.93e-01 | 1.14e-01 | 8.83e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 26 | 3.13e-01 | 1.14e-01 | 8.08e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 12 | 4.93e-01 | 1.14e-01 | 8.83e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 6.58e-01 | 1.14e-01 | 9.30e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 18 | 4.01e-01 | 1.14e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 6.28e-01 | -1.14e-01 | 9.25e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 45 | 1.85e-01 | 1.14e-01 | 7.19e-01 |
| GOCC PHAGOCYTIC VESICLE LUMEN | 5 | 6.58e-01 | -1.14e-01 | 9.30e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 12 | 4.94e-01 | -1.14e-01 | 8.83e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 134 | 2.26e-02 | 1.14e-01 | 3.21e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 357 | 2.13e-04 | -1.14e-01 | 2.37e-02 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 28 | 2.96e-01 | 1.14e-01 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS | 5 | 6.59e-01 | 1.14e-01 | 9.30e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 11 | 5.13e-01 | -1.14e-01 | 8.89e-01 |
| GOMF ADENYLATE CYCLASE BINDING | 12 | 4.95e-01 | -1.14e-01 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 43 | 1.97e-01 | 1.14e-01 | 7.27e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 20 | 3.79e-01 | -1.14e-01 | 8.36e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 369 | 1.76e-04 | 1.14e-01 | 2.07e-02 |
| GOBP LIPID GLYCOSYLATION | 12 | 4.95e-01 | 1.14e-01 | 8.83e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 23 | 3.46e-01 | -1.14e-01 | 8.24e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 594 | 2.23e-06 | 1.14e-01 | 8.45e-04 |
| GOBP REGULATION OF SYNAPTIC VESICLE CLUSTERING | 6 | 6.30e-01 | 1.14e-01 | 9.25e-01 |
| GOCC STEREOCILIUM MEMBRANE | 6 | 6.30e-01 | 1.14e-01 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 24 | 3.36e-01 | 1.14e-01 | 8.20e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 24 | 3.36e-01 | -1.14e-01 | 8.20e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 26 | 3.17e-01 | 1.13e-01 | 8.09e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 35 | 2.45e-01 | 1.13e-01 | 7.68e-01 |
| GOMF PROLINE RICH REGION BINDING | 17 | 4.18e-01 | 1.13e-01 | 8.53e-01 |
| GOBP PROTEIN HYDROXYLATION | 23 | 3.47e-01 | 1.13e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 28 | 2.99e-01 | 1.13e-01 | 8.00e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 155 | 1.49e-02 | 1.13e-01 | 2.62e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 59 | 1.33e-01 | 1.13e-01 | 6.51e-01 |
| GOBP HEMOSTASIS | 220 | 3.82e-03 | 1.13e-01 | 1.31e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 23 | 3.48e-01 | 1.13e-01 | 8.26e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 27 | 3.09e-01 | 1.13e-01 | 8.05e-01 |
| GOBP NUCLEOTIDE SALVAGE | 17 | 4.20e-01 | 1.13e-01 | 8.54e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 7 | 6.05e-01 | 1.13e-01 | 9.20e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 47 | 1.80e-01 | 1.13e-01 | 7.13e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 9 | 5.57e-01 | 1.13e-01 | 9.03e-01 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 6 | 6.32e-01 | -1.13e-01 | 9.25e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRANSPORT | 6 | 6.32e-01 | -1.13e-01 | 9.25e-01 |
| GOBP GRANULOCYTE ACTIVATION | 48 | 1.76e-01 | 1.13e-01 | 7.09e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 245 | 2.36e-03 | 1.13e-01 | 9.80e-02 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 658 | 7.92e-07 | 1.13e-01 | 3.68e-04 |
| GOCC NEURONAL DENSE CORE VESICLE MEMBRANE | 5 | 6.62e-01 | -1.13e-01 | 9.31e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 34 | 2.55e-01 | -1.13e-01 | 7.76e-01 |
| GOBP NEURON CELL CELL ADHESION | 13 | 4.82e-01 | -1.13e-01 | 8.80e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 5.58e-01 | -1.13e-01 | 9.03e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 6 | 6.33e-01 | -1.13e-01 | 9.25e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 78 | 8.55e-02 | 1.13e-01 | 5.70e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 7 | 6.06e-01 | 1.13e-01 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 6.63e-01 | -1.13e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 5 | 6.63e-01 | 1.13e-01 | 9.31e-01 |
| GOMF PHOSPHOLIPASE D ACTIVITY | 6 | 6.33e-01 | 1.12e-01 | 9.25e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 26 | 3.21e-01 | -1.12e-01 | 8.10e-01 |
| GOCC SPERM HEAD | 17 | 4.22e-01 | -1.12e-01 | 8.55e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 25 | 3.31e-01 | -1.12e-01 | 8.15e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 137 | 2.31e-02 | 1.12e-01 | 3.24e-01 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 5.38e-01 | 1.12e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 27 | 3.12e-01 | 1.12e-01 | 8.08e-01 |
| GOMF GPI LINKED EPHRIN RECEPTOR ACTIVITY | 6 | 6.34e-01 | -1.12e-01 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 83 | 7.70e-02 | 1.12e-01 | 5.48e-01 |
| GOBP POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS | 5 | 6.64e-01 | 1.12e-01 | 9.31e-01 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 7 | 6.07e-01 | 1.12e-01 | 9.20e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 20 | 3.85e-01 | 1.12e-01 | 8.40e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 97 | 5.62e-02 | 1.12e-01 | 4.82e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 263 | 1.76e-03 | 1.12e-01 | 8.37e-02 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 26 | 3.23e-01 | 1.12e-01 | 8.10e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 203 | 5.98e-03 | 1.12e-01 | 1.68e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 6.08e-01 | -1.12e-01 | 9.20e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 95 | 5.95e-02 | 1.12e-01 | 4.93e-01 |
| GOBP LIVER REGENERATION | 28 | 3.06e-01 | 1.12e-01 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 34 | 2.59e-01 | -1.12e-01 | 7.79e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL | 6 | 6.35e-01 | 1.12e-01 | 9.25e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 16 | 4.39e-01 | -1.12e-01 | 8.62e-01 |
| GOBP B CELL HOMEOSTASIS | 31 | 2.82e-01 | 1.12e-01 | 7.93e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 10 | 5.41e-01 | 1.12e-01 | 8.96e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 20 | 3.87e-01 | 1.12e-01 | 8.41e-01 |
| GOCC SYNAPTOBREVIN 2 SNAP 25 SYNTAXIN 1A COMPLEX | 5 | 6.65e-01 | 1.12e-01 | 9.32e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 70 | 1.06e-01 | 1.12e-01 | 6.02e-01 |
| GOCC TERTIARY GRANULE LUMEN | 53 | 1.60e-01 | 1.12e-01 | 6.93e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 5.62e-01 | -1.12e-01 | 9.05e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 4.69e-01 | -1.12e-01 | 8.75e-01 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 7 | 6.09e-01 | 1.12e-01 | 9.20e-01 |
| GOBP ALPHA KETOGLUTARATE TRANSPORT | 7 | 6.09e-01 | -1.12e-01 | 9.20e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 6.09e-01 | 1.12e-01 | 9.20e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 10 | 5.41e-01 | -1.12e-01 | 8.96e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 17 | 4.26e-01 | 1.12e-01 | 8.57e-01 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 51 | 1.68e-01 | 1.12e-01 | 7.00e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 13 | 4.86e-01 | 1.12e-01 | 8.80e-01 |
| GOBP SPERM MOTILITY | 127 | 3.01e-02 | -1.11e-01 | 3.70e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 32 | 2.75e-01 | -1.11e-01 | 7.88e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 9 | 5.63e-01 | 1.11e-01 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 17 | 4.27e-01 | 1.11e-01 | 8.58e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 5.86e-01 | 1.11e-01 | 9.10e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 15 | 4.55e-01 | 1.11e-01 | 8.70e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 80 | 8.53e-02 | 1.11e-01 | 5.70e-01 |
| GOBP GOLGI RIBBON FORMATION | 10 | 5.42e-01 | 1.11e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 30 | 2.92e-01 | 1.11e-01 | 7.97e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 257 | 2.16e-03 | 1.11e-01 | 9.32e-02 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 13 | 4.88e-01 | -1.11e-01 | 8.82e-01 |
| GOBP STABILIZATION OF MEMBRANE POTENTIAL | 17 | 4.28e-01 | 1.11e-01 | 8.59e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 233 | 3.51e-03 | 1.11e-01 | 1.25e-01 |
| GOBP PROTEIN POLYMERIZATION | 271 | 1.66e-03 | 1.11e-01 | 8.20e-02 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 5 | 6.67e-01 | 1.11e-01 | 9.33e-01 |
| GOMF MYOSIN II BINDING | 12 | 5.06e-01 | 1.11e-01 | 8.88e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 15 | 4.57e-01 | -1.11e-01 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 14 | 4.73e-01 | -1.11e-01 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 19 | 4.03e-01 | 1.11e-01 | 8.46e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 30 | 2.93e-01 | 1.11e-01 | 7.97e-01 |
| GOBP SYNAPTIC VESICLE DOCKING | 10 | 5.44e-01 | -1.11e-01 | 8.98e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 36 | 2.50e-01 | 1.11e-01 | 7.72e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 27 | 3.19e-01 | 1.11e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 39 | 2.32e-01 | 1.11e-01 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 31 | 2.86e-01 | 1.11e-01 | 7.95e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 79 | 8.92e-02 | 1.11e-01 | 5.77e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 7 | 6.12e-01 | -1.11e-01 | 9.21e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 52 | 1.68e-01 | 1.11e-01 | 7.00e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 12 | 5.08e-01 | 1.10e-01 | 8.89e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 8 | 5.89e-01 | 1.10e-01 | 9.11e-01 |
| GOBP RHOMBOMERE DEVELOPMENT | 8 | 5.89e-01 | -1.10e-01 | 9.11e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 4.05e-01 | 1.10e-01 | 8.49e-01 |
| GOMF ALL TRANS RETINAL BINDING | 5 | 6.69e-01 | -1.10e-01 | 9.34e-01 |
| GOBP ENDOCYTOSIS | 681 | 9.26e-07 | 1.10e-01 | 4.12e-04 |
| GOBP RESPONSE TO ALDOSTERONE | 16 | 4.45e-01 | 1.10e-01 | 8.66e-01 |
| GOBP RESPONSE TO VITAMIN E | 8 | 5.89e-01 | 1.10e-01 | 9.11e-01 |
| GOBP TRNA TRANSPORT | 6 | 6.40e-01 | 1.10e-01 | 9.28e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 48 | 1.87e-01 | -1.10e-01 | 7.23e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 376 | 2.45e-04 | 1.10e-01 | 2.55e-02 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 20 | 3.94e-01 | 1.10e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 19 | 4.06e-01 | 1.10e-01 | 8.49e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 8 | 5.90e-01 | 1.10e-01 | 9.11e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 18 | 4.19e-01 | 1.10e-01 | 8.54e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 88 | 7.45e-02 | 1.10e-01 | 5.41e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 11 | 5.28e-01 | -1.10e-01 | 8.93e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 25 | 3.41e-01 | -1.10e-01 | 8.22e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 292 | 1.23e-03 | 1.10e-01 | 6.74e-02 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 5.28e-01 | -1.10e-01 | 8.93e-01 |
| GOCC SORTING ENDOSOME | 6 | 6.41e-01 | 1.10e-01 | 9.28e-01 |
| GOBP T CELL DIFFERENTIATION | 300 | 1.06e-03 | 1.10e-01 | 6.38e-02 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 8 | 5.90e-01 | -1.10e-01 | 9.11e-01 |
| GOMF TRNA BINDING | 73 | 1.05e-01 | -1.10e-01 | 5.99e-01 |
| GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION | 7 | 6.15e-01 | -1.10e-01 | 9.21e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 221 | 4.91e-03 | 1.10e-01 | 1.48e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 164 | 1.53e-02 | 1.10e-01 | 2.64e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 67 | 1.20e-01 | 1.10e-01 | 6.31e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 11 | 5.29e-01 | 1.10e-01 | 8.93e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 8 | 5.91e-01 | -1.10e-01 | 9.11e-01 |
| GOMF DEATH RECEPTOR BINDING | 19 | 4.08e-01 | -1.10e-01 | 8.49e-01 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 23 | 3.63e-01 | -1.10e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF COLLATERAL SPROUTING | 10 | 5.49e-01 | 1.10e-01 | 9.00e-01 |
| GOBP AMINO ACID TRANSPORT | 142 | 2.43e-02 | 1.10e-01 | 3.32e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 35 | 2.62e-01 | 1.09e-01 | 7.83e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 376 | 2.70e-04 | 1.09e-01 | 2.66e-02 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 6 | 6.43e-01 | 1.09e-01 | 9.28e-01 |
| GOBP POSITIVE T CELL SELECTION | 39 | 2.37e-01 | 1.09e-01 | 7.63e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 6.43e-01 | -1.09e-01 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 7 | 6.16e-01 | 1.09e-01 | 9.22e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 491 | 3.32e-05 | 1.09e-01 | 7.08e-03 |
| GOBP BLASTODERM SEGMENTATION | 24 | 3.54e-01 | 1.09e-01 | 8.28e-01 |
| GOMF DELTA CATENIN BINDING | 9 | 5.70e-01 | 1.09e-01 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 12 | 5.12e-01 | 1.09e-01 | 8.89e-01 |
| GOMF COPPER ION BINDING | 58 | 1.50e-01 | 1.09e-01 | 6.80e-01 |
| GOMF HSP70 PROTEIN BINDING | 50 | 1.82e-01 | -1.09e-01 | 7.14e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 7 | 6.17e-01 | 1.09e-01 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 55 | 1.62e-01 | -1.09e-01 | 6.95e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 23 | 3.65e-01 | -1.09e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 48 | 1.91e-01 | 1.09e-01 | 7.25e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 94 | 6.78e-02 | 1.09e-01 | 5.21e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 139 | 2.66e-02 | 1.09e-01 | 3.47e-01 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 29 | 3.10e-01 | 1.09e-01 | 8.06e-01 |
| GOBP PH REDUCTION | 6 | 6.44e-01 | 1.09e-01 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 183 | 1.11e-02 | 1.09e-01 | 2.27e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 7 | 6.18e-01 | 1.09e-01 | 9.22e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 5.94e-01 | -1.09e-01 | 9.12e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 9 | 5.72e-01 | 1.09e-01 | 9.06e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 11 | 5.32e-01 | 1.09e-01 | 8.94e-01 |
| GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY | 9 | 5.72e-01 | -1.09e-01 | 9.06e-01 |
| GOBP REGULATION OF MESONEPHROS DEVELOPMENT | 5 | 6.74e-01 | 1.09e-01 | 9.36e-01 |
| GOBP AORTA DEVELOPMENT | 65 | 1.30e-01 | 1.09e-01 | 6.48e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 32 | 2.87e-01 | -1.09e-01 | 7.95e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 21 | 3.89e-01 | 1.09e-01 | 8.41e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 5.52e-01 | -1.09e-01 | 9.01e-01 |
| GOBP SYMPATHETIC GANGLION DEVELOPMENT | 9 | 5.73e-01 | 1.09e-01 | 9.06e-01 |
| GOBP COPULATION | 19 | 4.13e-01 | -1.09e-01 | 8.51e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 14 | 4.82e-01 | 1.09e-01 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 71 | 1.14e-01 | 1.08e-01 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 11 | 5.34e-01 | -1.08e-01 | 8.94e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 129 | 3.36e-02 | 1.08e-01 | 3.88e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 461 | 6.82e-05 | 1.08e-01 | 1.14e-02 |
| GOBP OPSONIZATION | 16 | 4.54e-01 | 1.08e-01 | 8.70e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 6 | 6.46e-01 | 1.08e-01 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 482 | 4.77e-05 | 1.08e-01 | 8.57e-03 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 5.54e-01 | 1.08e-01 | 9.01e-01 |
| GOBP HIS PURKINJE SYSTEM DEVELOPMENT | 7 | 6.20e-01 | 1.08e-01 | 9.23e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 75 | 1.06e-01 | 1.08e-01 | 6.02e-01 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 6 | 6.47e-01 | -1.08e-01 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION | 8 | 5.97e-01 | -1.08e-01 | 9.15e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 107 | 5.36e-02 | 1.08e-01 | 4.76e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 65 | 1.32e-01 | 1.08e-01 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 46 | 2.05e-01 | 1.08e-01 | 7.36e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 17 | 4.41e-01 | -1.08e-01 | 8.63e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 34 | 2.76e-01 | 1.08e-01 | 7.88e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 216 | 6.29e-03 | 1.08e-01 | 1.73e-01 |
| GOBP MRNA TRANSCRIPTION | 47 | 2.01e-01 | 1.08e-01 | 7.32e-01 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 8 | 5.97e-01 | 1.08e-01 | 9.15e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 52 | 1.79e-01 | -1.08e-01 | 7.11e-01 |
| GOMF OLIGOSACCHARIDE BINDING | 15 | 4.70e-01 | -1.08e-01 | 8.75e-01 |
| GOBP LUNG SECRETORY CELL DIFFERENTIATION | 11 | 5.36e-01 | 1.08e-01 | 8.94e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 55 | 1.67e-01 | 1.08e-01 | 7.00e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 21 | 3.93e-01 | -1.08e-01 | 8.43e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 10 | 5.55e-01 | -1.08e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 8 | 5.98e-01 | -1.08e-01 | 9.15e-01 |
| GOBP NEURON PROJECTION REGENERATION | 54 | 1.71e-01 | -1.08e-01 | 7.04e-01 |
| GOBP BONE MATURATION | 25 | 3.52e-01 | 1.08e-01 | 8.27e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 36 | 2.64e-01 | 1.08e-01 | 7.83e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 18 | 4.30e-01 | 1.08e-01 | 8.60e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 8 | 5.99e-01 | 1.07e-01 | 9.15e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 24 | 3.62e-01 | 1.07e-01 | 8.33e-01 |
| GOBP CAMP CATABOLIC PROCESS | 9 | 5.77e-01 | 1.07e-01 | 9.06e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 33 | 2.86e-01 | 1.07e-01 | 7.95e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 25 | 3.53e-01 | 1.07e-01 | 8.27e-01 |
| GOMF LNCRNA BINDING | 18 | 4.31e-01 | -1.07e-01 | 8.60e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 13 | 5.03e-01 | 1.07e-01 | 8.87e-01 |
| GOCC PROTEIN LIPID COMPLEX | 38 | 2.53e-01 | 1.07e-01 | 7.75e-01 |
| GOBP NEUROTRANSMITTER BIOSYNTHETIC PROCESS | 14 | 4.87e-01 | 1.07e-01 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 6.49e-01 | -1.07e-01 | 9.30e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 173 | 1.50e-02 | 1.07e-01 | 2.62e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 17 | 4.44e-01 | 1.07e-01 | 8.66e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 70 | 1.21e-01 | 1.07e-01 | 6.33e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 32 | 2.94e-01 | 1.07e-01 | 7.98e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 21 | 3.96e-01 | 1.07e-01 | 8.45e-01 |
| GOBP FEEDING BEHAVIOR | 102 | 6.17e-02 | 1.07e-01 | 4.98e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 80 | 9.79e-02 | 1.07e-01 | 5.95e-01 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 6.79e-01 | 1.07e-01 | 9.38e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 13 | 5.04e-01 | 1.07e-01 | 8.87e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 29 | 3.19e-01 | 1.07e-01 | 8.10e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 29 | 3.19e-01 | -1.07e-01 | 8.10e-01 |
| GOBP CHOLINE TRANSPORT | 9 | 5.79e-01 | 1.07e-01 | 9.07e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 20 | 4.08e-01 | -1.07e-01 | 8.49e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 188 | 1.15e-02 | 1.07e-01 | 2.29e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 181 | 1.32e-02 | 1.07e-01 | 2.50e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 18 | 4.33e-01 | 1.07e-01 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 27 | 3.37e-01 | 1.07e-01 | 8.21e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 400 | 2.52e-04 | 1.07e-01 | 2.60e-02 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 6 | 6.51e-01 | 1.07e-01 | 9.30e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 12 | 5.23e-01 | 1.07e-01 | 8.91e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 18 | 4.34e-01 | 1.07e-01 | 8.60e-01 |
| GOBP REGULATED EXOCYTOSIS | 214 | 7.22e-03 | 1.07e-01 | 1.82e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 294 | 1.69e-03 | 1.06e-01 | 8.22e-02 |
| GOBP RESPONSE TO TESTOSTERONE | 41 | 2.38e-01 | -1.06e-01 | 7.63e-01 |
| GOBP PLACENTA DEVELOPMENT | 146 | 2.65e-02 | 1.06e-01 | 3.47e-01 |
| GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS | 6 | 6.52e-01 | -1.06e-01 | 9.30e-01 |
| GOBP REGULATION OF ASYMMETRIC CELL DIVISION | 5 | 6.80e-01 | -1.06e-01 | 9.39e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 37 | 2.63e-01 | 1.06e-01 | 7.83e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 85 | 9.01e-02 | 1.06e-01 | 5.78e-01 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 6 | 6.52e-01 | 1.06e-01 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 11 | 5.42e-01 | -1.06e-01 | 8.96e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 161 | 2.00e-02 | 1.06e-01 | 3.01e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 19 | 4.23e-01 | 1.06e-01 | 8.55e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 46 | 2.13e-01 | 1.06e-01 | 7.44e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 6.52e-01 | 1.06e-01 | 9.30e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 20 | 4.11e-01 | 1.06e-01 | 8.49e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 30 | 3.14e-01 | 1.06e-01 | 8.08e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 24 | 3.68e-01 | 1.06e-01 | 8.33e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 19 | 4.23e-01 | 1.06e-01 | 8.56e-01 |
| GOBP ERBB SIGNALING PATHWAY | 122 | 4.30e-02 | 1.06e-01 | 4.24e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 72 | 1.20e-01 | 1.06e-01 | 6.30e-01 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 6.03e-01 | 1.06e-01 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 33 | 2.92e-01 | 1.06e-01 | 7.97e-01 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 14 | 4.92e-01 | 1.06e-01 | 8.83e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 61 | 1.52e-01 | 1.06e-01 | 6.83e-01 |
| GOBP SYNAPTIC VESICLE UNCOATING | 6 | 6.53e-01 | -1.06e-01 | 9.30e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 65 | 1.39e-01 | 1.06e-01 | 6.60e-01 |
| GOCC PHAGOCYTIC VESICLE | 131 | 3.62e-02 | 1.06e-01 | 3.97e-01 |
| GOBP VESICLE ORGANIZATION | 350 | 6.60e-04 | 1.06e-01 | 4.70e-02 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 87 | 8.76e-02 | 1.06e-01 | 5.74e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 32 | 3.00e-01 | -1.06e-01 | 8.00e-01 |
| GOCC SERINE TYPE PEPTIDASE COMPLEX | 13 | 5.08e-01 | -1.06e-01 | 8.89e-01 |
| GOMF TOXIC SUBSTANCE BINDING | 10 | 5.62e-01 | -1.06e-01 | 9.05e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 29 | 3.24e-01 | 1.06e-01 | 8.10e-01 |
| GOMF UBIQUITIN BINDING | 99 | 6.87e-02 | 1.06e-01 | 5.23e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 57 | 1.67e-01 | -1.06e-01 | 7.00e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 458 | 1.04e-04 | 1.06e-01 | 1.57e-02 |
| GOBP RETINAL CELL PROGRAMMED CELL DEATH | 6 | 6.54e-01 | -1.06e-01 | 9.30e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 27 | 3.41e-01 | 1.06e-01 | 8.22e-01 |
| GOBP RESPONSE TO BLUE LIGHT | 6 | 6.54e-01 | 1.06e-01 | 9.30e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 9 | 5.83e-01 | 1.06e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 111 | 5.45e-02 | 1.06e-01 | 4.78e-01 |
| GOMF AMINE BINDING | 11 | 5.44e-01 | 1.06e-01 | 8.98e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 7 | 6.29e-01 | -1.06e-01 | 9.25e-01 |
| GOBP MICROTUBULE ANCHORING | 23 | 3.81e-01 | 1.06e-01 | 8.37e-01 |
| GOBP LIPID PHOSPHORYLATION | 10 | 5.64e-01 | -1.05e-01 | 9.05e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 10 | 5.64e-01 | -1.05e-01 | 9.05e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 8 | 6.05e-01 | 1.05e-01 | 9.20e-01 |
| GOBP THROMBOPOIETIN MEDIATED SIGNALING PATHWAY | 5 | 6.83e-01 | -1.05e-01 | 9.40e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 62 | 1.51e-01 | 1.05e-01 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 9 | 5.84e-01 | -1.05e-01 | 9.09e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 23 | 3.81e-01 | -1.05e-01 | 8.37e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 22 | 3.92e-01 | -1.05e-01 | 8.43e-01 |
| GOBP NEURAL PLATE REGIONALIZATION | 6 | 6.55e-01 | 1.05e-01 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 14 | 4.95e-01 | 1.05e-01 | 8.83e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 15 | 4.80e-01 | 1.05e-01 | 8.80e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 9 | 5.84e-01 | -1.05e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 7 | 6.30e-01 | 1.05e-01 | 9.25e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 11 | 5.46e-01 | 1.05e-01 | 8.98e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 71 | 1.25e-01 | -1.05e-01 | 6.41e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 23 | 3.83e-01 | -1.05e-01 | 8.38e-01 |
| GOBP ANTIMICROBIAL PEPTIDE PRODUCTION | 11 | 5.46e-01 | -1.05e-01 | 8.99e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 6.30e-01 | -1.05e-01 | 9.25e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 14 | 4.96e-01 | -1.05e-01 | 8.83e-01 |
| GOMF FILAMIN BINDING | 14 | 4.96e-01 | -1.05e-01 | 8.83e-01 |
| GOBP RESPONSE TO VITAMIN | 82 | 1.00e-01 | 1.05e-01 | 5.95e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 18 | 4.40e-01 | 1.05e-01 | 8.63e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 6.56e-01 | -1.05e-01 | 9.30e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 14 | 4.97e-01 | -1.05e-01 | 8.83e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 90 | 8.55e-02 | 1.05e-01 | 5.70e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 25 | 3.64e-01 | 1.05e-01 | 8.33e-01 |
| GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 14 | 4.97e-01 | -1.05e-01 | 8.84e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 19 | 4.29e-01 | 1.05e-01 | 8.59e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 18 | 4.41e-01 | 1.05e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 271 | 2.98e-03 | 1.05e-01 | 1.14e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 45 | 2.24e-01 | 1.05e-01 | 7.57e-01 |
| GOBP RRNA TRANSPORT | 5 | 6.85e-01 | -1.05e-01 | 9.40e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 481 | 8.31e-05 | 1.05e-01 | 1.35e-02 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 16 | 4.68e-01 | 1.05e-01 | 8.75e-01 |
| GOBP MACROPHAGE FUSION | 6 | 6.57e-01 | -1.05e-01 | 9.30e-01 |
| GOBP EXCRETION | 29 | 3.29e-01 | -1.05e-01 | 8.15e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 26 | 3.56e-01 | -1.05e-01 | 8.30e-01 |
| GOMF INITIATOR METHIONYL AMINOPEPTIDASE ACTIVITY | 5 | 6.85e-01 | 1.05e-01 | 9.41e-01 |
| GOCC RESPIRASOME | 85 | 9.55e-02 | -1.05e-01 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 6 | 6.57e-01 | 1.05e-01 | 9.30e-01 |
| GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.32e-01 | -1.05e-01 | 9.25e-01 |
| GOBP ATRIOVENTRICULAR NODE DEVELOPMENT | 9 | 5.87e-01 | 1.05e-01 | 9.11e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 48 | 2.10e-01 | 1.05e-01 | 7.42e-01 |
| GOBP ADP TRANSPORT | 10 | 5.67e-01 | 1.04e-01 | 9.05e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 4.84e-01 | -1.04e-01 | 8.80e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 86 | 9.40e-02 | 1.04e-01 | 5.89e-01 |
| GOBP URETERIC BUD ELONGATION | 8 | 6.09e-01 | 1.04e-01 | 9.20e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 19 | 4.31e-01 | 1.04e-01 | 8.60e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 9 | 5.87e-01 | 1.04e-01 | 9.11e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION | 6 | 6.58e-01 | -1.04e-01 | 9.30e-01 |
| GOBP PEPTIDOGLYCAN METABOLIC PROCESS | 6 | 6.58e-01 | 1.04e-01 | 9.30e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 133 | 3.77e-02 | 1.04e-01 | 4.04e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 52 | 1.93e-01 | 1.04e-01 | 7.26e-01 |
| GOMF PHOSPHOLIPID BINDING | 456 | 1.34e-04 | 1.04e-01 | 1.78e-02 |
| GOBP REGULATION OF WNT PROTEIN SECRETION | 5 | 6.86e-01 | 1.04e-01 | 9.41e-01 |
| GOBP WNT PROTEIN SECRETION | 5 | 6.86e-01 | 1.04e-01 | 9.41e-01 |
| GOCC SYNAPTIC CLEFT | 21 | 4.09e-01 | 1.04e-01 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 10 | 5.68e-01 | 1.04e-01 | 9.06e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 16 | 4.71e-01 | 1.04e-01 | 8.76e-01 |
| GOMF ISOPRENOID BINDING | 44 | 2.32e-01 | 1.04e-01 | 7.61e-01 |
| GOMF CALCIUM SENSITIVE GUANYLATE CYCLASE ACTIVATOR ACTIVITY | 5 | 6.87e-01 | 1.04e-01 | 9.41e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 366 | 6.29e-04 | 1.04e-01 | 4.53e-02 |
| GOMF THIAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.34e-01 | -1.04e-01 | 9.25e-01 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 5.33e-01 | 1.04e-01 | 8.94e-01 |
| GOBP CARDIOBLAST PROLIFERATION | 11 | 5.50e-01 | 1.04e-01 | 9.01e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 25 | 3.68e-01 | -1.04e-01 | 8.33e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 12 | 5.33e-01 | -1.04e-01 | 8.94e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 49 | 2.08e-01 | 1.04e-01 | 7.39e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 64 | 1.50e-01 | 1.04e-01 | 6.81e-01 |
| GOBP CELL ACTIVATION | 1058 | 1.11e-08 | 1.04e-01 | 1.14e-05 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 412 | 2.96e-04 | 1.04e-01 | 2.78e-02 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 100 | 7.26e-02 | 1.04e-01 | 5.36e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 42 | 2.44e-01 | 1.04e-01 | 7.68e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 12 | 5.33e-01 | -1.04e-01 | 8.94e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 18 | 4.46e-01 | -1.04e-01 | 8.66e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 36 | 2.81e-01 | 1.04e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 27 | 3.51e-01 | 1.04e-01 | 8.26e-01 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 3.89e-01 | -1.04e-01 | 8.41e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 133 | 3.89e-02 | 1.04e-01 | 4.08e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 107 | 6.39e-02 | 1.04e-01 | 5.07e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 10 | 5.71e-01 | 1.04e-01 | 9.06e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 12 | 5.35e-01 | -1.04e-01 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 10 | 5.71e-01 | -1.04e-01 | 9.06e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 122 | 4.82e-02 | 1.04e-01 | 4.52e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 13 | 5.18e-01 | 1.04e-01 | 8.90e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 46 | 2.25e-01 | 1.04e-01 | 7.57e-01 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 11 | 5.52e-01 | -1.03e-01 | 9.01e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 23 | 3.90e-01 | 1.03e-01 | 8.42e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 15 | 4.88e-01 | 1.03e-01 | 8.82e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 10 | 5.71e-01 | -1.03e-01 | 9.06e-01 |
| GOMF DINUCLEOTIDE PHOSPHATASE ACTIVITY | 8 | 6.13e-01 | 1.03e-01 | 9.21e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 5.71e-01 | -1.03e-01 | 9.06e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 38 | 2.70e-01 | 1.03e-01 | 7.85e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 35 | 2.90e-01 | 1.03e-01 | 7.96e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 192 | 1.35e-02 | 1.03e-01 | 2.52e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 25 | 3.71e-01 | 1.03e-01 | 8.33e-01 |
| GOBP RNA METHYLATION | 84 | 1.02e-01 | -1.03e-01 | 5.97e-01 |
| GOMF INTEGRIN BINDING | 150 | 2.91e-02 | 1.03e-01 | 3.62e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 6.89e-01 | 1.03e-01 | 9.42e-01 |
| GOBP PUTRESCINE BIOSYNTHETIC PROCESS | 5 | 6.90e-01 | 1.03e-01 | 9.42e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 12 | 5.36e-01 | 1.03e-01 | 8.94e-01 |
| GOBP REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 10 | 5.72e-01 | -1.03e-01 | 9.06e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 37 | 2.78e-01 | 1.03e-01 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 39 | 2.65e-01 | 1.03e-01 | 7.83e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 11 | 5.54e-01 | -1.03e-01 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING | 15 | 4.90e-01 | 1.03e-01 | 8.82e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 25 | 3.73e-01 | 1.03e-01 | 8.33e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 8 | 6.14e-01 | -1.03e-01 | 9.21e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 10 | 5.73e-01 | -1.03e-01 | 9.06e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 23 | 3.93e-01 | 1.03e-01 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 32 | 3.14e-01 | 1.03e-01 | 8.08e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 321 | 1.54e-03 | 1.03e-01 | 7.88e-02 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 98 | 7.87e-02 | 1.03e-01 | 5.51e-01 |
| GOBP VITAMIN E METABOLIC PROCESS | 6 | 6.63e-01 | 1.03e-01 | 9.31e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 41 | 2.55e-01 | 1.03e-01 | 7.76e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 26 | 3.65e-01 | -1.03e-01 | 8.33e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 28 | 3.47e-01 | 1.03e-01 | 8.26e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 23 | 3.94e-01 | -1.03e-01 | 8.44e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 9 | 5.94e-01 | -1.03e-01 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 5 | 6.91e-01 | -1.03e-01 | 9.42e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 60 | 1.69e-01 | 1.03e-01 | 7.01e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 6.63e-01 | -1.03e-01 | 9.31e-01 |
| GOCC FEMALE PRONUCLEUS | 10 | 5.74e-01 | -1.03e-01 | 9.06e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 11 | 5.56e-01 | 1.03e-01 | 9.02e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 10 | 5.74e-01 | -1.03e-01 | 9.06e-01 |
| GOBP PLATELET MORPHOGENESIS | 22 | 4.05e-01 | 1.03e-01 | 8.49e-01 |
| GOBP RESPONSE TO ETHER | 11 | 5.56e-01 | 1.02e-01 | 9.02e-01 |
| GOCC CELL SUBSTRATE JUNCTION | 418 | 3.28e-04 | 1.02e-01 | 2.97e-02 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 6 | 6.64e-01 | 1.02e-01 | 9.32e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 21 | 4.17e-01 | 1.02e-01 | 8.53e-01 |
| GOMF SEROTONIN RECEPTOR ACTIVITY | 26 | 3.66e-01 | 1.02e-01 | 8.33e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 200 | 1.26e-02 | 1.02e-01 | 2.44e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 234 | 7.00e-03 | 1.02e-01 | 1.80e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 5.07e-01 | -1.02e-01 | 8.89e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 604 | 1.76e-05 | 1.02e-01 | 4.40e-03 |
| GOBP CELL FATE SPECIFICATION | 107 | 6.77e-02 | 1.02e-01 | 5.21e-01 |
| GOBP ADENOHYPOPHYSIS DEVELOPMENT | 16 | 4.79e-01 | 1.02e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 65 | 1.54e-01 | 1.02e-01 | 6.87e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 626 | 1.27e-05 | 1.02e-01 | 3.73e-03 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 56 | 1.86e-01 | 1.02e-01 | 7.22e-01 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 7 | 6.40e-01 | -1.02e-01 | 9.28e-01 |
| GOBP REGULATION OF COAGULATION | 73 | 1.31e-01 | 1.02e-01 | 6.51e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 49 | 2.16e-01 | -1.02e-01 | 7.48e-01 |
| GOBP MEIOTIC CELL CYCLE PHASE TRANSITION | 13 | 5.24e-01 | -1.02e-01 | 8.91e-01 |
| GOBP CRANIAL NERVE FORMATION | 10 | 5.76e-01 | -1.02e-01 | 9.06e-01 |
| GOCC CHROMATOID BODY | 13 | 5.24e-01 | 1.02e-01 | 8.91e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 232 | 7.43e-03 | -1.02e-01 | 1.83e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 5.09e-01 | -1.02e-01 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 197 | 1.36e-02 | 1.02e-01 | 2.52e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 58 | 1.79e-01 | 1.02e-01 | 7.12e-01 |
| GOMF PH DOMAIN BINDING | 8 | 6.18e-01 | 1.02e-01 | 9.22e-01 |
| GOBP THIOESTER METABOLIC PROCESS | 88 | 9.85e-02 | 1.02e-01 | 5.95e-01 |
| GOBP URATE METABOLIC PROCESS | 12 | 5.41e-01 | 1.02e-01 | 8.96e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 6.93e-01 | 1.02e-01 | 9.43e-01 |
| GOBP REGULATION OF HEART MORPHOGENESIS | 10 | 5.77e-01 | -1.02e-01 | 9.06e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 63 | 1.62e-01 | -1.02e-01 | 6.95e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 249 | 5.68e-03 | 1.02e-01 | 1.64e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 95 | 8.66e-02 | 1.02e-01 | 5.72e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 45 | 2.38e-01 | -1.02e-01 | 7.63e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 20 | 4.31e-01 | 1.02e-01 | 8.60e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 7 | 6.41e-01 | -1.02e-01 | 9.28e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 6.41e-01 | -1.02e-01 | 9.28e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 7 | 6.41e-01 | -1.02e-01 | 9.28e-01 |
| GOBP ISOPRENOID CATABOLIC PROCESS | 10 | 5.78e-01 | 1.02e-01 | 9.06e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 26 | 3.70e-01 | 1.02e-01 | 8.33e-01 |
| GOMF NFAT PROTEIN BINDING | 5 | 6.94e-01 | 1.02e-01 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 9 | 5.98e-01 | -1.02e-01 | 9.15e-01 |
| GOBP N GLYCAN PROCESSING | 17 | 4.69e-01 | -1.02e-01 | 8.75e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 88 | 9.98e-02 | 1.01e-01 | 5.95e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 18 | 4.56e-01 | -1.01e-01 | 8.71e-01 |
| GOMF G PROTEIN ACTIVITY | 42 | 2.55e-01 | 1.01e-01 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 81 | 1.14e-01 | 1.01e-01 | 6.22e-01 |
| GOBP REGULATION OF APPETITE | 19 | 4.44e-01 | 1.01e-01 | 8.65e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 24 | 3.90e-01 | -1.01e-01 | 8.42e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 85 | 1.06e-01 | 1.01e-01 | 6.02e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 13 | 5.27e-01 | -1.01e-01 | 8.92e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 98 | 8.28e-02 | 1.01e-01 | 5.62e-01 |
| GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT | 21 | 4.21e-01 | 1.01e-01 | 8.54e-01 |
| GOBP SINOATRIAL NODE CELL DEVELOPMENT | 5 | 6.95e-01 | 1.01e-01 | 9.43e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 7 | 6.42e-01 | -1.01e-01 | 9.28e-01 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 17 | 4.69e-01 | -1.01e-01 | 8.75e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 181 | 1.87e-02 | 1.01e-01 | 2.95e-01 |
| GOBP POSITIVE CHEMOTAXIS | 61 | 1.71e-01 | 1.01e-01 | 7.04e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 17 | 4.70e-01 | 1.01e-01 | 8.75e-01 |
| GOBP HEAT GENERATION | 17 | 4.70e-01 | 1.01e-01 | 8.75e-01 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 11 | 5.61e-01 | -1.01e-01 | 9.05e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 24 | 3.91e-01 | 1.01e-01 | 8.42e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 54 | 1.98e-01 | 1.01e-01 | 7.29e-01 |
| GOMF SNARE BINDING | 104 | 7.49e-02 | 1.01e-01 | 5.43e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 41 | 2.63e-01 | -1.01e-01 | 7.83e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 13 | 5.28e-01 | -1.01e-01 | 8.93e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 27 | 3.64e-01 | 1.01e-01 | 8.33e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 91 | 9.59e-02 | 1.01e-01 | 5.90e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 10 | 5.80e-01 | 1.01e-01 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 57 | 1.87e-01 | 1.01e-01 | 7.23e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 20 | 4.35e-01 | 1.01e-01 | 8.60e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 10 | 5.80e-01 | 1.01e-01 | 9.08e-01 |
| GOMF CYCLIN BINDING | 34 | 3.09e-01 | 1.01e-01 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 9 | 6.01e-01 | -1.01e-01 | 9.16e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 44 | 2.47e-01 | 1.01e-01 | 7.69e-01 |
| GOBP RETINAL CONE CELL DEVELOPMENT | 11 | 5.63e-01 | -1.01e-01 | 9.05e-01 |
| GOBP REACTIVE GLIOSIS | 6 | 6.69e-01 | 1.01e-01 | 9.34e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 57 | 1.89e-01 | 1.01e-01 | 7.24e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 16 | 4.86e-01 | -1.01e-01 | 8.80e-01 |
| GOMF NETRIN RECEPTOR ACTIVITY | 5 | 6.97e-01 | -1.01e-01 | 9.43e-01 |
| GOCC MLL1 2 COMPLEX | 29 | 3.49e-01 | 1.01e-01 | 8.26e-01 |
| GOMF CGMP BINDING | 15 | 5.00e-01 | -1.01e-01 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 20 | 4.36e-01 | 1.01e-01 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 7 | 6.45e-01 | -1.01e-01 | 9.29e-01 |
| GOMF ALPHA GLUCOSIDASE ACTIVITY | 5 | 6.97e-01 | 1.00e-01 | 9.43e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 62 | 1.71e-01 | 1.00e-01 | 7.04e-01 |
| GOBP REGULATION OF CORE PROMOTER BINDING | 5 | 6.97e-01 | 1.00e-01 | 9.43e-01 |
| GOMF PHOSPHATIDYLCHOLINE STEROL O ACYLTRANSFERASE ACTIVATOR ACTIVITY | 6 | 6.70e-01 | -1.00e-01 | 9.35e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 44 | 2.49e-01 | -1.00e-01 | 7.71e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 102 | 7.98e-02 | 1.00e-01 | 5.54e-01 |
| GOBP SCHWANN CELL DEVELOPMENT | 30 | 3.42e-01 | -1.00e-01 | 8.22e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 10 | 5.83e-01 | 1.00e-01 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 8 | 6.23e-01 | 1.00e-01 | 9.24e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 5 | 6.98e-01 | 1.00e-01 | 9.43e-01 |
| GOBP IMPORT INTO CELL | 897 | 3.52e-07 | 1.00e-01 | 2.00e-04 |
| GOBP REGULATION OF ACTION POTENTIAL | 55 | 1.99e-01 | -1.00e-01 | 7.29e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 26 | 3.76e-01 | 1.00e-01 | 8.35e-01 |
| GOBP MECHANOSENSORY BEHAVIOR | 14 | 5.16e-01 | 1.00e-01 | 8.90e-01 |
| GOBP RENAL FILTRATION | 25 | 3.86e-01 | -1.00e-01 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 14 | 5.17e-01 | 1.00e-01 | 8.90e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 402 | 5.72e-04 | 1.00e-01 | 4.33e-02 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 93 | 9.52e-02 | 1.00e-01 | 5.89e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 38 | 2.86e-01 | 1.00e-01 | 7.95e-01 |
| GOBP PYRUVATE TRANSPORT | 7 | 6.47e-01 | 1.00e-01 | 9.29e-01 |
| GOCC TRAPP COMPLEX | 16 | 4.89e-01 | 1.00e-01 | 8.82e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 5.84e-01 | 1.00e-01 | 9.09e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 13 | 5.33e-01 | 9.99e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 6.99e-01 | 9.99e-02 | 9.43e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.25e-01 | 9.99e-02 | 9.25e-01 |
| GOBP T CELL PROLIFERATION | 202 | 1.44e-02 | 9.99e-02 | 2.57e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 8 | 6.25e-01 | -9.99e-02 | 9.25e-01 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 70 | 1.48e-01 | -9.99e-02 | 6.76e-01 |
| GOBP PULMONARY ARTERY MORPHOGENESIS | 6 | 6.72e-01 | 9.98e-02 | 9.35e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 38 | 2.87e-01 | 9.98e-02 | 7.95e-01 |
| GOCC SPERM MITOCHONDRIAL SHEATH | 5 | 6.99e-01 | -9.97e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR WOUND HEALING | 5 | 6.99e-01 | 9.97e-02 | 9.43e-01 |
| GOBP REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 5 | 7.00e-01 | -9.97e-02 | 9.43e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 9 | 6.05e-01 | -9.96e-02 | 9.20e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 1133 | 1.53e-08 | -9.96e-02 | 1.31e-05 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 7 | 6.48e-01 | 9.96e-02 | 9.30e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 14 | 5.19e-01 | 9.96e-02 | 8.90e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 24 | 3.98e-01 | -9.96e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 43 | 2.59e-01 | 9.96e-02 | 7.78e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 11 | 5.68e-01 | 9.95e-02 | 9.05e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 18 | 4.65e-01 | 9.95e-02 | 8.74e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 11 | 5.68e-01 | 9.95e-02 | 9.05e-01 |
| GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 7.00e-01 | 9.94e-02 | 9.44e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 14 | 5.20e-01 | 9.94e-02 | 8.90e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 9 | 6.06e-01 | -9.93e-02 | 9.20e-01 |
| GOBP RHYTHMIC BEHAVIOR | 44 | 2.54e-01 | 9.93e-02 | 7.76e-01 |
| GOBP REGULATION OF RENAL SODIUM EXCRETION | 8 | 6.27e-01 | -9.93e-02 | 9.25e-01 |
| GOBP SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION | 12 | 5.51e-01 | 9.93e-02 | 9.01e-01 |
| GOCC BRUSH BORDER MEMBRANE | 57 | 1.95e-01 | 9.93e-02 | 7.27e-01 |
| GOBP INTRACELLULAR PH ELEVATION | 7 | 6.49e-01 | 9.92e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 29 | 3.55e-01 | 9.92e-02 | 8.29e-01 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 14 | 5.20e-01 | -9.92e-02 | 8.90e-01 |
| GOCC MITOTIC SPINDLE POLE | 35 | 3.10e-01 | -9.92e-02 | 8.06e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 24 | 4.00e-01 | -9.92e-02 | 8.46e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 23 | 4.10e-01 | 9.92e-02 | 8.49e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR REGULATOR ACTIVITY | 13 | 5.36e-01 | 9.92e-02 | 8.94e-01 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 6 | 6.74e-01 | 9.92e-02 | 9.36e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 103 | 8.22e-02 | 9.91e-02 | 5.61e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 12 | 5.52e-01 | 9.91e-02 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 24 | 4.01e-01 | -9.91e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 39 | 2.84e-01 | -9.91e-02 | 7.95e-01 |
| GOBP RESPONSE TO COCAINE | 47 | 2.40e-01 | 9.90e-02 | 7.65e-01 |
| GOBP RESPONSE TO COBALT ION | 9 | 6.07e-01 | -9.89e-02 | 9.20e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 15 | 5.08e-01 | -9.88e-02 | 8.89e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 10 | 5.88e-01 | 9.88e-02 | 9.11e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 11 | 5.70e-01 | -9.88e-02 | 9.06e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 118 | 6.38e-02 | 9.88e-02 | 5.07e-01 |
| GOBP EXOCYTOSIS | 329 | 2.08e-03 | 9.87e-02 | 9.11e-02 |
| GOMF ACETYLCHOLINE BINDING | 10 | 5.89e-01 | -9.87e-02 | 9.11e-01 |
| GOCC CIS GOLGI NETWORK | 55 | 2.06e-01 | 9.87e-02 | 7.37e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 41 | 2.74e-01 | 9.87e-02 | 7.87e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 33 | 3.27e-01 | 9.86e-02 | 8.12e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 7 | 6.51e-01 | 9.86e-02 | 9.30e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 29 | 3.58e-01 | 9.86e-02 | 8.31e-01 |
| GOMF LEUCINE BINDING | 6 | 6.76e-01 | 9.86e-02 | 9.37e-01 |
| GOBP UREA METABOLIC PROCESS | 12 | 5.54e-01 | -9.86e-02 | 9.01e-01 |
| GOBP CGMP METABOLIC PROCESS | 16 | 4.95e-01 | -9.86e-02 | 8.83e-01 |
| GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION | 10 | 5.89e-01 | 9.86e-02 | 9.11e-01 |
| GOCC HFE TRANSFERRIN RECEPTOR COMPLEX | 8 | 6.29e-01 | 9.86e-02 | 9.25e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 6.09e-01 | 9.85e-02 | 9.20e-01 |
| GOBP REGULATION OF CELL PROJECTION SIZE | 12 | 5.55e-01 | -9.85e-02 | 9.02e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 21 | 4.35e-01 | -9.85e-02 | 8.60e-01 |
| GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING | 10 | 5.90e-01 | 9.85e-02 | 9.11e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 43 | 2.64e-01 | 9.84e-02 | 7.83e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 181 | 2.24e-02 | 9.84e-02 | 3.20e-01 |
| GOBP MRNA 3 END PROCESSING | 49 | 2.33e-01 | -9.84e-02 | 7.61e-01 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 7.03e-01 | -9.84e-02 | 9.44e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 7.03e-01 | -9.84e-02 | 9.44e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 138 | 4.60e-02 | 9.84e-02 | 4.41e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 62 | 1.80e-01 | 9.83e-02 | 7.13e-01 |
| GOCC ENDOSOME LUMEN | 37 | 3.01e-01 | 9.83e-02 | 8.01e-01 |
| GOBP RNA CAPPING | 35 | 3.14e-01 | -9.83e-02 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 9 | 6.10e-01 | -9.83e-02 | 9.20e-01 |
| GOBP BONE CELL DEVELOPMENT | 17 | 4.83e-01 | 9.82e-02 | 8.80e-01 |
| GOBP T CELL ACTIVATION | 537 | 9.92e-05 | 9.82e-02 | 1.52e-02 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 50 | 2.30e-01 | 9.82e-02 | 7.60e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 126 | 5.71e-02 | -9.81e-02 | 4.83e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 150 | 3.81e-02 | 9.81e-02 | 4.05e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 38 | 2.95e-01 | 9.81e-02 | 7.99e-01 |
| GOCC CILIARY TRANSITION ZONE | 71 | 1.53e-01 | -9.81e-02 | 6.84e-01 |
| GOBP INFLAMMATORY RESPONSE | 844 | 1.30e-06 | 9.81e-02 | 5.55e-04 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 25 | 3.96e-01 | 9.80e-02 | 8.45e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 6 | 6.78e-01 | 9.79e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 19 | 4.60e-01 | 9.79e-02 | 8.72e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 22 | 4.27e-01 | 9.78e-02 | 8.58e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 15 | 5.12e-01 | 9.78e-02 | 8.89e-01 |
| GOBP URETER MORPHOGENESIS | 7 | 6.54e-01 | 9.78e-02 | 9.30e-01 |
| GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 14 | 5.26e-01 | 9.78e-02 | 8.92e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 25 | 3.97e-01 | 9.78e-02 | 8.45e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 79 | 1.33e-01 | -9.78e-02 | 6.51e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 57 | 2.02e-01 | 9.78e-02 | 7.32e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 83 | 1.24e-01 | 9.77e-02 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 8 | 6.32e-01 | 9.77e-02 | 9.25e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 49 | 2.37e-01 | 9.77e-02 | 7.63e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 66 | 1.70e-01 | -9.77e-02 | 7.03e-01 |
| GOBP PEPTIDE TRANSPORT | 254 | 7.39e-03 | 9.76e-02 | 1.83e-01 |
| GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION | 9 | 6.12e-01 | -9.76e-02 | 9.21e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 61 | 1.87e-01 | -9.76e-02 | 7.23e-01 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 12 | 5.58e-01 | 9.76e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 73 | 1.49e-01 | 9.76e-02 | 6.79e-01 |
| GOCC ENDOCYTIC VESICLE | 325 | 2.50e-03 | 9.75e-02 | 1.01e-01 |
| GOBP DGMP METABOLIC PROCESS | 5 | 7.06e-01 | 9.75e-02 | 9.45e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 33 | 3.33e-01 | -9.74e-02 | 8.16e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 338 | 2.08e-03 | 9.74e-02 | 9.11e-02 |
| GOBP ENDOCARDIAL CELL DIFFERENTIATION | 6 | 6.80e-01 | 9.74e-02 | 9.38e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 18 | 4.75e-01 | 9.74e-02 | 8.77e-01 |
| GOCC KINETOCHORE MICROTUBULE | 20 | 4.51e-01 | -9.74e-02 | 8.70e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 89 | 1.13e-01 | -9.73e-02 | 6.18e-01 |
| GOBP T CELL SELECTION | 52 | 2.25e-01 | 9.73e-02 | 7.57e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 110 | 7.79e-02 | 9.73e-02 | 5.49e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 24 | 4.09e-01 | -9.73e-02 | 8.49e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 39 | 2.93e-01 | -9.73e-02 | 7.97e-01 |
| GOBP EXIT FROM MITOSIS | 31 | 3.49e-01 | 9.73e-02 | 8.26e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 7.06e-01 | -9.73e-02 | 9.45e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 84 | 1.24e-01 | 9.72e-02 | 6.38e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 406 | 7.77e-04 | 9.72e-02 | 5.30e-02 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 9 | 6.14e-01 | 9.72e-02 | 9.21e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 11 | 5.77e-01 | 9.72e-02 | 9.06e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 21 | 4.41e-01 | 9.72e-02 | 8.63e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 38 | 3.00e-01 | 9.71e-02 | 8.01e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 12 | 5.60e-01 | -9.71e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 39 | 2.95e-01 | -9.70e-02 | 7.98e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 118 | 6.89e-02 | 9.69e-02 | 5.23e-01 |
| GOBP NOTOCHORD DEVELOPMENT | 19 | 4.65e-01 | 9.69e-02 | 8.74e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 29 | 3.66e-01 | 9.69e-02 | 8.33e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 43 | 2.72e-01 | 9.68e-02 | 7.86e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 26 | 3.93e-01 | 9.68e-02 | 8.43e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 44 | 2.67e-01 | 9.68e-02 | 7.83e-01 |
| GOBP WOUND HEALING | 407 | 8.08e-04 | 9.68e-02 | 5.44e-02 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 7 | 6.58e-01 | -9.68e-02 | 9.30e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 29 | 3.67e-01 | 9.67e-02 | 8.33e-01 |
| GOBP VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS | 5 | 7.08e-01 | -9.67e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 7.08e-01 | 9.67e-02 | 9.45e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 138 | 5.00e-02 | 9.66e-02 | 4.58e-01 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 8 | 6.36e-01 | -9.66e-02 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 6.36e-01 | 9.66e-02 | 9.26e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 120 | 6.77e-02 | 9.66e-02 | 5.21e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 31 | 3.52e-01 | 9.65e-02 | 8.27e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 11 | 5.79e-01 | -9.65e-02 | 9.08e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 96 | 1.02e-01 | 9.65e-02 | 5.97e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 35 | 3.23e-01 | 9.65e-02 | 8.10e-01 |
| GOCC CELL LEADING EDGE | 408 | 8.29e-04 | 9.64e-02 | 5.54e-02 |
| GOBP MANNOSYLATION | 22 | 4.34e-01 | -9.64e-02 | 8.60e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 40 | 2.91e-01 | 9.64e-02 | 7.97e-01 |
| GOBP KETONE CATABOLIC PROCESS | 14 | 5.32e-01 | 9.64e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 9 | 6.17e-01 | -9.63e-02 | 9.22e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 218 | 1.42e-02 | 9.63e-02 | 2.56e-01 |
| GOCC HAUS COMPLEX | 7 | 6.59e-01 | 9.63e-02 | 9.30e-01 |
| GOBP DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS | 6 | 6.83e-01 | -9.63e-02 | 9.40e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 771 | 5.39e-06 | 9.63e-02 | 1.72e-03 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 36 | 3.18e-01 | 9.63e-02 | 8.10e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 33 | 3.39e-01 | 9.62e-02 | 8.22e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 38 | 3.05e-01 | 9.62e-02 | 8.02e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 59 | 2.01e-01 | 9.62e-02 | 7.32e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 14 | 5.33e-01 | 9.62e-02 | 8.94e-01 |
| GOBP FIBRINOLYSIS | 27 | 3.87e-01 | -9.61e-02 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 101 | 9.52e-02 | 9.61e-02 | 5.89e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 7.10e-01 | 9.61e-02 | 9.46e-01 |
| GOMF OXIDIZED DNA BINDING | 11 | 5.81e-01 | 9.61e-02 | 9.08e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 217 | 1.47e-02 | 9.61e-02 | 2.60e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 14 | 5.34e-01 | -9.60e-02 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 139 | 5.07e-02 | 9.60e-02 | 4.62e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 72 | 1.59e-01 | 9.60e-02 | 6.93e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 51 | 2.36e-01 | 9.60e-02 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 29 | 3.72e-01 | -9.59e-02 | 8.33e-01 |
| GOBP AMINE METABOLIC PROCESS | 107 | 8.67e-02 | 9.59e-02 | 5.72e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 60 | 1.99e-01 | 9.58e-02 | 7.29e-01 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 6 | 6.84e-01 | -9.58e-02 | 9.40e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 7.11e-01 | 9.58e-02 | 9.47e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 165 | 3.38e-02 | 9.58e-02 | 3.88e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 21 | 4.47e-01 | -9.58e-02 | 8.67e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 38 | 3.08e-01 | -9.57e-02 | 8.03e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 126 | 6.38e-02 | 9.56e-02 | 5.07e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 7.11e-01 | 9.56e-02 | 9.47e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 13 | 5.51e-01 | -9.56e-02 | 9.01e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 155 | 4.01e-02 | 9.55e-02 | 4.12e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 37 | 3.15e-01 | 9.55e-02 | 8.08e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 206 | 1.82e-02 | 9.55e-02 | 2.90e-01 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 138 | 5.28e-02 | 9.55e-02 | 4.73e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 26 | 4.00e-01 | 9.54e-02 | 8.46e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 81 | 1.38e-01 | 9.54e-02 | 6.58e-01 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 9 | 6.20e-01 | -9.54e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 10 | 6.01e-01 | 9.54e-02 | 9.17e-01 |
| GOMF ATP ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 6.86e-01 | 9.54e-02 | 9.41e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 18 | 4.84e-01 | 9.54e-02 | 8.80e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 58 | 2.09e-01 | 9.53e-02 | 7.40e-01 |
| GOBP RETINAL BLOOD VESSEL MORPHOGENESIS | 5 | 7.12e-01 | -9.52e-02 | 9.47e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 9 | 6.21e-01 | 9.52e-02 | 9.23e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 5.85e-01 | 9.51e-02 | 9.09e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 137 | 5.46e-02 | 9.51e-02 | 4.78e-01 |
| GOMF DYNEIN LIGHT CHAIN BINDING | 9 | 6.21e-01 | 9.51e-02 | 9.23e-01 |
| GOMF SNORNA BINDING | 31 | 3.60e-01 | -9.51e-02 | 8.31e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 24 | 4.20e-01 | -9.51e-02 | 8.54e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 165 | 3.51e-02 | 9.51e-02 | 3.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 6.42e-01 | -9.50e-02 | 9.28e-01 |
| GOBP ENERGY HOMEOSTASIS | 76 | 1.52e-01 | 9.50e-02 | 6.83e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 39 | 3.05e-01 | -9.50e-02 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 24 | 4.21e-01 | -9.49e-02 | 8.54e-01 |
| GOBP RESPONSE TO PEPTIDE | 498 | 2.87e-04 | 9.49e-02 | 2.72e-02 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 26 | 4.02e-01 | 9.49e-02 | 8.46e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 29 | 3.76e-01 | -9.49e-02 | 8.35e-01 |
| GOBP RETICULOPHAGY | 18 | 4.86e-01 | -9.48e-02 | 8.80e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 53 | 2.33e-01 | 9.48e-02 | 7.61e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED IRON SULFUR PROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 9 | 6.22e-01 | 9.48e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 49 | 2.51e-01 | -9.47e-02 | 7.74e-01 |
| GOMF LYSINE N ACETYLTRANSFERASE ACTIVITY ACTING ON ACETYL PHOSPHATE AS DONOR | 6 | 6.88e-01 | 9.47e-02 | 9.42e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 45 | 2.72e-01 | 9.47e-02 | 7.86e-01 |
| GOMF NEUROPEPTIDE BINDING | 31 | 3.62e-01 | -9.47e-02 | 8.33e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 192 | 2.38e-02 | 9.46e-02 | 3.28e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS NAD OR NADP AS ACCEPTOR | 6 | 6.88e-01 | -9.46e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF FEVER GENERATION | 7 | 6.65e-01 | 9.46e-02 | 9.32e-01 |
| GOBP HIPPO SIGNALING | 42 | 2.89e-01 | -9.46e-02 | 7.96e-01 |
| GOMF ATPASE INHIBITOR ACTIVITY | 5 | 7.14e-01 | 9.46e-02 | 9.47e-01 |
| GOBP MONOAMINE TRANSPORT | 86 | 1.29e-01 | 9.46e-02 | 6.48e-01 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 14 | 5.40e-01 | 9.46e-02 | 8.96e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 153 | 4.34e-02 | 9.46e-02 | 4.27e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 753 | 9.96e-06 | 9.46e-02 | 3.00e-03 |
| GOCC NUCLEAR PORE | 89 | 1.23e-01 | -9.46e-02 | 6.38e-01 |
| GOBP COP9 SIGNALOSOME ASSEMBLY | 5 | 7.14e-01 | -9.46e-02 | 9.47e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 38 | 3.13e-01 | -9.45e-02 | 8.08e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 198 | 2.18e-02 | 9.45e-02 | 3.18e-01 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 6.44e-01 | 9.45e-02 | 9.29e-01 |
| GOBP CHOLESTEROL CATABOLIC PROCESS | 9 | 6.24e-01 | 9.45e-02 | 9.24e-01 |
| GOBP CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS | 6 | 6.89e-01 | 9.45e-02 | 9.42e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 29 | 3.79e-01 | 9.44e-02 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 28 | 3.87e-01 | 9.44e-02 | 8.41e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 7.15e-01 | 9.44e-02 | 9.47e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 99 | 1.05e-01 | 9.44e-02 | 5.99e-01 |
| GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT | 8 | 6.44e-01 | 9.44e-02 | 9.29e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 17 | 5.01e-01 | 9.43e-02 | 8.86e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 44 | 2.79e-01 | 9.43e-02 | 7.93e-01 |
| GOMF SNRNA BINDING | 48 | 2.59e-01 | -9.42e-02 | 7.78e-01 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 12 | 5.72e-01 | -9.42e-02 | 9.06e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 366 | 1.96e-03 | 9.42e-02 | 8.77e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 10 | 6.06e-01 | -9.42e-02 | 9.20e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 11 | 5.89e-01 | 9.42e-02 | 9.11e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 23 | 4.34e-01 | 9.41e-02 | 8.60e-01 |
| GOCC KINOCILIUM | 9 | 6.25e-01 | 9.41e-02 | 9.25e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 12 | 5.72e-01 | -9.41e-02 | 9.06e-01 |
| GOBP FUCOSE CATABOLIC PROCESS | 9 | 6.25e-01 | 9.41e-02 | 9.25e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 1076 | 1.85e-07 | 9.41e-02 | 1.18e-04 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 19 | 4.78e-01 | 9.41e-02 | 8.79e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 248 | 1.07e-02 | 9.40e-02 | 2.25e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 9 | 6.25e-01 | 9.40e-02 | 9.25e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 51 | 2.45e-01 | 9.40e-02 | 7.68e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 19 | 4.78e-01 | 9.40e-02 | 8.79e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 498 | 3.32e-04 | 9.39e-02 | 2.98e-02 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 13 | 5.58e-01 | 9.39e-02 | 9.03e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 53 | 2.37e-01 | -9.39e-02 | 7.63e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 1381 | 4.86e-09 | -9.39e-02 | 5.52e-06 |
| GOCC GOLGI CIS CISTERNA | 14 | 5.43e-01 | -9.39e-02 | 8.97e-01 |
| GOBP RETINAL METABOLIC PROCESS | 18 | 4.91e-01 | 9.39e-02 | 8.82e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 11 | 5.90e-01 | 9.38e-02 | 9.11e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 12 | 5.74e-01 | 9.38e-02 | 9.06e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 41 | 2.99e-01 | 9.38e-02 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 16 | 5.16e-01 | 9.38e-02 | 8.90e-01 |
| GOBP REGULATION OF BEHAVIOR | 73 | 1.66e-01 | 9.37e-02 | 6.99e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 21 | 4.58e-01 | 9.36e-02 | 8.71e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 26 | 4.09e-01 | 9.36e-02 | 8.49e-01 |
| GOBP REGULATION OF HEAT GENERATION | 12 | 5.75e-01 | 9.36e-02 | 9.06e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 6.47e-01 | 9.36e-02 | 9.29e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 21 | 4.58e-01 | 9.36e-02 | 8.71e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 63 | 1.99e-01 | -9.36e-02 | 7.29e-01 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 6 | 6.92e-01 | 9.35e-02 | 9.43e-01 |
| GOBP MIRNA METABOLIC PROCESS | 101 | 1.05e-01 | 9.35e-02 | 5.99e-01 |
| GOBP TONGUE DEVELOPMENT | 20 | 4.69e-01 | 9.35e-02 | 8.75e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 30 | 3.76e-01 | -9.34e-02 | 8.35e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 6 | 6.92e-01 | 9.34e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 17 | 5.05e-01 | 9.34e-02 | 8.88e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 8 | 6.47e-01 | 9.34e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 18 | 4.93e-01 | -9.34e-02 | 8.83e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 360 | 2.33e-03 | 9.34e-02 | 9.74e-02 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 6.28e-01 | -9.34e-02 | 9.25e-01 |
| GOMF AXON GUIDANCE RECEPTOR ACTIVITY | 10 | 6.09e-01 | -9.34e-02 | 9.20e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 12 | 5.75e-01 | -9.34e-02 | 9.06e-01 |
| GOCC SECRETORY GRANULE | 855 | 3.57e-06 | 9.33e-02 | 1.18e-03 |
| GOBP INSULIN SECRETION | 193 | 2.54e-02 | 9.33e-02 | 3.38e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 19 | 4.81e-01 | 9.33e-02 | 8.80e-01 |
| GOBP PROTEIN SIALYLATION | 5 | 7.18e-01 | 9.33e-02 | 9.48e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 16 | 5.19e-01 | 9.32e-02 | 8.90e-01 |
| GOBP MICROGLIA DIFFERENTIATION | 11 | 5.93e-01 | 9.32e-02 | 9.12e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 39 | 3.14e-01 | 9.32e-02 | 8.08e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 5.93e-01 | 9.32e-02 | 9.12e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 11 | 5.93e-01 | 9.31e-02 | 9.12e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 125 | 7.21e-02 | 9.31e-02 | 5.34e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 6.29e-01 | 9.31e-02 | 9.25e-01 |
| GOBP HEART FIELD SPECIFICATION | 17 | 5.06e-01 | 9.31e-02 | 8.88e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 30 | 3.78e-01 | 9.31e-02 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 8 | 6.49e-01 | 9.30e-02 | 9.30e-01 |
| GOCC CAJAL BODY | 77 | 1.58e-01 | -9.30e-02 | 6.91e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 39 | 3.15e-01 | 9.30e-02 | 8.08e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 45 | 2.81e-01 | 9.30e-02 | 7.93e-01 |
| GOCC AUTOPHAGOSOME | 110 | 9.21e-02 | 9.30e-02 | 5.83e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 85 | 1.39e-01 | 9.29e-02 | 6.59e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 44 | 2.87e-01 | 9.29e-02 | 7.95e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 52 | 2.47e-01 | 9.27e-02 | 7.69e-01 |
| GOCC U1 SNRNP | 19 | 4.84e-01 | -9.27e-02 | 8.80e-01 |
| GOMF DOPAMINE BINDING | 6 | 6.94e-01 | -9.27e-02 | 9.43e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 11 | 5.94e-01 | 9.27e-02 | 9.13e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 73 | 1.71e-01 | 9.27e-02 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 15 | 5.34e-01 | -9.27e-02 | 8.94e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 220 | 1.78e-02 | 9.27e-02 | 2.86e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 262 | 9.85e-03 | 9.26e-02 | 2.13e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 26 | 4.14e-01 | -9.26e-02 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 11 | 5.95e-01 | 9.26e-02 | 9.13e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 51 | 2.53e-01 | -9.25e-02 | 7.75e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 122 | 7.77e-02 | 9.25e-02 | 5.49e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 6.95e-01 | 9.25e-02 | 9.43e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 10 | 6.13e-01 | 9.24e-02 | 9.21e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 121 | 7.92e-02 | 9.24e-02 | 5.52e-01 |
| GOBP PROSTATE GLAND GROWTH | 10 | 6.13e-01 | -9.24e-02 | 9.21e-01 |
| GOCC SPERM PRINCIPAL PIECE | 32 | 3.66e-01 | -9.24e-02 | 8.33e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 15 | 5.36e-01 | 9.23e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 30 | 3.82e-01 | 9.23e-02 | 8.37e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 36 | 3.38e-01 | 9.23e-02 | 8.21e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 254 | 1.13e-02 | 9.23e-02 | 2.29e-01 |
| GOBP RESPONSE TO SELENIUM ION | 8 | 6.51e-01 | -9.23e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS | 5 | 7.21e-01 | 9.23e-02 | 9.48e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 86 | 1.39e-01 | 9.22e-02 | 6.59e-01 |
| GOBP MISMATCH REPAIR | 32 | 3.67e-01 | 9.22e-02 | 8.33e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 487 | 4.93e-04 | 9.22e-02 | 3.94e-02 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 6.52e-01 | -9.22e-02 | 9.30e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 9 | 6.32e-01 | 9.21e-02 | 9.25e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 33 | 3.60e-01 | -9.21e-02 | 8.32e-01 |
| GOBP VESICLE CARGO LOADING | 29 | 3.91e-01 | 9.21e-02 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 38 | 3.26e-01 | 9.21e-02 | 8.11e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 17 | 5.11e-01 | -9.20e-02 | 8.89e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 281 | 7.95e-03 | 9.20e-02 | 1.91e-01 |
| GOBP SULFATE TRANSPORT | 17 | 5.11e-01 | -9.20e-02 | 8.89e-01 |
| GOCC SECRETORY VESICLE | 1019 | 6.80e-07 | 9.20e-02 | 3.31e-04 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 349 | 3.16e-03 | 9.20e-02 | 1.17e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 26 | 4.17e-01 | -9.20e-02 | 8.53e-01 |
| GOBP CARDIAC CONDUCTION | 94 | 1.23e-01 | 9.19e-02 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 7.22e-01 | 9.19e-02 | 9.48e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 12 | 5.82e-01 | 9.19e-02 | 9.08e-01 |
| GOBP ENAMEL MINERALIZATION | 19 | 4.88e-01 | -9.19e-02 | 8.82e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 242 | 1.38e-02 | 9.19e-02 | 2.52e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 223 | 1.81e-02 | 9.19e-02 | 2.89e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 42 | 3.03e-01 | 9.18e-02 | 8.02e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 25 | 4.27e-01 | -9.18e-02 | 8.58e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 12 | 5.82e-01 | 9.18e-02 | 9.08e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 25 | 4.27e-01 | -9.18e-02 | 8.58e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 7 | 6.74e-01 | 9.17e-02 | 9.36e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 279 | 8.36e-03 | 9.17e-02 | 1.97e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 310 | 5.48e-03 | 9.17e-02 | 1.62e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 8 | 6.53e-01 | -9.17e-02 | 9.30e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 232 | 1.61e-02 | 9.17e-02 | 2.73e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 8 | 6.53e-01 | -9.17e-02 | 9.30e-01 |
| GOBP NERVE DEVELOPMENT | 94 | 1.25e-01 | 9.17e-02 | 6.40e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 60 | 2.20e-01 | 9.16e-02 | 7.51e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 61 | 2.16e-01 | 9.16e-02 | 7.48e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 36 | 3.42e-01 | -9.16e-02 | 8.22e-01 |
| GOMF TELETHONIN BINDING | 7 | 6.75e-01 | 9.15e-02 | 9.36e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 42 | 3.05e-01 | 9.15e-02 | 8.02e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 6.98e-01 | -9.15e-02 | 9.43e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 94 | 1.25e-01 | 9.15e-02 | 6.41e-01 |
| GOMF ACTIN BINDING | 415 | 1.39e-03 | 9.15e-02 | 7.44e-02 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 67 | 1.96e-01 | -9.14e-02 | 7.27e-01 |
| GOBP TELOMERE CAPPING | 39 | 3.23e-01 | -9.14e-02 | 8.10e-01 |
| GOMF MOLYBDOPTERIN COFACTOR BINDING | 6 | 6.98e-01 | -9.14e-02 | 9.43e-01 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 32 | 3.71e-01 | -9.14e-02 | 8.33e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 32 | 3.71e-01 | -9.14e-02 | 8.33e-01 |
| GOBP PHENOTYPIC SWITCHING | 16 | 5.27e-01 | 9.13e-02 | 8.93e-01 |
| GOMF DIHYDROPYRIMIDINASE ACTIVITY | 6 | 6.99e-01 | -9.13e-02 | 9.43e-01 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 9 | 6.35e-01 | 9.13e-02 | 9.25e-01 |
| GOBP RESPONSE TO METAL ION | 344 | 3.62e-03 | 9.13e-02 | 1.27e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 25 | 4.30e-01 | -9.13e-02 | 8.60e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 45 | 2.90e-01 | -9.12e-02 | 7.96e-01 |
| GOBP PARAXIAL MESODERM FORMATION | 7 | 6.76e-01 | -9.12e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 3.79e-01 | 9.12e-02 | 8.36e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 64 | 2.07e-01 | 9.12e-02 | 7.38e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 38 | 3.31e-01 | 9.11e-02 | 8.15e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 6.99e-01 | 9.11e-02 | 9.43e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 66 | 2.01e-01 | -9.11e-02 | 7.32e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 59 | 2.26e-01 | 9.11e-02 | 7.59e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 18 | 5.03e-01 | 9.11e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 6.99e-01 | -9.11e-02 | 9.43e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 36 | 3.44e-01 | -9.11e-02 | 8.23e-01 |
| GOMF CENTROMERIC DNA BINDING | 6 | 6.99e-01 | -9.11e-02 | 9.43e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 24 | 4.40e-01 | -9.10e-02 | 8.63e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 14 | 5.56e-01 | 9.10e-02 | 9.02e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 11 | 6.01e-01 | -9.10e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 24 | 4.41e-01 | -9.10e-02 | 8.63e-01 |
| GOBP REPLACEMENT OSSIFICATION | 30 | 3.89e-01 | 9.10e-02 | 8.41e-01 |
| GOBP G1 TO G0 TRANSITION | 19 | 4.93e-01 | 9.09e-02 | 8.83e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 16 | 5.29e-01 | -9.09e-02 | 8.93e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 86 | 1.45e-01 | 9.09e-02 | 6.71e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 72 | 1.82e-01 | 9.09e-02 | 7.15e-01 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 25 | 4.32e-01 | -9.09e-02 | 8.60e-01 |
| GOMF U1 SNRNA BINDING | 8 | 6.57e-01 | 9.08e-02 | 9.30e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 57 | 2.36e-01 | 9.08e-02 | 7.62e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 5 | 7.25e-01 | -9.08e-02 | 9.50e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 12 | 5.86e-01 | -9.07e-02 | 9.10e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 9 | 6.38e-01 | -9.07e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 16 | 5.30e-01 | 9.07e-02 | 8.93e-01 |
| GOBP MESONEPHRIC TUBULE FORMATION | 10 | 6.20e-01 | -9.07e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 139 | 6.50e-02 | 9.06e-02 | 5.12e-01 |
| GOBP HORMONE TRANSPORT | 311 | 5.99e-03 | 9.06e-02 | 1.68e-01 |
| GOBP VESTIBULOCOCHLEAR NERVE DEVELOPMENT | 11 | 6.03e-01 | 9.06e-02 | 9.18e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 63 | 2.14e-01 | 9.06e-02 | 7.45e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 13 | 5.72e-01 | 9.06e-02 | 9.06e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 10 | 6.20e-01 | 9.05e-02 | 9.23e-01 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 107 | 1.06e-01 | -9.05e-02 | 6.02e-01 |
| GOMF GABA RECEPTOR BINDING | 18 | 5.06e-01 | -9.04e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 139 | 6.56e-02 | 9.04e-02 | 5.13e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 16 | 5.31e-01 | 9.04e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 16 | 5.31e-01 | -9.04e-02 | 8.93e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 16 | 5.31e-01 | 9.04e-02 | 8.93e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 34 | 3.62e-01 | -9.04e-02 | 8.33e-01 |
| GOBP NEURAL TUBE PATTERNING | 39 | 3.29e-01 | 9.04e-02 | 8.15e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 26 | 4.25e-01 | 9.03e-02 | 8.57e-01 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 9 | 6.39e-01 | -9.03e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL EFFLUX | 22 | 4.63e-01 | -9.03e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 47 | 2.84e-01 | -9.03e-02 | 7.95e-01 |
| GOBP REGULATION OF GLYCOGEN STARCH SYNTHASE ACTIVITY | 5 | 7.27e-01 | -9.02e-02 | 9.51e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 7 | 6.79e-01 | 9.02e-02 | 9.38e-01 |
| GOBP SECRETION | 923 | 3.36e-06 | 9.02e-02 | 1.15e-03 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 20 | 4.85e-01 | -9.02e-02 | 8.80e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEDIFFERENTIATION | 5 | 7.27e-01 | 9.02e-02 | 9.51e-01 |
| GOBP TAURINE METABOLIC PROCESS | 9 | 6.40e-01 | 9.01e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 10 | 6.22e-01 | -9.01e-02 | 9.24e-01 |
| GOCC VESICLE MEMBRANE | 1170 | 2.05e-07 | 9.01e-02 | 1.23e-04 |
| GOBP LYMPHOCYTE MIGRATION | 114 | 9.69e-02 | 9.00e-02 | 5.93e-01 |
| GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD | 8 | 6.59e-01 | -9.00e-02 | 9.30e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 8 | 6.59e-01 | 9.00e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 314 | 6.12e-03 | 9.00e-02 | 1.70e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 12 | 5.90e-01 | 8.99e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 8 | 6.60e-01 | -8.99e-02 | 9.30e-01 |
| GOCC SEPTIN CYTOSKELETON | 14 | 5.60e-01 | 8.99e-02 | 9.05e-01 |
| GOBP REGULATION OF VESICLE FUSION | 24 | 4.46e-01 | 8.99e-02 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 17 | 5.21e-01 | 8.99e-02 | 8.91e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 61 | 2.25e-01 | 8.99e-02 | 7.57e-01 |
| GOMF SYMPORTER ACTIVITY | 146 | 6.09e-02 | 8.98e-02 | 4.95e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 31 | 3.87e-01 | 8.98e-02 | 8.41e-01 |
| GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER | 6 | 7.03e-01 | 8.98e-02 | 9.44e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 101 | 1.19e-01 | 8.98e-02 | 6.30e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 20 | 4.87e-01 | 8.98e-02 | 8.81e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 74 | 1.82e-01 | 8.98e-02 | 7.14e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 67 | 2.04e-01 | 8.98e-02 | 7.34e-01 |
| GOBP TAXIS | 442 | 1.22e-03 | 8.97e-02 | 6.74e-02 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 93 | 1.35e-01 | 8.97e-02 | 6.53e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 27 | 4.20e-01 | -8.96e-02 | 8.54e-01 |
| GOBP PLASMA MEMBRANE FUSION | 30 | 3.95e-01 | -8.96e-02 | 8.45e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 200 | 2.89e-02 | -8.96e-02 | 3.61e-01 |
| GOBP CILIARY NEUROTROPHIC FACTOR MEDIATED SIGNALING PATHWAY | 5 | 7.29e-01 | 8.96e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 163 | 4.85e-02 | 8.96e-02 | 4.52e-01 |
| GOBP NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 5 | 7.29e-01 | -8.96e-02 | 9.51e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY BARORECEPTOR FEEDBACK | 5 | 7.29e-01 | 8.95e-02 | 9.51e-01 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 6 | 7.04e-01 | -8.95e-02 | 9.44e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 54 | 2.55e-01 | -8.95e-02 | 7.76e-01 |
| GOCC HEMOGLOBIN COMPLEX | 12 | 5.91e-01 | 8.95e-02 | 9.11e-01 |
| GOCC CELL PROJECTION MEMBRANE | 338 | 4.70e-03 | 8.95e-02 | 1.45e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 282 | 9.74e-03 | 8.94e-02 | 2.12e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 13 | 5.77e-01 | 8.94e-02 | 9.06e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 7.29e-01 | 8.94e-02 | 9.51e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 20 | 4.89e-01 | 8.94e-02 | 8.82e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 44 | 3.05e-01 | -8.94e-02 | 8.02e-01 |
| GOBP MONOCYTE EXTRAVASATION | 10 | 6.25e-01 | 8.94e-02 | 9.25e-01 |
| GOMF PRE MIRNA BINDING | 9 | 6.43e-01 | -8.94e-02 | 9.28e-01 |
| GOBP EMBRYONIC RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 6 | 7.05e-01 | 8.94e-02 | 9.44e-01 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 6 | 7.05e-01 | -8.93e-02 | 9.44e-01 |
| GOBP EPITHELIAL MESENCHYMAL CELL SIGNALING | 6 | 7.05e-01 | 8.93e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 8 | 6.62e-01 | -8.93e-02 | 9.31e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 107 | 1.10e-01 | 8.93e-02 | 6.14e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 12 | 5.92e-01 | -8.93e-02 | 9.12e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 38 | 3.41e-01 | 8.93e-02 | 8.22e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 50 | 2.75e-01 | -8.93e-02 | 7.88e-01 |
| GOCC BBAF COMPLEX | 10 | 6.25e-01 | -8.92e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 12 | 5.92e-01 | -8.92e-02 | 9.12e-01 |
| GOBP MUCOCILIARY CLEARANCE | 8 | 6.62e-01 | 8.92e-02 | 9.31e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 28 | 4.14e-01 | 8.92e-02 | 8.51e-01 |
| GOMF RNA POLYMERASE I ACTIVITY | 10 | 6.25e-01 | -8.92e-02 | 9.25e-01 |
| GOCC GROWTH FACTOR COMPLEX | 8 | 6.62e-01 | 8.92e-02 | 9.31e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 93 | 1.37e-01 | 8.91e-02 | 6.58e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 11 | 6.09e-01 | -8.91e-02 | 9.20e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 7 | 6.83e-01 | 8.91e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 46 | 2.96e-01 | -8.91e-02 | 7.99e-01 |
| GOBP B CELL ACTIVATION | 261 | 1.33e-02 | 8.90e-02 | 2.50e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 10 | 6.26e-01 | 8.90e-02 | 9.25e-01 |
| GOBP RNA GUANINE N7 METHYLATION | 6 | 7.06e-01 | -8.90e-02 | 9.45e-01 |
| GOBP STRESS GRANULE DISASSEMBLY | 5 | 7.31e-01 | 8.89e-02 | 9.52e-01 |
| GOMF HYDROPEROXY ICOSATETRAENOATE DEHYDRATASE ACTIVITY | 7 | 6.84e-01 | -8.89e-02 | 9.40e-01 |
| GOCC NSL COMPLEX | 9 | 6.44e-01 | 8.89e-02 | 9.29e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 77 | 1.78e-01 | 8.89e-02 | 7.10e-01 |
| GOBP RESPONSE TO PROTOZOAN | 31 | 3.92e-01 | -8.89e-02 | 8.43e-01 |
| GOBP RESPONSE TO STEROL | 35 | 3.63e-01 | -8.89e-02 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 15 | 5.51e-01 | 8.88e-02 | 9.01e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 103 | 1.19e-01 | 8.88e-02 | 6.30e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 23 | 4.61e-01 | -8.88e-02 | 8.72e-01 |
| GOBP RNA MODIFICATION | 168 | 4.71e-02 | -8.88e-02 | 4.46e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 39 | 3.38e-01 | 8.87e-02 | 8.21e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 20 | 4.92e-01 | -8.87e-02 | 8.83e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 7.31e-01 | 8.87e-02 | 9.52e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 52 | 2.69e-01 | -8.87e-02 | 7.84e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 5.80e-01 | 8.87e-02 | 9.08e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 20 | 4.92e-01 | -8.87e-02 | 8.83e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 165 | 4.94e-02 | 8.87e-02 | 4.56e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 16 | 5.39e-01 | 8.86e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 154 | 5.76e-02 | 8.86e-02 | 4.85e-01 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 8 | 6.64e-01 | -8.86e-02 | 9.32e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 261 | 1.37e-02 | 8.86e-02 | 2.52e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 29 | 4.09e-01 | -8.86e-02 | 8.49e-01 |
| GOCC TORC1 COMPLEX | 6 | 7.07e-01 | -8.86e-02 | 9.45e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 17 | 5.27e-01 | -8.86e-02 | 8.93e-01 |
| GOCC ACTOMYOSIN | 76 | 1.82e-01 | 8.85e-02 | 7.14e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 34 | 3.72e-01 | -8.85e-02 | 8.33e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 413 | 2.02e-03 | 8.85e-02 | 8.96e-02 |
| GOBP REGULATION OF SEROTONIN SECRETION | 6 | 7.07e-01 | 8.85e-02 | 9.45e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 27 | 4.26e-01 | -8.85e-02 | 8.57e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 167 | 4.85e-02 | 8.85e-02 | 4.52e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 12 | 5.96e-01 | -8.85e-02 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 94 | 1.38e-01 | 8.84e-02 | 6.59e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 235 | 1.95e-02 | 8.84e-02 | 3.00e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 66 | 2.14e-01 | 8.84e-02 | 7.45e-01 |
| GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR | 10 | 6.28e-01 | 8.84e-02 | 9.25e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 20 | 4.94e-01 | 8.84e-02 | 8.83e-01 |
| GOBP CAMP MEDIATED SIGNALING | 53 | 2.66e-01 | 8.84e-02 | 7.83e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 70 | 2.01e-01 | 8.84e-02 | 7.32e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 35 | 3.66e-01 | 8.83e-02 | 8.33e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 21 | 4.84e-01 | -8.82e-02 | 8.80e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 22 | 4.74e-01 | 8.82e-02 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 17 | 5.29e-01 | -8.82e-02 | 8.93e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 9 | 6.47e-01 | 8.82e-02 | 9.29e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1459 | 1.76e-08 | 8.81e-02 | 1.39e-05 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 34 | 3.74e-01 | 8.81e-02 | 8.34e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 108 | 1.14e-01 | 8.81e-02 | 6.21e-01 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 6.87e-01 | -8.81e-02 | 9.41e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 14 | 5.68e-01 | 8.81e-02 | 9.05e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 11 | 6.13e-01 | -8.81e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 28 | 4.20e-01 | 8.80e-02 | 8.54e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 10 | 6.30e-01 | 8.80e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 32 | 3.89e-01 | -8.80e-02 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 61 | 2.35e-01 | 8.80e-02 | 7.62e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS | 5 | 7.33e-01 | -8.80e-02 | 9.53e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 22 | 4.75e-01 | -8.80e-02 | 8.77e-01 |
| GOBP REGULATION OF FERTILIZATION | 17 | 5.30e-01 | -8.79e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 45 | 3.08e-01 | -8.79e-02 | 8.03e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 22 | 4.76e-01 | -8.78e-02 | 8.78e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 24 | 4.57e-01 | 8.78e-02 | 8.71e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 13 | 5.84e-01 | 8.78e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 15 | 5.56e-01 | 8.78e-02 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 26 | 4.39e-01 | 8.78e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 121 | 9.54e-02 | 8.78e-02 | 5.89e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 11 | 6.14e-01 | -8.77e-02 | 9.21e-01 |
| GOBP DETOXIFICATION OF NITROGEN COMPOUND | 5 | 7.34e-01 | -8.77e-02 | 9.53e-01 |
| GOCC RNA POLYMERASE COMPLEX | 97 | 1.36e-01 | -8.77e-02 | 6.54e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 69 | 2.08e-01 | -8.77e-02 | 7.39e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 35 | 3.70e-01 | -8.76e-02 | 8.33e-01 |
| GOBP ADENINE TRANSPORT | 5 | 7.34e-01 | 8.76e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 151 | 6.31e-02 | 8.76e-02 | 5.04e-01 |
| GOCC PRESPLICEOSOME | 16 | 5.44e-01 | 8.76e-02 | 8.98e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 24 | 4.58e-01 | 8.76e-02 | 8.71e-01 |
| GOBP REGULATION OF BILE ACID SECRETION | 6 | 7.10e-01 | -8.76e-02 | 9.47e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 22 | 4.78e-01 | -8.74e-02 | 8.79e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 14 | 5.71e-01 | -8.74e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 18 | 5.21e-01 | -8.74e-02 | 8.91e-01 |
| GOBP DEDIFFERENTIATION | 11 | 6.16e-01 | -8.73e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 14 | 5.72e-01 | -8.73e-02 | 9.06e-01 |
| GOCC LEADING EDGE MEMBRANE | 174 | 4.70e-02 | 8.73e-02 | 4.46e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 195 | 3.56e-02 | 8.73e-02 | 3.96e-01 |
| GOBP PYROPTOSIS | 36 | 3.65e-01 | 8.72e-02 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 11 | 6.16e-01 | -8.72e-02 | 9.22e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 67 | 2.17e-01 | 8.72e-02 | 7.49e-01 |
| GOBP AMP METABOLIC PROCESS | 22 | 4.79e-01 | -8.72e-02 | 8.79e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 91 | 1.51e-01 | -8.72e-02 | 6.81e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 6.17e-01 | -8.71e-02 | 9.22e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 45 | 3.12e-01 | 8.71e-02 | 8.08e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 6.17e-01 | -8.70e-02 | 9.22e-01 |
| GOBP PROLINE METABOLIC PROCESS | 10 | 6.34e-01 | -8.70e-02 | 9.25e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 60 | 2.44e-01 | 8.70e-02 | 7.67e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 2.60e-01 | -8.70e-02 | 7.81e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 91 | 1.52e-01 | 8.69e-02 | 6.83e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 34 | 3.80e-01 | 8.69e-02 | 8.37e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 21 | 4.90e-01 | 8.69e-02 | 8.82e-01 |
| GOBP OUTER EAR MORPHOGENESIS | 7 | 6.90e-01 | -8.69e-02 | 9.42e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 26 | 4.43e-01 | 8.69e-02 | 8.65e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 11 | 6.18e-01 | -8.69e-02 | 9.22e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 11 | 6.18e-01 | 8.69e-02 | 9.22e-01 |
| GOBP V D J RECOMBINATION | 19 | 5.12e-01 | -8.69e-02 | 8.89e-01 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 9 | 6.52e-01 | -8.69e-02 | 9.30e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 182 | 4.32e-02 | 8.69e-02 | 4.25e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 255 | 1.69e-02 | 8.69e-02 | 2.77e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 18 | 5.23e-01 | -8.69e-02 | 8.91e-01 |
| GOBP DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM | 8 | 6.71e-01 | -8.68e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 63 | 2.33e-01 | -8.68e-02 | 7.61e-01 |
| GOBP ENDODERMAL CELL FATE SPECIFICATION | 8 | 6.71e-01 | 8.68e-02 | 9.35e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 62 | 2.37e-01 | -8.68e-02 | 7.63e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 17 | 5.36e-01 | 8.68e-02 | 8.94e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 27 | 4.36e-01 | -8.67e-02 | 8.60e-01 |
| GOCC GAP JUNCTION | 29 | 4.19e-01 | 8.67e-02 | 8.54e-01 |
| GOMF MYOSIN V BINDING | 16 | 5.48e-01 | -8.67e-02 | 9.00e-01 |
| GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION | 8 | 6.71e-01 | 8.67e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 41 | 3.37e-01 | 8.67e-02 | 8.20e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 29 | 4.19e-01 | 8.67e-02 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 85 | 1.67e-01 | 8.67e-02 | 7.00e-01 |
| GOMF POTASSIUM CHANNEL ACTIVATOR ACTIVITY | 5 | 7.37e-01 | 8.67e-02 | 9.53e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 123 | 9.70e-02 | 8.66e-02 | 5.93e-01 |
| GOBP VIRAL TRANSCRIPTION | 50 | 2.89e-01 | -8.66e-02 | 7.96e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 17 | 5.36e-01 | 8.66e-02 | 8.94e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 37 | 3.62e-01 | 8.66e-02 | 8.33e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 19 | 5.13e-01 | 8.66e-02 | 8.89e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 306 | 9.19e-03 | 8.66e-02 | 2.07e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 60 | 2.46e-01 | 8.65e-02 | 7.68e-01 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 10 | 6.36e-01 | -8.65e-02 | 9.26e-01 |
| GOBP LONG TERM MEMORY | 36 | 3.69e-01 | 8.64e-02 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 274 | 1.39e-02 | 8.64e-02 | 2.52e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 541 | 5.89e-04 | 8.64e-02 | 4.40e-02 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 43 | 3.27e-01 | 8.64e-02 | 8.13e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 51 | 2.86e-01 | 8.63e-02 | 7.95e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 39 | 3.51e-01 | 8.63e-02 | 8.26e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 39 | 3.51e-01 | 8.62e-02 | 8.26e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 15 | 5.63e-01 | -8.62e-02 | 9.05e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 66 | 2.26e-01 | -8.62e-02 | 7.59e-01 |
| GOMF DNA HELICASE ACTIVITY | 57 | 2.60e-01 | -8.62e-02 | 7.81e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 30 | 4.14e-01 | -8.62e-02 | 8.51e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 7.38e-01 | -8.62e-02 | 9.53e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 18 | 5.27e-01 | 8.62e-02 | 8.92e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 48 | 3.01e-01 | 8.62e-02 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 31 | 4.06e-01 | -8.62e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 39 | 3.52e-01 | -8.62e-02 | 8.26e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 15 | 5.63e-01 | -8.62e-02 | 9.05e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 12 | 6.05e-01 | -8.62e-02 | 9.20e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 36 | 3.71e-01 | 8.62e-02 | 8.33e-01 |
| GOBP REGULATION OF FOREBRAIN NEURON DIFFERENTIATION | 5 | 7.39e-01 | -8.62e-02 | 9.53e-01 |
| GOBP HEART TRABECULA FORMATION | 15 | 5.64e-01 | 8.61e-02 | 9.05e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 35 | 3.78e-01 | 8.61e-02 | 8.36e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 107 | 1.24e-01 | 8.61e-02 | 6.38e-01 |
| GOBP NEGATIVE REGULATION OF ATP METABOLIC PROCESS | 7 | 6.93e-01 | -8.61e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 6.93e-01 | 8.60e-02 | 9.43e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 35 | 3.79e-01 | 8.60e-02 | 8.36e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 17 | 5.39e-01 | 8.60e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 370 | 4.53e-03 | 8.59e-02 | 1.43e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 21 | 4.96e-01 | 8.59e-02 | 8.83e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 22 | 4.85e-01 | 8.59e-02 | 8.80e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 153 | 6.66e-02 | 8.59e-02 | 5.18e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 76 | 1.95e-01 | 8.59e-02 | 7.27e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 22 | 4.85e-01 | 8.59e-02 | 8.80e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 68 | 2.21e-01 | -8.59e-02 | 7.53e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 6.56e-01 | 8.59e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 27 | 4.41e-01 | 8.58e-02 | 8.63e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 9 | 6.56e-01 | 8.58e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION | 5 | 7.40e-01 | 8.57e-02 | 9.53e-01 |
| GOBP REGULATION OF JNK CASCADE | 127 | 9.52e-02 | 8.57e-02 | 5.89e-01 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 6.95e-01 | 8.57e-02 | 9.43e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 262 | 1.70e-02 | 8.57e-02 | 2.78e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 24 | 4.68e-01 | -8.57e-02 | 8.75e-01 |
| GOBP TRNA PROCESSING | 126 | 9.68e-02 | -8.56e-02 | 5.93e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 13 | 5.93e-01 | 8.56e-02 | 9.12e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC ACTIN CYTOSKELETON | 6 | 7.16e-01 | 8.56e-02 | 9.48e-01 |
| GOCC SYNAPSE ASSOCIATED EXTRACELLULAR MATRIX | 12 | 6.08e-01 | -8.56e-02 | 9.20e-01 |
| GOCC INSULIN LIKE GROWTH FACTOR BINDING PROTEIN COMPLEX | 5 | 7.40e-01 | 8.56e-02 | 9.53e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 83 | 1.78e-01 | 8.55e-02 | 7.11e-01 |
| GOBP NADH METABOLIC PROCESS | 11 | 6.23e-01 | -8.55e-02 | 9.24e-01 |
| GOBP CELL AGGREGATION | 23 | 4.78e-01 | -8.55e-02 | 8.79e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 121 | 1.04e-01 | 8.55e-02 | 5.99e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 15 | 5.66e-01 | 8.55e-02 | 9.05e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 33 | 3.95e-01 | 8.55e-02 | 8.45e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 6.76e-01 | -8.54e-02 | 9.37e-01 |
| GOBP RESPONSE TO SALT STRESS | 24 | 4.69e-01 | 8.54e-02 | 8.75e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 67 | 2.27e-01 | -8.54e-02 | 7.59e-01 |
| GOBP BONE RESORPTION | 65 | 2.34e-01 | 8.54e-02 | 7.61e-01 |
| GOBP CELL CELL JUNCTION DISASSEMBLY | 5 | 7.41e-01 | 8.54e-02 | 9.53e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 151 | 7.02e-02 | 8.54e-02 | 5.28e-01 |
| GOCC EXOCYTIC VESICLE | 222 | 2.84e-02 | 8.54e-02 | 3.57e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 102 | 1.37e-01 | -8.53e-02 | 6.57e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 57 | 2.65e-01 | 8.53e-02 | 7.83e-01 |
| GOCC AZUROPHIL GRANULE | 151 | 7.04e-02 | 8.53e-02 | 5.28e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 75 | 2.02e-01 | 8.53e-02 | 7.32e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 15 | 5.67e-01 | 8.53e-02 | 9.05e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 14 | 5.81e-01 | -8.52e-02 | 9.08e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 6.58e-01 | 8.52e-02 | 9.30e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 6.76e-01 | 8.52e-02 | 9.37e-01 |
| GOBP RESPONSE TO FUNGICIDE | 7 | 6.96e-01 | 8.52e-02 | 9.43e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 6.96e-01 | -8.52e-02 | 9.43e-01 |
| GOBP CRANIAL GANGLION DEVELOPMENT | 5 | 7.41e-01 | 8.52e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 31 | 4.12e-01 | 8.52e-02 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 163 | 6.06e-02 | 8.52e-02 | 4.95e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 146 | 7.58e-02 | 8.51e-02 | 5.44e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 225 | 2.78e-02 | 8.51e-02 | 3.53e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 38 | 3.64e-01 | 8.51e-02 | 8.33e-01 |
| GOBP REGULATION OF GLUTAMATE RECEPTOR CLUSTERING | 6 | 7.18e-01 | 8.50e-02 | 9.48e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 73 | 2.09e-01 | -8.50e-02 | 7.40e-01 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 52 | 2.89e-01 | 8.50e-02 | 7.96e-01 |
| GOBP GLOMERULUS VASCULATURE MORPHOGENESIS | 6 | 7.19e-01 | 8.49e-02 | 9.48e-01 |
| GOBP PEPTIDE CROSS LINKING | 26 | 4.53e-01 | -8.49e-02 | 8.70e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 6.59e-01 | 8.49e-02 | 9.30e-01 |
| GOBP REGULATION OF FEMALE RECEPTIVITY | 7 | 6.97e-01 | -8.49e-02 | 9.43e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 7 | 6.97e-01 | -8.49e-02 | 9.43e-01 |
| GOCC MEMBRANE MICRODOMAIN | 279 | 1.47e-02 | 8.49e-02 | 2.60e-01 |
| GOCC RISC LOADING COMPLEX | 8 | 6.78e-01 | 8.49e-02 | 9.37e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 15 | 5.69e-01 | 8.48e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 22 | 4.91e-01 | 8.48e-02 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 17 | 5.45e-01 | -8.48e-02 | 8.98e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 514 | 9.99e-04 | 8.48e-02 | 6.09e-02 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 40 | 3.53e-01 | 8.48e-02 | 8.28e-01 |
| GOBP REGULATION OF SALIVA SECRETION | 7 | 6.98e-01 | -8.48e-02 | 9.43e-01 |
| GOBP HEMOPOIESIS | 911 | 1.44e-05 | 8.47e-02 | 3.90e-03 |
| GOBP ALLANTOIN METABOLIC PROCESS | 9 | 6.60e-01 | -8.47e-02 | 9.30e-01 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 38 | 3.66e-01 | 8.47e-02 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 182 | 4.88e-02 | 8.47e-02 | 4.54e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 284 | 1.42e-02 | 8.46e-02 | 2.56e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 71 | 2.18e-01 | 8.46e-02 | 7.49e-01 |
| GOBP REGULATION OF SECRETION | 601 | 3.98e-04 | 8.46e-02 | 3.42e-02 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 30 | 4.23e-01 | 8.46e-02 | 8.55e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 7.20e-01 | -8.45e-02 | 9.48e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 113 | 1.21e-01 | -8.45e-02 | 6.32e-01 |
| GOBP CELL CELL SIGNALING | 1625 | 1.33e-08 | 8.45e-02 | 1.24e-05 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 63 | 2.46e-01 | -8.45e-02 | 7.68e-01 |
| GOMF CYCLASE INHIBITOR ACTIVITY | 5 | 7.43e-01 | -8.45e-02 | 9.53e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 22 | 4.93e-01 | 8.45e-02 | 8.83e-01 |
| GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT | 10 | 6.44e-01 | -8.45e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 12 | 6.13e-01 | -8.44e-02 | 9.21e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 174 | 5.47e-02 | 8.44e-02 | 4.79e-01 |
| GOCC CORTICAL CYTOSKELETON | 101 | 1.43e-01 | 8.44e-02 | 6.67e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 156 | 6.90e-02 | -8.44e-02 | 5.23e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 106 | 1.33e-01 | 8.44e-02 | 6.52e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 57 | 2.71e-01 | 8.44e-02 | 7.85e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 5.99e-01 | -8.43e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 13 | 5.99e-01 | 8.43e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 354 | 6.43e-03 | 8.43e-02 | 1.74e-01 |
| GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY | 27 | 4.48e-01 | 8.43e-02 | 8.68e-01 |
| GOBP RESPONSE TO COPPER ION | 35 | 3.88e-01 | 8.43e-02 | 8.41e-01 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 102 | 1.41e-01 | 8.43e-02 | 6.64e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 19 | 5.25e-01 | 8.42e-02 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 86 | 1.77e-01 | 8.42e-02 | 7.10e-01 |
| GOBP VACUOLE FUSION | 12 | 6.14e-01 | -8.41e-02 | 9.21e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 16 | 5.60e-01 | -8.41e-02 | 9.05e-01 |
| GOBP REGULATION OF OSTEOCLAST PROLIFERATION | 6 | 7.21e-01 | 8.41e-02 | 9.48e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 29 | 4.34e-01 | -8.40e-02 | 8.60e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 57 | 2.73e-01 | -8.40e-02 | 7.87e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 320 | 9.78e-03 | 8.40e-02 | 2.13e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 32 | 4.11e-01 | 8.40e-02 | 8.49e-01 |
| GOCC SPECIFIC GRANULE LUMEN | 60 | 2.61e-01 | 8.40e-02 | 7.82e-01 |
| GOBP MEMBRANE FUSION | 174 | 5.61e-02 | 8.39e-02 | 4.82e-01 |
| GOBP MAST CELL DIFFERENTIATION | 6 | 7.22e-01 | 8.39e-02 | 9.48e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 24 | 4.77e-01 | 8.39e-02 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 37 | 3.77e-01 | 8.39e-02 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 11 | 6.30e-01 | 8.39e-02 | 9.25e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 41 | 3.53e-01 | 8.39e-02 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 16 | 5.61e-01 | 8.39e-02 | 9.05e-01 |
| GOBP AMINE CATABOLIC PROCESS | 15 | 5.74e-01 | -8.38e-02 | 9.06e-01 |
| GOBP REGULATION OF HYPERSENSITIVITY | 7 | 7.01e-01 | 8.38e-02 | 9.44e-01 |
| GOCC FILOPODIUM TIP | 18 | 5.38e-01 | 8.38e-02 | 8.96e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 22 | 4.96e-01 | -8.38e-02 | 8.83e-01 |
| GOBP HISTAMINE TRANSPORT | 15 | 5.75e-01 | -8.37e-02 | 9.06e-01 |
| GOBP ETHER METABOLIC PROCESS | 26 | 4.60e-01 | 8.37e-02 | 8.72e-01 |
| GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 15 | 5.75e-01 | -8.37e-02 | 9.06e-01 |
| GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 6 | 7.23e-01 | 8.37e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 418 | 3.34e-03 | 8.37e-02 | 1.21e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 68 | 2.33e-01 | -8.37e-02 | 7.61e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 90 | 1.70e-01 | 8.36e-02 | 7.03e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 476 | 1.79e-03 | 8.35e-02 | 8.37e-02 |
| GOBP MYOBLAST DIFFERENTIATION | 109 | 1.32e-01 | 8.35e-02 | 6.51e-01 |
| GOBP REGULATION OF HISTONE METHYLATION | 16 | 5.63e-01 | 8.35e-02 | 9.05e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 24 | 4.79e-01 | -8.35e-02 | 8.79e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 26 | 4.61e-01 | -8.35e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 8 | 6.83e-01 | -8.35e-02 | 9.40e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 32 | 4.14e-01 | 8.35e-02 | 8.51e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 31 | 4.21e-01 | 8.35e-02 | 8.54e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 19 | 5.29e-01 | 8.34e-02 | 8.93e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 21 | 5.08e-01 | 8.34e-02 | 8.89e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 4.22e-01 | 8.34e-02 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 50 | 3.08e-01 | 8.34e-02 | 8.03e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 96 | 1.58e-01 | -8.34e-02 | 6.91e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 198 | 4.31e-02 | 8.34e-02 | 4.25e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 53 | 2.94e-01 | -8.34e-02 | 7.98e-01 |
| GOBP RESPONSE TO CAFFEINE | 15 | 5.76e-01 | -8.33e-02 | 9.06e-01 |
| GOBP PIRNA PROCESSING | 23 | 4.89e-01 | 8.33e-02 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 15 | 5.76e-01 | -8.33e-02 | 9.06e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 302 | 1.28e-02 | 8.33e-02 | 2.46e-01 |
| GOBP CHOLESTEROL IMPORT | 9 | 6.65e-01 | -8.33e-02 | 9.32e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 364 | 6.36e-03 | 8.33e-02 | 1.74e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 19 | 5.30e-01 | 8.32e-02 | 8.93e-01 |
| GOCC LATE ENDOSOME | 296 | 1.38e-02 | 8.32e-02 | 2.52e-01 |
| GOBP REGULATION OF LUTEINIZING HORMONE SECRETION | 6 | 7.24e-01 | 8.32e-02 | 9.49e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 19 | 5.30e-01 | 8.32e-02 | 8.93e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 109 | 1.34e-01 | -8.32e-02 | 6.52e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 48 | 3.19e-01 | 8.32e-02 | 8.10e-01 |
| GOCC TRANS GOLGI NETWORK | 246 | 2.47e-02 | 8.31e-02 | 3.34e-01 |
| GOBP SYNAPTIC SIGNALING | 746 | 1.11e-04 | 8.31e-02 | 1.61e-02 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 451 | 2.49e-03 | 8.31e-02 | 1.01e-01 |
| GOBP SPINAL CORD PATTERNING | 21 | 5.10e-01 | 8.31e-02 | 8.89e-01 |
| GOBP IMPORT INTO NUCLEUS | 162 | 6.81e-02 | -8.31e-02 | 5.21e-01 |
| GOBP REGULATION OF WOUND HEALING | 129 | 1.03e-01 | 8.30e-02 | 5.98e-01 |
| GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY | 8 | 6.84e-01 | -8.30e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 36 | 3.89e-01 | 8.30e-02 | 8.41e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 87 | 1.81e-01 | 8.30e-02 | 7.13e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 6.49e-01 | 8.30e-02 | 9.30e-01 |
| GOBP KERATINIZATION | 75 | 2.14e-01 | -8.30e-02 | 7.45e-01 |
| GOBP CYTOKINE PRODUCTION | 835 | 4.60e-05 | 8.30e-02 | 8.41e-03 |
| GOMF LIGASE ACTIVITY | 159 | 7.09e-02 | 8.30e-02 | 5.30e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 150 | 7.94e-02 | 8.30e-02 | 5.52e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 12 | 6.19e-01 | 8.29e-02 | 9.22e-01 |
| GOMF NUCLEOSOME BINDING | 67 | 2.40e-01 | -8.29e-02 | 7.65e-01 |
| GOBP EMBRYONIC SKELETAL JOINT MORPHOGENESIS | 11 | 6.34e-01 | 8.29e-02 | 9.25e-01 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 11 | 6.34e-01 | 8.29e-02 | 9.25e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 6.34e-01 | -8.29e-02 | 9.25e-01 |
| GOMF ALKALI METAL ION BINDING | 19 | 5.32e-01 | -8.29e-02 | 8.94e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 7.25e-01 | 8.28e-02 | 9.50e-01 |
| GOCC ATAC COMPLEX | 13 | 6.05e-01 | 8.28e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 7.48e-01 | -8.28e-02 | 9.53e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 87 | 1.82e-01 | -8.28e-02 | 7.14e-01 |
| GOBP L SERINE BIOSYNTHETIC PROCESS | 5 | 7.49e-01 | 8.28e-02 | 9.53e-01 |
| GOBP EXPORT FROM CELL | 867 | 3.56e-05 | 8.27e-02 | 7.24e-03 |
| GOBP MEMBRANOUS SEPTUM MORPHOGENESIS | 8 | 6.85e-01 | -8.27e-02 | 9.41e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 28 | 4.49e-01 | 8.27e-02 | 8.68e-01 |
| GOBP FOREBRAIN REGIONALIZATION | 24 | 4.83e-01 | 8.27e-02 | 8.80e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 13 | 6.06e-01 | 8.26e-02 | 9.20e-01 |
| GOBP CHOLESTEROL STORAGE | 25 | 4.75e-01 | -8.26e-02 | 8.77e-01 |
| GOBP REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION | 12 | 6.20e-01 | 8.26e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 11 | 6.35e-01 | -8.26e-02 | 9.25e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 77 | 2.10e-01 | 8.26e-02 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 466 | 2.25e-03 | 8.26e-02 | 9.52e-02 |
| GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY | 6 | 7.26e-01 | 8.26e-02 | 9.51e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 865 | 3.75e-05 | 8.26e-02 | 7.24e-03 |
| GOBP MANGANESE ION TRANSPORT | 11 | 6.35e-01 | 8.25e-02 | 9.25e-01 |
| GOCC CELL CORTEX | 296 | 1.46e-02 | 8.25e-02 | 2.59e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 7.49e-01 | 8.25e-02 | 9.53e-01 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 4.75e-01 | 8.24e-02 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 10 | 6.52e-01 | 8.24e-02 | 9.30e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 12 | 6.21e-01 | -8.24e-02 | 9.23e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 44 | 3.44e-01 | 8.24e-02 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 4.35e-01 | 8.24e-02 | 8.60e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 677 | 2.57e-04 | 8.24e-02 | 2.61e-02 |
| GOCC INTERSTITIAL MATRIX | 11 | 6.36e-01 | 8.24e-02 | 9.26e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 13 | 6.07e-01 | 8.24e-02 | 9.20e-01 |
| GOBP RESPONSE TO DSRNA | 52 | 3.04e-01 | 8.24e-02 | 8.02e-01 |
| GOBP RESPONSE TO AXON INJURY | 79 | 2.06e-01 | -8.23e-02 | 7.37e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 63 | 2.58e-01 | -8.23e-02 | 7.78e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 42 | 3.56e-01 | 8.23e-02 | 8.30e-01 |
| GOBP TELOMERE ORGANIZATION | 178 | 5.82e-02 | -8.23e-02 | 4.87e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 146 | 8.60e-02 | 8.23e-02 | 5.70e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 35 | 3.99e-01 | -8.23e-02 | 8.46e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 30 | 4.35e-01 | -8.23e-02 | 8.60e-01 |
| GOBP LIPID DIGESTION | 21 | 5.14e-01 | -8.23e-02 | 8.89e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 91 | 1.75e-01 | 8.23e-02 | 7.06e-01 |
| GOCC DENDRITIC SPINE MEMBRANE | 13 | 6.08e-01 | -8.23e-02 | 9.20e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 384 | 5.65e-03 | 8.23e-02 | 1.64e-01 |
| GOMF GABA GATED CHLORIDE ION CHANNEL ACTIVITY | 11 | 6.37e-01 | 8.22e-02 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 143 | 8.99e-02 | 8.21e-02 | 5.78e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 45 | 3.40e-01 | 8.21e-02 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF CELL VOLUME | 5 | 7.50e-01 | -8.21e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 12 | 6.22e-01 | 8.21e-02 | 9.24e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 49 | 3.20e-01 | 8.21e-02 | 8.10e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 13 | 6.08e-01 | -8.21e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 170 | 6.51e-02 | 8.20e-02 | 5.12e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 16 | 5.70e-01 | -8.19e-02 | 9.06e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 47 | 3.31e-01 | -8.19e-02 | 8.15e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 32 | 4.23e-01 | 8.19e-02 | 8.55e-01 |
| GOBP ACETYLCHOLINE SECRETION | 5 | 7.51e-01 | -8.19e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 43 | 3.53e-01 | 8.19e-02 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 17 | 5.59e-01 | 8.18e-02 | 9.04e-01 |
| GOCC MEMBRANE COAT | 93 | 1.73e-01 | 8.18e-02 | 7.05e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 71 | 2.34e-01 | 8.18e-02 | 7.61e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLIPPASE ACTIVITY | 5 | 7.52e-01 | -8.17e-02 | 9.54e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 42 | 3.59e-01 | 8.17e-02 | 8.31e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 54 | 2.99e-01 | -8.17e-02 | 7.99e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 67 | 2.48e-01 | 8.17e-02 | 7.69e-01 |
| GOBP CELL MATRIX ADHESION | 231 | 3.25e-02 | 8.17e-02 | 3.85e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 8 | 6.89e-01 | 8.17e-02 | 9.42e-01 |
| GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS | 8 | 6.89e-01 | 8.17e-02 | 9.42e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 11 | 6.39e-01 | 8.16e-02 | 9.28e-01 |
| GOCC FILOPODIUM | 103 | 1.52e-01 | 8.16e-02 | 6.83e-01 |
| GOBP GENOMIC IMPRINTING | 18 | 5.49e-01 | -8.16e-02 | 9.00e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 27 | 4.63e-01 | -8.16e-02 | 8.74e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 71 | 2.34e-01 | -8.16e-02 | 7.61e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 6.39e-01 | 8.16e-02 | 9.28e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 7 | 7.09e-01 | 8.16e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 14 | 5.97e-01 | -8.16e-02 | 9.15e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 48 | 3.28e-01 | 8.15e-02 | 8.14e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 560 | 9.72e-04 | 8.15e-02 | 5.99e-02 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 9 | 6.72e-01 | 8.15e-02 | 9.35e-01 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 17 | 5.61e-01 | -8.15e-02 | 9.05e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 7.53e-01 | -8.14e-02 | 9.54e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 330 | 1.10e-02 | 8.14e-02 | 2.27e-01 |
| GOBP RECEPTOR INTERNALIZATION | 122 | 1.20e-01 | 8.14e-02 | 6.32e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 56 | 2.92e-01 | 8.14e-02 | 7.97e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 14 | 5.98e-01 | -8.14e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 29 | 4.48e-01 | 8.14e-02 | 8.68e-01 |
| GOBP VASODILATION | 46 | 3.40e-01 | 8.14e-02 | 8.22e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 41 | 3.67e-01 | 8.13e-02 | 8.33e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 30 | 4.41e-01 | 8.13e-02 | 8.63e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 30 | 4.41e-01 | 8.13e-02 | 8.63e-01 |
| GOCC MOTILE CILIUM | 248 | 2.75e-02 | -8.13e-02 | 3.52e-01 |
| GOCC STEREOCILIUM BASE | 5 | 7.53e-01 | 8.12e-02 | 9.54e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 44 | 3.51e-01 | 8.12e-02 | 8.26e-01 |
| GOBP REGULATION OF OSSIFICATION | 116 | 1.31e-01 | 8.12e-02 | 6.51e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 139 | 9.88e-02 | 8.11e-02 | 5.95e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION | 5 | 7.54e-01 | -8.11e-02 | 9.54e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 31 | 4.35e-01 | -8.11e-02 | 8.60e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 74 | 2.28e-01 | 8.10e-02 | 7.60e-01 |
| GOBP CHLORIDE TRANSPORT | 116 | 1.32e-01 | 8.10e-02 | 6.51e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 67 | 2.52e-01 | 8.10e-02 | 7.74e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR DIMERIC COMPLEX | 7 | 7.11e-01 | -8.10e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 32 | 4.28e-01 | 8.10e-02 | 8.59e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 22 | 5.11e-01 | 8.09e-02 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 36 | 4.01e-01 | -8.09e-02 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 45 | 3.48e-01 | 8.09e-02 | 8.26e-01 |
| GOMF ALPHA KETOGLUTARATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.32e-01 | -8.09e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 35 | 4.08e-01 | -8.09e-02 | 8.49e-01 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 6 | 7.32e-01 | 8.08e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 33 | 4.22e-01 | 8.08e-02 | 8.54e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 28 | 4.60e-01 | -8.08e-02 | 8.72e-01 |
| GOBP REGULATION OF BONE DEVELOPMENT | 9 | 6.75e-01 | -8.08e-02 | 9.36e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 144 | 9.44e-02 | 8.07e-02 | 5.89e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 46 | 3.44e-01 | 8.07e-02 | 8.23e-01 |
| GOMF HORMONE RECEPTOR BINDING | 29 | 4.52e-01 | 8.07e-02 | 8.70e-01 |
| GOBP PROLINE TRANSPORT | 11 | 6.43e-01 | -8.07e-02 | 9.29e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 108 | 1.48e-01 | 8.07e-02 | 6.75e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 64 | 2.65e-01 | 8.06e-02 | 7.83e-01 |
| GOBP HEPOXILIN METABOLIC PROCESS | 9 | 6.75e-01 | 8.06e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 54 | 3.06e-01 | 8.06e-02 | 8.02e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 69 | 2.47e-01 | 8.06e-02 | 7.69e-01 |
| GOBP IRON ION IMPORT ACROSS PLASMA MEMBRANE | 5 | 7.55e-01 | -8.05e-02 | 9.54e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 42 | 3.66e-01 | 8.05e-02 | 8.33e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 112 | 1.41e-01 | 8.05e-02 | 6.62e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 37 | 3.97e-01 | -8.05e-02 | 8.45e-01 |
| GOBP INDOLE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 5 | 7.55e-01 | 8.05e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 5 | 7.55e-01 | 8.05e-02 | 9.54e-01 |
| GOBP REGULATION OF LYMPHANGIOGENESIS | 6 | 7.33e-01 | -8.04e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 8 | 6.94e-01 | -8.04e-02 | 9.43e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 405 | 5.47e-03 | 8.04e-02 | 1.62e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 48 | 3.35e-01 | 8.04e-02 | 8.19e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 6.30e-01 | -8.04e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 22 | 5.14e-01 | 8.04e-02 | 8.89e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 24 | 4.96e-01 | -8.03e-02 | 8.83e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 16 | 5.78e-01 | 8.03e-02 | 9.06e-01 |
| GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL | 7 | 7.13e-01 | 8.03e-02 | 9.47e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 130 | 1.14e-01 | 8.03e-02 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 36 | 4.05e-01 | 8.03e-02 | 8.48e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 64 | 2.67e-01 | 8.02e-02 | 7.83e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 6.31e-01 | -8.02e-02 | 9.25e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 13 | 6.17e-01 | -8.02e-02 | 9.22e-01 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 11 | 6.45e-01 | 8.01e-02 | 9.29e-01 |
| GOCC GLIAL CELL PROJECTION | 36 | 4.05e-01 | 8.01e-02 | 8.49e-01 |
| GOBP PROTEIN HEXAMERIZATION | 9 | 6.77e-01 | 8.01e-02 | 9.37e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 29 | 4.55e-01 | 8.01e-02 | 8.70e-01 |
| GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION | 12 | 6.31e-01 | -8.01e-02 | 9.25e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 27 | 4.71e-01 | 8.01e-02 | 8.76e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 808 | 1.09e-04 | 8.01e-02 | 1.60e-02 |
| GOMF HELICASE ACTIVITY | 148 | 9.28e-02 | -8.00e-02 | 5.85e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 12 | 6.31e-01 | 8.00e-02 | 9.25e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 8 | 6.95e-01 | 8.00e-02 | 9.43e-01 |
| GOBP RESPONSE TO PHEROMONE | 7 | 7.14e-01 | 8.00e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 5 | 7.57e-01 | 7.99e-02 | 9.54e-01 |
| GOCC T TUBULE | 51 | 3.24e-01 | -7.99e-02 | 8.10e-01 |
| GOBP CELL SUBSTRATE ADHESION | 342 | 1.11e-02 | 7.99e-02 | 2.27e-01 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 7.57e-01 | 7.99e-02 | 9.54e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY TYPE I | 5 | 7.57e-01 | -7.99e-02 | 9.54e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 102 | 1.64e-01 | 7.98e-02 | 6.96e-01 |
| GOMF UBIQUINONE BINDING | 5 | 7.57e-01 | -7.98e-02 | 9.54e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 15 | 5.92e-01 | -7.98e-02 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF GROWTH | 233 | 3.58e-02 | 7.98e-02 | 3.96e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 19 | 5.47e-01 | 7.98e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 63 | 2.73e-01 | 7.98e-02 | 7.87e-01 |
| GOBP REGULATION OF HEART RATE | 99 | 1.70e-01 | 7.98e-02 | 7.03e-01 |
| GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 9 | 6.79e-01 | 7.97e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 12 | 6.33e-01 | 7.97e-02 | 9.25e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 5.48e-01 | -7.97e-02 | 9.00e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 12 | 6.33e-01 | 7.96e-02 | 9.25e-01 |
| GOBP REGULATION OF PRIMARY MIRNA PROCESSING | 5 | 7.58e-01 | 7.96e-02 | 9.54e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 23 | 5.09e-01 | 7.96e-02 | 8.89e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 7.58e-01 | 7.96e-02 | 9.54e-01 |
| GOBP MYOBLAST PROLIFERATION | 34 | 4.22e-01 | 7.96e-02 | 8.54e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 25 | 4.91e-01 | 7.96e-02 | 8.82e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 19 | 5.49e-01 | 7.95e-02 | 9.00e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 111 | 1.48e-01 | -7.95e-02 | 6.76e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 10 | 6.64e-01 | -7.94e-02 | 9.31e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 23 | 5.10e-01 | -7.94e-02 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1615 | 1.03e-07 | 7.94e-02 | 7.06e-05 |
| GOBP HEPARIN METABOLIC PROCESS | 17 | 5.71e-01 | -7.94e-02 | 9.06e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 6.07e-01 | 7.94e-02 | 9.20e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 11 | 6.49e-01 | 7.94e-02 | 9.30e-01 |
| GOBP REGULATION OF CELL MATURATION | 20 | 5.39e-01 | 7.93e-02 | 8.96e-01 |
| GOBP CELLULAR RESPONSE TO HISTAMINE | 7 | 7.16e-01 | 7.93e-02 | 9.48e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 105 | 1.60e-01 | 7.93e-02 | 6.93e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 148 | 9.57e-02 | 7.93e-02 | 5.89e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 105 | 1.60e-01 | 7.93e-02 | 6.93e-01 |
| GOBP REGULATION OF ENDODERMAL CELL DIFFERENTIATION | 7 | 7.16e-01 | 7.93e-02 | 9.48e-01 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 25 | 4.93e-01 | -7.93e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 6.64e-01 | 7.93e-02 | 9.32e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 12 | 6.34e-01 | -7.93e-02 | 9.25e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 618 | 7.69e-04 | 7.92e-02 | 5.30e-02 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 65 | 2.69e-01 | -7.92e-02 | 7.84e-01 |
| GOBP BODY FLUID SECRETION | 87 | 2.01e-01 | 7.92e-02 | 7.32e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 11 | 6.49e-01 | 7.92e-02 | 9.30e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 19 | 5.50e-01 | -7.92e-02 | 9.01e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.98e-01 | -7.92e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE ADAPTATION | 13 | 6.21e-01 | 7.92e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 60 | 2.89e-01 | 7.92e-02 | 7.96e-01 |
| GOBP VESICLE DOCKING | 64 | 2.73e-01 | 7.92e-02 | 7.87e-01 |
| GOBP RESPONSE TO WOUNDING | 538 | 1.68e-03 | 7.92e-02 | 8.22e-02 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 61 | 2.85e-01 | 7.91e-02 | 7.95e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 120 | 1.34e-01 | 7.91e-02 | 6.53e-01 |
| GOCC BRUSH BORDER | 103 | 1.65e-01 | 7.91e-02 | 6.98e-01 |
| GOMF POLYSOME BINDING | 6 | 7.37e-01 | -7.91e-02 | 9.53e-01 |
| GOBP REGULATION OF NEURON MATURATION | 8 | 6.99e-01 | -7.91e-02 | 9.43e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 155 | 8.94e-02 | -7.91e-02 | 5.77e-01 |
| GOCC EGG COAT | 5 | 7.60e-01 | -7.90e-02 | 9.55e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 43 | 3.70e-01 | 7.90e-02 | 8.33e-01 |
| GOMF CHEMOKINE ACTIVITY | 45 | 3.59e-01 | 7.90e-02 | 8.31e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 47 | 3.49e-01 | 7.90e-02 | 8.26e-01 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 6 | 7.38e-01 | 7.89e-02 | 9.53e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 26 | 4.86e-01 | -7.89e-02 | 8.80e-01 |
| GOBP MESENCHYMAL CELL APOPTOTIC PROCESS | 15 | 5.97e-01 | 7.89e-02 | 9.15e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 95 | 1.84e-01 | 7.88e-02 | 7.18e-01 |
| GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 5 | 7.60e-01 | -7.88e-02 | 9.55e-01 |
| GOCC ASTER | 10 | 6.66e-01 | -7.88e-02 | 9.32e-01 |
| GOBP DNA STRAND ELONGATION | 36 | 4.13e-01 | -7.88e-02 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF GROWTH HORMONE SECRETION | 9 | 6.82e-01 | 7.88e-02 | 9.40e-01 |
| GOMF POLY G BINDING | 7 | 7.18e-01 | 7.88e-02 | 9.48e-01 |
| GOMF GROWTH HORMONE RECEPTOR BINDING | 7 | 7.18e-01 | -7.87e-02 | 9.48e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 10 | 6.67e-01 | -7.86e-02 | 9.33e-01 |
| GOMF PHOSPHOLIPASE BINDING | 20 | 5.43e-01 | 7.86e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 108 | 1.58e-01 | 7.86e-02 | 6.91e-01 |
| GOCC XY BODY | 15 | 5.98e-01 | 7.86e-02 | 9.15e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 7.61e-01 | -7.85e-02 | 9.55e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 12 | 6.38e-01 | 7.85e-02 | 9.26e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 9 | 6.84e-01 | 7.85e-02 | 9.40e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 5.54e-01 | -7.85e-02 | 9.01e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 11 | 6.52e-01 | -7.85e-02 | 9.30e-01 |
| GOBP HEART FORMATION | 33 | 4.35e-01 | 7.85e-02 | 8.60e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 38 | 4.03e-01 | 7.84e-02 | 8.46e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 13 | 6.25e-01 | -7.84e-02 | 9.25e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 63 | 2.82e-01 | 7.84e-02 | 7.93e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 5 | 7.62e-01 | 7.84e-02 | 9.55e-01 |
| GOBP STOMACH DEVELOPMENT | 5 | 7.62e-01 | 7.84e-02 | 9.55e-01 |
| GOBP CALCIUM ION IMPORT | 46 | 3.58e-01 | 7.83e-02 | 8.31e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 95 | 1.87e-01 | 7.83e-02 | 7.23e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 24 | 5.07e-01 | 7.83e-02 | 8.89e-01 |
| GOBP DEPHOSPHORYLATION | 286 | 2.27e-02 | 7.83e-02 | 3.22e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 18 | 5.65e-01 | -7.83e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 32 | 4.44e-01 | 7.83e-02 | 8.65e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 17 | 5.76e-01 | 7.83e-02 | 9.06e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 41 | 3.86e-01 | -7.82e-02 | 8.40e-01 |
| GOCC SIDE OF MEMBRANE | 674 | 5.35e-04 | 7.82e-02 | 4.18e-02 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 28 | 4.74e-01 | 7.82e-02 | 8.77e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 102 | 1.72e-01 | 7.82e-02 | 7.04e-01 |
| GOBP RRNA TRANSCRIPTION | 37 | 4.11e-01 | -7.82e-02 | 8.49e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 25 | 4.99e-01 | 7.81e-02 | 8.85e-01 |
| GOBP CAMP METABOLIC PROCESS | 23 | 5.17e-01 | 7.81e-02 | 8.90e-01 |
| GOMF CYCLASE ACTIVITY | 21 | 5.36e-01 | 7.81e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 1007 | 2.77e-05 | 7.81e-02 | 6.29e-03 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 18 | 5.66e-01 | -7.80e-02 | 9.05e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 32 | 4.45e-01 | -7.80e-02 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 31 | 4.52e-01 | 7.80e-02 | 8.70e-01 |
| GOBP RECEPTOR CATABOLIC PROCESS | 27 | 4.83e-01 | 7.80e-02 | 8.80e-01 |
| GOBP RESPONSE TO FORSKOLIN | 14 | 6.14e-01 | -7.80e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 460 | 4.17e-03 | 7.79e-02 | 1.35e-01 |
| GOBP SEQUESTERING OF IRON ION | 6 | 7.41e-01 | 7.79e-02 | 9.53e-01 |
| GOMF MRNA 5 UTR BINDING | 23 | 5.18e-01 | 7.79e-02 | 8.90e-01 |
| GOBP QUINOLINATE METABOLIC PROCESS | 5 | 7.63e-01 | -7.79e-02 | 9.56e-01 |
| GOBP CELLULAR GLUCURONIDATION | 18 | 5.67e-01 | 7.79e-02 | 9.05e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 76 | 2.41e-01 | 7.79e-02 | 7.65e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 92 | 1.97e-01 | 7.78e-02 | 7.28e-01 |
| GOBP REGULATION OF IRON ION TRANSPORT | 7 | 7.21e-01 | 7.78e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 94 | 1.92e-01 | 7.78e-02 | 7.26e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 28 | 4.76e-01 | -7.78e-02 | 8.78e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 31 | 4.54e-01 | -7.78e-02 | 8.70e-01 |
| GOCC WEIBEL PALADE BODY | 5 | 7.63e-01 | 7.78e-02 | 9.56e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 10 | 6.70e-01 | 7.78e-02 | 9.35e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 61 | 2.94e-01 | 7.77e-02 | 7.98e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 18 | 5.68e-01 | -7.77e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 7.22e-01 | -7.77e-02 | 9.48e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 107 | 1.65e-01 | 7.76e-02 | 6.98e-01 |
| GOBP RESPONSE TO TUMOR CELL | 42 | 3.85e-01 | 7.75e-02 | 8.39e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 19 | 5.58e-01 | -7.75e-02 | 9.03e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 190 | 6.54e-02 | 7.75e-02 | 5.12e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 1306 | 2.54e-06 | 7.75e-02 | 9.28e-04 |
| GOBP RESPONSE TO AMMONIUM ION | 6 | 7.42e-01 | 7.75e-02 | 9.53e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 7.04e-01 | 7.75e-02 | 9.44e-01 |
| GOBP CARDIAC FIBROBLAST CELL DIFFERENTIATION | 5 | 7.64e-01 | -7.74e-02 | 9.57e-01 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 10 | 6.72e-01 | 7.74e-02 | 9.35e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 13 | 6.29e-01 | 7.74e-02 | 9.25e-01 |
| GOBP PROTEIN METHYLATION | 75 | 2.46e-01 | -7.74e-02 | 7.68e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 6.16e-01 | -7.74e-02 | 9.22e-01 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 7.43e-01 | -7.73e-02 | 9.53e-01 |
| GOBP REGULATION OF CELL PROLIFERATION IN BONE MARROW | 8 | 7.05e-01 | 7.73e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 56 | 3.17e-01 | 7.73e-02 | 8.09e-01 |
| GOCC ENZYME ACTIVATOR COMPLEX | 16 | 5.92e-01 | 7.73e-02 | 9.12e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 13 | 6.29e-01 | 7.73e-02 | 9.25e-01 |
| GOBP APOPTOTIC PROCESS | 1853 | 3.44e-08 | 7.73e-02 | 2.52e-05 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 14 | 6.17e-01 | -7.73e-02 | 9.22e-01 |
| GOBP NEURON MIGRATION | 166 | 8.57e-02 | -7.73e-02 | 5.70e-01 |
| GOBP ORNITHINE TRANSPORT | 6 | 7.43e-01 | -7.73e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 128 | 1.31e-01 | 7.73e-02 | 6.51e-01 |
| GOBP RUFFLE ORGANIZATION | 57 | 3.13e-01 | 7.73e-02 | 8.08e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 12 | 6.43e-01 | 7.73e-02 | 9.29e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 13 | 6.30e-01 | 7.73e-02 | 9.25e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 8 | 7.05e-01 | 7.72e-02 | 9.44e-01 |
| GOBP RESPONSE TO LEUCINE | 15 | 6.04e-01 | 7.72e-02 | 9.20e-01 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 50 | 3.45e-01 | 7.72e-02 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 52 | 3.36e-01 | 7.72e-02 | 8.20e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 34 | 4.36e-01 | 7.72e-02 | 8.60e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 81 | 2.30e-01 | 7.71e-02 | 7.60e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 12 | 6.44e-01 | -7.71e-02 | 9.29e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 38 | 4.11e-01 | -7.71e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 15 | 6.05e-01 | 7.71e-02 | 9.20e-01 |
| GOBP NK T CELL PROLIFERATION | 8 | 7.06e-01 | -7.70e-02 | 9.45e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 15 | 6.06e-01 | -7.69e-02 | 9.20e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 8 | 7.06e-01 | -7.69e-02 | 9.45e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 10 | 6.74e-01 | -7.69e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 71 | 2.63e-01 | -7.69e-02 | 7.83e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 35 | 4.31e-01 | 7.69e-02 | 8.60e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 7.44e-01 | -7.69e-02 | 9.53e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 7.44e-01 | -7.69e-02 | 9.53e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 29 | 4.74e-01 | -7.69e-02 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 46 | 3.67e-01 | 7.68e-02 | 8.33e-01 |
| GOCC REPLISOME | 13 | 6.31e-01 | 7.68e-02 | 9.25e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 89 | 2.10e-01 | 7.68e-02 | 7.42e-01 |
| GOCC BASAL CORTEX | 5 | 7.66e-01 | 7.68e-02 | 9.57e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 278 | 2.76e-02 | 7.68e-02 | 3.52e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 23 | 5.24e-01 | 7.68e-02 | 8.91e-01 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 20 | 5.53e-01 | 7.67e-02 | 9.01e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ACTIVITY | 7 | 7.25e-01 | -7.67e-02 | 9.50e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 87 | 2.16e-01 | 7.67e-02 | 7.48e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 54 | 3.30e-01 | 7.67e-02 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 15 | 6.07e-01 | -7.67e-02 | 9.20e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 6 | 7.45e-01 | -7.66e-02 | 9.53e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL CELL ADHESION | 5 | 7.67e-01 | 7.66e-02 | 9.58e-01 |
| GOBP RRNA MODIFICATION | 32 | 4.53e-01 | -7.66e-02 | 8.70e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 34 | 4.39e-01 | 7.66e-02 | 8.62e-01 |
| GOBP METANEPHRIC TUBULE MORPHOGENESIS | 11 | 6.60e-01 | 7.66e-02 | 9.30e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 15 | 6.08e-01 | -7.65e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 90 | 2.10e-01 | 7.65e-02 | 7.41e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 9 | 6.91e-01 | 7.65e-02 | 9.43e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 68 | 2.76e-01 | 7.65e-02 | 7.88e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 54 | 3.31e-01 | -7.65e-02 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 68 | 2.76e-01 | -7.64e-02 | 7.88e-01 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 20 | 5.54e-01 | 7.64e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 5 | 7.67e-01 | -7.64e-02 | 9.58e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 35 | 4.34e-01 | 7.64e-02 | 8.60e-01 |
| GOBP REGULATION OF ANOIKIS | 24 | 5.17e-01 | -7.64e-02 | 8.90e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 6.76e-01 | 7.63e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 37 | 4.22e-01 | 7.63e-02 | 8.54e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 86 | 2.21e-01 | 7.63e-02 | 7.54e-01 |
| GOMF LIPID BINDING | 808 | 2.27e-04 | 7.63e-02 | 2.45e-02 |
| GOMF CHEMOREPELLENT ACTIVITY | 28 | 4.85e-01 | 7.63e-02 | 8.80e-01 |
| GOMF DIOXYGENASE ACTIVITY | 86 | 2.22e-01 | 7.63e-02 | 7.54e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 24 | 5.18e-01 | 7.62e-02 | 8.90e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 577 | 1.76e-03 | 7.62e-02 | 8.37e-02 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 93 | 2.04e-01 | 7.62e-02 | 7.35e-01 |
| GOBP SYNCYTIUM FORMATION | 65 | 2.88e-01 | 7.61e-02 | 7.96e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 75 | 2.54e-01 | 7.61e-02 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 27 | 4.94e-01 | 7.61e-02 | 8.83e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 27 | 4.94e-01 | 7.61e-02 | 8.83e-01 |
| GOCC 90S PRERIBOSOME | 28 | 4.86e-01 | -7.61e-02 | 8.80e-01 |
| GOMF MRNA 3 UTR BINDING | 230 | 4.68e-02 | -7.61e-02 | 4.45e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 6 | 7.47e-01 | 7.61e-02 | 9.53e-01 |
| GOBP GLIAL CELL MIGRATION | 57 | 3.21e-01 | -7.61e-02 | 8.10e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 52 | 3.43e-01 | 7.60e-02 | 8.22e-01 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 6.93e-01 | -7.60e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 7.68e-01 | -7.60e-02 | 9.58e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 30 | 4.71e-01 | 7.60e-02 | 8.76e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 271 | 3.13e-02 | -7.60e-02 | 3.78e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 21 | 5.47e-01 | -7.60e-02 | 8.99e-01 |
| GOBP GLIAL CELL ACTIVATION | 57 | 3.21e-01 | 7.60e-02 | 8.10e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 76 | 2.52e-01 | 7.60e-02 | 7.74e-01 |
| GOMF ACYL COA BINDING | 19 | 5.66e-01 | 7.60e-02 | 9.05e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 60 | 3.09e-01 | 7.60e-02 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 14 | 6.23e-01 | 7.59e-02 | 9.24e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 36 | 4.31e-01 | -7.59e-02 | 8.60e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 605 | 1.43e-03 | 7.59e-02 | 7.53e-02 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 20 | 5.57e-01 | 7.59e-02 | 9.02e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 19 | 5.67e-01 | -7.59e-02 | 9.05e-01 |
| GOBP OTIC VESICLE DEVELOPMENT | 15 | 6.11e-01 | 7.59e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 32 | 4.58e-01 | 7.58e-02 | 8.71e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 362 | 1.32e-02 | 7.58e-02 | 2.50e-01 |
| GOCC SARCOPLASMIC RETICULUM | 72 | 2.66e-01 | 7.58e-02 | 7.83e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 614 | 1.34e-03 | 7.58e-02 | 7.22e-02 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 75 | 2.57e-01 | 7.58e-02 | 7.78e-01 |
| GOMF ARRESTIN FAMILY PROTEIN BINDING | 9 | 6.94e-01 | 7.57e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 60 | 3.11e-01 | 7.57e-02 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 36 | 4.32e-01 | 7.57e-02 | 8.60e-01 |
| GOBP BONE REMODELING | 89 | 2.18e-01 | 7.56e-02 | 7.49e-01 |
| GOCC SNARE COMPLEX | 47 | 3.70e-01 | 7.56e-02 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 10 | 6.79e-01 | -7.55e-02 | 9.38e-01 |
| GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 12 | 6.51e-01 | 7.55e-02 | 9.30e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 115 | 1.62e-01 | 7.55e-02 | 6.95e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 1128 | 1.90e-05 | 7.55e-02 | 4.62e-03 |
| GOBP RESPONSE TO SALT | 350 | 1.53e-02 | 7.55e-02 | 2.64e-01 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 9 | 6.95e-01 | 7.55e-02 | 9.43e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 38 | 4.21e-01 | 7.55e-02 | 8.54e-01 |
| GOMF SMAD BINDING | 75 | 2.58e-01 | 7.55e-02 | 7.78e-01 |
| GOCC CHROMOCENTER | 13 | 6.38e-01 | 7.55e-02 | 9.26e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 46 | 3.76e-01 | -7.55e-02 | 8.35e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 24 | 5.22e-01 | 7.54e-02 | 8.91e-01 |
| GOMF PROSTAGLANDIN E RECEPTOR ACTIVITY | 5 | 7.70e-01 | -7.54e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 31 | 4.67e-01 | -7.54e-02 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 855 | 1.81e-04 | 7.54e-02 | 2.10e-02 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 232 | 4.78e-02 | -7.54e-02 | 4.50e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 250 | 4.00e-02 | 7.54e-02 | 4.12e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 26 | 5.06e-01 | 7.54e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 21 | 5.50e-01 | 7.54e-02 | 9.01e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1451 | 1.53e-06 | 7.54e-02 | 6.24e-04 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 18 | 5.80e-01 | 7.54e-02 | 9.08e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 11 | 6.65e-01 | -7.53e-02 | 9.32e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 7 | 7.30e-01 | 7.53e-02 | 9.52e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 62 | 3.05e-01 | 7.53e-02 | 8.02e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 17 | 5.91e-01 | -7.53e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 7.30e-01 | 7.53e-02 | 9.52e-01 |
| GOBP BILE ACID SIGNALING PATHWAY | 11 | 6.65e-01 | 7.53e-02 | 9.32e-01 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 6 | 7.49e-01 | 7.53e-02 | 9.53e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 14 | 6.26e-01 | -7.53e-02 | 9.25e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 35 | 4.41e-01 | 7.53e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 66 | 2.90e-01 | 7.53e-02 | 7.96e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 12 | 6.52e-01 | -7.52e-02 | 9.30e-01 |
| GOCC A BAND | 33 | 4.55e-01 | 7.52e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 41 | 4.05e-01 | 7.52e-02 | 8.48e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 37 | 4.29e-01 | -7.52e-02 | 8.59e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN AXIS ELONGATION | 6 | 7.50e-01 | -7.52e-02 | 9.53e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 57 | 3.26e-01 | 7.52e-02 | 8.11e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 46 | 3.78e-01 | 7.52e-02 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 15 | 6.14e-01 | -7.52e-02 | 9.21e-01 |
| GOMF THIOESTERASE BINDING | 9 | 6.96e-01 | 7.51e-02 | 9.43e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 485 | 4.59e-03 | 7.51e-02 | 1.44e-01 |
| GOBP RNA DESTABILIZATION | 162 | 9.91e-02 | -7.51e-02 | 5.95e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 12 | 6.52e-01 | 7.51e-02 | 9.30e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 17 | 5.92e-01 | -7.51e-02 | 9.12e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 15 | 6.15e-01 | 7.50e-02 | 9.21e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 117 | 1.61e-01 | -7.50e-02 | 6.95e-01 |
| GOBP CHROMOSOME CONDENSATION | 46 | 3.79e-01 | -7.50e-02 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 325 | 2.01e-02 | 7.50e-02 | 3.04e-01 |
| GOBP CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS | 5 | 7.72e-01 | 7.50e-02 | 9.58e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 8 | 7.14e-01 | -7.50e-02 | 9.47e-01 |
| GOBP CELLULAR SENESCENCE | 106 | 1.82e-01 | 7.49e-02 | 7.15e-01 |
| GOBP PROSTATE GLANDULAR ACINUS MORPHOGENESIS | 6 | 7.51e-01 | -7.49e-02 | 9.53e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 7.51e-01 | -7.49e-02 | 9.53e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 482 | 4.84e-03 | 7.49e-02 | 1.47e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 62 | 3.08e-01 | -7.49e-02 | 8.03e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 12 | 6.53e-01 | 7.49e-02 | 9.30e-01 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 7 | 7.32e-01 | 7.49e-02 | 9.52e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 25 | 5.17e-01 | 7.49e-02 | 8.90e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 29 | 4.85e-01 | 7.49e-02 | 8.80e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 23 | 5.34e-01 | -7.49e-02 | 8.94e-01 |
| GOCC SAGA COMPLEX | 23 | 5.35e-01 | 7.48e-02 | 8.94e-01 |
| GOBP NEURONAL SIGNAL TRANSDUCTION | 7 | 7.32e-01 | 7.48e-02 | 9.52e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 6.28e-01 | 7.48e-02 | 9.25e-01 |
| GOBP OOCYTE DIFFERENTIATION | 64 | 3.01e-01 | 7.47e-02 | 8.02e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 29 | 4.86e-01 | 7.47e-02 | 8.80e-01 |
| GOBP ATP METABOLIC PROCESS | 124 | 1.51e-01 | -7.47e-02 | 6.82e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.15e-01 | 7.47e-02 | 9.47e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 31 | 4.72e-01 | -7.47e-02 | 8.77e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 13 | 6.41e-01 | 7.47e-02 | 9.28e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 35 | 4.45e-01 | 7.47e-02 | 8.66e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 426 | 8.23e-03 | 7.46e-02 | 1.95e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 115 | 1.67e-01 | 7.46e-02 | 7.00e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 7.52e-01 | -7.46e-02 | 9.54e-01 |
| GOBP TRNA MODIFICATION | 87 | 2.29e-01 | -7.46e-02 | 7.60e-01 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 7.52e-01 | 7.46e-02 | 9.54e-01 |
| GOBP RESPONSE TO CADMIUM ION | 56 | 3.34e-01 | 7.46e-02 | 8.19e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 34 | 4.52e-01 | -7.46e-02 | 8.70e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 240 | 4.66e-02 | 7.46e-02 | 4.44e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 176 | 8.81e-02 | 7.45e-02 | 5.75e-01 |
| GOBP RESPONSE TO 2 3 7 8 TETRACHLORODIBENZODIOXINE | 5 | 7.73e-01 | 7.45e-02 | 9.58e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 13 | 6.42e-01 | 7.45e-02 | 9.28e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 140 | 1.28e-01 | 7.45e-02 | 6.44e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 123 | 1.54e-01 | 7.45e-02 | 6.86e-01 |
| GOBP IP 10 PRODUCTION | 5 | 7.73e-01 | 7.44e-02 | 9.58e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 160 | 1.04e-01 | 7.44e-02 | 5.99e-01 |
| GOBP BONE MARROW DEVELOPMENT | 9 | 6.99e-01 | -7.44e-02 | 9.43e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 39 | 4.21e-01 | -7.44e-02 | 8.54e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 27 | 5.04e-01 | 7.43e-02 | 8.87e-01 |
| GOCC APICAL PART OF CELL | 450 | 6.88e-03 | 7.43e-02 | 1.80e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 666 | 1.08e-03 | 7.43e-02 | 6.38e-02 |
| GOMF VITAMIN BINDING | 144 | 1.24e-01 | 7.43e-02 | 6.38e-01 |
| GOBP BILE ACID SECRETION | 12 | 6.56e-01 | 7.43e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 7 | 7.34e-01 | 7.42e-02 | 9.53e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 113 | 1.74e-01 | -7.41e-02 | 7.05e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 42 | 4.06e-01 | 7.41e-02 | 8.49e-01 |
| GOBP FACE MORPHOGENESIS | 30 | 4.83e-01 | 7.40e-02 | 8.80e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 15 | 6.20e-01 | -7.40e-02 | 9.23e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 325 | 2.19e-02 | 7.40e-02 | 3.18e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 16 | 6.09e-01 | -7.39e-02 | 9.20e-01 |
| GOBP RNA IMPORT INTO MITOCHONDRION | 5 | 7.75e-01 | 7.39e-02 | 9.58e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 14 | 6.32e-01 | -7.38e-02 | 9.25e-01 |
| GOBP CARDIAC MUSCLE CELL FATE COMMITMENT | 11 | 6.72e-01 | 7.37e-02 | 9.35e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 6 | 7.55e-01 | 7.37e-02 | 9.54e-01 |
| GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY | 11 | 6.72e-01 | -7.37e-02 | 9.35e-01 |
| GOBP RESPONSE TO BMP | 170 | 9.74e-02 | 7.37e-02 | 5.94e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 157 | 1.11e-01 | 7.37e-02 | 6.15e-01 |
| GOBP REGULATION OF NAD P H OXIDASE ACTIVITY | 7 | 7.36e-01 | 7.37e-02 | 9.53e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ASSEMBLY | 7 | 7.36e-01 | 7.37e-02 | 9.53e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 16 | 6.10e-01 | -7.36e-02 | 9.20e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 102 | 1.99e-01 | 7.36e-02 | 7.29e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 6.22e-01 | -7.35e-02 | 9.24e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 945 | 1.30e-04 | 7.35e-02 | 1.77e-02 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 45 | 3.94e-01 | 7.34e-02 | 8.44e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 24 | 5.34e-01 | 7.34e-02 | 8.94e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 1357 | 5.70e-06 | -7.34e-02 | 1.77e-03 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 48 | 3.79e-01 | 7.34e-02 | 8.36e-01 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 7.37e-01 | -7.33e-02 | 9.53e-01 |
| GOMF VIRION BINDING | 13 | 6.47e-01 | 7.33e-02 | 9.29e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 32 | 4.73e-01 | 7.33e-02 | 8.77e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 22 | 5.52e-01 | 7.33e-02 | 9.01e-01 |
| GOBP CELL FATE COMMITMENT | 279 | 3.51e-02 | 7.33e-02 | 3.95e-01 |
| GOBP RESPONSE TO ALKALOID | 90 | 2.30e-01 | 7.33e-02 | 7.60e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 58 | 3.34e-01 | 7.33e-02 | 8.19e-01 |
| GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX | 15 | 6.23e-01 | -7.32e-02 | 9.24e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 180 | 9.01e-02 | 7.32e-02 | 5.78e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 33 | 4.67e-01 | 7.32e-02 | 8.75e-01 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 8 | 7.20e-01 | -7.32e-02 | 9.48e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 28 | 5.03e-01 | -7.31e-02 | 8.87e-01 |
| GOBP SIGNAL RELEASE | 467 | 6.79e-03 | 7.31e-02 | 1.79e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 382 | 1.42e-02 | 7.31e-02 | 2.56e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 54 | 3.53e-01 | -7.31e-02 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 121 | 1.65e-01 | 7.31e-02 | 6.98e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 6 | 7.57e-01 | 7.30e-02 | 9.54e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 143 | 1.32e-01 | -7.30e-02 | 6.51e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 117 | 1.73e-01 | -7.30e-02 | 7.04e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 684 | 1.14e-03 | 7.30e-02 | 6.42e-02 |
| GOMF OXO ACID LYASE ACTIVITY | 7 | 7.38e-01 | 7.30e-02 | 9.53e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 212 | 6.71e-02 | 7.30e-02 | 5.20e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 9 | 7.05e-01 | 7.29e-02 | 9.44e-01 |
| GOBP CELL PROLIFERATION IN BONE MARROW | 10 | 6.90e-01 | -7.29e-02 | 9.42e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 15 | 6.25e-01 | -7.29e-02 | 9.25e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 120 | 1.68e-01 | 7.29e-02 | 7.00e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 27 | 5.12e-01 | -7.29e-02 | 8.89e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 13 | 6.49e-01 | 7.28e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 591 | 2.48e-03 | 7.28e-02 | 1.01e-01 |
| GOBP INTERFERON BETA PRODUCTION | 56 | 3.46e-01 | 7.28e-02 | 8.25e-01 |
| GOCC LEWY BODY | 8 | 7.21e-01 | 7.28e-02 | 9.48e-01 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 33 | 4.69e-01 | 7.28e-02 | 8.75e-01 |
| GOBP B CELL DIFFERENTIATION | 142 | 1.34e-01 | 7.28e-02 | 6.53e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 19 | 5.83e-01 | -7.28e-02 | 9.08e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1694 | 6.31e-07 | 7.27e-02 | 3.23e-04 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 34 | 4.63e-01 | -7.27e-02 | 8.74e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 13 | 6.50e-01 | 7.27e-02 | 9.30e-01 |
| GOBP SEGMENTATION | 99 | 2.11e-01 | 7.27e-02 | 7.43e-01 |
| GOBP JNK CASCADE | 154 | 1.20e-01 | 7.27e-02 | 6.30e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 19 | 5.84e-01 | 7.26e-02 | 9.09e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 8 | 7.22e-01 | 7.26e-02 | 9.48e-01 |
| GOMF PROTEOGLYCAN BINDING | 36 | 4.51e-01 | -7.26e-02 | 8.70e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 159 | 1.14e-01 | 7.26e-02 | 6.22e-01 |
| GOCC MALE PRONUCLEUS | 8 | 7.22e-01 | -7.26e-02 | 9.48e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 83 | 2.53e-01 | 7.26e-02 | 7.75e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 80 | 2.62e-01 | 7.26e-02 | 7.83e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 7.79e-01 | 7.26e-02 | 9.60e-01 |
| GOBP SNRNA 3 END PROCESSING | 20 | 5.74e-01 | -7.26e-02 | 9.06e-01 |
| GOBP SNRNA PROCESSING | 25 | 5.30e-01 | -7.25e-02 | 8.93e-01 |
| GOBP CHROMOSOME LOCALIZATION | 117 | 1.76e-01 | -7.25e-02 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 6 | 7.58e-01 | -7.25e-02 | 9.54e-01 |
| GOBP STRIATED MUSCLE ATROPHY | 7 | 7.40e-01 | 7.25e-02 | 9.53e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 26 | 5.22e-01 | -7.25e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 853 | 3.26e-04 | 7.25e-02 | 2.97e-02 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 38 | 4.40e-01 | 7.24e-02 | 8.62e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 6 | 7.59e-01 | -7.24e-02 | 9.54e-01 |
| GOBP TRNA CATABOLIC PROCESS | 16 | 6.16e-01 | 7.24e-02 | 9.22e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 27 | 5.15e-01 | -7.24e-02 | 8.90e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 69 | 2.98e-01 | -7.24e-02 | 7.99e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 56 | 3.49e-01 | 7.24e-02 | 8.26e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 89 | 2.38e-01 | -7.24e-02 | 7.63e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 20 | 5.75e-01 | -7.24e-02 | 9.06e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 21 | 5.66e-01 | -7.23e-02 | 9.05e-01 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 21 | 5.66e-01 | 7.23e-02 | 9.05e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 43 | 4.12e-01 | 7.23e-02 | 8.50e-01 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 7 | 7.41e-01 | 7.23e-02 | 9.53e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 46 | 3.97e-01 | 7.22e-02 | 8.45e-01 |
| GOBP LIPID MODIFICATION | 185 | 9.02e-02 | 7.22e-02 | 5.78e-01 |
| GOBP RESPIRATORY BURST | 32 | 4.80e-01 | 7.22e-02 | 8.79e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 13 | 6.52e-01 | -7.22e-02 | 9.30e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 5.96e-01 | 7.22e-02 | 9.14e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 5 | 7.80e-01 | -7.21e-02 | 9.60e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 967 | 1.46e-04 | 7.21e-02 | 1.85e-02 |
| GOBP POSITIVE REGULATION OF FEAR RESPONSE | 6 | 7.60e-01 | 7.21e-02 | 9.55e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 219 | 6.60e-02 | 7.21e-02 | 5.15e-01 |
| GOBP VAGINA DEVELOPMENT | 10 | 6.93e-01 | 7.21e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 67 | 3.08e-01 | 7.21e-02 | 8.03e-01 |
| GOCC BLOC 1 COMPLEX | 9 | 7.08e-01 | 7.20e-02 | 9.45e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 8 | 7.24e-01 | 7.20e-02 | 9.50e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 443 | 9.37e-03 | 7.20e-02 | 2.08e-01 |
| GOBP GLYCOSIDE TRANSPORT | 5 | 7.80e-01 | 7.20e-02 | 9.60e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 7.81e-01 | 7.20e-02 | 9.60e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 10 | 6.94e-01 | 7.19e-02 | 9.43e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 110 | 1.92e-01 | 7.19e-02 | 7.26e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 97 | 2.21e-01 | 7.19e-02 | 7.53e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 16 | 6.19e-01 | 7.19e-02 | 9.22e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 359 | 1.93e-02 | 7.19e-02 | 2.99e-01 |
| GOCC GOLGI MEMBRANE | 640 | 1.92e-03 | 7.19e-02 | 8.77e-02 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 132 | 1.54e-01 | 7.19e-02 | 6.86e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 18 | 5.98e-01 | -7.18e-02 | 9.15e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN THERMOCEPTION | 5 | 7.81e-01 | -7.18e-02 | 9.60e-01 |
| GOBP GLUCOSE IMPORT ACROSS PLASMA MEMBRANE | 5 | 7.81e-01 | -7.18e-02 | 9.60e-01 |
| GOMF PROTEIN ARGININE DEIMINASE ACTIVITY | 5 | 7.81e-01 | 7.18e-02 | 9.60e-01 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 7.09e-01 | -7.18e-02 | 9.46e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 50 | 3.80e-01 | 7.17e-02 | 8.37e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 13 | 6.54e-01 | 7.17e-02 | 9.30e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 51 | 3.76e-01 | -7.17e-02 | 8.35e-01 |
| GOBP PREVENTION OF POLYSPERMY | 7 | 7.43e-01 | 7.17e-02 | 9.53e-01 |
| GOCC MYOSIN COMPLEX | 56 | 3.53e-01 | -7.17e-02 | 8.28e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 36 | 4.57e-01 | 7.17e-02 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 7.43e-01 | -7.16e-02 | 9.53e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 7 | 7.43e-01 | -7.16e-02 | 9.53e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 7.61e-01 | -7.16e-02 | 9.55e-01 |
| GOMF TORC2 COMPLEX BINDING | 5 | 7.81e-01 | 7.16e-02 | 9.60e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 21 | 5.70e-01 | -7.16e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 27 | 5.20e-01 | -7.16e-02 | 8.90e-01 |
| GOBP ANAGEN | 5 | 7.82e-01 | -7.15e-02 | 9.60e-01 |
| GOBP VESICLE TARGETING | 65 | 3.19e-01 | 7.14e-02 | 8.10e-01 |
| GOMF THYROID HORMONE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.44e-01 | 7.14e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 10 | 6.96e-01 | -7.14e-02 | 9.43e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 272 | 4.29e-02 | 7.13e-02 | 4.24e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 24 | 5.45e-01 | 7.13e-02 | 8.98e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 89 | 2.45e-01 | -7.13e-02 | 7.68e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 89 | 2.45e-01 | 7.13e-02 | 7.68e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 9 | 7.11e-01 | 7.13e-02 | 9.47e-01 |
| GOMF DNA POLYMERASE BINDING | 22 | 5.63e-01 | 7.13e-02 | 9.05e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 6 | 7.62e-01 | -7.13e-02 | 9.56e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 93 | 2.35e-01 | -7.13e-02 | 7.62e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 18 | 6.01e-01 | 7.12e-02 | 9.17e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 12 | 6.69e-01 | 7.12e-02 | 9.34e-01 |
| GOCC RETROMER COMPLEX | 11 | 6.83e-01 | 7.12e-02 | 9.40e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 79 | 2.74e-01 | 7.12e-02 | 7.87e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 11 | 6.83e-01 | -7.12e-02 | 9.40e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 67 | 3.14e-01 | -7.12e-02 | 8.08e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 23 | 5.55e-01 | 7.12e-02 | 9.01e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 17 | 6.11e-01 | -7.12e-02 | 9.21e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 28 | 5.15e-01 | 7.12e-02 | 8.90e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 77 | 2.80e-01 | -7.12e-02 | 7.93e-01 |
| GOCC RIBBON SYNAPSE | 15 | 6.33e-01 | 7.12e-02 | 9.25e-01 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 21 | 5.73e-01 | -7.11e-02 | 9.06e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 483 | 7.48e-03 | 7.10e-02 | 1.83e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 29 | 5.08e-01 | 7.10e-02 | 8.89e-01 |
| GOBP REGULATION OF CELL GROWTH | 397 | 1.51e-02 | 7.10e-02 | 2.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 91 | 2.42e-01 | -7.10e-02 | 7.65e-01 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 5 | 7.83e-01 | 7.10e-02 | 9.60e-01 |
| GOBP ROUNDABOUT SIGNALING PATHWAY | 5 | 7.83e-01 | -7.10e-02 | 9.60e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 13 | 6.58e-01 | -7.10e-02 | 9.30e-01 |
| GOBP DUMP CATABOLIC PROCESS | 6 | 7.63e-01 | 7.10e-02 | 9.56e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 46 | 4.05e-01 | 7.10e-02 | 8.49e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 41 | 4.32e-01 | -7.09e-02 | 8.60e-01 |
| GOBP GLYCOSYLATION | 214 | 7.39e-02 | 7.09e-02 | 5.41e-01 |
| GOBP SNORNA LOCALIZATION | 6 | 7.64e-01 | 7.09e-02 | 9.56e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 109 | 2.01e-01 | -7.08e-02 | 7.32e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 749 | 9.67e-04 | -7.08e-02 | 5.99e-02 |
| GOBP LEUCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 7.84e-01 | 7.08e-02 | 9.60e-01 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 12 | 6.71e-01 | 7.08e-02 | 9.35e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 6.71e-01 | 7.08e-02 | 9.35e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 68 | 3.13e-01 | -7.07e-02 | 8.08e-01 |
| GOBP FEVER GENERATION | 11 | 6.85e-01 | 7.07e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 5 | 7.84e-01 | -7.07e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 499 | 6.90e-03 | 7.06e-02 | 1.80e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 7 | 7.46e-01 | 7.06e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 17 | 6.14e-01 | 7.06e-02 | 9.21e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 507 | 6.52e-03 | 7.06e-02 | 1.76e-01 |
| GOCC HOPS COMPLEX | 9 | 7.14e-01 | 7.05e-02 | 9.47e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 101 | 2.21e-01 | 7.05e-02 | 7.53e-01 |
| GOCC SPERM MIDPIECE | 51 | 3.84e-01 | -7.05e-02 | 8.38e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 5 | 7.85e-01 | -7.05e-02 | 9.60e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 47 | 4.03e-01 | -7.05e-02 | 8.46e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 329 | 2.80e-02 | 7.05e-02 | 3.54e-01 |
| GOBP ANTERIOR COMMISSURE MORPHOGENESIS | 7 | 7.47e-01 | 7.05e-02 | 9.53e-01 |
| GOMF CHOLINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.47e-01 | 7.05e-02 | 9.53e-01 |
| GOMF STEROL TRANSPORTER ACTIVITY | 36 | 4.64e-01 | 7.05e-02 | 8.74e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 291 | 3.87e-02 | 7.04e-02 | 4.08e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 445 | 1.09e-02 | 7.04e-02 | 2.26e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 60 | 3.46e-01 | 7.04e-02 | 8.24e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 14 | 6.48e-01 | -7.04e-02 | 9.30e-01 |
| GOBP FOREBRAIN MORPHOGENESIS | 13 | 6.61e-01 | 7.03e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 75 | 2.92e-01 | 7.03e-02 | 7.97e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 41 | 4.36e-01 | 7.03e-02 | 8.60e-01 |
| GOBP REGULATION OF CELL SHAPE | 134 | 1.60e-01 | 7.03e-02 | 6.93e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 54 | 3.72e-01 | 7.02e-02 | 8.33e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 35 | 4.72e-01 | -7.02e-02 | 8.77e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 173 | 1.11e-01 | -7.02e-02 | 6.15e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 141 | 1.50e-01 | 7.02e-02 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 71 | 3.07e-01 | 7.02e-02 | 8.03e-01 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 146 | 1.44e-01 | 7.01e-02 | 6.68e-01 |
| GOCC CELL POLE | 7 | 7.48e-01 | -7.01e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS | 5 | 7.86e-01 | -7.01e-02 | 9.60e-01 |
| GOBP INSULIN METABOLIC PROCESS | 16 | 6.28e-01 | 7.00e-02 | 9.25e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 9 | 7.16e-01 | 7.00e-02 | 9.48e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 26 | 5.37e-01 | -7.00e-02 | 8.95e-01 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 7.49e-01 | -7.00e-02 | 9.53e-01 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 587 | 3.77e-03 | 7.00e-02 | 1.31e-01 |
| GOBP UTERUS DEVELOPMENT | 23 | 5.61e-01 | 6.99e-02 | 9.05e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 20 | 5.89e-01 | 6.98e-02 | 9.11e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 13 | 6.63e-01 | 6.98e-02 | 9.31e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 17 | 6.18e-01 | 6.98e-02 | 9.22e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 19 | 5.99e-01 | 6.98e-02 | 9.15e-01 |
| GOBP NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 6 | 7.67e-01 | 6.97e-02 | 9.58e-01 |
| GOCC BARR BODY | 7 | 7.49e-01 | -6.97e-02 | 9.53e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 17 | 6.19e-01 | 6.97e-02 | 9.22e-01 |
| GOMF HMG BOX DOMAIN BINDING | 13 | 6.63e-01 | 6.97e-02 | 9.31e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 7 | 7.49e-01 | -6.97e-02 | 9.53e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 7.87e-01 | 6.97e-02 | 9.60e-01 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 52 | 3.84e-01 | 6.97e-02 | 8.39e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 6 | 7.68e-01 | 6.96e-02 | 9.58e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 15 | 6.41e-01 | 6.96e-02 | 9.28e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 7.03e-01 | 6.96e-02 | 9.44e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 7.03e-01 | -6.96e-02 | 9.44e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 75 | 2.97e-01 | -6.96e-02 | 7.99e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 257 | 5.48e-02 | 6.96e-02 | 4.79e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 26 | 5.39e-01 | -6.96e-02 | 8.96e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 19 | 6.00e-01 | 6.96e-02 | 9.15e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 42 | 4.36e-01 | 6.95e-02 | 8.60e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 25 | 5.47e-01 | -6.95e-02 | 9.00e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 117 | 1.94e-01 | 6.95e-02 | 7.27e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 56 | 3.68e-01 | 6.95e-02 | 8.33e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 251 | 5.80e-02 | 6.95e-02 | 4.86e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 132 | 1.68e-01 | 6.95e-02 | 7.00e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 22 | 5.73e-01 | 6.95e-02 | 9.06e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 363 | 2.31e-02 | 6.94e-02 | 3.24e-01 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 7.68e-01 | 6.94e-02 | 9.58e-01 |
| GOBP ENDOCANNABINOID SIGNALING PATHWAY | 5 | 7.88e-01 | 6.94e-02 | 9.60e-01 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 13 | 6.65e-01 | 6.94e-02 | 9.32e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 15 | 6.42e-01 | -6.94e-02 | 9.28e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 135 | 1.64e-01 | 6.94e-02 | 6.97e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 12 | 6.77e-01 | 6.93e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINESIS | 7 | 7.51e-01 | 6.93e-02 | 9.53e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 137 | 1.61e-01 | -6.93e-02 | 6.95e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 330 | 3.05e-02 | 6.93e-02 | 3.72e-01 |
| GOCC CHECKPOINT CLAMP COMPLEX | 5 | 7.89e-01 | -6.93e-02 | 9.60e-01 |
| GOBP VESICLE UNCOATING | 8 | 7.35e-01 | -6.92e-02 | 9.53e-01 |
| GOMF LYASE ACTIVITY | 190 | 9.99e-02 | 6.92e-02 | 5.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 7.19e-01 | 6.92e-02 | 9.48e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 36 | 4.72e-01 | 6.92e-02 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 772 | 1.07e-03 | 6.92e-02 | 6.38e-02 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 298 | 3.99e-02 | 6.92e-02 | 4.12e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 53 | 3.84e-01 | 6.91e-02 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 24 | 5.58e-01 | 6.91e-02 | 9.03e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 25 | 5.50e-01 | 6.91e-02 | 9.01e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 53 | 3.84e-01 | 6.91e-02 | 8.39e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 53 | 3.84e-01 | -6.91e-02 | 8.39e-01 |
| GOBP XENOPHAGY | 14 | 6.55e-01 | 6.90e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 692 | 1.97e-03 | 6.90e-02 | 8.77e-02 |
| GOBP EATING BEHAVIOR | 37 | 4.67e-01 | 6.90e-02 | 8.75e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 42 | 4.39e-01 | 6.90e-02 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 72 | 3.12e-01 | -6.89e-02 | 8.08e-01 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 13 | 6.67e-01 | -6.89e-02 | 9.33e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 10 | 7.06e-01 | -6.89e-02 | 9.45e-01 |
| GOCC SITE OF POLARIZED GROWTH | 162 | 1.30e-01 | 6.89e-02 | 6.50e-01 |
| GOBP GLOMERULUS MORPHOGENESIS | 9 | 7.21e-01 | 6.89e-02 | 9.48e-01 |
| GOCC ANCHORING JUNCTION | 863 | 6.00e-04 | 6.88e-02 | 4.45e-02 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 209 | 8.65e-02 | 6.88e-02 | 5.72e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 976 | 2.73e-04 | 6.88e-02 | 2.66e-02 |
| GOCC NADH DEHYDROGENASE COMPLEX | 40 | 4.52e-01 | -6.88e-02 | 8.70e-01 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 267 | 5.32e-02 | 6.87e-02 | 4.75e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 66 | 3.35e-01 | 6.87e-02 | 8.19e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 15 | 6.45e-01 | -6.86e-02 | 9.29e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 8 | 7.37e-01 | -6.86e-02 | 9.53e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 11 | 6.93e-01 | -6.86e-02 | 9.43e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 21 | 5.86e-01 | -6.86e-02 | 9.10e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 19 | 6.05e-01 | -6.86e-02 | 9.20e-01 |
| GOCC ESC E Z COMPLEX | 9 | 7.22e-01 | 6.85e-02 | 9.48e-01 |
| GOMF ALCOHOL BINDING | 87 | 2.70e-01 | 6.85e-02 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 460 | 1.18e-02 | 6.85e-02 | 2.34e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 42 | 4.43e-01 | -6.85e-02 | 8.64e-01 |
| GOBP PROPIONATE METABOLIC PROCESS | 5 | 7.91e-01 | 6.85e-02 | 9.61e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 39 | 4.60e-01 | 6.84e-02 | 8.72e-01 |
| GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS | 12 | 6.82e-01 | -6.84e-02 | 9.40e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 101 | 2.35e-01 | 6.84e-02 | 7.62e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 21 | 5.88e-01 | 6.83e-02 | 9.11e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 17 | 6.26e-01 | 6.83e-02 | 9.25e-01 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 14 | 6.58e-01 | 6.82e-02 | 9.30e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 39 | 4.61e-01 | -6.82e-02 | 8.72e-01 |
| GOBP SNRNA METABOLIC PROCESS | 53 | 3.90e-01 | -6.82e-02 | 8.42e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 29 | 5.25e-01 | -6.82e-02 | 8.91e-01 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 52 | 3.95e-01 | 6.82e-02 | 8.45e-01 |
| GOCC PINOSOME | 7 | 7.55e-01 | 6.82e-02 | 9.54e-01 |
| GOBP OVULATION CYCLE | 72 | 3.17e-01 | 6.82e-02 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 693 | 2.23e-03 | 6.81e-02 | 9.46e-02 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 52 | 3.95e-01 | 6.81e-02 | 8.45e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 36 | 4.79e-01 | 6.81e-02 | 8.79e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 6.37e-01 | 6.81e-02 | 9.26e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 403 | 1.89e-02 | 6.81e-02 | 2.97e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 7.23e-01 | 6.81e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 71 | 3.21e-01 | 6.81e-02 | 8.10e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 1438 | 1.52e-05 | 6.81e-02 | 4.00e-03 |
| GOBP REGULATION OF LIPID LOCALIZATION | 183 | 1.12e-01 | 6.81e-02 | 6.17e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 29 | 5.26e-01 | 6.81e-02 | 8.92e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 8 | 7.39e-01 | 6.81e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 51 | 4.01e-01 | 6.80e-02 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 13 | 6.71e-01 | 6.80e-02 | 9.35e-01 |
| GOMF KINASE BINDING | 737 | 1.67e-03 | 6.80e-02 | 8.20e-02 |
| GOBP TYPE II INTERFERON PRODUCTION | 111 | 2.16e-01 | 6.80e-02 | 7.48e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 323 | 3.57e-02 | 6.80e-02 | 3.96e-01 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 29 | 5.26e-01 | -6.80e-02 | 8.92e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 45 | 4.30e-01 | 6.80e-02 | 8.60e-01 |
| GOBP ERBB2 EGFR SIGNALING PATHWAY | 7 | 7.56e-01 | -6.80e-02 | 9.54e-01 |
| GOBP INTESTINAL ABSORPTION | 41 | 4.51e-01 | 6.80e-02 | 8.70e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 39 | 4.63e-01 | 6.80e-02 | 8.74e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 24 | 5.64e-01 | 6.80e-02 | 9.05e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 203 | 9.52e-02 | 6.79e-02 | 5.89e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 928 | 4.55e-04 | 6.79e-02 | 3.72e-02 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 48 | 4.16e-01 | -6.79e-02 | 8.52e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 41 | 4.52e-01 | 6.78e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 31 | 5.13e-01 | 6.78e-02 | 8.89e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 407 | 1.89e-02 | 6.78e-02 | 2.97e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 1466 | 1.40e-05 | 6.78e-02 | 3.90e-03 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN RELEASING HORMONE | 5 | 7.93e-01 | -6.77e-02 | 9.61e-01 |
| GOCC APICAL CORTEX | 8 | 7.40e-01 | 6.77e-02 | 9.53e-01 |
| GOBP RIBOSOME ASSEMBLY | 58 | 3.73e-01 | -6.77e-02 | 8.33e-01 |
| GOCC X CHROMOSOME | 11 | 6.97e-01 | -6.77e-02 | 9.43e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 34 | 4.95e-01 | 6.77e-02 | 8.83e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 5.83e-01 | 6.77e-02 | 9.08e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 652 | 3.23e-03 | 6.76e-02 | 1.18e-01 |
| GOBP CAVEOLA ASSEMBLY | 5 | 7.94e-01 | -6.75e-02 | 9.61e-01 |
| GOCC TRANSPORT VESICLE | 408 | 1.93e-02 | 6.75e-02 | 2.99e-01 |
| GOCC CLATHRIN COATED VESICLE | 201 | 9.90e-02 | 6.75e-02 | 5.95e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 7.57e-01 | 6.75e-02 | 9.54e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 105 | 2.33e-01 | 6.74e-02 | 7.61e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 111 | 2.20e-01 | 6.74e-02 | 7.51e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 54 | 3.92e-01 | 6.73e-02 | 8.43e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 18 | 6.21e-01 | 6.73e-02 | 9.23e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 85 | 2.83e-01 | 6.73e-02 | 7.95e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 579 | 5.65e-03 | 6.73e-02 | 1.64e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 13 | 6.75e-01 | 6.72e-02 | 9.36e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 95 | 2.57e-01 | -6.72e-02 | 7.78e-01 |
| GOBP INTRACELLULAR GLUTAMATE HOMEOSTASIS | 5 | 7.95e-01 | -6.72e-02 | 9.61e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 19 | 6.12e-01 | 6.72e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 10 | 7.13e-01 | 6.72e-02 | 9.47e-01 |
| GOBP NUCLEAR EXPORT | 156 | 1.48e-01 | 6.71e-02 | 6.75e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 34 | 4.98e-01 | -6.71e-02 | 8.84e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 9 | 7.28e-01 | -6.71e-02 | 9.51e-01 |
| GOBP OLFACTORY BEHAVIOR | 10 | 7.14e-01 | -6.70e-02 | 9.47e-01 |
| GOBP BODY MORPHOGENESIS | 46 | 4.32e-01 | 6.70e-02 | 8.60e-01 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 82 | 2.94e-01 | 6.70e-02 | 7.98e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 28 | 5.40e-01 | -6.70e-02 | 8.96e-01 |
| GOBP ERAD PATHWAY | 108 | 2.29e-01 | 6.70e-02 | 7.60e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 10 | 7.14e-01 | 6.69e-02 | 9.47e-01 |
| GOMF HEPARAN SULFATE GLUCOSAMINE 3 SULFOTRANSFERASE 1 ACTIVITY | 7 | 7.59e-01 | -6.69e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 98 | 2.52e-01 | 6.69e-02 | 7.75e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 14 | 6.65e-01 | 6.69e-02 | 9.32e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 370 | 2.72e-02 | 6.69e-02 | 3.50e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 40 | 4.64e-01 | 6.69e-02 | 8.74e-01 |
| GOCC INTERCELLULAR CANALICULUS | 6 | 7.77e-01 | 6.69e-02 | 9.59e-01 |
| GOCC PRESYNAPSE | 539 | 7.93e-03 | 6.69e-02 | 1.91e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 19 | 6.14e-01 | -6.68e-02 | 9.21e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 15 | 6.54e-01 | 6.68e-02 | 9.30e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 6.65e-01 | 6.68e-02 | 9.32e-01 |
| GOBP ENDOCRINE PROCESS | 87 | 2.83e-01 | 6.66e-02 | 7.94e-01 |
| GOBP RETINAL CELL APOPTOTIC PROCESS | 7 | 7.60e-01 | -6.66e-02 | 9.55e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 97 | 2.58e-01 | -6.65e-02 | 7.78e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 342 | 3.46e-02 | 6.65e-02 | 3.93e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 11 | 7.03e-01 | -6.65e-02 | 9.44e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 43 | 4.51e-01 | 6.65e-02 | 8.70e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 10 | 7.16e-01 | 6.65e-02 | 9.48e-01 |
| GOBP ORGANELLE INHERITANCE | 15 | 6.56e-01 | -6.65e-02 | 9.30e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 24 | 5.73e-01 | 6.65e-02 | 9.06e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 73 | 3.26e-01 | 6.64e-02 | 8.12e-01 |
| GOBP PROTEASOME ASSEMBLY | 11 | 7.03e-01 | 6.64e-02 | 9.44e-01 |
| GOBP MONOCYTE ACTIVATION | 12 | 6.90e-01 | 6.64e-02 | 9.42e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 208 | 9.89e-02 | 6.64e-02 | 5.95e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 58 | 3.82e-01 | -6.64e-02 | 8.37e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 162 | 1.45e-01 | 6.64e-02 | 6.71e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 14 | 6.67e-01 | -6.63e-02 | 9.33e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 7 | 7.61e-01 | -6.63e-02 | 9.55e-01 |
| GOMF HISTONE KINASE ACTIVITY | 20 | 6.08e-01 | 6.63e-02 | 9.20e-01 |
| GOMF TAT PROTEIN BINDING | 10 | 7.17e-01 | 6.63e-02 | 9.48e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 7.61e-01 | -6.63e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 6 | 7.79e-01 | -6.63e-02 | 9.60e-01 |
| GOBP ADP METABOLIC PROCESS | 8 | 7.46e-01 | 6.62e-02 | 9.53e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 16 | 6.46e-01 | -6.62e-02 | 9.29e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 13 | 6.79e-01 | 6.62e-02 | 9.38e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 1243 | 8.57e-05 | 6.62e-02 | 1.37e-02 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 18 | 6.27e-01 | 6.62e-02 | 9.25e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 599 | 5.64e-03 | 6.62e-02 | 1.64e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 132 | 1.89e-01 | 6.62e-02 | 7.24e-01 |
| GOCC MICROBODY | 143 | 1.72e-01 | 6.62e-02 | 7.04e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 16 | 6.47e-01 | 6.62e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 7.98e-01 | -6.62e-02 | 9.61e-01 |
| GOBP ORGANIC CATION TRANSPORT | 62 | 3.68e-01 | 6.62e-02 | 8.33e-01 |
| GOCC MICROBODY LUMEN | 51 | 4.14e-01 | 6.61e-02 | 8.51e-01 |
| GOBP FAS SIGNALING PATHWAY | 8 | 7.46e-01 | 6.61e-02 | 9.53e-01 |
| GOCC NUCLEOID | 43 | 4.54e-01 | -6.61e-02 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF TUBULIN DEACETYLATION | 5 | 7.98e-01 | 6.60e-02 | 9.61e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 63 | 3.65e-01 | 6.60e-02 | 8.33e-01 |
| GOBP FACE DEVELOPMENT | 49 | 4.24e-01 | 6.60e-02 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 10 | 7.18e-01 | 6.60e-02 | 9.48e-01 |
| GOMF NUCLEOSIDE BINDING | 8 | 7.47e-01 | 6.60e-02 | 9.53e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 7.80e-01 | 6.60e-02 | 9.60e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 13 | 6.81e-01 | 6.59e-02 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 17 | 6.38e-01 | -6.59e-02 | 9.27e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 1244 | 9.28e-05 | 6.59e-02 | 1.44e-02 |
| GOBP ANTIBACTERIAL PEPTIDE PRODUCTION | 9 | 7.32e-01 | 6.59e-02 | 9.52e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 1396 | 3.71e-05 | 6.59e-02 | 7.24e-03 |
| GOBP REGULATION OF PROTEIN TARGETING | 77 | 3.18e-01 | 6.59e-02 | 8.10e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 5.33e-01 | -6.58e-02 | 8.94e-01 |
| GOCC LAMELLIPODIUM | 194 | 1.14e-01 | 6.58e-02 | 6.22e-01 |
| GOBP HISTONE METHYLATION | 35 | 5.01e-01 | 6.58e-02 | 8.86e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 392 | 2.54e-02 | -6.58e-02 | 3.38e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 32 | 5.20e-01 | -6.58e-02 | 8.90e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 9 | 7.33e-01 | 6.58e-02 | 9.52e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 175 | 1.33e-01 | 6.58e-02 | 6.52e-01 |
| GOMF PEROXISOME TARGETING SEQUENCE BINDING | 5 | 7.99e-01 | 6.57e-02 | 9.61e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 25 | 5.69e-01 | -6.57e-02 | 9.06e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 37 | 4.89e-01 | 6.57e-02 | 8.82e-01 |
| GOBP OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA TYPE EYE DEVELOPMENT | 7 | 7.63e-01 | -6.57e-02 | 9.56e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 348 | 3.52e-02 | 6.57e-02 | 3.95e-01 |
| GOMF GTPASE ACTIVITY | 305 | 4.87e-02 | 6.56e-02 | 4.54e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 59 | 3.84e-01 | 6.56e-02 | 8.38e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 142 | 1.77e-01 | 6.56e-02 | 7.10e-01 |
| GOBP PROTEIN DESTABILIZATION | 46 | 4.42e-01 | 6.55e-02 | 8.64e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 38 | 4.85e-01 | 6.55e-02 | 8.80e-01 |
| GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 9 | 7.34e-01 | 6.55e-02 | 9.53e-01 |
| GOCC CENTRIOLAR SATELLITE | 107 | 2.42e-01 | -6.55e-02 | 7.65e-01 |
| GOMF GATED CHANNEL ACTIVITY | 308 | 4.81e-02 | 6.55e-02 | 4.52e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 30 | 5.35e-01 | -6.54e-02 | 8.94e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 205 | 1.06e-01 | 6.54e-02 | 6.02e-01 |
| GOCC CELL CORTEX REGION | 38 | 4.85e-01 | -6.54e-02 | 8.80e-01 |
| GOBP TRANSPOSITION | 38 | 4.85e-01 | -6.54e-02 | 8.80e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 106 | 2.45e-01 | 6.54e-02 | 7.68e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 597 | 6.40e-03 | -6.53e-02 | 1.74e-01 |
| GOMF LIPASE ACTIVITY | 132 | 1.96e-01 | 6.52e-02 | 7.27e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 54 | 4.07e-01 | 6.52e-02 | 8.49e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 54 | 4.07e-01 | 6.52e-02 | 8.49e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 28 | 5.50e-01 | -6.52e-02 | 9.01e-01 |
| GOBP MAPK CASCADE | 737 | 2.58e-03 | 6.52e-02 | 1.04e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 11 | 7.08e-01 | -6.52e-02 | 9.45e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 780 | 1.97e-03 | 6.51e-02 | 8.77e-02 |
| GOBP AMELOGENESIS | 24 | 5.81e-01 | -6.51e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 189 | 1.23e-01 | -6.51e-02 | 6.36e-01 |
| GOMF CHLORIDE ION BINDING | 10 | 7.21e-01 | -6.51e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 14 | 6.73e-01 | 6.51e-02 | 9.36e-01 |
| GOBP DORSAL SPINAL CORD DEVELOPMENT | 20 | 6.14e-01 | 6.51e-02 | 9.21e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 54 | 4.09e-01 | -6.50e-02 | 8.49e-01 |
| GOMF GUANYL NUCLEOTIDE BINDING | 370 | 3.19e-02 | 6.50e-02 | 3.81e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 26 | 5.67e-01 | -6.49e-02 | 9.05e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 21 | 6.07e-01 | -6.49e-02 | 9.20e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 37 | 4.95e-01 | 6.48e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 191 | 1.22e-01 | 6.48e-02 | 6.36e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 8 | 7.51e-01 | 6.48e-02 | 9.53e-01 |
| GOBP BEHAVIORAL RESPONSE TO ETHANOL | 10 | 7.23e-01 | 6.48e-02 | 9.49e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 13 | 6.86e-01 | -6.48e-02 | 9.41e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 5.75e-01 | -6.48e-02 | 9.06e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 220 | 9.77e-02 | 6.48e-02 | 5.95e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 34 | 5.13e-01 | 6.48e-02 | 8.89e-01 |
| GOBP TELOMERE MAINTENANCE | 149 | 1.72e-01 | -6.48e-02 | 7.04e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 72 | 3.42e-01 | 6.47e-02 | 8.22e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 16 | 6.54e-01 | -6.47e-02 | 9.30e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 1554 | 2.06e-05 | 6.47e-02 | 4.80e-03 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 23 | 5.91e-01 | 6.47e-02 | 9.11e-01 |
| GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY | 6 | 7.84e-01 | -6.46e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 73 | 3.40e-01 | -6.46e-02 | 8.22e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 37 | 4.96e-01 | 6.46e-02 | 8.83e-01 |
| GOBP HISTONE DEACETYLATION | 19 | 6.26e-01 | 6.46e-02 | 9.25e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 44 | 4.58e-01 | -6.46e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 8 | 7.52e-01 | -6.46e-02 | 9.54e-01 |
| GOBP BLASTOCYST FORMATION | 45 | 4.54e-01 | -6.46e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 19 | 6.26e-01 | 6.45e-02 | 9.25e-01 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 11 | 7.11e-01 | 6.45e-02 | 9.47e-01 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 17 | 6.45e-01 | 6.45e-02 | 9.29e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 110 | 2.43e-01 | 6.45e-02 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 66 | 3.65e-01 | 6.44e-02 | 8.33e-01 |
| GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 8 | 7.52e-01 | -6.44e-02 | 9.54e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 34 | 5.16e-01 | -6.44e-02 | 8.90e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 37 | 4.98e-01 | -6.44e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 81 | 3.16e-01 | -6.44e-02 | 8.09e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 11 | 7.11e-01 | 6.44e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 25 | 5.77e-01 | 6.44e-02 | 9.06e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 31 | 5.35e-01 | 6.44e-02 | 8.94e-01 |
| GOBP REGULATION OF GTP BINDING | 11 | 7.12e-01 | 6.43e-02 | 9.47e-01 |
| GOBP ORGANIC ANION TRANSPORT | 428 | 2.25e-02 | 6.43e-02 | 3.21e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 19 | 6.28e-01 | -6.43e-02 | 9.25e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 89 | 2.95e-01 | 6.43e-02 | 7.98e-01 |
| GOMF ANTIPORTER ACTIVITY | 127 | 2.11e-01 | 6.43e-02 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 8 | 7.53e-01 | 6.42e-02 | 9.54e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 11 | 7.12e-01 | -6.42e-02 | 9.47e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 217 | 1.03e-01 | 6.42e-02 | 5.98e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 44 | 4.61e-01 | 6.42e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 67 | 3.64e-01 | 6.42e-02 | 8.33e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 49 | 4.37e-01 | 6.42e-02 | 8.61e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 15 | 6.67e-01 | 6.42e-02 | 9.33e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 14 | 6.78e-01 | -6.42e-02 | 9.37e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 20 | 6.19e-01 | 6.42e-02 | 9.23e-01 |
| GOBP ORGANIC ACID TRANSPORT | 340 | 4.21e-02 | 6.42e-02 | 4.21e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 14 | 6.78e-01 | -6.41e-02 | 9.37e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 16 | 6.57e-01 | -6.41e-02 | 9.30e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 19 | 6.29e-01 | 6.41e-02 | 9.25e-01 |
| GOCC VACUOLAR MEMBRANE | 463 | 1.82e-02 | 6.40e-02 | 2.90e-01 |
| GOBP ANIMAL ORGAN MATURATION | 29 | 5.51e-01 | 6.40e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 630 | 6.15e-03 | 6.39e-02 | 1.71e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 26 | 5.73e-01 | -6.39e-02 | 9.06e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 12 | 7.02e-01 | -6.39e-02 | 9.44e-01 |
| GOBP CELLULAR RESPONSE TO ALDOSTERONE | 7 | 7.70e-01 | -6.39e-02 | 9.58e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 152 | 1.74e-01 | -6.39e-02 | 7.05e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 76 | 3.36e-01 | 6.39e-02 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW | 6 | 7.87e-01 | -6.39e-02 | 9.60e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 9 | 7.40e-01 | -6.38e-02 | 9.53e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 53 | 4.22e-01 | 6.38e-02 | 8.54e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 400 | 2.86e-02 | 6.38e-02 | 3.59e-01 |
| GOBP OTIC VESICLE MORPHOGENESIS | 10 | 7.27e-01 | -6.38e-02 | 9.51e-01 |
| GOBP TRNA METHYLATION | 38 | 4.97e-01 | -6.37e-02 | 8.83e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 11 | 7.14e-01 | -6.37e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 6 | 7.87e-01 | 6.37e-02 | 9.60e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 8.05e-01 | 6.37e-02 | 9.63e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 17 | 6.49e-01 | -6.37e-02 | 9.30e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 503 | 1.45e-02 | 6.37e-02 | 2.58e-01 |
| GOBP CILIUM MOVEMENT | 194 | 1.26e-01 | -6.37e-02 | 6.43e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 186 | 1.34e-01 | 6.37e-02 | 6.53e-01 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 8 | 7.55e-01 | 6.36e-02 | 9.54e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 35 | 5.15e-01 | 6.36e-02 | 8.90e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 32 | 5.34e-01 | 6.36e-02 | 8.94e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 447 | 2.12e-02 | 6.36e-02 | 3.14e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 6.92e-01 | 6.35e-02 | 9.43e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 23 | 5.98e-01 | 6.35e-02 | 9.15e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 26 | 5.75e-01 | 6.35e-02 | 9.06e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 31 | 5.41e-01 | -6.35e-02 | 8.96e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 161 | 1.64e-01 | 6.35e-02 | 6.97e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 143 | 1.90e-01 | 6.35e-02 | 7.24e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 140 | 1.95e-01 | 6.35e-02 | 7.27e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 194 | 1.27e-01 | 6.35e-02 | 6.43e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 16 | 6.60e-01 | 6.35e-02 | 9.30e-01 |
| GOBP MOTOR NEURON MIGRATION | 13 | 6.92e-01 | 6.34e-02 | 9.43e-01 |
| GOCC VACUOLE | 809 | 2.18e-03 | 6.34e-02 | 9.32e-02 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 126 | 2.19e-01 | 6.34e-02 | 7.51e-01 |
| GOBP RNA PROCESSING | 1248 | 1.67e-04 | -6.33e-02 | 2.04e-02 |
| GOBP ALANINE TRANSPORT | 16 | 6.61e-01 | -6.33e-02 | 9.31e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 126 | 2.20e-01 | 6.33e-02 | 7.51e-01 |
| GOBP DNA LIGATION | 16 | 6.61e-01 | 6.33e-02 | 9.31e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 7 | 7.72e-01 | -6.33e-02 | 9.58e-01 |
| GOBP RESPONSE TO FUNGUS | 62 | 3.89e-01 | 6.33e-02 | 8.41e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 12 | 7.04e-01 | 6.33e-02 | 9.44e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 278 | 6.95e-02 | 6.33e-02 | 5.25e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 5.36e-01 | 6.33e-02 | 8.94e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 29 | 5.56e-01 | -6.32e-02 | 9.02e-01 |
| GOMF GTPASE BINDING | 297 | 6.09e-02 | 6.32e-02 | 4.95e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 27 | 5.70e-01 | 6.32e-02 | 9.06e-01 |
| GOBP GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS | 6 | 7.89e-01 | 6.32e-02 | 9.60e-01 |
| GOBP ANTERIOR POSTERIOR AXON GUIDANCE | 7 | 7.72e-01 | 6.32e-02 | 9.58e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 547 | 1.15e-02 | 6.32e-02 | 2.29e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 129 | 2.16e-01 | 6.31e-02 | 7.48e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 34 | 5.24e-01 | 6.31e-02 | 8.91e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 261 | 7.92e-02 | 6.31e-02 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 18 | 6.43e-01 | 6.30e-02 | 9.29e-01 |
| GOBP TYPE III INTERFERON PRODUCTION | 5 | 8.07e-01 | 6.30e-02 | 9.64e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 871 | 1.60e-03 | 6.30e-02 | 7.98e-02 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 1037 | 6.06e-04 | -6.30e-02 | 4.46e-02 |
| GOBP OPTIC NERVE DEVELOPMENT | 20 | 6.26e-01 | -6.29e-02 | 9.25e-01 |
| GOBP RHYTHMIC PROCESS | 287 | 6.66e-02 | 6.29e-02 | 5.18e-01 |
| GOMF IODIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.08e-01 | 6.29e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1720 | 1.45e-05 | 6.29e-02 | 3.90e-03 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 8 | 7.58e-01 | 6.29e-02 | 9.54e-01 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 9 | 7.44e-01 | 6.29e-02 | 9.53e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 38 | 5.03e-01 | -6.28e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 112 | 2.51e-01 | 6.28e-02 | 7.73e-01 |
| GOCC VESICLE LUMEN | 311 | 5.69e-02 | 6.28e-02 | 4.83e-01 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 7.74e-01 | 6.28e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 71 | 3.60e-01 | 6.28e-02 | 8.32e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 60 | 4.00e-01 | 6.28e-02 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 38 | 5.03e-01 | 6.27e-02 | 8.87e-01 |
| GOBP CALCIUM ION HOMEOSTASIS | 319 | 5.41e-02 | 6.27e-02 | 4.78e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 7.59e-01 | -6.27e-02 | 9.54e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 1129 | 3.82e-04 | 6.27e-02 | 3.34e-02 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 125 | 2.26e-01 | -6.27e-02 | 7.59e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 172 | 1.56e-01 | 6.26e-02 | 6.91e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 60 | 4.01e-01 | 6.26e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 11 | 7.19e-01 | -6.26e-02 | 9.48e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 22 | 6.11e-01 | -6.26e-02 | 9.21e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 12 | 7.07e-01 | -6.26e-02 | 9.45e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 8 | 7.59e-01 | 6.26e-02 | 9.55e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 19 | 6.37e-01 | -6.25e-02 | 9.26e-01 |
| GOMF CARBOHYDRATE BINDING | 260 | 8.27e-02 | 6.25e-02 | 5.62e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 21 | 6.20e-01 | -6.25e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 35 | 5.22e-01 | 6.25e-02 | 8.91e-01 |
| GOBP L LYSINE TRANSPORT | 7 | 7.75e-01 | 6.25e-02 | 9.58e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.75e-01 | 6.25e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 133 | 2.14e-01 | 6.24e-02 | 7.45e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 573 | 1.07e-02 | 6.24e-02 | 2.24e-01 |
| GOBP LACRIMAL GLAND DEVELOPMENT | 7 | 7.75e-01 | -6.24e-02 | 9.58e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 83 | 3.26e-01 | 6.24e-02 | 8.11e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 17 | 6.56e-01 | -6.23e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 546 | 1.27e-02 | 6.23e-02 | 2.46e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 780 | 3.07e-03 | 6.23e-02 | 1.16e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 20 | 6.30e-01 | 6.23e-02 | 9.25e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 67 | 3.78e-01 | 6.23e-02 | 8.36e-01 |
| GOBP REGULATION OF METAL ION TRANSPORT | 380 | 3.71e-02 | 6.23e-02 | 4.03e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 265 | 8.10e-02 | 6.23e-02 | 5.58e-01 |
| GOBP PROTEIN ACYLATION | 134 | 2.13e-01 | 6.23e-02 | 7.45e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 5.69e-01 | -6.22e-02 | 9.06e-01 |
| GOBP PROTEIN TETRAMERIZATION | 88 | 3.13e-01 | 6.22e-02 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 100 | 2.82e-01 | 6.22e-02 | 7.94e-01 |
| GOBP REGULATION OF GROWTH | 585 | 1.02e-02 | 6.22e-02 | 2.16e-01 |
| GOBP EMBRYONIC CLEAVAGE | 8 | 7.61e-01 | -6.22e-02 | 9.55e-01 |
| GOBP BONE DEVELOPMENT | 203 | 1.27e-01 | 6.21e-02 | 6.43e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 44 | 4.76e-01 | 6.21e-02 | 8.78e-01 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 24 | 5.98e-01 | -6.21e-02 | 9.15e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 225 | 1.08e-01 | 6.21e-02 | 6.06e-01 |
| GOBP MUSCLE ADAPTATION | 117 | 2.46e-01 | 6.21e-02 | 7.68e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 34 | 5.31e-01 | 6.21e-02 | 8.93e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1735 | 1.73e-05 | 6.21e-02 | 4.40e-03 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 27 | 5.77e-01 | 6.21e-02 | 9.06e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 15 | 6.78e-01 | 6.20e-02 | 9.37e-01 |
| GOMF WD40 REPEAT DOMAIN BINDING | 5 | 8.10e-01 | 6.20e-02 | 9.66e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 276 | 7.67e-02 | 6.19e-02 | 5.48e-01 |
| GOBP RESPONSE TO HORMONE | 838 | 2.33e-03 | 6.19e-02 | 9.74e-02 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 318 | 5.77e-02 | 6.19e-02 | 4.85e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 58 | 4.15e-01 | 6.19e-02 | 8.51e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 140 | 2.06e-01 | 6.19e-02 | 7.37e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 217 | 1.16e-01 | 6.18e-02 | 6.26e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 172 | 1.62e-01 | 6.18e-02 | 6.95e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 26 | 5.86e-01 | 6.18e-02 | 9.10e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 51 | 4.45e-01 | 6.18e-02 | 8.66e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 7.48e-01 | 6.17e-02 | 9.53e-01 |
| GOBP L CYSTINE TRANSPORT | 6 | 7.93e-01 | 6.17e-02 | 9.61e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 216 | 1.18e-01 | 6.17e-02 | 6.30e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 184 | 1.49e-01 | -6.17e-02 | 6.78e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 93 | 3.04e-01 | 6.17e-02 | 8.02e-01 |
| GOBP CELLULAR HOMEOSTASIS | 779 | 3.42e-03 | 6.17e-02 | 1.23e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 556 | 1.30e-02 | 6.16e-02 | 2.49e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 29 | 5.66e-01 | 6.16e-02 | 9.05e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 7.36e-01 | -6.16e-02 | 9.53e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 35 | 5.29e-01 | -6.16e-02 | 8.93e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 12 | 7.12e-01 | 6.15e-02 | 9.47e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 527 | 1.57e-02 | 6.15e-02 | 2.69e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 99 | 2.90e-01 | 6.15e-02 | 7.96e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 26 | 5.87e-01 | 6.15e-02 | 9.11e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 7.94e-01 | -6.15e-02 | 9.61e-01 |
| GOCC BASEMENT MEMBRANE | 85 | 3.27e-01 | -6.15e-02 | 8.13e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 62 | 4.03e-01 | -6.14e-02 | 8.46e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 81 | 3.39e-01 | -6.14e-02 | 8.22e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 88 | 3.20e-01 | 6.14e-02 | 8.10e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 54 | 4.35e-01 | 6.14e-02 | 8.60e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 143 | 2.05e-01 | 6.14e-02 | 7.36e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 15 | 6.81e-01 | 6.14e-02 | 9.39e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 4.53e-01 | -6.13e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 14 | 6.91e-01 | -6.13e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 24 | 6.03e-01 | 6.12e-02 | 9.19e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 101 | 2.88e-01 | 6.12e-02 | 7.95e-01 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 6 | 7.95e-01 | -6.12e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 151 | 1.94e-01 | -6.12e-02 | 7.27e-01 |
| GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT | 7 | 7.79e-01 | -6.12e-02 | 9.60e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 17 | 6.62e-01 | 6.12e-02 | 9.31e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 7.51e-01 | -6.12e-02 | 9.53e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 18 | 6.53e-01 | 6.12e-02 | 9.30e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 10 | 7.38e-01 | 6.12e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 27 | 5.82e-01 | -6.12e-02 | 9.08e-01 |
| GOCC PLATELET ALPHA GRANULE | 82 | 3.38e-01 | 6.11e-02 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 313 | 6.29e-02 | 6.11e-02 | 5.04e-01 |
| GOMF ROUNDABOUT BINDING | 8 | 7.65e-01 | -6.11e-02 | 9.57e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 10 | 7.38e-01 | 6.11e-02 | 9.53e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 18 | 6.54e-01 | 6.11e-02 | 9.30e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 31 | 5.56e-01 | 6.11e-02 | 9.02e-01 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 37 | 5.20e-01 | -6.11e-02 | 8.90e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 953 | 1.40e-03 | 6.11e-02 | 7.45e-02 |
| GOBP MALE MEIOSIS I | 27 | 5.83e-01 | -6.11e-02 | 9.08e-01 |
| GOBP RENAL SYSTEM PROCESS | 117 | 2.54e-01 | 6.11e-02 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 6 | 7.96e-01 | 6.11e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 59 | 4.17e-01 | -6.10e-02 | 8.53e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 43 | 4.89e-01 | 6.10e-02 | 8.82e-01 |
| GOCC RSC TYPE COMPLEX | 15 | 6.82e-01 | -6.10e-02 | 9.40e-01 |
| GOBP PROTEIN ACETYLATION | 97 | 2.99e-01 | 6.10e-02 | 7.99e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 539 | 1.55e-02 | 6.09e-02 | 2.67e-01 |
| GOCC EARLY ENDOSOME LUMEN | 5 | 8.13e-01 | -6.09e-02 | 9.67e-01 |
| GOCC GOLGI APPARATUS | 1535 | 6.67e-05 | 6.09e-02 | 1.14e-02 |
| GOBP RESPONSE TO CYTOKINE | 901 | 1.93e-03 | 6.09e-02 | 8.77e-02 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 104 | 2.83e-01 | 6.09e-02 | 7.94e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 164 | 1.78e-01 | -6.09e-02 | 7.11e-01 |
| GOBP SOMITOGENESIS | 64 | 4.00e-01 | 6.09e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1187 | 4.09e-04 | 6.09e-02 | 3.47e-02 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 32 | 5.51e-01 | 6.09e-02 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 33 | 5.45e-01 | 6.09e-02 | 8.98e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 9 | 7.52e-01 | 6.08e-02 | 9.54e-01 |
| GOMF NARROW PORE CHANNEL ACTIVITY | 19 | 6.46e-01 | -6.08e-02 | 9.29e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 21 | 6.29e-01 | -6.08e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 14 | 6.94e-01 | 6.08e-02 | 9.43e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 127 | 2.37e-01 | 6.08e-02 | 7.63e-01 |
| GOBP RESPONSE TO ATP | 31 | 5.58e-01 | -6.08e-02 | 9.03e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 7.15e-01 | 6.08e-02 | 9.48e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 103 | 2.87e-01 | 6.08e-02 | 7.95e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 55 | 4.36e-01 | -6.07e-02 | 8.60e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 84 | 3.36e-01 | 6.07e-02 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 65 | 3.97e-01 | -6.07e-02 | 8.45e-01 |
| GOMF MACROLIDE BINDING | 12 | 7.16e-01 | 6.07e-02 | 9.48e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 59 | 4.20e-01 | 6.07e-02 | 8.54e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 6.74e-01 | -6.07e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 65 | 3.98e-01 | -6.07e-02 | 8.45e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 17 | 6.65e-01 | -6.07e-02 | 9.32e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 73 | 3.70e-01 | -6.07e-02 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 14 | 6.94e-01 | 6.06e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 104 | 2.85e-01 | 6.06e-02 | 7.95e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 6.75e-01 | -6.06e-02 | 9.36e-01 |
| GOMF VITAMIN B6 BINDING | 54 | 4.41e-01 | 6.06e-02 | 8.63e-01 |
| GOBP RESPONSE TO WATER DEPRIVATION | 5 | 8.14e-01 | 6.06e-02 | 9.68e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 60 | 4.17e-01 | 6.06e-02 | 8.53e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 285 | 7.84e-02 | 6.06e-02 | 5.50e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 10 | 7.40e-01 | 6.06e-02 | 9.53e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 130 | 2.33e-01 | 6.06e-02 | 7.61e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 11 | 7.28e-01 | 6.05e-02 | 9.51e-01 |
| GOMF PHOSPHATASE ACTIVITY | 255 | 9.59e-02 | 6.05e-02 | 5.90e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 9 | 7.53e-01 | -6.05e-02 | 9.54e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 20 | 6.39e-01 | -6.05e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 7 | 7.82e-01 | -6.05e-02 | 9.60e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 26 | 5.93e-01 | 6.05e-02 | 9.12e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 18 | 6.57e-01 | 6.04e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 13 | 7.06e-01 | 6.04e-02 | 9.45e-01 |
| GOBP CIRCADIAN RHYTHM | 196 | 1.45e-01 | 6.04e-02 | 6.70e-01 |
| GOBP CHROMOSOME SEPARATION | 81 | 3.47e-01 | -6.04e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 426 | 3.25e-02 | 6.04e-02 | 3.85e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 10 | 7.41e-01 | -6.04e-02 | 9.53e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 6 | 7.98e-01 | -6.04e-02 | 9.61e-01 |
| GOBP LENS FIBER CELL MORPHOGENESIS | 6 | 7.98e-01 | -6.04e-02 | 9.61e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 6 | 7.98e-01 | -6.04e-02 | 9.61e-01 |
| GOBP CELL GROWTH | 474 | 2.43e-02 | 6.04e-02 | 3.32e-01 |
| GOMF OXYGEN BINDING | 38 | 5.20e-01 | -6.04e-02 | 8.90e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 18 | 6.58e-01 | -6.04e-02 | 9.30e-01 |
| GOMF G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR ACTIVITY | 7 | 7.82e-01 | 6.04e-02 | 9.60e-01 |
| GOCC GOLGI STACK | 128 | 2.39e-01 | 6.03e-02 | 7.63e-01 |
| GOBP POSITIVE REGULATION OF CELL FATE COMMITMENT | 13 | 7.06e-01 | 6.03e-02 | 9.45e-01 |
| GOBP FIBROBLAST MIGRATION | 52 | 4.52e-01 | 6.03e-02 | 8.70e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS | 9 | 7.54e-01 | 6.03e-02 | 9.54e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 165 | 1.82e-01 | 6.03e-02 | 7.14e-01 |
| GOBP SEROTONIN UPTAKE | 12 | 7.18e-01 | -6.03e-02 | 9.48e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 35 | 5.37e-01 | 6.03e-02 | 8.95e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 24 | 6.09e-01 | 6.03e-02 | 9.20e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 516 | 1.92e-02 | 6.03e-02 | 2.99e-01 |
| GOBP HISTONE H4 ACETYLATION | 11 | 7.29e-01 | 6.02e-02 | 9.52e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 37 | 5.26e-01 | 6.02e-02 | 8.92e-01 |
| GOBP ACTIVATION OF MEIOSIS | 6 | 7.98e-01 | 6.02e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 17 | 6.68e-01 | 6.01e-02 | 9.33e-01 |
| GOBP PROTEIN TRIMERIZATION | 17 | 6.68e-01 | 6.01e-02 | 9.33e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 44 | 4.90e-01 | 6.01e-02 | 8.82e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 702 | 6.65e-03 | 6.01e-02 | 1.79e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 1081 | 8.49e-04 | 6.01e-02 | 5.61e-02 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE | 19 | 6.50e-01 | -6.01e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 52 | 4.54e-01 | 6.00e-02 | 8.70e-01 |
| GOBP STEROL METABOLIC PROCESS | 149 | 2.06e-01 | 6.00e-02 | 7.37e-01 |
| GOBP LATE NUCLEOPHAGY | 8 | 7.69e-01 | -5.99e-02 | 9.58e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 13 | 7.08e-01 | 5.99e-02 | 9.45e-01 |
| GOCC DISTAL AXON | 261 | 9.56e-02 | 5.99e-02 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 33 | 5.51e-01 | -5.99e-02 | 9.01e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 14 | 6.98e-01 | 5.99e-02 | 9.43e-01 |
| GOMF RETINOIC ACID 4 HYDROXYLASE ACTIVITY | 10 | 7.43e-01 | 5.99e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 351 | 5.38e-02 | 5.99e-02 | 4.76e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 6.88e-01 | -5.99e-02 | 9.42e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 11 | 7.31e-01 | 5.99e-02 | 9.52e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION | 8 | 7.69e-01 | -5.99e-02 | 9.58e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 50 | 4.64e-01 | -5.98e-02 | 8.74e-01 |
| GOBP MOTOR BEHAVIOR | 22 | 6.27e-01 | 5.98e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 145 | 2.14e-01 | -5.98e-02 | 7.45e-01 |
| GOBP CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 8.00e-01 | 5.98e-02 | 9.61e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 42 | 5.03e-01 | 5.98e-02 | 8.87e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 180 | 1.67e-01 | -5.97e-02 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 22 | 6.28e-01 | -5.97e-02 | 9.25e-01 |
| GOBP EPOXYGENASE P450 PATHWAY | 17 | 6.70e-01 | -5.97e-02 | 9.35e-01 |
| GOMF CHOLESTEROL BINDING | 51 | 4.61e-01 | 5.97e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 15 | 6.89e-01 | 5.96e-02 | 9.42e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 96 | 3.13e-01 | 5.96e-02 | 8.08e-01 |
| GOBP RESPONSE TO CALCIUM ION | 139 | 2.25e-01 | 5.96e-02 | 7.57e-01 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 10 | 7.44e-01 | -5.96e-02 | 9.53e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 94 | 3.19e-01 | -5.95e-02 | 8.10e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 247 | 1.07e-01 | 5.95e-02 | 6.05e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 58 | 4.33e-01 | -5.95e-02 | 8.60e-01 |
| GOBP TNFSF11 MEDIATED SIGNALING PATHWAY | 5 | 8.18e-01 | 5.95e-02 | 9.68e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 6.07e-01 | -5.95e-02 | 9.20e-01 |
| GOBP MEMBRANE ORGANIZATION | 773 | 4.90e-03 | 5.95e-02 | 1.48e-01 |
| GOMF C X C CHEMOKINE BINDING | 5 | 8.18e-01 | 5.95e-02 | 9.68e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 86 | 3.40e-01 | 5.95e-02 | 8.22e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 191 | 1.57e-01 | 5.94e-02 | 6.91e-01 |
| GOBP REGULATION OF TRANSPORT | 1706 | 4.42e-05 | 5.94e-02 | 8.22e-03 |
| GOCC PRONUCLEUS | 14 | 7.00e-01 | -5.94e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 7 | 7.85e-01 | 5.94e-02 | 9.60e-01 |
| GOBP ENDOSOMAL TRANSPORT | 239 | 1.14e-01 | 5.94e-02 | 6.21e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 564 | 1.59e-02 | 5.94e-02 | 2.72e-01 |
| GOBP GROWTH | 881 | 2.77e-03 | 5.94e-02 | 1.07e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 62 | 4.19e-01 | 5.94e-02 | 8.53e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 7.86e-01 | 5.93e-02 | 9.60e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 15 | 6.91e-01 | -5.93e-02 | 9.42e-01 |
| GOBP FAT CELL DIFFERENTIATION | 243 | 1.11e-01 | 5.93e-02 | 6.15e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 82 | 3.53e-01 | -5.93e-02 | 8.28e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 26 | 6.01e-01 | 5.93e-02 | 9.17e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 17 | 6.72e-01 | -5.93e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 23 | 6.23e-01 | 5.93e-02 | 9.24e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 61 | 4.23e-01 | 5.93e-02 | 8.56e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 7.72e-01 | -5.92e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 48 | 4.78e-01 | -5.92e-02 | 8.79e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 23 | 6.23e-01 | 5.91e-02 | 9.24e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 19 | 6.55e-01 | -5.91e-02 | 9.30e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 72 | 3.86e-01 | 5.91e-02 | 8.40e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 52 | 4.61e-01 | -5.91e-02 | 8.72e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 12 | 7.23e-01 | 5.91e-02 | 9.49e-01 |
| GOBP PLASMINOGEN ACTIVATION | 26 | 6.02e-01 | -5.91e-02 | 9.17e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 95 | 3.20e-01 | 5.91e-02 | 8.10e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 13 | 7.12e-01 | 5.90e-02 | 9.47e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 59 | 4.33e-01 | 5.90e-02 | 8.60e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 239 | 1.16e-01 | -5.90e-02 | 6.26e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 24 | 6.17e-01 | -5.90e-02 | 9.22e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 34 | 5.52e-01 | -5.90e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 587 | 1.47e-02 | 5.90e-02 | 2.60e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 157 | 2.02e-01 | 5.89e-02 | 7.33e-01 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 72 | 3.87e-01 | 5.89e-02 | 8.41e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 19 | 6.57e-01 | -5.89e-02 | 9.30e-01 |
| GOBP PROTEIN UNFOLDING | 5 | 8.20e-01 | -5.88e-02 | 9.68e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 40 | 5.20e-01 | 5.88e-02 | 8.90e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 8 | 7.73e-01 | 5.88e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 125 | 2.57e-01 | -5.87e-02 | 7.78e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 15 | 6.94e-01 | 5.87e-02 | 9.43e-01 |
| GOBP GENITALIA DEVELOPMENT | 46 | 4.91e-01 | -5.87e-02 | 8.82e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 78 | 3.70e-01 | -5.87e-02 | 8.33e-01 |
| GOBP RESPONSE TO NUTRIENT | 147 | 2.20e-01 | 5.87e-02 | 7.51e-01 |
| GOBP NODAL SIGNALING PATHWAY | 16 | 6.85e-01 | -5.87e-02 | 9.40e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 336 | 6.46e-02 | 5.87e-02 | 5.11e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 21 | 6.42e-01 | 5.86e-02 | 9.28e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 16 | 6.85e-01 | -5.86e-02 | 9.40e-01 |
| GOMF MAGNESIUM ION BINDING | 212 | 1.41e-01 | 5.86e-02 | 6.64e-01 |
| GOBP TRNA METABOLIC PROCESS | 188 | 1.66e-01 | -5.86e-02 | 6.99e-01 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 131 | 2.47e-01 | 5.86e-02 | 7.69e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 162 | 1.98e-01 | -5.86e-02 | 7.29e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 880 | 3.22e-03 | 5.85e-02 | 1.18e-01 |
| GOBP REGULATION OF MYELINATION | 45 | 4.97e-01 | -5.85e-02 | 8.84e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 41 | 5.17e-01 | 5.84e-02 | 8.90e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 305 | 7.93e-02 | 5.84e-02 | 5.52e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 7.89e-01 | 5.84e-02 | 9.60e-01 |
| GOBP CARBON DIOXIDE TRANSPORT | 15 | 6.95e-01 | 5.84e-02 | 9.43e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 127 | 2.56e-01 | 5.84e-02 | 7.77e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 98 | 3.18e-01 | 5.84e-02 | 8.10e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 126 | 2.58e-01 | 5.84e-02 | 7.78e-01 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 39 | 5.28e-01 | 5.84e-02 | 8.93e-01 |
| GOMF PHOSPHATASE BINDING | 184 | 1.72e-01 | 5.83e-02 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 10 | 7.49e-01 | -5.83e-02 | 9.53e-01 |
| GOCC CELL SURFACE | 838 | 4.14e-03 | 5.83e-02 | 1.35e-01 |
| GOBP CELL CELL SIGNALING BY WNT | 441 | 3.58e-02 | 5.83e-02 | 3.96e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 7.62e-01 | -5.83e-02 | 9.56e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 8 | 7.75e-01 | 5.83e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 38 | 5.34e-01 | -5.83e-02 | 8.94e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 39 | 5.29e-01 | -5.83e-02 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 22 | 6.36e-01 | -5.82e-02 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF STEROL TRANSPORT | 31 | 5.75e-01 | -5.82e-02 | 9.06e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 12 | 7.27e-01 | -5.82e-02 | 9.51e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 561 | 1.84e-02 | 5.82e-02 | 2.92e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 45 | 4.99e-01 | -5.82e-02 | 8.85e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 13 | 7.16e-01 | 5.82e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 323 | 7.23e-02 | 5.82e-02 | 5.35e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 28 | 5.94e-01 | -5.81e-02 | 9.13e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 44 | 5.05e-01 | 5.81e-02 | 8.88e-01 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 14 | 7.07e-01 | 5.81e-02 | 9.45e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 40 | 5.25e-01 | 5.81e-02 | 8.91e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 63 | 4.25e-01 | 5.81e-02 | 8.57e-01 |
| GOBP CYTOKINETIC PROCESS | 42 | 5.15e-01 | 5.81e-02 | 8.90e-01 |
| GOCC SWI SNF COMPLEX | 30 | 5.82e-01 | -5.80e-02 | 9.08e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 299 | 8.45e-02 | 5.80e-02 | 5.68e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 14 | 7.07e-01 | -5.80e-02 | 9.45e-01 |
| GOBP FLUID TRANSPORT | 37 | 5.42e-01 | 5.79e-02 | 8.97e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 155 | 2.14e-01 | 5.79e-02 | 7.45e-01 |
| GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY | 5 | 8.23e-01 | 5.79e-02 | 9.69e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 43 | 5.11e-01 | -5.79e-02 | 8.89e-01 |
| GOBP INSEMINATION | 12 | 7.29e-01 | 5.78e-02 | 9.51e-01 |
| GOMF CALCIUM ION BINDING | 675 | 1.05e-02 | 5.78e-02 | 2.22e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 12 | 7.29e-01 | 5.78e-02 | 9.51e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 14 | 7.08e-01 | 5.77e-02 | 9.45e-01 |
| GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING | 5 | 8.23e-01 | -5.77e-02 | 9.69e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 38 | 5.38e-01 | 5.77e-02 | 8.96e-01 |
| GOCC CILIARY TIP | 45 | 5.03e-01 | -5.77e-02 | 8.87e-01 |
| GOMF POTASSIUM ION BINDING | 13 | 7.19e-01 | -5.77e-02 | 9.48e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 9 | 7.64e-01 | -5.77e-02 | 9.57e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 198 | 1.62e-01 | 5.77e-02 | 6.95e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 92 | 3.39e-01 | 5.77e-02 | 8.22e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 22 | 6.40e-01 | -5.77e-02 | 9.28e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 44 | 5.08e-01 | -5.77e-02 | 8.89e-01 |
| GOBP GLYCOLYTIC PROCESS | 85 | 3.58e-01 | 5.76e-02 | 8.31e-01 |
| GOMF EPHRIN RECEPTOR ACTIVITY | 18 | 6.72e-01 | 5.76e-02 | 9.35e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 8 | 7.78e-01 | 5.76e-02 | 9.60e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 319 | 7.69e-02 | 5.76e-02 | 5.48e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 452 | 3.59e-02 | 5.76e-02 | 3.97e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 34 | 5.62e-01 | -5.75e-02 | 9.05e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 353 | 6.35e-02 | 5.75e-02 | 5.06e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 127 | 2.63e-01 | 5.75e-02 | 7.83e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 570 | 1.90e-02 | 5.75e-02 | 2.97e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 5 | 8.24e-01 | -5.74e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 887 | 3.71e-03 | 5.74e-02 | 1.29e-01 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 4.70e-01 | -5.74e-02 | 8.75e-01 |
| GOCC ACTIN CYTOSKELETON | 484 | 3.05e-02 | 5.74e-02 | 3.72e-01 |
| GOBP NEURON RECOGNITION | 45 | 5.06e-01 | -5.74e-02 | 8.88e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 26 | 6.13e-01 | 5.73e-02 | 9.21e-01 |
| GOMF 11 CIS RETINAL BINDING | 7 | 7.93e-01 | -5.73e-02 | 9.61e-01 |
| GOMF LAMININ BINDING | 28 | 6.00e-01 | 5.73e-02 | 9.15e-01 |
| GOBP BRADYKININ CATABOLIC PROCESS | 7 | 7.93e-01 | -5.73e-02 | 9.61e-01 |
| GOCC GROWTH CONE MEMBRANE | 8 | 7.79e-01 | -5.73e-02 | 9.60e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 266 | 1.08e-01 | 5.73e-02 | 6.05e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 115 | 2.90e-01 | 5.72e-02 | 7.96e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 603 | 1.66e-02 | 5.71e-02 | 2.75e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 199 | 1.65e-01 | 5.71e-02 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 13 | 7.22e-01 | 5.70e-02 | 9.48e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 34 | 5.65e-01 | 5.70e-02 | 9.05e-01 |
| GOBP GLUTAMATE SECRETION | 28 | 6.02e-01 | 5.70e-02 | 9.17e-01 |
| GOBP AEROBIC RESPIRATION | 170 | 2.00e-01 | -5.70e-02 | 7.30e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 302 | 8.83e-02 | 5.70e-02 | 5.75e-01 |
| GOBP PROTEIN STABILIZATION | 202 | 1.62e-01 | 5.70e-02 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 91 | 3.48e-01 | -5.70e-02 | 8.26e-01 |
| GOBP COMPLEMENT ACTIVATION | 56 | 4.61e-01 | -5.70e-02 | 8.72e-01 |
| GOCC AXONAL GROWTH CONE | 25 | 6.22e-01 | -5.69e-02 | 9.24e-01 |
| GOBP PROTEIN PHOSPHORYLATION | 1268 | 6.61e-04 | 5.69e-02 | 4.70e-02 |
| GOCC MICROBODY MEMBRANE | 62 | 4.39e-01 | 5.68e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 10 | 7.56e-01 | 5.68e-02 | 9.54e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 7.81e-01 | 5.68e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 25 | 6.23e-01 | 5.68e-02 | 9.24e-01 |
| GOCC MYELIN SHEATH | 42 | 5.24e-01 | 5.68e-02 | 8.91e-01 |
| GOBP B CELL PROLIFERATION | 96 | 3.36e-01 | 5.68e-02 | 8.20e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 85 | 3.65e-01 | 5.68e-02 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 134 | 2.57e-01 | 5.68e-02 | 7.78e-01 |
| GOBP PHOSPHORYLATION | 1518 | 2.21e-04 | 5.67e-02 | 2.43e-02 |
| GOBP RIBOSOME DISASSEMBLY | 12 | 7.34e-01 | 5.67e-02 | 9.53e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 329 | 7.70e-02 | 5.67e-02 | 5.48e-01 |
| GOBP RESPONSE TO WATER | 13 | 7.23e-01 | 5.67e-02 | 9.49e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 49 | 4.93e-01 | -5.67e-02 | 8.83e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 11 | 7.45e-01 | 5.66e-02 | 9.53e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 59 | 4.52e-01 | 5.66e-02 | 8.70e-01 |
| GOMF TRANSPORTER ACTIVITY | 1171 | 1.10e-03 | 5.66e-02 | 6.38e-02 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 26 | 6.17e-01 | 5.66e-02 | 9.22e-01 |
| GOBP SPROUTING ANGIOGENESIS | 183 | 1.87e-01 | 5.66e-02 | 7.23e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 14 | 7.14e-01 | 5.66e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 14 | 7.14e-01 | 5.66e-02 | 9.47e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 131 | 2.63e-01 | 5.66e-02 | 7.83e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 15 | 7.04e-01 | 5.66e-02 | 9.44e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 79 | 3.85e-01 | 5.66e-02 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 167 | 2.07e-01 | 5.65e-02 | 7.38e-01 |
| GOMF BETA CATENIN BINDING | 80 | 3.82e-01 | 5.65e-02 | 8.37e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 58 | 4.56e-01 | -5.65e-02 | 8.71e-01 |
| GOBP MACROMOLECULE METHYLATION | 195 | 1.73e-01 | -5.65e-02 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 452 | 3.94e-02 | 5.65e-02 | 4.11e-01 |
| GOBP REGULATION OF CELL ADHESION | 771 | 7.59e-03 | 5.65e-02 | 1.85e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 15 | 7.05e-01 | 5.65e-02 | 9.44e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 33 | 5.75e-01 | 5.65e-02 | 9.06e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 32 | 5.80e-01 | 5.65e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 14 | 7.15e-01 | -5.65e-02 | 9.47e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 127 | 2.72e-01 | -5.64e-02 | 7.86e-01 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 7 | 7.96e-01 | -5.64e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 27 | 6.12e-01 | 5.64e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 189 | 1.81e-01 | 5.64e-02 | 7.14e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 52 | 4.82e-01 | -5.64e-02 | 8.80e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 37 | 5.53e-01 | 5.64e-02 | 9.01e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 93 | 3.48e-01 | 5.64e-02 | 8.26e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 26 | 6.19e-01 | 5.64e-02 | 9.22e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 45 | 5.13e-01 | -5.63e-02 | 8.89e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 8 | 7.83e-01 | -5.63e-02 | 9.60e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 44 | 5.18e-01 | 5.63e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 33 | 5.76e-01 | 5.63e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 11 | 7.47e-01 | -5.63e-02 | 9.53e-01 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 8 | 7.83e-01 | -5.63e-02 | 9.60e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 47 | 5.05e-01 | 5.62e-02 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 683 | 1.23e-02 | 5.62e-02 | 2.40e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1672 | 1.30e-04 | 5.62e-02 | 1.77e-02 |
| GOBP CONVERGENT EXTENSION | 15 | 7.07e-01 | -5.61e-02 | 9.45e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 39 | 5.44e-01 | 5.61e-02 | 8.98e-01 |
| GOBP VACUOLE ORGANIZATION | 219 | 1.52e-01 | 5.61e-02 | 6.83e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1773 | 8.75e-05 | 5.61e-02 | 1.38e-02 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 242 | 1.33e-01 | 5.61e-02 | 6.51e-01 |
| GOBP SUCKLING BEHAVIOR | 12 | 7.37e-01 | 5.60e-02 | 9.53e-01 |
| GOBP C X C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY | 5 | 8.28e-01 | -5.60e-02 | 9.70e-01 |
| GOBP DIOL METABOLIC PROCESS | 30 | 5.95e-01 | -5.60e-02 | 9.13e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 11 | 7.48e-01 | 5.60e-02 | 9.53e-01 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 15 | 7.07e-01 | 5.60e-02 | 9.45e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 23 | 6.42e-01 | -5.60e-02 | 9.28e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 996 | 2.78e-03 | 5.60e-02 | 1.07e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 16 | 6.98e-01 | 5.60e-02 | 9.43e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 23 | 6.42e-01 | 5.60e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 18 | 6.81e-01 | 5.60e-02 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 35 | 5.67e-01 | -5.60e-02 | 9.05e-01 |
| GOBP STRIATUM DEVELOPMENT | 20 | 6.65e-01 | -5.59e-02 | 9.32e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 48 | 5.02e-01 | -5.59e-02 | 8.87e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 19 | 6.73e-01 | 5.59e-02 | 9.36e-01 |
| GOBP LIPID METABOLIC PROCESS | 1343 | 5.85e-04 | 5.59e-02 | 4.40e-02 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 16 | 6.99e-01 | 5.59e-02 | 9.43e-01 |
| GOBP MUSCLE ATROPHY | 10 | 7.60e-01 | 5.59e-02 | 9.55e-01 |
| GOBP CELL KILLING | 212 | 1.61e-01 | -5.59e-02 | 6.95e-01 |
| GOBP GLAND DEVELOPMENT | 428 | 4.75e-02 | 5.59e-02 | 4.48e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 17 | 6.90e-01 | 5.58e-02 | 9.42e-01 |
| GOBP TRABECULA MORPHOGENESIS | 47 | 5.08e-01 | 5.58e-02 | 8.89e-01 |
| GOMF KINASE ACTIVITY | 706 | 1.15e-02 | 5.58e-02 | 2.29e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 179 | 1.98e-01 | -5.58e-02 | 7.29e-01 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 499 | 3.28e-02 | 5.58e-02 | 3.86e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 274 | 1.12e-01 | 5.58e-02 | 6.17e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 22 | 6.51e-01 | -5.58e-02 | 9.30e-01 |
| GOBP ENTRY INTO HOST | 157 | 2.28e-01 | 5.58e-02 | 7.60e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY VIA JNK CASCADE | 6 | 8.13e-01 | 5.58e-02 | 9.67e-01 |
| GOCC PLATELET DENSE GRANULE | 20 | 6.66e-01 | -5.58e-02 | 9.32e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 32 | 5.85e-01 | 5.58e-02 | 9.10e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 243 | 1.35e-01 | 5.57e-02 | 6.53e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 8.29e-01 | 5.56e-02 | 9.70e-01 |
| GOCC SYNAPSE | 1375 | 5.42e-04 | 5.56e-02 | 4.20e-02 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 31 | 5.92e-01 | -5.56e-02 | 9.12e-01 |
| GOCC FLOTILLIN COMPLEX | 9 | 7.73e-01 | -5.55e-02 | 9.58e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 7 | 7.99e-01 | -5.55e-02 | 9.61e-01 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 6 | 8.14e-01 | 5.55e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 22 | 6.52e-01 | -5.55e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 104 | 3.28e-01 | -5.55e-02 | 8.14e-01 |
| GOBP RIBOSOME BIOGENESIS | 303 | 9.69e-02 | -5.54e-02 | 5.93e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN VENTRAL SPINAL CORD PATTERNING | 8 | 7.86e-01 | -5.54e-02 | 9.60e-01 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 12 | 7.40e-01 | -5.54e-02 | 9.53e-01 |
| GOMF JUN KINASE BINDING | 11 | 7.50e-01 | -5.54e-02 | 9.53e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 35 | 5.71e-01 | 5.54e-02 | 9.06e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 169 | 2.14e-01 | -5.54e-02 | 7.45e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 5.65e-01 | -5.54e-02 | 9.05e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 9 | 7.74e-01 | -5.54e-02 | 9.58e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 8.00e-01 | -5.54e-02 | 9.61e-01 |
| GOBP AMINO ACID SALVAGE | 7 | 8.00e-01 | 5.53e-02 | 9.61e-01 |
| GOCC CEREBELLAR MOSSY FIBER | 7 | 8.00e-01 | -5.53e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 10 | 7.62e-01 | 5.53e-02 | 9.56e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 9 | 7.74e-01 | 5.53e-02 | 9.58e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 61 | 4.55e-01 | 5.52e-02 | 8.70e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 50 | 4.99e-01 | -5.52e-02 | 8.85e-01 |
| GOBP RNA LOCALIZATION | 182 | 1.99e-01 | -5.52e-02 | 7.29e-01 |
| GOMF P53 BINDING | 64 | 4.45e-01 | 5.52e-02 | 8.66e-01 |
| GOBP ERYTHROCYTE MATURATION | 17 | 6.94e-01 | -5.52e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 11 | 7.51e-01 | -5.52e-02 | 9.54e-01 |
| GOMF NEUROTRANSMITTER BINDING | 16 | 7.02e-01 | -5.52e-02 | 9.44e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 18 | 6.85e-01 | 5.52e-02 | 9.41e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 6.94e-01 | -5.52e-02 | 9.43e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 12 | 7.41e-01 | -5.52e-02 | 9.53e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 12 | 7.41e-01 | -5.52e-02 | 9.53e-01 |
| GOBP IRON IMPORT INTO CELL | 10 | 7.63e-01 | 5.52e-02 | 9.56e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 20 | 6.69e-01 | 5.52e-02 | 9.34e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 12 | 7.41e-01 | -5.51e-02 | 9.53e-01 |
| GOBP HEART PROCESS | 245 | 1.37e-01 | 5.51e-02 | 6.58e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1705 | 1.52e-04 | 5.51e-02 | 1.90e-02 |
| GOBP LOCOMOTION | 1260 | 9.98e-04 | 5.51e-02 | 6.09e-02 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 885 | 5.39e-03 | 5.51e-02 | 1.60e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 188 | 1.93e-01 | -5.51e-02 | 7.26e-01 |
| GOBP PRONEPHROS DEVELOPMENT | 9 | 7.75e-01 | -5.50e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 65 | 4.43e-01 | 5.50e-02 | 8.64e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 342 | 8.03e-02 | 5.50e-02 | 5.56e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 34 | 5.79e-01 | 5.50e-02 | 9.07e-01 |
| GOBP REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION | 7 | 8.01e-01 | 5.50e-02 | 9.62e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 325 | 8.85e-02 | 5.50e-02 | 5.75e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 36 | 5.68e-01 | 5.49e-02 | 9.05e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 25 | 6.35e-01 | -5.49e-02 | 9.25e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 46 | 5.19e-01 | 5.49e-02 | 8.90e-01 |
| GOBP RESPONSE TO HISTAMINE | 11 | 7.52e-01 | 5.49e-02 | 9.54e-01 |
| GOBP THORAX AND ANTERIOR ABDOMEN DETERMINATION | 5 | 8.32e-01 | 5.49e-02 | 9.71e-01 |
| GOCC LATERAL PART OF CELL | 5 | 8.32e-01 | 5.49e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 474 | 4.08e-02 | 5.48e-02 | 4.16e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 21 | 6.64e-01 | 5.48e-02 | 9.31e-01 |
| GOBP PROTEIN DEGLUTAMYLATION | 6 | 8.16e-01 | -5.48e-02 | 9.68e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 42 | 5.39e-01 | -5.48e-02 | 8.96e-01 |
| GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 11 | 7.53e-01 | -5.48e-02 | 9.54e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 10 | 7.64e-01 | -5.48e-02 | 9.57e-01 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 298 | 1.04e-01 | 5.47e-02 | 5.99e-01 |
| GOBP MUSCULAR SEPTUM MORPHOGENESIS | 5 | 8.32e-01 | -5.47e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION | 8 | 7.89e-01 | -5.47e-02 | 9.60e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 509 | 3.48e-02 | 5.47e-02 | 3.93e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 12 | 7.43e-01 | -5.46e-02 | 9.53e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 12 | 7.43e-01 | -5.46e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 21 | 6.65e-01 | -5.46e-02 | 9.32e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 286 | 1.12e-01 | 5.46e-02 | 6.17e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 7 | 8.02e-01 | 5.46e-02 | 9.62e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 456 | 4.57e-02 | 5.46e-02 | 4.40e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 26 | 6.30e-01 | 5.46e-02 | 9.25e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 37 | 5.66e-01 | -5.46e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 13 | 7.34e-01 | -5.45e-02 | 9.53e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 104 | 3.37e-01 | -5.45e-02 | 8.20e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 460 | 4.52e-02 | 5.45e-02 | 4.37e-01 |
| GOMF ISOMERASE ACTIVITY | 154 | 2.43e-01 | 5.45e-02 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 43 | 5.36e-01 | 5.45e-02 | 8.94e-01 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 9 | 7.77e-01 | -5.45e-02 | 9.59e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 159 | 2.36e-01 | 5.45e-02 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 26 | 6.31e-01 | 5.45e-02 | 9.25e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 992 | 3.69e-03 | 5.45e-02 | 1.29e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 155 | 2.42e-01 | -5.45e-02 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 10 | 7.66e-01 | 5.45e-02 | 9.57e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 68 | 4.37e-01 | 5.45e-02 | 8.61e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 51 | 5.01e-01 | 5.44e-02 | 8.86e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 104 | 3.37e-01 | 5.44e-02 | 8.21e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 26 | 6.31e-01 | -5.44e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 26 | 6.31e-01 | 5.44e-02 | 9.25e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 166 | 2.26e-01 | 5.44e-02 | 7.59e-01 |
| GOBP CHROMOSOME ORGANIZATION | 604 | 2.24e-02 | -5.44e-02 | 3.20e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 92 | 3.67e-01 | -5.44e-02 | 8.33e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 140 | 2.67e-01 | 5.44e-02 | 7.83e-01 |
| GOBP ICOSANOID SECRETION | 46 | 5.24e-01 | 5.43e-02 | 8.91e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 77 | 4.10e-01 | 5.43e-02 | 8.49e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 8 | 7.90e-01 | 5.43e-02 | 9.61e-01 |
| GOMF 5ALPHA ANDROSTANE 3BETA 17BETA DIOL DEHYDROGENASE ACTIVITY | 6 | 8.18e-01 | 5.43e-02 | 9.68e-01 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 8 | 7.91e-01 | 5.42e-02 | 9.61e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 80 | 4.02e-01 | 5.42e-02 | 8.46e-01 |
| GOBP SELECTIVE AUTOPHAGY | 92 | 3.69e-01 | 5.42e-02 | 8.33e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 54 | 4.91e-01 | 5.42e-02 | 8.82e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 24 | 6.46e-01 | -5.41e-02 | 9.29e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 50 | 5.08e-01 | -5.41e-02 | 8.89e-01 |
| GOBP RESPONSE TO ACTIVITY | 72 | 4.27e-01 | 5.41e-02 | 8.58e-01 |
| GOCC PERICHROMATIN FIBRILS | 5 | 8.34e-01 | 5.41e-02 | 9.71e-01 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 12 | 7.46e-01 | 5.41e-02 | 9.53e-01 |
| GOBP REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA | 5 | 8.34e-01 | -5.41e-02 | 9.71e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 38 | 5.64e-01 | 5.41e-02 | 9.05e-01 |
| GOCC RECYCLING ENDOSOME | 194 | 1.94e-01 | 5.41e-02 | 7.27e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 224 | 1.63e-01 | 5.40e-02 | 6.96e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 115 | 3.17e-01 | 5.40e-02 | 8.09e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 21 | 6.68e-01 | -5.40e-02 | 9.33e-01 |
| GOBP REGULATION OF COA TRANSFERASE ACTIVITY | 10 | 7.67e-01 | 5.40e-02 | 9.58e-01 |
| GOMF FIBRONECTIN BINDING | 29 | 6.15e-01 | 5.40e-02 | 9.21e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 1004 | 3.80e-03 | 5.40e-02 | 1.31e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 102 | 3.46e-01 | -5.40e-02 | 8.26e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 488 | 4.12e-02 | 5.40e-02 | 4.17e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 230 | 1.59e-01 | 5.40e-02 | 6.92e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 289 | 1.15e-01 | 5.39e-02 | 6.23e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 8 | 7.92e-01 | 5.39e-02 | 9.61e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 91 | 3.74e-01 | 5.39e-02 | 8.34e-01 |
| GOCC AXONEMAL MICROTUBULE | 38 | 5.65e-01 | -5.39e-02 | 9.05e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 8 | 7.92e-01 | 5.39e-02 | 9.61e-01 |
| GOBP METHYLATION | 260 | 1.35e-01 | -5.38e-02 | 6.53e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 11 | 7.57e-01 | 5.38e-02 | 9.54e-01 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 8.35e-01 | -5.38e-02 | 9.71e-01 |
| GOBP PROTEIN AUTOPROCESSING | 28 | 6.22e-01 | -5.38e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 8.20e-01 | -5.38e-02 | 9.68e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 15 | 7.18e-01 | -5.38e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 54 | 4.94e-01 | -5.38e-02 | 8.83e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 60 | 4.71e-01 | -5.38e-02 | 8.76e-01 |
| GOBP INTERKINETIC NUCLEAR MIGRATION | 5 | 8.35e-01 | 5.37e-02 | 9.71e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 37 | 5.72e-01 | -5.37e-02 | 9.06e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 7.58e-01 | -5.36e-02 | 9.54e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 148 | 2.60e-01 | 5.36e-02 | 7.81e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 53 | 5.00e-01 | 5.36e-02 | 8.85e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 15 | 7.19e-01 | 5.36e-02 | 9.48e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID IMPORT | 6 | 8.20e-01 | 5.36e-02 | 9.68e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 210 | 1.81e-01 | -5.36e-02 | 7.13e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 40 | 5.58e-01 | 5.36e-02 | 9.03e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 52 | 5.04e-01 | 5.36e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 1396 | 7.98e-04 | 5.35e-02 | 5.41e-02 |
| GOBP INORGANIC ANION TRANSPORT | 162 | 2.40e-01 | 5.35e-02 | 7.64e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 27 | 6.30e-01 | -5.35e-02 | 9.25e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 11 | 7.59e-01 | -5.35e-02 | 9.54e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 254 | 1.42e-01 | 5.35e-02 | 6.65e-01 |
| GOMF RNA POLYMERASE BINDING | 57 | 4.85e-01 | -5.35e-02 | 8.80e-01 |
| GOCC CATION CHANNEL COMPLEX | 188 | 2.06e-01 | 5.35e-02 | 7.37e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 150 | 2.59e-01 | 5.34e-02 | 7.78e-01 |
| GOCC AXON | 618 | 2.33e-02 | 5.34e-02 | 3.26e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 131 | 2.91e-01 | 5.34e-02 | 7.97e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 422 | 5.98e-02 | 5.34e-02 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 236 | 1.57e-01 | 5.34e-02 | 6.91e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 24 | 6.51e-01 | 5.34e-02 | 9.30e-01 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 39 | 5.64e-01 | -5.34e-02 | 9.05e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 10 | 7.70e-01 | -5.34e-02 | 9.58e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 19 | 6.87e-01 | 5.34e-02 | 9.41e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 16 | 7.12e-01 | 5.33e-02 | 9.47e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 19 | 6.87e-01 | 5.33e-02 | 9.42e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 55 | 4.94e-01 | 5.33e-02 | 8.83e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 71 | 4.37e-01 | -5.33e-02 | 8.61e-01 |
| GOBP SPERM DNA CONDENSATION | 17 | 7.04e-01 | -5.33e-02 | 9.44e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 700 | 1.63e-02 | 5.33e-02 | 2.73e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 19 | 6.88e-01 | 5.32e-02 | 9.42e-01 |
| GOBP CEREBELLAR PURKINJE CELL GRANULE CELL PRECURSOR CELL SIGNALING INVOLVED IN REGULATION OF GRANULE CELL PRECURSOR CELL PROLIFERATION | 5 | 8.37e-01 | -5.32e-02 | 9.71e-01 |
| GOBP TUBULIN DEACETYLATION | 19 | 6.88e-01 | 5.32e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 55 | 4.95e-01 | -5.32e-02 | 8.83e-01 |
| GOMF AMP BINDING | 15 | 7.21e-01 | -5.32e-02 | 9.48e-01 |
| GOCC COATED VESICLE | 296 | 1.16e-01 | 5.32e-02 | 6.25e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 158 | 2.49e-01 | -5.32e-02 | 7.71e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 21 | 6.73e-01 | -5.32e-02 | 9.36e-01 |
| GOBP MALE SEX DIFFERENTIATION | 163 | 2.42e-01 | 5.31e-02 | 7.65e-01 |
| GOMF RNA STEM LOOP BINDING | 14 | 7.31e-01 | -5.31e-02 | 9.52e-01 |
| GOBP ERBB2 ERBB4 SIGNALING PATHWAY | 5 | 8.37e-01 | 5.31e-02 | 9.71e-01 |
| GOBP OVULATION CYCLE PROCESS | 50 | 5.16e-01 | 5.31e-02 | 8.90e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 58 | 4.84e-01 | 5.31e-02 | 8.80e-01 |
| GOMF ANKYRIN BINDING | 19 | 6.89e-01 | -5.31e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 177 | 2.23e-01 | 5.31e-02 | 7.56e-01 |
| GOBP RUFFLE ASSEMBLY | 45 | 5.38e-01 | 5.31e-02 | 8.96e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 131 | 2.94e-01 | 5.31e-02 | 7.98e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 236 | 1.60e-01 | -5.30e-02 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 37 | 5.77e-01 | -5.30e-02 | 9.06e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 10 | 7.72e-01 | 5.30e-02 | 9.58e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 36 | 5.82e-01 | 5.30e-02 | 9.08e-01 |
| GOBP SEX DIFFERENTIATION | 266 | 1.37e-01 | 5.29e-02 | 6.58e-01 |
| GOBP XENOBIOTIC TRANSPORT | 59 | 4.82e-01 | -5.29e-02 | 8.80e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 19 | 6.90e-01 | 5.29e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 27 | 6.34e-01 | -5.29e-02 | 9.25e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 19 | 6.90e-01 | 5.29e-02 | 9.42e-01 |
| GOBP MACROPHAGE MIGRATION | 61 | 4.75e-01 | 5.29e-02 | 8.77e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 7.61e-01 | 5.29e-02 | 9.55e-01 |
| GOBP INTERMEDIATE FILAMENT BUNDLE ASSEMBLY | 8 | 7.96e-01 | -5.29e-02 | 9.61e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 131 | 2.96e-01 | 5.29e-02 | 7.99e-01 |
| GOCC COATED VESICLE MEMBRANE | 191 | 2.08e-01 | 5.29e-02 | 7.39e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 15 | 7.23e-01 | -5.28e-02 | 9.49e-01 |
| GOBP AMELOBLAST DIFFERENTIATION | 5 | 8.38e-01 | 5.28e-02 | 9.71e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 93 | 3.79e-01 | 5.28e-02 | 8.36e-01 |
| GOBP TRACHEA FORMATION | 7 | 8.09e-01 | 5.28e-02 | 9.65e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 20 | 6.83e-01 | -5.28e-02 | 9.40e-01 |
| GOCC CELL BODY MEMBRANE | 32 | 6.05e-01 | -5.28e-02 | 9.20e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 7.96e-01 | 5.28e-02 | 9.61e-01 |
| GOBP RNA 3 URIDYLATION | 5 | 8.38e-01 | -5.28e-02 | 9.71e-01 |
| GOBP DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY | 6 | 8.23e-01 | -5.28e-02 | 9.69e-01 |
| GOMF CYTOKINE BINDING | 133 | 2.93e-01 | 5.28e-02 | 7.97e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 45 | 5.40e-01 | 5.27e-02 | 8.96e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 106 | 3.48e-01 | 5.27e-02 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 158 | 2.53e-01 | 5.27e-02 | 7.75e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 479 | 4.82e-02 | 5.27e-02 | 4.52e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 14 | 7.33e-01 | 5.26e-02 | 9.53e-01 |
| GOMF ALPHA TUBULIN BINDING | 37 | 5.80e-01 | 5.25e-02 | 9.08e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 177 | 2.28e-01 | 5.25e-02 | 7.60e-01 |
| GOCC CILIARY BASE | 44 | 5.47e-01 | -5.25e-02 | 8.99e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 28 | 6.31e-01 | -5.25e-02 | 9.25e-01 |
| GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 11 | 7.63e-01 | 5.24e-02 | 9.56e-01 |
| GOBP MITOTIC RECOMBINATION | 25 | 6.50e-01 | -5.24e-02 | 9.30e-01 |
| GOCC AXOLEMMA | 15 | 7.25e-01 | -5.24e-02 | 9.50e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 226 | 1.75e-01 | 5.24e-02 | 7.05e-01 |
| GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION | 5 | 8.39e-01 | -5.24e-02 | 9.72e-01 |
| GOCC MULTIVESICULAR BODY | 65 | 4.65e-01 | 5.24e-02 | 8.74e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 83 | 4.09e-01 | 5.24e-02 | 8.49e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 682 | 1.97e-02 | 5.24e-02 | 3.01e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 72 | 4.42e-01 | 5.24e-02 | 8.64e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 92 | 3.85e-01 | -5.24e-02 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 7.98e-01 | 5.24e-02 | 9.61e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 8.39e-01 | -5.24e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 32 | 6.08e-01 | 5.24e-02 | 9.20e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 290 | 1.25e-01 | 5.23e-02 | 6.41e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 540 | 3.76e-02 | 5.23e-02 | 4.04e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 208 | 1.93e-01 | 5.23e-02 | 7.26e-01 |
| GOCC ISWI TYPE COMPLEX | 12 | 7.54e-01 | -5.23e-02 | 9.54e-01 |
| GOBP SENSORY PERCEPTION OF UMAMI TASTE | 7 | 8.11e-01 | -5.23e-02 | 9.66e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 108 | 3.48e-01 | 5.23e-02 | 8.26e-01 |
| GOMF TETRAPYRROLE BINDING | 143 | 2.81e-01 | 5.23e-02 | 7.93e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 19 | 6.93e-01 | -5.23e-02 | 9.43e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 10 | 7.75e-01 | 5.22e-02 | 9.58e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 5.98e-01 | 5.22e-02 | 9.15e-01 |
| GOBP DOPAMINE TRANSPORT | 55 | 5.03e-01 | 5.22e-02 | 8.87e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 7 | 8.11e-01 | -5.22e-02 | 9.66e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 65 | 4.67e-01 | 5.22e-02 | 8.75e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 8 | 7.98e-01 | 5.22e-02 | 9.61e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 1078 | 3.82e-03 | 5.22e-02 | 1.31e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 40 | 5.68e-01 | 5.22e-02 | 9.05e-01 |
| GOBP CORTISOL METABOLIC PROCESS | 12 | 7.54e-01 | 5.22e-02 | 9.54e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 129 | 3.07e-01 | -5.21e-02 | 8.03e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 249 | 1.57e-01 | 5.21e-02 | 6.91e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 27 | 6.39e-01 | -5.21e-02 | 9.28e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 380 | 8.14e-02 | 5.21e-02 | 5.59e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 13 | 7.45e-01 | 5.21e-02 | 9.53e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 19 | 6.95e-01 | -5.20e-02 | 9.43e-01 |
| GOCC EXTRINSIC COMPONENT OF PRESYNAPTIC MEMBRANE | 6 | 8.25e-01 | -5.20e-02 | 9.69e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 36 | 5.89e-01 | 5.20e-02 | 9.11e-01 |
| GOBP SPINDLE ASSEMBLY | 125 | 3.15e-01 | -5.20e-02 | 8.08e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 26 | 6.46e-01 | 5.20e-02 | 9.29e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 21 | 6.80e-01 | 5.20e-02 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 17 | 7.11e-01 | -5.20e-02 | 9.47e-01 |
| GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 14 | 7.36e-01 | -5.20e-02 | 9.53e-01 |
| GOBP STEM CELL DEVELOPMENT | 87 | 4.02e-01 | 5.19e-02 | 8.46e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 14 | 7.37e-01 | -5.19e-02 | 9.53e-01 |
| GOCC ENDOSOME | 986 | 5.81e-03 | 5.19e-02 | 1.66e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 18 | 7.03e-01 | -5.19e-02 | 9.44e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 129 | 3.09e-01 | -5.19e-02 | 8.05e-01 |
| GOBP LIPID DROPLET FORMATION | 13 | 7.46e-01 | -5.18e-02 | 9.53e-01 |
| GOBP REGULATION OF INTESTINAL LIPID ABSORPTION | 10 | 7.77e-01 | 5.18e-02 | 9.59e-01 |
| GOCC CELL DIVISION SITE | 70 | 4.54e-01 | 5.18e-02 | 8.70e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 340 | 1.01e-01 | 5.18e-02 | 5.95e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 25 | 6.54e-01 | 5.18e-02 | 9.30e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1414 | 1.10e-03 | 5.18e-02 | 6.38e-02 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 49 | 5.31e-01 | 5.18e-02 | 8.93e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 153 | 2.69e-01 | 5.18e-02 | 7.84e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 51 | 5.22e-01 | 5.18e-02 | 8.91e-01 |
| GOBP CELL FATE DETERMINATION | 42 | 5.61e-01 | 5.18e-02 | 9.05e-01 |
| GOCC NBAF COMPLEX | 16 | 7.20e-01 | -5.18e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 1191 | 2.61e-03 | 5.18e-02 | 1.04e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 33 | 6.07e-01 | 5.18e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 96 | 3.81e-01 | 5.17e-02 | 8.37e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 18 | 7.04e-01 | -5.17e-02 | 9.44e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 121 | 3.26e-01 | 5.17e-02 | 8.11e-01 |
| GOCC NUCLEAR REPLICATION FORK | 32 | 6.13e-01 | 5.17e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 222 | 1.85e-01 | 5.16e-02 | 7.19e-01 |
| GOBP HISTIDINE CATABOLIC PROCESS | 8 | 8.00e-01 | 5.16e-02 | 9.61e-01 |
| GOCC BOX C D RNP COMPLEX | 6 | 8.27e-01 | 5.16e-02 | 9.70e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 10 | 7.78e-01 | -5.16e-02 | 9.59e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 83 | 4.17e-01 | 5.16e-02 | 8.53e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 255 | 1.56e-01 | 5.16e-02 | 6.91e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 18 | 7.05e-01 | 5.16e-02 | 9.44e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 13 | 7.48e-01 | 5.15e-02 | 9.53e-01 |
| GOMF PORIN ACTIVITY | 6 | 8.27e-01 | -5.15e-02 | 9.70e-01 |
| GOBP GOLGI LOCALIZATION | 14 | 7.39e-01 | -5.15e-02 | 9.53e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 54 | 5.13e-01 | 5.14e-02 | 8.89e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 814 | 1.26e-02 | 5.14e-02 | 2.45e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 13 | 7.48e-01 | 5.14e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 8 | 8.01e-01 | -5.14e-02 | 9.62e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 41 | 5.69e-01 | -5.14e-02 | 9.06e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 57 | 5.02e-01 | -5.14e-02 | 8.87e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 1011 | 5.73e-03 | 5.14e-02 | 1.64e-01 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 56 | 5.06e-01 | 5.13e-02 | 8.88e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 8 | 8.01e-01 | -5.13e-02 | 9.62e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 29 | 6.33e-01 | -5.12e-02 | 9.25e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 41 | 5.70e-01 | 5.12e-02 | 9.06e-01 |
| GOBP PEPTIDYL LYSINE OXIDATION | 5 | 8.43e-01 | -5.12e-02 | 9.73e-01 |
| GOMF PROTEIN LYSINE 6 OXIDASE ACTIVITY | 5 | 8.43e-01 | -5.12e-02 | 9.73e-01 |
| GOCC PCG PROTEIN COMPLEX | 35 | 6.00e-01 | 5.12e-02 | 9.16e-01 |
| GOMF L ASCORBIC ACID BINDING | 20 | 6.92e-01 | 5.12e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 13 | 7.49e-01 | 5.12e-02 | 9.53e-01 |
| GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING | 9 | 7.90e-01 | -5.12e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 1211 | 2.71e-03 | 5.12e-02 | 1.06e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 449 | 6.30e-02 | -5.12e-02 | 5.04e-01 |
| GOMF D LOOP DNA BINDING | 5 | 8.43e-01 | 5.12e-02 | 9.73e-01 |
| GOCC PLASMA MEMBRANE REGION | 1248 | 2.38e-03 | 5.11e-02 | 9.84e-02 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 65 | 4.76e-01 | 5.11e-02 | 8.78e-01 |
| GOBP CALCIUM ION TRANSPORT | 426 | 7.03e-02 | 5.11e-02 | 5.28e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 98 | 3.82e-01 | 5.11e-02 | 8.37e-01 |
| GOBP SENSORY PERCEPTION OF SWEET TASTE | 7 | 8.15e-01 | -5.11e-02 | 9.68e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 18 | 7.07e-01 | 5.11e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 108 | 3.59e-01 | 5.11e-02 | 8.31e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 203 | 2.10e-01 | 5.10e-02 | 7.42e-01 |
| GOMF NMDA GLUTAMATE RECEPTOR ACTIVITY | 8 | 8.03e-01 | -5.10e-02 | 9.62e-01 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 9 | 7.91e-01 | -5.10e-02 | 9.61e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 49 | 5.37e-01 | 5.10e-02 | 8.95e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 9 | 7.91e-01 | -5.10e-02 | 9.61e-01 |
| GOBP RECOGNITION OF APOPTOTIC CELL | 7 | 8.15e-01 | -5.10e-02 | 9.68e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 25 | 6.59e-01 | -5.10e-02 | 9.30e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 7 | 8.15e-01 | -5.10e-02 | 9.68e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 175 | 2.45e-01 | 5.09e-02 | 7.68e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 161 | 2.65e-01 | 5.09e-02 | 7.83e-01 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 10 | 7.81e-01 | -5.09e-02 | 9.60e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 51 | 5.30e-01 | 5.09e-02 | 8.93e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 11 | 7.70e-01 | -5.08e-02 | 9.58e-01 |
| GOCC OUTER DYNEIN ARM | 11 | 7.70e-01 | -5.08e-02 | 9.58e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 7.42e-01 | 5.08e-02 | 9.53e-01 |
| GOBP LEUKOTRIENE D4 METABOLIC PROCESS | 7 | 8.16e-01 | 5.08e-02 | 9.68e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 7 | 8.16e-01 | 5.08e-02 | 9.68e-01 |
| GOCC REPLICATION FORK | 64 | 4.83e-01 | 5.08e-02 | 8.80e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 69 | 4.66e-01 | 5.07e-02 | 8.75e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 44 | 5.61e-01 | 5.07e-02 | 9.05e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 48 | 5.43e-01 | -5.07e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 33 | 6.14e-01 | 5.07e-02 | 9.21e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 142 | 2.97e-01 | 5.07e-02 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 26 | 6.55e-01 | -5.07e-02 | 9.30e-01 |
| GOBP ASTROCYTE DEVELOPMENT | 42 | 5.70e-01 | -5.06e-02 | 9.06e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 24 | 6.68e-01 | 5.06e-02 | 9.33e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 84 | 4.23e-01 | -5.05e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 143 | 2.97e-01 | 5.05e-02 | 7.99e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 16 | 7.26e-01 | 5.05e-02 | 9.51e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 52 | 5.29e-01 | -5.05e-02 | 8.93e-01 |
| GOBP REGULATION OF FEAR RESPONSE | 9 | 7.93e-01 | 5.05e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 60 | 4.99e-01 | 5.05e-02 | 8.85e-01 |
| GOBP SNRNA TRANSCRIPTION | 19 | 7.03e-01 | -5.05e-02 | 9.44e-01 |
| GOMF TELOMERIC DNA BINDING | 38 | 5.91e-01 | 5.04e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 34 | 6.11e-01 | 5.04e-02 | 9.21e-01 |
| GOMF CADHERIN BINDING | 329 | 1.16e-01 | 5.04e-02 | 6.26e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 10 | 7.83e-01 | 5.04e-02 | 9.60e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 9 | 7.93e-01 | -5.04e-02 | 9.61e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 23 | 6.76e-01 | 5.04e-02 | 9.37e-01 |
| GOCC VESICLE TETHERING COMPLEX | 56 | 5.14e-01 | 5.04e-02 | 8.90e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 46 | 5.55e-01 | 5.03e-02 | 9.01e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 66 | 4.79e-01 | -5.03e-02 | 8.79e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 68 | 4.73e-01 | 5.03e-02 | 8.77e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 304 | 1.31e-01 | -5.03e-02 | 6.51e-01 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 25 | 6.63e-01 | 5.03e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 30 | 6.34e-01 | -5.03e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 46 | 5.55e-01 | -5.03e-02 | 9.02e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 27 | 6.51e-01 | 5.03e-02 | 9.30e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 249 | 1.72e-01 | 5.03e-02 | 7.04e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 13 | 7.54e-01 | -5.02e-02 | 9.54e-01 |
| GOBP CARTILAGE CONDENSATION | 19 | 7.05e-01 | 5.02e-02 | 9.44e-01 |
| GOBP REGULATION OF LUNG BLOOD PRESSURE | 5 | 8.46e-01 | -5.01e-02 | 9.73e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 23 | 6.77e-01 | -5.01e-02 | 9.37e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 182 | 2.43e-01 | 5.01e-02 | 7.67e-01 |
| GOBP INNATE IMMUNE RESPONSE | 896 | 1.10e-02 | 5.01e-02 | 2.27e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 47 | 5.52e-01 | 5.01e-02 | 9.01e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 379 | 9.42e-02 | 5.01e-02 | 5.89e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 50 | 5.40e-01 | 5.01e-02 | 8.96e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 8.32e-01 | 5.01e-02 | 9.71e-01 |
| GOBP DEFENSE RESPONSE | 1720 | 5.57e-04 | 5.00e-02 | 4.26e-02 |
| GOMF ACTININ BINDING | 35 | 6.08e-01 | 5.00e-02 | 9.20e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 8.06e-01 | 5.00e-02 | 9.64e-01 |
| GOCC PERINEURONAL NET | 10 | 7.84e-01 | -5.00e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 941 | 9.36e-03 | 5.00e-02 | 2.08e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 221 | 2.00e-01 | -5.00e-02 | 7.32e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 89 | 4.15e-01 | -5.00e-02 | 8.52e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 64 | 4.89e-01 | 5.00e-02 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 34 | 6.14e-01 | 4.99e-02 | 9.21e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 98 | 3.93e-01 | 4.99e-02 | 8.43e-01 |
| GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 7.65e-01 | 4.99e-02 | 9.57e-01 |
| GOBP SPERMATID DIFFERENTIATION | 201 | 2.23e-01 | -4.99e-02 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 42 | 5.76e-01 | -4.99e-02 | 9.06e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 41 | 5.81e-01 | 4.99e-02 | 9.08e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 318 | 1.27e-01 | 4.98e-02 | 6.43e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 48 | 5.50e-01 | 4.98e-02 | 9.01e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 153 | 2.87e-01 | 4.98e-02 | 7.95e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 118 | 3.50e-01 | -4.98e-02 | 8.26e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 16 | 7.30e-01 | 4.98e-02 | 9.52e-01 |
| GOBP RENAL SODIUM EXCRETION | 11 | 7.75e-01 | -4.97e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 86 | 4.26e-01 | 4.97e-02 | 8.57e-01 |
| GOCC GOLGI CISTERNA | 97 | 3.98e-01 | 4.97e-02 | 8.46e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 22 | 6.87e-01 | 4.96e-02 | 9.41e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 331 | 1.21e-01 | 4.96e-02 | 6.32e-01 |
| GOCC ENDOSOME MEMBRANE | 524 | 5.19e-02 | 4.96e-02 | 4.67e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 15 | 7.40e-01 | -4.96e-02 | 9.53e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 25 | 6.68e-01 | -4.95e-02 | 9.33e-01 |
| GOMF HORMONE BINDING | 83 | 4.35e-01 | 4.95e-02 | 8.60e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE FORMATION | 11 | 7.76e-01 | 4.95e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 9 | 7.97e-01 | -4.95e-02 | 9.61e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 8.34e-01 | 4.95e-02 | 9.71e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 15 | 7.40e-01 | 4.94e-02 | 9.53e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 715 | 2.43e-02 | 4.94e-02 | 3.32e-01 |
| GOCC HOST CELLULAR COMPONENT | 9 | 7.97e-01 | 4.94e-02 | 9.61e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 21 | 6.95e-01 | 4.94e-02 | 9.43e-01 |
| GOMF APOLIPOPROTEIN RECEPTOR BINDING | 7 | 8.21e-01 | 4.94e-02 | 9.68e-01 |
| GOBP NCRNA PROCESSING | 415 | 8.46e-02 | -4.94e-02 | 5.68e-01 |
| GOBP PANCREATIC A CELL DIFFERENTIATION | 11 | 7.77e-01 | 4.93e-02 | 9.59e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 64 | 4.95e-01 | -4.93e-02 | 8.83e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 32 | 6.29e-01 | -4.93e-02 | 9.25e-01 |
| GOBP LUNG MORPHOGENESIS | 54 | 5.31e-01 | 4.93e-02 | 8.93e-01 |
| GOMF TUBULIN BINDING | 357 | 1.10e-01 | 4.93e-02 | 6.11e-01 |
| GOBP HEART DEVELOPMENT | 598 | 3.96e-02 | 4.93e-02 | 4.12e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 77 | 4.55e-01 | 4.92e-02 | 8.70e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 165 | 2.75e-01 | 4.92e-02 | 7.88e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 57 | 5.20e-01 | 4.92e-02 | 8.90e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 107 | 3.79e-01 | 4.92e-02 | 8.36e-01 |
| GOCC PARANODE REGION OF AXON | 12 | 7.68e-01 | -4.92e-02 | 9.58e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 438 | 7.78e-02 | 4.92e-02 | 5.49e-01 |
| GOBP HOMEOSTATIC PROCESS | 1655 | 8.68e-04 | 4.91e-02 | 5.66e-02 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 172 | 2.66e-01 | -4.91e-02 | 7.83e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 134 | 3.26e-01 | -4.91e-02 | 8.11e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 175 | 2.62e-01 | 4.91e-02 | 7.83e-01 |
| GOBP PODOCYTE CELL MIGRATION | 7 | 8.22e-01 | -4.91e-02 | 9.69e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 103 | 3.89e-01 | 4.91e-02 | 8.41e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 30 | 6.42e-01 | 4.91e-02 | 9.28e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 175 | 2.63e-01 | 4.91e-02 | 7.83e-01 |
| GOBP DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY | 5 | 8.49e-01 | -4.90e-02 | 9.74e-01 |
| GOBP RESPONSE TO VITAMIN A | 15 | 7.42e-01 | -4.90e-02 | 9.53e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 309 | 1.38e-01 | 4.90e-02 | 6.59e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 131 | 3.33e-01 | 4.90e-02 | 8.16e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 33 | 6.26e-01 | -4.90e-02 | 9.25e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 47 | 5.61e-01 | -4.90e-02 | 9.05e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 46 | 5.66e-01 | 4.89e-02 | 9.05e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 21 | 6.98e-01 | 4.89e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 458 | 7.31e-02 | 4.89e-02 | 5.36e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 59 | 5.16e-01 | 4.89e-02 | 8.90e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 8.36e-01 | 4.89e-02 | 9.71e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 54 | 5.35e-01 | 4.88e-02 | 8.94e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 10 | 7.89e-01 | 4.88e-02 | 9.60e-01 |
| GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.36e-01 | 4.88e-02 | 9.71e-01 |
| GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS | 9 | 8.00e-01 | -4.88e-02 | 9.61e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 46 | 5.67e-01 | 4.88e-02 | 9.05e-01 |
| GOBP PROTEIN REFOLDING | 27 | 6.61e-01 | 4.88e-02 | 9.31e-01 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 8.36e-01 | 4.88e-02 | 9.71e-01 |
| GOBP REGULATION OF DNA REPLICATION | 121 | 3.54e-01 | -4.88e-02 | 8.28e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 33 | 6.28e-01 | -4.87e-02 | 9.25e-01 |
| GOCC NPBAF COMPLEX | 14 | 7.52e-01 | 4.87e-02 | 9.54e-01 |
| GOBP UV PROTECTION | 12 | 7.70e-01 | -4.87e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 15 | 7.44e-01 | 4.87e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 37 | 6.08e-01 | 4.87e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 21 | 6.99e-01 | 4.87e-02 | 9.43e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 42 | 5.85e-01 | -4.87e-02 | 9.10e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 85 | 4.38e-01 | 4.86e-02 | 8.62e-01 |
| GOBP PROTEIN PALMITOYLATION | 28 | 6.56e-01 | 4.86e-02 | 9.30e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 15 | 7.45e-01 | 4.86e-02 | 9.53e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 8 | 8.12e-01 | 4.86e-02 | 9.67e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 16 | 7.37e-01 | 4.86e-02 | 9.53e-01 |
| GOBP REGULATION OF LOCOMOTION | 1080 | 7.05e-03 | 4.85e-02 | 1.81e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION | 11 | 7.80e-01 | 4.85e-02 | 9.60e-01 |
| GOCC FIBRILLAR CENTER | 144 | 3.15e-01 | 4.85e-02 | 8.08e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 37 | 6.10e-01 | -4.85e-02 | 9.20e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 34 | 6.25e-01 | 4.85e-02 | 9.25e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 26 | 6.69e-01 | 4.84e-02 | 9.34e-01 |
| GOCC POSTSYNAPTIC ENDOSOME | 13 | 7.63e-01 | -4.84e-02 | 9.56e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 57 | 5.27e-01 | 4.84e-02 | 8.93e-01 |
| GOBP VESICLE LOCALIZATION | 208 | 2.30e-01 | 4.83e-02 | 7.60e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 16 | 7.38e-01 | -4.83e-02 | 9.53e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 166 | 2.83e-01 | -4.83e-02 | 7.94e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 31 | 6.42e-01 | 4.83e-02 | 9.28e-01 |
| GOBP AMYLOID BETA CLEARANCE | 39 | 6.02e-01 | -4.83e-02 | 9.17e-01 |
| GOBP TERMINAL BUTTON ORGANIZATION | 6 | 8.38e-01 | 4.83e-02 | 9.71e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 7.16e-01 | -4.82e-02 | 9.48e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 10 | 7.92e-01 | 4.82e-02 | 9.61e-01 |
| GOBP DIAPEDESIS | 6 | 8.38e-01 | 4.82e-02 | 9.71e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 7.92e-01 | 4.82e-02 | 9.61e-01 |
| GOBP EMBRYO DEVELOPMENT | 1091 | 7.26e-03 | 4.81e-02 | 1.82e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 28 | 6.59e-01 | 4.81e-02 | 9.30e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 286 | 1.61e-01 | 4.81e-02 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 28 | 6.60e-01 | 4.81e-02 | 9.30e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 44 | 5.81e-01 | 4.81e-02 | 9.08e-01 |
| GOBP STEROL TRANSPORT | 141 | 3.24e-01 | 4.81e-02 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 61 | 5.16e-01 | -4.80e-02 | 8.90e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 17 | 7.32e-01 | -4.80e-02 | 9.52e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 96 | 4.16e-01 | 4.80e-02 | 8.53e-01 |
| GOBP MESENCHYME DEVELOPMENT | 310 | 1.46e-01 | 4.80e-02 | 6.73e-01 |
| GOCC INTERCELLULAR BRIDGE | 90 | 4.31e-01 | 4.80e-02 | 8.60e-01 |
| GOCC NUCLEAR MEMBRANE | 296 | 1.55e-01 | 4.80e-02 | 6.89e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 77 | 4.67e-01 | -4.80e-02 | 8.75e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 31 | 6.44e-01 | -4.80e-02 | 9.29e-01 |
| GOBP G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION | 6 | 8.39e-01 | -4.80e-02 | 9.71e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 18 | 7.25e-01 | 4.80e-02 | 9.50e-01 |
| GOBP REGULATION OF TUBE SIZE | 142 | 3.24e-01 | 4.79e-02 | 8.10e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 8 | 8.14e-01 | -4.79e-02 | 9.68e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 19 | 7.18e-01 | -4.79e-02 | 9.48e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY | 22 | 6.97e-01 | 4.79e-02 | 9.43e-01 |
| GOBP TISSUE REMODELING | 179 | 2.69e-01 | 4.79e-02 | 7.84e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 24 | 6.85e-01 | 4.78e-02 | 9.40e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 8.39e-01 | -4.78e-02 | 9.72e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 68 | 4.96e-01 | -4.78e-02 | 8.83e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 54 | 5.44e-01 | 4.78e-02 | 8.97e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 26 | 6.74e-01 | -4.77e-02 | 9.36e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 393 | 1.05e-01 | 4.77e-02 | 5.99e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 65 | 5.06e-01 | 4.77e-02 | 8.88e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 68 | 4.97e-01 | 4.77e-02 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 20 | 7.12e-01 | 4.77e-02 | 9.47e-01 |
| GOBP MEMBRANE INVAGINATION | 62 | 5.17e-01 | 4.76e-02 | 8.90e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 232 | 2.12e-01 | 4.76e-02 | 7.44e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 50 | 5.61e-01 | -4.76e-02 | 9.05e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 129 | 3.51e-01 | 4.75e-02 | 8.26e-01 |
| GOBP INTEGRIN ACTIVATION | 26 | 6.75e-01 | -4.75e-02 | 9.36e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 96 | 4.21e-01 | 4.75e-02 | 8.54e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 146 | 3.22e-01 | -4.75e-02 | 8.10e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 913 | 1.50e-02 | 4.75e-02 | 2.62e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 32 | 6.42e-01 | 4.74e-02 | 9.28e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID | 5 | 8.54e-01 | -4.74e-02 | 9.75e-01 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 8.54e-01 | -4.74e-02 | 9.75e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 43 | 5.91e-01 | 4.74e-02 | 9.11e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 7.35e-01 | 4.74e-02 | 9.53e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 43 | 5.91e-01 | 4.73e-02 | 9.11e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 106 | 4.00e-01 | 4.73e-02 | 8.46e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 468 | 7.95e-02 | 4.73e-02 | 5.52e-01 |
| GOBP REGULATION OF RELAXATION OF CARDIAC MUSCLE | 6 | 8.41e-01 | -4.73e-02 | 9.73e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 18 | 7.28e-01 | -4.73e-02 | 9.51e-01 |
| GOCC M BAND | 21 | 7.08e-01 | -4.73e-02 | 9.45e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 84 | 4.54e-01 | 4.73e-02 | 8.70e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 17 | 7.36e-01 | 4.73e-02 | 9.53e-01 |
| GOMF FAD BINDING | 39 | 6.10e-01 | 4.73e-02 | 9.20e-01 |
| GOCC GBAF COMPLEX | 14 | 7.60e-01 | 4.72e-02 | 9.55e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 14 | 7.60e-01 | 4.72e-02 | 9.55e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 34 | 6.34e-01 | 4.72e-02 | 9.25e-01 |
| GOMF AMYLOID BETA BINDING | 82 | 4.60e-01 | -4.71e-02 | 8.72e-01 |
| GOMF U6 SNRNA BINDING | 14 | 7.60e-01 | 4.71e-02 | 9.55e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 392 | 1.09e-01 | 4.71e-02 | 6.09e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 26 | 6.78e-01 | 4.71e-02 | 9.37e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 19 | 7.22e-01 | -4.71e-02 | 9.49e-01 |
| GOBP REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY | 6 | 8.42e-01 | -4.71e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 8 | 8.18e-01 | -4.71e-02 | 9.68e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 1147 | 7.21e-03 | 4.71e-02 | 1.82e-01 |
| GOBP ASTROCYTE ACTIVATION | 25 | 6.84e-01 | -4.70e-02 | 9.40e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 101 | 4.14e-01 | 4.70e-02 | 8.51e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 561 | 5.70e-02 | 4.70e-02 | 4.83e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1864 | 7.74e-04 | 4.70e-02 | 5.30e-02 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 17 | 7.37e-01 | 4.70e-02 | 9.53e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 80 | 4.68e-01 | 4.69e-02 | 8.75e-01 |
| GOBP GABAERGIC NEURON DIFFERENTIATION | 19 | 7.23e-01 | -4.69e-02 | 9.49e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 68 | 5.04e-01 | 4.69e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 70 | 4.98e-01 | 4.69e-02 | 8.84e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 96 | 4.28e-01 | 4.68e-02 | 8.59e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 8 | 8.19e-01 | -4.68e-02 | 9.68e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 309 | 1.57e-01 | 4.68e-02 | 6.91e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 16 | 7.46e-01 | 4.68e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 108 | 4.01e-01 | -4.68e-02 | 8.46e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 122 | 3.72e-01 | 4.68e-02 | 8.33e-01 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 6.92e-01 | 4.68e-02 | 9.43e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 1422 | 3.15e-03 | 4.67e-02 | 1.17e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 35 | 6.32e-01 | 4.67e-02 | 9.25e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 24 | 6.92e-01 | 4.67e-02 | 9.43e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 147 | 3.28e-01 | 4.67e-02 | 8.14e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 8.57e-01 | -4.67e-02 | 9.75e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1430 | 3.13e-03 | 4.67e-02 | 1.17e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 139 | 3.42e-01 | 4.66e-02 | 8.22e-01 |
| GOMF INTERFERON RECEPTOR ACTIVITY | 5 | 8.57e-01 | -4.66e-02 | 9.75e-01 |
| GOBP VIRAL TRANSLATION | 20 | 7.18e-01 | 4.66e-02 | 9.48e-01 |
| GOCC PERIKARYON | 142 | 3.38e-01 | 4.66e-02 | 8.21e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 973 | 1.38e-02 | 4.66e-02 | 2.52e-01 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 21 | 7.12e-01 | -4.65e-02 | 9.47e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 67 | 5.10e-01 | -4.65e-02 | 8.89e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 24 | 6.93e-01 | 4.65e-02 | 9.43e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 22 | 7.06e-01 | -4.65e-02 | 9.45e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 355 | 1.32e-01 | 4.65e-02 | 6.51e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 10 | 7.99e-01 | 4.65e-02 | 9.61e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1668 | 1.58e-03 | 4.65e-02 | 7.94e-02 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE EPINEPHRINE | 8 | 8.20e-01 | -4.64e-02 | 9.68e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 59 | 5.37e-01 | 4.64e-02 | 8.95e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 34 | 6.40e-01 | 4.64e-02 | 9.28e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 190 | 2.70e-01 | 4.64e-02 | 7.85e-01 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 5 | 8.57e-01 | 4.64e-02 | 9.75e-01 |
| GOMF ANNEALING ACTIVITY | 8 | 8.20e-01 | 4.64e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 33 | 6.45e-01 | 4.64e-02 | 9.29e-01 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 11 | 7.90e-01 | 4.64e-02 | 9.61e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 31 | 6.55e-01 | 4.64e-02 | 9.30e-01 |
| GOBP DNA DEAMINATION | 13 | 7.72e-01 | -4.63e-02 | 9.58e-01 |
| GOBP VIRION ASSEMBLY | 34 | 6.40e-01 | 4.63e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 41 | 6.08e-01 | -4.63e-02 | 9.20e-01 |
| GOBP RESPONSE TO ETHANOL | 117 | 3.87e-01 | 4.63e-02 | 8.41e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 551 | 6.31e-02 | 4.63e-02 | 5.04e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 60 | 5.36e-01 | 4.62e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 148 | 3.32e-01 | -4.62e-02 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 48 | 5.80e-01 | 4.62e-02 | 9.08e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 276 | 1.86e-01 | 4.62e-02 | 7.22e-01 |
| GOMF CARNITINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.58e-01 | 4.62e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF EPINEPHRINE SECRETION | 5 | 8.58e-01 | 4.62e-02 | 9.76e-01 |
| GOCC AMPHISOME MEMBRANE | 11 | 7.91e-01 | -4.62e-02 | 9.61e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 37 | 6.27e-01 | 4.62e-02 | 9.25e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 74 | 4.93e-01 | 4.61e-02 | 8.83e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 163 | 3.10e-01 | 4.61e-02 | 8.06e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 57 | 5.47e-01 | -4.61e-02 | 8.99e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 10 | 8.01e-01 | -4.61e-02 | 9.62e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 239 | 2.20e-01 | 4.60e-02 | 7.52e-01 |
| GOMF HISTONE H3K9ME2 H3K9ME3 DEMETHYLASE ACTIVITY | 5 | 8.59e-01 | -4.60e-02 | 9.76e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 218 | 2.42e-01 | 4.60e-02 | 7.65e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 6.38e-01 | 4.60e-02 | 9.26e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 49 | 5.78e-01 | -4.60e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT | 10 | 8.01e-01 | 4.60e-02 | 9.62e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 49 | 5.78e-01 | 4.59e-02 | 9.07e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 23 | 7.03e-01 | 4.59e-02 | 9.44e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 12 | 7.83e-01 | 4.59e-02 | 9.60e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 460 | 9.22e-02 | 4.58e-02 | 5.83e-01 |
| GOMF HAPTOGLOBIN BINDING | 10 | 8.02e-01 | -4.58e-02 | 9.62e-01 |
| GOBP REGULATION OF CELL SIZE | 176 | 2.95e-01 | 4.57e-02 | 7.98e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 1417 | 3.92e-03 | 4.57e-02 | 1.32e-01 |
| GOBP RESPONSE TO KETONE | 197 | 2.69e-01 | 4.57e-02 | 7.84e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 541 | 6.90e-02 | 4.57e-02 | 5.23e-01 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 123 | 3.82e-01 | 4.57e-02 | 8.37e-01 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 11 | 7.93e-01 | 4.57e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 1240 | 6.80e-03 | 4.57e-02 | 1.79e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 134 | 3.61e-01 | 4.57e-02 | 8.33e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 36 | 6.35e-01 | 4.57e-02 | 9.25e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 89 | 4.57e-01 | -4.56e-02 | 8.71e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 365 | 1.34e-01 | -4.56e-02 | 6.53e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 130 | 3.69e-01 | -4.56e-02 | 8.33e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 177 | 2.95e-01 | 4.56e-02 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 891 | 2.10e-02 | 4.56e-02 | 3.12e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 813 | 2.72e-02 | 4.56e-02 | 3.50e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 12 | 7.85e-01 | -4.55e-02 | 9.60e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 613 | 5.43e-02 | 4.55e-02 | 4.78e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 44 | 6.01e-01 | 4.55e-02 | 9.17e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 15 | 7.60e-01 | 4.55e-02 | 9.55e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 387 | 1.25e-01 | 4.55e-02 | 6.40e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 66 | 5.23e-01 | -4.55e-02 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 327 | 1.58e-01 | -4.55e-02 | 6.91e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 26 | 6.88e-01 | -4.54e-02 | 9.42e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 70 | 5.11e-01 | -4.54e-02 | 8.89e-01 |
| GOMF FERROUS IRON BINDING | 24 | 7.00e-01 | 4.54e-02 | 9.44e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 19 | 7.32e-01 | 4.54e-02 | 9.52e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 101 | 4.30e-01 | -4.54e-02 | 8.60e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 45 | 5.98e-01 | 4.54e-02 | 9.15e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 20 | 7.26e-01 | -4.53e-02 | 9.50e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 10 | 8.04e-01 | -4.53e-02 | 9.63e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 92 | 4.54e-01 | -4.52e-02 | 8.70e-01 |
| GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY | 10 | 8.05e-01 | 4.52e-02 | 9.63e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 14 | 7.70e-01 | 4.51e-02 | 9.58e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 8 | 8.25e-01 | 4.51e-02 | 9.69e-01 |
| GOMF VASOPRESSIN RECEPTOR ACTIVITY | 6 | 8.48e-01 | -4.51e-02 | 9.74e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 183 | 2.93e-01 | 4.51e-02 | 7.97e-01 |
| GOCC EXOCYST | 14 | 7.70e-01 | 4.51e-02 | 9.58e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 7 | 8.36e-01 | 4.51e-02 | 9.71e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 7 | 8.36e-01 | 4.51e-02 | 9.71e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 22 | 7.14e-01 | 4.51e-02 | 9.47e-01 |
| GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE | 7 | 8.36e-01 | 4.51e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 9 | 8.15e-01 | -4.51e-02 | 9.68e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 169 | 3.12e-01 | 4.50e-02 | 8.08e-01 |
| GOBP PROTEIN SUMOYLATION | 64 | 5.33e-01 | -4.50e-02 | 8.94e-01 |
| GOBP CELL ADHESION | 1462 | 3.96e-03 | 4.50e-02 | 1.33e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 14 | 7.70e-01 | 4.50e-02 | 9.58e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 59 | 5.50e-01 | -4.50e-02 | 9.01e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 74 | 5.04e-01 | -4.50e-02 | 8.87e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 28 | 6.81e-01 | -4.49e-02 | 9.39e-01 |
| GOBP LIPID CATABOLIC PROCESS | 328 | 1.62e-01 | 4.49e-02 | 6.95e-01 |
| GOCC ESCRT I COMPLEX | 11 | 7.97e-01 | -4.49e-02 | 9.61e-01 |
| GOBP FERTILIZATION | 194 | 2.81e-01 | -4.49e-02 | 7.93e-01 |
| GOBP NAIL DEVELOPMENT | 11 | 7.97e-01 | 4.49e-02 | 9.61e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 8.49e-01 | -4.48e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 10 | 8.06e-01 | 4.48e-02 | 9.64e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 8.49e-01 | 4.48e-02 | 9.74e-01 |
| GOCC MIDBODY | 196 | 2.81e-01 | 4.47e-02 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 74 | 5.06e-01 | 4.47e-02 | 8.88e-01 |
| GOBP HYPOTHALAMUS CELL MIGRATION | 6 | 8.50e-01 | 4.47e-02 | 9.74e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 79 | 4.92e-01 | 4.47e-02 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 53 | 5.74e-01 | -4.47e-02 | 9.06e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 113 | 4.12e-01 | -4.46e-02 | 8.50e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 14 | 7.73e-01 | -4.46e-02 | 9.58e-01 |
| GOBP RESPONSE TO UV C | 14 | 7.73e-01 | -4.46e-02 | 9.58e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 454 | 1.03e-01 | 4.46e-02 | 5.98e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 178 | 3.04e-01 | 4.46e-02 | 8.02e-01 |
| GOBP VIRAL GENOME REPLICATION | 124 | 3.91e-01 | -4.46e-02 | 8.42e-01 |
| GOBP THYMIC T CELL SELECTION | 23 | 7.11e-01 | 4.46e-02 | 9.47e-01 |
| GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 5 | 8.63e-01 | -4.46e-02 | 9.77e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 20 | 7.30e-01 | 4.46e-02 | 9.52e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 41 | 6.22e-01 | 4.46e-02 | 9.24e-01 |
| GOBP THERMOCEPTION | 8 | 8.27e-01 | 4.45e-02 | 9.70e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 16 | 7.58e-01 | 4.45e-02 | 9.54e-01 |
| GOCC INO80 TYPE COMPLEX | 26 | 6.94e-01 | -4.45e-02 | 9.43e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 61 | 5.48e-01 | 4.45e-02 | 9.00e-01 |
| GOMF METAL ION SEQUESTERING ACTIVITY | 5 | 8.63e-01 | 4.45e-02 | 9.77e-01 |
| GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING | 6 | 8.50e-01 | -4.45e-02 | 9.74e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 22 | 7.18e-01 | -4.45e-02 | 9.48e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 8.39e-01 | -4.45e-02 | 9.71e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1507 | 3.91e-03 | 4.45e-02 | 1.32e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 70 | 5.20e-01 | 4.45e-02 | 8.90e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 1194 | 9.69e-03 | 4.44e-02 | 2.12e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 260 | 2.17e-01 | 4.44e-02 | 7.49e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 306 | 1.81e-01 | -4.44e-02 | 7.14e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 687 | 4.74e-02 | 4.44e-02 | 4.48e-01 |
| GOBP ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 8.64e-01 | -4.44e-02 | 9.77e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 17 | 7.52e-01 | 4.44e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 39 | 6.32e-01 | -4.43e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 398 | 1.29e-01 | 4.43e-02 | 6.47e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 298 | 1.88e-01 | 4.43e-02 | 7.24e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 26 | 6.96e-01 | 4.43e-02 | 9.43e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 729 | 4.18e-02 | 4.43e-02 | 4.20e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 20 | 7.32e-01 | 4.43e-02 | 9.52e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 14 | 7.75e-01 | -4.42e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 118 | 4.07e-01 | 4.42e-02 | 8.49e-01 |
| GOBP NUCLEOPHAGY | 18 | 7.46e-01 | -4.42e-02 | 9.53e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1268 | 8.20e-03 | 4.42e-02 | 1.95e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 10 | 8.09e-01 | 4.41e-02 | 9.66e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 7 | 8.40e-01 | 4.41e-02 | 9.72e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 406 | 1.27e-01 | 4.41e-02 | 6.43e-01 |
| GOBP BONE MORPHOGENESIS | 98 | 4.51e-01 | 4.41e-02 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 18 | 7.46e-01 | 4.41e-02 | 9.53e-01 |
| GOBP GOLGI DISASSEMBLY | 6 | 8.52e-01 | -4.41e-02 | 9.74e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 18 | 7.46e-01 | -4.41e-02 | 9.53e-01 |
| GOMF GLYCOLIPID BINDING | 28 | 6.87e-01 | 4.41e-02 | 9.41e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 129 | 3.88e-01 | 4.40e-02 | 8.41e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 11 | 8.00e-01 | 4.40e-02 | 9.61e-01 |
| GOCC STEREOCILIUM BUNDLE | 60 | 5.55e-01 | 4.40e-02 | 9.02e-01 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 6 | 8.52e-01 | 4.40e-02 | 9.74e-01 |
| GOBP BLASTOCYST GROWTH | 21 | 7.27e-01 | -4.40e-02 | 9.51e-01 |
| GOBP UTERINE SMOOTH MUSCLE CONTRACTION | 9 | 8.19e-01 | 4.40e-02 | 9.68e-01 |
| GOMF GLUCOSE BINDING | 10 | 8.10e-01 | 4.40e-02 | 9.66e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 51 | 5.87e-01 | -4.39e-02 | 9.11e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 13 | 7.84e-01 | 4.39e-02 | 9.60e-01 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 8.41e-01 | 4.39e-02 | 9.72e-01 |
| GOBP NEURON REMODELING | 15 | 7.69e-01 | -4.39e-02 | 9.58e-01 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 88 | 4.77e-01 | 4.39e-02 | 8.79e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 215 | 2.68e-01 | -4.38e-02 | 7.83e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 245 | 2.37e-01 | 4.38e-02 | 7.63e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 44 | 6.15e-01 | 4.38e-02 | 9.21e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 39 | 6.36e-01 | -4.38e-02 | 9.26e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 341 | 1.64e-01 | 4.38e-02 | 6.97e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 20 | 7.34e-01 | -4.38e-02 | 9.53e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 74 | 5.15e-01 | 4.38e-02 | 8.90e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 29 | 6.83e-01 | 4.38e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 10 | 8.11e-01 | 4.38e-02 | 9.66e-01 |
| GOBP ADULT BEHAVIOR | 141 | 3.70e-01 | 4.38e-02 | 8.33e-01 |
| GOBP ENDOCYTIC RECYCLING | 82 | 4.93e-01 | 4.38e-02 | 8.83e-01 |
| GOBP OPTIC NERVE MORPHOGENESIS | 6 | 8.53e-01 | 4.37e-02 | 9.74e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 223 | 2.60e-01 | 4.37e-02 | 7.81e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 45 | 6.12e-01 | -4.37e-02 | 9.21e-01 |
| GOBP DEVELOPMENTAL GROWTH | 629 | 6.12e-02 | 4.37e-02 | 4.97e-01 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 10 | 8.11e-01 | -4.37e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 22 | 7.23e-01 | 4.37e-02 | 9.49e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 9 | 8.20e-01 | -4.37e-02 | 9.68e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 34 | 6.59e-01 | 4.37e-02 | 9.30e-01 |
| GOCC PML BODY | 104 | 4.41e-01 | -4.37e-02 | 8.63e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 73 | 5.19e-01 | -4.37e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 8.53e-01 | -4.36e-02 | 9.74e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 55 | 5.76e-01 | -4.36e-02 | 9.06e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 15 | 7.70e-01 | -4.36e-02 | 9.58e-01 |
| GOMF BILE ACID SODIUM SYMPORTER ACTIVITY | 5 | 8.66e-01 | 4.36e-02 | 9.77e-01 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 48 | 6.01e-01 | 4.36e-02 | 9.17e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 74 | 5.17e-01 | 4.36e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 1207 | 1.08e-02 | 4.36e-02 | 2.26e-01 |
| GOBP MEMORY | 120 | 4.10e-01 | 4.36e-02 | 8.49e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 194 | 2.96e-01 | 4.35e-02 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1805 | 2.15e-03 | 4.35e-02 | 9.32e-02 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 143 | 3.69e-01 | 4.35e-02 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 26 | 7.01e-01 | -4.35e-02 | 9.44e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 36 | 6.52e-01 | -4.35e-02 | 9.30e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 110 | 4.31e-01 | 4.35e-02 | 8.60e-01 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 12 | 7.94e-01 | 4.35e-02 | 9.61e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 121 | 4.09e-01 | -4.35e-02 | 8.49e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 31 | 6.75e-01 | 4.35e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 307 | 1.90e-01 | 4.35e-02 | 7.24e-01 |
| GOBP OSSIFICATION | 424 | 1.25e-01 | 4.34e-02 | 6.41e-01 |
| GOBP PARTURITION | 14 | 7.79e-01 | -4.34e-02 | 9.60e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 9 | 8.22e-01 | -4.34e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 5 | 8.67e-01 | -4.34e-02 | 9.77e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 202 | 2.88e-01 | 4.34e-02 | 7.95e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 143 | 3.71e-01 | -4.33e-02 | 8.33e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 16 | 7.64e-01 | -4.33e-02 | 9.57e-01 |
| GOMF TELOMERASE INHIBITOR ACTIVITY | 5 | 8.67e-01 | 4.33e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 52 | 5.89e-01 | 4.33e-02 | 9.11e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 542 | 8.48e-02 | 4.33e-02 | 5.68e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 23 | 7.19e-01 | 4.33e-02 | 9.48e-01 |
| GOCC ACROSOMAL VESICLE | 138 | 3.80e-01 | -4.33e-02 | 8.37e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 8 | 8.32e-01 | 4.33e-02 | 9.71e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 1143 | 1.37e-02 | 4.32e-02 | 2.52e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 25 | 7.08e-01 | -4.32e-02 | 9.45e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 62 | 5.56e-01 | 4.32e-02 | 9.02e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 89 | 4.81e-01 | 4.32e-02 | 8.80e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 7 | 8.43e-01 | 4.32e-02 | 9.73e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 20 | 7.38e-01 | 4.32e-02 | 9.53e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 53 | 5.87e-01 | 4.32e-02 | 9.11e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 257 | 2.34e-01 | 4.32e-02 | 7.61e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 16 | 7.65e-01 | 4.31e-02 | 9.57e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 16 | 7.65e-01 | -4.31e-02 | 9.57e-01 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 15 | 7.73e-01 | -4.31e-02 | 9.58e-01 |
| GOMF BETA TUBULIN BINDING | 35 | 6.59e-01 | -4.31e-02 | 9.30e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 10 | 8.13e-01 | 4.31e-02 | 9.67e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 140 | 3.79e-01 | -4.31e-02 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 31 | 6.78e-01 | -4.31e-02 | 9.37e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 51 | 5.95e-01 | 4.30e-02 | 9.13e-01 |
| GOCC DENDRITIC TREE | 589 | 7.43e-02 | 4.30e-02 | 5.41e-01 |
| GOBP RESPONSE TO ALCOHOL | 246 | 2.45e-01 | 4.30e-02 | 7.68e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 19 | 7.46e-01 | 4.30e-02 | 9.53e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 48 | 6.06e-01 | 4.30e-02 | 9.20e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT | 10 | 8.14e-01 | -4.30e-02 | 9.68e-01 |
| GOBP MRNA PROCESSING | 449 | 1.19e-01 | -4.29e-02 | 6.30e-01 |
| GOMF FUCOSE BINDING | 8 | 8.33e-01 | -4.29e-02 | 9.71e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 88 | 4.86e-01 | 4.29e-02 | 8.80e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 240 | 2.52e-01 | 4.29e-02 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 7 | 8.44e-01 | -4.29e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 46 | 6.15e-01 | 4.29e-02 | 9.21e-01 |
| GOCC GABA ERGIC SYNAPSE | 73 | 5.26e-01 | 4.29e-02 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 9 | 8.24e-01 | 4.29e-02 | 9.69e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 15 | 7.74e-01 | 4.29e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1430 | 6.62e-03 | 4.29e-02 | 1.78e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 44 | 6.23e-01 | 4.29e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 139 | 3.83e-01 | -4.29e-02 | 8.38e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 8.56e-01 | -4.29e-02 | 9.75e-01 |
| GOBP CARTILAGE DEVELOPMENT | 199 | 2.97e-01 | 4.28e-02 | 7.99e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 78 | 5.13e-01 | 4.28e-02 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 12 | 7.97e-01 | 4.28e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 8.56e-01 | -4.28e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 974 | 2.37e-02 | 4.28e-02 | 3.28e-01 |
| GOCC NUCLEOLUS | 1318 | 9.10e-03 | -4.28e-02 | 2.06e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 12 | 7.98e-01 | 4.28e-02 | 9.61e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 27 | 7.01e-01 | 4.27e-02 | 9.44e-01 |
| GOMF PEPTIDE HORMONE BINDING | 48 | 6.09e-01 | 4.27e-02 | 9.20e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 156 | 3.58e-01 | 4.26e-02 | 8.31e-01 |
| GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 8.25e-01 | -4.26e-02 | 9.69e-01 |
| GOBP MICROGLIAL CELL MIGRATION | 8 | 8.35e-01 | -4.26e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 52 | 5.95e-01 | 4.26e-02 | 9.13e-01 |
| GOBP SIRNA PROCESSING | 9 | 8.25e-01 | -4.26e-02 | 9.69e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 8.35e-01 | -4.26e-02 | 9.71e-01 |
| GOBP B 1 B CELL DIFFERENTIATION | 5 | 8.69e-01 | -4.26e-02 | 9.78e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 155 | 3.60e-01 | 4.26e-02 | 8.32e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 18 | 7.55e-01 | 4.26e-02 | 9.54e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 28 | 6.97e-01 | 4.26e-02 | 9.43e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 655 | 6.32e-02 | 4.25e-02 | 5.04e-01 |
| GOCC FLEMMING BODY | 34 | 6.68e-01 | 4.25e-02 | 9.33e-01 |
| GOBP REGULATION OF DNA BINDING | 82 | 5.06e-01 | -4.25e-02 | 8.88e-01 |
| GOCC SPINDLE MICROTUBULE | 76 | 5.22e-01 | 4.25e-02 | 8.91e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 22 | 7.30e-01 | -4.25e-02 | 9.52e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 544 | 9.04e-02 | 4.25e-02 | 5.78e-01 |
| GOBP SOMITE DEVELOPMENT | 82 | 5.07e-01 | 4.24e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 74 | 5.28e-01 | 4.24e-02 | 8.93e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 15 | 7.76e-01 | -4.24e-02 | 9.59e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 11 | 8.08e-01 | 4.24e-02 | 9.64e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 117 | 4.29e-01 | -4.24e-02 | 8.59e-01 |
| GOMF PRE MRNA BINDING | 39 | 6.47e-01 | 4.23e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 7 | 8.46e-01 | -4.23e-02 | 9.73e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 139 | 3.89e-01 | 4.23e-02 | 8.41e-01 |
| GOCC TERMINAL BOUTON | 43 | 6.31e-01 | 4.23e-02 | 9.25e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 1202 | 1.36e-02 | 4.23e-02 | 2.52e-01 |
| GOBP PROLACTIN SECRETION | 5 | 8.70e-01 | 4.23e-02 | 9.79e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 24 | 7.20e-01 | 4.22e-02 | 9.48e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 169 | 3.43e-01 | 4.22e-02 | 8.23e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 13 | 7.92e-01 | 4.22e-02 | 9.61e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 13 | 7.92e-01 | 4.22e-02 | 9.61e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 5.56e-01 | -4.22e-02 | 9.02e-01 |
| GOCC PROTEIN DNA COMPLEX | 1325 | 9.89e-03 | 4.22e-02 | 2.14e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 17 | 7.63e-01 | -4.22e-02 | 9.56e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 18 | 7.57e-01 | 4.22e-02 | 9.54e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 731 | 5.21e-02 | 4.22e-02 | 4.68e-01 |
| GOBP ARTERY MORPHOGENESIS | 81 | 5.12e-01 | 4.22e-02 | 8.89e-01 |
| GOBP PROTEIN PROCESSING | 233 | 2.68e-01 | 4.21e-02 | 7.83e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 7 | 8.47e-01 | -4.21e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 93 | 4.83e-01 | 4.21e-02 | 8.80e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 14 | 7.85e-01 | 4.21e-02 | 9.60e-01 |
| GOBP CELLULAR RESPIRATION | 216 | 2.87e-01 | -4.21e-02 | 7.95e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 46 | 6.22e-01 | 4.21e-02 | 9.24e-01 |
| GOMF E BOX BINDING | 58 | 5.80e-01 | 4.20e-02 | 9.08e-01 |
| GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT | 12 | 8.01e-01 | -4.20e-02 | 9.62e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 28 | 7.00e-01 | 4.20e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF GLUTAMATE SECRETION | 6 | 8.59e-01 | -4.20e-02 | 9.76e-01 |
| GOMF 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE BINDING | 9 | 8.27e-01 | 4.20e-02 | 9.70e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 36 | 6.63e-01 | 4.20e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 231 | 2.72e-01 | 4.20e-02 | 7.86e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 16 | 7.71e-01 | -4.19e-02 | 9.58e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 99 | 4.71e-01 | 4.19e-02 | 8.76e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 16 | 7.72e-01 | -4.19e-02 | 9.58e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 233 | 2.71e-01 | 4.19e-02 | 7.85e-01 |
| GOMF RETINAL BINDING | 19 | 7.52e-01 | -4.19e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 208 | 2.98e-01 | 4.19e-02 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 11 | 8.10e-01 | -4.19e-02 | 9.66e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 96 | 4.79e-01 | 4.19e-02 | 8.79e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 577 | 8.59e-02 | 4.18e-02 | 5.70e-01 |
| GOBP CELL CELL ADHESION | 918 | 3.16e-02 | 4.18e-02 | 3.80e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 98 | 4.74e-01 | -4.18e-02 | 8.77e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 317 | 2.01e-01 | 4.18e-02 | 7.32e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 27 | 7.07e-01 | 4.18e-02 | 9.45e-01 |
| GOBP PARACRINE SIGNALING | 6 | 8.59e-01 | 4.18e-02 | 9.76e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 65 | 5.60e-01 | -4.18e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 89 | 4.96e-01 | -4.17e-02 | 8.83e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 248 | 2.58e-01 | 4.17e-02 | 7.78e-01 |
| GOMF HISTONE READER ACTIVITY | 12 | 8.03e-01 | -4.16e-02 | 9.62e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 38 | 6.57e-01 | -4.16e-02 | 9.30e-01 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 8.72e-01 | -4.16e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 1211 | 1.49e-02 | 4.16e-02 | 2.62e-01 |
| GOBP RESPONSE TO LIPID | 890 | 3.55e-02 | 4.15e-02 | 3.96e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 14 | 7.88e-01 | 4.15e-02 | 9.60e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 20 | 7.48e-01 | -4.15e-02 | 9.53e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 74 | 5.37e-01 | 4.15e-02 | 8.95e-01 |
| GOBP PROTEIN TARGETING | 316 | 2.05e-01 | 4.15e-02 | 7.35e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 129 | 4.16e-01 | -4.15e-02 | 8.52e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 10 | 8.20e-01 | 4.15e-02 | 9.68e-01 |
| GOMF ALPHA ACTININ BINDING | 28 | 7.04e-01 | 4.15e-02 | 9.44e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 99 | 4.76e-01 | 4.14e-02 | 8.78e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 65 | 5.64e-01 | 4.14e-02 | 9.05e-01 |
| GOBP CELL MOTILITY | 1713 | 4.42e-03 | 4.14e-02 | 1.41e-01 |
| GOBP PROTEIN MATURATION | 515 | 1.08e-01 | 4.13e-02 | 6.06e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 259 | 2.52e-01 | 4.13e-02 | 7.74e-01 |
| GOBP HEAD MORPHOGENESIS | 35 | 6.72e-01 | 4.13e-02 | 9.36e-01 |
| GOBP ENDODERM DEVELOPMENT | 81 | 5.21e-01 | -4.13e-02 | 8.90e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 8.13e-01 | 4.13e-02 | 9.67e-01 |
| GOBP GLIAL CELL PROLIFERATION | 53 | 6.03e-01 | 4.13e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 49 | 6.18e-01 | 4.12e-02 | 9.22e-01 |
| GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY | 6 | 8.61e-01 | -4.12e-02 | 9.77e-01 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 91 | 4.98e-01 | 4.11e-02 | 8.84e-01 |
| GOBP LIPID LOCALIZATION | 495 | 1.18e-01 | 4.11e-02 | 6.29e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 17 | 7.69e-01 | 4.11e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 10 | 8.22e-01 | -4.10e-02 | 9.69e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 101 | 4.76e-01 | 4.10e-02 | 8.78e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 207 | 3.09e-01 | -4.10e-02 | 8.05e-01 |
| GOBP EAR DEVELOPMENT | 217 | 2.98e-01 | 4.10e-02 | 7.99e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 6 | 8.62e-01 | -4.09e-02 | 9.77e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 206 | 3.11e-01 | 4.09e-02 | 8.08e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 290 | 2.31e-01 | 4.09e-02 | 7.60e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 109 | 4.61e-01 | 4.09e-02 | 8.72e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 199 | 3.20e-01 | 4.09e-02 | 8.10e-01 |
| GOBP CELL MIGRATION IN HINDBRAIN | 16 | 7.77e-01 | 4.09e-02 | 9.59e-01 |
| GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT | 6 | 8.62e-01 | 4.08e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 9 | 8.32e-01 | -4.08e-02 | 9.71e-01 |
| GOBP SPHINGOLIPID TRANSLOCATION | 5 | 8.75e-01 | -4.08e-02 | 9.79e-01 |
| GOBP NEUROBLAST PROLIFERATION | 80 | 5.28e-01 | -4.08e-02 | 8.93e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 90 | 5.04e-01 | 4.08e-02 | 8.87e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 658 | 7.46e-02 | 4.07e-02 | 5.41e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 1148 | 1.99e-02 | 4.07e-02 | 3.01e-01 |
| GOBP OLIGODENDROCYTE PROGENITOR PROLIFERATION | 8 | 8.42e-01 | 4.07e-02 | 9.73e-01 |
| GOBP RESPONSE TO PAIN | 34 | 6.81e-01 | -4.07e-02 | 9.39e-01 |
| GOCC NEUROFIBRILLARY TANGLE | 5 | 8.75e-01 | 4.07e-02 | 9.79e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 60 | 5.86e-01 | 4.07e-02 | 9.10e-01 |
| GOBP OTIC VESICLE FORMATION | 8 | 8.42e-01 | -4.07e-02 | 9.73e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 11 | 8.15e-01 | 4.07e-02 | 9.68e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 32 | 6.91e-01 | -4.06e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 8 | 8.42e-01 | 4.06e-02 | 9.73e-01 |
| GOCC CENTRIOLE | 151 | 3.89e-01 | -4.06e-02 | 8.41e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 240 | 2.79e-01 | 4.06e-02 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 43 | 6.45e-01 | 4.06e-02 | 9.29e-01 |
| GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 8.42e-01 | -4.06e-02 | 9.73e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 10 | 8.24e-01 | 4.06e-02 | 9.69e-01 |
| GOBP CRISTAE FORMATION | 15 | 7.86e-01 | 4.06e-02 | 9.60e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 82 | 5.25e-01 | -4.06e-02 | 8.92e-01 |
| GOCC SPINDLE MIDZONE | 35 | 6.78e-01 | -4.06e-02 | 9.37e-01 |
| GOBP CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM | 5 | 8.75e-01 | -4.05e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 66 | 5.69e-01 | -4.05e-02 | 9.06e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 10 | 8.24e-01 | 4.05e-02 | 9.69e-01 |
| GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 21 | 7.48e-01 | 4.05e-02 | 9.53e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 8.25e-01 | -4.05e-02 | 9.69e-01 |
| GOBP FORMATION OF ANATOMICAL BOUNDARY | 7 | 8.53e-01 | 4.05e-02 | 9.74e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 41 | 6.54e-01 | 4.05e-02 | 9.30e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 78 | 5.37e-01 | 4.04e-02 | 8.95e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 39 | 6.62e-01 | -4.04e-02 | 9.31e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 110 | 4.65e-01 | 4.04e-02 | 8.74e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 345 | 1.98e-01 | 4.03e-02 | 7.29e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 26 | 7.22e-01 | -4.03e-02 | 9.48e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 930 | 3.72e-02 | 4.03e-02 | 4.03e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 22 | 7.44e-01 | 4.03e-02 | 9.53e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1616 | 6.94e-03 | 4.03e-02 | 1.80e-01 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 24 | 7.33e-01 | 4.03e-02 | 9.52e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT | 9 | 8.35e-01 | -4.02e-02 | 9.71e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 31 | 6.98e-01 | -4.02e-02 | 9.43e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 77 | 5.42e-01 | -4.02e-02 | 8.97e-01 |
| GOBP REGULATION OF ACROSOME REACTION | 17 | 7.74e-01 | -4.02e-02 | 9.58e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 36 | 6.77e-01 | -4.02e-02 | 9.37e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 21 | 7.50e-01 | -4.02e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION | 6 | 8.65e-01 | -4.01e-02 | 9.77e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 254 | 2.71e-01 | 4.01e-02 | 7.85e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 36 | 6.77e-01 | -4.01e-02 | 9.37e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 15 | 7.88e-01 | -4.01e-02 | 9.60e-01 |
| GOMF CHROMATIN BINDING | 551 | 1.08e-01 | 4.01e-02 | 6.05e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 30 | 7.04e-01 | 4.01e-02 | 9.44e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 72 | 5.57e-01 | 4.01e-02 | 9.02e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 17 | 7.75e-01 | -4.01e-02 | 9.58e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 10 | 8.26e-01 | -4.00e-02 | 9.70e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 60 | 5.92e-01 | 4.00e-02 | 9.12e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 24 | 7.34e-01 | 4.00e-02 | 9.53e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 7.35e-01 | -4.00e-02 | 9.53e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 38 | 6.70e-01 | 4.00e-02 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION | 5 | 8.77e-01 | -4.00e-02 | 9.79e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 7 | 8.55e-01 | 3.99e-02 | 9.75e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 14 | 7.96e-01 | 3.99e-02 | 9.61e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 103 | 4.84e-01 | 3.99e-02 | 8.80e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 179 | 3.57e-01 | -3.99e-02 | 8.31e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 29 | 7.10e-01 | -3.99e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 141 | 4.13e-01 | 3.99e-02 | 8.51e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 17 | 7.76e-01 | 3.99e-02 | 9.59e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 31 | 7.01e-01 | -3.99e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 8 | 8.45e-01 | 3.99e-02 | 9.73e-01 |
| GOBP REGULATION OF RENAL SYSTEM PROCESS | 21 | 7.52e-01 | -3.98e-02 | 9.54e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 28 | 7.15e-01 | 3.98e-02 | 9.48e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 20 | 7.58e-01 | -3.98e-02 | 9.54e-01 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 11 | 8.19e-01 | 3.98e-02 | 9.68e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 47 | 6.37e-01 | -3.98e-02 | 9.26e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 25 | 7.31e-01 | 3.98e-02 | 9.52e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 60 | 5.94e-01 | -3.98e-02 | 9.13e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 8.78e-01 | -3.97e-02 | 9.79e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN ANOTHER COMPOUND AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 6 | 8.66e-01 | 3.97e-02 | 9.77e-01 |
| GOBP NUCLEOSIDE TRANSPORT | 10 | 8.28e-01 | -3.97e-02 | 9.70e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 7.71e-01 | -3.97e-02 | 9.58e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 51 | 6.24e-01 | 3.97e-02 | 9.24e-01 |
| GOBP REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 8 | 8.46e-01 | 3.97e-02 | 9.73e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 8.20e-01 | -3.97e-02 | 9.68e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 27 | 7.21e-01 | -3.97e-02 | 9.48e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 31 | 7.02e-01 | -3.97e-02 | 9.44e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 518 | 1.22e-01 | 3.97e-02 | 6.36e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 170 | 3.72e-01 | 3.97e-02 | 8.33e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 8 | 8.46e-01 | 3.96e-02 | 9.73e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 27 | 7.22e-01 | -3.96e-02 | 9.48e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 10 | 8.28e-01 | 3.96e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 24 | 7.37e-01 | -3.96e-02 | 9.53e-01 |
| GOBP MAMMARY GLAND INVOLUTION | 8 | 8.46e-01 | 3.96e-02 | 9.73e-01 |
| GOBP FOREBRAIN DORSAL VENTRAL PATTERN FORMATION | 7 | 8.56e-01 | -3.96e-02 | 9.75e-01 |
| GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY | 16 | 7.84e-01 | 3.96e-02 | 9.60e-01 |
| GOBP RECEPTOR TRANSACTIVATION | 5 | 8.78e-01 | 3.96e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 9 | 8.37e-01 | -3.95e-02 | 9.71e-01 |
| GOMF CUPRIC ION BINDING | 5 | 8.78e-01 | 3.95e-02 | 9.79e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 8.67e-01 | -3.95e-02 | 9.77e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 888 | 4.56e-02 | 3.95e-02 | 4.39e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 7 | 8.56e-01 | -3.95e-02 | 9.75e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 45 | 6.47e-01 | -3.95e-02 | 9.29e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 387 | 1.83e-01 | -3.95e-02 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 92 | 5.13e-01 | 3.95e-02 | 8.89e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 15 | 7.92e-01 | 3.94e-02 | 9.61e-01 |
| GOMF MRNA BINDING | 540 | 1.17e-01 | -3.94e-02 | 6.28e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 74 | 5.58e-01 | 3.94e-02 | 9.03e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 8.29e-01 | -3.94e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 339 | 2.13e-01 | 3.94e-02 | 7.44e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 44 | 6.52e-01 | -3.93e-02 | 9.30e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 185 | 3.56e-01 | 3.93e-02 | 8.30e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 9 | 8.38e-01 | -3.93e-02 | 9.71e-01 |
| GOMF NEUREGULIN BINDING | 5 | 8.79e-01 | -3.93e-02 | 9.79e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 36 | 6.83e-01 | -3.93e-02 | 9.40e-01 |
| GOBP EXOCYTIC PROCESS | 82 | 5.39e-01 | 3.93e-02 | 8.96e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 132 | 4.36e-01 | -3.93e-02 | 8.60e-01 |
| GOBP POTASSIUM ION TRANSPORT | 234 | 3.01e-01 | 3.93e-02 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 495 | 1.35e-01 | 3.92e-02 | 6.53e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 576 | 1.08e-01 | 3.92e-02 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 19 | 7.67e-01 | -3.92e-02 | 9.58e-01 |
| GOMF PHOSPHATE ION BINDING | 11 | 8.22e-01 | 3.92e-02 | 9.69e-01 |
| GOBP FLAVONOID METABOLIC PROCESS | 11 | 8.22e-01 | 3.92e-02 | 9.69e-01 |
| GOMF HEMOGLOBIN ALPHA BINDING | 5 | 8.80e-01 | -3.91e-02 | 9.79e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 8.68e-01 | -3.91e-02 | 9.78e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 945 | 4.20e-02 | 3.90e-02 | 4.21e-01 |
| GOCC MICROTUBULE | 441 | 1.60e-01 | 3.90e-02 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 101 | 4.98e-01 | 3.90e-02 | 8.84e-01 |
| GOBP NEUROBLAST DIVISION | 13 | 8.08e-01 | 3.90e-02 | 9.64e-01 |
| GOBP BASE EXCISION REPAIR | 42 | 6.62e-01 | -3.90e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 21 | 7.57e-01 | -3.90e-02 | 9.54e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 1478 | 1.22e-02 | 3.90e-02 | 2.38e-01 |
| GOBP NEURAL PLATE PATTERN SPECIFICATION | 8 | 8.49e-01 | 3.90e-02 | 9.74e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 83 | 5.39e-01 | -3.90e-02 | 8.96e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 563 | 1.14e-01 | 3.89e-02 | 6.22e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 1532 | 1.09e-02 | 3.89e-02 | 2.26e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 70 | 5.73e-01 | 3.89e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 24 | 7.41e-01 | -3.89e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 83 | 5.40e-01 | -3.89e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION | 7 | 8.59e-01 | -3.88e-02 | 9.76e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 263 | 2.78e-01 | 3.88e-02 | 7.92e-01 |
| GOBP TISSUE MORPHOGENESIS | 618 | 9.94e-02 | 3.88e-02 | 5.95e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 68 | 5.80e-01 | 3.88e-02 | 9.08e-01 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 15 | 7.95e-01 | 3.88e-02 | 9.61e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 41 | 6.67e-01 | -3.88e-02 | 9.33e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 8.81e-01 | -3.88e-02 | 9.79e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 81 | 5.47e-01 | -3.87e-02 | 8.99e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 19 | 7.70e-01 | 3.87e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 12 | 8.17e-01 | -3.87e-02 | 9.68e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 25 | 7.38e-01 | -3.86e-02 | 9.53e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 23 | 7.48e-01 | -3.86e-02 | 9.53e-01 |
| GOBP ZYMOGEN ACTIVATION | 57 | 6.14e-01 | 3.86e-02 | 9.21e-01 |
| GOMF GLYCEROL CHANNEL ACTIVITY | 5 | 8.81e-01 | -3.86e-02 | 9.79e-01 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 8.81e-01 | -3.85e-02 | 9.79e-01 |
| GOCC NEURON PROJECTION | 1246 | 2.21e-02 | 3.85e-02 | 3.19e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 17 | 7.83e-01 | 3.85e-02 | 9.60e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 224 | 3.21e-01 | 3.85e-02 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 140 | 4.32e-01 | 3.85e-02 | 8.60e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 11 | 8.25e-01 | 3.85e-02 | 9.69e-01 |
| GOBP VACUOLAR TRANSPORT | 163 | 3.97e-01 | 3.84e-02 | 8.45e-01 |
| GOMF CATECHOLAMINE BINDING | 12 | 8.18e-01 | 3.84e-02 | 9.68e-01 |
| GOCC INNER KINETOCHORE | 17 | 7.84e-01 | -3.84e-02 | 9.60e-01 |
| GOBP NEUROMUSCULAR PROCESS | 159 | 4.03e-01 | 3.84e-02 | 8.47e-01 |
| GOBP REGULATION OF PH | 95 | 5.18e-01 | 3.84e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 216 | 3.32e-01 | 3.83e-02 | 8.15e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 13 | 8.11e-01 | -3.83e-02 | 9.66e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 169 | 3.91e-01 | 3.82e-02 | 8.42e-01 |
| GOCC SIN3 TYPE COMPLEX | 20 | 7.67e-01 | 3.82e-02 | 9.58e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 73 | 5.72e-01 | 3.82e-02 | 9.06e-01 |
| GOBP RENAL VESICLE DEVELOPMENT | 18 | 7.79e-01 | -3.82e-02 | 9.60e-01 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 8 | 8.52e-01 | -3.82e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 112 | 4.85e-01 | 3.82e-02 | 8.80e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 46 | 6.54e-01 | 3.82e-02 | 9.30e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 169 | 3.92e-01 | 3.82e-02 | 8.43e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 12 | 8.19e-01 | -3.82e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 166 | 3.96e-01 | 3.82e-02 | 8.45e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 18 | 7.79e-01 | 3.82e-02 | 9.60e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 25 | 7.42e-01 | 3.81e-02 | 9.53e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 58 | 6.17e-01 | -3.80e-02 | 9.22e-01 |
| GOBP HEART MORPHOGENESIS | 262 | 2.90e-01 | 3.80e-02 | 7.96e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 118 | 4.76e-01 | -3.80e-02 | 8.78e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 17 | 7.86e-01 | -3.80e-02 | 9.60e-01 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 87 | 5.41e-01 | 3.79e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 21 | 7.64e-01 | 3.79e-02 | 9.56e-01 |
| GOCC KNL1 SPC105 COMPLEX | 6 | 8.72e-01 | 3.79e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 71 | 5.81e-01 | -3.79e-02 | 9.08e-01 |
| GOBP CITRULLINE METABOLIC PROCESS | 7 | 8.62e-01 | -3.79e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 12 | 8.20e-01 | -3.79e-02 | 9.68e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 9 | 8.44e-01 | 3.78e-02 | 9.73e-01 |
| GOMF CELL ADHESIVE PROTEIN BINDING INVOLVED IN BUNDLE OF HIS CELL PURKINJE MYOCYTE COMMUNICATION | 5 | 8.84e-01 | -3.78e-02 | 9.80e-01 |
| GOBP EGG ACTIVATION | 11 | 8.28e-01 | 3.78e-02 | 9.70e-01 |
| GOMF LIPID KINASE ACTIVITY | 40 | 6.79e-01 | 3.78e-02 | 9.38e-01 |
| GOMF SUMO BINDING | 16 | 7.94e-01 | -3.78e-02 | 9.61e-01 |
| GOCC ESCRT COMPLEX | 27 | 7.34e-01 | -3.78e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 24 | 7.49e-01 | 3.78e-02 | 9.53e-01 |
| GOBP RRNA METABOLIC PROCESS | 253 | 3.01e-01 | -3.78e-02 | 8.02e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 101 | 5.12e-01 | 3.77e-02 | 8.89e-01 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 298 | 2.63e-01 | 3.77e-02 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 18 | 7.82e-01 | -3.77e-02 | 9.60e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 7.35e-01 | -3.77e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 21 | 7.65e-01 | -3.76e-02 | 9.57e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 97 | 5.22e-01 | -3.76e-02 | 8.91e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 49 | 6.49e-01 | 3.76e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 126 | 4.66e-01 | 3.76e-02 | 8.75e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 507 | 1.47e-01 | 3.76e-02 | 6.74e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 17 | 7.88e-01 | -3.76e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 198 | 3.62e-01 | 3.76e-02 | 8.33e-01 |
| GOBP CGMP MEDIATED SIGNALING | 30 | 7.22e-01 | -3.76e-02 | 9.48e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 82 | 5.56e-01 | 3.76e-02 | 9.02e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 45 | 6.63e-01 | -3.76e-02 | 9.31e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 17 | 7.89e-01 | -3.76e-02 | 9.60e-01 |
| GOCC BASAL PART OF CELL | 291 | 2.70e-01 | 3.76e-02 | 7.85e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 63 | 6.06e-01 | 3.75e-02 | 9.20e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 37 | 6.93e-01 | -3.75e-02 | 9.43e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT | 5 | 8.84e-01 | 3.75e-02 | 9.80e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 12 | 8.22e-01 | -3.75e-02 | 9.69e-01 |
| GOMF PROTEIN SELF ASSOCIATION | 70 | 5.87e-01 | 3.75e-02 | 9.11e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 8 | 8.54e-01 | 3.75e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 18 | 7.83e-01 | -3.75e-02 | 9.60e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 18 | 7.83e-01 | 3.75e-02 | 9.60e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 223 | 3.35e-01 | 3.75e-02 | 8.19e-01 |
| GOMF SULFUR COMPOUND BINDING | 263 | 2.96e-01 | 3.74e-02 | 7.99e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 218 | 3.41e-01 | 3.74e-02 | 8.22e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 295 | 2.70e-01 | 3.73e-02 | 7.85e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 139 | 4.48e-01 | 3.73e-02 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 36 | 6.99e-01 | -3.73e-02 | 9.43e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 10 | 8.38e-01 | -3.73e-02 | 9.71e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 15 | 8.03e-01 | 3.72e-02 | 9.62e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 145 | 4.39e-01 | 3.72e-02 | 8.62e-01 |
| GOBP NUCLEAR MIGRATION | 25 | 7.47e-01 | 3.72e-02 | 9.53e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 10 | 8.39e-01 | 3.72e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 41 | 6.80e-01 | 3.72e-02 | 9.39e-01 |
| GOBP MELANOSOME ASSEMBLY | 18 | 7.85e-01 | 3.72e-02 | 9.60e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 13 | 8.17e-01 | -3.72e-02 | 9.68e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 8 | 8.56e-01 | -3.71e-02 | 9.75e-01 |
| GOBP CEREBRAL CORTEX REGIONALIZATION | 7 | 8.65e-01 | 3.71e-02 | 9.77e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 6 | 8.75e-01 | 3.71e-02 | 9.79e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 200 | 3.66e-01 | 3.71e-02 | 8.33e-01 |
| GOCC OUTER MEMBRANE | 229 | 3.34e-01 | 3.71e-02 | 8.18e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 29 | 7.30e-01 | -3.71e-02 | 9.52e-01 |
| GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB | 7 | 8.65e-01 | -3.71e-02 | 9.77e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 46 | 6.64e-01 | 3.70e-02 | 9.31e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 1036 | 4.38e-02 | 3.70e-02 | 4.29e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 26 | 7.44e-01 | -3.70e-02 | 9.53e-01 |
| GOCC BLOOD MICROPARTICLE | 111 | 5.01e-01 | -3.70e-02 | 8.86e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 15 | 8.04e-01 | 3.70e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 212 | 3.54e-01 | 3.69e-02 | 8.28e-01 |
| GOCC POSTSYNAPSE | 614 | 1.18e-01 | 3.69e-02 | 6.30e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 26 | 7.45e-01 | 3.69e-02 | 9.53e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 8.86e-01 | 3.69e-02 | 9.81e-01 |
| GOMF CYTOKINE ACTIVITY | 223 | 3.43e-01 | 3.69e-02 | 8.22e-01 |
| GOBP MALE GAMETE GENERATION | 568 | 1.33e-01 | -3.69e-02 | 6.51e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 141 | 4.50e-01 | 3.69e-02 | 8.69e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 198 | 3.71e-01 | 3.69e-02 | 8.33e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS | 34 | 7.10e-01 | -3.69e-02 | 9.46e-01 |
| GOCC NEURON PROJECTION TERMINUS | 123 | 4.80e-01 | 3.69e-02 | 8.80e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 48 | 6.59e-01 | 3.68e-02 | 9.30e-01 |
| GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX | 14 | 8.12e-01 | -3.68e-02 | 9.67e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 198 | 3.72e-01 | 3.68e-02 | 8.33e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 478 | 1.69e-01 | 3.68e-02 | 7.01e-01 |
| GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY | 7 | 8.66e-01 | 3.68e-02 | 9.77e-01 |
| GOBP AXIS SPECIFICATION | 91 | 5.45e-01 | 3.68e-02 | 8.98e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 33 | 7.15e-01 | -3.67e-02 | 9.47e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 18 | 7.87e-01 | 3.67e-02 | 9.60e-01 |
| GOBP PROTEIN NEDDYLATION | 28 | 7.37e-01 | 3.67e-02 | 9.53e-01 |
| GOCC DYNEIN COMPLEX | 53 | 6.44e-01 | -3.67e-02 | 9.29e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 24 | 7.56e-01 | 3.67e-02 | 9.54e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 152 | 4.35e-01 | 3.67e-02 | 8.60e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 8.57e-01 | 3.67e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 38 | 6.96e-01 | -3.67e-02 | 9.43e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 8.33e-01 | 3.67e-02 | 9.71e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 669 | 1.06e-01 | 3.66e-02 | 6.02e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 72 | 5.91e-01 | 3.66e-02 | 9.11e-01 |
| GOBP STEROID CATABOLIC PROCESS | 24 | 7.56e-01 | -3.66e-02 | 9.54e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 40 | 6.89e-01 | 3.66e-02 | 9.42e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION | 6 | 8.77e-01 | 3.66e-02 | 9.79e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 9 | 8.49e-01 | -3.66e-02 | 9.74e-01 |
| GOMF CARBONATE DEHYDRATASE ACTIVITY | 14 | 8.13e-01 | -3.66e-02 | 9.67e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 27 | 7.42e-01 | 3.66e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 27 | 7.43e-01 | 3.65e-02 | 9.53e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 26 | 7.47e-01 | 3.65e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 109 | 5.10e-01 | 3.65e-02 | 8.89e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 220 | 3.51e-01 | -3.65e-02 | 8.26e-01 |
| GOCC NUCLEAR ENVELOPE | 464 | 1.79e-01 | 3.64e-02 | 7.11e-01 |
| GOBP EMBRYO IMPLANTATION | 57 | 6.35e-01 | -3.64e-02 | 9.25e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 29 | 7.34e-01 | -3.64e-02 | 9.53e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 24 | 7.58e-01 | 3.64e-02 | 9.54e-01 |
| GOMF SH3 DOMAIN BINDING | 114 | 5.02e-01 | 3.64e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 135 | 4.66e-01 | -3.64e-02 | 8.75e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 42 | 6.84e-01 | -3.63e-02 | 9.40e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 208 | 3.67e-01 | 3.63e-02 | 8.33e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 256 | 3.18e-01 | -3.63e-02 | 8.10e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY NITROGENOUS GROUP AS ACCEPTOR | 6 | 8.78e-01 | 3.63e-02 | 9.79e-01 |
| GOBP GASTRULATION | 188 | 3.92e-01 | 3.62e-02 | 8.42e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 25 | 7.54e-01 | -3.62e-02 | 9.54e-01 |
| GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT | 8 | 8.59e-01 | -3.62e-02 | 9.76e-01 |
| GOCC COPI VESICLE COAT | 13 | 8.21e-01 | 3.62e-02 | 9.68e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 8.59e-01 | 3.62e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 47 | 6.68e-01 | -3.62e-02 | 9.33e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 21 | 7.74e-01 | 3.62e-02 | 9.58e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 7.96e-01 | 3.62e-02 | 9.61e-01 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 8.36e-01 | -3.61e-02 | 9.71e-01 |
| GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 8 | 8.60e-01 | -3.61e-02 | 9.76e-01 |
| GOCC ACROSOMAL MEMBRANE | 32 | 7.24e-01 | 3.61e-02 | 9.49e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY | 8 | 8.60e-01 | 3.61e-02 | 9.76e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 242 | 3.33e-01 | -3.61e-02 | 8.18e-01 |
| GOBP PEROXISOME ORGANIZATION | 34 | 7.16e-01 | -3.61e-02 | 9.48e-01 |
| GOBP TISSUE REGENERATION | 73 | 5.94e-01 | 3.61e-02 | 9.12e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 31 | 7.28e-01 | -3.61e-02 | 9.51e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 503 | 1.66e-01 | 3.61e-02 | 6.99e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 8 | 8.60e-01 | -3.61e-02 | 9.76e-01 |
| GOBP FRUCTOSE METABOLIC PROCESS | 13 | 8.22e-01 | -3.60e-02 | 9.69e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 357 | 2.42e-01 | 3.60e-02 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 297 | 2.86e-01 | 3.60e-02 | 7.95e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 5 | 8.89e-01 | 3.60e-02 | 9.81e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 26 | 7.51e-01 | 3.60e-02 | 9.53e-01 |
| GOBP AXON CHOICE POINT RECOGNITION | 7 | 8.69e-01 | 3.59e-02 | 9.78e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 54 | 6.48e-01 | -3.59e-02 | 9.30e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 21 | 7.76e-01 | 3.59e-02 | 9.59e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 67 | 6.12e-01 | 3.59e-02 | 9.21e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 506 | 1.67e-01 | -3.58e-02 | 7.00e-01 |
| GOBP ACTION POTENTIAL | 139 | 4.66e-01 | 3.58e-02 | 8.75e-01 |
| GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS | 10 | 8.45e-01 | -3.58e-02 | 9.73e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 19 | 7.87e-01 | 3.58e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS | 6 | 8.79e-01 | -3.58e-02 | 9.79e-01 |
| GOBP MUSCLE CONTRACTION | 338 | 2.58e-01 | 3.58e-02 | 7.78e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 8 | 8.61e-01 | -3.58e-02 | 9.76e-01 |
| GOBP SYNAPSE PRUNING | 14 | 8.17e-01 | -3.58e-02 | 9.68e-01 |
| GOBP REGULATION OF CELL DIVISION | 176 | 4.13e-01 | 3.58e-02 | 8.51e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 9 | 8.53e-01 | -3.57e-02 | 9.74e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 62 | 6.27e-01 | 3.57e-02 | 9.25e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 10 | 8.45e-01 | 3.57e-02 | 9.73e-01 |
| GOCC VACUOLAR LUMEN | 167 | 4.27e-01 | 3.56e-02 | 8.58e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 450 | 1.95e-01 | 3.56e-02 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 17 | 7.99e-01 | 3.56e-02 | 9.61e-01 |
| GOBP PROTEIN DEACETYLATION | 51 | 6.60e-01 | -3.56e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 317 | 2.76e-01 | 3.56e-02 | 7.88e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1605 | 1.75e-02 | 3.56e-02 | 2.83e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 30 | 7.36e-01 | 3.55e-02 | 9.53e-01 |
| GOCC LIPID DROPLET | 93 | 5.54e-01 | 3.55e-02 | 9.01e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 83 | 5.76e-01 | 3.55e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 6 | 8.80e-01 | -3.55e-02 | 9.79e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 19 | 7.89e-01 | 3.55e-02 | 9.60e-01 |
| GOBP ARTERY DEVELOPMENT | 111 | 5.20e-01 | 3.54e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 9 | 8.54e-01 | -3.54e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 52 | 6.59e-01 | 3.54e-02 | 9.30e-01 |
| GOMF TRANSITION METAL ION BINDING | 1035 | 5.46e-02 | 3.53e-02 | 4.78e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 13 | 8.25e-01 | 3.53e-02 | 9.69e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY | 10 | 8.47e-01 | -3.53e-02 | 9.73e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 23 | 7.70e-01 | -3.53e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 133 | 4.82e-01 | 3.53e-02 | 8.80e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 14 | 8.19e-01 | -3.53e-02 | 9.68e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 837 | 8.31e-02 | 3.53e-02 | 5.64e-01 |
| GOBP ANOIKIS | 33 | 7.26e-01 | -3.53e-02 | 9.51e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 9 | 8.55e-01 | -3.52e-02 | 9.75e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 546 | 1.60e-01 | -3.52e-02 | 6.93e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 67 | 6.19e-01 | -3.51e-02 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 14 | 8.20e-01 | -3.51e-02 | 9.68e-01 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 18 | 7.96e-01 | -3.51e-02 | 9.61e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 8.63e-01 | -3.51e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 14 | 8.20e-01 | 3.51e-02 | 9.68e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 55 | 6.53e-01 | 3.51e-02 | 9.30e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 22 | 7.76e-01 | 3.51e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 65 | 6.25e-01 | 3.51e-02 | 9.25e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 130 | 4.90e-01 | 3.51e-02 | 8.82e-01 |
| GOMF AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.82e-01 | 3.51e-02 | 9.79e-01 |
| GOMF MANGANESE ION BINDING | 63 | 6.30e-01 | 3.51e-02 | 9.25e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 278 | 3.14e-01 | 3.51e-02 | 8.08e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 422 | 2.17e-01 | 3.50e-02 | 7.49e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 39 | 7.05e-01 | -3.50e-02 | 9.44e-01 |
| GOMF MICROTUBULE BINDING | 261 | 3.30e-01 | 3.50e-02 | 8.15e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 20 | 7.86e-01 | 3.50e-02 | 9.60e-01 |
| GOMF MAP KINASE ACTIVITY | 16 | 8.08e-01 | -3.50e-02 | 9.65e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 16 | 8.09e-01 | -3.50e-02 | 9.65e-01 |
| GOMF CHEMOKINE BINDING | 31 | 7.36e-01 | -3.50e-02 | 9.53e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 7 | 8.73e-01 | -3.50e-02 | 9.79e-01 |
| GOMF TOLL LIKE RECEPTOR 4 BINDING | 5 | 8.93e-01 | 3.49e-02 | 9.82e-01 |
| GOBP THIAMINE CONTAINING COMPOUND METABOLIC PROCESS | 6 | 8.82e-01 | 3.49e-02 | 9.79e-01 |
| GOBP MAINTENANCE OF LOCATION | 334 | 2.74e-01 | 3.48e-02 | 7.87e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 341 | 2.69e-01 | 3.48e-02 | 7.84e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 80 | 5.90e-01 | -3.48e-02 | 9.11e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 11 | 8.42e-01 | -3.48e-02 | 9.73e-01 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 23 | 7.73e-01 | -3.48e-02 | 9.58e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 55 | 6.55e-01 | 3.48e-02 | 9.30e-01 |
| GOBP REGULATION OF HISTONE MODIFICATION | 36 | 7.18e-01 | 3.48e-02 | 9.48e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 8.65e-01 | -3.48e-02 | 9.77e-01 |
| GOBP TUBE DEVELOPMENT | 1120 | 4.97e-02 | 3.48e-02 | 4.57e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 183 | 4.18e-01 | 3.47e-02 | 8.53e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 57 | 6.50e-01 | 3.47e-02 | 9.30e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 1019 | 6.13e-02 | 3.47e-02 | 4.97e-01 |
| GOCC EARLY ENDOSOME | 412 | 2.28e-01 | 3.46e-02 | 7.60e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 624 | 1.40e-01 | 3.46e-02 | 6.61e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 6 | 8.83e-01 | -3.46e-02 | 9.80e-01 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 13 | 8.29e-01 | -3.45e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 20 | 7.89e-01 | 3.45e-02 | 9.60e-01 |
| GOBP DIRECT OSSIFICATION | 7 | 8.74e-01 | -3.45e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 65 | 6.30e-01 | 3.45e-02 | 9.25e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 157 | 4.55e-01 | 3.45e-02 | 8.70e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 124 | 5.07e-01 | -3.45e-02 | 8.89e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 92 | 5.67e-01 | -3.45e-02 | 9.05e-01 |
| GOBP AXON GUIDANCE | 223 | 3.75e-01 | -3.45e-02 | 8.35e-01 |
| GOBP REGULATION OF HOMOPHILIC CELL ADHESION | 5 | 8.94e-01 | -3.45e-02 | 9.82e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 8.17e-01 | -3.45e-02 | 9.68e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 32 | 7.36e-01 | 3.44e-02 | 9.53e-01 |
| GOMF RETINOL BINDING | 16 | 8.12e-01 | -3.44e-02 | 9.67e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 54 | 6.62e-01 | -3.44e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 51 | 6.71e-01 | -3.43e-02 | 9.35e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 8.24e-01 | -3.43e-02 | 9.69e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 14 | 8.24e-01 | -3.43e-02 | 9.69e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 132 | 4.96e-01 | 3.43e-02 | 8.83e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 18 | 8.01e-01 | -3.43e-02 | 9.62e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 7 | 8.75e-01 | -3.43e-02 | 9.79e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 11 | 8.44e-01 | 3.42e-02 | 9.73e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 283 | 3.23e-01 | 3.42e-02 | 8.10e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 101 | 5.54e-01 | -3.41e-02 | 9.01e-01 |
| GOBP T CELL MIGRATION | 67 | 6.29e-01 | 3.41e-02 | 9.25e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 401 | 2.41e-01 | -3.41e-02 | 7.65e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 21 | 7.87e-01 | -3.41e-02 | 9.60e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 18 | 8.02e-01 | 3.41e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 1065 | 6.04e-02 | 3.41e-02 | 4.94e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 21 | 7.87e-01 | -3.40e-02 | 9.60e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 13 | 8.32e-01 | 3.40e-02 | 9.71e-01 |
| GOCC DENDRITE MEMBRANE | 36 | 7.24e-01 | 3.40e-02 | 9.49e-01 |
| GOBP MITOTIC CELL CYCLE | 898 | 8.39e-02 | 3.40e-02 | 5.66e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 46 | 6.90e-01 | -3.40e-02 | 9.42e-01 |
| GOBP CYTOSOLIC TRANSPORT | 174 | 4.40e-01 | 3.40e-02 | 8.62e-01 |
| GOCC CORE MEDIATOR COMPLEX | 25 | 7.69e-01 | -3.40e-02 | 9.58e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 239 | 3.66e-01 | -3.40e-02 | 8.33e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 164 | 4.53e-01 | -3.40e-02 | 8.70e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 12 | 8.39e-01 | 3.39e-02 | 9.71e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 27 | 7.60e-01 | 3.39e-02 | 9.55e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 320 | 2.97e-01 | 3.39e-02 | 7.99e-01 |
| GOCC POLAR MICROTUBULE | 5 | 8.96e-01 | 3.39e-02 | 9.82e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 28 | 7.57e-01 | 3.38e-02 | 9.54e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 8.53e-01 | 3.38e-02 | 9.74e-01 |
| GOBP RECOMBINATIONAL REPAIR | 169 | 4.48e-01 | -3.38e-02 | 8.68e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 87 | 5.86e-01 | -3.38e-02 | 9.10e-01 |
| GOMF TITIN BINDING | 13 | 8.33e-01 | 3.38e-02 | 9.71e-01 |
| GOCC RAGULATOR COMPLEX | 5 | 8.96e-01 | -3.38e-02 | 9.82e-01 |
| GOBP APPENDAGE DEVELOPMENT | 177 | 4.38e-01 | 3.38e-02 | 8.62e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 44 | 6.99e-01 | 3.37e-02 | 9.43e-01 |
| GOMF TROPOMYOSIN BINDING | 15 | 8.21e-01 | 3.37e-02 | 9.68e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 125 | 5.15e-01 | -3.37e-02 | 8.90e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 1131 | 5.59e-02 | 3.37e-02 | 4.81e-01 |
| GOCC COSTAMERE | 16 | 8.16e-01 | 3.37e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 7 | 8.77e-01 | 3.37e-02 | 9.79e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 8.77e-01 | 3.37e-02 | 9.79e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 338 | 2.88e-01 | -3.36e-02 | 7.95e-01 |
| GOBP RESPONSE TO FOOD | 35 | 7.31e-01 | 3.36e-02 | 9.52e-01 |
| GOBP RESPONSE TO UV | 147 | 4.82e-01 | -3.36e-02 | 8.80e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 50 | 6.81e-01 | 3.36e-02 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 59 | 6.56e-01 | -3.36e-02 | 9.30e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 430 | 2.33e-01 | 3.35e-02 | 7.61e-01 |
| GOBP FATTY ACID TRANSPORT | 114 | 5.36e-01 | 3.35e-02 | 8.94e-01 |
| GOBP VASCULAR WOUND HEALING | 22 | 7.86e-01 | -3.35e-02 | 9.60e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 29 | 7.55e-01 | -3.35e-02 | 9.54e-01 |
| GOBP SMOOTH MUSCLE CELL MATRIX ADHESION | 6 | 8.87e-01 | -3.35e-02 | 9.81e-01 |
| GOBP RESPONSE TO PROGESTERONE | 40 | 7.14e-01 | 3.35e-02 | 9.47e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 94 | 5.75e-01 | 3.35e-02 | 9.06e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 33 | 7.40e-01 | 3.34e-02 | 9.53e-01 |
| GOMF CONNEXIN BINDING | 5 | 8.97e-01 | 3.34e-02 | 9.82e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 35 | 7.32e-01 | -3.34e-02 | 9.52e-01 |
| GOBP PROTEOLYSIS | 1550 | 2.81e-02 | 3.34e-02 | 3.54e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 19 | 8.01e-01 | 3.34e-02 | 9.62e-01 |
| GOMF PROTEIN KINASE A BINDING | 49 | 6.86e-01 | 3.34e-02 | 9.41e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 851 | 9.82e-02 | 3.34e-02 | 5.95e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 14 | 8.29e-01 | 3.34e-02 | 9.70e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 42 | 7.08e-01 | 3.34e-02 | 9.45e-01 |
| GOBP MINERALOCORTICOID BIOSYNTHETIC PROCESS | 11 | 8.48e-01 | -3.33e-02 | 9.74e-01 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 8 | 8.70e-01 | -3.33e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 11 | 8.48e-01 | -3.33e-02 | 9.74e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 219 | 3.96e-01 | 3.33e-02 | 8.45e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 135 | 5.05e-01 | -3.33e-02 | 8.87e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 1196 | 5.31e-02 | 3.32e-02 | 4.74e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 15 | 8.24e-01 | 3.32e-02 | 9.69e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 25 | 7.74e-01 | -3.32e-02 | 9.58e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 140 | 4.98e-01 | -3.32e-02 | 8.84e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 8.98e-01 | 3.31e-02 | 9.82e-01 |
| GOMF DYNEIN COMPLEX BINDING | 23 | 7.83e-01 | -3.31e-02 | 9.60e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 5 | 8.98e-01 | 3.31e-02 | 9.82e-01 |
| GOBP DNA PROTECTION | 6 | 8.88e-01 | 3.31e-02 | 9.81e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 980 | 7.95e-02 | 3.31e-02 | 5.52e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 1175 | 5.61e-02 | 3.31e-02 | 4.82e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 147 | 4.89e-01 | 3.31e-02 | 8.82e-01 |
| GOBP VESICLE TETHERING | 31 | 7.50e-01 | 3.31e-02 | 9.53e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 61 | 6.56e-01 | 3.30e-02 | 9.30e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 14 | 8.31e-01 | 3.30e-02 | 9.71e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 25 | 7.76e-01 | -3.29e-02 | 9.59e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED ASCORBATE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 5 | 8.99e-01 | -3.29e-02 | 9.83e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 15 | 8.25e-01 | -3.29e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 193 | 4.31e-01 | 3.29e-02 | 8.60e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 47 | 6.96e-01 | -3.29e-02 | 9.43e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 15 | 8.25e-01 | -3.29e-02 | 9.69e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 469 | 2.23e-01 | 3.28e-02 | 7.56e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 27 | 7.68e-01 | -3.28e-02 | 9.58e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 177 | 4.51e-01 | 3.28e-02 | 8.70e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 26 | 7.72e-01 | 3.28e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 45 | 7.04e-01 | -3.28e-02 | 9.44e-01 |
| GOBP GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY | 5 | 8.99e-01 | 3.28e-02 | 9.83e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 17 | 8.15e-01 | 3.27e-02 | 9.68e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 865 | 1.03e-01 | 3.27e-02 | 5.97e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 12 | 8.45e-01 | -3.27e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 12 | 8.45e-01 | 3.27e-02 | 9.73e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 459 | 2.30e-01 | 3.27e-02 | 7.60e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 41 | 7.17e-01 | 3.27e-02 | 9.48e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 959 | 8.65e-02 | -3.27e-02 | 5.72e-01 |
| GOBP MRNA METABOLIC PROCESS | 741 | 1.30e-01 | -3.27e-02 | 6.48e-01 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 7 | 8.81e-01 | 3.26e-02 | 9.79e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 28 | 7.65e-01 | -3.26e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 22 | 7.91e-01 | -3.26e-02 | 9.61e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 13 | 8.39e-01 | -3.26e-02 | 9.71e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 56 | 6.73e-01 | 3.26e-02 | 9.36e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 7 | 8.82e-01 | -3.25e-02 | 9.79e-01 |
| GOCC MYOSIN FILAMENT | 24 | 7.83e-01 | 3.25e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 88 | 5.98e-01 | 3.25e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 42 | 7.16e-01 | 3.25e-02 | 9.48e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 5 | 9.00e-01 | -3.24e-02 | 9.83e-01 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 271 | 3.58e-01 | -3.24e-02 | 8.31e-01 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 30 | 7.59e-01 | 3.24e-02 | 9.54e-01 |
| GOCC POLE PLASM | 24 | 7.83e-01 | -3.24e-02 | 9.60e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 12 | 8.46e-01 | -3.24e-02 | 9.73e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 11 | 8.52e-01 | -3.24e-02 | 9.74e-01 |
| GOCC GERM CELL NUCLEUS | 68 | 6.45e-01 | 3.23e-02 | 9.29e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 64 | 6.55e-01 | 3.23e-02 | 9.30e-01 |
| GOCC CHROMOSOMAL REGION | 379 | 2.80e-01 | -3.23e-02 | 7.93e-01 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 6 | 8.91e-01 | 3.23e-02 | 9.82e-01 |
| GOMF PROTEIN KINASE C BINDING | 50 | 6.93e-01 | 3.23e-02 | 9.43e-01 |
| GOBP CHORION DEVELOPMENT | 10 | 8.60e-01 | 3.22e-02 | 9.76e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 127 | 5.31e-01 | 3.22e-02 | 8.93e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 54 | 6.82e-01 | -3.22e-02 | 9.40e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 1026 | 8.13e-02 | 3.22e-02 | 5.59e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 82 | 6.14e-01 | 3.22e-02 | 9.21e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 717 | 1.42e-01 | 3.22e-02 | 6.65e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 9.01e-01 | 3.22e-02 | 9.83e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 45 | 7.09e-01 | -3.21e-02 | 9.46e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 196 | 4.38e-01 | 3.21e-02 | 8.62e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 69 | 6.44e-01 | 3.21e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 65 | 6.54e-01 | 3.21e-02 | 9.30e-01 |
| GOCC LYSOSOMAL LUMEN | 91 | 5.96e-01 | 3.21e-02 | 9.14e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 27 | 7.73e-01 | 3.21e-02 | 9.58e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 61 | 6.64e-01 | -3.21e-02 | 9.32e-01 |
| GOBP CGMP BIOSYNTHETIC PROCESS | 10 | 8.60e-01 | 3.21e-02 | 9.76e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 24 | 7.85e-01 | 3.21e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 8 | 8.75e-01 | -3.21e-02 | 9.79e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 993 | 8.70e-02 | 3.21e-02 | 5.73e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 64 | 6.57e-01 | 3.21e-02 | 9.30e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 246 | 3.86e-01 | 3.21e-02 | 8.40e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 132 | 5.25e-01 | 3.21e-02 | 8.91e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 559 | 1.96e-01 | 3.20e-02 | 7.27e-01 |
| GOBP ACTIN FILAMENT SEVERING | 16 | 8.25e-01 | 3.20e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 8.92e-01 | -3.20e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 31 | 7.58e-01 | -3.20e-02 | 9.54e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 7 | 8.84e-01 | 3.20e-02 | 9.80e-01 |
| GOBP SKIN DEVELOPMENT | 306 | 3.36e-01 | -3.20e-02 | 8.20e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 76 | 6.30e-01 | 3.19e-02 | 9.25e-01 |
| GOBP DNA REPLICATION INITIATION | 35 | 7.44e-01 | -3.19e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 25 | 7.82e-01 | -3.19e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 36 | 7.41e-01 | -3.19e-02 | 9.53e-01 |
| GOBP NEPHRON TUBULE FORMATION | 20 | 8.05e-01 | 3.19e-02 | 9.63e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 240 | 3.96e-01 | 3.18e-02 | 8.45e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 14 | 8.37e-01 | -3.18e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE | 8 | 8.76e-01 | -3.18e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 38 | 7.35e-01 | 3.18e-02 | 9.53e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 587 | 1.89e-01 | 3.18e-02 | 7.24e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 38 | 7.35e-01 | 3.18e-02 | 9.53e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 591 | 1.87e-01 | 3.17e-02 | 7.23e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 6.06e-01 | -3.16e-02 | 9.20e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 138 | 5.21e-01 | 3.16e-02 | 8.91e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 337 | 3.19e-01 | 3.16e-02 | 8.10e-01 |
| GOBP RESPONSE TO ESTRADIOL | 109 | 5.69e-01 | 3.16e-02 | 9.06e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 81 | 6.23e-01 | -3.16e-02 | 9.24e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 180 | 4.65e-01 | 3.16e-02 | 8.74e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 89 | 6.07e-01 | -3.15e-02 | 9.20e-01 |
| GOBP MEIOTIC CELL CYCLE | 275 | 3.68e-01 | -3.15e-02 | 8.33e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 49 | 7.03e-01 | -3.15e-02 | 9.44e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 8.70e-01 | 3.15e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 8.94e-01 | -3.15e-02 | 9.82e-01 |
| GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY | 22 | 7.98e-01 | -3.14e-02 | 9.61e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 79 | 6.29e-01 | -3.14e-02 | 9.25e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 286 | 3.61e-01 | -3.14e-02 | 8.32e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 11 | 8.57e-01 | -3.14e-02 | 9.75e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1888 | 2.40e-02 | 3.14e-02 | 3.30e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 38 | 7.38e-01 | -3.14e-02 | 9.53e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 115 | 5.61e-01 | -3.13e-02 | 9.05e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 16 | 8.28e-01 | -3.13e-02 | 9.70e-01 |
| GOBP LUTEINIZING HORMONE SECRETION | 10 | 8.64e-01 | 3.13e-02 | 9.77e-01 |
| GOBP FATTY ACID OMEGA OXIDATION | 5 | 9.03e-01 | 3.13e-02 | 9.83e-01 |
| GOCC SPINDLE POLE | 166 | 4.87e-01 | -3.13e-02 | 8.81e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 207 | 4.38e-01 | 3.13e-02 | 8.62e-01 |
| GOMF AROMATASE ACTIVITY | 26 | 7.83e-01 | -3.13e-02 | 9.60e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY TYPE I | 5 | 9.04e-01 | 3.12e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 29 | 7.71e-01 | 3.12e-02 | 9.58e-01 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 9 | 8.71e-01 | -3.12e-02 | 9.79e-01 |
| GOBP LOCOMOTOR RHYTHM | 15 | 8.34e-01 | -3.12e-02 | 9.71e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 12 | 8.52e-01 | 3.12e-02 | 9.74e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 20 | 8.09e-01 | -3.12e-02 | 9.66e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1521 | 4.24e-02 | 3.12e-02 | 4.23e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 8 | 8.79e-01 | 3.12e-02 | 9.79e-01 |
| GOBP SPLEEN DEVELOPMENT | 38 | 7.40e-01 | 3.11e-02 | 9.53e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 11 | 8.58e-01 | 3.11e-02 | 9.76e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 18 | 8.19e-01 | -3.11e-02 | 9.68e-01 |
| GOBP COCHLEA DEVELOPMENT | 46 | 7.15e-01 | -3.11e-02 | 9.48e-01 |
| GOBP NEURAL CREST FORMATION | 15 | 8.35e-01 | 3.11e-02 | 9.71e-01 |
| GOMF PRIMARY AMINE OXIDASE ACTIVITY | 7 | 8.87e-01 | -3.11e-02 | 9.81e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 106 | 5.81e-01 | 3.10e-02 | 9.08e-01 |
| GOCC CAVEOLA | 81 | 6.30e-01 | -3.10e-02 | 9.25e-01 |
| GOBP REGULATION OF ATPASE COUPLED CALCIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.95e-01 | 3.10e-02 | 9.82e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION | 9 | 8.72e-01 | -3.10e-02 | 9.79e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 47 | 7.13e-01 | 3.10e-02 | 9.47e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 264 | 3.87e-01 | 3.10e-02 | 8.41e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 772 | 1.43e-01 | 3.10e-02 | 6.68e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 25 | 7.89e-01 | -3.09e-02 | 9.60e-01 |
| GOMF MANNOSE BINDING | 24 | 7.93e-01 | 3.09e-02 | 9.61e-01 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 9 | 8.72e-01 | 3.09e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 124 | 5.52e-01 | -3.09e-02 | 9.01e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 26 | 7.85e-01 | -3.09e-02 | 9.60e-01 |
| GOBP NEPHRON DEVELOPMENT | 152 | 5.12e-01 | -3.08e-02 | 8.89e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 11 | 8.60e-01 | -3.08e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 110 | 5.77e-01 | 3.07e-02 | 9.06e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 84 | 6.26e-01 | -3.07e-02 | 9.25e-01 |
| GOCC TRANSPORTER COMPLEX | 391 | 2.97e-01 | 3.07e-02 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 8 | 8.81e-01 | 3.07e-02 | 9.79e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 24 | 7.95e-01 | -3.07e-02 | 9.61e-01 |
| GOMF SYNTAXIN BINDING | 65 | 6.69e-01 | 3.07e-02 | 9.34e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 92 | 6.12e-01 | 3.06e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 26 | 7.87e-01 | 3.06e-02 | 9.60e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 12 | 8.54e-01 | 3.06e-02 | 9.75e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 21 | 8.08e-01 | 3.06e-02 | 9.65e-01 |
| GOBP AMINO ACID METABOLIC PROCESS | 277 | 3.81e-01 | 3.06e-02 | 8.37e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 63 | 6.74e-01 | -3.06e-02 | 9.36e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 38 | 7.44e-01 | 3.06e-02 | 9.53e-01 |
| GOCC ASTROCYTE END FOOT | 9 | 8.74e-01 | -3.06e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 6 | 8.97e-01 | 3.05e-02 | 9.82e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 436 | 2.74e-01 | -3.05e-02 | 7.87e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 39 | 7.41e-01 | 3.05e-02 | 9.53e-01 |
| GOMF CALMODULIN BINDING | 197 | 4.60e-01 | 3.05e-02 | 8.72e-01 |
| GOMF PRERIBOSOME BINDING | 6 | 8.97e-01 | -3.05e-02 | 9.82e-01 |
| GOBP AMINO ACID ACTIVATION | 43 | 7.29e-01 | -3.05e-02 | 9.51e-01 |
| GOBP REGULATION OF AXON EXTENSION | 85 | 6.27e-01 | 3.05e-02 | 9.25e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 77 | 6.43e-01 | 3.05e-02 | 9.29e-01 |
| GOBP ASSOCIATIVE LEARNING | 84 | 6.29e-01 | -3.05e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 24 | 7.96e-01 | -3.05e-02 | 9.61e-01 |
| GOBP GENITALIA MORPHOGENESIS | 11 | 8.61e-01 | -3.05e-02 | 9.76e-01 |
| GOBP METANEPHRIC GLOMERULUS DEVELOPMENT | 16 | 8.33e-01 | -3.05e-02 | 9.71e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 29 | 7.77e-01 | -3.04e-02 | 9.59e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 197 | 4.62e-01 | 3.04e-02 | 8.72e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 35 | 7.56e-01 | -3.04e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 40 | 7.39e-01 | -3.04e-02 | 9.53e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 48 | 7.16e-01 | -3.04e-02 | 9.48e-01 |
| GOCC PROTEIN KINASE COMPLEX | 135 | 5.42e-01 | 3.04e-02 | 8.97e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 110 | 5.83e-01 | 3.03e-02 | 9.08e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 551 | 2.24e-01 | 3.03e-02 | 7.57e-01 |
| GOCC POLYSOME | 60 | 6.85e-01 | -3.03e-02 | 9.40e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 16 | 8.34e-01 | 3.03e-02 | 9.71e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 24 | 7.97e-01 | -3.03e-02 | 9.61e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 17 | 8.29e-01 | 3.02e-02 | 9.70e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 9.07e-01 | -3.02e-02 | 9.84e-01 |
| GOCC MICROTUBULE END | 34 | 7.61e-01 | 3.02e-02 | 9.55e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 168 | 5.00e-01 | 3.01e-02 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 58 | 6.91e-01 | 3.01e-02 | 9.43e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 335 | 3.43e-01 | 3.01e-02 | 8.22e-01 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 10 | 8.69e-01 | -3.01e-02 | 9.78e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 42 | 7.36e-01 | 3.01e-02 | 9.53e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 268 | 3.97e-01 | -3.01e-02 | 8.45e-01 |
| GOBP BEHAVIOR | 629 | 1.98e-01 | 3.01e-02 | 7.29e-01 |
| GOBP MRNA CATABOLIC PROCESS | 294 | 3.75e-01 | -3.01e-02 | 8.35e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 85 | 6.32e-01 | 3.01e-02 | 9.25e-01 |
| GOMF GANGLIOSIDE BINDING | 5 | 9.07e-01 | -3.01e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 27 | 7.87e-01 | -3.01e-02 | 9.60e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 8.63e-01 | -3.00e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 15 | 8.40e-01 | 3.00e-02 | 9.72e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 14 | 8.46e-01 | 3.00e-02 | 9.73e-01 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 64 | 6.78e-01 | 3.00e-02 | 9.37e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 36 | 7.55e-01 | -3.00e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 21 | 8.12e-01 | 3.00e-02 | 9.67e-01 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 11 | 8.63e-01 | 3.00e-02 | 9.77e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 106 | 5.94e-01 | -3.00e-02 | 9.12e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 57 | 6.96e-01 | 3.00e-02 | 9.43e-01 |
| GOCC PRERIBOSOME | 104 | 5.98e-01 | -2.99e-02 | 9.15e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 230 | 4.35e-01 | 2.99e-02 | 8.60e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 178 | 4.92e-01 | 2.99e-02 | 8.83e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 58 | 6.95e-01 | -2.98e-02 | 9.43e-01 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 7 | 8.92e-01 | 2.98e-02 | 9.82e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 746 | 1.67e-01 | 2.98e-02 | 7.00e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 9.08e-01 | 2.97e-02 | 9.84e-01 |
| GOBP RESPONSE TO MONOSACCHARIDE | 200 | 4.68e-01 | 2.97e-02 | 8.75e-01 |
| GOBP MIDBODY ABSCISSION | 17 | 8.32e-01 | -2.97e-02 | 9.71e-01 |
| GOMF DNA BINDING BENDING | 16 | 8.37e-01 | 2.97e-02 | 9.71e-01 |
| GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION | 10 | 8.71e-01 | -2.97e-02 | 9.79e-01 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 8 | 8.85e-01 | -2.97e-02 | 9.80e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 25 | 7.98e-01 | -2.96e-02 | 9.61e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 803 | 1.53e-01 | -2.96e-02 | 6.85e-01 |
| GOBP SEROTONIN TRANSPORT | 20 | 8.19e-01 | -2.96e-02 | 9.68e-01 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 22 | 8.10e-01 | -2.96e-02 | 9.66e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 102 | 6.05e-01 | 2.96e-02 | 9.20e-01 |
| GOBP LUNG VASCULATURE DEVELOPMENT | 8 | 8.85e-01 | 2.96e-02 | 9.80e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 170 | 5.06e-01 | 2.96e-02 | 8.88e-01 |
| GOBP ODONTOGENESIS | 126 | 5.67e-01 | 2.95e-02 | 9.05e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 77 | 6.55e-01 | -2.95e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 59 | 6.95e-01 | 2.95e-02 | 9.43e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 16 | 8.38e-01 | -2.95e-02 | 9.71e-01 |
| GOBP PHOTOPERIODISM | 28 | 7.88e-01 | -2.94e-02 | 9.60e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 549 | 2.39e-01 | 2.94e-02 | 7.63e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 90 | 6.30e-01 | 2.94e-02 | 9.25e-01 |
| GOBP TRABECULA FORMATION | 26 | 7.95e-01 | 2.94e-02 | 9.61e-01 |
| GOBP DNA CATABOLIC PROCESS | 29 | 7.84e-01 | -2.94e-02 | 9.60e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY | 6 | 9.01e-01 | 2.94e-02 | 9.83e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 183 | 4.94e-01 | 2.93e-02 | 8.83e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 42 | 7.42e-01 | 2.93e-02 | 9.53e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 12 | 8.60e-01 | -2.93e-02 | 9.76e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 25 | 8.00e-01 | 2.93e-02 | 9.61e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 9 | 8.79e-01 | 2.93e-02 | 9.79e-01 |
| GOBP MYELIN MAINTENANCE | 17 | 8.35e-01 | -2.93e-02 | 9.71e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 18 | 8.30e-01 | -2.93e-02 | 9.70e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 7 | 8.93e-01 | -2.92e-02 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 69 | 6.75e-01 | 2.92e-02 | 9.36e-01 |
| GOCC MKS COMPLEX | 13 | 8.55e-01 | 2.92e-02 | 9.75e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 20 | 8.21e-01 | 2.92e-02 | 9.68e-01 |
| GOBP RESPONSE TO LEPTIN | 21 | 8.17e-01 | -2.92e-02 | 9.68e-01 |
| GOMF COLLAGEN BINDING | 68 | 6.77e-01 | 2.92e-02 | 9.37e-01 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 10 | 8.73e-01 | 2.92e-02 | 9.79e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 18 | 8.31e-01 | 2.91e-02 | 9.71e-01 |
| GOCC INCLUSION BODY | 69 | 6.76e-01 | -2.91e-02 | 9.37e-01 |
| GOBP OXYGEN TRANSPORT | 15 | 8.45e-01 | -2.91e-02 | 9.73e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 13 | 8.56e-01 | 2.91e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 48 | 7.27e-01 | -2.91e-02 | 9.51e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 21 | 8.18e-01 | 2.90e-02 | 9.68e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 12 | 8.62e-01 | 2.90e-02 | 9.77e-01 |
| GOBP HORMONE CATABOLIC PROCESS | 11 | 8.68e-01 | 2.90e-02 | 9.78e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 120 | 5.84e-01 | 2.90e-02 | 9.09e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 91 | 6.33e-01 | 2.90e-02 | 9.25e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 66 | 6.84e-01 | -2.89e-02 | 9.40e-01 |
| GOBP AXONEME ASSEMBLY | 92 | 6.31e-01 | 2.89e-02 | 9.25e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 23 | 8.10e-01 | -2.89e-02 | 9.66e-01 |
| GOMF ZINC ION BINDING | 774 | 1.72e-01 | 2.89e-02 | 7.04e-01 |
| GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS | 6 | 9.03e-01 | -2.89e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 78 | 6.60e-01 | 2.88e-02 | 9.30e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 26 | 7.99e-01 | 2.88e-02 | 9.61e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 40 | 7.52e-01 | 2.88e-02 | 9.54e-01 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 80 | 6.56e-01 | 2.88e-02 | 9.30e-01 |
| GOBP RECEPTOR RECYCLING | 46 | 7.35e-01 | 2.88e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 7 | 8.95e-01 | 2.88e-02 | 9.82e-01 |
| GOBP RESPONSE TO CORTISOL | 6 | 9.03e-01 | 2.88e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 12 | 8.63e-01 | 2.88e-02 | 9.77e-01 |
| GOBP CELL RECOGNITION | 152 | 5.41e-01 | 2.87e-02 | 8.96e-01 |
| GOBP LYSOSOMAL TRANSPORT | 128 | 5.75e-01 | 2.87e-02 | 9.06e-01 |
| GOCC CHYLOMICRON | 12 | 8.64e-01 | -2.87e-02 | 9.77e-01 |
| GOBP NEUROBLAST MIGRATION | 6 | 9.03e-01 | -2.87e-02 | 9.83e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 252 | 4.34e-01 | 2.86e-02 | 8.60e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 35 | 7.70e-01 | 2.86e-02 | 9.58e-01 |
| GOCC CELL CELL JUNCTION | 485 | 2.81e-01 | 2.86e-02 | 7.93e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 18 | 8.34e-01 | 2.86e-02 | 9.71e-01 |
| GOBP RNA STABILIZATION | 66 | 6.89e-01 | 2.85e-02 | 9.42e-01 |
| GOBP RENAL PROTEIN ABSORPTION | 7 | 8.96e-01 | -2.85e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 147 | 5.52e-01 | 2.85e-02 | 9.01e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 42 | 7.50e-01 | -2.84e-02 | 9.53e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 23 | 8.14e-01 | 2.84e-02 | 9.67e-01 |
| GOCC EXCITATORY SYNAPSE | 57 | 7.11e-01 | -2.84e-02 | 9.47e-01 |
| GOBP DENDRITE EXTENSION | 34 | 7.74e-01 | -2.84e-02 | 9.58e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 121 | 5.90e-01 | 2.84e-02 | 9.11e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 145 | 5.57e-01 | -2.83e-02 | 9.02e-01 |
| GOMF CHROMATIN DNA BINDING | 110 | 6.08e-01 | 2.83e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 11 | 8.71e-01 | 2.82e-02 | 9.79e-01 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 9.05e-01 | 2.82e-02 | 9.84e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1566 | 6.21e-02 | 2.82e-02 | 4.99e-01 |
| GOBP SPERM CAPACITATION | 30 | 7.89e-01 | -2.82e-02 | 9.60e-01 |
| GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT | 15 | 8.50e-01 | 2.82e-02 | 9.74e-01 |
| GOBP REGULATION OF DNA REPAIR | 205 | 4.86e-01 | -2.82e-02 | 8.80e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 61 | 7.03e-01 | -2.82e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 8.71e-01 | -2.82e-02 | 9.79e-01 |
| GOBP CELL DIVISION | 613 | 2.33e-01 | 2.82e-02 | 7.61e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 87 | 6.50e-01 | 2.81e-02 | 9.30e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 17 | 8.41e-01 | -2.81e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 26 | 8.04e-01 | 2.81e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 9.05e-01 | -2.81e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 127 | 5.84e-01 | -2.81e-02 | 9.09e-01 |
| GOMF 7S RNA BINDING | 7 | 8.98e-01 | -2.81e-02 | 9.82e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 43 | 7.50e-01 | -2.81e-02 | 9.53e-01 |
| GOBP GOLGI ORGANIZATION | 139 | 5.68e-01 | -2.81e-02 | 9.05e-01 |
| GOBP ENDOCARDIUM MORPHOGENESIS | 6 | 9.05e-01 | -2.81e-02 | 9.84e-01 |
| GOBP CENTROSOME SEPARATION | 15 | 8.51e-01 | -2.80e-02 | 9.74e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 150 | 5.54e-01 | 2.80e-02 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 12 | 8.67e-01 | -2.80e-02 | 9.77e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 42 | 7.54e-01 | -2.80e-02 | 9.54e-01 |
| GOBP CHEMOREPULSION OF AXON | 6 | 9.06e-01 | 2.80e-02 | 9.84e-01 |
| GOBP NEUROBLAST DIFFERENTIATION | 8 | 8.91e-01 | -2.79e-02 | 9.82e-01 |
| GOCC ZYMOGEN GRANULE | 14 | 8.57e-01 | 2.79e-02 | 9.75e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 68 | 6.91e-01 | 2.79e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 142 | 5.66e-01 | 2.79e-02 | 9.05e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 40 | 7.60e-01 | -2.79e-02 | 9.55e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 102 | 6.27e-01 | -2.79e-02 | 9.25e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 33 | 7.82e-01 | 2.79e-02 | 9.60e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 106 | 6.21e-01 | -2.78e-02 | 9.23e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 102 | 6.27e-01 | 2.78e-02 | 9.25e-01 |
| GOBP NADH OXIDATION | 6 | 9.06e-01 | 2.78e-02 | 9.84e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 16 | 8.47e-01 | -2.78e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 89 | 6.51e-01 | -2.78e-02 | 9.30e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 9.06e-01 | 2.77e-02 | 9.84e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 19 | 8.34e-01 | 2.77e-02 | 9.71e-01 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 26 | 8.07e-01 | -2.77e-02 | 9.64e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 82 | 6.65e-01 | 2.77e-02 | 9.32e-01 |
| GOBP REGULATION OF HEART GROWTH | 68 | 6.93e-01 | 2.77e-02 | 9.43e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 71 | 6.87e-01 | 2.77e-02 | 9.41e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 128 | 5.89e-01 | -2.77e-02 | 9.11e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 128 | 5.90e-01 | -2.76e-02 | 9.11e-01 |
| GOBP PANCREAS DEVELOPMENT | 78 | 6.74e-01 | -2.76e-02 | 9.36e-01 |
| GOBP SYNAPSE ASSEMBLY | 184 | 5.19e-01 | 2.76e-02 | 8.90e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 16 | 8.49e-01 | 2.75e-02 | 9.74e-01 |
| GOBP GALACTOSE TRANSMEMBRANE TRANSPORT | 5 | 9.15e-01 | -2.75e-02 | 9.86e-01 |
| GOMF U3 SNORNA BINDING | 10 | 8.80e-01 | 2.75e-02 | 9.79e-01 |
| GOBP VESICLE COATING | 38 | 7.69e-01 | 2.75e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 23 | 8.20e-01 | 2.75e-02 | 9.68e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 14 | 8.59e-01 | -2.74e-02 | 9.76e-01 |
| GOBP CHROMOSOME SEGREGATION | 406 | 3.43e-01 | -2.74e-02 | 8.22e-01 |
| GOCC MALE GERM CELL NUCLEUS | 52 | 7.32e-01 | 2.74e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 461 | 3.13e-01 | 2.74e-02 | 8.08e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 57 | 7.21e-01 | 2.74e-02 | 9.48e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 12 | 8.69e-01 | -2.74e-02 | 9.78e-01 |
| GOBP SYNAPSE MATURATION | 33 | 7.85e-01 | 2.74e-02 | 9.60e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 149 | 5.64e-01 | -2.74e-02 | 9.05e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 9.16e-01 | 2.74e-02 | 9.86e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 259 | 4.48e-01 | 2.74e-02 | 8.68e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 46 | 7.48e-01 | -2.74e-02 | 9.53e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 8.93e-01 | -2.73e-02 | 9.82e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 35 | 7.80e-01 | 2.73e-02 | 9.60e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 51 | 7.36e-01 | -2.73e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 37 | 7.74e-01 | -2.73e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 66 | 7.02e-01 | 2.73e-02 | 9.44e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 114 | 6.15e-01 | 2.73e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 12 | 8.70e-01 | -2.73e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION | 13 | 8.65e-01 | 2.73e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 82 | 6.70e-01 | 2.72e-02 | 9.35e-01 |
| GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX | 6 | 9.08e-01 | -2.72e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 10 | 8.82e-01 | 2.72e-02 | 9.79e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 59 | 7.18e-01 | 2.72e-02 | 9.48e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 201 | 5.07e-01 | 2.72e-02 | 8.88e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 61 | 7.14e-01 | -2.72e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 60 | 7.16e-01 | 2.72e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 72 | 6.90e-01 | 2.71e-02 | 9.42e-01 |
| GOBP ORGAN INDUCTION | 22 | 8.26e-01 | 2.71e-02 | 9.69e-01 |
| GOMF COLLAGEN RECEPTOR ACTIVITY | 5 | 9.16e-01 | -2.71e-02 | 9.87e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 1297 | 1.01e-01 | 2.71e-02 | 5.95e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 566 | 2.71e-01 | 2.71e-02 | 7.85e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 44 | 7.56e-01 | -2.71e-02 | 9.54e-01 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 13 | 8.66e-01 | 2.71e-02 | 9.77e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 18 | 8.43e-01 | -2.70e-02 | 9.73e-01 |
| GOBP RESPONSE TO HEAT | 99 | 6.42e-01 | -2.70e-02 | 9.28e-01 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 44 | 7.56e-01 | -2.70e-02 | 9.54e-01 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 57 | 7.24e-01 | -2.70e-02 | 9.49e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 247 | 4.65e-01 | 2.70e-02 | 8.74e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 41 | 7.65e-01 | 2.70e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 5 | 9.17e-01 | 2.70e-02 | 9.87e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 81 | 6.75e-01 | 2.70e-02 | 9.36e-01 |
| GOCC CALYX OF HELD | 19 | 8.39e-01 | 2.70e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 25 | 8.16e-01 | -2.69e-02 | 9.68e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 114 | 6.19e-01 | 2.69e-02 | 9.23e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 11 | 8.77e-01 | 2.69e-02 | 9.79e-01 |
| GOCC DNA POLYMERASE COMPLEX | 18 | 8.44e-01 | 2.69e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 30 | 7.99e-01 | -2.69e-02 | 9.61e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 76 | 6.86e-01 | 2.69e-02 | 9.41e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 29 | 8.02e-01 | -2.69e-02 | 9.62e-01 |
| GOBP FOREGUT MORPHOGENESIS | 10 | 8.83e-01 | 2.69e-02 | 9.80e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 24 | 8.20e-01 | -2.68e-02 | 9.68e-01 |
| GOBP L PROLINE BIOSYNTHETIC PROCESS | 6 | 9.09e-01 | 2.68e-02 | 9.84e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 191 | 5.24e-01 | 2.67e-02 | 8.91e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE CELL FATE COMMITMENT | 5 | 9.18e-01 | 2.67e-02 | 9.87e-01 |
| GOMF FRIZZLED BINDING | 36 | 7.82e-01 | -2.67e-02 | 9.60e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 9.10e-01 | -2.67e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 15 | 8.58e-01 | 2.66e-02 | 9.76e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 18 | 8.45e-01 | -2.66e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 50 | 7.45e-01 | 2.66e-02 | 9.53e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 27 | 8.11e-01 | 2.66e-02 | 9.66e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 30 | 8.01e-01 | 2.66e-02 | 9.62e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 86 | 6.70e-01 | 2.66e-02 | 9.35e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 799 | 2.01e-01 | 2.66e-02 | 7.32e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 92 | 6.60e-01 | 2.65e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 61 | 7.21e-01 | 2.65e-02 | 9.48e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 7 | 9.03e-01 | -2.65e-02 | 9.83e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 626 | 2.58e-01 | 2.65e-02 | 7.78e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 9 | 8.91e-01 | 2.64e-02 | 9.82e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 21 | 8.34e-01 | -2.64e-02 | 9.71e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 269 | 4.56e-01 | -2.64e-02 | 8.70e-01 |
| GOBP PROTEIN FOLDING | 208 | 5.11e-01 | 2.64e-02 | 8.89e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 82 | 6.79e-01 | -2.64e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 62 | 7.20e-01 | 2.63e-02 | 9.48e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 17 | 8.51e-01 | 2.63e-02 | 9.74e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 595 | 2.73e-01 | -2.63e-02 | 7.87e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 121 | 6.17e-01 | -2.63e-02 | 9.22e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 248 | 4.76e-01 | 2.63e-02 | 8.78e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 208 | 5.13e-01 | -2.63e-02 | 8.89e-01 |
| GOBP NEURAL TUBE FORMATION | 103 | 6.45e-01 | 2.62e-02 | 9.29e-01 |
| GOBP STRAND INVASION | 6 | 9.12e-01 | -2.62e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 11 | 8.81e-01 | 2.61e-02 | 9.79e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1345 | 1.08e-01 | 2.61e-02 | 6.05e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 951 | 1.73e-01 | 2.61e-02 | 7.05e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 34 | 7.92e-01 | -2.61e-02 | 9.61e-01 |
| GOBP REGULATION OF BINDING | 253 | 4.75e-01 | 2.61e-02 | 8.77e-01 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 9.12e-01 | 2.61e-02 | 9.85e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 302 | 4.36e-01 | -2.61e-02 | 8.60e-01 |
| GOBP CELL MATURATION | 191 | 5.35e-01 | 2.61e-02 | 8.94e-01 |
| GOMF CALCIUM POTASSIUM SODIUM ANTIPORTER ACTIVITY | 5 | 9.20e-01 | -2.60e-02 | 9.87e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 101 | 6.51e-01 | 2.60e-02 | 9.30e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 74 | 6.99e-01 | 2.60e-02 | 9.43e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 44 | 7.65e-01 | 2.60e-02 | 9.57e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 311 | 4.31e-01 | -2.60e-02 | 8.60e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 508 | 3.17e-01 | 2.60e-02 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 229 | 4.99e-01 | 2.60e-02 | 8.85e-01 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 27 | 8.15e-01 | 2.59e-02 | 9.68e-01 |
| GOBP REGULATION OF NK T CELL DIFFERENTIATION | 6 | 9.12e-01 | 2.59e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 34 | 7.94e-01 | 2.59e-02 | 9.61e-01 |
| GOBP T CELL EXTRAVASATION | 10 | 8.87e-01 | 2.59e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 461 | 3.41e-01 | 2.59e-02 | 8.22e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 8.99e-01 | -2.59e-02 | 9.83e-01 |
| GOBP SEQUESTERING OF METAL ION | 10 | 8.87e-01 | -2.59e-02 | 9.81e-01 |
| GOBP TONIC SMOOTH MUSCLE CONTRACTION | 11 | 8.82e-01 | -2.59e-02 | 9.79e-01 |
| GOCC CHROMOSOME | 1811 | 6.79e-02 | 2.59e-02 | 5.21e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 32 | 8.00e-01 | 2.59e-02 | 9.61e-01 |
| GOMF ANTIGEN BINDING | 66 | 7.16e-01 | -2.59e-02 | 9.48e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 18 | 8.49e-01 | -2.59e-02 | 9.74e-01 |
| GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY | 6 | 9.13e-01 | -2.58e-02 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 9 | 8.93e-01 | -2.58e-02 | 9.82e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 146 | 5.91e-01 | -2.58e-02 | 9.11e-01 |
| GOMF SYNTAXIN 1 BINDING | 19 | 8.46e-01 | -2.58e-02 | 9.73e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 61 | 7.28e-01 | 2.58e-02 | 9.51e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 9 | 8.94e-01 | 2.57e-02 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 170 | 5.63e-01 | 2.57e-02 | 9.05e-01 |
| GOBP REGULATION OF URINE VOLUME | 20 | 8.43e-01 | 2.56e-02 | 9.73e-01 |
| GOCC BLEB | 9 | 8.94e-01 | 2.56e-02 | 9.82e-01 |
| GOCC DENSE CORE GRANULE MEMBRANE | 7 | 9.07e-01 | 2.56e-02 | 9.84e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 284 | 4.58e-01 | 2.56e-02 | 8.72e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 90 | 6.75e-01 | -2.56e-02 | 9.36e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 50 | 7.55e-01 | 2.55e-02 | 9.54e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 66 | 7.20e-01 | -2.55e-02 | 9.48e-01 |
| GOBP RNA SPLICING | 420 | 3.69e-01 | -2.55e-02 | 8.33e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 82 | 6.90e-01 | 2.55e-02 | 9.42e-01 |
| GOBP RESPONSE TO VITAMIN D | 36 | 7.91e-01 | 2.55e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 122 | 6.27e-01 | 2.55e-02 | 9.25e-01 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 9.14e-01 | -2.55e-02 | 9.85e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 13 | 8.74e-01 | 2.54e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 18 | 8.52e-01 | -2.54e-02 | 9.74e-01 |
| GOMF ADENOSINE RECEPTOR BINDING | 7 | 9.07e-01 | 2.54e-02 | 9.84e-01 |
| GOCC PLASMA MEMBRANE RAFT | 112 | 6.42e-01 | 2.54e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 33 | 8.01e-01 | -2.54e-02 | 9.61e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 188 | 5.48e-01 | 2.54e-02 | 9.00e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 10 | 8.89e-01 | -2.54e-02 | 9.82e-01 |
| GOBP TUBE MORPHOGENESIS | 914 | 1.93e-01 | 2.54e-02 | 7.26e-01 |
| GOBP INNER EAR MORPHOGENESIS | 103 | 6.57e-01 | 2.53e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 752 | 2.37e-01 | 2.53e-02 | 7.63e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 586 | 2.96e-01 | 2.53e-02 | 7.99e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 29 | 8.14e-01 | 2.53e-02 | 9.67e-01 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 8.65e-01 | -2.53e-02 | 9.77e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 33 | 8.02e-01 | 2.53e-02 | 9.62e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 89 | 6.80e-01 | -2.53e-02 | 9.39e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 38 | 7.88e-01 | -2.53e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 9.22e-01 | 2.52e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 9 | 8.96e-01 | -2.52e-02 | 9.82e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 136 | 6.11e-01 | 2.52e-02 | 9.21e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 125 | 6.27e-01 | 2.52e-02 | 9.25e-01 |
| GOBP VASCULAR TRANSPORT | 84 | 6.90e-01 | 2.52e-02 | 9.42e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 9.02e-01 | -2.52e-02 | 9.83e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 7.95e-01 | -2.51e-02 | 9.61e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 16 | 8.62e-01 | 2.50e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 9 | 8.97e-01 | -2.50e-02 | 9.82e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 468 | 3.54e-01 | 2.50e-02 | 8.28e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 9 | 8.97e-01 | -2.50e-02 | 9.82e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 74 | 7.10e-01 | -2.50e-02 | 9.47e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 14 | 8.72e-01 | 2.50e-02 | 9.79e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 8.81e-01 | -2.50e-02 | 9.79e-01 |
| GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS | 8 | 9.03e-01 | -2.49e-02 | 9.83e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 63 | 7.33e-01 | 2.48e-02 | 9.53e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 15 | 8.68e-01 | 2.48e-02 | 9.78e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 13 | 8.77e-01 | 2.48e-02 | 9.79e-01 |
| GOMF C C CHEMOKINE BINDING | 23 | 8.37e-01 | -2.48e-02 | 9.71e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 24 | 8.34e-01 | 2.48e-02 | 9.71e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 8 | 9.04e-01 | -2.47e-02 | 9.83e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 18 | 8.56e-01 | 2.47e-02 | 9.75e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 46 | 7.73e-01 | -2.46e-02 | 9.58e-01 |
| GOCC RECEPTOR COMPLEX | 380 | 4.10e-01 | 2.46e-02 | 8.49e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 23 | 8.38e-01 | 2.46e-02 | 9.71e-01 |
| GOBP REGULATION OF HAIR CYCLE | 27 | 8.25e-01 | 2.46e-02 | 9.69e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 12 | 8.83e-01 | -2.46e-02 | 9.79e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 31 | 8.13e-01 | -2.46e-02 | 9.67e-01 |
| GOBP VACUOLAR ACIDIFICATION | 32 | 8.10e-01 | 2.46e-02 | 9.66e-01 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 9.17e-01 | -2.46e-02 | 9.87e-01 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 44 | 7.78e-01 | -2.45e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 60 | 7.42e-01 | 2.45e-02 | 9.53e-01 |
| GOCC CONNEXIN COMPLEX | 19 | 8.53e-01 | 2.45e-02 | 9.74e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 109 | 6.59e-01 | 2.45e-02 | 9.30e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 13 | 8.78e-01 | 2.45e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 5 | 9.25e-01 | -2.45e-02 | 9.88e-01 |
| GOBP TRICUSPID VALVE DEVELOPMENT | 6 | 9.17e-01 | -2.44e-02 | 9.87e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 26 | 8.29e-01 | -2.44e-02 | 9.70e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 15 | 8.70e-01 | -2.44e-02 | 9.79e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 913 | 2.11e-01 | -2.44e-02 | 7.43e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 50 | 7.65e-01 | 2.44e-02 | 9.57e-01 |
| GOBP MANCHETTE ASSEMBLY | 6 | 9.18e-01 | 2.44e-02 | 9.87e-01 |
| GOBP REGULATION OF EPINEPHRINE SECRETION | 7 | 9.11e-01 | 2.43e-02 | 9.84e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 423 | 3.91e-01 | 2.43e-02 | 8.42e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 115 | 6.53e-01 | 2.43e-02 | 9.30e-01 |
| GOBP ELASTIC FIBER ASSEMBLY | 9 | 9.00e-01 | 2.43e-02 | 9.83e-01 |
| GOBP NEUROGENESIS | 1643 | 1.01e-01 | 2.43e-02 | 5.97e-01 |
| GOMF HISTONE BINDING | 220 | 5.35e-01 | 2.42e-02 | 8.94e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 49 | 7.69e-01 | 2.42e-02 | 9.58e-01 |
| GOBP MESODERM MORPHOGENESIS | 76 | 7.15e-01 | 2.42e-02 | 9.47e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 19 | 8.55e-01 | -2.42e-02 | 9.75e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 15 | 8.71e-01 | -2.42e-02 | 9.79e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 54 | 7.58e-01 | 2.42e-02 | 9.54e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 56 | 7.54e-01 | 2.42e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 20 | 8.52e-01 | -2.42e-02 | 9.74e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 127 | 6.38e-01 | 2.42e-02 | 9.27e-01 |
| GOBP THYMUS DEVELOPMENT | 49 | 7.70e-01 | 2.42e-02 | 9.58e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 46 | 7.77e-01 | -2.41e-02 | 9.59e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 113 | 6.58e-01 | 2.41e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 286 | 4.84e-01 | -2.41e-02 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 36 | 8.03e-01 | 2.40e-02 | 9.62e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 45 | 7.81e-01 | 2.40e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 76 | 7.18e-01 | -2.40e-02 | 9.48e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 7 | 9.13e-01 | -2.40e-02 | 9.85e-01 |
| GOBP REGULATION OF FEVER GENERATION | 9 | 9.01e-01 | 2.39e-02 | 9.83e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 11 | 8.91e-01 | 2.39e-02 | 9.82e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 17 | 8.65e-01 | 2.39e-02 | 9.77e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 14 | 8.77e-01 | 2.38e-02 | 9.79e-01 |
| GOBP ORGANELLE FISSION | 478 | 3.73e-01 | -2.38e-02 | 8.33e-01 |
| GOBP ORGANELLE DISASSEMBLY | 137 | 6.31e-01 | 2.38e-02 | 9.25e-01 |
| GOMF G PROTEIN COUPLED NEUROTRANSMITTER RECEPTOR ACTIVITY | 11 | 8.91e-01 | 2.38e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 17 | 8.65e-01 | -2.37e-02 | 9.77e-01 |
| GOBP ISOLEUCINE TRANSPORT | 5 | 9.27e-01 | 2.37e-02 | 9.88e-01 |
| GOCC APOLIPOPROTEIN B MRNA EDITING ENZYME COMPLEX | 5 | 9.27e-01 | 2.37e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 15 | 8.74e-01 | 2.37e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 62 | 7.47e-01 | 2.37e-02 | 9.53e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 17 | 8.66e-01 | -2.37e-02 | 9.77e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 28 | 8.28e-01 | 2.37e-02 | 9.70e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 19 | 8.58e-01 | -2.37e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 689 | 2.90e-01 | 2.36e-02 | 7.96e-01 |
| GOCC RIBOSOME | 224 | 5.43e-01 | -2.36e-02 | 8.97e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 125 | 6.49e-01 | -2.36e-02 | 9.30e-01 |
| GOMF MYOSIN BINDING | 71 | 7.32e-01 | 2.35e-02 | 9.52e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 46 | 7.83e-01 | 2.35e-02 | 9.60e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 33 | 8.16e-01 | -2.35e-02 | 9.68e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 8.98e-01 | 2.35e-02 | 9.82e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 8.98e-01 | 2.35e-02 | 9.82e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 70 | 7.34e-01 | 2.35e-02 | 9.53e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 208 | 5.60e-01 | -2.35e-02 | 9.05e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 8.43e-01 | 2.34e-02 | 9.73e-01 |
| GOMF STEROID BINDING | 97 | 6.90e-01 | -2.34e-02 | 9.42e-01 |
| GOBP ACUTE PHASE RESPONSE | 46 | 7.84e-01 | -2.34e-02 | 9.60e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 41 | 7.96e-01 | -2.34e-02 | 9.61e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 88 | 7.05e-01 | -2.34e-02 | 9.44e-01 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 9.15e-01 | 2.33e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF PINOCYTOSIS | 5 | 9.28e-01 | -2.33e-02 | 9.88e-01 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 14 | 8.80e-01 | -2.33e-02 | 9.79e-01 |
| GOBP WATER TRANSPORT | 28 | 8.31e-01 | 2.33e-02 | 9.71e-01 |
| GOBP IODIDE TRANSPORT | 9 | 9.04e-01 | 2.32e-02 | 9.83e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 17 | 8.68e-01 | -2.32e-02 | 9.78e-01 |
| GOMF AMIDE BINDING | 381 | 4.37e-01 | 2.32e-02 | 8.61e-01 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 14 | 8.81e-01 | 2.32e-02 | 9.79e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 201 | 5.71e-01 | -2.32e-02 | 9.06e-01 |
| GOMF MHC PROTEIN BINDING | 32 | 8.21e-01 | 2.31e-02 | 9.68e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 146 | 6.29e-01 | 2.31e-02 | 9.25e-01 |
| GOBP RESPONSE TO CAMP | 81 | 7.19e-01 | 2.31e-02 | 9.48e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 337 | 4.66e-01 | 2.31e-02 | 8.75e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 131 | 6.48e-01 | 2.31e-02 | 9.30e-01 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 16 | 8.73e-01 | 2.30e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 49 | 7.80e-01 | -2.30e-02 | 9.60e-01 |
| GOMF CORECEPTOR ACTIVITY | 47 | 7.85e-01 | 2.30e-02 | 9.60e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 41 | 7.99e-01 | 2.30e-02 | 9.61e-01 |
| GOBP OVULATION FROM OVARIAN FOLLICLE | 8 | 9.10e-01 | 2.30e-02 | 9.84e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 155 | 6.22e-01 | -2.29e-02 | 9.24e-01 |
| GOMF METHYL CPG BINDING | 24 | 8.46e-01 | -2.29e-02 | 9.73e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 78 | 7.26e-01 | -2.29e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 9 | 9.05e-01 | -2.29e-02 | 9.84e-01 |
| GOBP LIPID STORAGE | 93 | 7.03e-01 | -2.29e-02 | 9.44e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 806 | 2.69e-01 | 2.29e-02 | 7.84e-01 |
| GOBP FERMENTATION | 5 | 9.29e-01 | 2.29e-02 | 9.88e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 30 | 8.28e-01 | 2.29e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 15 | 8.78e-01 | -2.29e-02 | 9.79e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 99 | 6.95e-01 | 2.28e-02 | 9.43e-01 |
| GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR | 11 | 8.96e-01 | 2.28e-02 | 9.82e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 33 | 8.21e-01 | 2.28e-02 | 9.68e-01 |
| GOCC HETEROCHROMATIN | 76 | 7.31e-01 | 2.28e-02 | 9.52e-01 |
| GOBP GENERATION OF NEURONS | 1416 | 1.51e-01 | 2.28e-02 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 29 | 8.32e-01 | 2.27e-02 | 9.71e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 25 | 8.44e-01 | -2.27e-02 | 9.73e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 17 | 8.71e-01 | -2.27e-02 | 9.79e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 12 | 8.92e-01 | -2.27e-02 | 9.82e-01 |
| GOBP SEXUAL REPRODUCTION | 985 | 2.28e-01 | -2.27e-02 | 7.60e-01 |
| GOBP VASOCONSTRICTION | 80 | 7.26e-01 | 2.27e-02 | 9.50e-01 |
| GOBP SKELETAL MYOFIBRIL ASSEMBLY | 10 | 9.01e-01 | -2.27e-02 | 9.83e-01 |
| GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION | 13 | 8.88e-01 | -2.27e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 7 | 9.17e-01 | -2.26e-02 | 9.87e-01 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 11 | 8.97e-01 | -2.26e-02 | 9.82e-01 |
| GOBP ORGANELLE LOCALIZATION | 588 | 3.49e-01 | 2.26e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 17 | 8.72e-01 | -2.26e-02 | 9.79e-01 |
| GOBP GMP METABOLIC PROCESS | 25 | 8.45e-01 | -2.26e-02 | 9.73e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 8.88e-01 | 2.26e-02 | 9.81e-01 |
| GOBP MATURATION OF SSU RRNA | 51 | 7.80e-01 | -2.26e-02 | 9.60e-01 |
| GOMF CCR3 CHEMOKINE RECEPTOR BINDING | 5 | 9.30e-01 | 2.25e-02 | 9.88e-01 |
| GOBP OSTEOCLAST PROLIFERATION | 11 | 8.97e-01 | 2.25e-02 | 9.82e-01 |
| GOCC DESMOSOME | 25 | 8.45e-01 | -2.25e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 70 | 7.45e-01 | -2.25e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 9.12e-01 | -2.25e-02 | 9.85e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 8.43e-01 | 2.25e-02 | 9.73e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 52 | 7.80e-01 | 2.24e-02 | 9.60e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 149 | 6.37e-01 | 2.24e-02 | 9.26e-01 |
| GOCC ASTROCYTE PROJECTION | 19 | 8.66e-01 | 2.24e-02 | 9.77e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 15 | 8.81e-01 | -2.24e-02 | 9.79e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 117 | 6.76e-01 | 2.24e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 74 | 7.39e-01 | 2.24e-02 | 9.53e-01 |
| GOCC CMG COMPLEX | 11 | 8.98e-01 | 2.23e-02 | 9.82e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 12 | 8.93e-01 | -2.23e-02 | 9.82e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 40 | 8.07e-01 | 2.23e-02 | 9.64e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 14 | 8.85e-01 | 2.23e-02 | 9.80e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 467 | 4.09e-01 | 2.23e-02 | 8.49e-01 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 9.13e-01 | -2.23e-02 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 47 | 7.91e-01 | -2.23e-02 | 9.61e-01 |
| GOBP PERISTALSIS | 12 | 8.94e-01 | 2.23e-02 | 9.82e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 31 | 8.30e-01 | 2.23e-02 | 9.70e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 16 | 8.77e-01 | -2.23e-02 | 9.79e-01 |
| GOCC AGGRESOME | 33 | 8.26e-01 | -2.22e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 16 | 8.78e-01 | 2.22e-02 | 9.79e-01 |
| GOBP REGULATION OF AUTOPHAGY | 337 | 4.85e-01 | 2.21e-02 | 8.80e-01 |
| GOBP L SERINE CATABOLIC PROCESS | 5 | 9.32e-01 | -2.21e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 48 | 7.91e-01 | -2.21e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 14 | 8.86e-01 | -2.21e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS | 7 | 9.20e-01 | 2.20e-02 | 9.87e-01 |
| GOBP GAMETE GENERATION | 721 | 3.14e-01 | -2.20e-02 | 8.08e-01 |
| GOBP RESPONSE TO LUTEINIZING HORMONE | 7 | 9.20e-01 | -2.20e-02 | 9.87e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 245 | 5.53e-01 | 2.20e-02 | 9.01e-01 |
| GOBP MATING BEHAVIOR | 36 | 8.19e-01 | -2.20e-02 | 9.68e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 182 | 6.09e-01 | 2.20e-02 | 9.20e-01 |
| GOBP ESTROUS CYCLE | 16 | 8.79e-01 | 2.20e-02 | 9.79e-01 |
| GOBP NUCLEUS LOCALIZATION | 33 | 8.27e-01 | -2.19e-02 | 9.70e-01 |
| GOCC CORNIFIED ENVELOPE | 55 | 7.78e-01 | -2.19e-02 | 9.60e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 83 | 7.30e-01 | 2.19e-02 | 9.52e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 10 | 9.05e-01 | -2.19e-02 | 9.84e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 127 | 6.71e-01 | 2.19e-02 | 9.35e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 8.73e-01 | 2.18e-02 | 9.79e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 148 | 6.47e-01 | 2.18e-02 | 9.29e-01 |
| GOMF HYDRO LYASE ACTIVITY | 57 | 7.76e-01 | 2.18e-02 | 9.59e-01 |
| GOCC MICROTUBULE PLUS END | 24 | 8.54e-01 | 2.18e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 9.33e-01 | -2.18e-02 | 9.88e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 507 | 4.02e-01 | 2.18e-02 | 8.46e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 9 | 9.10e-01 | -2.17e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF ACTION POTENTIAL | 6 | 9.27e-01 | -2.17e-02 | 9.88e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 142 | 6.55e-01 | 2.17e-02 | 9.30e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 9.05e-01 | -2.17e-02 | 9.84e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 72 | 7.50e-01 | -2.17e-02 | 9.53e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 9 | 9.10e-01 | -2.17e-02 | 9.84e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 11 | 9.01e-01 | 2.17e-02 | 9.83e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 33 | 8.30e-01 | -2.17e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 33 | 8.30e-01 | -2.16e-02 | 9.70e-01 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 272 | 5.40e-01 | 2.16e-02 | 8.96e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 171 | 6.26e-01 | -2.16e-02 | 9.25e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 19 | 8.71e-01 | -2.16e-02 | 9.79e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 52 | 7.88e-01 | 2.16e-02 | 9.60e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 150 | 6.49e-01 | -2.16e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY | 8 | 9.16e-01 | 2.16e-02 | 9.86e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 734 | 3.20e-01 | 2.15e-02 | 8.10e-01 |
| GOBP HISTONE MODIFICATION | 106 | 7.02e-01 | 2.15e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 32 | 8.33e-01 | -2.15e-02 | 9.71e-01 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 9.11e-01 | 2.15e-02 | 9.84e-01 |
| GOMF HISTONE H4K20 MONOMETHYLTRANSFERASE ACTIVITY | 6 | 9.27e-01 | -2.15e-02 | 9.88e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 26 | 8.50e-01 | 2.15e-02 | 9.74e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 122 | 6.82e-01 | 2.15e-02 | 9.40e-01 |
| GOMF LIM DOMAIN BINDING | 5 | 9.34e-01 | -2.14e-02 | 9.88e-01 |
| GOBP INTRACILIARY TRANSPORT | 45 | 8.04e-01 | -2.13e-02 | 9.63e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 22 | 8.63e-01 | -2.13e-02 | 9.77e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 11 | 9.03e-01 | -2.13e-02 | 9.83e-01 |
| GOMF PEPTIDOGLYCAN MURALYTIC ACTIVITY | 13 | 8.94e-01 | -2.13e-02 | 9.82e-01 |
| GOBP DNA METABOLIC PROCESS | 982 | 2.59e-01 | -2.13e-02 | 7.78e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 9.07e-01 | 2.13e-02 | 9.84e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 101 | 7.12e-01 | -2.13e-02 | 9.47e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 512 | 4.11e-01 | 2.12e-02 | 8.49e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 9 | 9.12e-01 | 2.12e-02 | 9.85e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 53 | 7.90e-01 | -2.12e-02 | 9.61e-01 |
| GOBP RESPONSE TO ESTROGEN | 66 | 7.66e-01 | -2.12e-02 | 9.57e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 65 | 7.68e-01 | -2.12e-02 | 9.58e-01 |
| GOCC CILIARY BASAL BODY | 158 | 6.46e-01 | -2.12e-02 | 9.29e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 15 | 8.87e-01 | 2.11e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 9.35e-01 | 2.11e-02 | 9.88e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 23 | 8.61e-01 | 2.11e-02 | 9.76e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 9.08e-01 | 2.11e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 149 | 6.56e-01 | 2.11e-02 | 9.30e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 17 | 8.80e-01 | 2.11e-02 | 9.79e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 51 | 7.95e-01 | -2.11e-02 | 9.61e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 78 | 7.48e-01 | -2.11e-02 | 9.53e-01 |
| GOBP TUBE FORMATION | 149 | 6.57e-01 | 2.11e-02 | 9.30e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 85 | 7.38e-01 | 2.10e-02 | 9.53e-01 |
| GOBP GERM CELL DEVELOPMENT | 344 | 5.03e-01 | -2.10e-02 | 8.87e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 8 | 9.18e-01 | -2.10e-02 | 9.87e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 104 | 7.11e-01 | 2.10e-02 | 9.47e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 9 | 9.13e-01 | -2.10e-02 | 9.85e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 92 | 7.28e-01 | -2.10e-02 | 9.51e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 72 | 7.58e-01 | 2.10e-02 | 9.54e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 18 | 8.78e-01 | 2.10e-02 | 9.79e-01 |
| GOMF NADPH BINDING | 15 | 8.88e-01 | -2.10e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 8 | 9.18e-01 | -2.09e-02 | 9.87e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 8.75e-01 | 2.09e-02 | 9.79e-01 |
| GOBP DNA RECOMBINATION | 318 | 5.22e-01 | -2.09e-02 | 8.91e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 52 | 7.95e-01 | -2.09e-02 | 9.61e-01 |
| GOBP RRNA METHYLATION | 24 | 8.60e-01 | 2.08e-02 | 9.76e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 64 | 7.73e-01 | -2.08e-02 | 9.58e-01 |
| GOBP TONGUE MORPHOGENESIS | 10 | 9.09e-01 | 2.08e-02 | 9.84e-01 |
| GOBP OSTEOCLAST FUSION | 6 | 9.30e-01 | -2.08e-02 | 9.88e-01 |
| GOBP CORTISOL BIOSYNTHETIC PROCESS | 10 | 9.09e-01 | 2.08e-02 | 9.84e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 9 | 9.14e-01 | -2.07e-02 | 9.85e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 19 | 8.76e-01 | 2.07e-02 | 9.79e-01 |
| GOMF DEAMINASE ACTIVITY | 33 | 8.37e-01 | 2.07e-02 | 9.71e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 67 | 7.70e-01 | 2.06e-02 | 9.58e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 22 | 8.67e-01 | 2.06e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF CGMP MEDIATED SIGNALING | 5 | 9.36e-01 | 2.06e-02 | 9.89e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 8.73e-01 | 2.06e-02 | 9.79e-01 |
| GOBP REGULATION OF NEUROGENESIS | 373 | 4.95e-01 | 2.06e-02 | 8.83e-01 |
| GOCC APICAL DENDRITE | 15 | 8.90e-01 | 2.06e-02 | 9.82e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 31 | 8.43e-01 | -2.06e-02 | 9.73e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 139 | 6.76e-01 | 2.06e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 61 | 7.82e-01 | 2.05e-02 | 9.60e-01 |
| GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION | 10 | 9.11e-01 | 2.05e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 24 | 8.62e-01 | 2.05e-02 | 9.77e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 16 | 8.87e-01 | 2.05e-02 | 9.81e-01 |
| GOBP RETINAL CONE CELL DIFFERENTIATION | 13 | 8.98e-01 | -2.05e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 898 | 2.97e-01 | 2.05e-02 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 21 | 8.71e-01 | -2.05e-02 | 9.79e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 9.11e-01 | -2.05e-02 | 9.84e-01 |
| GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 6 | 9.31e-01 | -2.05e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 102 | 7.21e-01 | -2.05e-02 | 9.48e-01 |
| GOBP SEGMENT SPECIFICATION | 16 | 8.87e-01 | -2.04e-02 | 9.81e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 8 | 9.20e-01 | 2.04e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 68 | 7.71e-01 | 2.04e-02 | 9.58e-01 |
| GOCC ENVELOPE | 1183 | 2.37e-01 | 2.04e-02 | 7.63e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 57 | 7.90e-01 | -2.04e-02 | 9.61e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 44 | 8.15e-01 | 2.04e-02 | 9.68e-01 |
| GOMF IRON ION BINDING | 145 | 6.72e-01 | 2.04e-02 | 9.35e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 22 | 8.69e-01 | -2.03e-02 | 9.78e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 8 | 9.21e-01 | 2.03e-02 | 9.88e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 54 | 7.97e-01 | -2.03e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 6 | 9.31e-01 | 2.03e-02 | 9.88e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 128 | 6.92e-01 | -2.03e-02 | 9.43e-01 |
| GOBP CELLULAR RESPONSE TO MAGNESIUM ION | 7 | 9.26e-01 | -2.02e-02 | 9.88e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 42 | 8.21e-01 | -2.02e-02 | 9.68e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 65 | 7.79e-01 | 2.02e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 161 | 6.59e-01 | 2.02e-02 | 9.30e-01 |
| GOBP COBALT ION TRANSPORT | 6 | 9.32e-01 | 2.01e-02 | 9.88e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 108 | 7.19e-01 | 2.01e-02 | 9.48e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 38 | 8.31e-01 | 2.00e-02 | 9.71e-01 |
| GOBP FUNGIFORM PAPILLA MORPHOGENESIS | 5 | 9.38e-01 | -2.00e-02 | 9.90e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE REGULATOR ACTIVITY | 5 | 9.38e-01 | -2.00e-02 | 9.90e-01 |
| GOBP RNA CATABOLIC PROCESS | 348 | 5.21e-01 | -2.00e-02 | 8.90e-01 |
| GOBP DNA CONFORMATION CHANGE | 87 | 7.47e-01 | -2.00e-02 | 9.53e-01 |
| GOCC ATPASE COMPLEX | 140 | 6.83e-01 | -2.00e-02 | 9.40e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 44 | 8.19e-01 | -2.00e-02 | 9.68e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 32 | 8.45e-01 | 2.00e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 118 | 7.08e-01 | -2.00e-02 | 9.45e-01 |
| GOBP RESPONSE TO HEPARIN | 7 | 9.27e-01 | 1.99e-02 | 9.88e-01 |
| GOMF HORMONE ACTIVITY | 119 | 7.07e-01 | 1.99e-02 | 9.45e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 9 | 9.18e-01 | 1.99e-02 | 9.87e-01 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 50 | 8.07e-01 | 1.99e-02 | 9.64e-01 |
| GOMF DAMAGED DNA BINDING | 70 | 7.73e-01 | -1.99e-02 | 9.58e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 9.23e-01 | 1.99e-02 | 9.88e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 38 | 8.32e-01 | 1.98e-02 | 9.71e-01 |
| GOBP DOSAGE COMPENSATION | 27 | 8.58e-01 | -1.98e-02 | 9.76e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 9.39e-01 | -1.98e-02 | 9.90e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 126 | 7.01e-01 | 1.98e-02 | 9.44e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 173 | 6.54e-01 | 1.98e-02 | 9.30e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 10 | 9.14e-01 | -1.98e-02 | 9.85e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 53 | 8.04e-01 | 1.98e-02 | 9.62e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 150 | 6.77e-01 | -1.97e-02 | 9.37e-01 |
| GOBP NEURON PROJECTION ORGANIZATION | 84 | 7.55e-01 | 1.97e-02 | 9.54e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 19 | 8.82e-01 | 1.97e-02 | 9.79e-01 |
| GOBP FIBROBLAST PROLIFERATION | 104 | 7.29e-01 | -1.97e-02 | 9.51e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 22 | 8.73e-01 | -1.97e-02 | 9.79e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 478 | 4.62e-01 | 1.97e-02 | 8.73e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 34 | 8.43e-01 | 1.96e-02 | 9.73e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 9 | 9.19e-01 | -1.96e-02 | 9.87e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 19 | 8.82e-01 | 1.96e-02 | 9.79e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 21 | 8.77e-01 | 1.96e-02 | 9.79e-01 |
| GOMF SPLICING FACTOR BINDING | 5 | 9.40e-01 | -1.96e-02 | 9.90e-01 |
| GOMF GLUCOSE SODIUM SYMPORTER ACTIVITY | 7 | 9.29e-01 | 1.96e-02 | 9.88e-01 |
| GOMF STEROL BINDING | 61 | 7.92e-01 | 1.96e-02 | 9.61e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 47 | 8.17e-01 | -1.96e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 166 | 6.64e-01 | 1.96e-02 | 9.31e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 14 | 8.99e-01 | 1.96e-02 | 9.83e-01 |
| GOBP DEVELOPMENTAL MATURATION | 317 | 5.49e-01 | 1.96e-02 | 9.01e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 38 | 8.35e-01 | -1.96e-02 | 9.71e-01 |
| GOBP RESPONSE TO NEMATODE | 7 | 9.29e-01 | -1.95e-02 | 9.88e-01 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 64 | 7.87e-01 | 1.95e-02 | 9.60e-01 |
| GOCC CILIUM | 704 | 3.77e-01 | -1.95e-02 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 73 | 7.73e-01 | -1.95e-02 | 9.58e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 370 | 5.19e-01 | 1.95e-02 | 8.90e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 128 | 7.04e-01 | 1.95e-02 | 9.44e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 13 | 9.03e-01 | -1.95e-02 | 9.83e-01 |
| GOBP ANIMAL ORGAN FORMATION | 66 | 7.85e-01 | 1.95e-02 | 9.60e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 9 | 9.19e-01 | 1.95e-02 | 9.87e-01 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 11 | 9.11e-01 | 1.95e-02 | 9.84e-01 |
| GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION | 12 | 9.07e-01 | -1.94e-02 | 9.84e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 225 | 6.15e-01 | 1.94e-02 | 9.21e-01 |
| GOBP REGULATION OF GLIOGENESIS | 106 | 7.30e-01 | 1.94e-02 | 9.52e-01 |
| GOBP RESPONSE TO BACTERIUM | 660 | 3.95e-01 | 1.94e-02 | 8.45e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 37 | 8.38e-01 | 1.94e-02 | 9.71e-01 |
| GOBP PIGMENTATION | 108 | 7.28e-01 | 1.93e-02 | 9.51e-01 |
| GOBP CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE | 7 | 9.29e-01 | 1.93e-02 | 9.88e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 14 | 9.01e-01 | -1.93e-02 | 9.83e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 27 | 8.62e-01 | -1.93e-02 | 9.77e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 58 | 8.00e-01 | -1.93e-02 | 9.61e-01 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 15 | 8.97e-01 | -1.92e-02 | 9.82e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 111 | 7.26e-01 | 1.92e-02 | 9.51e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 57 | 8.02e-01 | 1.92e-02 | 9.62e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 23 | 8.73e-01 | 1.92e-02 | 9.79e-01 |
| GOMF GUANYLATE CYCLASE REGULATOR ACTIVITY | 8 | 9.25e-01 | 1.92e-02 | 9.88e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 32 | 8.51e-01 | 1.92e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 138 | 6.97e-01 | 1.92e-02 | 9.43e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 76 | 7.73e-01 | -1.92e-02 | 9.58e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 61 | 7.96e-01 | -1.92e-02 | 9.61e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 52 | 8.11e-01 | -1.92e-02 | 9.66e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 1213 | 2.61e-01 | 1.92e-02 | 7.83e-01 |
| GOBP MEMBRANE FISSION | 42 | 8.30e-01 | -1.92e-02 | 9.70e-01 |
| GOBP VASCULATURE DEVELOPMENT | 794 | 3.59e-01 | 1.91e-02 | 8.31e-01 |
| GOCC PEPTIDASE COMPLEX | 116 | 7.22e-01 | -1.91e-02 | 9.48e-01 |
| GOBP STEM CELL DIFFERENTIATION | 240 | 6.10e-01 | -1.91e-02 | 9.20e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 35 | 8.45e-01 | 1.91e-02 | 9.73e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 55 | 8.07e-01 | 1.91e-02 | 9.64e-01 |
| GOCC INTERCALATED DISC | 49 | 8.18e-01 | -1.90e-02 | 9.68e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 91 | 7.54e-01 | 1.90e-02 | 9.54e-01 |
| GOMF OLFACTORY RECEPTOR BINDING | 6 | 9.36e-01 | -1.90e-02 | 9.89e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 63 | 7.95e-01 | -1.89e-02 | 9.61e-01 |
| GOBP NEGATIVE T CELL SELECTION | 13 | 9.06e-01 | 1.89e-02 | 9.84e-01 |
| GOCC NEURON SPINE | 168 | 6.73e-01 | 1.89e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 152 | 6.88e-01 | 1.89e-02 | 9.42e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 34 | 8.49e-01 | -1.89e-02 | 9.74e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 115 | 7.27e-01 | 1.88e-02 | 9.51e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 68 | 7.89e-01 | 1.88e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 15 | 9.00e-01 | -1.88e-02 | 9.83e-01 |
| GOMF HYALURONIC ACID BINDING | 24 | 8.74e-01 | -1.88e-02 | 9.79e-01 |
| GOBP CELL CYCLE PROCESS | 1242 | 2.66e-01 | 1.88e-02 | 7.83e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 113 | 7.30e-01 | 1.88e-02 | 9.52e-01 |
| GOBP NADPH OXIDATION | 5 | 9.42e-01 | -1.88e-02 | 9.90e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 15 | 9.00e-01 | -1.87e-02 | 9.83e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 10 | 9.18e-01 | -1.87e-02 | 9.87e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 38 | 8.42e-01 | -1.87e-02 | 9.73e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 9.23e-01 | -1.87e-02 | 9.88e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 27 | 8.67e-01 | 1.87e-02 | 9.77e-01 |
| GOMF COA HYDROLASE ACTIVITY | 21 | 8.82e-01 | -1.86e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 9 | 9.23e-01 | 1.86e-02 | 9.88e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 136 | 7.08e-01 | -1.86e-02 | 9.45e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 59 | 8.05e-01 | 1.86e-02 | 9.63e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 20 | 8.85e-01 | 1.86e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 66 | 7.94e-01 | 1.86e-02 | 9.61e-01 |
| GOCC PERICILIARY MEMBRANE COMPARTMENT | 5 | 9.43e-01 | 1.86e-02 | 9.90e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 103 | 7.45e-01 | -1.86e-02 | 9.53e-01 |
| GOBP RESPONSE TO RADIATION | 410 | 5.19e-01 | -1.86e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 1463 | 2.35e-01 | 1.86e-02 | 7.62e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 19 | 8.89e-01 | -1.85e-02 | 9.81e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 50 | 8.21e-01 | 1.85e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 166 | 6.81e-01 | 1.85e-02 | 9.39e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 36 | 8.48e-01 | -1.85e-02 | 9.74e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 93 | 7.59e-01 | 1.84e-02 | 9.54e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 13 | 9.08e-01 | 1.84e-02 | 9.84e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 132 | 7.15e-01 | 1.84e-02 | 9.47e-01 |
| GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS | 5 | 9.43e-01 | -1.84e-02 | 9.90e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 36 | 8.48e-01 | -1.84e-02 | 9.74e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 7 | 9.33e-01 | -1.84e-02 | 9.88e-01 |
| GOBP GERM CELL MIGRATION | 8 | 9.28e-01 | -1.84e-02 | 9.88e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 62 | 8.02e-01 | -1.84e-02 | 9.62e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 57 | 8.10e-01 | -1.84e-02 | 9.66e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 325 | 5.69e-01 | 1.84e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 5 | 9.43e-01 | 1.84e-02 | 9.90e-01 |
| GOBP RNA SURVEILLANCE | 17 | 8.96e-01 | -1.83e-02 | 9.82e-01 |
| GOBP REGULATION OF LIPID STORAGE | 54 | 8.16e-01 | -1.83e-02 | 9.68e-01 |
| GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY | 15 | 9.02e-01 | 1.83e-02 | 9.83e-01 |
| GOBP VIRAL PROCESS | 412 | 5.24e-01 | 1.83e-02 | 8.91e-01 |
| GOBP RENAL TUBULAR SECRETION | 19 | 8.90e-01 | -1.83e-02 | 9.82e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 128 | 7.21e-01 | -1.83e-02 | 9.48e-01 |
| GOCC MITOCHONDRION | 1569 | 2.29e-01 | 1.82e-02 | 7.60e-01 |
| GOBP SPINDLE ORGANIZATION | 192 | 6.64e-01 | -1.82e-02 | 9.32e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 12 | 9.13e-01 | 1.81e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 6 | 9.39e-01 | 1.81e-02 | 9.90e-01 |
| GOBP LIMB BUD FORMATION | 9 | 9.25e-01 | 1.81e-02 | 9.88e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 12 | 9.14e-01 | -1.81e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 14 | 9.07e-01 | 1.81e-02 | 9.84e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 49 | 8.27e-01 | 1.81e-02 | 9.70e-01 |
| GOCC CILIARY MEMBRANE | 72 | 7.91e-01 | 1.80e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 88 | 7.71e-01 | -1.80e-02 | 9.58e-01 |
| GOBP DETOXIFICATION | 152 | 7.02e-01 | 1.80e-02 | 9.44e-01 |
| GOCC MITOTIC SPINDLE | 174 | 6.82e-01 | 1.80e-02 | 9.40e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 11 | 9.18e-01 | 1.80e-02 | 9.87e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 9.30e-01 | 1.80e-02 | 9.88e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 27 | 8.72e-01 | 1.80e-02 | 9.79e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 10 | 9.22e-01 | -1.80e-02 | 9.88e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 175 | 6.83e-01 | 1.79e-02 | 9.40e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.26e-01 | 1.79e-02 | 9.88e-01 |
| GOMF XMP 5 NUCLEOSIDASE ACTIVITY | 6 | 9.40e-01 | -1.79e-02 | 9.90e-01 |
| GOBP LEUCINE METABOLIC PROCESS | 8 | 9.30e-01 | -1.79e-02 | 9.88e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 27 | 8.72e-01 | 1.79e-02 | 9.79e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 57 | 8.16e-01 | 1.78e-02 | 9.68e-01 |
| GOBP COLLATERAL SPROUTING IN ABSENCE OF INJURY | 5 | 9.45e-01 | 1.78e-02 | 9.90e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 32 | 8.62e-01 | 1.78e-02 | 9.77e-01 |
| GOCC AP 2 ADAPTOR COMPLEX | 10 | 9.22e-01 | -1.78e-02 | 9.88e-01 |
| GOBP NEURON MATURATION | 47 | 8.33e-01 | 1.78e-02 | 9.71e-01 |
| GOCC NUCLEAR SPECK | 395 | 5.45e-01 | 1.78e-02 | 8.98e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 40 | 8.46e-01 | -1.77e-02 | 9.73e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1758 | 2.17e-01 | 1.77e-02 | 7.48e-01 |
| GOBP ORGAN GROWTH | 168 | 6.92e-01 | 1.77e-02 | 9.43e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 9.40e-01 | 1.77e-02 | 9.90e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 9.31e-01 | -1.77e-02 | 9.88e-01 |
| GOBP SERINE TRANSPORT | 9 | 9.27e-01 | -1.77e-02 | 9.88e-01 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.27e-01 | -1.77e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 44 | 8.39e-01 | 1.77e-02 | 9.72e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 216 | 6.54e-01 | 1.77e-02 | 9.30e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 9 | 9.27e-01 | -1.76e-02 | 9.88e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 9.27e-01 | 1.76e-02 | 9.88e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 40 | 8.47e-01 | -1.76e-02 | 9.74e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 927 | 3.64e-01 | -1.76e-02 | 8.33e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 8.00e-01 | -1.76e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 11 | 9.20e-01 | -1.76e-02 | 9.87e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 248 | 6.34e-01 | 1.75e-02 | 9.25e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 70 | 8.00e-01 | 1.75e-02 | 9.61e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 16 | 9.04e-01 | -1.75e-02 | 9.83e-01 |
| GOBP VIRAL LIFE CYCLE | 307 | 5.98e-01 | 1.75e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 15 | 9.07e-01 | -1.75e-02 | 9.84e-01 |
| GOBP MALE MATING BEHAVIOR | 6 | 9.41e-01 | -1.75e-02 | 9.90e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 9.41e-01 | 1.75e-02 | 9.90e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 445 | 5.28e-01 | 1.75e-02 | 8.93e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 18 | 8.98e-01 | -1.74e-02 | 9.82e-01 |
| GOBP TRANSITION BETWEEN FAST AND SLOW FIBER | 9 | 9.28e-01 | -1.74e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 9.32e-01 | -1.74e-02 | 9.88e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 118 | 7.44e-01 | -1.74e-02 | 9.53e-01 |
| GOBP REGULATION OF RNA SPLICING | 163 | 7.01e-01 | 1.74e-02 | 9.44e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 17 | 9.01e-01 | -1.74e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 67 | 8.05e-01 | -1.74e-02 | 9.63e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 30 | 8.69e-01 | -1.74e-02 | 9.78e-01 |
| GOMF PDZ DOMAIN BINDING | 84 | 7.83e-01 | -1.74e-02 | 9.60e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 76 | 7.93e-01 | -1.74e-02 | 9.61e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 99 | 7.65e-01 | 1.74e-02 | 9.57e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 40 | 8.49e-01 | -1.74e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 24 | 8.83e-01 | -1.73e-02 | 9.80e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 21 | 8.91e-01 | -1.73e-02 | 9.82e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 46 | 8.39e-01 | 1.73e-02 | 9.71e-01 |
| GOBP CELL CYCLE | 1732 | 2.31e-01 | 1.73e-02 | 7.61e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 32 | 8.65e-01 | 1.73e-02 | 9.77e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 9 | 9.28e-01 | -1.73e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 26 | 8.79e-01 | -1.73e-02 | 9.79e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 53 | 8.28e-01 | -1.73e-02 | 9.70e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 25 | 8.82e-01 | 1.72e-02 | 9.79e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 28 | 8.75e-01 | -1.72e-02 | 9.79e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 9.37e-01 | 1.72e-02 | 9.89e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 9.37e-01 | 1.72e-02 | 9.89e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 31 | 8.69e-01 | -1.72e-02 | 9.78e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 15 | 9.09e-01 | -1.71e-02 | 9.84e-01 |
| GOBP DTTP METABOLIC PROCESS | 5 | 9.47e-01 | -1.70e-02 | 9.90e-01 |
| GOBP INNER EAR RECEPTOR CELL FATE COMMITMENT | 5 | 9.48e-01 | 1.70e-02 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 58 | 8.23e-01 | 1.70e-02 | 9.69e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 90 | 7.81e-01 | -1.70e-02 | 9.60e-01 |
| GOCC RIPOPTOSOME | 6 | 9.43e-01 | 1.69e-02 | 9.90e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 99 | 7.71e-01 | 1.69e-02 | 9.58e-01 |
| GOBP ICOSANOID TRANSPORT | 63 | 8.17e-01 | -1.69e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 24 | 8.86e-01 | 1.69e-02 | 9.81e-01 |
| GOBP HARD PALATE DEVELOPMENT | 8 | 9.34e-01 | -1.69e-02 | 9.88e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 64 | 8.16e-01 | 1.69e-02 | 9.68e-01 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 18 | 9.02e-01 | -1.68e-02 | 9.83e-01 |
| GOBP CELL MORPHOGENESIS | 911 | 3.89e-01 | 1.68e-02 | 8.41e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 679 | 4.55e-01 | 1.68e-02 | 8.70e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 31 | 8.71e-01 | 1.68e-02 | 9.79e-01 |
| GOMF SIRNA BINDING | 7 | 9.39e-01 | 1.68e-02 | 9.90e-01 |
| GOBP STEM CELL PROLIFERATION | 120 | 7.51e-01 | -1.68e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 36 | 8.62e-01 | 1.68e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 16 | 9.08e-01 | 1.68e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 37 | 8.60e-01 | 1.68e-02 | 9.76e-01 |
| GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 9.27e-01 | -1.68e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 37 | 8.60e-01 | -1.67e-02 | 9.76e-01 |
| GOBP SARCOMERE ORGANIZATION | 45 | 8.46e-01 | -1.67e-02 | 9.73e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 142 | 7.31e-01 | 1.67e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 9 | 9.31e-01 | -1.67e-02 | 9.88e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 136 | 7.37e-01 | 1.67e-02 | 9.53e-01 |
| GOCC ELONGIN COMPLEX | 5 | 9.48e-01 | -1.67e-02 | 9.90e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 9.49e-01 | -1.67e-02 | 9.90e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 47 | 8.44e-01 | 1.66e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 9 | 9.31e-01 | -1.66e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 201 | 6.85e-01 | 1.66e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 21 | 8.95e-01 | 1.66e-02 | 9.82e-01 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 15 | 9.12e-01 | 1.66e-02 | 9.85e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 26 | 8.84e-01 | -1.66e-02 | 9.80e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 1138 | 3.46e-01 | 1.66e-02 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 21 | 8.96e-01 | -1.65e-02 | 9.82e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 126 | 7.49e-01 | -1.65e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 9.49e-01 | -1.65e-02 | 9.90e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 16 | 9.09e-01 | -1.65e-02 | 9.84e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 57 | 8.29e-01 | 1.65e-02 | 9.70e-01 |
| GOCC CILIARY PLASM | 158 | 7.21e-01 | 1.65e-02 | 9.48e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 150 | 7.27e-01 | 1.65e-02 | 9.51e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 76 | 8.04e-01 | 1.65e-02 | 9.63e-01 |
| GOBP TISSUE MIGRATION | 364 | 5.89e-01 | 1.65e-02 | 9.11e-01 |
| GOCC SEROTONIN RECEPTOR COMPLEX | 8 | 9.36e-01 | -1.64e-02 | 9.89e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 48 | 8.44e-01 | -1.64e-02 | 9.73e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 19 | 9.02e-01 | 1.64e-02 | 9.83e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 21 | 8.97e-01 | -1.64e-02 | 9.82e-01 |
| GOBP SYNAPSE ORGANIZATION | 446 | 5.53e-01 | 1.64e-02 | 9.01e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 94 | 7.84e-01 | -1.64e-02 | 9.60e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 9 | 9.32e-01 | 1.64e-02 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 24 | 8.90e-01 | -1.64e-02 | 9.82e-01 |
| GOBP RELAXATION OF MUSCLE | 33 | 8.71e-01 | 1.63e-02 | 9.79e-01 |
| GOMF VITAMIN D BINDING | 6 | 9.45e-01 | 1.63e-02 | 9.90e-01 |
| GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 9.00e-01 | 1.63e-02 | 9.83e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 26 | 8.86e-01 | -1.63e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 6 | 9.45e-01 | 1.62e-02 | 9.90e-01 |
| GOBP CENTRIOLE ASSEMBLY | 47 | 8.47e-01 | 1.62e-02 | 9.74e-01 |
| GOCC NUCLEAR PERIPHERY | 142 | 7.39e-01 | 1.62e-02 | 9.53e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 7 | 9.41e-01 | -1.62e-02 | 9.90e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 84 | 7.98e-01 | -1.61e-02 | 9.61e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 23 | 8.94e-01 | -1.61e-02 | 9.82e-01 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 11 | 9.26e-01 | -1.61e-02 | 9.88e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 23 | 8.94e-01 | 1.61e-02 | 9.82e-01 |
| GOCC PROTEASOME CORE COMPLEX | 20 | 9.01e-01 | -1.61e-02 | 9.83e-01 |
| GOBP NEURON FATE DETERMINATION | 10 | 9.30e-01 | 1.61e-02 | 9.88e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 91 | 7.91e-01 | 1.61e-02 | 9.61e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 9 | 9.34e-01 | 1.60e-02 | 9.88e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 45 | 8.53e-01 | 1.60e-02 | 9.74e-01 |
| GOCC TRANSFERASE COMPLEX | 789 | 4.45e-01 | 1.60e-02 | 8.66e-01 |
| GOBP BONE MINERALIZATION | 116 | 7.67e-01 | -1.60e-02 | 9.57e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 128 | 7.55e-01 | -1.59e-02 | 9.54e-01 |
| GOBP TRANSPORT ALONG MICROTUBULE | 164 | 7.25e-01 | 1.59e-02 | 9.50e-01 |
| GOBP AXONAL TRANSPORT | 62 | 8.29e-01 | -1.59e-02 | 9.70e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 86 | 7.99e-01 | -1.59e-02 | 9.61e-01 |
| GOBP PONS DEVELOPMENT | 11 | 9.27e-01 | 1.59e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 74 | 8.13e-01 | -1.59e-02 | 9.67e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 34 | 8.73e-01 | 1.58e-02 | 9.79e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 17 | 9.10e-01 | 1.58e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 65 | 8.26e-01 | -1.58e-02 | 9.69e-01 |
| GOCC SEX CHROMOSOME | 33 | 8.75e-01 | 1.58e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 31 | 8.79e-01 | 1.58e-02 | 9.79e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 28 | 8.85e-01 | -1.58e-02 | 9.80e-01 |
| GOCC KINESIN COMPLEX | 46 | 8.54e-01 | 1.57e-02 | 9.75e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 13 | 9.22e-01 | -1.57e-02 | 9.88e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 17 | 9.11e-01 | 1.57e-02 | 9.84e-01 |
| GOCC CLEAVAGE FURROW | 51 | 8.47e-01 | 1.56e-02 | 9.73e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 55 | 8.41e-01 | 1.56e-02 | 9.73e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 793 | 4.55e-01 | -1.56e-02 | 8.70e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 935 | 4.19e-01 | -1.56e-02 | 8.54e-01 |
| GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX | 11 | 9.29e-01 | -1.56e-02 | 9.88e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 50 | 8.49e-01 | 1.56e-02 | 9.74e-01 |
| GOCC TIGHT JUNCTION | 122 | 7.66e-01 | 1.56e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 37 | 8.70e-01 | -1.56e-02 | 9.79e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 28 | 8.87e-01 | 1.55e-02 | 9.81e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 139 | 7.52e-01 | -1.55e-02 | 9.54e-01 |
| GOBP MICROTUBULE NUCLEATION | 43 | 8.60e-01 | 1.55e-02 | 9.76e-01 |
| GOMF PROTEASE BINDING | 139 | 7.52e-01 | 1.55e-02 | 9.54e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 64 | 8.30e-01 | 1.55e-02 | 9.70e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 71 | 8.21e-01 | 1.55e-02 | 9.68e-01 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 6 | 9.48e-01 | -1.55e-02 | 9.90e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 93 | 7.96e-01 | 1.55e-02 | 9.61e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 713 | 4.81e-01 | 1.55e-02 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 12 | 9.26e-01 | -1.55e-02 | 9.88e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 24 | 8.96e-01 | -1.55e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATURATION | 8 | 9.40e-01 | -1.55e-02 | 9.90e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 270 | 6.63e-01 | -1.54e-02 | 9.31e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 9.52e-01 | -1.54e-02 | 9.90e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 10 | 9.33e-01 | 1.54e-02 | 9.88e-01 |
| GOMF NEUROTROPHIN RECEPTOR ACTIVITY | 5 | 9.53e-01 | -1.54e-02 | 9.90e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 46 | 8.57e-01 | -1.54e-02 | 9.75e-01 |
| GOBP NAD METABOLIC PROCESS | 42 | 8.64e-01 | 1.53e-02 | 9.77e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 47 | 8.56e-01 | 1.53e-02 | 9.75e-01 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 8 | 9.40e-01 | 1.53e-02 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 11 | 9.30e-01 | -1.53e-02 | 9.88e-01 |
| GOBP REGULATION OF PIGMENTATION | 17 | 9.13e-01 | 1.53e-02 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 155 | 7.43e-01 | 1.53e-02 | 9.53e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 114 | 7.79e-01 | -1.52e-02 | 9.60e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 70 | 8.26e-01 | 1.52e-02 | 9.69e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 39 | 8.69e-01 | 1.52e-02 | 9.78e-01 |
| GOBP POSTREPLICATION REPAIR | 33 | 8.80e-01 | 1.52e-02 | 9.79e-01 |
| GOBP T CELL HOMEOSTASIS | 44 | 8.62e-01 | -1.52e-02 | 9.77e-01 |
| GOMF C X C CHEMOKINE RECEPTOR ACTIVITY | 7 | 9.45e-01 | -1.52e-02 | 9.90e-01 |
| GOBP DNA MODIFICATION | 99 | 7.94e-01 | 1.52e-02 | 9.61e-01 |
| GOCC DENSE CORE GRANULE | 38 | 8.72e-01 | 1.52e-02 | 9.79e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 15 | 9.19e-01 | 1.51e-02 | 9.87e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 118 | 7.77e-01 | -1.51e-02 | 9.59e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 197 | 7.15e-01 | 1.51e-02 | 9.47e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 29 | 8.88e-01 | 1.51e-02 | 9.81e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 74 | 8.23e-01 | 1.51e-02 | 9.69e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 29 | 8.89e-01 | 1.50e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 16 | 9.17e-01 | 1.50e-02 | 9.87e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 14 | 9.23e-01 | -1.50e-02 | 9.88e-01 |
| GOBP SISTER CHROMATID COHESION | 52 | 8.52e-01 | 1.49e-02 | 9.74e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 108 | 7.89e-01 | -1.49e-02 | 9.60e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 382 | 6.18e-01 | 1.49e-02 | 9.22e-01 |
| GOBP MACROAUTOPHAGY | 317 | 6.49e-01 | 1.49e-02 | 9.30e-01 |
| GOBP SYNAPTIC SIGNALING VIA NEUROPEPTIDE | 6 | 9.50e-01 | -1.48e-02 | 9.90e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 160 | 7.46e-01 | 1.48e-02 | 9.53e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 102 | 7.96e-01 | 1.48e-02 | 9.61e-01 |
| GOBP CENTROSOME DUPLICATION | 74 | 8.26e-01 | 1.48e-02 | 9.69e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 95 | 8.03e-01 | 1.48e-02 | 9.62e-01 |
| GOBP NCRNA TRANSCRIPTION | 134 | 7.68e-01 | 1.48e-02 | 9.58e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 246 | 6.90e-01 | -1.48e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 28 | 8.92e-01 | -1.48e-02 | 9.82e-01 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 7 | 9.46e-01 | 1.48e-02 | 9.90e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 103 | 7.96e-01 | 1.47e-02 | 9.61e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 48 | 8.60e-01 | 1.47e-02 | 9.76e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 27 | 8.95e-01 | 1.47e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 165 | 7.45e-01 | 1.47e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 29 | 8.91e-01 | 1.47e-02 | 9.82e-01 |
| GOMF ACTIN MONOMER BINDING | 24 | 9.01e-01 | 1.46e-02 | 9.83e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 34 | 8.83e-01 | 1.46e-02 | 9.79e-01 |
| GOBP NCRNA METABOLIC PROCESS | 603 | 5.40e-01 | -1.46e-02 | 8.96e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 15 | 9.22e-01 | 1.46e-02 | 9.88e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 13 | 9.28e-01 | 1.45e-02 | 9.88e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 21 | 9.08e-01 | -1.45e-02 | 9.84e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1821 | 3.04e-01 | 1.45e-02 | 8.02e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 31 | 8.89e-01 | 1.45e-02 | 9.81e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 37 | 8.79e-01 | -1.45e-02 | 9.79e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 9.31e-01 | -1.44e-02 | 9.88e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 38 | 8.78e-01 | -1.44e-02 | 9.79e-01 |
| GOBP ATP TRANSPORT | 17 | 9.18e-01 | -1.44e-02 | 9.87e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 100 | 8.04e-01 | 1.44e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 21 | 9.09e-01 | 1.44e-02 | 9.84e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 28 | 8.96e-01 | -1.43e-02 | 9.82e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 11 | 9.34e-01 | -1.43e-02 | 9.88e-01 |
| GOBP LEARNING | 145 | 7.66e-01 | -1.43e-02 | 9.57e-01 |
| GOBP FATTY ACID ELONGATION | 12 | 9.32e-01 | -1.43e-02 | 9.88e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 15 | 9.24e-01 | -1.43e-02 | 9.88e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 46 | 8.67e-01 | 1.43e-02 | 9.77e-01 |
| GOCC MEDIATOR COMPLEX | 34 | 8.86e-01 | -1.43e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY | 6 | 9.52e-01 | -1.43e-02 | 9.90e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 6 | 9.52e-01 | 1.43e-02 | 9.90e-01 |
| GOBP THIAMINE DIPHOSPHATE METABOLIC PROCESS | 5 | 9.56e-01 | 1.42e-02 | 9.91e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 14 | 9.26e-01 | -1.42e-02 | 9.88e-01 |
| GOMF MICROFIBRIL BINDING | 5 | 9.56e-01 | 1.42e-02 | 9.91e-01 |
| GOBP CHOLESTEROL EFFLUX | 73 | 8.34e-01 | -1.42e-02 | 9.71e-01 |
| GOBP BICARBONATE TRANSPORT | 35 | 8.84e-01 | 1.42e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 94 | 8.12e-01 | -1.42e-02 | 9.67e-01 |
| GOBP ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION | 6 | 9.52e-01 | -1.41e-02 | 9.90e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 83 | 8.24e-01 | 1.41e-02 | 9.69e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 27 | 8.99e-01 | -1.41e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 5 | 9.56e-01 | -1.41e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 573 | 5.64e-01 | 1.41e-02 | 9.05e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 82 | 8.25e-01 | -1.41e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 59 | 8.52e-01 | -1.40e-02 | 9.74e-01 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 85 | 8.24e-01 | -1.40e-02 | 9.69e-01 |
| GOCC AXON CYTOPLASM | 60 | 8.51e-01 | -1.40e-02 | 9.74e-01 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 9.45e-01 | -1.40e-02 | 9.90e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 71 | 8.39e-01 | -1.40e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 10 | 9.39e-01 | -1.39e-02 | 9.90e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 93 | 8.17e-01 | 1.39e-02 | 9.68e-01 |
| GOBP TRANSLESION SYNTHESIS | 25 | 9.05e-01 | 1.38e-02 | 9.84e-01 |
| GOBP HYDROCARBON METABOLIC PROCESS | 7 | 9.49e-01 | -1.38e-02 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 9.57e-01 | 1.38e-02 | 9.91e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 28 | 8.99e-01 | -1.38e-02 | 9.83e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 36 | 8.86e-01 | 1.38e-02 | 9.81e-01 |
| GOMF ATPASE BINDING | 82 | 8.29e-01 | 1.38e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 9.40e-01 | -1.37e-02 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 14 | 9.29e-01 | 1.37e-02 | 9.88e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 80 | 8.32e-01 | -1.37e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 9.24e-01 | -1.37e-02 | 9.88e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 9 | 9.43e-01 | 1.37e-02 | 9.90e-01 |
| GOBP ADHERENS JUNCTION MAINTENANCE | 7 | 9.50e-01 | -1.37e-02 | 9.90e-01 |
| GOCC CHROMAFFIN GRANULE | 13 | 9.32e-01 | -1.37e-02 | 9.88e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 130 | 7.88e-01 | -1.37e-02 | 9.60e-01 |
| GOBP URETER DEVELOPMENT | 18 | 9.20e-01 | 1.37e-02 | 9.87e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 265 | 7.01e-01 | -1.37e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 23 | 9.10e-01 | -1.37e-02 | 9.84e-01 |
| GOBP RESPONSE TO REDOX STATE | 14 | 9.30e-01 | 1.36e-02 | 9.88e-01 |
| GOBP URINARY BLADDER SMOOTH MUSCLE CONTRACTION | 7 | 9.50e-01 | 1.36e-02 | 9.90e-01 |
| GOBP CYTOKINESIS | 177 | 7.55e-01 | 1.36e-02 | 9.54e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 66 | 8.48e-01 | 1.36e-02 | 9.74e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 46 | 8.73e-01 | -1.36e-02 | 9.79e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 9 | 9.44e-01 | 1.36e-02 | 9.90e-01 |
| GOCC CELL BODY FIBER | 7 | 9.50e-01 | -1.36e-02 | 9.90e-01 |
| GOBP HORMONE METABOLIC PROCESS | 229 | 7.23e-01 | -1.36e-02 | 9.49e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 160 | 7.67e-01 | 1.36e-02 | 9.58e-01 |
| GOCC SYNAPTIC MEMBRANE | 368 | 6.55e-01 | -1.36e-02 | 9.30e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 387 | 6.48e-01 | -1.35e-02 | 9.30e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 29 | 9.00e-01 | 1.35e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 61 | 8.56e-01 | 1.35e-02 | 9.75e-01 |
| GOBP COCHLEA MORPHOGENESIS | 23 | 9.11e-01 | -1.35e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 20 | 9.17e-01 | -1.34e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 46 | 8.75e-01 | -1.34e-02 | 9.79e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 37 | 8.88e-01 | 1.34e-02 | 9.81e-01 |
| GOCC SITE OF DNA DAMAGE | 113 | 8.06e-01 | -1.34e-02 | 9.64e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 558 | 5.89e-01 | 1.34e-02 | 9.11e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 12 | 9.36e-01 | -1.34e-02 | 9.89e-01 |
| GOMF TAU PROTEIN BINDING | 42 | 8.81e-01 | 1.33e-02 | 9.79e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 35 | 8.91e-01 | 1.33e-02 | 9.82e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 90 | 8.27e-01 | -1.33e-02 | 9.70e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 83 | 8.34e-01 | -1.33e-02 | 9.71e-01 |
| GOBP EAR MORPHOGENESIS | 123 | 7.99e-01 | 1.33e-02 | 9.61e-01 |
| GOMF INTERMEDIATE FILAMENT BINDING | 10 | 9.42e-01 | -1.33e-02 | 9.90e-01 |
| GOBP DNA REPAIR | 561 | 5.91e-01 | -1.33e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 9 | 9.45e-01 | -1.33e-02 | 9.90e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 208 | 7.42e-01 | 1.33e-02 | 9.53e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 49 | 8.73e-01 | -1.32e-02 | 9.79e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 360 | 6.67e-01 | 1.32e-02 | 9.33e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 14 | 9.32e-01 | -1.32e-02 | 9.88e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 16 | 9.27e-01 | 1.32e-02 | 9.88e-01 |
| GOBP PLASMA MEMBRANE RAFT ASSEMBLY | 7 | 9.52e-01 | -1.31e-02 | 9.90e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 28 | 9.04e-01 | -1.31e-02 | 9.83e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 6 | 9.56e-01 | 1.31e-02 | 9.91e-01 |
| GOBP NECROPTOTIC PROCESS | 45 | 8.79e-01 | -1.31e-02 | 9.79e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 86 | 8.33e-01 | -1.31e-02 | 9.71e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 37 | 8.90e-01 | 1.31e-02 | 9.82e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 422 | 6.45e-01 | 1.31e-02 | 9.29e-01 |
| GOCC TROPONIN COMPLEX | 9 | 9.46e-01 | 1.30e-02 | 9.90e-01 |
| GOBP EPITHELIAL CELL MATURATION | 24 | 9.12e-01 | -1.30e-02 | 9.85e-01 |
| GOCC NASCENT POLYPEPTIDE ASSOCIATED COMPLEX | 5 | 9.60e-01 | 1.30e-02 | 9.91e-01 |
| GOBP SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 11 | 9.40e-01 | -1.30e-02 | 9.90e-01 |
| GOMF MONOSACCHARIDE BINDING | 73 | 8.48e-01 | 1.30e-02 | 9.74e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 13 | 9.35e-01 | -1.30e-02 | 9.89e-01 |
| GOBP RETINOL METABOLIC PROCESS | 50 | 8.75e-01 | 1.29e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 12 | 9.38e-01 | -1.29e-02 | 9.90e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 38 | 8.91e-01 | -1.29e-02 | 9.82e-01 |
| GOBP NUCLEOBASE TRANSPORT | 12 | 9.39e-01 | 1.29e-02 | 9.90e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 51 | 8.74e-01 | -1.28e-02 | 9.79e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 24 | 9.14e-01 | -1.28e-02 | 9.85e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 8 | 9.50e-01 | 1.28e-02 | 9.90e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 9 | 9.47e-01 | 1.28e-02 | 9.90e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 11 | 9.42e-01 | -1.28e-02 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 9 | 9.47e-01 | 1.27e-02 | 9.90e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 8 | 9.50e-01 | -1.27e-02 | 9.90e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 14 | 9.35e-01 | -1.26e-02 | 9.88e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 232 | 7.40e-01 | -1.26e-02 | 9.53e-01 |
| GOBP TORC1 SIGNALING | 95 | 8.31e-01 | 1.26e-02 | 9.71e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 20 | 9.22e-01 | -1.26e-02 | 9.88e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 28 | 9.08e-01 | 1.26e-02 | 9.84e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 15 | 9.33e-01 | -1.26e-02 | 9.88e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 126 | 8.07e-01 | 1.26e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 112 | 8.18e-01 | 1.26e-02 | 9.68e-01 |
| GOMF C X3 C CHEMOKINE BINDING | 5 | 9.61e-01 | 1.26e-02 | 9.91e-01 |
| GOBP OXALATE TRANSPORT | 12 | 9.40e-01 | -1.25e-02 | 9.90e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 119 | 8.13e-01 | 1.25e-02 | 9.67e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 9.40e-01 | 1.25e-02 | 9.90e-01 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 9.51e-01 | 1.25e-02 | 9.90e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 92 | 8.36e-01 | 1.25e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 33 | 9.01e-01 | 1.25e-02 | 9.83e-01 |
| GOMF BMP RECEPTOR ACTIVITY | 7 | 9.54e-01 | 1.25e-02 | 9.91e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 34 | 9.00e-01 | 1.25e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 9 | 9.48e-01 | -1.25e-02 | 9.90e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 124 | 8.11e-01 | 1.25e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION | 5 | 9.62e-01 | -1.25e-02 | 9.91e-01 |
| GOBP GLAND MORPHOGENESIS | 119 | 8.14e-01 | -1.25e-02 | 9.68e-01 |
| GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS | 6 | 9.58e-01 | -1.25e-02 | 9.91e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 16 | 9.31e-01 | -1.25e-02 | 9.88e-01 |
| GOCC PROTEASOME COMPLEX | 59 | 8.69e-01 | -1.24e-02 | 9.78e-01 |
| GOCC INHIBITORY SYNAPSE | 14 | 9.36e-01 | -1.24e-02 | 9.89e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 54 | 8.75e-01 | -1.24e-02 | 9.79e-01 |
| GOBP RNA DECAPPING | 19 | 9.26e-01 | -1.24e-02 | 9.88e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 85 | 8.44e-01 | -1.24e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 46 | 8.85e-01 | 1.24e-02 | 9.80e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 23 | 9.18e-01 | 1.24e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 132 | 8.07e-01 | 1.23e-02 | 9.64e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 35 | 9.00e-01 | -1.23e-02 | 9.83e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 79 | 8.50e-01 | -1.23e-02 | 9.74e-01 |
| GOBP PARAXIAL MESODERM MORPHOGENESIS | 10 | 9.46e-01 | 1.23e-02 | 9.90e-01 |
| GOBP VIRAL BUDDING | 25 | 9.15e-01 | -1.23e-02 | 9.86e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 538 | 6.26e-01 | -1.23e-02 | 9.25e-01 |
| GOBP VESTIBULOCOCHLEAR NERVE MORPHOGENESIS | 7 | 9.55e-01 | -1.23e-02 | 9.91e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 176 | 7.79e-01 | -1.23e-02 | 9.60e-01 |
| GOBP MIRNA PROCESSING | 45 | 8.87e-01 | 1.23e-02 | 9.81e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 18 | 9.28e-01 | 1.22e-02 | 9.88e-01 |
| GOBP RETINA LAYER FORMATION | 23 | 9.19e-01 | 1.22e-02 | 9.87e-01 |
| GOBP REGULATION OF CHLORIDE TRANSPORT | 6 | 9.59e-01 | -1.22e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 15 | 9.35e-01 | -1.22e-02 | 9.88e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 19 | 9.27e-01 | -1.22e-02 | 9.88e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 36 | 8.99e-01 | 1.22e-02 | 9.83e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 13 | 9.40e-01 | -1.21e-02 | 9.90e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 106 | 8.29e-01 | 1.21e-02 | 9.70e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 42 | 8.92e-01 | 1.21e-02 | 9.82e-01 |
| GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION | 7 | 9.56e-01 | -1.21e-02 | 9.91e-01 |
| GOBP NUCLEUS ORGANIZATION | 142 | 8.04e-01 | 1.21e-02 | 9.62e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 117 | 8.21e-01 | 1.21e-02 | 9.68e-01 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 8 | 9.53e-01 | 1.21e-02 | 9.90e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 75 | 8.57e-01 | -1.21e-02 | 9.75e-01 |
| GOMF PRE MRNA 5 SPLICE SITE BINDING | 6 | 9.59e-01 | 1.20e-02 | 9.91e-01 |
| GOBP REPRODUCTION | 1408 | 4.50e-01 | -1.20e-02 | 8.69e-01 |
| GOCC FASCIA ADHERENS | 8 | 9.53e-01 | -1.20e-02 | 9.90e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 18 | 9.30e-01 | 1.20e-02 | 9.88e-01 |
| GOBP REGULATION OF SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 5 | 9.63e-01 | 1.20e-02 | 9.91e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 16 | 9.34e-01 | -1.20e-02 | 9.88e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 142 | 8.05e-01 | 1.20e-02 | 9.63e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 24 | 9.19e-01 | -1.20e-02 | 9.87e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 10 | 9.48e-01 | -1.19e-02 | 9.90e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 99 | 8.38e-01 | -1.19e-02 | 9.71e-01 |
| GOBP MEMBRANE DISASSEMBLY | 11 | 9.46e-01 | -1.19e-02 | 9.90e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 13 | 9.41e-01 | 1.19e-02 | 9.90e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 187 | 7.80e-01 | 1.19e-02 | 9.60e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 54 | 8.80e-01 | 1.18e-02 | 9.79e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 15 | 9.37e-01 | 1.18e-02 | 9.89e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 9.57e-01 | -1.18e-02 | 9.91e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 40 | 8.98e-01 | -1.18e-02 | 9.82e-01 |
| GOBP PALLIUM DEVELOPMENT | 180 | 7.86e-01 | -1.17e-02 | 9.60e-01 |
| GOBP LACTATION | 37 | 9.02e-01 | 1.17e-02 | 9.83e-01 |
| GOBP NUCLEOBASE CATABOLIC PROCESS | 10 | 9.49e-01 | 1.17e-02 | 9.90e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 22 | 9.24e-01 | 1.17e-02 | 9.88e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 369 | 7.00e-01 | -1.17e-02 | 9.44e-01 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 16 | 9.36e-01 | -1.17e-02 | 9.89e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 32 | 9.09e-01 | 1.17e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 7 | 9.57e-01 | -1.17e-02 | 9.91e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 9.58e-01 | -1.16e-02 | 9.91e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 60 | 8.76e-01 | 1.16e-02 | 9.79e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 37 | 9.03e-01 | 1.16e-02 | 9.83e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 54 | 8.83e-01 | 1.16e-02 | 9.79e-01 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 7 | 9.58e-01 | 1.16e-02 | 9.91e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 16 | 9.36e-01 | -1.16e-02 | 9.89e-01 |
| GOCC SWR1 COMPLEX | 13 | 9.43e-01 | -1.16e-02 | 9.90e-01 |
| GOBP BLOOD VESSEL REMODELING | 46 | 8.92e-01 | 1.16e-02 | 9.82e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 24 | 9.22e-01 | -1.15e-02 | 9.88e-01 |
| GOBP MESODERM DEVELOPMENT | 124 | 8.24e-01 | 1.15e-02 | 9.69e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 12 | 9.45e-01 | 1.15e-02 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 61 | 8.77e-01 | -1.15e-02 | 9.79e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 450 | 6.76e-01 | -1.15e-02 | 9.37e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 47 | 8.92e-01 | -1.14e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 31 | 9.12e-01 | -1.14e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 52 | 8.87e-01 | -1.14e-02 | 9.81e-01 |
| GOCC KAINATE SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 5 | 9.65e-01 | -1.14e-02 | 9.91e-01 |
| GOMF KAINATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 5 | 9.65e-01 | -1.14e-02 | 9.91e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 24 | 9.23e-01 | -1.14e-02 | 9.88e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 61 | 8.78e-01 | -1.14e-02 | 9.79e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 113 | 8.35e-01 | 1.13e-02 | 9.71e-01 |
| GOBP DNA REPLICATION | 272 | 7.48e-01 | -1.13e-02 | 9.53e-01 |
| GOMF PROTON CHANNEL ACTIVITY | 24 | 9.23e-01 | 1.13e-02 | 9.88e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 101 | 8.44e-01 | 1.13e-02 | 9.73e-01 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 9.59e-01 | -1.12e-02 | 9.91e-01 |
| GOBP AXON MIDLINE CHOICE POINT RECOGNITION | 5 | 9.65e-01 | 1.12e-02 | 9.91e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY | 18 | 9.34e-01 | -1.12e-02 | 9.88e-01 |
| GOBP HISTAMINE SECRETION | 12 | 9.47e-01 | -1.11e-02 | 9.90e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 9.16e-01 | 1.11e-02 | 9.86e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 64 | 8.78e-01 | -1.11e-02 | 9.79e-01 |
| GOMF PEPTIDE BINDING | 302 | 7.41e-01 | -1.11e-02 | 9.53e-01 |
| GOMF RDNA BINDING | 10 | 9.52e-01 | -1.11e-02 | 9.90e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 10 | 9.52e-01 | 1.10e-02 | 9.90e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 46 | 8.97e-01 | -1.10e-02 | 9.82e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 13 | 9.45e-01 | 1.10e-02 | 9.90e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 54 | 8.89e-01 | 1.09e-02 | 9.82e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 25 | 9.25e-01 | -1.09e-02 | 9.88e-01 |
| GOBP LEUCINE CATABOLIC PROCESS | 6 | 9.63e-01 | 1.08e-02 | 9.91e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 28 | 9.21e-01 | 1.08e-02 | 9.88e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 967 | 5.68e-01 | 1.08e-02 | 9.05e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 9.67e-01 | 1.08e-02 | 9.91e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 102 | 8.50e-01 | -1.08e-02 | 9.74e-01 |
| GOCC CENTRAL ELEMENT | 7 | 9.61e-01 | -1.08e-02 | 9.91e-01 |
| GOBP GAS TRANSPORT | 22 | 9.30e-01 | -1.08e-02 | 9.88e-01 |
| GOBP BRUSH BORDER ASSEMBLY | 7 | 9.61e-01 | 1.08e-02 | 9.91e-01 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 873 | 5.90e-01 | -1.07e-02 | 9.11e-01 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 323 | 7.40e-01 | 1.07e-02 | 9.53e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 9.61e-01 | 1.07e-02 | 9.91e-01 |
| GOCC CTF18 RFC LIKE COMPLEX | 7 | 9.61e-01 | 1.06e-02 | 9.91e-01 |
| GOBP SPINDLE LOCALIZATION | 62 | 8.85e-01 | -1.06e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION | 6 | 9.64e-01 | -1.05e-02 | 9.91e-01 |
| GOBP ZINC ION TRANSPORT | 28 | 9.23e-01 | 1.05e-02 | 9.88e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 9.68e-01 | -1.05e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 241 | 7.79e-01 | -1.05e-02 | 9.60e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 295 | 7.56e-01 | -1.05e-02 | 9.54e-01 |
| GOBP RESPONSE TO VASOPRESSIN | 8 | 9.59e-01 | -1.05e-02 | 9.91e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 9.57e-01 | -1.05e-02 | 9.91e-01 |
| GOCC AMPHISOME | 13 | 9.48e-01 | 1.04e-02 | 9.90e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 58 | 8.91e-01 | 1.04e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 249 | 7.77e-01 | 1.04e-02 | 9.59e-01 |
| GOCC SARCOPLASM | 90 | 8.65e-01 | 1.04e-02 | 9.77e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 84 | 8.70e-01 | -1.04e-02 | 9.79e-01 |
| GOCC KATANIN COMPLEX | 5 | 9.68e-01 | -1.03e-02 | 9.91e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 37 | 9.13e-01 | -1.03e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 13 | 9.49e-01 | 1.03e-02 | 9.90e-01 |
| GOCC CONTRACTILE FIBER | 238 | 7.85e-01 | 1.03e-02 | 9.60e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 116 | 8.49e-01 | -1.03e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 395 | 7.27e-01 | 1.02e-02 | 9.51e-01 |
| GOCC I BAND | 141 | 8.34e-01 | -1.02e-02 | 9.71e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 23 | 9.33e-01 | 1.02e-02 | 9.88e-01 |
| GOBP FUNGIFORM PAPILLA DEVELOPMENT | 6 | 9.66e-01 | -1.02e-02 | 9.91e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 171 | 8.19e-01 | 1.01e-02 | 9.68e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 38 | 9.14e-01 | 1.01e-02 | 9.85e-01 |
| GOCC CYTOSOLIC RIBOSOME | 107 | 8.57e-01 | 1.01e-02 | 9.75e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 155 | 8.28e-01 | 1.01e-02 | 9.70e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 9.52e-01 | -1.01e-02 | 9.90e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 43 | 9.09e-01 | 1.00e-02 | 9.84e-01 |
| GOCC GOLGI LUMEN | 96 | 8.65e-01 | 1.00e-02 | 9.77e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 14 | 9.48e-01 | -1.00e-02 | 9.90e-01 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 14 | 9.48e-01 | -1.00e-02 | 9.90e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 57 | 8.96e-01 | 1.00e-02 | 9.82e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 658 | 6.62e-01 | 1.00e-02 | 9.31e-01 |
| GOBP REGULATION OF AXONOGENESIS | 145 | 8.36e-01 | 9.98e-03 | 9.71e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 9.57e-01 | 9.96e-03 | 9.91e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 43 | 9.10e-01 | -9.96e-03 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 190 | 8.13e-01 | 9.95e-03 | 9.67e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 7 | 9.64e-01 | -9.94e-03 | 9.91e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 64 | 8.91e-01 | -9.93e-03 | 9.82e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 12 | 9.53e-01 | 9.90e-03 | 9.90e-01 |
| GOBP ENDOTHELIAL CELL FATE COMMITMENT | 8 | 9.61e-01 | 9.89e-03 | 9.91e-01 |
| GOBP RESPONSE TO X RAY | 28 | 9.28e-01 | 9.87e-03 | 9.88e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 304 | 7.67e-01 | 9.87e-03 | 9.58e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 28 | 9.28e-01 | 9.86e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF KIDNEY DEVELOPMENT | 9 | 9.59e-01 | 9.85e-03 | 9.91e-01 |
| GOCC CONDENSED CHROMOSOME | 265 | 7.82e-01 | -9.85e-03 | 9.60e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 35 | 9.20e-01 | 9.85e-03 | 9.87e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 11 | 9.55e-01 | 9.84e-03 | 9.91e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 23 | 9.35e-01 | -9.81e-03 | 9.88e-01 |
| GOBP MUSCLE HYPERTROPHY | 103 | 8.64e-01 | 9.80e-03 | 9.77e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 9.44e-01 | -9.76e-03 | 9.90e-01 |
| GOBP LIPID IMPORT INTO CELL | 20 | 9.40e-01 | -9.74e-03 | 9.90e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 21 | 9.38e-01 | 9.74e-03 | 9.90e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 10 | 9.58e-01 | 9.73e-03 | 9.91e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 14 | 9.50e-01 | 9.69e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 391 | 7.43e-01 | -9.67e-03 | 9.53e-01 |
| GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 9 | 9.60e-01 | 9.67e-03 | 9.91e-01 |
| GOCC CASPASE COMPLEX | 10 | 9.58e-01 | 9.67e-03 | 9.91e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 9.67e-01 | -9.66e-03 | 9.91e-01 |
| GOBP LIVER MORPHOGENESIS | 25 | 9.34e-01 | 9.63e-03 | 9.88e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 747 | 6.55e-01 | 9.61e-03 | 9.30e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 9 | 9.60e-01 | 9.61e-03 | 9.91e-01 |
| GOBP GLUTATHIONE CATABOLIC PROCESS | 6 | 9.68e-01 | 9.60e-03 | 9.91e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 231 | 8.02e-01 | 9.58e-03 | 9.62e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 54 | 9.03e-01 | -9.56e-03 | 9.83e-01 |
| GOMF GLUTATHIONE BINDING | 10 | 9.58e-01 | 9.54e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 272 | 7.87e-01 | 9.53e-03 | 9.60e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 168 | 8.31e-01 | 9.53e-03 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 65 | 8.94e-01 | -9.52e-03 | 9.82e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 32 | 9.26e-01 | -9.51e-03 | 9.88e-01 |
| GOBP T TUBULE ORGANIZATION | 6 | 9.68e-01 | -9.51e-03 | 9.91e-01 |
| GOCC U6 SNRNP | 8 | 9.63e-01 | 9.51e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 31 | 9.27e-01 | -9.49e-03 | 9.88e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 126 | 8.54e-01 | -9.46e-03 | 9.75e-01 |
| GOBP TRNA TRANSCRIPTION | 11 | 9.57e-01 | -9.44e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 27 | 9.32e-01 | -9.43e-03 | 9.88e-01 |
| GOMF PEPTIDASE ACTIVITY | 561 | 7.03e-01 | 9.43e-03 | 9.44e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 24 | 9.36e-01 | 9.42e-03 | 9.89e-01 |
| GOBP I KAPPAB PHOSPHORYLATION | 15 | 9.50e-01 | -9.41e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 107 | 8.67e-01 | -9.41e-03 | 9.77e-01 |
| GOBP ACTIN NUCLEATION | 53 | 9.06e-01 | -9.34e-03 | 9.84e-01 |
| GOCC COPII VESICLE COAT | 16 | 9.48e-01 | 9.33e-03 | 9.90e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 91 | 8.78e-01 | -9.32e-03 | 9.79e-01 |
| GOCC COP9 SIGNALOSOME | 16 | 9.49e-01 | -9.32e-03 | 9.90e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 158 | 8.40e-01 | -9.30e-03 | 9.72e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 322 | 7.74e-01 | 9.29e-03 | 9.58e-01 |
| GOBP NUCLEAR TRANSPORT | 312 | 7.78e-01 | 9.27e-03 | 9.60e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 135 | 8.53e-01 | 9.25e-03 | 9.74e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 21 | 9.41e-01 | 9.25e-03 | 9.90e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 156 | 8.42e-01 | -9.22e-03 | 9.73e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 56 | 9.05e-01 | 9.20e-03 | 9.84e-01 |
| GOBP VASCULOGENESIS | 81 | 8.87e-01 | -9.14e-03 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 8 | 9.64e-01 | 9.14e-03 | 9.91e-01 |
| GOMF OXYGEN CARRIER ACTIVITY | 14 | 9.53e-01 | -9.13e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 30 | 9.31e-01 | -9.13e-03 | 9.88e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 28 | 9.34e-01 | -9.10e-03 | 9.88e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 15 | 9.51e-01 | 9.09e-03 | 9.90e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 11 | 9.58e-01 | 9.07e-03 | 9.91e-01 |
| GOCC OUTER KINETOCHORE | 20 | 9.44e-01 | -9.07e-03 | 9.90e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 22 | 9.41e-01 | 9.07e-03 | 9.90e-01 |
| GOBP CUT CATABOLIC PROCESS | 5 | 9.72e-01 | -9.05e-03 | 9.92e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 20 | 9.44e-01 | -9.04e-03 | 9.90e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 45 | 9.16e-01 | -9.04e-03 | 9.87e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 6 | 9.70e-01 | 9.01e-03 | 9.92e-01 |
| GOCC RIBOSOMAL SUBUNIT | 177 | 8.36e-01 | -9.01e-03 | 9.71e-01 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 144 | 8.52e-01 | -8.99e-03 | 9.74e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 23 | 9.41e-01 | -8.96e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 150 | 8.50e-01 | 8.94e-03 | 9.74e-01 |
| GOBP CANNABINOID SIGNALING PATHWAY | 9 | 9.63e-01 | -8.93e-03 | 9.91e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 23 | 9.41e-01 | -8.90e-03 | 9.90e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 105 | 8.75e-01 | 8.88e-03 | 9.79e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 163 | 8.45e-01 | 8.85e-03 | 9.73e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 13 | 9.56e-01 | -8.82e-03 | 9.91e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 15 | 9.53e-01 | -8.82e-03 | 9.90e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 155 | 8.50e-01 | 8.81e-03 | 9.74e-01 |
| GOBP RESPONSE TO VIRUS | 419 | 7.57e-01 | 8.81e-03 | 9.54e-01 |
| GOMF NEUTRAL L AMINO ACID SODIUM SYMPORTER ACTIVITY | 8 | 9.66e-01 | 8.81e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 89 | 8.86e-01 | 8.80e-03 | 9.81e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 6 | 9.70e-01 | 8.78e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 179 | 8.40e-01 | 8.77e-03 | 9.72e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 11 | 9.60e-01 | 8.68e-03 | 9.91e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 34 | 9.30e-01 | 8.66e-03 | 9.88e-01 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 9.71e-01 | -8.65e-03 | 9.92e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 9 | 9.64e-01 | -8.64e-03 | 9.91e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 38 | 9.27e-01 | 8.59e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 42 | 9.23e-01 | 8.59e-03 | 9.88e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 24 | 9.42e-01 | 8.58e-03 | 9.90e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 18 | 9.50e-01 | -8.54e-03 | 9.90e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 98 | 8.84e-01 | -8.51e-03 | 9.80e-01 |
| GOBP PROTEIN NITROSYLATION | 15 | 9.55e-01 | 8.50e-03 | 9.91e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 13 | 9.58e-01 | 8.49e-03 | 9.91e-01 |
| GOMF GROWTH FACTOR BINDING | 130 | 8.67e-01 | 8.49e-03 | 9.78e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 100 | 8.83e-01 | 8.48e-03 | 9.80e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 25 | 9.42e-01 | -8.47e-03 | 9.90e-01 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 10 | 9.63e-01 | 8.47e-03 | 9.91e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 17 | 9.52e-01 | 8.46e-03 | 9.90e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 51 | 9.17e-01 | 8.46e-03 | 9.87e-01 |
| GOCC PRC1 COMPLEX | 16 | 9.53e-01 | 8.45e-03 | 9.91e-01 |
| GOBP PRE MIRNA PROCESSING | 17 | 9.52e-01 | 8.44e-03 | 9.90e-01 |
| GOBP PHOTOTRANSDUCTION | 42 | 9.25e-01 | 8.43e-03 | 9.88e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 210 | 8.34e-01 | -8.40e-03 | 9.71e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 112 | 8.78e-01 | -8.40e-03 | 9.79e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 165 | 8.53e-01 | 8.37e-03 | 9.74e-01 |
| GOBP LYSINE METABOLIC PROCESS | 8 | 9.67e-01 | -8.37e-03 | 9.91e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 1539 | 5.85e-01 | 8.32e-03 | 9.10e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 14 | 9.57e-01 | -8.31e-03 | 9.91e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 116 | 8.78e-01 | 8.28e-03 | 9.79e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 63 | 9.10e-01 | 8.25e-03 | 9.84e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 33 | 9.35e-01 | 8.24e-03 | 9.88e-01 |
| GOBP DNA INTEGRATION | 8 | 9.68e-01 | 8.23e-03 | 9.91e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 90 | 8.93e-01 | 8.21e-03 | 9.82e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 25 | 9.43e-01 | 8.20e-03 | 9.90e-01 |
| GOMF DEACETYLASE ACTIVITY | 36 | 9.32e-01 | 8.19e-03 | 9.88e-01 |
| GOBP MUSCLE CELL MIGRATION | 100 | 8.87e-01 | 8.19e-03 | 9.81e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 684 | 7.17e-01 | 8.13e-03 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 336 | 7.99e-01 | -8.09e-03 | 9.61e-01 |
| GOBP L SERINE TRANSPORT | 7 | 9.70e-01 | -8.08e-03 | 9.92e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 9.70e-01 | -8.08e-03 | 9.92e-01 |
| GOBP SALIVA SECRETION | 13 | 9.60e-01 | 8.08e-03 | 9.91e-01 |
| GOMF EXONUCLEASE ACTIVITY | 81 | 9.00e-01 | 8.07e-03 | 9.83e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 11 | 9.63e-01 | -8.05e-03 | 9.91e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 302 | 8.10e-01 | -8.05e-03 | 9.66e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 77 | 9.03e-01 | 8.04e-03 | 9.83e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 92 | 8.94e-01 | 8.03e-03 | 9.82e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 17 | 9.55e-01 | 7.96e-03 | 9.91e-01 |
| GOBP CHROMATIN REMODELING | 577 | 7.44e-01 | -7.94e-03 | 9.53e-01 |
| GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 9 | 9.67e-01 | -7.94e-03 | 9.91e-01 |
| GOBP METANEPHROS DEVELOPMENT | 91 | 8.97e-01 | 7.88e-03 | 9.82e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 80 | 9.03e-01 | 7.85e-03 | 9.83e-01 |
| GOBP RESPONSE TO THYROXINE | 5 | 9.76e-01 | 7.83e-03 | 9.94e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 23 | 9.48e-01 | 7.82e-03 | 9.90e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 198 | 8.50e-01 | -7.82e-03 | 9.74e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 9.72e-01 | 7.80e-03 | 9.92e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 57 | 9.19e-01 | -7.77e-03 | 9.87e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 49 | 9.25e-01 | 7.75e-03 | 9.88e-01 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 13 | 9.61e-01 | 7.75e-03 | 9.91e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 27 | 9.44e-01 | 7.75e-03 | 9.90e-01 |
| GOCC SCAR COMPLEX | 12 | 9.63e-01 | 7.74e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 170 | 8.62e-01 | 7.73e-03 | 9.77e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 73 | 9.09e-01 | 7.73e-03 | 9.84e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 96 | 8.96e-01 | 7.70e-03 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 30 | 9.42e-01 | -7.64e-03 | 9.90e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 22 | 9.51e-01 | 7.63e-03 | 9.90e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 45 | 9.29e-01 | -7.63e-03 | 9.88e-01 |
| GOBP HEXOSE CATABOLIC PROCESS | 42 | 9.32e-01 | 7.58e-03 | 9.88e-01 |
| GOBP AXONAL FASCICULATION | 21 | 9.52e-01 | -7.58e-03 | 9.90e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 29 | 9.44e-01 | 7.55e-03 | 9.90e-01 |
| GOMF KINESIN BINDING | 43 | 9.32e-01 | 7.53e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 120 | 8.87e-01 | 7.50e-03 | 9.81e-01 |
| GOCC SODIUM CHANNEL COMPLEX | 24 | 9.49e-01 | -7.50e-03 | 9.90e-01 |
| GOBP CELL PART MORPHOGENESIS | 642 | 7.47e-01 | 7.46e-03 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 10 | 9.67e-01 | 7.44e-03 | 9.91e-01 |
| GOBP SINGLE FERTILIZATION | 158 | 8.72e-01 | -7.44e-03 | 9.79e-01 |
| GOBP TRANSLATIONAL ELONGATION | 68 | 9.16e-01 | 7.42e-03 | 9.86e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 59 | 9.22e-01 | -7.40e-03 | 9.88e-01 |
| GOBP MEMBRANE BIOGENESIS | 59 | 9.22e-01 | -7.39e-03 | 9.88e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 9.69e-01 | -7.37e-03 | 9.92e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 51 | 9.28e-01 | -7.36e-03 | 9.88e-01 |
| GOCC SAGA TYPE COMPLEX | 35 | 9.40e-01 | -7.36e-03 | 9.90e-01 |
| GOMF ARYL SULFOTRANSFERASE ACTIVITY | 7 | 9.73e-01 | 7.34e-03 | 9.92e-01 |
| GOBP MOLTING CYCLE PROCESS | 92 | 9.03e-01 | 7.34e-03 | 9.83e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 53 | 9.26e-01 | 7.34e-03 | 9.88e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 9.29e-01 | -7.27e-03 | 9.88e-01 |
| GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION | 6 | 9.76e-01 | -7.19e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 9 | 9.70e-01 | -7.16e-03 | 9.92e-01 |
| GOBP MACROMOLECULE DEACYLATION | 63 | 9.22e-01 | -7.15e-03 | 9.88e-01 |
| GOBP TISSUE HOMEOSTASIS | 264 | 8.42e-01 | -7.11e-03 | 9.73e-01 |
| GOBP DENDRITE DEVELOPMENT | 218 | 8.57e-01 | 7.10e-03 | 9.75e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 47 | 9.33e-01 | -7.08e-03 | 9.88e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 46 | 9.34e-01 | -7.07e-03 | 9.88e-01 |
| GOBP AXON DEVELOPMENT | 480 | 7.91e-01 | -7.05e-03 | 9.61e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 12 | 9.66e-01 | 7.05e-03 | 9.91e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 38 | 9.40e-01 | -7.04e-03 | 9.90e-01 |
| GOBP PROTEIN DENEDDYLATION | 11 | 9.68e-01 | -7.03e-03 | 9.91e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 35 | 9.43e-01 | -7.02e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 203 | 8.63e-01 | 7.02e-03 | 9.77e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 23 | 9.54e-01 | 7.02e-03 | 9.91e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 12 | 9.66e-01 | -7.01e-03 | 9.91e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 15 | 9.63e-01 | -6.98e-03 | 9.91e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 58 | 9.27e-01 | 6.98e-03 | 9.88e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 454 | 8.00e-01 | 6.95e-03 | 9.61e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 8 | 9.73e-01 | 6.95e-03 | 9.92e-01 |
| GOBP ENDODERM FORMATION | 57 | 9.28e-01 | -6.92e-03 | 9.88e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 35 | 9.44e-01 | 6.92e-03 | 9.90e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 15 | 9.63e-01 | 6.91e-03 | 9.91e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 282 | 8.42e-01 | -6.91e-03 | 9.73e-01 |
| GOBP REFLEX | 21 | 9.56e-01 | 6.91e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 112 | 9.00e-01 | -6.89e-03 | 9.83e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 10 | 9.70e-01 | -6.88e-03 | 9.92e-01 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 9 | 9.72e-01 | -6.87e-03 | 9.92e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 67 | 9.23e-01 | -6.86e-03 | 9.88e-01 |
| GOBP GLUCOSE IMPORT | 75 | 9.18e-01 | -6.86e-03 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 123 | 8.96e-01 | 6.84e-03 | 9.82e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 11 | 9.69e-01 | -6.84e-03 | 9.91e-01 |
| GOBP UREA CYCLE | 10 | 9.70e-01 | -6.82e-03 | 9.92e-01 |
| GOBP NEPHRON MORPHOGENESIS | 77 | 9.18e-01 | -6.82e-03 | 9.87e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 74 | 9.19e-01 | 6.81e-03 | 9.87e-01 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 9.77e-01 | -6.79e-03 | 9.95e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 64 | 9.25e-01 | -6.77e-03 | 9.88e-01 |
| GOCC CATALYTIC COMPLEX | 1609 | 6.51e-01 | 6.76e-03 | 9.30e-01 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 16 | 9.63e-01 | 6.76e-03 | 9.91e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 85 | 9.14e-01 | 6.76e-03 | 9.85e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 188 | 8.73e-01 | -6.75e-03 | 9.79e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 12 | 9.68e-01 | -6.72e-03 | 9.91e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 44 | 9.39e-01 | -6.72e-03 | 9.90e-01 |
| GOMF DENEDDYLASE ACTIVITY | 6 | 9.77e-01 | 6.72e-03 | 9.95e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 11 | 9.69e-01 | 6.71e-03 | 9.92e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 21 | 9.58e-01 | -6.70e-03 | 9.91e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 37 | 9.44e-01 | 6.69e-03 | 9.90e-01 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 516 | 7.95e-01 | 6.69e-03 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 28 | 9.51e-01 | 6.67e-03 | 9.90e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 89 | 9.14e-01 | -6.66e-03 | 9.85e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 8 | 9.74e-01 | -6.64e-03 | 9.93e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 71 | 9.23e-01 | -6.64e-03 | 9.88e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 20 | 9.59e-01 | -6.63e-03 | 9.91e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 22 | 9.57e-01 | 6.60e-03 | 9.91e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 102 | 9.09e-01 | -6.56e-03 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 49 | 9.37e-01 | -6.53e-03 | 9.89e-01 |
| GOCC ENDONUCLEASE COMPLEX | 37 | 9.45e-01 | 6.52e-03 | 9.90e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 204 | 8.72e-01 | 6.52e-03 | 9.79e-01 |
| GOCC CYTOPLASMIC REGION | 277 | 8.52e-01 | 6.52e-03 | 9.74e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 21 | 9.59e-01 | 6.51e-03 | 9.91e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 20 | 9.60e-01 | 6.46e-03 | 9.91e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 72 | 9.25e-01 | -6.45e-03 | 9.88e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 24 | 9.56e-01 | 6.44e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 9.72e-01 | 6.42e-03 | 9.92e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 394 | 8.27e-01 | 6.41e-03 | 9.70e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 32 | 9.50e-01 | 6.37e-03 | 9.90e-01 |
| GOMF FRUCTOSE BINDING | 6 | 9.78e-01 | 6.37e-03 | 9.95e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 431 | 8.21e-01 | -6.35e-03 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 139 | 8.97e-01 | -6.34e-03 | 9.82e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 30 | 9.52e-01 | -6.33e-03 | 9.90e-01 |
| GOCC NUCLEAR CHROMOSOME | 213 | 8.74e-01 | -6.33e-03 | 9.79e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 37 | 9.47e-01 | 6.29e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 15 | 9.66e-01 | -6.28e-03 | 9.91e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 63 | 9.32e-01 | -6.22e-03 | 9.88e-01 |
| GOBP P BODY ASSEMBLY | 20 | 9.62e-01 | 6.22e-03 | 9.91e-01 |
| GOCC BRAHMA COMPLEX | 14 | 9.68e-01 | 6.20e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 27 | 9.56e-01 | 6.19e-03 | 9.91e-01 |
| GOBP REGULATION OF CYTOKINESIS | 86 | 9.21e-01 | -6.18e-03 | 9.88e-01 |
| GOBP MEMBRANE REPOLARIZATION | 52 | 9.39e-01 | 6.16e-03 | 9.90e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 17 | 9.65e-01 | -6.14e-03 | 9.91e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 75 | 9.27e-01 | 6.14e-03 | 9.88e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 158 | 8.95e-01 | -6.10e-03 | 9.82e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 140 | 9.01e-01 | 6.10e-03 | 9.83e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 271 | 8.65e-01 | -6.01e-03 | 9.77e-01 |
| GOBP CILIUM ORGANIZATION | 408 | 8.35e-01 | -6.00e-03 | 9.71e-01 |
| GOCC DYNACTIN COMPLEX | 8 | 9.77e-01 | -6.00e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 72 | 9.30e-01 | -5.98e-03 | 9.88e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 341 | 8.50e-01 | 5.96e-03 | 9.74e-01 |
| GOBP GLIOGENESIS | 327 | 8.53e-01 | 5.94e-03 | 9.74e-01 |
| GOBP MEIOTIC CYTOKINESIS | 8 | 9.77e-01 | -5.93e-03 | 9.95e-01 |
| GOBP BIOLOGICAL PHASE | 11 | 9.73e-01 | 5.92e-03 | 9.92e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 27 | 9.58e-01 | 5.86e-03 | 9.91e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 42 | 9.48e-01 | -5.86e-03 | 9.90e-01 |
| GOBP DEMETHYLATION | 51 | 9.42e-01 | 5.86e-03 | 9.90e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 331 | 8.55e-01 | 5.85e-03 | 9.75e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 75 | 9.30e-01 | 5.84e-03 | 9.88e-01 |
| GOBP DNA DEALKYLATION | 37 | 9.51e-01 | -5.82e-03 | 9.90e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 91 | 9.24e-01 | 5.82e-03 | 9.88e-01 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 177 | 8.94e-01 | -5.79e-03 | 9.82e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 72 | 9.33e-01 | -5.77e-03 | 9.88e-01 |
| GOBP HEART GROWTH | 94 | 9.23e-01 | 5.77e-03 | 9.88e-01 |
| GOBP NEURON DEVELOPMENT | 1086 | 7.49e-01 | 5.76e-03 | 9.53e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 5 | 9.82e-01 | 5.75e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 31 | 9.56e-01 | -5.73e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 14 | 9.71e-01 | 5.70e-03 | 9.92e-01 |
| GOMF CHONDROITIN SULFATE BINDING | 10 | 9.75e-01 | 5.64e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 13 | 9.72e-01 | -5.62e-03 | 9.92e-01 |
| GOBP REGULATION OF MESODERMAL CELL FATE SPECIFICATION | 5 | 9.83e-01 | 5.59e-03 | 9.96e-01 |
| GOMF RIBOSOME BINDING | 101 | 9.23e-01 | 5.57e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 45 | 9.49e-01 | -5.56e-03 | 9.90e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 32 | 9.57e-01 | -5.54e-03 | 9.91e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 35 | 9.55e-01 | 5.53e-03 | 9.91e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 165 | 9.03e-01 | -5.52e-03 | 9.83e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 41 | 9.51e-01 | -5.51e-03 | 9.90e-01 |
| GOBP TOOTH MINERALIZATION | 28 | 9.60e-01 | -5.50e-03 | 9.91e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 8 | 9.79e-01 | 5.49e-03 | 9.95e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 568 | 8.23e-01 | -5.49e-03 | 9.69e-01 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 6 | 9.81e-01 | -5.49e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 30 | 9.59e-01 | 5.47e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 18 | 9.68e-01 | 5.46e-03 | 9.91e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 189 | 8.97e-01 | 5.44e-03 | 9.82e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 316 | 8.68e-01 | 5.42e-03 | 9.78e-01 |
| GOBP MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER | 5 | 9.83e-01 | -5.41e-03 | 9.96e-01 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 13 | 9.73e-01 | -5.39e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 24 | 9.64e-01 | 5.36e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 6 | 9.82e-01 | 5.33e-03 | 9.96e-01 |
| GOBP DNA DAMAGE RESPONSE | 831 | 7.94e-01 | -5.33e-03 | 9.61e-01 |
| GOBP FEMALE GAMETE GENERATION | 158 | 9.08e-01 | -5.31e-03 | 9.84e-01 |
| GOBP KIDNEY MORPHOGENESIS | 94 | 9.29e-01 | 5.30e-03 | 9.88e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 9.79e-01 | 5.30e-03 | 9.96e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 169 | 9.06e-01 | 5.29e-03 | 9.84e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 163 | 9.07e-01 | 5.28e-03 | 9.84e-01 |
| GOBP NEURON PROJECTION EXTENSION | 167 | 9.06e-01 | -5.27e-03 | 9.84e-01 |
| GOMF HEPARIN BINDING | 169 | 9.06e-01 | 5.26e-03 | 9.84e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 9.80e-01 | -5.24e-03 | 9.96e-01 |
| GOBP TOR SIGNALING | 157 | 9.10e-01 | 5.23e-03 | 9.84e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 49 | 9.50e-01 | 5.22e-03 | 9.90e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 28 | 9.62e-01 | -5.20e-03 | 9.91e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 45 | 9.52e-01 | 5.18e-03 | 9.90e-01 |
| GOCC NEUROFILAMENT | 9 | 9.79e-01 | 5.18e-03 | 9.95e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 40 | 9.55e-01 | -5.18e-03 | 9.91e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 96 | 9.30e-01 | -5.17e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 19 | 9.69e-01 | -5.14e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF DOPAMINE SECRETION | 5 | 9.84e-01 | -5.13e-03 | 9.97e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 114 | 9.25e-01 | 5.12e-03 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 21 | 9.68e-01 | -5.12e-03 | 9.91e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 220 | 8.96e-01 | 5.12e-03 | 9.82e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 7 | 9.81e-01 | -5.10e-03 | 9.96e-01 |
| GOMF TYPE 1 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 5 | 9.84e-01 | -5.10e-03 | 9.97e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 8 | 9.80e-01 | 5.07e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING | 10 | 9.78e-01 | -5.07e-03 | 9.95e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 33 | 9.60e-01 | -5.06e-03 | 9.91e-01 |
| GOCC APICAL JUNCTION COMPLEX | 140 | 9.18e-01 | 5.03e-03 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 45 | 9.54e-01 | 5.00e-03 | 9.91e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 27 | 9.64e-01 | -4.99e-03 | 9.91e-01 |
| GOMF FLIPPASE ACTIVITY | 15 | 9.73e-01 | 4.98e-03 | 9.92e-01 |
| GOBP ACROSOME ASSEMBLY | 27 | 9.65e-01 | 4.93e-03 | 9.91e-01 |
| GOBP FAT PAD DEVELOPMENT | 8 | 9.81e-01 | -4.89e-03 | 9.96e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 389 | 8.69e-01 | 4.89e-03 | 9.78e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 98 | 9.34e-01 | 4.87e-03 | 9.88e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 22 | 9.68e-01 | 4.86e-03 | 9.91e-01 |
| GOBP EXPLORATION BEHAVIOR | 28 | 9.65e-01 | 4.85e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 189 | 9.09e-01 | -4.83e-03 | 9.84e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 6 | 9.84e-01 | 4.80e-03 | 9.97e-01 |
| GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 9.72e-01 | -4.79e-03 | 9.92e-01 |
| GOBP TRANSPORT OF VIRUS | 21 | 9.70e-01 | 4.79e-03 | 9.92e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 437 | 8.64e-01 | 4.78e-03 | 9.77e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 92 | 9.37e-01 | -4.77e-03 | 9.89e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 522 | 8.52e-01 | 4.77e-03 | 9.74e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 9.65e-01 | -4.77e-03 | 9.91e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 271 | 8.93e-01 | -4.74e-03 | 9.82e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 81 | 9.41e-01 | -4.73e-03 | 9.90e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 40 | 9.59e-01 | 4.73e-03 | 9.91e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 66 | 9.47e-01 | 4.73e-03 | 9.90e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1562 | 7.57e-01 | 4.70e-03 | 9.54e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 166 | 9.17e-01 | -4.68e-03 | 9.87e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 541 | 8.53e-01 | 4.64e-03 | 9.74e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 31 | 9.64e-01 | 4.62e-03 | 9.91e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 8 | 9.82e-01 | -4.60e-03 | 9.96e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 84 | 9.42e-01 | 4.58e-03 | 9.90e-01 |
| GOBP RESPONSE TO STARVATION | 208 | 9.09e-01 | -4.57e-03 | 9.84e-01 |
| GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING | 6 | 9.85e-01 | -4.56e-03 | 9.97e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 204 | 9.11e-01 | -4.56e-03 | 9.84e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 31 | 9.65e-01 | -4.55e-03 | 9.91e-01 |
| GOCC PHOSPHATASE COMPLEX | 51 | 9.55e-01 | -4.55e-03 | 9.91e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 26 | 9.68e-01 | -4.55e-03 | 9.91e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 35 | 9.63e-01 | -4.54e-03 | 9.91e-01 |
| GOBP UBIQUITIN RECYCLING | 13 | 9.77e-01 | -4.53e-03 | 9.95e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 19 | 9.73e-01 | -4.52e-03 | 9.92e-01 |
| GOBP QUINONE METABOLIC PROCESS | 39 | 9.61e-01 | -4.50e-03 | 9.91e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 90 | 9.42e-01 | 4.47e-03 | 9.90e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 14 | 9.77e-01 | 4.46e-03 | 9.95e-01 |
| GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION | 9 | 9.82e-01 | -4.45e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 36 | 9.63e-01 | 4.43e-03 | 9.91e-01 |
| GOBP REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION | 9 | 9.82e-01 | -4.42e-03 | 9.96e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 418 | 8.77e-01 | 4.41e-03 | 9.79e-01 |
| GOBP MITOCHONDRIAL FISSION | 40 | 9.62e-01 | -4.40e-03 | 9.91e-01 |
| GOBP RESPONSE TO NICOTINE | 49 | 9.58e-01 | 4.37e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 12 | 9.79e-01 | -4.35e-03 | 9.96e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 54 | 9.56e-01 | -4.35e-03 | 9.91e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 24 | 9.71e-01 | -4.33e-03 | 9.92e-01 |
| GOCC SPINDLE | 404 | 8.82e-01 | -4.30e-03 | 9.79e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 63 | 9.53e-01 | 4.30e-03 | 9.90e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 19 | 9.74e-01 | 4.29e-03 | 9.93e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 18 | 9.75e-01 | -4.29e-03 | 9.93e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 9.87e-01 | -4.24e-03 | 9.97e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 407 | 8.83e-01 | 4.24e-03 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 107 | 9.40e-01 | 4.22e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF TOOTH MINERALIZATION | 7 | 9.85e-01 | -4.19e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 51 | 9.59e-01 | 4.18e-03 | 9.91e-01 |
| GOBP MICROTUBULE BASED PROCESS | 897 | 8.33e-01 | 4.16e-03 | 9.71e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 15 | 9.78e-01 | -4.14e-03 | 9.95e-01 |
| GOBP BONE GROWTH | 32 | 9.68e-01 | -4.14e-03 | 9.91e-01 |
| GOBP MITOTIC CYTOKINESIS | 85 | 9.47e-01 | -4.14e-03 | 9.90e-01 |
| GOBP HEAD DEVELOPMENT | 721 | 8.51e-01 | 4.11e-03 | 9.74e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 27 | 9.71e-01 | -4.08e-03 | 9.92e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 52 | 9.59e-01 | -4.08e-03 | 9.91e-01 |
| GOBP TRANSLATIONAL INITIATION | 110 | 9.41e-01 | 4.07e-03 | 9.90e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 145 | 9.33e-01 | 4.03e-03 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO UV | 87 | 9.48e-01 | -4.02e-03 | 9.90e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 12 | 9.81e-01 | 4.01e-03 | 9.96e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 177 | 9.27e-01 | 3.99e-03 | 9.88e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 9.73e-01 | 3.97e-03 | 9.92e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 6 | 9.87e-01 | -3.97e-03 | 9.97e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 711 | 8.57e-01 | -3.96e-03 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 335 | 9.01e-01 | -3.96e-03 | 9.83e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 376 | 8.95e-01 | -3.95e-03 | 9.82e-01 |
| GOMF DEMETHYLASE ACTIVITY | 35 | 9.68e-01 | -3.95e-03 | 9.91e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 25 | 9.73e-01 | 3.94e-03 | 9.92e-01 |
| GOCC MAIN AXON | 67 | 9.56e-01 | -3.94e-03 | 9.91e-01 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 46 | 9.63e-01 | -3.92e-03 | 9.91e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 978 | 8.36e-01 | 3.92e-03 | 9.71e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 12 | 9.81e-01 | -3.91e-03 | 9.96e-01 |
| GOBP IRON ION TRANSPORT | 53 | 9.61e-01 | 3.88e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 16 | 9.79e-01 | -3.87e-03 | 9.95e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 34 | 9.69e-01 | -3.86e-03 | 9.91e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 27 | 9.73e-01 | 3.81e-03 | 9.92e-01 |
| GOBP ABSCISSION | 6 | 9.87e-01 | 3.78e-03 | 9.97e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 82 | 9.53e-01 | 3.77e-03 | 9.90e-01 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 9.85e-01 | -3.75e-03 | 9.97e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 7 | 9.86e-01 | 3.74e-03 | 9.97e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 47 | 9.65e-01 | -3.68e-03 | 9.91e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 17 | 9.79e-01 | -3.68e-03 | 9.96e-01 |
| GOBP PROTEIN OXIDATION | 13 | 9.82e-01 | -3.67e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 126 | 9.43e-01 | -3.66e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION | 7 | 9.87e-01 | 3.65e-03 | 9.97e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 78 | 9.56e-01 | 3.61e-03 | 9.91e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 305 | 9.14e-01 | 3.60e-03 | 9.85e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 15 | 9.81e-01 | -3.60e-03 | 9.96e-01 |
| GOBP OOGENESIS | 108 | 9.49e-01 | -3.56e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 8 | 9.86e-01 | -3.56e-03 | 9.97e-01 |
| GOBP R LOOP PROCESSING | 6 | 9.88e-01 | -3.56e-03 | 9.97e-01 |
| GOBP MRNA TRANSPORT | 112 | 9.48e-01 | -3.54e-03 | 9.90e-01 |
| GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY | 7 | 9.87e-01 | 3.54e-03 | 9.97e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 42 | 9.69e-01 | -3.52e-03 | 9.91e-01 |
| GOCC CELL CELL CONTACT ZONE | 70 | 9.59e-01 | -3.52e-03 | 9.91e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 53 | 9.65e-01 | -3.47e-03 | 9.91e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 43 | 9.69e-01 | -3.44e-03 | 9.91e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 181 | 9.37e-01 | 3.41e-03 | 9.89e-01 |
| GOCC NUCLEAR BODY | 812 | 8.69e-01 | -3.40e-03 | 9.78e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 20 | 9.79e-01 | -3.39e-03 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 14 | 9.83e-01 | -3.38e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 9.90e-01 | -3.33e-03 | 9.98e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 713 | 8.81e-01 | 3.29e-03 | 9.79e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 83 | 9.59e-01 | -3.24e-03 | 9.91e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 17 | 9.82e-01 | -3.20e-03 | 9.96e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 755 | 8.82e-01 | 3.18e-03 | 9.79e-01 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 19 | 9.81e-01 | 3.17e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 307 | 9.25e-01 | -3.13e-03 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 49 | 9.70e-01 | 3.10e-03 | 9.92e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 294 | 9.27e-01 | -3.09e-03 | 9.88e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 197 | 9.41e-01 | -3.06e-03 | 9.90e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 61 | 9.67e-01 | 3.05e-03 | 9.91e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 68 | 9.65e-01 | -3.05e-03 | 9.91e-01 |
| GOBP CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 9.90e-01 | -3.04e-03 | 9.98e-01 |
| GOCC P BODY | 98 | 9.59e-01 | 3.01e-03 | 9.91e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 914 | 8.78e-01 | 2.99e-03 | 9.79e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 18 | 9.83e-01 | -2.96e-03 | 9.96e-01 |
| GOBP URETERIC BUD FORMATION | 7 | 9.89e-01 | 2.95e-03 | 9.98e-01 |
| GOBP DNA METHYLATION | 47 | 9.72e-01 | 2.95e-03 | 9.92e-01 |
| GOBP ORGANELLE ASSEMBLY | 957 | 8.78e-01 | 2.93e-03 | 9.79e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 15 | 9.84e-01 | 2.92e-03 | 9.97e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 76 | 9.66e-01 | -2.86e-03 | 9.91e-01 |
| GOBP CDP CHOLINE PATHWAY | 6 | 9.90e-01 | 2.86e-03 | 9.98e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 9 | 9.88e-01 | -2.85e-03 | 9.97e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 117 | 9.58e-01 | 2.85e-03 | 9.91e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 65 | 9.68e-01 | 2.83e-03 | 9.91e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 7 | 9.90e-01 | 2.82e-03 | 9.98e-01 |
| GOBP REGULATION OF RNA BINDING | 8 | 9.89e-01 | 2.78e-03 | 9.98e-01 |
| GOBP COGNITION | 303 | 9.34e-01 | -2.77e-03 | 9.88e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 204 | 9.46e-01 | -2.76e-03 | 9.90e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 209 | 9.45e-01 | -2.75e-03 | 9.90e-01 |
| GOBP FAT CELL PROLIFERATION | 14 | 9.86e-01 | 2.74e-03 | 9.97e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 136 | 9.56e-01 | -2.74e-03 | 9.91e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 13 | 9.87e-01 | -2.70e-03 | 9.97e-01 |
| GOBP REGENERATION | 181 | 9.50e-01 | 2.68e-03 | 9.90e-01 |
| GOCC MITOCHONDRIAL MATRIX | 466 | 9.21e-01 | -2.67e-03 | 9.88e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 233 | 9.44e-01 | 2.65e-03 | 9.90e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 9.91e-01 | -2.64e-03 | 9.98e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 6 | 9.91e-01 | 2.60e-03 | 9.98e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 12 | 9.88e-01 | -2.57e-03 | 9.97e-01 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 751 | 9.05e-01 | 2.57e-03 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF DOPAMINE SECRETION | 6 | 9.91e-01 | -2.54e-03 | 9.98e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 30 | 9.81e-01 | -2.54e-03 | 9.96e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 132 | 9.60e-01 | -2.52e-03 | 9.91e-01 |
| GOBP REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION | 8 | 9.90e-01 | -2.51e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE MATURATION | 9 | 9.90e-01 | 2.44e-03 | 9.98e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 25 | 9.83e-01 | -2.43e-03 | 9.96e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 14 | 9.87e-01 | 2.42e-03 | 9.97e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 33 | 9.81e-01 | 2.41e-03 | 9.96e-01 |
| GOBP SPERM EGG RECOGNITION | 51 | 9.76e-01 | 2.40e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 15 | 9.87e-01 | 2.37e-03 | 9.97e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 211 | 9.53e-01 | 2.36e-03 | 9.90e-01 |
| GOBP ACROSOME REACTION | 40 | 9.79e-01 | 2.35e-03 | 9.96e-01 |
| GOCC NON MOTILE CILIUM | 152 | 9.60e-01 | -2.34e-03 | 9.91e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 28 | 9.83e-01 | 2.33e-03 | 9.96e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1135 | 8.96e-01 | -2.29e-03 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 5 | 9.93e-01 | -2.25e-03 | 9.98e-01 |
| GOMF GAMMA TUBULIN BINDING | 30 | 9.83e-01 | -2.21e-03 | 9.96e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 87 | 9.72e-01 | 2.20e-03 | 9.92e-01 |
| GOBP THYROID HORMONE GENERATION | 22 | 9.86e-01 | 2.20e-03 | 9.97e-01 |
| GOBP AMIDE METABOLIC PROCESS | 1219 | 8.97e-01 | -2.19e-03 | 9.82e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 148 | 9.63e-01 | -2.19e-03 | 9.91e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 38 | 9.82e-01 | -2.15e-03 | 9.96e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 73 | 9.75e-01 | -2.14e-03 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 6 | 9.93e-01 | 2.13e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 26 | 9.85e-01 | 2.13e-03 | 9.97e-01 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 8 | 9.92e-01 | -2.12e-03 | 9.98e-01 |
| GOBP VIRAL GENE EXPRESSION | 99 | 9.71e-01 | -2.11e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION | 6 | 9.93e-01 | -2.10e-03 | 9.98e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 229 | 9.56e-01 | -2.10e-03 | 9.91e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY | 7 | 9.92e-01 | -2.08e-03 | 9.98e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 170 | 9.63e-01 | 2.06e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 9.93e-01 | 2.04e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 8 | 9.92e-01 | 2.03e-03 | 9.98e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 58 | 9.79e-01 | 2.02e-03 | 9.95e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 197 | 9.62e-01 | 1.99e-03 | 9.91e-01 |
| GOBP AXON EXTENSION | 111 | 9.71e-01 | 1.97e-03 | 9.92e-01 |
| GOBP VISUAL BEHAVIOR | 55 | 9.80e-01 | -1.97e-03 | 9.96e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 11 | 9.91e-01 | -1.96e-03 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 9.91e-01 | -1.96e-03 | 9.98e-01 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 88 | 9.75e-01 | 1.94e-03 | 9.93e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 26 | 9.86e-01 | -1.94e-03 | 9.97e-01 |
| GOBP CD40 SIGNALING PATHWAY | 15 | 9.90e-01 | 1.94e-03 | 9.98e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 8 | 9.93e-01 | -1.89e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 155 | 9.68e-01 | -1.89e-03 | 9.91e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 45 | 9.83e-01 | 1.88e-03 | 9.96e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 20 | 9.88e-01 | -1.87e-03 | 9.97e-01 |
| GOMF APOLIPOPROTEIN BINDING | 17 | 9.89e-01 | 1.85e-03 | 9.98e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 119 | 9.72e-01 | -1.84e-03 | 9.92e-01 |
| GOCC MLL3 4 COMPLEX | 10 | 9.92e-01 | -1.84e-03 | 9.98e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 9.92e-01 | -1.84e-03 | 9.98e-01 |
| GOMF PROTEASOME BINDING | 17 | 9.90e-01 | -1.84e-03 | 9.98e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 298 | 9.58e-01 | -1.78e-03 | 9.91e-01 |
| GOBP FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION | 5 | 9.95e-01 | -1.78e-03 | 9.98e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 22 | 9.89e-01 | -1.76e-03 | 9.97e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 42 | 9.84e-01 | 1.75e-03 | 9.97e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 25 | 9.88e-01 | 1.72e-03 | 9.97e-01 |
| GOBP STEROL HOMEOSTASIS | 99 | 9.76e-01 | -1.72e-03 | 9.94e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 29 | 9.87e-01 | -1.70e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 7 | 9.94e-01 | 1.70e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 380 | 9.55e-01 | -1.68e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 18 | 9.90e-01 | 1.67e-03 | 9.98e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 22 | 9.89e-01 | 1.66e-03 | 9.98e-01 |
| GOBP DENDRITE MORPHOGENESIS | 129 | 9.74e-01 | 1.66e-03 | 9.93e-01 |
| GOBP DETECTION OF CELL DENSITY | 9 | 9.93e-01 | 1.65e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 61 | 9.82e-01 | -1.64e-03 | 9.96e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 39 | 9.86e-01 | 1.57e-03 | 9.97e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 10 | 9.93e-01 | -1.56e-03 | 9.98e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 41 | 9.86e-01 | -1.55e-03 | 9.97e-01 |
| GOBP GLYCOSYLCERAMIDE CATABOLIC PROCESS | 6 | 9.95e-01 | 1.50e-03 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 148 | 9.75e-01 | 1.49e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 8 | 9.94e-01 | -1.45e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 21 | 9.91e-01 | 1.39e-03 | 9.98e-01 |
| GOMF CASPASE BINDING | 13 | 9.93e-01 | 1.39e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 14 | 9.93e-01 | -1.37e-03 | 9.98e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 9.94e-01 | 1.33e-03 | 9.98e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 48 | 9.88e-01 | 1.29e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 48 | 9.88e-01 | -1.29e-03 | 9.97e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 1361 | 9.37e-01 | 1.29e-03 | 9.89e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 49 | 9.88e-01 | 1.28e-03 | 9.97e-01 |
| GOCC CELL BODY | 529 | 9.60e-01 | -1.26e-03 | 9.91e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 17 | 9.93e-01 | -1.22e-03 | 9.98e-01 |
| GOBP REGULATION OF CELL CYCLE | 1068 | 9.47e-01 | 1.21e-03 | 9.90e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 101 | 9.83e-01 | 1.21e-03 | 9.96e-01 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 16 | 9.93e-01 | 1.21e-03 | 9.98e-01 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 5 | 9.96e-01 | -1.19e-03 | 9.99e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 56 | 9.88e-01 | 1.18e-03 | 9.97e-01 |
| GOBP REGULATION OF CELL KILLING | 110 | 9.83e-01 | 1.18e-03 | 9.96e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 1323 | 9.43e-01 | 1.16e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE BY EPINEPHRINE NOREPINEPHRINE | 5 | 9.96e-01 | -1.16e-03 | 9.99e-01 |
| GOCC CENTROSOME | 607 | 9.61e-01 | 1.15e-03 | 9.91e-01 |
| GOCC WASH COMPLEX | 8 | 9.96e-01 | -1.13e-03 | 9.99e-01 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 10 | 9.95e-01 | 1.09e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 10 | 9.95e-01 | 1.04e-03 | 9.99e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 31 | 9.92e-01 | -1.03e-03 | 9.98e-01 |
| GOBP OVULATION | 15 | 9.95e-01 | -1.02e-03 | 9.98e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 9.97e-01 | 1.01e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 18 | 9.94e-01 | -9.78e-04 | 9.98e-01 |
| GOBP EYE MORPHOGENESIS | 159 | 9.83e-01 | 9.68e-04 | 9.96e-01 |
| GOBP REGULATION OF HISTONE ACETYLATION | 18 | 9.94e-01 | 9.48e-04 | 9.98e-01 |
| GOCC ADHERENS JUNCTION | 179 | 9.83e-01 | -9.22e-04 | 9.96e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 18 | 9.95e-01 | 8.21e-04 | 9.98e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 9.94e-01 | 8.17e-04 | 9.98e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 152 | 9.86e-01 | -8.13e-04 | 9.97e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 10 | 9.96e-01 | -8.12e-04 | 9.99e-01 |
| GOBP LIPID HOMEOSTASIS | 169 | 9.86e-01 | 8.10e-04 | 9.97e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 121 | 9.88e-01 | 7.90e-04 | 9.97e-01 |
| GOBP MOLTING CYCLE | 112 | 9.89e-01 | -7.77e-04 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION | 8 | 9.97e-01 | 7.75e-04 | 9.99e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 205 | 9.85e-01 | 7.71e-04 | 9.97e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 15 | 9.96e-01 | -7.69e-04 | 9.99e-01 |
| GOBP PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 5 | 9.98e-01 | -7.57e-04 | 9.99e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 42 | 9.93e-01 | -7.48e-04 | 9.98e-01 |
| GOBP G0 TO G1 TRANSITION | 36 | 9.94e-01 | 6.90e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 20 | 9.96e-01 | -6.84e-04 | 9.99e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 194 | 9.87e-01 | 6.70e-04 | 9.97e-01 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 9.98e-01 | 6.47e-04 | 9.99e-01 |
| GOBP SEPTUM PRIMUM DEVELOPMENT | 5 | 9.98e-01 | 6.47e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 209 | 9.87e-01 | -6.35e-04 | 9.97e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 38 | 9.95e-01 | 6.06e-04 | 9.98e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 18 | 9.97e-01 | -5.93e-04 | 9.99e-01 |
| GOMF DYNACTIN BINDING | 12 | 9.97e-01 | 5.70e-04 | 9.99e-01 |
| GOBP NK T CELL DIFFERENTIATION | 11 | 9.97e-01 | -5.68e-04 | 9.99e-01 |
| GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING | 10 | 9.98e-01 | 5.47e-04 | 9.99e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 20 | 9.97e-01 | -5.34e-04 | 9.99e-01 |
| GOBP RESPONSE TO CHEMOKINE | 93 | 9.93e-01 | 5.18e-04 | 9.98e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 163 | 9.91e-01 | -5.06e-04 | 9.98e-01 |
| GOBP STEROID METABOLIC PROCESS | 310 | 9.88e-01 | 4.99e-04 | 9.97e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 56 | 9.96e-01 | -4.08e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 7 | 9.99e-01 | 3.71e-04 | 9.99e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 73 | 9.96e-01 | 3.66e-04 | 9.99e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 115 | 9.95e-01 | -3.60e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 202 | 9.93e-01 | 3.52e-04 | 9.98e-01 |
| GOMF NUCLEASE ACTIVITY | 206 | 9.93e-01 | -3.51e-04 | 9.98e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 12 | 9.98e-01 | 3.27e-04 | 9.99e-01 |
| GOBP STARTLE RESPONSE | 26 | 9.98e-01 | 3.16e-04 | 9.99e-01 |
| GOCC SARCOLEMMA | 136 | 9.95e-01 | 3.14e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 228 | 9.95e-01 | -2.43e-04 | 9.98e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 36 | 9.98e-01 | 2.38e-04 | 9.99e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 39 | 9.98e-01 | -2.03e-04 | 9.99e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 100 | 9.97e-01 | 1.93e-04 | 9.99e-01 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 36 | 9.99e-01 | 1.62e-04 | 9.99e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 57 | 9.98e-01 | 1.53e-04 | 9.99e-01 |
| GOBP PEXOPHAGY | 6 | 1.00e+00 | 1.37e-04 | 1.00e+00 |
| GOBP TOLERANCE INDUCTION | 29 | 9.99e-01 | -8.97e-05 | 1.00e+00 |
| GOBP MITOCHONDRIAL FUSION | 32 | 1.00e+00 | 5.13e-05 | 1.00e+00 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 26 | 1.00e+00 | -4.56e-05 | 1.00e+00 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 19 | 1.00e+00 | -4.08e-05 | 1.00e+00 |
| GOMF RS DOMAIN BINDING | 5 | 1.00e+00 | 9.12e-06 | 1.00e+00 |
Detailed Gene set reports
GOBP_PROTECTION_FROM_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
| set | GOBP_PROTECTION_FROM_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY |
| setSize | 6 |
| pANOVA | 0.000204 |
| s.dist | -0.876 |
| p.adjustANOVA | 0.0229 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-A | -8036 |
| HLA-B | -7865 |
| SERPINB4 | -6649 |
| SERPINB9 | -6608 |
| HLA-E | -6342 |
| HLA-G | -5821 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HLA-A | -8036 |
| HLA-B | -7865 |
| SERPINB4 | -6649 |
| SERPINB9 | -6608 |
| HLA-E | -6342 |
| HLA-G | -5821 |
GOMF_FATTY_ACYL_COA_SYNTHASE_ACTIVITY
| set | GOMF_FATTY_ACYL_COA_SYNTHASE_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.000318 |
| s.dist | 0.849 |
| p.adjustANOVA | 0.0293 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ACSM2B | 13200 |
| ACSM6 | 13017 |
| ACSM5 | 12098 |
| ACSM1 | 11833 |
| ACSM4 | 11240 |
| ACSM3 | 10760 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ACSM2B | 13200 |
| ACSM6 | 13017 |
| ACSM5 | 12098 |
| ACSM1 | 11833 |
| ACSM4 | 11240 |
| ACSM3 | 10760 |
GOMF_IGE_BINDING
| set | GOMF_IGE_BINDING |
| setSize | 5 |
| pANOVA | 0.0011 |
| s.dist | 0.843 |
| p.adjustANOVA | 0.0638 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FCER2 | 13273 |
| MS4A2 | 12951 |
| FCER1G | 12702 |
| LGALS3 | 11561 |
| FCER1A | 9314 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FCER2 | 13273 |
| MS4A2 | 12951 |
| FCER1G | 12702 |
| LGALS3 | 11561 |
| FCER1A | 9314 |
GOMF_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY
| set | GOMF_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.000617 |
| s.dist | 0.807 |
| p.adjustANOVA | 0.0451 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FCGR3A | 13337 |
| FCER2 | 13273 |
| CD200R1 | 12938 |
| FCER1G | 12702 |
| FCER1A | 9314 |
| PIGR | 7850 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FCGR3A | 13337 |
| FCER2 | 13273 |
| CD200R1 | 12938 |
| FCER1G | 12702 |
| FCER1A | 9314 |
| PIGR | 7850 |
GOBP_POSITIVE_REGULATION_OF_PYROPTOSIS
| set | GOBP_POSITIVE_REGULATION_OF_PYROPTOSIS |
| setSize | 5 |
| pANOVA | 0.00178 |
| s.dist | -0.807 |
| p.adjustANOVA | 0.0837 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GBP5 | -7911 |
| GBP2 | -6528 |
| GBP3 | -6367 |
| GBP1 | -5377 |
| CASP3 | -4488 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GBP5 | -7911 |
| GBP2 | -6528 |
| GBP3 | -6367 |
| GBP1 | -5377 |
| CASP3 | -4488 |
GOBP_MEDIUM_CHAIN_FATTY_ACID_CATABOLIC_PROCESS
| set | GOBP_MEDIUM_CHAIN_FATTY_ACID_CATABOLIC_PROCESS |
| setSize | 5 |
| pANOVA | 0.00408 |
| s.dist | 0.742 |
| p.adjustANOVA | 0.135 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ABHD1 | 12408 |
| ABHD2 | 11806 |
| GLYATL2 | 11752 |
| ABHD3 | 11512 |
| ACADM | 6773 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ABHD1 | 12408 |
| ABHD2 | 11806 |
| GLYATL2 | 11752 |
| ABHD3 | 11512 |
| ACADM | 6773 |
GOBP_CYTOLYSIS_BY_HOST_OF_SYMBIONT_CELLS
| set | GOBP_CYTOLYSIS_BY_HOST_OF_SYMBIONT_CELLS |
| setSize | 6 |
| pANOVA | 0.00179 |
| s.dist | -0.736 |
| p.adjustANOVA | 0.0837 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CFHR2 | -8068 |
| HRG | -7604 |
| APOL1 | -7568 |
| CFHR5 | -7478 |
| F2 | -1795 |
| ROMO1 | 358 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CFHR2 | -8068 |
| HRG | -7604 |
| APOL1 | -7568 |
| CFHR5 | -7478 |
| F2 | -1795 |
| ROMO1 | 358 |
GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT
| set | GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT |
| setSize | 5 |
| pANOVA | 0.00481 |
| s.dist | 0.728 |
| p.adjustANOVA | 0.147 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HOXA5 | 13656 |
| AGR2 | 13327 |
| IL13 | 11791 |
| ADAMTSL2 | 9307 |
| SPDEF | 5426 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HOXA5 | 13656 |
| AGR2 | 13327 |
| IL13 | 11791 |
| ADAMTSL2 | 9307 |
| SPDEF | 5426 |
GOMF_MEDIUM_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY
| set | GOMF_MEDIUM_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY |
| setSize | 8 |
| pANOVA | 0.000479 |
| s.dist | 0.713 |
| p.adjustANOVA | 0.0389 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ACSM2B | 13200 |
| ACSM6 | 13017 |
| ACSM5 | 12098 |
| ACSM1 | 11833 |
| ACSM4 | 11240 |
| ACSM3 | 10760 |
| ACSF2 | 6960 |
| ACSL3 | 5168 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ACSM2B | 13200 |
| ACSM6 | 13017 |
| ACSM5 | 12098 |
| ACSM1 | 11833 |
| ACSM4 | 11240 |
| ACSM3 | 10760 |
| ACSF2 | 6960 |
| ACSL3 | 5168 |
GOBP_LOBAR_BRONCHUS_DEVELOPMENT
| set | GOBP_LOBAR_BRONCHUS_DEVELOPMENT |
| setSize | 6 |
| pANOVA | 0.00269 |
| s.dist | 0.707 |
| p.adjustANOVA | 0.106 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HOXA5 | 13656 |
| AGR2 | 13327 |
| IL13 | 11791 |
| WNT7B | 9346 |
| ADAMTSL2 | 9307 |
| SPDEF | 5426 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HOXA5 | 13656 |
| AGR2 | 13327 |
| IL13 | 11791 |
| WNT7B | 9346 |
| ADAMTSL2 | 9307 |
| SPDEF | 5426 |
GOCC_CLATHRIN_COMPLEX
| set | GOCC_CLATHRIN_COMPLEX |
| setSize | 6 |
| pANOVA | 0.00275 |
| s.dist | 0.706 |
| p.adjustANOVA | 0.107 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SCN10A | 12907 |
| CLTA | 11128 |
| CLTC | 10706 |
| SCLT1 | 9775 |
| BAIAP2L2 | 9458 |
| CLTCL1 | 8778 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SCN10A | 12907 |
| CLTA | 11128 |
| CLTC | 10706 |
| SCLT1 | 9775 |
| BAIAP2L2 | 9458 |
| CLTCL1 | 8778 |
GOBP_TRACHEA_CARTILAGE_DEVELOPMENT
| set | GOBP_TRACHEA_CARTILAGE_DEVELOPMENT |
| setSize | 7 |
| pANOVA | 0.00177 |
| s.dist | 0.682 |
| p.adjustANOVA | 0.0837 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HOXA5 | 13656 |
| RSPO2 | 11921 |
| RARA | 11372 |
| SOX9 | 11105 |
| WNT7B | 9346 |
| SRF | 8978 |
| RARG | 5007 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HOXA5 | 13656 |
| RSPO2 | 11921 |
| RARA | 11372 |
| SOX9 | 11105 |
| WNT7B | 9346 |
| SRF | 8978 |
| RARG | 5007 |
GOMF_ACETYLESTERASE_ACTIVITY
| set | GOMF_ACETYLESTERASE_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0089 |
| s.dist | 0.675 |
| p.adjustANOVA | 0.203 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ABHD1 | 12408 |
| ABHD2 | 11806 |
| CEL | 11784 |
| ABHD3 | 11512 |
| SIAE | 3117 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ABHD1 | 12408 |
| ABHD2 | 11806 |
| CEL | 11784 |
| ABHD3 | 11512 |
| SIAE | 3117 |
GOBP_SMOOTH_MUSCLE_ADAPTATION
| set | GOBP_SMOOTH_MUSCLE_ADAPTATION |
| setSize | 5 |
| pANOVA | 0.009 |
| s.dist | 0.674 |
| p.adjustANOVA | 0.205 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IL1B | 13114 |
| MIR17 | 11900 |
| NOS3 | 11697 |
| HMOX1 | 7319 |
| CYBA | 6541 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IL1B | 13114 |
| MIR17 | 11900 |
| NOS3 | 11697 |
| HMOX1 | 7319 |
| CYBA | 6541 |
GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING
| set | GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING |
| setSize | 5 |
| pANOVA | 0.0109 |
| s.dist | -0.658 |
| p.adjustANOVA | 0.226 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CXCL9 | -8055 |
| CXCL13 | -7258 |
| PF4 | -6646 |
| CXCL10 | -6031 |
| CXCL11 | 5513 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CXCL9 | -8055 |
| CXCL13 | -7258 |
| PF4 | -6646 |
| CXCL10 | -6031 |
| CXCL11 | 5513 |
GOBP_EXOCYST_LOCALIZATION
| set | GOBP_EXOCYST_LOCALIZATION |
| setSize | 5 |
| pANOVA | 0.0111 |
| s.dist | 0.655 |
| p.adjustANOVA | 0.227 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RALB | 12133 |
| EXOC3L4 | 12056 |
| EXOC3L1 | 12003 |
| TNFAIP2 | 10592 |
| EXOC3 | 2745 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RALB | 12133 |
| EXOC3L4 | 12056 |
| EXOC3L1 | 12003 |
| TNFAIP2 | 10592 |
| EXOC3 | 2745 |
GOBP_LEUKOTRIENE_CATABOLIC_PROCESS
| set | GOBP_LEUKOTRIENE_CATABOLIC_PROCESS |
| setSize | 6 |
| pANOVA | 0.00573 |
| s.dist | 0.651 |
| p.adjustANOVA | 0.164 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CYP4A11 | 13132 |
| DPEP2 | 11530 |
| CYP4F12 | 11125 |
| DPEP1 | 10262 |
| CYP4F3 | 9673 |
| CYP4F2 | 3432 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CYP4A11 | 13132 |
| DPEP2 | 11530 |
| CYP4F12 | 11125 |
| DPEP1 | 10262 |
| CYP4F3 | 9673 |
| CYP4F2 | 3432 |
GOMF_N_ACETYLLACTOSAMINE_SYNTHASE_ACTIVITY
| set | GOMF_N_ACETYLLACTOSAMINE_SYNTHASE_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0119 |
| s.dist | 0.649 |
| p.adjustANOVA | 0.236 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| B4GALT5 | 12588 |
| B4GALT1 | 12130 |
| B4GALT2 | 11287 |
| B4GALT3 | 9078 |
| B4GALT4 | 4101 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| B4GALT5 | 12588 |
| B4GALT1 | 12130 |
| B4GALT2 | 11287 |
| B4GALT3 | 9078 |
| B4GALT4 | 4101 |
GOBP_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT
| set | GOBP_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT |
| setSize | 7 |
| pANOVA | 0.003 |
| s.dist | 0.648 |
| p.adjustANOVA | 0.114 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TBX21 | 12847 |
| TNFSF18 | 12836 |
| IL12RB1 | 9522 |
| IL12B | 9447 |
| LOXL3 | 9075 |
| IL23R | 7809 |
| IL23A | 7206 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TBX21 | 12847 |
| TNFSF18 | 12836 |
| IL12RB1 | 9522 |
| IL12B | 9447 |
| LOXL3 | 9075 |
| IL23R | 7809 |
| IL23A | 7206 |
GOBP_POSITIVE_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION
| set | GOBP_POSITIVE_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION |
| setSize | 9 |
| pANOVA | 0.000862 |
| s.dist | 0.641 |
| p.adjustANOVA | 0.0566 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-DRB1 | 13677 |
| TNFSF4 | 12226 |
| PCK1 | 11354 |
| IL12RB1 | 9522 |
| IL12B | 9447 |
| HLA-DRA | 8756 |
| IL23R | 7809 |
| CD46 | 7750 |
| IL23A | 7206 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HLA-DRB1 | 13677 |
| TNFSF4 | 12226 |
| PCK1 | 11354 |
| IL12RB1 | 9522 |
| IL12B | 9447 |
| HLA-DRA | 8756 |
| IL23R | 7809 |
| CD46 | 7750 |
| IL23A | 7206 |
GOMF_DIACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY
| set | GOMF_DIACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0136 |
| s.dist | 0.637 |
| p.adjustANOVA | 0.252 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MOGAT3 | 11845 |
| MOGAT1 | 11065 |
| DGAT2 | 9028 |
| DGAT1 | 8764 |
| MOGAT2 | 7814 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MOGAT3 | 11845 |
| MOGAT1 | 11065 |
| DGAT2 | 9028 |
| DGAT1 | 8764 |
| MOGAT2 | 7814 |
GOBP_DISRUPTION_OF_PLASMA_MEMBRANE_INTEGRITY_IN_ANOTHER_ORGANISM
| set | GOBP_DISRUPTION_OF_PLASMA_MEMBRANE_INTEGRITY_IN_ANOTHER_ORGANISM |
| setSize | 6 |
| pANOVA | 0.0072 |
| s.dist | -0.633 |
| p.adjustANOVA | 0.182 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DEFA1 | -8237 |
| DEFA1B | -8237 |
| DEFA3 | -8237 |
| DEFA4 | -8127 |
| DEFA5 | -5006 |
| DEFA6 | 12455 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DEFA1 | -8237 |
| DEFA1B | -8237 |
| DEFA3 | -8237 |
| DEFA4 | -8127 |
| DEFA5 | -5006 |
| DEFA6 | 12455 |
GOCC_MUSCLE_MYOSIN_COMPLEX
| set | GOCC_MUSCLE_MYOSIN_COMPLEX |
| setSize | 15 |
| pANOVA | 5.13e-05 |
| s.dist | -0.604 |
| p.adjustANOVA | 0.00905 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MYL5 | -8153 |
| MYH2 | -7966 |
| MYL9 | -7902 |
| MYH8 | -7334 |
| MYL3 | -6904 |
| MYL6B | -6619 |
| MYH4 | -6518 |
| MYH13 | -5700 |
| MYH7 | -5269 |
| MYL11 | -3653 |
| MYH11 | -1333 |
| MYH6 | -98 |
| MYL1 | 836 |
| MYH1 | 1056 |
| MYH3 | 7007 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MYL5 | -8153 |
| MYH2 | -7966 |
| MYL9 | -7902 |
| MYH8 | -7334 |
| MYL3 | -6904 |
| MYL6B | -6619 |
| MYH4 | -6518 |
| MYH13 | -5700 |
| MYH7 | -5269 |
| MYL11 | -3653 |
| MYH11 | -1333 |
| MYH6 | -98 |
| MYL1 | 836 |
| MYH1 | 1056 |
| MYH3 | 7007 |
GOBP_MICROGLIAL_CELL_MEDIATED_CYTOTOXICITY
| set | GOBP_MICROGLIAL_CELL_MEDIATED_CYTOTOXICITY |
| setSize | 5 |
| pANOVA | 0.0196 |
| s.dist | 0.603 |
| p.adjustANOVA | 0.3 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| STAP1 | 13220 |
| TYROBP | 12065 |
| SPI1 | 11976 |
| ITGAM | 5981 |
| CX3CR1 | 3403 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| STAP1 | 13220 |
| TYROBP | 12065 |
| SPI1 | 11976 |
| ITGAM | 5981 |
| CX3CR1 | 3403 |
GOBP_DISRUPTION_OF_CELLULAR_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM
| set | GOBP_DISRUPTION_OF_CELLULAR_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM |
| setSize | 10 |
| pANOVA | 0.000964 |
| s.dist | -0.603 |
| p.adjustANOVA | 0.0599 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DEFA1 | -8237 |
| DEFA1B | -8237 |
| DEFA3 | -8237 |
| DEFA4 | -8127 |
| REG1A | -6734 |
| REG1B | -5664 |
| DEFA5 | -5006 |
| REG3G | -2231 |
| REG3A | 1089 |
| DEFA6 | 12455 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DEFA1 | -8237 |
| DEFA1B | -8237 |
| DEFA3 | -8237 |
| DEFA4 | -8127 |
| REG1A | -6734 |
| REG1B | -5664 |
| DEFA5 | -5006 |
| REG3G | -2231 |
| REG3A | 1089 |
| DEFA6 | 12455 |
GOBP_RESPONSE_TO_OZONE
| set | GOBP_RESPONSE_TO_OZONE |
| setSize | 5 |
| pANOVA | 0.021 |
| s.dist | 0.596 |
| p.adjustANOVA | 0.312 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IL1A | 13092 |
| SCGB1A1 | 12108 |
| EDN1 | 10014 |
| CAT | 9149 |
| TACR1 | 1914 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IL1A | 13092 |
| SCGB1A1 | 12108 |
| EDN1 | 10014 |
| CAT | 9149 |
| TACR1 | 1914 |
GOCC_NLRP3_INFLAMMASOME_COMPLEX
| set | GOCC_NLRP3_INFLAMMASOME_COMPLEX |
| setSize | 7 |
| pANOVA | 0.00672 |
| s.dist | 0.592 |
| p.adjustANOVA | 0.179 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NLRP3 | 12335 |
| CARD8 | 12037 |
| PYCARD | 11616 |
| GSDMD | 10370 |
| CASP1 | 9185 |
| CARD16 | 5025 |
| DHX33 | 3864 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NLRP3 | 12335 |
| CARD8 | 12037 |
| PYCARD | 11616 |
| GSDMD | 10370 |
| CASP1 | 9185 |
| CARD16 | 5025 |
| DHX33 | 3864 |
GOMF_TRAIL_BINDING
| set | GOMF_TRAIL_BINDING |
| setSize | 5 |
| pANOVA | 0.0229 |
| s.dist | 0.587 |
| p.adjustANOVA | 0.323 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TNFSF10 | 12834 |
| TNFRSF10C | 11497 |
| TNFRSF10D | 9460 |
| TNFRSF10B | 7369 |
| TNFRSF10A | 4640 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TNFSF10 | 12834 |
| TNFRSF10C | 11497 |
| TNFRSF10D | 9460 |
| TNFRSF10B | 7369 |
| TNFRSF10A | 4640 |
GOBP_INTERNEURON_MIGRATION_FROM_THE_SUBPALLIUM_TO_THE_CORTEX
| set | GOBP_INTERNEURON_MIGRATION_FROM_THE_SUBPALLIUM_TO_THE_CORTEX |
| setSize | 7 |
| pANOVA | 0.00711 |
| s.dist | -0.587 |
| p.adjustANOVA | 0.181 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LHX6 | -8158 |
| DRD1 | -6296 |
| ARL13B | -5451 |
| NRG3 | -3651 |
| CNTN2 | -2267 |
| DRD2 | -2035 |
| FEZF2 | 1775 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LHX6 | -8158 |
| DRD1 | -6296 |
| ARL13B | -5451 |
| NRG3 | -3651 |
| CNTN2 | -2267 |
| DRD2 | -2035 |
| FEZF2 | 1775 |
GOMF_PHOSPHOLIPASE_A2_INHIBITOR_ACTIVITY
| set | GOMF_PHOSPHOLIPASE_A2_INHIBITOR_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0131 |
| s.dist | 0.585 |
| p.adjustANOVA | 0.25 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ANXA9 | 12998 |
| SCGB1A1 | 12108 |
| ANXA2 | 10928 |
| ANXA2P2 | 9002 |
| ANXA1 | 7758 |
| ANXA3 | 1979 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ANXA9 | 12998 |
| SCGB1A1 | 12108 |
| ANXA2 | 10928 |
| ANXA2P2 | 9002 |
| ANXA1 | 7758 |
| ANXA3 | 1979 |
GOBP_MEDIUM_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS
| set | GOBP_MEDIUM_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS |
| setSize | 6 |
| pANOVA | 0.0132 |
| s.dist | 0.584 |
| p.adjustANOVA | 0.25 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ABHD1 | 12408 |
| ABHD2 | 11806 |
| ABHD3 | 11512 |
| ACOT7 | 11336 |
| OXSM | 9090 |
| OLAH | -1417 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ABHD1 | 12408 |
| ABHD2 | 11806 |
| ABHD3 | 11512 |
| ACOT7 | 11336 |
| OXSM | 9090 |
| OLAH | -1417 |
GOBP_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY
| set | GOBP_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0134 |
| s.dist | 0.583 |
| p.adjustANOVA | 0.251 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GUCA1B | 12479 |
| NOS3 | 11697 |
| NOS1 | 10265 |
| GUCA1A | 8561 |
| NOS2 | 7978 |
| RD3 | 3687 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GUCA1B | 12479 |
| NOS3 | 11697 |
| NOS1 | 10265 |
| GUCA1A | 8561 |
| NOS2 | 7978 |
| RD3 | 3687 |
GOBP_MONOACYLGLYCEROL_BIOSYNTHETIC_PROCESS
| set | GOBP_MONOACYLGLYCEROL_BIOSYNTHETIC_PROCESS |
| setSize | 5 |
| pANOVA | 0.0246 |
| s.dist | 0.58 |
| p.adjustANOVA | 0.333 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MOGAT3 | 11845 |
| DGAT2 | 9028 |
| DGAT1 | 8764 |
| PLA2G4A | 7962 |
| MOGAT2 | 7814 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MOGAT3 | 11845 |
| DGAT2 | 9028 |
| DGAT1 | 8764 |
| PLA2G4A | 7962 |
| MOGAT2 | 7814 |
GOBP_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS
| set | GOBP_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS |
| setSize | 8 |
| pANOVA | 0.00466 |
| s.dist | 0.578 |
| p.adjustANOVA | 0.145 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CYP4A11 | 13132 |
| GLYATL2 | 11752 |
| ADTRP | 11301 |
| CYP4F12 | 11125 |
| ACADL | 10604 |
| CYP4F3 | 9673 |
| CYP4F2 | 3432 |
| AIG1 | 1396 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CYP4A11 | 13132 |
| GLYATL2 | 11752 |
| ADTRP | 11301 |
| CYP4F12 | 11125 |
| ACADL | 10604 |
| CYP4F3 | 9673 |
| CYP4F2 | 3432 |
| AIG1 | 1396 |
GOMF_BUTYRATE_COA_LIGASE_ACTIVITY
| set | GOMF_BUTYRATE_COA_LIGASE_ACTIVITY |
| setSize | 8 |
| pANOVA | 0.00478 |
| s.dist | 0.576 |
| p.adjustANOVA | 0.146 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ACSM2B | 13200 |
| ACSM6 | 13017 |
| ACSM5 | 12098 |
| ACSM1 | 11833 |
| ACSM4 | 11240 |
| ACSM3 | 10760 |
| ACSF2 | 6960 |
| ACSS3 | -6843 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ACSM2B | 13200 |
| ACSM6 | 13017 |
| ACSM5 | 12098 |
| ACSM1 | 11833 |
| ACSM4 | 11240 |
| ACSM3 | 10760 |
| ACSF2 | 6960 |
| ACSS3 | -6843 |
GOBP_IMMUNOLOGICAL_MEMORY_FORMATION_PROCESS
| set | GOBP_IMMUNOLOGICAL_MEMORY_FORMATION_PROCESS |
| setSize | 14 |
| pANOVA | 0.000195 |
| s.dist | 0.575 |
| p.adjustANOVA | 0.0222 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-DRB1 | 13677 |
| FGL2 | 13243 |
| TNFSF4 | 12226 |
| PCK1 | 11354 |
| ST3GAL1 | 10463 |
| IL12RB1 | 9522 |
| IL12B | 9447 |
| HLA-DRA | 8756 |
| IL23R | 7809 |
| CD46 | 7750 |
| IL23A | 7206 |
| BCL6 | 6508 |
| IFNL1 | 4388 |
| TSC1 | 3925 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HLA-DRB1 | 13677 |
| FGL2 | 13243 |
| TNFSF4 | 12226 |
| PCK1 | 11354 |
| ST3GAL1 | 10463 |
| IL12RB1 | 9522 |
| IL12B | 9447 |
| HLA-DRA | 8756 |
| IL23R | 7809 |
| CD46 | 7750 |
| IL23A | 7206 |
| BCL6 | 6508 |
| IFNL1 | 4388 |
| TSC1 | 3925 |
GOMF_SERINE_TYPE_CARBOXYPEPTIDASE_ACTIVITY
| set | GOMF_SERINE_TYPE_CARBOXYPEPTIDASE_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0286 |
| s.dist | 0.565 |
| p.adjustANOVA | 0.359 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SCPEP1 | 11953 |
| CPVL | 10221 |
| CTSA | 10070 |
| CPD | 7137 |
| PRCP | 5205 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SCPEP1 | 11953 |
| CPVL | 10221 |
| CTSA | 10070 |
| CPD | 7137 |
| PRCP | 5205 |
GOBP_INTERLEUKIN_3_MEDIATED_SIGNALING_PATHWAY
| set | GOBP_INTERLEUKIN_3_MEDIATED_SIGNALING_PATHWAY |
| setSize | 6 |
| pANOVA | 0.0167 |
| s.dist | 0.564 |
| p.adjustANOVA | 0.275 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FCER1G | 12702 |
| IL3 | 11420 |
| CSF2RB | 10837 |
| STAT5A | 9494 |
| SYK | 8613 |
| JAK2 | 372 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FCER1G | 12702 |
| IL3 | 11420 |
| CSF2RB | 10837 |
| STAT5A | 9494 |
| SYK | 8613 |
| JAK2 | 372 |
GOMF_2_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY
| set | GOMF_2_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0169 |
| s.dist | 0.563 |
| p.adjustANOVA | 0.277 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MOGAT3 | 11845 |
| MOGAT1 | 11065 |
| DGAT2 | 9028 |
| DGAT1 | 8764 |
| MOGAT2 | 7814 |
| LPGAT1 | 4835 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MOGAT3 | 11845 |
| MOGAT1 | 11065 |
| DGAT2 | 9028 |
| DGAT1 | 8764 |
| MOGAT2 | 7814 |
| LPGAT1 | 4835 |
GOCC_CORTICAL_ENDOPLASMIC_RETICULUM
| set | GOCC_CORTICAL_ENDOPLASMIC_RETICULUM |
| setSize | 5 |
| pANOVA | 0.0294 |
| s.dist | 0.562 |
| p.adjustANOVA | 0.365 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARV1 | 11499 |
| STIM1 | 9207 |
| STIMATE | 8860 |
| ASPH | 7550 |
| C2CD2L | 7311 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ARV1 | 11499 |
| STIM1 | 9207 |
| STIMATE | 8860 |
| ASPH | 7550 |
| C2CD2L | 7311 |
GOBP_REGULATION_OF_MUCUS_SECRETION
| set | GOBP_REGULATION_OF_MUCUS_SECRETION |
| setSize | 8 |
| pANOVA | 0.00589 |
| s.dist | 0.562 |
| p.adjustANOVA | 0.167 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| P2RY2 | 13172 |
| NLRP6 | 12579 |
| ADORA1 | 9781 |
| PRKCE | 9616 |
| ATG5 | 9459 |
| ADA | 7138 |
| CYBA | 6541 |
| ALOX12B | 2773 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| P2RY2 | 13172 |
| NLRP6 | 12579 |
| ADORA1 | 9781 |
| PRKCE | 9616 |
| ATG5 | 9459 |
| ADA | 7138 |
| CYBA | 6541 |
| ALOX12B | 2773 |
GOBP_COMPARTMENT_PATTERN_SPECIFICATION
| set | GOBP_COMPARTMENT_PATTERN_SPECIFICATION |
| setSize | 5 |
| pANOVA | 0.0298 |
| s.dist | 0.561 |
| p.adjustANOVA | 0.368 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PBX3 | 13030 |
| LFNG | 11509 |
| DLL1 | 10314 |
| DLL3 | 7929 |
| NOTCH1 | 1569 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PBX3 | 13030 |
| LFNG | 11509 |
| DLL1 | 10314 |
| DLL3 | 7929 |
| NOTCH1 | 1569 |
GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION
| set | GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION |
| setSize | 11 |
| pANOVA | 0.00129 |
| s.dist | 0.56 |
| p.adjustANOVA | 0.0702 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| KCNE2 | 13171 |
| KCNE4 | 12952 |
| KCNH2 | 12854 |
| KCNE3 | 12330 |
| KCNE1 | 11051 |
| KCNJ5 | 10597 |
| KCNJ8 | 8805 |
| SCN2B | 5038 |
| KCNQ1 | 4253 |
| KCNJ3 | 3752 |
| KCND3 | 2669 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| KCNE2 | 13171 |
| KCNE4 | 12952 |
| KCNH2 | 12854 |
| KCNE3 | 12330 |
| KCNE1 | 11051 |
| KCNJ5 | 10597 |
| KCNJ8 | 8805 |
| SCN2B | 5038 |
| KCNQ1 | 4253 |
| KCNJ3 | 3752 |
| KCND3 | 2669 |
GOBP_REGULATION_OF_HISTAMINE_SECRETION_BY_MAST_CELL
| set | GOBP_REGULATION_OF_HISTAMINE_SECRETION_BY_MAST_CELL |
| setSize | 6 |
| pANOVA | 0.0188 |
| s.dist | -0.554 |
| p.adjustANOVA | 0.295 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| VAMP2 | -7340 |
| SNX6 | -5958 |
| VAMP8 | -4163 |
| SNX4 | -3809 |
| PLA2G3 | -253 |
| VAMP3 | 1363 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| VAMP2 | -7340 |
| SNX6 | -5958 |
| VAMP8 | -4163 |
| SNX4 | -3809 |
| PLA2G3 | -253 |
| VAMP3 | 1363 |
GOBP_L_PHENYLALANINE_METABOLIC_PROCESS
| set | GOBP_L_PHENYLALANINE_METABOLIC_PROCESS |
| setSize | 8 |
| pANOVA | 0.00672 |
| s.dist | 0.553 |
| p.adjustANOVA | 0.179 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HGD | 12773 |
| HPD | 12621 |
| PAH | 12029 |
| TAT | 11049 |
| FAH | 9855 |
| QDPR | 8985 |
| GSTZ1 | 1939 |
| IL4I1 | 1029 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HGD | 12773 |
| HPD | 12621 |
| PAH | 12029 |
| TAT | 11049 |
| FAH | 9855 |
| QDPR | 8985 |
| GSTZ1 | 1939 |
| IL4I1 | 1029 |
GOMF_COPPER_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY
| set | GOMF_COPPER_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0194 |
| s.dist | 0.551 |
| p.adjustANOVA | 0.299 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC31A1 | 11888 |
| ATP7B | 11296 |
| SLC31A2 | 8875 |
| SLC46A3 | 8738 |
| SLC39A11 | 8250 |
| SLC11A2 | 3505 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SLC31A1 | 11888 |
| ATP7B | 11296 |
| SLC31A2 | 8875 |
| SLC46A3 | 8738 |
| SLC39A11 | 8250 |
| SLC11A2 | 3505 |
GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS
| set | GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS |
| setSize | 12 |
| pANOVA | 0.00096 |
| s.dist | 0.55 |
| p.adjustANOVA | 0.0599 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOC2 | 13601 |
| HTR2B | 12953 |
| CHP1 | 12542 |
| RAB38 | 12523 |
| ENPP7 | 12376 |
| FABP3 | 10409 |
| PRKCD | 10340 |
| HTR2A | 7749 |
| CAPN2 | 7416 |
| ADGRF5 | 5301 |
| ACSL3 | 5168 |
| NR1H4 | -5352 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| APOC2 | 13601 |
| HTR2B | 12953 |
| CHP1 | 12542 |
| RAB38 | 12523 |
| ENPP7 | 12376 |
| FABP3 | 10409 |
| PRKCD | 10340 |
| HTR2A | 7749 |
| CAPN2 | 7416 |
| ADGRF5 | 5301 |
| ACSL3 | 5168 |
| NR1H4 | -5352 |
GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DEVELOPMENT
| set | GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DEVELOPMENT |
| setSize | 6 |
| pANOVA | 0.0198 |
| s.dist | -0.549 |
| p.adjustANOVA | 0.301 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LHX6 | -8158 |
| DRD1 | -6296 |
| RAC3 | -2878 |
| CNTN2 | -2267 |
| DRD2 | -2035 |
| FEZF2 | 1775 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LHX6 | -8158 |
| DRD1 | -6296 |
| RAC3 | -2878 |
| CNTN2 | -2267 |
| DRD2 | -2035 |
| FEZF2 | 1775 |
GOBP_SATELLITE_CELL_ACTIVATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION
| set | GOBP_SATELLITE_CELL_ACTIVATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION |
| setSize | 5 |
| pANOVA | 0.0334 |
| s.dist | 0.549 |
| p.adjustANOVA | 0.388 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GJD4 | 12565 |
| KPNA1 | 10747 |
| SOX15 | 10297 |
| CAPN3 | 5370 |
| KLF5 | 4725 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GJD4 | 12565 |
| KPNA1 | 10747 |
| SOX15 | 10297 |
| CAPN3 | 5370 |
| KLF5 | 4725 |
GOCC_OTHER_ORGANISM_PART
| set | GOCC_OTHER_ORGANISM_PART |
| setSize | 5 |
| pANOVA | 0.0343 |
| s.dist | -0.547 |
| p.adjustANOVA | 0.392 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GBP5 | -7911.0 |
| C9 | -6262.0 |
| GBP1 | -5377.0 |
| CFH | -5216.0 |
| C4B | 8372.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GBP5 | -7911.0 |
| C9 | -6262.0 |
| GBP1 | -5377.0 |
| CFH | -5216.0 |
| C4B | 8372.5 |
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.4.0 (2024-04-24)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.3.4
## [2] GGally_2.2.1
## [3] ggplot2_3.5.1
## [4] reshape2_1.4.4
## [5] gplots_3.1.3.1
## [6] gtools_3.9.5
## [7] tibble_3.2.1
## [8] dplyr_1.1.4
## [9] echarts4r_0.4.5
## [10] plyr_1.8.9
## [11] png_0.1-8
## [12] gridExtra_2.3
## [13] missMethyl_1.36.0
## [14] beeswarm_0.4.0
## [15] kableExtra_1.4.0
## [16] mitch_1.15.6
## [17] tictoc_1.2.1
## [18] HGNChelper_0.8.1
## [19] IlluminaHumanMethylationEPICanno.ilm10b4.hg19_0.6.0
## [20] IlluminaHumanMethylation450kanno.ilmn12.hg19_0.6.1
## [21] minfi_1.48.0
## [22] bumphunter_1.44.0
## [23] locfit_1.5-9.9
## [24] iterators_1.0.14
## [25] foreach_1.5.2
## [26] Biostrings_2.70.2
## [27] XVector_0.42.0
## [28] SummarizedExperiment_1.32.0
## [29] Biobase_2.62.0
## [30] MatrixGenerics_1.14.0
## [31] matrixStats_1.3.0
## [32] GenomicRanges_1.54.1
## [33] GenomeInfoDb_1.38.6
## [34] IRanges_2.36.0
## [35] S4Vectors_0.40.2
## [36] BiocGenerics_0.48.1
## [37] eulerr_7.0.2
## [38] limma_3.58.1
##
## loaded via a namespace (and not attached):
## [1] splines_4.4.0 later_1.3.2
## [3] BiocIO_1.12.0 bitops_1.0-7
## [5] filelock_1.0.3 preprocessCore_1.64.0
## [7] XML_3.99-0.16.1 lifecycle_1.0.4
## [9] lattice_0.22-6 MASS_7.3-60.2
## [11] base64_2.0.1 scrime_1.3.5
## [13] magrittr_2.0.3 sass_0.4.9
## [15] rmarkdown_2.26 jquerylib_0.1.4
## [17] yaml_2.3.8 httpuv_1.6.15
## [19] doRNG_1.8.6 askpass_1.2.0
## [21] DBI_1.2.2 RColorBrewer_1.1-3
## [23] abind_1.4-5 zlibbioc_1.48.0
## [25] quadprog_1.5-8 purrr_1.0.2
## [27] RCurl_1.98-1.14 rappdirs_0.3.3
## [29] GenomeInfoDbData_1.2.11 genefilter_1.84.0
## [31] annotate_1.80.0 svglite_2.1.3
## [33] DelayedMatrixStats_1.24.0 codetools_0.2-20
## [35] DelayedArray_0.28.0 xml2_1.3.6
## [37] tidyselect_1.2.1 farver_2.1.1
## [39] beanplot_1.3.1 BiocFileCache_2.10.1
## [41] illuminaio_0.44.0 GenomicAlignments_1.38.2
## [43] jsonlite_1.8.8 multtest_2.58.0
## [45] survival_3.6-4 systemfonts_1.0.6
## [47] tools_4.4.0 progress_1.2.3
## [49] Rcpp_1.0.12 glue_1.7.0
## [51] SparseArray_1.2.4 xfun_0.43
## [53] HDF5Array_1.30.1 withr_3.0.0
## [55] fastmap_1.1.1 rhdf5filters_1.14.1
## [57] fansi_1.0.6 openssl_2.1.2
## [59] caTools_1.18.2 digest_0.6.35
## [61] R6_2.5.1 mime_0.12
## [63] colorspace_2.1-0 biomaRt_2.58.2
## [65] RSQLite_2.3.6 utf8_1.2.4
## [67] tidyr_1.3.1 generics_0.1.3
## [69] data.table_1.15.4 rtracklayer_1.62.0
## [71] prettyunits_1.2.0 httr_1.4.7
## [73] htmlwidgets_1.6.4 S4Arrays_1.2.0
## [75] ggstats_0.6.0 pkgconfig_2.0.3
## [77] gtable_0.3.5 blob_1.2.4
## [79] siggenes_1.76.0 htmltools_0.5.8.1
## [81] scales_1.3.0 knitr_1.46
## [83] rstudioapi_0.16.0 tzdb_0.4.0
## [85] rjson_0.2.21 nlme_3.1-164
## [87] curl_5.2.1 org.Hs.eg.db_3.18.0
## [89] cachem_1.0.8 rhdf5_2.46.1
## [91] stringr_1.5.1 KernSmooth_2.23-22
## [93] AnnotationDbi_1.64.1 restfulr_0.0.15
## [95] GEOquery_2.70.0 pillar_1.9.0
## [97] grid_4.4.0 reshape_0.8.9
## [99] vctrs_0.6.5 promises_1.3.0
## [101] dbplyr_2.5.0 xtable_1.8-4
## [103] evaluate_0.23 readr_2.1.5
## [105] GenomicFeatures_1.54.3 cli_3.6.2
## [107] compiler_4.4.0 Rsamtools_2.18.0
## [109] rlang_1.1.3 crayon_1.5.2
## [111] rngtools_1.5.2 labeling_0.4.3
## [113] nor1mix_1.3-3 mclust_6.1.1
## [115] stringi_1.8.3 viridisLite_0.4.2
## [117] BiocParallel_1.36.0 munsell_0.5.1
## [119] Matrix_1.7-0 hms_1.1.3
## [121] sparseMatrixStats_1.14.0 bit64_4.0.5
## [123] Rhdf5lib_1.24.2 KEGGREST_1.42.0
## [125] statmod_1.5.0 shiny_1.8.1.1
## [127] highr_0.10 memoise_2.0.1.9000
## [129] bslib_0.7.0 bit_4.0.5END of report